ID   UBL4A_HUMAN             Reviewed;         157 AA.
AC   P11441; Q5HY80;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   23-MAY-2018, entry version 169.
DE   RecName: Full=Ubiquitin-like protein 4A;
DE   AltName: Full=Ubiquitin-like protein GDX;
GN   Name=UBL4A; Synonyms=DXS254E, GDX, UBL4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2829204; DOI=10.1073/pnas.85.3.851;
RA   Toniolo D., Persico M., Alcalay M.;
RT   "A 'housekeeping' gene on the X chromosome encodes a protein similar
RT   to ubiquitin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:851-855(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8733135; DOI=10.1093/hmg/5.5.659;
RA   Chen E.Y., Zollo M., Mazzarella R.A., Ciccodicola A., Chen C.-N.,
RA   Zuo L., Heiner C., Burough F.W., Ripetto M., Schlessinger D.,
RA   D'Urso M.;
RT   "Long-range sequence analysis in Xq28: thirteen known and six
RT   candidate genes in 219.4 kb of high GC DNA between the RCP/GCP and
RT   G6PD loci.";
RL   Hum. Mol. Genet. 5:659-668(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND IDENTIFICATION IN THE BAG6/BAT3 COMPLEX.
RX   PubMed=20676083; DOI=10.1038/nature09296;
RA   Mariappan M., Li X., Stefanovic S., Sharma A., Mateja A., Keenan R.J.,
RA   Hegde R.S.;
RT   "A ribosome-associating factor chaperones tail-anchored membrane
RT   proteins.";
RL   Nature 466:1120-1124(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21636303; DOI=10.1016/j.molcel.2011.05.010;
RA   Wang Q., Liu Y., Soetandyo N., Baek K., Hegde R., Ye Y.;
RT   "A ubiquitin ligase-associated chaperone holdase maintains
RT   polypeptides in soluble states for proteasome degradation.";
RL   Mol. Cell 42:758-770(2011).
RN   [12]
RP   FUNCTION.
RX   PubMed=21743475; DOI=10.1038/nature10181;
RA   Hessa T., Sharma A., Mariappan M., Eshleman H.D., Gutierrez E.,
RA   Hegde R.S.;
RT   "Protein targeting and degradation are coupled for elimination of
RT   mislocalized proteins.";
RL   Nature 475:394-397(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   INTERACTION WITH USP13, UBIQUITINATION AT LYS-48 BY AMFR,
RP   DEUBIQUITINATION BY USP13, AND MUTAGENESIS OF LYS-48.
RX   PubMed=24424410; DOI=10.7554/eLife.01369;
RA   Liu Y., Soetandyo N., Lee J.G., Liu L., Xu Y., Clemons W.M. Jr.,
RA   Ye Y.;
RT   "USP13 antagonizes gp78 to maintain functionality of a chaperone in
RT   ER-associated degradation.";
RL   Elife 3:E01369-E01369(2014).
RN   [16]
RP   FUNCTION.
RX   PubMed=28104892; DOI=10.1126/science.aah6130;
RA   Shao S., Rodrigo-Brenni M.C., Kivlen M.H., Hegde R.S.;
RT   "Mechanistic basis for a molecular triage reaction.";
RL   Science 355:298-302(2017).
RN   [17]
RP   STRUCTURE BY NMR OF 1-74.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminal ubiquitin-like domain in human
RT   ubiquitin-like protein 4A (GDX).";
RL   Submitted (MAR-2007) to the PDB data bank.
CC   -!- FUNCTION: As part of a cytosolic protein quality control complex,
CC       the BAG6/BAT3 complex, maintains misfolded and hydrophobic
CC       patches-containing proteins in a soluble state and participates to
CC       their proper delivery to the endoplasmic reticulum or
CC       alternatively can promote their sorting to the proteasome where
CC       they undergo degradation (PubMed:20676083, PubMed:21636303,
CC       PubMed:21743475, PubMed:28104892). The BAG6/BAT3 complex is
CC       involved in the post-translational delivery of tail-anchored/type
CC       II transmembrane proteins to the endoplasmic reticulum membrane.
CC       Recruited to ribosomes, it interacts with the transmembrane region
CC       of newly synthesized tail-anchored proteins and together with SGTA
CC       and ASNA1 mediates their delivery to the endoplasmic reticulum
CC       (PubMed:20676083, PubMed:28104892). Client proteins that cannot be
CC       properly delivered to the endoplasmic reticulum are ubiquitinated
CC       and sorted to the proteasome (PubMed:28104892). Similarly, the
CC       BAG6/BAT3 complex also functions as a sorting platform for
CC       proteins of the secretory pathway that are mislocalized to the
CC       cytosol either delivering them to the proteasome for degradation
CC       or to the endoplasmic reticulum (PubMed:21743475). The BAG6/BAT3
CC       complex also plays a role in the endoplasmic reticulum-associated
CC       degradation (ERAD), a quality control mechanism that eliminates
CC       unwanted proteins of the endoplasmic reticulum through their
CC       retrotranslocation to the cytosol and their targeting to the
CC       proteasome. It maintains these retrotranslocated proteins in an
CC       unfolded yet soluble state condition in the cytosol to ensure
CC       their proper delivery to the proteasome (PubMed:21636303).
CC       {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303,
CC       ECO:0000269|PubMed:21743475, ECO:0000269|PubMed:28104892}.
CC   -!- SUBUNIT: Component of the BAG6/BAT3 complex, at least composed of
CC       BAG6, UBL4A and GET4/TRC35 (PubMed:20676083). Interacts with
CC       USP13; may be indirect via BAG6 (PubMed:24424410).
CC       {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:24424410}.
CC   -!- INTERACTION:
CC       Q96GN5:CDCA7L; NbExp=3; IntAct=EBI-356983, EBI-5278764;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-356983, EBI-748397;
CC       O43765:SGTA; NbExp=4; IntAct=EBI-356983, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=5; IntAct=EBI-356983, EBI-744081;
CC       Q9BUZ4:TRAF4; NbExp=7; IntAct=EBI-356983, EBI-3650647;
CC       P12504:vif (xeno); NbExp=2; IntAct=EBI-356983, EBI-779991;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303}.
CC       Nucleus {ECO:0000269|PubMed:21636303}.
CC   -!- PTM: Polyubiquitinated. Ubiquitination by AMFR and
CC       deubiquitination by USP13 may regulate the interaction between the
CC       BAG6/BAT3 complex and SGTA and therefore may regulate client
CC       proteins fate. {ECO:0000269|PubMed:24424410}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03589; AAA36790.1; -; Genomic_DNA.
DR   EMBL; L44140; AAA92650.1; -; Genomic_DNA.
DR   EMBL; BX664739; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471172; EAW72700.1; -; Genomic_DNA.
DR   EMBL; BC043346; AAH43346.1; -; mRNA.
DR   EMBL; BC053589; AAH53589.1; -; mRNA.
DR   CCDS; CCDS14754.1; -.
DR   PIR; A31084; A31084.
DR   RefSeq; NP_055050.1; NM_014235.4.
DR   UniGene; Hs.76480; -.
DR   PDB; 2DZI; NMR; -; A=1-74.
DR   PDB; 4WWR; X-ray; 2.00 A; B/D/F/H=93-139.
DR   PDB; 4X86; X-ray; 1.85 A; A=95-147.
DR   PDBsum; 2DZI; -.
DR   PDBsum; 4WWR; -.
DR   PDBsum; 4X86; -.
DR   ProteinModelPortal; P11441; -.
DR   SMR; P11441; -.
DR   BioGrid; 113885; 308.
DR   IntAct; P11441; 50.
DR   MINT; P11441; -.
DR   STRING; 9606.ENSP00000358674; -.
DR   iPTMnet; P11441; -.
DR   PhosphoSitePlus; P11441; -.
DR   DMDM; 136662; -.
DR   EPD; P11441; -.
DR   MaxQB; P11441; -.
DR   PaxDb; P11441; -.
DR   PeptideAtlas; P11441; -.
DR   PRIDE; P11441; -.
DR   DNASU; 8266; -.
DR   Ensembl; ENST00000369660; ENSP00000358674; ENSG00000102178.
DR   GeneID; 8266; -.
DR   KEGG; hsa:8266; -.
DR   UCSC; uc004flo.4; human.
DR   CTD; 8266; -.
DR   DisGeNET; 8266; -.
DR   EuPathDB; HostDB:ENSG00000102178.12; -.
DR   GeneCards; UBL4A; -.
DR   HGNC; HGNC:12505; UBL4A.
DR   HPA; HPA003617; -.
DR   MIM; 312070; gene.
DR   neXtProt; NX_P11441; -.
DR   OpenTargets; ENSG00000102178; -.
DR   PharmGKB; PA37152; -.
DR   eggNOG; KOG0001; Eukaryota.
DR   eggNOG; COG5272; LUCA.
DR   GeneTree; ENSGT00730000111022; -.
DR   HOGENOM; HOG000006827; -.
DR   HOVERGEN; HBG072205; -.
DR   InParanoid; P11441; -.
DR   OMA; YPGIKDG; -.
DR   PhylomeDB; P11441; -.
DR   TreeFam; TF354228; -.
DR   EvolutionaryTrace; P11441; -.
DR   GeneWiki; UBL4A; -.
DR   GenomeRNAi; 8266; -.
DR   PRO; PR:P11441; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102178; -.
DR   CleanEx; HS_UBL4A; -.
DR   ExpressionAtlas; P11441; baseline and differential.
DR   Genevisible; P11441; HS.
DR   GO; GO:0071818; C:BAT3 complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:BHF-UCL.
DR   GO; GO:0019787; F:ubiquitin-like protein transferase activity; TAS:ProtInc.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; IMP:UniProtKB.
DR   InterPro; IPR019956; Ubiquitin.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF00240; ubiquitin; 1.
DR   PRINTS; PR00348; UBIQUITIN.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00299; UBIQUITIN_1; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Transport; Ubl conjugation.
FT   CHAIN         1    157       Ubiquitin-like protein 4A.
FT                                /FTId=PRO_0000114864.
FT   DOMAIN        1     76       Ubiquitin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   MOD_RES      90     90       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK     48     48       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:24424410}.
FT   MUTAGEN      48     48       K->R: Loss of polyubiquitination by AMFR.
FT                                {ECO:0000269|PubMed:24424410}.
FT   STRAND        1      7       {ECO:0000244|PDB:2DZI}.
FT   STRAND       12     17       {ECO:0000244|PDB:2DZI}.
FT   HELIX        23     33       {ECO:0000244|PDB:2DZI}.
FT   TURN         38     40       {ECO:0000244|PDB:2DZI}.
FT   STRAND       42     45       {ECO:0000244|PDB:2DZI}.
FT   HELIX        56     59       {ECO:0000244|PDB:2DZI}.
FT   STRAND       63     65       {ECO:0000244|PDB:2DZI}.
FT   STRAND       68     70       {ECO:0000244|PDB:2DZI}.
FT   HELIX        95    106       {ECO:0000244|PDB:4X86}.
FT   HELIX       109    129       {ECO:0000244|PDB:4X86}.
FT   HELIX       132    142       {ECO:0000244|PDB:4X86}.
SQ   SEQUENCE   157 AA;  17777 MW;  9D6EE2D20D2C4C60 CRC64;
     MQLTVKALQG RECSLQVPED ELVSTLKQLV SEKLNVPVRQ QRLLFKGKAL ADGKRLSDYS
     IGPNSKLNLV VKPLEKVLLE EGEAQRLADS PPPQVWQLIS KVLARHFSAA DASRVLEQLQ
     RDYERSLSRL TLDDIERLAS RFLHPEVTET MEKGFSK
//
ID   ASNA_HUMAN              Reviewed;         348 AA.
AC   O43681; A6NHP8; A8K740; Q53FC6; Q92849;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   23-MAY-2018, entry version 169.
DE   RecName: Full=ATPase ASNA1 {ECO:0000255|HAMAP-Rule:MF_03112};
DE            EC=3.6.-.- {ECO:0000255|HAMAP-Rule:MF_03112};
DE   AltName: Full=Arsenical pump-driving ATPase {ECO:0000255|HAMAP-Rule:MF_03112};
DE   AltName: Full=Arsenite-stimulated ATPase {ECO:0000255|HAMAP-Rule:MF_03112};
DE   AltName: Full=Transmembrane domain recognition complex 40 kDa ATPase subunit;
DE   AltName: Full=hARSA-I;
DE   AltName: Full=hASNA-I;
GN   Name=ASNA1 {ECO:0000255|HAMAP-Rule:MF_03112}; Synonyms=ARSA, TRC40;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Hu G.;
RT   "Human homolog of bacterial and mouse arsenite translocating ATPase
RT   gene, ArsA.";
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Salivary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-332.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 18-348.
RX   PubMed=8884272; DOI=10.1006/geno.1996.0494;
RA   Kurdi-Haidar B., Aebi S., Heath D., Enns R.E., Naredi P., Hom D.K.,
RA   Howell S.B.;
RT   "Isolation of the ATP-binding human homolog of the arsA component of
RT   the bacterial arsenite transporter.";
RL   Genomics 36:486-491(1996).
RN   [9]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9712828; DOI=10.1074/jbc.273.35.22173;
RA   Kurdi-Haidar B., Heath D., Aebi S., Howell S.B.;
RT   "Biochemical characterization of the human arsenite-stimulated ATPase
RT   (hASNA-I).";
RL   J. Biol. Chem. 273:22173-22176(1998).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9736449;
RX   DOI=10.1002/(SICI)1097-4644(19981001)71:1<1::AID-JCB1>3.3.CO;2-R;
RA   Kurdi-Haidar B., Hom D.K., Flittner D.E., Heath D., Fink L.,
RA   Naredi P., Howell S.B.;
RT   "Dual cytoplasmic and nuclear distribution of the novel arsenite-
RT   stimulated human ATPase (hASNA-I).";
RL   J. Cell. Biochem. 71:1-10(1998).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=9774623; DOI=10.1177/002215549804601104;
RA   Kurdi-Haidar B., Heath D., Naredi P., Varki N., Howell S.B.;
RT   "Immunohistochemical analysis of the distribution of the human ATPase
RT   (hASNA-I) in normal tissues and its overexpression in breast adenomas
RT   and carcinomas.";
RL   J. Histochem. Cytochem. 46:1243-1248(1998).
RN   [12]
RP   FUNCTION, IDENTIFICATION IN THE TRC COMPLEX, MUTAGENESIS OF GLY-46,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SEC61B.
RX   PubMed=17382883; DOI=10.1016/j.cell.2007.01.036;
RA   Stefanovic S., Hegde R.S.;
RT   "Identification of a targeting factor for posttranslational membrane
RT   protein insertion into the ER.";
RL   Cell 128:1147-1159(2007).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH SERP1 AND SEC61B.
RX   PubMed=18477612; DOI=10.1242/jcs.020321;
RA   Favaloro V., Spasic M., Schwappach B., Dobberstein B.;
RT   "Distinct targeting pathways for the membrane insertion of tail-
RT   anchored (TA) proteins.";
RL   J. Cell Sci. 121:1832-1840(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   INTERACTION WITH WRB, AND SUBCELLULAR LOCATION.
RX   PubMed=21444755; DOI=10.1242/jcs.084277;
RA   Vilardi F., Lorenz H., Dobberstein B.;
RT   "WRB is the receptor for TRC40/Asna1-mediated insertion of tail-
RT   anchored proteins into the ER membrane.";
RL   J. Cell Sci. 124:1301-1307(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: ATPase required for the post-translational delivery of
CC       tail-anchored (TA) proteins to the endoplasmic reticulum.
CC       Recognizes and selectively binds the transmembrane domain of TA
CC       proteins in the cytosol. This complex then targets to the
CC       endoplasmic reticulum by membrane-bound receptors, where the tail-
CC       anchored protein is released for insertion. This process is
CC       regulated by ATP binding and hydrolysis. ATP binding drives the
CC       homodimer towards the closed dimer state, facilitating recognition
CC       of newly synthesized TA membrane proteins. ATP hydrolysis is
CC       required for insertion. Subsequently, the homodimer reverts
CC       towards the open dimer state, lowering its affinity for the
CC       membrane-bound receptor, and returning it to the cytosol to
CC       initiate a new round of targeting (By similarity). May be involved
CC       in insulin signaling. {ECO:0000255|HAMAP-Rule:MF_03112,
CC       ECO:0000269|PubMed:17382883, ECO:0000269|PubMed:18477612}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.22 mM for ATP {ECO:0000269|PubMed:9712828};
CC         Vmax=16.6 nmol/min/mg enzyme for ATP
CC         {ECO:0000269|PubMed:9712828};
CC   -!- SUBUNIT: Homodimer (By similarity). Component of a transmembrane
CC       domain recognition complex (TRC) (By similarity). Interacts with
CC       SERP1 and SEC61B (By similarity). Interacts with WRB.
CC       {ECO:0000255|HAMAP-Rule:MF_03112, ECO:0000269|PubMed:17382883,
CC       ECO:0000269|PubMed:18477612, ECO:0000269|PubMed:21444755}.
CC   -!- INTERACTION:
CC       Q12797:ASPH; NbExp=3; IntAct=EBI-2515857, EBI-2967294;
CC       Q12797-6:ASPH; NbExp=4; IntAct=EBI-2515857, EBI-12092171;
CC       Q7L5D6:GET4; NbExp=3; IntAct=EBI-2515857, EBI-711823;
CC       Q96SL4:GPX7; NbExp=5; IntAct=EBI-2515857, EBI-749411;
CC       Q9Y5L2:HILPDA; NbExp=3; IntAct=EBI-2515857, EBI-8803836;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Endoplasmic reticulum. Nucleus,
CC       nucleolus.
CC   -!- TISSUE SPECIFICITY: Expressed in the epithelial cells of the
CC       liver, kidney, and stomach wall, in the adrenal medulla, in the
CC       islet cells of the pancreas, in the red pulp of the spleen, and in
CC       cardiac and skeletal muscle. {ECO:0000269|PubMed:9774623}.
CC   -!- SIMILARITY: Belongs to the arsA ATPase family. {ECO:0000255|HAMAP-
CC       Rule:MF_03112}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50731.1; Type=Frameshift; Positions=19; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/asna1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF047469; AAC03551.1; -; mRNA.
DR   EMBL; AK291855; BAF84544.1; -; mRNA.
DR   EMBL; AK223363; BAD97083.1; -; mRNA.
DR   EMBL; AY304483; AAP45050.1; -; Genomic_DNA.
DR   EMBL; AC018761; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84303.1; -; Genomic_DNA.
DR   EMBL; BC002651; AAH02651.1; -; mRNA.
DR   EMBL; U60276; AAC50731.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS32920.1; -.
DR   RefSeq; NP_004308.2; NM_004317.3.
DR   UniGene; Hs.465985; -.
DR   ProteinModelPortal; O43681; -.
DR   SMR; O43681; -.
DR   BioGrid; 106931; 48.
DR   IntAct; O43681; 19.
DR   MINT; O43681; -.
DR   STRING; 9606.ENSP00000349887; -.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   TCDB; 3.A.19.1.1; the tms recognition/insertion complex (trc) family.
DR   CarbonylDB; O43681; -.
DR   iPTMnet; O43681; -.
DR   PhosphoSitePlus; O43681; -.
DR   SwissPalm; O43681; -.
DR   BioMuta; ASNA1; -.
DR   OGP; O43681; -.
DR   EPD; O43681; -.
DR   MaxQB; O43681; -.
DR   PaxDb; O43681; -.
DR   PeptideAtlas; O43681; -.
DR   PRIDE; O43681; -.
DR   DNASU; 439; -.
DR   Ensembl; ENST00000357332; ENSP00000349887; ENSG00000198356.
DR   Ensembl; ENST00000591090; ENSP00000466379; ENSG00000198356.
DR   GeneID; 439; -.
DR   KEGG; hsa:439; -.
DR   UCSC; uc002muv.3; human.
DR   CTD; 439; -.
DR   DisGeNET; 439; -.
DR   EuPathDB; HostDB:ENSG00000198356.11; -.
DR   GeneCards; ASNA1; -.
DR   HGNC; HGNC:752; ASNA1.
DR   HPA; HPA045951; -.
DR   HPA; HPA048087; -.
DR   MIM; 601913; gene.
DR   neXtProt; NX_O43681; -.
DR   OpenTargets; ENSG00000198356; -.
DR   PharmGKB; PA25051; -.
DR   eggNOG; KOG2825; Eukaryota.
DR   eggNOG; COG0003; LUCA.
DR   GeneTree; ENSGT00390000003817; -.
DR   HOGENOM; HOG000197637; -.
DR   InParanoid; O43681; -.
DR   KO; K01551; -.
DR   OMA; DQIADLY; -.
DR   OrthoDB; EOG091G0CAR; -.
DR   PhylomeDB; O43681; -.
DR   BRENDA; 3.6.3.16; 2681.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   SABIO-RK; O43681; -.
DR   ChiTaRS; ASNA1; human.
DR   GeneWiki; ASNA1; -.
DR   GenomeRNAi; 439; -.
DR   PRO; PR:O43681; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000198356; -.
DR   CleanEx; HS_ARSA; -.
DR   CleanEx; HS_ASNA1; -.
DR   ExpressionAtlas; O43681; baseline and differential.
DR   Genevisible; O43681; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0015105; F:arsenite transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATPase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005215; F:transporter activity; TAS:ProtInc.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   CDD; cd02035; ArsA; 1.
DR   HAMAP; MF_03112; Asna1_Get3; 1.
DR   InterPro; IPR025723; Anion-transp_ATPase-like_dom.
DR   InterPro; IPR016300; ATPase_ArsA/GET3.
DR   InterPro; IPR027542; ATPase_ArsA/GET3_euk.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10803; PTHR10803; 1.
DR   PANTHER; PTHR10803:SF3; PTHR10803:SF3; 1.
DR   Pfam; PF02374; ArsA_ATPase; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00345; GET3_arsA_TRC40; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Complete proteome; Cytoplasm;
KW   Endoplasmic reticulum; Hydrolase; Metal-binding; Nucleotide-binding;
KW   Nucleus; Polymorphism; Reference proteome; Transport; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    348       ATPase ASNA1.
FT                                /FTId=PRO_0000152253.
FT   NP_BIND      45     52       ATP. {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   ACT_SITE     74     74       {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   METAL       289    289       Zinc; shared with dimeric partner.
FT                                {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   METAL       292    292       Zinc; shared with dimeric partner.
FT                                {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   BINDING     251    251       ATP. {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   BINDING     278    278       ATP. {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   VARIANT     332    332       N -> S (in dbSNP:rs8177499).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_018844.
FT   MUTAGEN      46     46       G->R: Abolishes ATPase activity,
FT                                dominantly inhibits the TA protein
FT                                insertion pathway.
FT                                {ECO:0000269|PubMed:17382883}.
FT   CONFLICT    113    114       EL -> DV (in Ref. 8; AAC50731).
FT                                {ECO:0000305}.
FT   CONFLICT    205    205       C -> F (in Ref. 1; AAC03551).
FT                                {ECO:0000305}.
FT   CONFLICT    303    303       L -> P (in Ref. 3; BAD97083).
FT                                {ECO:0000305}.
SQ   SEQUENCE   348 AA;  38793 MW;  DA52C4ACC35C7A36 CRC64;
     MAAGVAGWGV EAEEFEDAPD VEPLEPTLSN IIEQRSLKWI FVGGKGGVGK TTCSCSLAVQ
     LSKGRESVLI ISTDPAHNIS DAFDQKFSKV PTKVKGYDNL FAMEIDPSLG VAELPDEFFE
     EDNMLSMGKK MMQEAMSAFP GIDEAMSYAE VMRLVKGMNF SVVVFDTAPT GHTLRLLNFP
     TIVERGLGRL MQIKNQISPF ISQMCNMLGL GDMNADQLAS KLEETLPVIR SVSEQFKDPE
     QTTFICVCIA EFLSLYETER LIQELAKCKI DTHNIIVNQL VFPDPEKPCK MCEARHKIQA
     KYLDQMEDLY EDFHIVKLPL LPHEVRGADK VNTFSALLLE PYKPPSAQ
//
ID   A0A087WW63_HUMAN        Unreviewed;      2512 AA.
AC   A0A087WW63;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   23-MAY-2018, entry version 36.
DE   RecName: Full=Voltage-dependent P/Q-type calcium channel subunit alpha {ECO:0000256|RuleBase:RU003808};
GN   Name=CACNA1A {ECO:0000313|Ensembl:ENSP00000479983};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000479983, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000479983, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000479983}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
RN   [3] {ECO:0000313|Ensembl:ENSP00000489829}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2016) to UniProtKB.
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1A
CC       gives rise to P and/or Q-type calcium currents. P/Q-type calcium
CC       channels belong to the 'high-voltage activated' (HVA) group and
CC       are blocked by the funnel toxin (Ftx) and by the omega-agatoxin-
CC       IVA (omega-Aga-IVA). They are however insensitive to
CC       dihydropyridines (DHP), and omega-conotoxin-GVIA (omega-CTx-GVIA).
CC       {ECO:0000256|RuleBase:RU003808}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU003808};
CC       Multi-pass membrane protein {ECO:0000256|RuleBase:RU003808}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000256|RuleBase:RU003808}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005305; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011446; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022436; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093062; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098781; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124224; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456505; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_075461.2; NM_023035.2.
DR   UniGene; Hs.501632; -.
DR   PeptideAtlas; A0A087WW63; -.
DR   PRIDE; A0A087WW63; -.
DR   Ensembl; ENST00000614285; ENSP00000479983; ENSG00000141837.
DR   Ensembl; ENST00000638029; ENSP00000489829; ENSG00000141837.
DR   GeneID; 773; -.
DR   UCSC; uc060uig.1; human.
DR   CTD; 773; -.
DR   EuPathDB; HostDB:ENSG00000141837.18; -.
DR   HGNC; HGNC:1388; CACNA1A.
DR   OpenTargets; ENSG00000141837; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   OMA; EKDCRGK; -.
DR   OrthoDB; EOG091G0TKO; -.
DR   ChiTaRS; CACNA1A; human.
DR   GenomeRNAi; 773; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000141837; -.
DR   ExpressionAtlas; A0A087WW63; baseline and differential.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:Ensembl.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IEA:Ensembl.
DR   GO; GO:0007628; P:adult walking behavior; IEA:Ensembl.
DR   GO; GO:0048266; P:behavioral response to pain; IEA:Ensembl.
DR   GO; GO:0048791; P:calcium ion-regulated exocytosis of neurotransmitter; IEA:Ensembl.
DR   GO; GO:0030644; P:cellular chloride ion homeostasis; IEA:Ensembl.
DR   GO; GO:0021679; P:cerebellar molecular layer development; IEA:Ensembl.
DR   GO; GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl.
DR   GO; GO:0021590; P:cerebellum maturation; IEA:Ensembl.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0014051; P:gamma-aminobutyric acid secretion; IEA:Ensembl.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0051899; P:membrane depolarization; IEA:Ensembl.
DR   GO; GO:0050883; P:musculoskeletal movement, spinal reflex action; IEA:Ensembl.
DR   GO; GO:0032353; P:negative regulation of hormone biosynthetic process; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl.
DR   GO; GO:0007270; P:neuron-neuron synaptic transmission; IEA:Ensembl.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0043113; P:receptor clustering; IEA:Ensembl.
DR   GO; GO:0014056; P:regulation of acetylcholine secretion, neurotransmission; IEA:Ensembl.
DR   GO; GO:0050770; P:regulation of axonogenesis; IEA:Ensembl.
DR   GO; GO:0017158; P:regulation of calcium ion-dependent exocytosis; IEA:Ensembl.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   GO; GO:0031335; P:regulation of sulfur amino acid metabolic process; IEA:Ensembl.
DR   GO; GO:0060024; P:rhythmic synaptic transmission; IEA:Ensembl.
DR   GO; GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl.
DR   GO; GO:0007416; P:synapse assembly; IEA:Ensembl.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0019226; P:transmission of nerve impulse; IEA:Ensembl.
DR   GO; GO:0021750; P:vestibular nucleus development; IEA:Ensembl.
DR   Gene3D; 1.20.120.350; -; 4.
DR   InterPro; IPR005448; CACNA1A.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01632; PQVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   Calcium {ECO:0000256|RuleBase:RU003808};
KW   Calcium channel {ECO:0000256|RuleBase:RU003808};
KW   Calcium transport {ECO:0000256|RuleBase:RU003808};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Ion channel {ECO:0000256|RuleBase:RU003808};
KW   Ion transport {ECO:0000256|RuleBase:RU003808};
KW   Membrane {ECO:0000256|SAAS:SAAS00084701, ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:A0A087WW63,
KW   ECO:0000213|PeptideAtlas:A0A087WW63};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00084701,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00084701,
KW   ECO:0000256|SAM:Phobius}; Transport {ECO:0000256|RuleBase:RU003808};
KW   Voltage-gated channel {ECO:0000256|RuleBase:RU003808}.
FT   TRANSMEM    102    119       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    139    159       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    222    245       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    337    359       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    488    507       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    519    539       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    614    636       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    690    714       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1246   1265       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1285   1306       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1318   1335       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1380   1402       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1492   1517       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1573   1591       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1603   1626       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1696   1714       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1792   1816       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN     1953   1987       Ca_chan_IQ. {ECO:0000259|SMART:SM01062}.
FT   COILED      367    387       {ECO:0000256|SAM:Coils}.
FT   COILED      714    749       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   2512 AA;  283131 MW;  1671032E96D172D0 CRC64;
     MARFGDEMPA RYGGGGSGAA AGVVVGSGGG RGAGGSRQGG QPGAQRMYKQ SMAQRARTMA
     LYNPIPVRQN CLTVNRSLFL FSEDNVVRKY AKKITEWPPF EYMILATIIA NCIVLALEQH
     LPDDDKTPMS ERLDDTEPYF IGIFCFEAGI KIIALGFAFH KGSYLRNGWN VMDFVVVLTG
     ILATVGTEFD LRTLRAVRVL RPLKLVSGIP SLQVVLKSIM KAMIPLLQIG LLLFFAILIF
     AIIGLEFYMG KFHTTCFEEG TDDIQGESPA PCGTEEPART CPNGTKCQPY WEGPNNGITQ
     FDNILFAVLT VFQCITMEGW TDLLYNSNDA SGNTWNWLYF IPLIIIGSFF MLNLVLGVLS
     GEFAKERERV ENRRAFLKLR RQQQIERELN GYMEWISKAE EVILAEDETD GEQRHPFDGA
     LRRTTIKKSK TDLLNPEEAE DQLADIASVG SPFARASIKS AKLENSTFFH KKERRMRFYI
     RRMVKTQAFY WTVLSLVALN TLCVAIVHYN QPEWLSDFLY YAEFIFLGLF MSEMFIKMYG
     LGTRPYFHSS FNCFDCGVII GSIFEVIWAV IKPGTSFGIS VLRALRLLRI FKVTKYWASL
     RNLVVSLLNS MKSIISLLFL LFLFIVVFAL LGMQLFGGQF NFDEGTPPTN FDTFPAAIMT
     VFQILTGEDW NEVMYDGIKS QGGVQGGMVF SIYFIVLTLF GNYTLLNVFL AIAVDNLANA
     QELTKVEADE QEEEEAANQK LALQKAKEVA EVSPLSAANM SIAVKEQQKN QKPAKSVWEQ
     RTSEMRKQNL LASREALYNE MDPDERWKAA YTRHLRPDMK THLDRPLVVD PQENRNNNTN
     KSRAAEPTVD QRLGQQRAED FLRKQARYHD RARDPSGSAG LDARRPWAGS QEAELSREGP
     YGRESDHHAR EGSLEQPGFW EGEAERGKAG DPHRRHVHRQ GGSRESRSGS PRTGADGEHR
     RHRAHRRPGE EGPEDKAERR ARHREGSRPA RGGEGEGEGP DGGERRRRHR HGAPATYEGD
     ARREDKERRH RRRKENQGSG VPVSGPNLST TRPIQQDLGR QDPPLAEDID NMKNNKLATA
     ESAAPHGSLG HAGLPQSPAK MGNSTDPGPM LAIPAMATNP QNAASRRTPN NPGNPSNPGP
     PKTPENSLIV TNPSGTQTNS AKTARKPDHT TVDIPPACPP PLNHTVVQVN KNANPDPLPK
     KEEEKKEEEE DDRGEDGPKP MPPYSSMFIL STTNPLRRLC HYILNLRYFE MCILMVIAMS
     SIALAAEDPV QPNAPRNNVL RYFDYVFTGV FTFEMVIKMI DLGLVLHQGA YFRDLWNILD
     FIVVSGALVA FAFTGNSKGK DINTIKSLRV LRVLRPLKTI KRLPKLKAVF DCVVNSLKNV
     FNILIVYMLF MFIFAVVAVQ LFKGKFFHCT DESKEFEKDC RGKYLLYEKN EVKARDREWK
     KYEFHYDNVL WALLTLFTVS TGEGWPQVLK HSVDATFENQ GPSPGYRMEM SIFYVVYFVV
     FPFFFVNIFV ALIIITFQEQ GDKMMEEYSL EKNERACIDF AISAKPLTRH MPQNKQSFQY
     RMWQFVVSPP FEYTIMAMIA LNTIVLMMKF YGASVAYENA LRVFNIVFTS LFSLECVLKV
     MAFGILNYFR DAWNIFDFVT VLGSITDILV TEFGNPNNFI NLSFLRLFRA ARLIKLLRQG
     YTIRILLWTF VQSFKALPYV CLLIAMLFFI YAIIGMQVFG NIGIDVEDED SDEDEFQITE
     HNNFRTFFQA LMLLFRSATG EAWHNIMLSC LSGKPCDKNS GILTRECGNE FAYFYFVSFI
     FLCSFLMLNL FVAVIMDNFE YLTRDSSILG PHHLDEYVRV WAEYDPAAWG RMPYLDMYQM
     LRHMSPPLGL GKKCPARVAY KRLLRMDLPV ADDNTVHFNS TLMALIRTAL DIKIAKGGAD
     KQQMDAELRK EMMAIWPNLS QKTLDLLVTP HKSTDLTVGK IYAAMMIMEY YRQSKAKKLQ
     AMREEQDRTP LMFQRMEPPS PTQEGGPGQN ALPSTQLDPG GALMAHESGL KESPSWVTQR
     AQEMFQKTGT WSPEQGPPTD MPNSQPNSQS VEMREMGRDG YSDSEHYLPM EGQGRAASMP
     RLPAENQRRR GRPRGNNLST ISDTSPMKRS ASVLGPKARR LDDYSLERVP PEENQRHHQR
     RRDRSHRASE RSLGRYTDVD TGLGTDLSMT TQSGDLPSKE RDQERGRPKD RKHRQHHHHH
     HHHHHPPPPD KDRYAQERPD HGRARARDQR WSRSPSEGRE HMAHRQGSSS VSGSPAPSTS
     GTSTPRRGRR QLPQTPSTPR PHVSYSPVIR KAGGSGPPQQ QQQQQQQQQQ QAVARPGRAA
     TSGPRRYPGP TAEPLAGDRP PTGGHSSGRS PRMERRVPGP ARSESPRACR HGGARWPASG
     PHVSEGPPGP RHHGYYRGSD YDEADGPGSG GGEEAMAGAY DAPPPVRHAS SGATGRSPRT
     PRASGPACAS PSRHGRRLPN GYYPAHGLAR PRGPGSRKGL HEPYSESDDD WC
//
ID   A0A1B0GVQ9_HUMAN        Unreviewed;      2266 AA.
AC   A0A1B0GVQ9;
DT   05-OCT-2016, integrated into UniProtKB/TrEMBL.
DT   05-OCT-2016, sequence version 1.
DT   23-MAY-2018, entry version 17.
DE   RecName: Full=Voltage-dependent P/Q-type calcium channel subunit alpha {ECO:0000256|RuleBase:RU003808};
GN   Name=CACNA1A {ECO:0000313|Ensembl:ENSP00000490617};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000490617, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000490617, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000490617}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2016) to UniProtKB.
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1A
CC       gives rise to P and/or Q-type calcium currents. P/Q-type calcium
CC       channels belong to the 'high-voltage activated' (HVA) group and
CC       are blocked by the funnel toxin (Ftx) and by the omega-agatoxin-
CC       IVA (omega-Aga-IVA). They are however insensitive to
CC       dihydropyridines (DHP), and omega-conotoxin-GVIA (omega-CTx-GVIA).
CC       {ECO:0000256|RuleBase:RU003808}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU003808};
CC       Multi-pass membrane protein {ECO:0000256|RuleBase:RU003808}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000256|RuleBase:RU003808}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005305; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011446; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022436; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093062; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098781; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124224; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456505; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_000059.3; NM_000068.3.
DR   UniGene; Hs.501632; -.
DR   PeptideAtlas; A0A1B0GVQ9; -.
DR   PRIDE; A0A1B0GVQ9; -.
DR   Ensembl; ENST00000637432; ENSP00000490617; ENSG00000141837.
DR   GeneID; 773; -.
DR   CTD; 773; -.
DR   HGNC; HGNC:1388; CACNA1A.
DR   OpenTargets; ENSG00000141837; -.
DR   GeneTree; ENSGT00830000128247; -.
DR   ChiTaRS; CACNA1A; human.
DR   Proteomes; UP000005640; Chromosome 19.
DR   ExpressionAtlas; A0A1B0GVQ9; baseline and differential.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:InterPro.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.120.350; -; 4.
DR   InterPro; IPR005448; CACNA1A.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01632; PQVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   Calcium {ECO:0000256|RuleBase:RU003808};
KW   Calcium channel {ECO:0000256|RuleBase:RU003808};
KW   Calcium transport {ECO:0000256|RuleBase:RU003808};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Ion channel {ECO:0000256|RuleBase:RU003808};
KW   Ion transport {ECO:0000256|RuleBase:RU003808};
KW   Membrane {ECO:0000256|SAAS:SAAS00084701, ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:A0A1B0GVQ9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00084701,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00084701,
KW   ECO:0000256|SAM:Phobius}; Transport {ECO:0000256|RuleBase:RU003808};
KW   Voltage-gated channel {ECO:0000256|RuleBase:RU003808}.
FT   TRANSMEM    102    119       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    139    159       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    222    245       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    337    359       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    488    507       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    519    539       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    614    636       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    690    714       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1246   1265       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1285   1306       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1318   1335       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1380   1402       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1492   1517       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1573   1591       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1603   1626       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1696   1714       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1792   1816       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN     1953   1987       Ca_chan_IQ. {ECO:0000259|SMART:SM01062}.
FT   COILED      367    387       {ECO:0000256|SAM:Coils}.
FT   COILED      714    749       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   2266 AA;  257443 MW;  70EDC422B08A1775 CRC64;
     MARFGDEMPA RYGGGGSGAA AGVVVGSGGG RGAGGSRQGG QPGAQRMYKQ SMAQRARTMA
     LYNPIPVRQN CLTVNRSLFL FSEDNVVRKY AKKITEWPPF EYMILATIIA NCIVLALEQH
     LPDDDKTPMS ERLDDTEPYF IGIFCFEAGI KIIALGFAFH KGSYLRNGWN VMDFVVVLTG
     ILATVGTEFD LRTLRAVRVL RPLKLVSGIP SLQVVLKSIM KAMIPLLQIG LLLFFAILIF
     AIIGLEFYMG KFHTTCFEEG TDDIQGESPA PCGTEEPART CPNGTKCQPY WEGPNNGITQ
     FDNILFAVLT VFQCITMEGW TDLLYNSNDA SGNTWNWLYF IPLIIIGSFF MLNLVLGVLS
     GEFAKERERV ENRRAFLKLR RQQQIERELN GYMEWISKAE EVILAEDETD GEQRHPFDGA
     LRRTTIKKSK TDLLNPEEAE DQLADIASVG SPFARASIKS AKLENSTFFH KKERRMRFYI
     RRMVKTQAFY WTVLSLVALN TLCVAIVHYN QPEWLSDFLY YAEFIFLGLF MSEMFIKMYG
     LGTRPYFHSS FNCFDCGVII GSIFEVIWAV IKPGTSFGIS VLRALRLLRI FKVTKYWASL
     RNLVVSLLNS MKSIISLLFL LFLFIVVFAL LGMQLFGGQF NFDEGTPPTN FDTFPAAIMT
     VFQILTGEDW NEVMYDGIKS QGGVQGGMVF SIYFIVLTLF GNYTLLNVFL AIAVDNLANA
     QELTKVEADE QEEEEAANQK LALQKAKEVA EVSPLSAANM SIAVKEQQKN QKPAKSVWEQ
     RTSEMRKQNL LASREALYNE MDPDERWKAA YTRHLRPDMK THLDRPLVVD PQENRNNNTN
     KSRAAEPTVD QRLGQQRAED FLRKQARYHD RARDPSGSAG LDARRPWAGS QEAELSREGP
     YGRESDHHAR EGSLEQPGFW EGEAERGKAG DPHRRHVHRQ GGSRESRSGS PRTGADGEHR
     RHRAHRRPGE EGPEDKAERR ARHREGSRPA RGGEGEGEGP DGGERRRRHR HGAPATYEGD
     ARREDKERRH RRRKENQGSG VPVSGPNLST TRPIQQDLGR QDPPLAEDID NMKNNKLATA
     ESAAPHGSLG HAGLPQSPAK MGNSTDPGPM LAIPAMATNP QNAASRRTPN NPGNPSNPGP
     PKTPENSLIV TNPSGTQTNS AKTARKPDHT TVDIPPACPP PLNHTVVQVN KNANPDPLPK
     KEEEKKEEEE DDRGEDGPKP MPPYSSMFIL STTNPLRRLC HYILNLRYFE MCILMVIAMS
     SIALAAEDPV QPNAPRNNVL RYFDYVFTGV FTFEMVIKMI DLGLVLHQGA YFRDLWNILD
     FIVVSGALVA FAFTGNSKGK DINTIKSLRV LRVLRPLKTI KRLPKLKAVF DCVVNSLKNV
     FNILIVYMLF MFIFAVVAVQ LFKGKFFHCT DESKEFEKDC RGKYLLYEKN EVKARDREWK
     KYEFHYDNVL WALLTLFTVS TGEGWPQVLK HSVDATFENQ GPSPGYRMEM SIFYVVYFVV
     FPFFFVNIFV ALIIITFQEQ GDKMMEEYSL EKNERACIDF AISAKPLTRH MPQNKQSFQY
     RMWQFVVSPP FEYTIMAMIA LNTIVLMMKF YGASVAYENA LRVFNIVFTS LFSLECVLKV
     MAFGILNYFR DAWNIFDFVT VLGSITDILV TEFGNPNNFI NLSFLRLFRA ARLIKLLRQG
     YTIRILLWTF VQSFKALPYV CLLIAMLFFI YAIIGMQVFG NIGIDVEDED SDEDEFQITE
     HNNFRTFFQA LMLLFRSATG EAWHNIMLSC LSGKPCDKNS GILTRECGNE FAYFYFVSFI
     FLCSFLMLNL FVAVIMDNFE YLTRDSSILG PHHLDEYVRV WAEYDPAAWG RMPYLDMYQM
     LRHMSPPLGL GKKCPARVAY KRLLRMDLPV ADDNTVHFNS TLMALIRTAL DIKIAKGGAD
     KQQMDAELRK EMMAIWPNLS QKTLDLLVTP HKSTDLTVGK IYAAMMIMEY YRQSKAKKLQ
     AMREEQDRTP LMFQRMEPPS PTQEGGPGQN ALPSTQLDPG GALMAHESGL KESPSWVTQR
     AQEMFQKTGT WSPEQGPPTD MPNSQPNSQS VEMREMGRDG YSDSEHYLPM EGQGRAASMP
     RLPAENQRRR GRPRGNNLST ISDTSPMKRS ASVLGPKARR LDDYSLERVP PEENQRHHQR
     RRDRSHRASE RSLGRYTDVD TGLGTDLSMT TQSGDLPSKE RDQERGRPKD RKHRQHHHHH
     HHHHHPPPPD KDRYAQERPD HGRARARDQR WSRSPSEGRE HMAHRQ
//
ID   B5TYJ1_HUMAN            Unreviewed;      2263 AA.
AC   B5TYJ1;
DT   04-NOV-2008, integrated into UniProtKB/TrEMBL.
DT   04-NOV-2008, sequence version 1.
DT   23-MAY-2018, entry version 79.
DE   RecName: Full=Voltage-dependent P/Q-type calcium channel subunit alpha {ECO:0000256|RuleBase:RU003808};
GN   Name=CACNA1A {ECO:0000313|EMBL:ACH89974.1,
GN   ECO:0000313|Ensembl:ENSP00000490578};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACH89974.1};
RN   [1] {ECO:0000313|EMBL:ACH89974.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:ACH89974.1};
RX   PubMed=11742003; DOI=10.1074/jbc.M110948200;
RA   Wappl E., Koschak A., Poteser M., Sinnegger M.J., Walter D.,
RA   Eberhart A., Groschner K., Glossmann H., Kraus R.L., Grabner M.,
RA   Striessnig J.;
RT   "Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense
RT   mutations associated with episodic ataxia type 2 and progressive
RT   ataxia.";
RL   J. Biol. Chem. 277:6960-6966(2002).
RN   [2] {ECO:0000313|Ensembl:ENSP00000490578, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3] {ECO:0000313|EMBL:ACH89974.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:ACH89974.1};
RA   Gebhart M., Sinnegger-Brauns M.J., Grabner M.;
RL   Submitted (AUG-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|Ensembl:ENSP00000490578}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2016) to UniProtKB.
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1A
CC       gives rise to P and/or Q-type calcium currents. P/Q-type calcium
CC       channels belong to the 'high-voltage activated' (HVA) group and
CC       are blocked by the funnel toxin (Ftx) and by the omega-agatoxin-
CC       IVA (omega-Aga-IVA). They are however insensitive to
CC       dihydropyridines (DHP), and omega-conotoxin-GVIA (omega-CTx-GVIA).
CC       {ECO:0000256|RuleBase:RU003808}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU003808};
CC       Multi-pass membrane protein {ECO:0000256|RuleBase:RU003808}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000256|RuleBase:RU003808}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005305; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011446; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022436; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093062; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098781; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124224; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456505; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FJ040507; ACH89974.1; -; mRNA.
DR   RefSeq; NP_001167551.1; NM_001174080.1.
DR   UniGene; Hs.501632; -.
DR   MaxQB; B5TYJ1; -.
DR   PeptideAtlas; B5TYJ1; -.
DR   PRIDE; B5TYJ1; -.
DR   DNASU; 773; -.
DR   Ensembl; ENST00000636549; ENSP00000490578; ENSG00000141837.
DR   GeneID; 773; -.
DR   CTD; 773; -.
DR   HGNC; HGNC:1388; CACNA1A.
DR   OpenTargets; ENSG00000141837; -.
DR   PharmGKB; PA26007; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   HOVERGEN; HBG050763; -.
DR   ChiTaRS; CACNA1A; human.
DR   GenomeRNAi; 773; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   ExpressionAtlas; B5TYJ1; baseline and differential.
DR   Genevisible; B5TYJ1; HS.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IEA:InterPro.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.120.350; -; 4.
DR   InterPro; IPR005448; CACNA1A.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01632; PQVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   Calcium {ECO:0000256|RuleBase:RU003808};
KW   Calcium channel {ECO:0000256|RuleBase:RU003808};
KW   Calcium transport {ECO:0000256|RuleBase:RU003808};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Ion channel {ECO:0000256|RuleBase:RU003808};
KW   Ion transport {ECO:0000256|RuleBase:RU003808};
KW   Membrane {ECO:0000256|SAAS:SAAS00084701, ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:B5TYJ1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00084701,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00084701,
KW   ECO:0000256|SAM:Phobius}; Transport {ECO:0000256|RuleBase:RU003808};
KW   Voltage-gated channel {ECO:0000256|RuleBase:RU003808}.
FT   TRANSMEM    102    119       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    139    159       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    222    245       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    337    359       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    488    507       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    519    539       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    614    636       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    690    714       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1243   1262       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1282   1303       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1315   1332       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1377   1399       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1489   1514       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1570   1588       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1600   1623       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1693   1711       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1789   1813       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN     1950   1984       Ca_chan_IQ. {ECO:0000259|SMART:SM01062}.
FT   COILED      367    387       {ECO:0000256|SAM:Coils}.
FT   COILED      710    746       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   2263 AA;  257143 MW;  C331009AE19A1959 CRC64;
     MARFGDEMPA RYGGGGSGAA AGVVVGSGGG RGAGGSRQGG QPGAQRMYKQ SMAQRARTMA
     LYNPIPVRQN CLTVNRSLFL FSEDNVVRKY AKKITEWPPF EYMILATIIA NCIVLALEQH
     LPDDDKTPMS ERLDDTEPYF IGIFCFEAGI KIIALGFAFH KGSYLRNGWN VMDFVVVLTG
     ILATVGTEFD LRTLRAVRVL RPLKLVSGIP SLQVVLKSIM KAMIPLLQIG LLLFFAILIF
     AIIGLEFYMG KFHTTCFEEG TDDIQGESPA PCGTEEPART CPNGTKCQPY WEGPNNGITQ
     FDNILFAVLT VFQCITMEGW TDLLYNSNDA SGNTWNWLYF IPLIIIGSFF MLNLVLGVLS
     GEFAKERERV ENRRAFLKLR RQQQIERELN GYMEWISKAE EVILAEDETD GEQRHPFDGA
     LRRTTIKKSK TDLLNPEEAE DQLADIASVG SPFARASIKS AKLENSTFFH KKERRMRFYI
     RRMVKTQAFY WTVLSLVALN TLCVAIVHYN QPEWLSDFLY YAEFIFLGLF MSEMFIKMYG
     LGTRPYFHSS FNCFDCGVII GSIFEVIWAV IKPGTSFGIS VLRALRLLRI FKVTKYWASL
     RNLVVSLLNS MKSIISLLFL LFLFIVVFAL LGMQLFGGQF NFDEGTPPTN FDTFPAAIMT
     VFQILTGEDW NEVMYDGIKS QGGVQGGMVF SIYFIVLTLF GNYTLLNVFL AIAVDNLANA
     QELTKDEQEE EEAANQKLAL QKAKEVAEVS PLSAANMSIA VKEQQKNQKP AKSVWEQRTS
     EMRKQNLLAS REALYNEMDP DERWKAAYTR HLRPDMKTHL DRPLVVDPQE NRNNNTNKSR
     AAEPTVDQRL GQQRAEDFLR KQARYHDRAR DPSGSAGLDA RRPWAGSQEA ELSREGPYGR
     ESDHHAREGS LEQPGFWEGE AERGKAGDPH RRHVHRQGGS RESRSGSPRT GADGEHRRHR
     AHRRPGEEGP EDKAERRARH REGSRPARGG EGEGEGPDGG ERRRRHRHGA PATYEGDARR
     EDKERRHRRR KENQGSGVPV SGPNLSTTRP IQQDLGRQDP PLAEDIDNMK NNKLATAESA
     APHGSLGHAG LPQSPAKMGN STDPGPMLAI PAMATNPQNA ASRRTPNNPG NPSNPGPPKT
     PENSLIVTNP SGTQTNSAKT ARKPDHTTVD IPPACPPPLN HTVVQVNKNA NPDPLPKKEE
     EKKEEEEDDR GEDGPKPMPP YSSMFILSTT NPLRRLCHYI LNLRYFEMCI LMVIAMSSIA
     LAAEDPVQPN APRNNVLRYF DYVFTGVFTF EMVIKMIDLG LVLHQGAYFR DLWNILDFIV
     VSGALVAFAF TGNSKGKDIN TIKSLRVLRV LRPLKTIKRL PKLKAVFDCV VNSLKNVFNI
     LIVYMLFMFI FAVVAVQLFK GKFFHCTDES KEFEKDCRGK YLLYEKNEVK ARDREWKKYE
     FHYDNVLWAL LTLFTVSTGE GWPQVLKHSV DATFENQGPS PGYRMEMSIF YVVYFVVFPF
     FFVNIFVALI IITFQEQGDK MMEEYSLEKN ERACIDFAIS AKPLTRHMPQ NKQSFQYRMW
     QFVVSPPFEY TIMAMIALNT IVLMMKFYGA SVAYENALRV FNIVFTSLFS LECVLKVMAF
     GILNYFRDAW NIFDFVTVLG SITDILVTEF GNPNNFINLS FLRLFRAARL IKLLRQGYTI
     RILLWTFVQS FKALPYVCLL IAMLFFIYAI IGMQVFGNIG IDVEDEDSDE DEFQITEHNN
     FRTFFQALML LFRSATGEAW HNIMLSCLSG KPCDKNSGIL TRECGNEFAY FYFVSFIFLC
     SFLMLNLFVA VIMDNFEYLT RDSSILGPHH LDEYVRVWAE YDPAAWGRMP YLDMYQMLRH
     MSPPLGLGKK CPARVAYKRL LRMDLPVADD NTVHFNSTLM ALIRTALDIK IAKGGADKQQ
     MDAELRKEMM AIWPNLSQKT LDLLVTPHKS TDLTVGKIYA AMMIMEYYRQ SKAKKLQAMR
     EEQDRTPLMF QRMEPPSPTQ EGGPGQNALP STQLDPGGAL MAHESGLKES PSWVTQRAQE
     MFQKTGTWSP EQGPPTDMPN SQPNSQSVEM REMGRDGYSD SEHYLPMEGQ GRAASMPRLP
     AENQRRRGRP RGNNLSTISD TSPMKRSASV LGPKARRLDD YSLERVPPEE NQRHHQRRRD
     RSHRASERSL GRYTDVDTGL GTDLSMTTQS GDLPSKERDQ ERGRPKDRKH RQHHHHHHHH
     HHPPPPDKDR YAQERPDHGR ARARDQRWSR SPSEGREHMA HRQ
//
ID   CAC1A_HUMAN             Reviewed;        2505 AA.
AC   O00555; J3KP41; P78510; P78511; Q16290; Q92690; Q99790; Q99791;
AC   Q99792; Q99793; Q9NS88; Q9UDC4;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   28-FEB-2018, entry version 189.
DE   RecName: Full=Voltage-dependent P/Q-type calcium channel subunit alpha-1A;
DE   AltName: Full=Brain calcium channel I;
DE            Short=BI;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide isoform 4;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav2.1;
GN   Name=CACNA1A; Synonyms=CACH4, CACN3, CACNL1A4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Neuron;
RX   PubMed=10049321; DOI=10.1016/S0006-3495(99)77300-5;
RA   Hans M., Urrutia A., Deal C., Brust P.F., Stauderman K., Ellis S.B.,
RA   Harpold M.M., Johnson E.C., Williams M.E.;
RT   "Structural elements in domain IV that influence biophysical and
RT   pharmacological properties of human alpha1A-containing high-voltage-
RT   activated calcium channels.";
RL   Biophys. J. 76:1384-1400(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 3), VARIANTS FHM1
RP   GLN-192; MET-666; ALA-714 AND LEU-1810, VARIANT THR-454, AND
RP   INVOLVEMENT IN EA2.
RC   TISSUE=Cerebellum;
RX   PubMed=8898206; DOI=10.1016/S0092-8674(00)81373-2;
RA   Ophoff R.A., Terwindt G.M., Vergouwe M.N., van Eijk R., Oefner P.J.,
RA   Hoffman S.M.G., Lamerdin J.E., Mohrenweiser H.W., Bulman D.E.,
RA   Ferrari M., Haan J., Lindhout D., van Ommen G.-J.B., Hofker M.H.,
RA   Ferrari M.D., Frants R.R.;
RT   "Familial hemiplegic migraine and episodic ataxia type-2 are caused by
RT   mutations in the Ca2+ channel gene CACNL1A4.";
RL   Cell 87:543-552(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1313-2505 (ISOFORMS 1; 2; 3 AND 6), ALTERNATIVE SPLICING, AND
RP   INVOLVEMENT IN SCA6.
RC   TISSUE=Brain;
RX   PubMed=8988170; DOI=10.1038/ng0197-62;
RA   Zhuchenko O., Bailey J., Bonnen P.E., Ashizawa T., Stockton D.W.,
RA   Amos C., Dobyns W.B., Subramony S.H., Zoghbi H.Y., Lee C.C.;
RT   "Autosomal dominant cerebellar ataxia (SCA6) associated with small
RT   polyglutamine expansions in the alpha 1A-voltage-dependent calcium
RT   channel.";
RL   Nat. Genet. 15:62-69(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8), VARIANT SER-1105, AND
RP   FUNCTION.
RC   TISSUE=Cerebellum;
RX   PubMed=10753886; DOI=10.1074/jbc.275.15.10893;
RA   Toru S., Murakoshi T., Ishikawa K., Saegusa H., Fujigasaki H.,
RA   Uchihara T., Nagayama S., Osanai M., Mizusawa H., Tanabe T.;
RT   "Spinocerebellar ataxia type 6 mutation alters P-type calcium channel
RT   function.";
RL   J. Biol. Chem. 275:10893-10898(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1693-1807.
RC   TISSUE=Lung carcinoma;
RX   PubMed=7823133;
RA   Barry E.L.R., Viglione M.P., Kim Y.I., Froehner S.C.;
RT   "Expression and antibody inhibition of P-type calcium channels in
RT   human small-cell lung carcinoma cells.";
RL   J. Neurosci. 15:274-283(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1702-1822, AND TISSUE SPECIFICITY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=1335101; DOI=10.1016/S0025-6196(12)61144-6;
RA   Oguro-Okano M., Griesmann G.E., Wieben E.D., Slaymaker S.J.,
RA   Snutch T.P., Lennon V.A.;
RT   "Molecular diversity of neuronal-type calcium channels identified in
RT   small cell lung carcinoma.";
RL   Mayo Clin. Proc. 67:1150-1159(1992).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2038-2258 (ISOFORMS 1/2/3/4).
RC   TISSUE=Frontal cortex;
RX   PubMed=8525433; DOI=10.1007/BF02255782;
RA   Margolis R.L., Breschel T.S., Li S.H., Kidwai A.S., Antonarakis S.E.,
RA   McInnis M.G., Ross C.A.;
RT   "Characterization of cDNA clones containing CCA trinucleotide repeats
RT   derived from human brain.";
RL   Somat. Cell Mol. Genet. 21:279-284(1995).
RN   [9]
RP   INTERACTION WITH CABP1.
RX   PubMed=11865310; DOI=10.1038/nn805;
RA   Lee A., Westenbroek R.E., Haeseleer F., Palczewski K., Scheuer T.,
RA   Catterall W.A.;
RT   "Differential modulation of Ca(v)2.1 channels by calmodulin and Ca2+-
RT   binding protein 1.";
RL   Nat. Neurosci. 5:210-217(2002).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 1955-1975.
RX   PubMed=18400181; DOI=10.1016/j.str.2008.01.011;
RA   Mori M.X., Vander Kooi C.W., Leahy D.J., Yue D.T.;
RT   "Crystal structure of the CaV2 IQ domain in complex with
RT   Ca2+/calmodulin: high-resolution mechanistic implications for channel
RT   regulation by Ca2+.";
RL   Structure 16:607-620(2008).
RN   [11]
RP   VARIANT SCA6 ARG-293.
RX   PubMed=9345107; DOI=10.1086/301613;
RA   Yue Q., Jen J.C., Nelson S.F., Baloh R.W.;
RT   "Progressive ataxia due to a missense mutation in a calcium-channel
RT   gene.";
RL   Am. J. Hum. Genet. 61:1078-1087(1997).
RN   [12]
RP   POLYMORPHISM, AND INVOLVEMENT IN SCA6 AND EA2.
RX   PubMed=9302278; DOI=10.1093/hmg/6.11.1973;
RA   Jodice C., Mantuano E., Veneziano L., Trettel F., Sabbadini G.,
RA   Calandriello L., Francia A., Spadaro M., Pierelli F., Salvi F.,
RA   Ophoff R.A., Frants R.R., Frontali M.;
RT   "Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6)
RT   due to CAG repeat expansion in the CACNA1A gene on chromosome 19p.";
RL   Hum. Mol. Genet. 6:1973-1978(1997).
RN   [13]
RP   VARIANT EA2 HIS-1661.
RX   PubMed=10987655; DOI=10.1007/s004390051099;
RA   Friend K.L., Crimmins D., Phan T.G., Sue C.M., Colley A., Fung V.S.,
RA   Morris J.G., Sutherland G.R., Richards R.I.;
RT   "Detection of a novel missense mutation and second recurrent mutation
RT   in the CACNA1A gene in individuals with EA-2 and FHM.";
RL   Hum. Genet. 105:261-265(1999).
RN   [14]
RP   VARIANT VAL-993, AND VARIANT FHM1 LEU-1456.
RX   PubMed=10408532; DOI=10.1212/WNL.53.1.26;
RA   Carrera P., Piatti M., Stenirri S., Grimaldi L.M., Marchioni E.,
RA   Curcio M., Righetti P.G., Ferrari M., Gelfi C.;
RT   "Genetic heterogeneity in Italian families with familial hemiplegic
RT   migraine.";
RL   Neurology 53:26-33(1999).
RN   [15]
RP   VARIANT FHM1 LEU-218.
RX   PubMed=11409427; DOI=10.1002/ana.1031;
RA   Kors E.E., Terwindt G.M., Vermeulen F.L., Fitzsimons R.B.,
RA   Jardine P.E., Heywood P., Love S., van den Maagdenberg A.M., Haan J.,
RA   Frants R.R., Ferrari M.D.;
RT   "Delayed cerebral edema and fatal coma after minor head trauma: role
RT   of the CACNA1A calcium channel subunit gene and relationship with
RT   familial hemiplegic migraine.";
RL   Ann. Neurol. 49:753-760(2001).
RN   [16]
RP   VARIANT EA2 LYS-1756.
RX   PubMed=11176968; DOI=10.1001/archneur.58.2.292;
RA   Denier C., Ducros A., Durr A., Eymard B., Chassande B.,
RA   Tournier-Lasserve E.;
RT   "Missense CACNA1A mutation causing episodic ataxia type 2.";
RL   Arch. Neurol. 58:292-295(2001).
RN   [17]
RP   VARIANTS FHM1 LYS-195; GLN-583; MET-666; GLU-715; GLU-1335; CYS-1384;
RP   TRP-1667; ARG-1683 AND ILE-1695.
RX   PubMed=11439943; DOI=10.1056/NEJM200107053450103;
RA   Ducros A., Denier C., Joutel A., Cecillon M., Lescoat C., Vahedi K.,
RA   Darcel F., Vicaut E., Bousser M.G., Tournier-Lasserve E.;
RT   "The clinical spectrum of familial hemiplegic migraine associated with
RT   mutations in a neuronal calcium channel.";
RL   N. Engl. J. Med. 345:17-24(2001).
RN   [18]
RP   VARIANT EA2 CYS-1403, CHARACTERIZATION OF VARIANT EA2 CYS-1403, AND
RP   FUNCTION.
RX   PubMed=11723274; DOI=10.1212/WNL.57.10.1843;
RA   Jen J., Wan J., Graves M., Yu H., Mock A.F., Coulin C.J., Kim G.,
RA   Yue Q., Papazian D.M., Baloh R.W.;
RT   "Loss-of-function EA2 mutations are associated with impaired
RT   neuromuscular transmission.";
RL   Neurology 57:1843-1848(2001).
RN   [19]
RP   VARIANT EA2 TYR-253.
RX   PubMed=12420090; DOI=10.1007/s00415-002-0860-8;
RA   van den Maagdenberg A.M., Kors E.E., Brunt E.R., van Paesschen W.,
RA   Pascual J., Ravine D., Keeling S., Vanmolkot K.R., Vermeulen F.L.,
RA   Terwindt G.M., Haan J., Frants R.R., Ferrari M.D.;
RT   "Episodic ataxia type 2. Three novel truncating mutations and one
RT   novel missense mutation in the CACNA1A gene.";
RL   J. Neurol. 249:1515-1519(2002).
RN   [20]
RP   VARIANT EA2 LEU-1736, CHARACTERIZATION OF VARIANT EA2 LEU-1736, AND
RP   FUNCTION.
RX   PubMed=15293273; DOI=10.1002/ana.20169;
RA   Spacey S.D., Hildebrand M.E., Materek L.A., Bird T.D., Snutch T.P.;
RT   "Functional implications of a novel EA2 mutation in the P/Q-type
RT   calcium channel.";
RL   Ann. Neurol. 56:213-220(2004).
RN   [21]
RP   VARIANT FHM1 GLN-1346.
RX   PubMed=15032980; DOI=10.1111/j..2004.00187.x;
RA   Alonso I., Barros J., Tuna A., Seixas A., Coutinho P., Sequeiros J.,
RA   Silveira I.;
RT   "A novel R1347Q mutation in the predicted voltage sensor segment of
RT   the P/Q-type calcium-channel alpha-subunit in a family with
RT   progressive cerebellar ataxia and hemiplegic migraine.";
RL   Clin. Genet. 65:70-72(2004).
RN   [22]
RP   VARIANTS EA2 ARG-256; ARG-1482; SER-1490; ILE-1493 AND CYS-2135.
RX   PubMed=15173248; DOI=10.1136/jmg.2003.015396;
RA   Mantuano E., Veneziano L., Spadaro M., Giunti P., Guida S.,
RA   Leggio M.G., Verriello L., Wood N., Jodice C., Frontali M.;
RT   "Clusters of non-truncating mutations of P/Q type Ca2+ channel subunit
RT   Ca(v)2.1 causing episodic ataxia 2.";
RL   J. Med. Genet. 41:E82-E82(2004).
RN   [23]
RP   VARIANTS EA2 TYR-287; ARG-293 AND MET-666.
RX   PubMed=14718690; DOI=10.1212/01.WNL.0000101675.61074.50;
RA   Jen J., Kim G.W., Baloh R.W.;
RT   "Clinical spectrum of episodic ataxia type 2.";
RL   Neurology 62:17-22(2004).
RN   [24]
RP   VARIANTS ASP-918; VAL-993 AND SER-1105.
RX   PubMed=16866717; DOI=10.1111/j.1526-4610.2006.00504.x;
RA   von Brevern M., Ta N., Shankar A., Wiste A., Siegel A., Radtke A.,
RA   Sander T., Escayg A.;
RT   "Migrainous vertigo: mutation analysis of the candidate genes CACNA1A,
RT   ATP1A2, SCN1A, and CACNB4.";
RL   Headache 46:1136-1141(2006).
RN   [25]
RP   VARIANT SCA6 GLN-1664.
RX   PubMed=16325861; DOI=10.1016/j.jns.2005.10.007;
RA   Tonelli A., D'Angelo M.G., Salati R., Villa L., Germinasi C.,
RA   Frattini T., Meola G., Turconi A.C., Bresolin N., Bassi M.T.;
RT   "Early onset, non fluctuating spinocerebellar ataxia and a novel
RT   missense mutation in CACNA1A gene.";
RL   J. Neurol. Sci. 241:13-17(2006).
RN   [26]
RP   VARIANT FHM1 GLN-1346.
RX   PubMed=18400034; DOI=10.1111/j.1399-0004.2008.00996.x;
RA   Stam A.H., Vanmolkot K.R., Kremer H.P., Gartner J., Brown J.,
RA   Leshinsky-Silver E., Gilad R., Kors E.E., Frankhuizen W.S.,
RA   Ginjaar H.B., Haan J., Frants R.R., Ferrari M.D.,
RA   van den Maagdenberg A.M., Terwindt G.M.;
RT   "CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic
RT   migraine.";
RL   Clin. Genet. 74:481-485(2008).
RN   [27]
RP   VARIANT EA2 CYS-248.
RX   PubMed=18602318; DOI=10.1016/j.ejpn.2008.02.011;
RA   Zafeiriou D.I., Lehmann-Horn F., Vargiami E., Teflioudi E.,
RA   Ververi A., Jurkat-Rott K.;
RT   "Episodic ataxia type 2 showing ictal hyperhidrosis with hypothermia
RT   and interictal chronic diarrhea due to a novel CACNA1A mutation.";
RL   Eur. J. Paediatr. Neurol. 13:191-193(2009).
RN   [28]
RP   VARIANT EA2 ASP-638, CHARACTERIZATION OF VARIANT EA2 ASP-638, AND
RP   FUNCTION.
RX   PubMed=19232643; DOI=10.1016/j.jns.2009.01.005;
RA   Cuenca-Leon E., Banchs I., Serra S.A., Latorre P.,
RA   Fernandez-Castillo N., Corominas R., Valverde M.A., Volpini V.,
RA   Fernandez-Fernandez J.M., Macaya A., Cormand B.;
RT   "Late-onset episodic ataxia type 2 associated with a novel loss-of-
RT   function mutation in the CACNA1A gene.";
RL   J. Neurol. Sci. 280:10-14(2009).
RN   [29]
RP   VARIANTS ASP-918 AND VAL-993.
RX   PubMed=19429006; DOI=10.1016/j.neulet.2009.01.081;
RA   D'Onofrio M., Ambrosini A., Di Mambro A., Arisi I., Santorelli F.M.,
RA   Grieco G.S., Nicoletti F., Nappi G., Pierelli F., Schoenen J.,
RA   Buzzi M.G.;
RT   "The interplay of two single nucleotide polymorphisms in the CACNA1A
RT   gene may contribute to migraine susceptibility.";
RL   Neurosci. Lett. 453:12-15(2009).
RN   [30]
RP   VARIANT SCA6 THR-405.
RX   PubMed=20682717; DOI=10.1136/jnnp.2008.163402;
RA   Romaniello R., Zucca C., Tonelli A., Bonato S., Baschirotto C.,
RA   Zanotta N., Epifanio R., Righini A., Bresolin N., Bassi M.T.,
RA   Borgatti R.;
RT   "A wide spectrum of clinical, neurophysiological and neuroradiological
RT   abnormalities in a family with a novel CACNA1A mutation.";
RL   J. Neurol. Neurosurg. Psych. 81:840-843(2010).
RN   [31]
RP   VARIANTS EA2 PHE-389; MET-501; THR-798; ARG-897; CYS-1679 AND
RP   ARG-1869.
RX   PubMed=20129625; DOI=10.1016/j.jns.2010.01.010;
RA   Mantuano E., Romano S., Veneziano L., Gellera C., Castellotti B.,
RA   Caimi S., Testa D., Estienne M., Zorzi G., Bugiani M., Rajabally Y.A.,
RA   Barcina M.J., Servidei S., Panico A., Frontali M., Mariotti C.;
RT   "Identification of novel and recurrent CACNA1A gene mutations in
RT   fifteen patients with episodic ataxia type 2.";
RL   J. Neurol. Sci. 291:30-36(2010).
RN   [32]
RP   VARIANT EA2 LYS-388.
RX   PubMed=21696515; DOI=10.1111/j.1442-200X.2011.03390.x;
RA   Nikaido K., Tachi N., Ohya K., Wada T., Tsutsumi H.;
RT   "New mutation of CACNA1A gene in episodic ataxia type 2.";
RL   Pediatr. Int. 53:415-416(2011).
RN   [33]
RP   VARIANT FHM1 PHE-1502 DEL, CHARACTERIZATION OF VARIANT FHM1 PHE-1502
RP   DEL, AND FUNCTION.
RX   PubMed=24836863; DOI=10.1016/j.jns.2014.04.027;
RA   Garcia Segarra N., Gautschi I., Mittaz-Crettol L., Kallay Zetchi C.,
RA   Al-Qusairi L., Van Bemmelen M.X., Maeder P., Bonafe L., Schild L.,
RA   Roulet-Perez E.;
RT   "Congenital ataxia and hemiplegic migraine with cerebral edema
RT   associated with a novel gain of function mutation in the calcium
RT   channel CACNA1A.";
RL   J. Neurol. Sci. 342:69-78(2014).
RN   [34]
RP   VARIANT FHM1 PHE-1502 DEL, CHARACTERIZATION OF VARIANT FHM1 PHE-1502
RP   DEL, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=26716990; DOI=10.1371/journal.pone.0146035;
RA   Bahamonde M.I., Serra S.A., Drechsel O., Rahman R., Marce-Grau A.,
RA   Prieto M., Ossowski S., Macaya A., Fernandez-Fernandez J.M.;
RT   "A single amino acid deletion (deltaf1502) in the s6 segment of cav2.1
RT   domain iii associated with congenital ataxia increases channel
RT   activity and promotes ca2+ influx.";
RL   PLoS ONE 10:E0146035-E0146035(2015).
RN   [35]
RP   INVOLVEMENT IN EIEE42, AND VARIANTS EIEE42 GLN-101; THR-713 AND
RP   SER-1508.
RX   PubMed=27476654; DOI=10.1016/j.ajhg.2016.06.003;
RG   Epi4K Consortium;
RT   "De novo mutations in SLC1A2 and CACNA1A are important causes of
RT   epileptic encephalopathies.";
RL   Am. J. Hum. Genet. 99:287-298(2016).
RN   [36]
RP   VARIANT EIEE42 ARG-1436.
RX   PubMed=27250579; DOI=10.1002/ajmg.a.37678;
RA   Reinson K., Oiglane-Shlik E., Talvik I., Vaher U., Ounapuu A.,
RA   Ennok M., Teek R., Pajusalu S., Murumets U., Tomberg T., Puusepp S.,
RA   Piirsoo A., Reimand T., Ounap K.;
RT   "Biallelic CACNA1A mutations cause early onset epileptic
RT   encephalopathy with progressive cerebral, cerebellar, and optic nerve
RT   atrophy.";
RL   Am. J. Med. Genet. A 170:2173-2176(2016).
RN   [37]
RP   VARIANT FHM1 GLN-583.
RX   PubMed=28900389; DOI=10.3389/fncel.2017.00263;
RA   Khaiboullina S.F., Mendelevich E.G., Shigapova L.H.,
RA   Shagimardanova E., Gazizova G., Nikitin A., Martynova E.,
RA   Davidyuk Y.N., Bogdanov E.I., Gusev O., van den Maagdenberg A.M.J.M.,
RA   Giniatullin R.A., Rizvanov A.A.;
RT   "Cerebellar Atrophy and Changes in Cytokines Associated with the
RT   CACNA1A R583Q Mutation in a Russian Familial Hemiplegic Migraine Type
RT   1 Family.";
RL   Front. Cell. Neurosci. 11:263-263(2017).
RN   [38]
RP   VARIANTS GLN-1664 AND PRO-1673, AND CHARACTERIZATION OF VARIANTS
RP   GLN-1664 AND PRO-1673.
RX   PubMed=28742085; DOI=10.1371/journal.pgen.1006905;
RG   Members of the UDN;
RA   Luo X., Rosenfeld J.A., Yamamoto S., Harel T., Zuo Z., Hall M.,
RA   Wierenga K.J., Pastore M.T., Bartholomew D., Delgado M.R.,
RA   Rotenberg J., Lewis R.A., Emrick L., Bacino C.A., Eldomery M.K.,
RA   Coban Akdemir Z., Xia F., Yang Y., Lalani S.R., Lotze T., Lupski J.R.,
RA   Lee B., Bellen H.J., Wangler M.F.;
RT   "Clinically severe CACNA1A alleles affect synaptic function and
RT   neurodegeneration differentially.";
RL   PLoS Genet. 13:E1006905-E1006905(2017).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1A
CC       gives rise to P and/or Q-type calcium currents. P/Q-type calcium
CC       channels belong to the 'high-voltage activated' (HVA) group and
CC       are blocked by the funnel toxin (Ftx) and by the omega-agatoxin-
CC       IVA (omega-Aga-IVA). They are however insensitive to
CC       dihydropyridines (DHP), and omega-conotoxin-GVIA (omega-CTx-GVIA).
CC       {ECO:0000269|PubMed:10049321, ECO:0000269|PubMed:10753886,
CC       ECO:0000269|PubMed:11723274, ECO:0000269|PubMed:15293273,
CC       ECO:0000269|PubMed:19232643, ECO:0000269|PubMed:24836863,
CC       ECO:0000269|PubMed:26716990}.
CC   -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1, alpha-2, beta and delta subunits
CC       in a 1:1:1:1 ratio. The channel activity is directed by the pore-
CC       forming and voltage-sensitive alpha-1 subunit. In many cases, this
CC       subunit is sufficient to generate voltage-sensitive calcium
CC       channel activity. The auxiliary subunits beta and alpha-2/delta
CC       linked by a disulfide bridge regulate the channel activity.
CC       Interact (via C-terminal CDB motif) with CABP1 in the pre- and
CC       postsynaptic membranes. {ECO:0000269|PubMed:11865310}.
CC   -!- INTERACTION:
CC       Q8IZP0:ABI1; NbExp=2; IntAct=EBI-766279, EBI-375446;
CC       O94910:ADGRL1; NbExp=2; IntAct=EBI-766279, EBI-3389315;
CC       Q86SJ2:AMIGO2; NbExp=2; IntAct=EBI-766279, EBI-3866830;
CC       Q7Z5H3:ARHGAP22; NbExp=2; IntAct=EBI-766279, EBI-3866859;
CC       P67870:CSNK2B; NbExp=2; IntAct=EBI-766279, EBI-348169;
CC       O75953:DNAJB5; NbExp=2; IntAct=EBI-766279, EBI-5655937;
CC       P28799:GRN; NbExp=2; IntAct=EBI-766279, EBI-747754;
CC       P15822:HIVEP1; NbExp=2; IntAct=EBI-766279, EBI-722264;
CC       Q8N2S1:LTBP4; NbExp=2; IntAct=EBI-766279, EBI-947718;
CC       O00339:MATN2; NbExp=2; IntAct=EBI-766279, EBI-949020;
CC       O75095:MEGF6; NbExp=2; IntAct=EBI-766279, EBI-947597;
CC       Q7Z7M0:MEGF8; NbExp=2; IntAct=EBI-766279, EBI-947617;
CC       Q9UHX1:PUF60; NbExp=2; IntAct=EBI-766279, EBI-1053259;
CC       Q8IXT5:RBM12B; NbExp=2; IntAct=EBI-766279, EBI-3044077;
CC       O95153:TSPOAP1; NbExp=2; IntAct=EBI-766279, EBI-5915931;
CC       Q9BVA1:TUBB2B; NbExp=2; IntAct=EBI-766279, EBI-355665;
CC       P22695:UQCRC2; NbExp=2; IntAct=EBI-766279, EBI-1051424;
CC       P49750:YLPM1; NbExp=2; IntAct=EBI-766279, EBI-712871;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10049321,
CC       ECO:0000269|PubMed:26716990}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=1A-1, BI-1-GGCAG;
CC         IsoId=O00555-1; Sequence=Displayed;
CC       Name=2; Synonyms=1A-2,BI-1;
CC         IsoId=O00555-2; Sequence=VSP_000875;
CC       Name=3; Synonyms=BI-1(V1);
CC         IsoId=O00555-3; Sequence=VSP_000871, VSP_000875;
CC       Name=4; Synonyms=BI-1(V1)-GGCAG;
CC         IsoId=O00555-4; Sequence=VSP_000871;
CC       Name=5; Synonyms=BI-1(V2);
CC         IsoId=O00555-5; Sequence=VSP_000872, VSP_000875;
CC       Name=6; Synonyms=BI-1(V2)-GGCAG;
CC         IsoId=O00555-6; Sequence=VSP_000872;
CC       Name=8;
CC         IsoId=O00555-8; Sequence=VSP_046165, VSP_046166;
CC   -!- TISSUE SPECIFICITY: Brain specific; mainly found in cerebellum,
CC       cerebral cortex, thalamus and hypothalamus. Expressed in the small
CC       cell lung carcinoma cell line SCC-9. No expression in heart,
CC       kidney, liver or muscle. Purkinje cells contain predominantly P-
CC       type VSCC, the Q-type being a prominent calcium current in
CC       cerebellar granule cells. {ECO:0000269|PubMed:1335101}.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- POLYMORPHISM: The poly-Gln region of CACNA1A is polymorphic: 6 to
CC       17 repeats in the normal population, expanded to about 21 to 30
CC       repeats in SCA6. Repeat expansion has been reported also in a EA2
CC       family. {ECO:0000269|PubMed:9302278}.
CC   -!- DISEASE: Spinocerebellar ataxia 6 (SCA6) [MIM:183086]:
CC       Spinocerebellar ataxia is a clinically and genetically
CC       heterogeneous group of cerebellar disorders. Patients show
CC       progressive incoordination of gait and often poor coordination of
CC       hands, speech and eye movements, due to degeneration of the
CC       cerebellum with variable involvement of the brainstem and spinal
CC       cord. SCA6 is an autosomal dominant cerebellar ataxia (ADCA),
CC       mainly caused by expansion of a CAG repeat in the coding region of
CC       CACNA1A. There seems to be a correlation between the repeat number
CC       and earlier onset of the disorder. {ECO:0000269|PubMed:16325861,
CC       ECO:0000269|PubMed:20682717, ECO:0000269|PubMed:8988170,
CC       ECO:0000269|PubMed:9302278, ECO:0000269|PubMed:9345107}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]: A
CC       subtype of migraine with aura associated with ictal hemiparesis
CC       and, in some families, cerebellar ataxia and atrophy. Migraine is
CC       a disabling symptom complex of periodic headaches, usually
CC       temporal and unilateral. Headaches are often accompanied by
CC       irritability, nausea, vomiting and photophobia, preceded by
CC       constriction of the cranial arteries. Migraine with aura is
CC       characterized by recurrent attacks of reversible neurological
CC       symptoms (aura) that precede or accompany the headache. Aura may
CC       include a combination of sensory disturbances, such as blurred
CC       vision, hallucinations, vertigo, numbness and difficulty in
CC       concentrating and speaking. {ECO:0000269|PubMed:10408532,
CC       ECO:0000269|PubMed:11409427, ECO:0000269|PubMed:11439943,
CC       ECO:0000269|PubMed:15032980, ECO:0000269|PubMed:18400034,
CC       ECO:0000269|PubMed:24836863, ECO:0000269|PubMed:26716990,
CC       ECO:0000269|PubMed:28900389, ECO:0000269|PubMed:8898206}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Episodic ataxia 2 (EA2) [MIM:108500]: An autosomal
CC       dominant disorder characterized by acetozolamide-responsive
CC       attacks of ataxia, migraine-like symptoms, interictal nystagmus,
CC       and cerebellar atrophy. {ECO:0000269|PubMed:10987655,
CC       ECO:0000269|PubMed:11176968, ECO:0000269|PubMed:11723274,
CC       ECO:0000269|PubMed:12420090, ECO:0000269|PubMed:14718690,
CC       ECO:0000269|PubMed:15173248, ECO:0000269|PubMed:15293273,
CC       ECO:0000269|PubMed:18602318, ECO:0000269|PubMed:19232643,
CC       ECO:0000269|PubMed:20129625, ECO:0000269|PubMed:21696515,
CC       ECO:0000269|PubMed:8898206, ECO:0000269|PubMed:9302278}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 42 (EIEE42)
CC       [MIM:617106]: A form of epileptic encephalopathy, a heterogeneous
CC       group of severe childhood onset epilepsies characterized by
CC       refractory seizures, neurodevelopmental impairment, and poor
CC       prognosis. Development is normal prior to seizure onset, after
CC       which cognitive and motor delays become apparent. EIEE42
CC       inheritance is autosomal dominant. {ECO:0000269|PubMed:27250579,
CC       ECO:0000269|PubMed:27476654}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1A subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB49678.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Calcium channel, voltage-dependent, P/Q type,
CC       alpha 1A subunit (CACNA1A); Note=Leiden Open Variation Database
CC       (LOVD);
CC       URL="http://chromium.lovd.nl/LOVD2/home.php?select_db=CACNA1A";
CC   -!- WEB RESOURCE: Name=Familial hemiplegic migraine (FHM) variation
CC       database, calcium channel, voltage-dependent, P/Q type, alpha 1A
CC       subunit (CACNA1A); Note=Leiden Open Variation Database (LOVD);
CC       URL="http://grenada.lumc.nl/LOVD2/FHM/home.php?select_db=CACNA1A";
CC   -!- WEB RESOURCE: Name=Undiagnosed Disease Network; Note=CACNA1A;
CC       URL="https://undiagnosed.hms.harvard.edu/updates/genes-of-interest/cacna1a-gene/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF004883; AAB61612.1; -; mRNA.
DR   EMBL; AF004884; AAB61613.1; -; mRNA.
DR   EMBL; X99897; CAA68172.1; -; mRNA.
DR   EMBL; Z80114; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z80115; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U79663; AAB49674.1; -; mRNA.
DR   EMBL; U79664; AAB49675.1; -; mRNA.
DR   EMBL; U79665; AAB49676.1; -; mRNA.
DR   EMBL; U79666; AAB64179.1; -; mRNA.
DR   EMBL; U79667; AAB49677.1; -; mRNA.
DR   EMBL; U79668; AAB49678.1; ALT_SEQ; mRNA.
DR   EMBL; AB035727; BAA94766.2; -; mRNA.
DR   EMBL; AC005305; AAC26839.1; -; Genomic_DNA.
DR   EMBL; AC005513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008540; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011446; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022436; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093062; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098781; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124224; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; S76537; AAB33068.1; -; mRNA.
DR   EMBL; U06702; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS45998.1; -. [O00555-8]
DR   CCDS; CCDS45999.1; -. [O00555-3]
DR   RefSeq; NP_000059.3; NM_000068.3.
DR   RefSeq; NP_001120693.1; NM_001127221.1. [O00555-3]
DR   RefSeq; NP_001120694.1; NM_001127222.1. [O00555-8]
DR   RefSeq; NP_001167551.1; NM_001174080.1.
DR   RefSeq; NP_075461.2; NM_023035.2.
DR   UniGene; Hs.501632; -.
DR   PDB; 3BXK; X-ray; 2.55 A; B/D=1955-1975.
DR   PDBsum; 3BXK; -.
DR   ProteinModelPortal; O00555; -.
DR   SMR; O00555; -.
DR   BioGrid; 107227; 100.
DR   CORUM; O00555; -.
DR   IntAct; O00555; 92.
DR   MINT; O00555; -.
DR   STRING; 9606.ENSP00000353362; -.
DR   BindingDB; O00555; -.
DR   ChEMBL; CHEMBL4266; -.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB00836; Loperamide.
DR   DrugBank; DB00230; Pregabalin.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB00661; Verapamil.
DR   TCDB; 1.A.1.11.27; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O00555; -.
DR   PhosphoSitePlus; O00555; -.
DR   BioMuta; CACNA1A; -.
DR   MaxQB; O00555; -.
DR   PaxDb; O00555; -.
DR   PeptideAtlas; O00555; -.
DR   PRIDE; O00555; -.
DR   DNASU; 773; -.
DR   Ensembl; ENST00000360228; ENSP00000353362; ENSG00000141837. [O00555-8]
DR   Ensembl; ENST00000635895; ENSP00000490323; ENSG00000141837. [O00555-2]
DR   Ensembl; ENST00000637276; ENSP00000489777; ENSG00000141837. [O00555-5]
DR   Ensembl; ENST00000638009; ENSP00000489913; ENSG00000141837. [O00555-3]
DR   GeneID; 773; -.
DR   KEGG; hsa:773; -.
DR   UCSC; uc002mwy.5; human. [O00555-1]
DR   CTD; 773; -.
DR   DisGeNET; 773; -.
DR   EuPathDB; HostDB:ENSG00000141837.18; -.
DR   GeneCards; CACNA1A; -.
DR   GeneReviews; CACNA1A; -.
DR   HGNC; HGNC:1388; CACNA1A.
DR   HPA; HPA064258; -.
DR   MalaCards; CACNA1A; -.
DR   MIM; 108500; phenotype.
DR   MIM; 141500; phenotype.
DR   MIM; 183086; phenotype.
DR   MIM; 601011; gene.
DR   MIM; 617106; phenotype.
DR   neXtProt; NX_O00555; -.
DR   OpenTargets; ENSG00000141837; -.
DR   Orphanet; 2131; Alternating hemiplegia of childhood.
DR   Orphanet; 71518; Benign paroxysmal torticollis of infancy.
DR   Orphanet; 569; Familial or sporadic hemiplegic migraine.
DR   Orphanet; 97; Familial paroxysmal ataxia.
DR   Orphanet; 98758; Spinocerebellar ataxia type 6.
DR   PharmGKB; PA26007; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   GeneTree; ENSGT00830000128247; -.
DR   HOGENOM; HOG000231530; -.
DR   HOVERGEN; HBG050763; -.
DR   InParanoid; O00555; -.
DR   KO; K04344; -.
DR   PhylomeDB; O00555; -.
DR   TreeFam; TF312805; -.
DR   Reactome; R-HSA-112308; Presynaptic depolarization and calcium channel opening.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   ChiTaRS; CACNA1A; human.
DR   EvolutionaryTrace; O00555; -.
DR   GeneWiki; Cav2.1; -.
DR   GenomeRNAi; 773; -.
DR   PRO; PR:O00555; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000141837; -.
DR   ExpressionAtlas; O00555; baseline and differential.
DR   Genevisible; O00555; HS.
DR   GO; GO:0042995; C:cell projection; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:ARUK-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0005262; F:calcium channel activity; TAS:Reactome.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019905; F:syntaxin binding; IDA:UniProtKB.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0008219; P:cell death; IDA:UniProtKB.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IDA:ARUK-UCL.
DR   GO; GO:0051899; P:membrane depolarization; TAS:Reactome.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   GO; GO:1904645; P:response to amyloid-beta; IDA:ARUK-UCL.
DR   Gene3D; 1.20.120.350; -; 4.
DR   InterPro; IPR005448; CACNA1A.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01632; PQVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Cell membrane; Complete proteome; Disease mutation;
KW   Disulfide bond; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Membrane; Metal-binding; Neurodegeneration; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Spinocerebellar ataxia;
KW   Transmembrane; Transmembrane helix; Transport;
KW   Triplet repeat expansion; Voltage-gated channel.
FT   CHAIN         1   2505       Voltage-dependent P/Q-type calcium
FT                                channel subunit alpha-1A.
FT                                /FTId=PRO_0000053916.
FT   TOPO_DOM      1     98       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     99    117       Helical; Name=S1 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    118    135       Extracellular. {ECO:0000255}.
FT   TRANSMEM    136    155       Helical; Name=S2 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    156    167       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    168    185       Helical; Name=S3 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    186    190       Extracellular. {ECO:0000255}.
FT   TRANSMEM    191    209       Helical; Name=S4 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    210    228       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    229    248       Helical; Name=S5 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    249    335       Extracellular. {ECO:0000255}.
FT   TRANSMEM    336    360       Helical; Name=S6 of repeat I.
FT                                {ECO:0000255}.
FT   TOPO_DOM    361    487       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    488    506       Helical; Name=S1 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    507    521       Extracellular. {ECO:0000255}.
FT   TRANSMEM    522    541       Helical; Name=S2 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    542    549       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    550    568       Helical; Name=S3 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    569    578       Extracellular. {ECO:0000255}.
FT   TRANSMEM    579    597       Helical; Name=S4 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    598    616       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    617    636       Helical; Name=S5 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    637    689       Extracellular. {ECO:0000255}.
FT   TRANSMEM    690    714       Helical; Name=S6 of repeat II.
FT                                {ECO:0000255}.
FT   TOPO_DOM    715   1242       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1243   1261       Helical; Name=S1 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1262   1277       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1278   1297       Helical; Name=S2 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1298   1309       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1310   1328       Helical; Name=S3 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1329   1339       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1340   1358       Helical; Name=S4 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1359   1377       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1378   1397       Helical; Name=S5 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1398   1484       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1485   1509       Helical; Name=S6 of repeat III.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1510   1564       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1565   1593       Helical; Name=S1 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1594   1598       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1599   1618       Helical; Name=S2 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1619   1626       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1627   1645       Helical; Name=S3 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1646   1652       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1653   1671       Helical; Name=S4 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1672   1690       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1691   1710       Helical; Name=S5 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1711   1782       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1783   1807       Helical; Name=S6 of repeat IV.
FT                                {ECO:0000255}.
FT   TOPO_DOM   1808   2505       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       85    363       I.
FT   REPEAT      473    717       II.
FT   REPEAT     1231   1514       III.
FT   REPEAT     1551   1814       IV.
FT   CA_BIND    1840   1851       {ECO:0000250}.
FT   REGION      383    400       Binding to the beta subunit.
FT                                {ECO:0000250}.
FT   COMPBIAS     13     18       Poly-Gly.
FT   COMPBIAS    727    732       Poly-Glu.
FT   COMPBIAS   1002   1007       Poly-Arg.
FT   COMPBIAS   1204   1207       Poly-Glu.
FT   COMPBIAS   2211   2220       Poly-His.
FT   COMPBIAS   2221   2224       Poly-Pro.
FT   COMPBIAS   2314   2324       Poly-Gln.
FT   SITE        318    318       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE        668    668       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1460   1460       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   SITE       1649   1649       Binds to omega-Aga-IVA. {ECO:0000250}.
FT   SITE       1756   1756       Calcium ion selectivity and permeability.
FT                                {ECO:0000250}.
FT   MOD_RES     409    409       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES     448    448       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES     451    451       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES     750    750       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES     753    753       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES     790    790       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    1085   1085       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    1094   1094       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    1822   1822       Phosphoserine; by PKA. {ECO:0000255}.
FT   MOD_RES    1984   1984       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    2047   2047       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P54282}.
FT   MOD_RES    2065   2065       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    2077   2077       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P54282}.
FT   MOD_RES    2079   2079       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P54282}.
FT   MOD_RES    2120   2120       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97445}.
FT   MOD_RES    2140   2140       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P54282}.
FT   CARBOHYD    283    283       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     419    419       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:10753886}.
FT                                /FTId=VSP_046165.
FT   VAR_SEQ    1844   1875       WGRMPYLDMYQMLRHMSPPLGLGKKCPARVAY -> CGRIH
FT                                YKDMYSLLRVISPPLGLGKKCPHRVAC (in isoform 3
FT                                and isoform 4).
FT                                {ECO:0000303|PubMed:8898206,
FT                                ECO:0000303|PubMed:8988170}.
FT                                /FTId=VSP_000871.
FT   VAR_SEQ    2103   2114       Missing (in isoform 5 and isoform 6).
FT                                {ECO:0000303|PubMed:8988170}.
FT                                /FTId=VSP_000872.
FT   VAR_SEQ    2262   2505       Missing (in isoform 2, isoform 3 and
FT                                isoform 5). {ECO:0000303|PubMed:10049321,
FT                                ECO:0000303|PubMed:8898206,
FT                                ECO:0000303|PubMed:8988170}.
FT                                /FTId=VSP_000875.
FT   VAR_SEQ    2314   2314       Q -> QQQ (in isoform 8).
FT                                {ECO:0000303|PubMed:10753886}.
FT                                /FTId=VSP_046166.
FT   VARIANT      21     21       A -> V (in dbSNP:rs15999).
FT                                /FTId=VAR_014456.
FT   VARIANT     101    101       E -> Q (in EIEE42).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077071.
FT   VARIANT     192    192       R -> Q (in FHM1; dbSNP:rs121908211).
FT                                {ECO:0000269|PubMed:8898206}.
FT                                /FTId=VAR_001491.
FT   VARIANT     195    195       R -> K (in FHM1; dbSNP:rs121908222).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043820.
FT   VARIANT     218    218       S -> L (in FHM1; dbSNP:rs121908225).
FT                                {ECO:0000269|PubMed:11409427}.
FT                                /FTId=VAR_043821.
FT   VARIANT     248    248       Y -> C (in EA2; dbSNP:rs121908238).
FT                                {ECO:0000269|PubMed:18602318}.
FT                                /FTId=VAR_063683.
FT   VARIANT     253    253       H -> Y (in EA2; dbSNP:rs121908228).
FT                                {ECO:0000269|PubMed:12420090}.
FT                                /FTId=VAR_043822.
FT   VARIANT     256    256       C -> R (in EA2; dbSNP:rs121908231).
FT                                {ECO:0000269|PubMed:15173248}.
FT                                /FTId=VAR_043823.
FT   VARIANT     287    287       C -> Y (in EA2; dbSNP:rs121908236).
FT                                {ECO:0000269|PubMed:14718690}.
FT                                /FTId=VAR_043824.
FT   VARIANT     293    293       G -> R (in EA2 and SCA6;
FT                                dbSNP:rs121908215).
FT                                {ECO:0000269|PubMed:14718690,
FT                                ECO:0000269|PubMed:9345107}.
FT                                /FTId=VAR_043825.
FT   VARIANT     388    388       E -> K (in EA2).
FT                                {ECO:0000269|PubMed:21696515}.
FT                                /FTId=VAR_067342.
FT   VARIANT     389    389       L -> F (in EA2; dbSNP:rs121908239).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063684.
FT   VARIANT     405    405       A -> T (in SCA6; dbSNP:rs121908245).
FT                                {ECO:0000269|PubMed:20682717}.
FT                                /FTId=VAR_063685.
FT   VARIANT     454    454       A -> T (in dbSNP:rs41276886).
FT                                {ECO:0000269|PubMed:8898206}.
FT                                /FTId=VAR_063686.
FT   VARIANT     501    501       T -> M (in EA2; dbSNP:rs121908240).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063687.
FT   VARIANT     583    583       R -> Q (in FHM1; dbSNP:rs121908217).
FT                                {ECO:0000269|PubMed:11439943,
FT                                ECO:0000269|PubMed:28900389}.
FT                                /FTId=VAR_043826.
FT   VARIANT     638    638       G -> D (in EA2; reduces P/Q current
FT                                densities; dbSNP:rs121908246).
FT                                {ECO:0000269|PubMed:19232643}.
FT                                /FTId=VAR_063688.
FT   VARIANT     666    666       T -> M (in FHM1 and EA2;
FT                                dbSNP:rs121908212).
FT                                {ECO:0000269|PubMed:11439943,
FT                                ECO:0000269|PubMed:14718690,
FT                                ECO:0000269|PubMed:8898206}.
FT                                /FTId=VAR_001492.
FT   VARIANT     713    713       A -> T (in EIEE42).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077072.
FT   VARIANT     714    714       V -> A (in FHM1; dbSNP:rs121908213).
FT                                {ECO:0000269|PubMed:8898206}.
FT                                /FTId=VAR_001493.
FT   VARIANT     715    715       D -> E (in FHM1; dbSNP:rs121908218).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043827.
FT   VARIANT     732    732       E -> A (in dbSNP:rs16019).
FT                                /FTId=VAR_059221.
FT   VARIANT     798    798       M -> T (in EA2; dbSNP:rs121908241).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063689.
FT   VARIANT     897    897       P -> R (in EA2; dbSNP:rs121908242).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063690.
FT   VARIANT     914    914       P -> S (in dbSNP:rs16020).
FT                                /FTId=VAR_014458.
FT   VARIANT     918    918       E -> D (in dbSNP:rs16022).
FT                                {ECO:0000269|PubMed:16866717,
FT                                ECO:0000269|PubMed:19429006}.
FT                                /FTId=VAR_014459.
FT   VARIANT     993    993       E -> V (in dbSNP:rs16023).
FT                                {ECO:0000269|PubMed:10408532,
FT                                ECO:0000269|PubMed:16866717,
FT                                ECO:0000269|PubMed:19429006}.
FT                                /FTId=VAR_043828.
FT   VARIANT    1015   1015       E -> K (in dbSNP:rs16024).
FT                                /FTId=VAR_014461.
FT   VARIANT    1105   1105       G -> S (in dbSNP:rs16027).
FT                                {ECO:0000269|PubMed:10753886,
FT                                ECO:0000269|PubMed:16866717}.
FT                                /FTId=VAR_014462.
FT   VARIANT    1173   1173       P -> L (in dbSNP:rs16028).
FT                                /FTId=VAR_059222.
FT   VARIANT    1335   1335       K -> E (in FHM1; dbSNP:rs121908223).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043829.
FT   VARIANT    1346   1346       R -> Q (in FHM1; with progressive
FT                                cerebellar ataxia; dbSNP:rs121908230).
FT                                {ECO:0000269|PubMed:15032980,
FT                                ECO:0000269|PubMed:18400034}.
FT                                /FTId=VAR_043830.
FT   VARIANT    1384   1384       Y -> C (in FHM1; dbSNP:rs121908219).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043831.
FT   VARIANT    1403   1403       F -> C (in EA2; loss of function;
FT                                dbSNP:rs121908227).
FT                                {ECO:0000269|PubMed:11723274}.
FT                                /FTId=VAR_043832.
FT   VARIANT    1436   1436       W -> R (in EIEE42).
FT                                {ECO:0000269|PubMed:27250579}.
FT                                /FTId=VAR_077073.
FT   VARIANT    1456   1456       V -> L (in FHM1; dbSNP:rs121908237).
FT                                {ECO:0000269|PubMed:10408532}.
FT                                /FTId=VAR_043833.
FT   VARIANT    1482   1482       G -> R (in EA2; dbSNP:rs121908232).
FT                                {ECO:0000269|PubMed:15173248}.
FT                                /FTId=VAR_043834.
FT   VARIANT    1490   1490       F -> S (in EA2; dbSNP:rs121908233).
FT                                {ECO:0000269|PubMed:15173248}.
FT                                /FTId=VAR_043835.
FT   VARIANT    1493   1493       V -> I (in EA2; dbSNP:rs121908234).
FT                                {ECO:0000269|PubMed:15173248}.
FT                                /FTId=VAR_043836.
FT   VARIANT    1502   1502       Missing (in FHM1; increased high voltage-
FT                                gated calcium channel activity).
FT                                {ECO:0000269|PubMed:24836863,
FT                                ECO:0000269|PubMed:26716990}.
FT                                /FTId=VAR_077074.
FT   VARIANT    1508   1508       A -> S (in EIEE42).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077075.
FT   VARIANT    1661   1661       R -> H (in EA2; dbSNP:rs121908216).
FT                                {ECO:0000269|PubMed:10987655}.
FT                                /FTId=VAR_043837.
FT   VARIANT    1664   1664       R -> Q (in SCA6; also found in patients
FT                                with global developmental delay and
FT                                congenital ataxia; loss of function
FT                                observed in the Drosophila homolog;
FT                                dbSNP:rs121908247).
FT                                {ECO:0000250|UniProtKB:P91645,
FT                                ECO:0000269|PubMed:16325861,
FT                                ECO:0000269|PubMed:28742085}.
FT                                /FTId=VAR_063691.
FT   VARIANT    1667   1667       R -> W (in FHM1; dbSNP:rs121908220).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043838.
FT   VARIANT    1673   1673       R -> P (also found in patients with
FT                                global developmental delay and congenital
FT                                ataxia; gain of function observed in the
FT                                Drosophila homolog).
FT                                {ECO:0000250|UniProtKB:P91645,
FT                                ECO:0000269|PubMed:28742085}.
FT                                /FTId=VAR_079826.
FT   VARIANT    1679   1679       R -> C (in EA2; dbSNP:rs121908243).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063692.
FT   VARIANT    1683   1683       W -> R (in FHM1; dbSNP:rs121908221).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_043839.
FT   VARIANT    1695   1695       V -> I (in FHM1; dbSNP:rs121908224).
FT                                {ECO:0000269|PubMed:11439943}.
FT                                /FTId=VAR_063706.
FT   VARIANT    1736   1736       H -> L (in EA2; changed high voltage-
FT                                gated calcium channel activity;
FT                                dbSNP:rs121908229).
FT                                {ECO:0000269|PubMed:15293273}.
FT                                /FTId=VAR_043840.
FT   VARIANT    1756   1756       E -> K (in EA2; dbSNP:rs121908226).
FT                                {ECO:0000269|PubMed:11176968}.
FT                                /FTId=VAR_043841.
FT   VARIANT    1810   1810       I -> L (in FHM1; dbSNP:rs121908214).
FT                                {ECO:0000269|PubMed:8898206}.
FT                                /FTId=VAR_001494.
FT   VARIANT    1869   1869       C -> R (in EA2; dbSNP:rs121908244).
FT                                {ECO:0000269|PubMed:20129625}.
FT                                /FTId=VAR_063693.
FT   VARIANT    2135   2135       R -> C (in EA2; dbSNP:rs121908235).
FT                                {ECO:0000269|PubMed:15173248}.
FT                                /FTId=VAR_043842.
FT   VARIANT    2394   2394       P -> S (in dbSNP:rs16056).
FT                                /FTId=VAR_014463.
FT   CONFLICT    725    725       K -> KVEA (in Ref. 1; AAB61613/AAB61612).
FT                                {ECO:0000305}.
FT   CONFLICT    896    896       G -> D (in Ref. 2; CAA68172 and 4;
FT                                BAA94766). {ECO:0000305}.
FT   CONFLICT    953    953       D -> N (in Ref. 4; BAA94766).
FT                                {ECO:0000305}.
FT   CONFLICT    964    964       R -> S (in Ref. 4; BAA94766).
FT                                {ECO:0000305}.
FT   CONFLICT   1207   1207       E -> EE (in Ref. 2; CAA68172).
FT                                {ECO:0000305}.
FT   CONFLICT   1313   1315       WNI -> ILP (in Ref. 3; AAB49674/AAB49675/
FT                                AAB49676/AAB49677/AAB49678).
FT                                {ECO:0000305}.
FT   CONFLICT   1459   1459       G -> A (in Ref. 2; CAA68172).
FT                                {ECO:0000305}.
FT   CONFLICT   1604   1604       V -> A (in Ref. 2; CAA68172).
FT                                {ECO:0000305}.
FT   CONFLICT   1617   1617       V -> A (in Ref. 2; CAA68172).
FT                                {ECO:0000305}.
FT   CONFLICT   1651   1651       G -> GNP (in Ref. 1; AAB61613/AAB61612).
FT                                {ECO:0000305}.
FT   CONFLICT   1693   1693       P -> A (in Ref. 6; AAB33068).
FT                                {ECO:0000305}.
FT   CONFLICT   2038   2038       E -> G (in Ref. 8; U06702).
FT                                {ECO:0000305}.
FT   CONFLICT   2314   2314       Q -> QQ (in Ref. 3; AAB49676).
FT                                {ECO:0000305}.
FT   HELIX      1956   1970       {ECO:0000244|PDB:3BXK}.
SQ   SEQUENCE   2505 AA;  282365 MW;  2F2F378ACE02FD56 CRC64;
     MARFGDEMPA RYGGGGSGAA AGVVVGSGGG RGAGGSRQGG QPGAQRMYKQ SMAQRARTMA
     LYNPIPVRQN CLTVNRSLFL FSEDNVVRKY AKKITEWPPF EYMILATIIA NCIVLALEQH
     LPDDDKTPMS ERLDDTEPYF IGIFCFEAGI KIIALGFAFH KGSYLRNGWN VMDFVVVLTG
     ILATVGTEFD LRTLRAVRVL RPLKLVSGIP SLQVVLKSIM KAMIPLLQIG LLLFFAILIF
     AIIGLEFYMG KFHTTCFEEG TDDIQGESPA PCGTEEPART CPNGTKCQPY WEGPNNGITQ
     FDNILFAVLT VFQCITMEGW TDLLYNSNDA SGNTWNWLYF IPLIIIGSFF MLNLVLGVLS
     GEFAKERERV ENRRAFLKLR RQQQIERELN GYMEWISKAE EVILAEDETD GEQRHPFDGA
     LRRTTIKKSK TDLLNPEEAE DQLADIASVG SPFARASIKS AKLENSTFFH KKERRMRFYI
     RRMVKTQAFY WTVLSLVALN TLCVAIVHYN QPEWLSDFLY YAEFIFLGLF MSEMFIKMYG
     LGTRPYFHSS FNCFDCGVII GSIFEVIWAV IKPGTSFGIS VLRALRLLRI FKVTKYWASL
     RNLVVSLLNS MKSIISLLFL LFLFIVVFAL LGMQLFGGQF NFDEGTPPTN FDTFPAAIMT
     VFQILTGEDW NEVMYDGIKS QGGVQGGMVF SIYFIVLTLF GNYTLLNVFL AIAVDNLANA
     QELTKDEQEE EEAANQKLAL QKAKEVAEVS PLSAANMSIA VKEQQKNQKP AKSVWEQRTS
     EMRKQNLLAS REALYNEMDP DERWKAAYTR HLRPDMKTHL DRPLVVDPQE NRNNNTNKSR
     AAEPTVDQRL GQQRAEDFLR KQARYHDRAR DPSGSAGLDA RRPWAGSQEA ELSREGPYGR
     ESDHHAREGS LEQPGFWEGE AERGKAGDPH RRHVHRQGGS RESRSGSPRT GADGEHRRHR
     AHRRPGEEGP EDKAERRARH REGSRPARGG EGEGEGPDGG ERRRRHRHGA PATYEGDARR
     EDKERRHRRR KENQGSGVPV SGPNLSTTRP IQQDLGRQDP PLAEDIDNMK NNKLATAESA
     APHGSLGHAG LPQSPAKMGN STDPGPMLAI PAMATNPQNA ASRRTPNNPG NPSNPGPPKT
     PENSLIVTNP SGTQTNSAKT ARKPDHTTVD IPPACPPPLN HTVVQVNKNA NPDPLPKKEE
     EKKEEEEDDR GEDGPKPMPP YSSMFILSTT NPLRRLCHYI LNLRYFEMCI LMVIAMSSIA
     LAAEDPVQPN APRNNVLRYF DYVFTGVFTF EMVIKMIDLG LVLHQGAYFR DLWNILDFIV
     VSGALVAFAF TGNSKGKDIN TIKSLRVLRV LRPLKTIKRL PKLKAVFDCV VNSLKNVFNI
     LIVYMLFMFI FAVVAVQLFK GKFFHCTDES KEFEKDCRGK YLLYEKNEVK ARDREWKKYE
     FHYDNVLWAL LTLFTVSTGE GWPQVLKHSV DATFENQGPS PGYRMEMSIF YVVYFVVFPF
     FFVNIFVALI IITFQEQGDK MMEEYSLEKN ERACIDFAIS AKPLTRHMPQ NKQSFQYRMW
     QFVVSPPFEY TIMAMIALNT IVLMMKFYGA SVAYENALRV FNIVFTSLFS LECVLKVMAF
     GILNYFRDAW NIFDFVTVLG SITDILVTEF GNNFINLSFL RLFRAARLIK LLRQGYTIRI
     LLWTFVQSFK ALPYVCLLIA MLFFIYAIIG MQVFGNIGID VEDEDSDEDE FQITEHNNFR
     TFFQALMLLF RSATGEAWHN IMLSCLSGKP CDKNSGILTR ECGNEFAYFY FVSFIFLCSF
     LMLNLFVAVI MDNFEYLTRD SSILGPHHLD EYVRVWAEYD PAAWGRMPYL DMYQMLRHMS
     PPLGLGKKCP ARVAYKRLLR MDLPVADDNT VHFNSTLMAL IRTALDIKIA KGGADKQQMD
     AELRKEMMAI WPNLSQKTLD LLVTPHKSTD LTVGKIYAAM MIMEYYRQSK AKKLQAMREE
     QDRTPLMFQR MEPPSPTQEG GPGQNALPST QLDPGGALMA HESGLKESPS WVTQRAQEMF
     QKTGTWSPEQ GPPTDMPNSQ PNSQSVEMRE MGRDGYSDSE HYLPMEGQGR AASMPRLPAE
     NQRRRGRPRG NNLSTISDTS PMKRSASVLG PKARRLDDYS LERVPPEENQ RHHQRRRDRS
     HRASERSLGR YTDVDTGLGT DLSMTTQSGD LPSKERDQER GRPKDRKHRQ HHHHHHHHHH
     PPPPDKDRYA QERPDHGRAR ARDQRWSRSP SEGREHMAHR QGSSSVSGSP APSTSGTSTP
     RRGRRQLPQT PSTPRPHVSY SPVIRKAGGS GPPQQQQQQQ QQQQAVARPG RAATSGPRRY
     PGPTAEPLAG DRPPTGGHSS GRSPRMERRV PGPARSESPR ACRHGGARWP ASGPHVSEGP
     PGPRHHGYYR GSDYDEADGP GSGGGEEAMA GAYDAPPPVR HASSGATGRS PRTPRASGPA
     CASPSRHGRR LPNGYYPAHG LARPRGPGSR KGLHEPYSES DDDWC
//
ID   Q9NS89_HUMAN            Unreviewed;      2472 AA.
AC   Q9NS89;
DT   01-OCT-2000, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 100.
DE   RecName: Full=Voltage-dependent P/Q-type calcium channel subunit alpha {ECO:0000256|RuleBase:RU003808};
DE   Flags: Fragment;
GN   Name=CACNA1A {ECO:0000313|EMBL:BAA94765.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAA94765.1};
RN   [1] {ECO:0000313|EMBL:BAA94765.1}
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=TMDN-SCA6-001 {ECO:0000313|EMBL:BAA94765.1};
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAA94765.1};
RX   PubMed=10753886; DOI=10.1074/jbc.275.15.10893;
RA   Toru S., Murakoshi T., Ishikawa K., Saegusa H., Fujigasaki H.,
RA   Uchihara T., Nagayama S., Osanai M., Mizusawa H., Tanabe T.;
RT   "Spinocerebellar ataxia type 6 mutation alters P-type calcium channel
RT   function.";
RL   J. Biol. Chem. 275:10893-10898(2000).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1A
CC       gives rise to P and/or Q-type calcium currents. P/Q-type calcium
CC       channels belong to the 'high-voltage activated' (HVA) group and
CC       are blocked by the funnel toxin (Ftx) and by the omega-agatoxin-
CC       IVA (omega-Aga-IVA). They are however insensitive to
CC       dihydropyridines (DHP), and omega-conotoxin-GVIA (omega-CTx-GVIA).
CC       {ECO:0000256|RuleBase:RU003808}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU003808};
CC       Multi-pass membrane protein {ECO:0000256|RuleBase:RU003808}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. {ECO:0000256|RuleBase:RU003808}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB035726; BAA94765.1; -; mRNA.
DR   RefSeq; NP_000059.3; NM_000068.3.
DR   RefSeq; NP_075461.2; NM_023035.2.
DR   UniGene; Hs.501632; -.
DR   ProteinModelPortal; Q9NS89; -.
DR   PeptideAtlas; Q9NS89; -.
DR   PRIDE; Q9NS89; -.
DR   GeneID; 773; -.
DR   CTD; 773; -.
DR   eggNOG; KOG2301; Eukaryota.
DR   eggNOG; ENOG410XNP6; LUCA.
DR   HOVERGEN; HBG050763; -.
DR   ChiTaRS; CACNA1A; human.
DR   GenomeRNAi; 773; -.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; NAS:UniProtKB.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0008219; P:cell death; NAS:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.120.350; -; 4.
DR   InterPro; IPR005448; CACNA1A.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01632; PQVDCCALPHA1.
DR   SMART; SM01062; Ca_chan_IQ; 1.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|RuleBase:RU003808};
KW   Calcium channel {ECO:0000256|RuleBase:RU003808};
KW   Calcium transport {ECO:0000256|RuleBase:RU003808};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Ion channel {ECO:0000256|RuleBase:RU003808};
KW   Ion transport {ECO:0000256|RuleBase:RU003808};
KW   Membrane {ECO:0000256|SAAS:SAAS00084701, ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00084701,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00084701,
KW   ECO:0000256|SAM:Phobius}; Transport {ECO:0000256|RuleBase:RU003808};
KW   Voltage-gated channel {ECO:0000256|RuleBase:RU003808}.
FT   TRANSMEM    102    119       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    139    159       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    222    245       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    337    359       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    488    507       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    519    539       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    614    636       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    690    714       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1243   1262       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1282   1303       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1315   1332       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1377   1399       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1489   1514       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1570   1588       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1600   1623       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1691   1709       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM   1787   1811       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN     1948   1982       Ca_chan_IQ. {ECO:0000259|SMART:SM01062}.
FT   COILED      367    387       {ECO:0000256|SAM:Coils}.
FT   COILED      714    746       {ECO:0000256|SAM:Coils}.
FT   COILED     2314   2337       {ECO:0000256|SAM:Coils}.
FT   NON_TER    2472   2472       {ECO:0000313|EMBL:BAA94765.1}.
SQ   SEQUENCE   2472 AA;  278848 MW;  7336313446F56240 CRC64;
     MARFGDEMPA RYGGGGSGAA AGVVVGSGGG RGAGGSRQGG QPGAQRMYKQ SMAQRARTMA
     LYNPIPVRQN CLTVNRSLFL FSEDNVVRKY AKKITEWPPF EYMILATIIA NCIVLALEQH
     LPDDDKTPMS ERLDDTEPYF IGIFCFEAGI KIIALGFAFH KGSYLRNGWN VMDFVVVLTG
     ILATVGTEFD LRTLRAVRVL RPLKLVSGIP SLQVVLKSIM KAMIPLLQIG LLLFFAILIF
     AIIGLEFYMG KFHTTCFEEG TDDIQGESPA PCGTEEPART CPNGTKCQPY WEGPNNGITQ
     FDNILFAVLT VFQCITMEGW TDLLYNSNDA SGNTWNWLYF IPLIIIGSFF MLNLVLGVLS
     GEFAKERERV ENRRAFLKLR RQQQIERELN GYMEWISKAE EVILAEDETD GEQRHPFDGA
     LRRTTIKKSK TDLLNPEEAE DQLADIASVG SPFARASIKS TKLENSTFFH KKERRMRFYI
     RRMVKTQAFY WTVLSLVALN TLCVAIVHYN QPEWLSDFLY YAEFIFLGLF MSEMFIKMYG
     LGTRPYFHSS FNCFDCGVII GSIFEVIWAV IKPGTSFGIS VLRALRLLRI FKVTKYWASL
     RNLVVSLLNS MKSIISLLFL LFLFIVVFAL LGMQLFGGQF NFDEGTPPTN FDTFPAARMT
     VFQSLTGEDW NEVMYDGIKS QGGVQGGMVF SIYFIVLTLF GNYTLLNVFL AIAVDNLANV
     LELTKDEQEE EEAANQKLAL QKAKEVAEVS PLSAANMSIA VKEQQKNQKP AKSVWEQRTS
     EMRKQNLLAS REALYNEMDP DERWKAAYTR HLRPDMKTHL DRPLVVDPQE NRNNNTNKSR
     AAEPTVDQRL GQQRAEDFLR KQARYHDRAR DPSGSAGLDA RRPWAGSQEA ELSREDPYGR
     ESDHHAREGS LEQPGFWDGE AERGKAGDPH RRHVHRQGGS RESRSGSPRT GADGEHRRHR
     AHRRPGEEGP EDKAERRARH REGSRPARGG EGEGEGPDGG ERRRRHRHGA PATYEGDARR
     EDKERRHRRR KENQGSGVPV SGPNLSTTRP IQQDLGRQDP PLAEDIDNMK NNKLATAESA
     APHGSLGHAG LPQSPAKMGN STDPGPMLAI PAMATNPQNA ASRRTPNNPG NPSNPGPPKT
     PENSLIVTNP SGTQTNSAKT ARKPDHTTVD IPPACPPPLN HTVVQVNKNA NPDPLPKKEE
     EKKEEEEDDR GEDGPKPMPP YSSMFILSTT NPLRRLCHYI LNLRYFEMCI LMVIAMSSIA
     LAAEDPVQPN APRNNVLRYF DYVFTGVFTF EMVIKMIDLG LVLHQGAYFR DLWNILDFIV
     VSGALVAFAF TGNSKGKDIN TIKSLRVLRV LRPLKTIKRL PKLKAVFDCV VNSLKNVFNI
     LIVYMLFMFI FAVVAVQLFK GKFFHCTDES KEFEKDCRGK YLLYEKNEVK ARDREWKKYE
     FHYDNVLWAL LTLFTVSTGE GWPQVLKHSV DATFENQGPS PGYRMEMSIF YVVYFVVFPF
     FFVNIFVALI IITFQEQGDK MMEEYSLEKN ERACIDFAIS AKPLTRHMPQ NKQSFQYRMW
     QFVVSPPFEY TIMAMIALNT IVLMMKFYGA SVAYENALRV FNIVFTSLFS LECVLKVMAF
     GILNYFRDAW NIFDFVTVLG SITDILVTEF GNNFINLSFL RLFRAARLIK LLRQGYTIRI
     LLWTFVQSFK ALPYVCLLIA MLFFIYAIIG MQVFGNIGID VEDEDSDEDE FQITEHNNFR
     TFFQALMLLF RSATGEAWHN IMLSCLSGKP CDKNSGILTR ECGNEFAYFY FVSFIFLCSF
     LMLNLFVAVI MDNFEYLTRD SSILGPHHLD EYVRVWAEYD PAACGRIHYK DMYSLLRVMS
     PPLGLGKKCP PGVAYKRLLR MDLPVADDNT VHFNSTLMAL IRTALDIKIA KGGADKQQMD
     AELRKEMMAI WPNLSQKTLD LLVTPHKSTD LTVGKIYAAM MIMEYYRQSK AKKLQAMREE
     QDRTPLMFQR MEPPSPTQEG GPGQNALPST QLDPGGALMA HESGLKESPS WVTQRAQEMF
     QKTGTWSPEQ GPPTDMPNSQ PNSQSVEMRE MGRDGYSDSE HYLPMEGQGR AASMPRLPAE
     NQRRRGRPRG NNLSTISDTS PMKRSASVLG PKARRLDDYS LERVPPEENQ RHHQRRRDRS
     HRASERSLGR YTDVDTGLGT DLSMTTQSGD LPSKERDQER GRPKDRKHRQ HHHHHHHHHH
     PPPPDKDRYA QERPDHGRAR ARDQRWSRSP SEGREHMAHR QGSSSVSGSP APSTSGTSTS
     RRGRRQLPQT PSTPRPHVSY SPVIRKAGGS GPPQQQQQQQ QQQQQQQQQQ QQQQQQQAVA
     RPGRAATSGP RRYPGPTAEP LAGDRPPTGG HSSGRSPRME RRVPGPARSE SPRACRHGGA
     RWPASGPHVS EGPPGPRHHG YYRGSDYDEA DGPGSGGGEE AMAGAYDAPP PVRHASSGAT
     GRSPRTPRAS GP
//
ID   K7ES52_HUMAN            Unreviewed;       180 AA.
AC   K7ES52;
DT   09-JAN-2013, integrated into UniProtKB/TrEMBL.
DT   09-JAN-2013, sequence version 1.
DT   23-MAY-2018, entry version 46.
DE   RecName: Full=Thymidine kinase {ECO:0000256|RuleBase:RU000544};
DE            EC=2.7.1.21 {ECO:0000256|RuleBase:RU000544};
GN   Name=TK1 {ECO:0000313|Ensembl:ENSP00000468556};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000468556, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000468556, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [3] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large scale characterization of plant versus mammal
RT   proteins reveals similar and idiosyncratic N-alpha-acetylation
RT   features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [6] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [7] {ECO:0000313|Ensembl:ENSP00000468556}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2012) to UniProtKB.
RN   [8] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- CATALYTIC ACTIVITY: ATP + thymidine = ADP + thymidine 5'-
CC       phosphate. {ECO:0000256|RuleBase:RU000544}.
CC   -!- SIMILARITY: Belongs to the thymidine kinase family.
CC       {ECO:0000256|RuleBase:RU004165}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC021593; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087645; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001333592.1; NM_001346663.1.
DR   UniGene; Hs.515122; -.
DR   ProteinModelPortal; K7ES52; -.
DR   SMR; K7ES52; -.
DR   MaxQB; K7ES52; -.
DR   PeptideAtlas; K7ES52; -.
DR   Ensembl; ENST00000590862; ENSP00000468556; ENSG00000167900.
DR   GeneID; 7083; -.
DR   UCSC; uc060ksz.1; human.
DR   CTD; 7083; -.
DR   EuPathDB; HostDB:ENSG00000167900.11; -.
DR   HGNC; HGNC:11830; TK1.
DR   OpenTargets; ENSG00000167900; -.
DR   eggNOG; KOG3125; Eukaryota.
DR   eggNOG; COG1435; LUCA.
DR   GeneTree; ENSGT00390000011309; -.
DR   ChiTaRS; TK1; human.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000167900; -.
DR   ExpressionAtlas; K7ES52; baseline and differential.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004797; F:thymidine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0071897; P:DNA biosynthetic process; IEA:UniProtKB-KW.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001267; Thymidine_kinase.
DR   PANTHER; PTHR11441; PTHR11441; 1.
DR   Pfam; PF00265; TK; 1.
DR   PIRSF; PIRSF035805; TK_cell; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|RuleBase:RU000544};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   DNA synthesis {ECO:0000256|RuleBase:RU000544};
KW   Kinase {ECO:0000256|RuleBase:RU000544};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000544};
KW   Proteomics identification {ECO:0000213|EPD:K7ES52,
KW   ECO:0000213|MaxQB:K7ES52, ECO:0000213|PeptideAtlas:K7ES52};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transferase {ECO:0000256|RuleBase:RU000544}.
FT   ACT_SITE     98     98       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR035805-1}.
SQ   SEQUENCE   180 AA;  19786 MW;  079C5F81644E82DA CRC64;
     MSCINLPTVL PGSPSKTRGQ IQVILGPMFS GKSTELMRRV RRFQIAQYKC LVIKYAKDTR
     YSSSFCTHDR NTMEALPACL LRDVAQEALG VAVIGIDEGQ FFPDIVEFCE AMANAGKTVI
     VAALDGTFQR KPFGAILNLV PLAESVVKLT AVCMECFREA AYTKRLGTEK EQILQCSPAN
//
ID   KITH_HUMAN              Reviewed;         234 AA.
AC   P04183; B2RC58; Q969V0; Q9UMG9;
DT   20-MAR-1987, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2002, sequence version 2.
DT   25-APR-2018, entry version 189.
DE   RecName: Full=Thymidine kinase, cytosolic;
DE            EC=2.7.1.21;
GN   Name=TK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6549046; DOI=10.1128/MCB.4.11.2316;
RA   Bradshaw H.D. Jr., Deininger P.L.;
RT   "Human thymidine kinase gene: molecular cloning and nucleotide
RT   sequence of a cDNA expressible in mammalian cells.";
RL   Mol. Cell. Biol. 4:2316-2320(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3301530; DOI=10.1016/0378-1119(87)90053-9;
RA   Flemington E., Bradshaw H.D. Jr., Traina-Dorge V., Slagel V.,
RA   Deininger P.L.;
RT   "Sequence, structure and promoter characterization of the human
RT   thymidine kinase gene.";
RL   Gene 52:267-277(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
RX   PubMed=3785218; DOI=10.1128/MCB.6.8.2903;
RA   Kreidberg J.A., Kelly T.J.;
RT   "Genetic analysis of the human thymidine kinase gene promoter.";
RL   Mol. Cell. Biol. 6:2903-2909(1986).
RN   [7]
RP   PHOSPHORYLATION AT SER-13.
RX   PubMed=9575153; DOI=10.1074/jbc.273.20.12095;
RA   Chang Z.F., Huang D.Y., Chi L.M.;
RT   "Serine 13 is the site of mitotic phosphorylation of human thymidine
RT   kinase.";
RL   J. Biol. Chem. 273:12095-12100(1998).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-231, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND SER-13, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 1-193 IN COMPLEX WITH ZINC
RP   IONS AND TTP, AND SUBUNIT.
RX   PubMed=15611477; DOI=10.1073/pnas.0406332102;
RA   Welin M., Kosinska U., Mikkelsen N.E., Carnrot C., Zhu C., Wang L.,
RA   Eriksson S., Munch-Petersen B., Eklund H.;
RT   "Structures of thymidine kinase 1 of human and mycoplasmic origin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:17970-17975(2004).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.83 ANGSTROMS) OF 15-194 IN COMPLEX WITH ZINC
RP   IONS AND TTP.
RX   PubMed=15733844; DOI=10.1016/j.febslet.2005.01.034;
RA   Birringer M.S., Claus M.T., Folkers G., Kloer D.P., Schulz G.E.,
RA   Scapozza L.;
RT   "Structure of a type II thymidine kinase with bound dTTP.";
RL   FEBS Lett. 579:1376-1382(2005).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH ZINC IONS;
RP   SUBSTRATE AND ATP ANALOG, AND SUBUNIT.
RX   PubMed=17407781; DOI=10.1016/j.jmb.2007.02.104;
RA   Segura-Pena D., Lutz S., Monnerjahn C., Konrad M., Lavie A.;
RT   "Binding of ATP to TK1-like enzymes is associated with a
RT   conformational change in the quaternary structure.";
RL   J. Mol. Biol. 369:129-141(2007).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-193 OF MUTANT SER-163,
RP   ZINC-BINDING SITES, AND MUTAGENESIS OF THR-163.
RX   PubMed=22385435; DOI=10.1111/j.1742-4658.2012.08554.x;
RA   Skovgaard T., Uhlin U., Munch-Petersen B.;
RT   "Comparative active-site mutation study of human and Caenorhabditis
RT   elegans thymidine kinase 1.";
RL   FEBS J. 279:1777-1787(2012).
CC   -!- CATALYTIC ACTIVITY: ATP + thymidine = ADP + thymidine 5'-
CC       phosphate.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15611477,
CC       ECO:0000269|PubMed:15733844, ECO:0000269|PubMed:17407781}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-712550, EBI-712550;
CC       Q1RN33:MAGEA4; NbExp=3; IntAct=EBI-712550, EBI-10194128;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- PTM: Phosphorylated on Ser-13 in mitosis.
CC       {ECO:0000269|PubMed:9575153}.
CC   -!- MISCELLANEOUS: Two forms have been identified in animal cells, one
CC       in cytosol and one in mitochondria. Activity of the cytosolic
CC       enzyme is high in proliferating cells and peaks during the S-phase
CC       of the cell cycle; it is very low in resting cells.
CC   -!- SIMILARITY: Belongs to the thymidine kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K02581; AAA61187.1; -; mRNA.
DR   EMBL; M15205; AAA61191.1; -; Genomic_DNA.
DR   EMBL; AK314950; BAG37455.1; -; mRNA.
DR   EMBL; BT006941; AAP35587.1; -; mRNA.
DR   EMBL; BC006484; AAH06484.1; -; mRNA.
DR   EMBL; BC007872; AAH07872.1; -; mRNA.
DR   EMBL; BC007986; AAH07986.1; -; mRNA.
DR   EMBL; M13643; AAA61189.1; -; Genomic_DNA.
DR   CCDS; CCDS11754.1; -.
DR   PIR; A27318; KIHUT.
DR   RefSeq; NP_003249.3; NM_003258.4.
DR   UniGene; Hs.515122; -.
DR   PDB; 1W4R; X-ray; 1.83 A; A/B/C/D/E/F/G/H=15-194.
DR   PDB; 1XBT; X-ray; 2.40 A; A/B/C/D/E/F/G/H=1-193.
DR   PDB; 2ORV; X-ray; 2.30 A; A/B=1-234.
DR   PDB; 2WVJ; X-ray; 2.20 A; A/B/C/D/E/F/G/H=1-193.
DR   PDBsum; 1W4R; -.
DR   PDBsum; 1XBT; -.
DR   PDBsum; 2ORV; -.
DR   PDBsum; 2WVJ; -.
DR   ProteinModelPortal; P04183; -.
DR   SMR; P04183; -.
DR   BioGrid; 112938; 174.
DR   IntAct; P04183; 160.
DR   MINT; P04183; -.
DR   STRING; 9606.ENSP00000301634; -.
DR   BindingDB; P04183; -.
DR   ChEMBL; CHEMBL2883; -.
DR   DrugBank; DB01692; Dithioerythritol.
DR   DrugBank; DB02452; Thymidine-5'-Triphosphate.
DR   DrugBank; DB00432; Trifluridine.
DR   DrugBank; DB00495; Zidovudine.
DR   iPTMnet; P04183; -.
DR   PhosphoSitePlus; P04183; -.
DR   BioMuta; TK1; -.
DR   DMDM; 23503074; -.
DR   EPD; P04183; -.
DR   MaxQB; P04183; -.
DR   PaxDb; P04183; -.
DR   PeptideAtlas; P04183; -.
DR   PRIDE; P04183; -.
DR   DNASU; 7083; -.
DR   Ensembl; ENST00000301634; ENSP00000301634; ENSG00000167900.
DR   GeneID; 7083; -.
DR   KEGG; hsa:7083; -.
DR   UCSC; uc002juw.3; human.
DR   CTD; 7083; -.
DR   DisGeNET; 7083; -.
DR   EuPathDB; HostDB:ENSG00000167900.11; -.
DR   GeneCards; TK1; -.
DR   HGNC; HGNC:11830; TK1.
DR   HPA; CAB004683; -.
DR   MIM; 188300; gene.
DR   neXtProt; NX_P04183; -.
DR   OpenTargets; ENSG00000167900; -.
DR   PharmGKB; PA352; -.
DR   eggNOG; KOG3125; Eukaryota.
DR   eggNOG; COG1435; LUCA.
DR   GeneTree; ENSGT00390000011309; -.
DR   HOGENOM; HOG000076390; -.
DR   HOVERGEN; HBG006215; -.
DR   InParanoid; P04183; -.
DR   KO; K00857; -.
DR   PhylomeDB; P04183; -.
DR   TreeFam; TF314839; -.
DR   BioCyc; MetaCyc:HS09657-MONOMER; -.
DR   BRENDA; 2.7.1.21; 2681.
DR   Reactome; R-HSA-539107; Activation of E2F1 target genes at G1/S.
DR   Reactome; R-HSA-73614; Pyrimidine salvage.
DR   SABIO-RK; P04183; -.
DR   SIGNOR; P04183; -.
DR   ChiTaRS; TK1; human.
DR   EvolutionaryTrace; P04183; -.
DR   GeneWiki; Thymidine_kinase_1; -.
DR   GenomeRNAi; 7083; -.
DR   PRO; PR:P04183; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000167900; -.
DR   CleanEx; HS_TK1; -.
DR   ExpressionAtlas; P04183; baseline and differential.
DR   Genevisible; P04183; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019206; F:nucleoside kinase activity; EXP:Reactome.
DR   GO; GO:0004797; F:thymidine kinase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0071897; P:DNA biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0006259; P:DNA metabolic process; IBA:GO_Central.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0051289; P:protein homotetramerization; IPI:UniProtKB.
DR   GO; GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome.
DR   GO; GO:0046104; P:thymidine metabolic process; IBA:GO_Central.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001267; Thymidine_kinase.
DR   InterPro; IPR020633; Thymidine_kinase_CS.
DR   PANTHER; PTHR11441; PTHR11441; 1.
DR   Pfam; PF00265; TK; 1.
DR   PIRSF; PIRSF035805; TK_cell; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00603; TK_CELLULAR_TYPE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Cytoplasm;
KW   DNA synthesis; Kinase; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Transferase; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    234       Thymidine kinase, cytosolic.
FT                                /FTId=PRO_0000174948.
FT   NP_BIND      26     33       ATP. {ECO:0000244|PDB:1W4R,
FT                                ECO:0000244|PDB:1XBT,
FT                                ECO:0000244|PDB:2ORV,
FT                                ECO:0000244|PDB:2WVJ,
FT                                ECO:0000269|PubMed:15611477,
FT                                ECO:0000269|PubMed:15733844,
FT                                ECO:0000269|PubMed:17407781,
FT                                ECO:0000269|PubMed:22385435}.
FT   NP_BIND      58     60       ATP. {ECO:0000244|PDB:1W4R,
FT                                ECO:0000244|PDB:1XBT,
FT                                ECO:0000244|PDB:2WVJ,
FT                                ECO:0000269|PubMed:15611477,
FT                                ECO:0000269|PubMed:15733844,
FT                                ECO:0000269|PubMed:22385435}.
FT   NP_BIND      97    100       ATP. {ECO:0000244|PDB:1W4R,
FT                                ECO:0000244|PDB:2WVJ,
FT                                ECO:0000269|PubMed:15733844,
FT                                ECO:0000269|PubMed:22385435}.
FT   REGION      172    176       Substrate binding. {ECO:0000244|PDB:1W4R,
FT                                ECO:0000244|PDB:1XBT,
FT                                ECO:0000244|PDB:2WVJ,
FT                                ECO:0000269|PubMed:15611477,
FT                                ECO:0000269|PubMed:15733844,
FT                                ECO:0000269|PubMed:22385435}.
FT   ACT_SITE     98     98       Proton acceptor. {ECO:0000255}.
FT   METAL       153    153       Zinc. {ECO:0000244|PDB:1W4R,
FT                                ECO:0000244|PDB:1XBT,
FT                                ECO:0000244|PDB:2ORV,
FT                                ECO:0000244|PDB:2WVJ,
FT                                ECO:0000269|PubMed:15611477,
FT                                ECO:0000269|PubMed:15733844,
FT                                ECO:0000269|PubMed:17407781,
FT                                ECO:0000269|PubMed:22385435}.
FT   METAL       156    156       Zinc. {ECO:0000244|PDB:1W4R,
FT                                ECO:0000244|PDB:1XBT,
FT                                ECO:0000244|PDB:2ORV,
FT                                ECO:0000244|PDB:2WVJ,
FT                                ECO:0000269|PubMed:15611477,
FT                                ECO:0000269|PubMed:15733844,
FT                                ECO:0000269|PubMed:17407781,
FT                                ECO:0000269|PubMed:22385435}.
FT   METAL       185    185       Zinc. {ECO:0000244|PDB:1W4R,
FT                                ECO:0000244|PDB:1XBT,
FT                                ECO:0000244|PDB:2ORV,
FT                                ECO:0000244|PDB:2WVJ,
FT                                ECO:0000269|PubMed:15611477,
FT                                ECO:0000269|PubMed:15733844,
FT                                ECO:0000269|PubMed:17407781,
FT                                ECO:0000269|PubMed:22385435}.
FT   METAL       188    188       Zinc. {ECO:0000244|PDB:1W4R,
FT                                ECO:0000244|PDB:1XBT,
FT                                ECO:0000244|PDB:2ORV,
FT                                ECO:0000244|PDB:2WVJ,
FT                                ECO:0000269|PubMed:15611477,
FT                                ECO:0000269|PubMed:15733844,
FT                                ECO:0000269|PubMed:17407781,
FT                                ECO:0000269|PubMed:22385435}.
FT   BINDING     128    128       Substrate; via amide nitrogen.
FT                                {ECO:0000244|PDB:1W4R,
FT                                ECO:0000244|PDB:1XBT,
FT                                ECO:0000244|PDB:2ORV,
FT                                ECO:0000244|PDB:2WVJ,
FT                                ECO:0000269|PubMed:15611477,
FT                                ECO:0000269|PubMed:15733844,
FT                                ECO:0000269|PubMed:17407781,
FT                                ECO:0000269|PubMed:22385435}.
FT   BINDING     181    181       Substrate. {ECO:0000244|PDB:1W4R,
FT                                ECO:0000244|PDB:1XBT,
FT                                ECO:0000244|PDB:2ORV,
FT                                ECO:0000269|PubMed:15611477,
FT                                ECO:0000269|PubMed:15733844,
FT                                ECO:0000269|PubMed:17407781,
FT                                ECO:0000269|PubMed:22385435}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:9575153}.
FT   MOD_RES     231    231       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:20068231}.
FT   MUTAGEN     163    163       T->S: 140-fold lower K(m) for AZT.
FT                                {ECO:0000269|PubMed:22385435}.
FT   CONFLICT    106    106       V -> M (in Ref. 1; AAA61187 and 2;
FT                                AAA61191). {ECO:0000305}.
FT   STRAND       20     26       {ECO:0000244|PDB:1W4R}.
FT   HELIX        32     45       {ECO:0000244|PDB:1W4R}.
FT   STRAND       50     55       {ECO:0000244|PDB:1W4R}.
FT   HELIX        61     63       {ECO:0000244|PDB:1W4R}.
FT   HELIX        67     72       {ECO:0000244|PDB:1W4R}.
FT   STRAND       73     80       {ECO:0000244|PDB:1W4R}.
FT   HELIX        81     84       {ECO:0000244|PDB:1W4R}.
FT   HELIX        85     89       {ECO:0000244|PDB:1W4R}.
FT   STRAND       92     98       {ECO:0000244|PDB:1W4R}.
FT   HELIX        99    101       {ECO:0000244|PDB:1W4R}.
FT   HELIX       105    114       {ECO:0000244|PDB:1W4R}.
FT   STRAND      118    126       {ECO:0000244|PDB:1W4R}.
FT   STRAND      130    132       {ECO:0000244|PDB:1W4R}.
FT   HELIX       136    142       {ECO:0000244|PDB:1W4R}.
FT   STRAND      144    148       {ECO:0000244|PDB:1W4R}.
FT   TURN        154    156       {ECO:0000244|PDB:1W4R}.
FT   STRAND      158    160       {ECO:0000244|PDB:1W4R}.
FT   STRAND      162    167       {ECO:0000244|PDB:1W4R}.
FT   TURN        178    180       {ECO:0000244|PDB:1W4R}.
FT   STRAND      181    184       {ECO:0000244|PDB:1W4R}.
FT   HELIX       186    189       {ECO:0000244|PDB:1W4R}.
SQ   SEQUENCE   234 AA;  25469 MW;  76901415C631EF21 CRC64;
     MSCINLPTVL PGSPSKTRGQ IQVILGPMFS GKSTELMRRV RRFQIAQYKC LVIKYAKDTR
     YSSSFCTHDR NTMEALPACL LRDVAQEALG VAVIGIDEGQ FFPDIVEFCE AMANAGKTVI
     VAALDGTFQR KPFGAILNLV PLAESVVKLT AVCMECFREA AYTKRLGTEK EVEVIGGADK
     YHSVCRLCYF KKASGQPAGP DNKENCPVPG KPGEAVAARK LFAPQQILQC SPAN
//
ID   E9KL36_HUMAN            Unreviewed;       147 AA.
AC   E9KL36;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   23-MAY-2018, entry version 63.
DE   RecName: Full=Transthyretin {ECO:0000256|RuleBase:RU361269};
GN   Name=HEL111 {ECO:0000313|EMBL:ACJ13724.1};
GN   Synonyms=TTR {ECO:0000313|EMBL:EAX01266.1};
GN   ORFNames=hCG_25470 {ECO:0000313|EMBL:EAX01266.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADU87635.1};
RN   [1] {ECO:0000313|EMBL:EAX01266.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX01266.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACJ13724.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ADU87635.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=20736409; DOI=10.1074/mcp.M110.001719;
RA   Li J., Liu F., Wang H., Liu X., Liu J., Li N., Wan F., Wang W.,
RA   Zhang C., Jin S., Liu J., Zhu P., Liu Y.;
RT   "Systematic mapping and functional analysis of a family of human
RT   epididymal secretory sperm-located proteins.";
RL   Mol. Cell. Proteomics 9:2517-2528(2010).
RN   [5] {ECO:0000313|EMBL:ADU87635.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RL   Submitted (JAN-2010) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Thyroid hormone-binding protein. Probably transports
CC       thyroxine from the bloodstream to the brain.
CC       {ECO:0000256|RuleBase:RU361269}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000256|RuleBase:RU361269}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|RuleBase:RU361269}.
CC   -!- SIMILARITY: Belongs to the transthyretin family.
CC       {ECO:0000256|RuleBase:RU361269}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU794670; ACJ13724.1; -; mRNA.
DR   EMBL; GU727633; ADU87635.1; -; mRNA.
DR   EMBL; CH471088; EAX01266.1; -; Genomic_DNA.
DR   RefSeq; NP_000362.1; NM_000371.3.
DR   UniGene; Hs.427202; -.
DR   SMR; E9KL36; -.
DR   PRIDE; E9KL36; -.
DR   DNASU; 7276; -.
DR   GeneID; 7276; -.
DR   KEGG; hsa:7276; -.
DR   CTD; 7276; -.
DR   EuPathDB; HostDB:ENSG00000118271.9; -.
DR   eggNOG; KOG3006; Eukaryota.
DR   eggNOG; COG2351; LUCA.
DR   KO; K20731; -.
DR   ChiTaRS; TTR; human.
DR   GenomeRNAi; 7276; -.
DR   Bgee; ENSG00000118271; -.
DR   ExpressionAtlas; E9KL36; baseline and differential.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0070324; F:thyroid hormone binding; IEA:InterPro.
DR   GO; GO:0042572; P:retinol metabolic process; IEA:InterPro.
DR   GO; GO:0070327; P:thyroid hormone transport; IEA:InterPro.
DR   Gene3D; 2.60.40.180; -; 1.
DR   InterPro; IPR023418; Thyroxine_BS.
DR   InterPro; IPR030178; Transthyretin.
DR   InterPro; IPR000895; Transthyretin/HIU_hydrolase.
DR   InterPro; IPR023416; Transthyretin/HIU_hydrolase_d.
DR   InterPro; IPR036817; Transthyretin/HIU_hydrolase_sf.
DR   InterPro; IPR023419; Transthyretin_CS.
DR   PANTHER; PTHR10395; PTHR10395; 1.
DR   PANTHER; PTHR10395:SF12; PTHR10395:SF12; 1.
DR   Pfam; PF00576; Transthyretin; 1.
DR   PRINTS; PR00189; TRNSTHYRETIN.
DR   SMART; SM00095; TR_THY; 1.
DR   SUPFAM; SSF49472; SSF49472; 1.
DR   PROSITE; PS00768; TRANSTHYRETIN_1; 1.
DR   PROSITE; PS00769; TRANSTHYRETIN_2; 1.
PE   2: Evidence at transcript level;
KW   Hormone {ECO:0000256|RuleBase:RU361269};
KW   Secreted {ECO:0000256|RuleBase:RU361269};
KW   Signal {ECO:0000256|RuleBase:RU361269};
KW   Thyroid hormone {ECO:0000256|RuleBase:RU361269}.
FT   SIGNAL        1     20       {ECO:0000256|RuleBase:RU361269}.
FT   CHAIN        21    147       Transthyretin.
FT                                {ECO:0000256|RuleBase:RU361269}.
FT                                /FTId=PRO_5014205518.
FT   DOMAIN       27    147       TR_THY. {ECO:0000259|SMART:SM00095}.
SQ   SEQUENCE   147 AA;  15887 MW;  3A6AEBCBBA56BC44 CRC64;
     MASHRLLLLC LAGLVFVSEA GPTGTGESKC PLMVKVLDAV RGSPAINVAV HVFRKAADDT
     WEPFASGKTS ESGELHGLTT EEEFVEGIYK VEIDTKSYWK ALGISPFHEH AEVVFTANDS
     GPRRYTIAAL LSPYSYSTTA VVTNPKE
//
ID   TTHY_HUMAN              Reviewed;         147 AA.
AC   P02766; Q549C7; Q6IB96; Q9UBZ6; Q9UCM9;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-1987, sequence version 1.
DT   23-MAY-2018, entry version 228.
DE   RecName: Full=Transthyretin;
DE   AltName: Full=ATTR;
DE   AltName: Full=Prealbumin;
DE   AltName: Full=TBPA;
DE   Flags: Precursor;
GN   Name=TTR; Synonyms=PALB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=6093805; DOI=10.1016/0006-291X(84)91590-0;
RA   Mita S., Maeda S., Shimada K., Araki S.;
RT   "Cloning and sequence analysis of cDNA for human prealbumin.";
RL   Biochem. Biophys. Res. Commun. 124:558-564(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2990465; DOI=10.1016/0006-291X(85)91956-4;
RA   Wallace M.R., Naylor S.L., Kluve-Beckerman B., Long G.L., McDonald L.,
RA   Shows T.B., Benson M.D.;
RT   "Localization of the human prealbumin gene to chromosome 18.";
RL   Biochem. Biophys. Res. Commun. 129:753-758(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=4054629; DOI=10.1016/0378-1119(85)90272-0;
RA   Sasaki H., Yoshioka N., Takagi Y., Sakaki Y.;
RT   "Structure of the chromosomal gene for human serum prealbumin.";
RL   Gene 37:191-197(1985).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2995367;
RA   Tsuzuki T., Mita S., Maeda S., Araki S., Shimada K.;
RT   "Structure of the human prealbumin gene.";
RL   J. Biol. Chem. 260:12224-12227(1985).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT AMYL-TTR MET-50.
RX   PubMed=3818577;
RA   Mita S., Maeda S., Shimada K., Araki S.;
RT   "Analyses of prealbumin mRNAs in individuals with familial amyloidotic
RT   polyneuropathy.";
RL   J. Biochem. 100:1215-1222(1986).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT AMYL-TTR MET-50.
RC   TISSUE=Liver;
RX   PubMed=3022108;
RA   Maeda S., Mita S., Araki S., Shimada K.;
RT   "Structure and expression of the mutant prealbumin gene associated
RT   with familial amyloidotic polyneuropathy.";
RL   Mol. Biol. Med. 3:329-338(1986).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 22-28.
RC   TISSUE=Liver;
RX   PubMed=2015890; DOI=10.1016/0014-5793(91)80387-I;
RA   Christmanson L., Betsholtz C., Gustavsson A., Johansson B.,
RA   Sletten K., Westermark P.;
RT   "The transthyretin cDNA sequence is normal in transthyretin-derived
RT   senile systemic amyloidosis.";
RL   FEBS Lett. 281:177-180(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=1666289;
RA   Gu J.R., Jiang H.Q., He L.P., Li D.Z., Zhou X.M., Dai W.L., Qian L.F.,
RA   Chen Y.Q., Schweinfest C., Papas T.;
RT   "Transthyretin (prealbumin) gene in human primary hepatic cancer.";
RL   Sci. China, Ser. B, Chem. Life Sci. Earth Sci. 34:1312-1318(1991).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Retina;
RX   PubMed=10328977; DOI=10.1006/exer.1998.0646;
RA   Getz R.K., Kennedy B.G., Mangini N.J.;
RT   "Transthyretin localization in cultured and native human retinal
RT   pigment epithelium.";
RL   Exp. Eye Res. 68:629-636(1999).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Corpus callosum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   PROTEIN SEQUENCE OF 21-147.
RX   PubMed=4607556;
RA   Kanda Y., Goodman D.S., Canfield R.E., Morgan F.J.;
RT   "The amino acid sequence of human plasma prealbumin.";
RL   J. Biol. Chem. 249:6796-6805(1974).
RN   [16]
RP   PRELIMINARY PROTEIN SEQUENCE OF 21-147, AND VARIANT SER-26.
RX   PubMed=6300852; DOI=10.1073/pnas.80.2.539;
RA   Pras M., Prelli F., Franklin E.C., Frangione B.;
RT   "Primary structure of an amyloid prealbumin variant in familial
RT   polyneuropathy of Jewish origin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:539-542(1983).
RN   [17]
RP   PROTEIN SEQUENCE OF 21-147, AND VARIANT AMYL-TTR MET-50.
RX   PubMed=6651852; DOI=10.1016/S0006-291X(83)80224-1;
RA   Tawara S., Nakazato M., Kangawa K., Matsuo H., Araki S.;
RT   "Identification of amyloid prealbumin variant in familial amyloidotic
RT   polyneuropathy (Japanese type).";
RL   Biochem. Biophys. Res. Commun. 116:880-888(1983).
RN   [18]
RP   PROTEIN SEQUENCE OF 21-147, AND VARIANT AMYL-TTR MET-50.
RX   PubMed=6583672; DOI=10.1073/pnas.81.3.694;
RA   Dwulet F.E., Benson M.D.;
RT   "Primary structure of an amyloid prealbumin and its plasma precursor
RT   in a heredofamilial polyneuropathy of Swedish origin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:694-698(1984).
RN   [19]
RP   PROTEIN SEQUENCE OF 21-147, AND VARIANT AMYL-TTR ILE-142.
RX   PubMed=3135807; DOI=10.1016/0006-291X(88)90188-X;
RA   Cornwell G.G. III, Sletten K., Johansson B., Westermark P.;
RT   "Evidence that the amyloid fibril protein in senile systemic
RT   amyloidosis is derived from normal prealbumin.";
RL   Biochem. Biophys. Res. Commun. 154:648-653(1988).
RN   [20]
RP   PROTEIN SEQUENCE OF 21-147, AND VARIANT AMYL-TTR MET-50.
RX   PubMed=1517749; DOI=10.1016/0022-510X(92)90048-P;
RA   Kametani F., Ikeda S., Yanagisawa N., Ishi T., Hanyu N.;
RT   "Characterization of a transthyretin-related amyloid fibril protein
RT   from cerebral amyloid angiopathy in type I familial amyloid
RT   polyneuropathy.";
RL   J. Neurol. Sci. 108:178-183(1992).
RN   [21]
RP   PROTEIN SEQUENCE OF 21-41.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 24-67, AND VARIANT AMYL-TTR
RP   LEU-53.
RX   PubMed=1932142; DOI=10.1016/0925-4439(91)90033-6;
RA   Harding J., Skare J., Skinner M.;
RT   "A second transthyretin mutation at position 33 (Leu/Phe) associated
RT   with familial amyloidotic polyneuropathy.";
RL   Biochim. Biophys. Acta 1097:183-186(1991).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 24-67, VARIANT AMYL-TTR GLY-62,
RP   AND VARIANT ASN-110.
RX   PubMed=7923855;
RA   Skare J.C., Jones L.A., Myles N., Kane K., Milunsky A., Cohen A.S.,
RA   Skinner M.;
RT   "Two transthyretin mutations (Glu42Gly, His90Asn) in an Italian family
RT   with amyloidosis.";
RL   Clin. Genet. 45:281-284(1994).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 31-147.
RX   PubMed=4044580;
RA   Soprano D.R., Herbert J., Soprano K.J., Schon E.A., Goodman D.S.;
RT   "Demonstration of transthyretin mRNA in the brain and other
RT   extrahepatic tissues in the rat.";
RL   J. Biol. Chem. 260:11793-11798(1985).
RN   [25]
RP   PROTEIN SEQUENCE OF 42-68; 101-123 AND 125-146, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [26]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 113-129, AND VARIANT DTTRH
RP   THR-129.
RX   PubMed=1979335; DOI=10.1172/JCI114938;
RA   Moses A.C., Rosen H.N., Moller D.E., Tsuzaki S., Haddow J.E.,
RA   Lawlor J., Liepnieks J.J., Nichols W.C., Benson M.D.;
RT   "A point mutation in transthyretin increases affinity for thyroxine
RT   and produces euthyroid hyperthyroxinemia.";
RL   J. Clin. Invest. 86:2025-2033(1990).
RN   [27]
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=7474944;
RA   Gustavsson A., Jahr H., Tobiassen R., Jacobson D.R., Sletten K.,
RA   Westermark P.;
RT   "Amyloid fibril composition and transthyretin gene structure in senile
RT   systemic amyloidosis.";
RL   Lab. Invest. 73:703-708(1995).
RN   [28]
RP   BINDING SITES FOR THYROID HORMONES.
RX   PubMed=201845; DOI=10.1038/268115a0;
RA   Blake C.C.F., Oatley S.J.;
RT   "Protein-DNA and protein-hormone interactions in prealbumin: a model
RT   of the thyroid hormone nuclear receptor?";
RL   Nature 268:115-120(1977).
RN   [29]
RP   FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=3714052; DOI=10.1212/WNL.36.7.900;
RA   Herbert J., Wilcox J.N., Pham K.T., Fremeau R.T. Jr., Zeviani M.,
RA   Dwork A., Soprano D.R., Makover A., Goodman D.S., Zimmerman E.A.,
RA   Roberts J.L., Schon E.A.;
RT   "Transthyretin: a choroid plexus-specific transport protein in human
RT   brain. The 1986 S. Weir Mitchell award.";
RL   Neurology 36:900-911(1986).
RN   [30]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Plasma;
RX   PubMed=14760718; DOI=10.1002/pmic.200300556;
RA   Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
RT   "Screening for N-glycosylated proteins by liquid chromatography mass
RT   spectrometry.";
RL   Proteomics 4:454-465(2004).
RN   [31]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-118.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [32]
RP   GAMMA-CARBOXYGLUTAMATION AT GLU-62, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=18221012; DOI=10.2174/092986608783330297;
RA   Rueggeberg S., Horn P., Li X., Vajkoczy P., Franz T.;
RT   "Detection of a gamma-carboxy-glutamate as novel post-translational
RT   modification of human transthyretin.";
RL   Protein Pept. Lett. 15:43-46(2008).
RN   [33]
RP   GLYCOSYLATION AT ASN-118, AND CHARACTERIZATION OF VARIANT AMYL-TTR
RP   GLY-38.
RX   PubMed=19167329; DOI=10.1016/j.cell.2008.11.047;
RA   Ruiz-Canada C., Kelleher D.J., Gilmore R.;
RT   "Cotranslational and posttranslational N-glycosylation of polypeptides
RT   by distinct mammalian OST isoforms.";
RL   Cell 136:272-283(2009).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=4216640; DOI=10.1016/0022-2836(74)90291-5;
RA   Blake C.C.F., Geisow M.J., Swan I.D.A., Rerat C., Rerat B.;
RT   "Structure of human plasma prealbumin at 2.5-A resolution. A
RT   preliminary report on the polypeptide chain conformation, quaternary
RT   structure and thyroxine binding.";
RL   J. Mol. Biol. 88:1-12(1974).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=671542; DOI=10.1016/0022-2836(78)90368-6;
RA   Blake C.C.F., Geisow M.J., Oatley S.J., Rerat B., Rerat C.;
RT   "Structure of prealbumin: secondary, tertiary and quaternary
RT   interactions determined by Fourier refinement at 1.8 A.";
RL   J. Mol. Biol. 121:339-356(1978).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF VARIANT AMYL-TTR MET-50.
RX   PubMed=8382610;
RA   Terry C.J., Damas A.M., Oliveira P., Saraiva M.J.M., Alves I.L.,
RA   Costa P.P., Matias P.M., Sakaki Y., Blake C.C.F.;
RT   "Structure of Met30 variant of transthyretin and its amyloidogenic
RT   implications.";
RL   EMBO J. 12:735-741(1993).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF VARIANT AMYL-TTR MET-50.
RX   PubMed=8428915;
RA   Hamilton J.A., Steinrauf L.K., Braden B.C., Liepnieks J., Benson M.D.,
RA   Holmgren G., Sandgren O., Steen L.;
RT   "The X-ray crystal structure refinements of normal human transthyretin
RT   and the amyloidogenic Val-30-->Met variant to 1.7-A resolution.";
RL   J. Biol. Chem. 268:2416-2424(1993).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF COMPLEX WITH RBP.
RX   PubMed=7754382; DOI=10.1126/science.7754382;
RA   Monaco H.L., Rizzi M., Coda A.;
RT   "Structure of a complex of two plasma proteins: transthyretin and
RT   retinol-binding protein.";
RL   Science 268:1039-1041(1995).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF VARIANTS.
RX   PubMed=9818054; DOI=10.3109/13506129809003843;
RA   Schormann N., Murrell J.R., Benson M.D.;
RT   "Tertiary structures of amyloidogenic and non-amyloidogenic
RT   transthyretin variants: new model for amyloid fibril formation.";
RL   Amyloid 5:175-187(1998).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 21-147 OF VARIANT AMYL-TTR
RP   PRO-75.
RX   PubMed=9733771; DOI=10.1074/jbc.273.38.24715;
RA   Sebastiao M.P., Saraiva M.J., Damas A.M.;
RT   "The crystal structure of amyloidogenic Leu55 --> Pro transthyretin
RT   variant reveals a possible pathway for transthyretin polymerization
RT   into amyloid fibrils.";
RL   J. Biol. Chem. 273:24715-24722(1998).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   PubMed=9789022; DOI=10.1073/pnas.95.22.12956;
RA   Peterson S.A., Klabunde T., Lashuel H.A., Purkey H., Sacchettini J.C.,
RA   Kelly J.W.;
RT   "Inhibiting transthyretin conformational changes that lead to amyloid
RT   fibril formation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:12956-12960(1998).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF COMPLEX WITH RBP4, AND
RP   SUBUNIT.
RX   PubMed=10052934; DOI=10.1021/bi982291i;
RA   Naylor H.M., Newcomer M.E.;
RT   "The structure of human retinol-binding protein (RBP) with its carrier
RT   protein transthyretin reveals an interaction with the carboxy terminus
RT   of RBP.";
RL   Biochemistry 38:2647-2653(1999).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 21-147.
RX   PubMed=10986125; DOI=10.1006/jmbi.2000.4078;
RA   Hoernberg A., Eneqvist T., Olofsson A., Lundgren E.,
RA   Sauer-Eriksson A.E.;
RT   "A comparative analysis of 23 structures of the amyloidogenic protein
RT   transthyretin.";
RL   J. Mol. Biol. 302:649-669(2000).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   PubMed=10742177; DOI=10.1038/74082;
RA   Klabunde T., Petrassi H.M., Oza V.B., Raman P., Kelly J.W.,
RA   Sacchettini J.C.;
RT   "Rational design of potent human transthyretin amyloid disease
RT   inhibitors.";
RL   Nat. Struct. Biol. 7:312-321(2000).
RN   [46]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 21-147, MUTAGENESIS OF
RP   PHE-107 AND LEU-130, IDENTIFICATION BY MASS SPECTROMETRY, FORMATION OF
RP   AMYLOID FIBERS AT ACIDIC PH, AND SUBUNIT.
RX   PubMed=11560492; DOI=10.1021/bi011194d;
RA   Jiang X., Smith C.S., Petrassi H.M., Hammarstroem P., White J.T.,
RA   Sacchettini J.C., Kelly J.W.;
RT   "An engineered transthyretin monomer that is nonamyloidogenic, unless
RT   it is partially denatured.";
RL   Biochemistry 40:11442-11452(2001).
RN   [47]
RP   X-RAY CRYSTALLOGRAPHY (1.1 ANGSTROMS) OF 30-144 OF VARIANT AMYL-TTR
RP   MET-50 AND VARIANT CHICAGO MET-139 IN COMPLEX WITH L-THYROXINE, AND
RP   SUBUNIT.
RX   PubMed=11243784; DOI=10.1006/jmbi.2000.4415;
RA   Sebastiao M.P., Lamzin V., Saraiva M.J., Damas A.M.;
RT   "Transthyretin stability as a key factor in amyloidogenesis: X-ray
RT   analysis at atomic resolution.";
RL   J. Mol. Biol. 306:733-744(2001).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 21-147 OF VARIANT AMYL-TTR
RP   CYS-134.
RX   PubMed=12403615; DOI=10.1021/bi025800w;
RA   Eneqvist T., Olofsson A., Ando Y., Miyakawa T., Katsuragi S., Jass J.,
RA   Lundgren E., Sauer-Eriksson A.E.;
RT   "Disulfide-bond formation in the transthyretin mutant Y114C prevents
RT   amyloid fibril formation in vivo and in vitro.";
RL   Biochemistry 41:13143-13151(2002).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS) OF 21-147IN COMPLEX WITH
RP   AMYLOIDOGENESIS INHIBITORS.
RX   PubMed=12820260; DOI=10.1002/anie.200351179;
RA   Razavi H., Palaninathan S.K., Powers E.T., Wiseman R.L., Purkey H.E.,
RA   Mohamedmohaideen N.N., Deechongkit S., Chiang K.P., Dendle M.T.A.,
RA   Sacchettini J.C., Kelly J.W.;
RT   "Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis,
RT   evaluation, and mechanism of action.";
RL   Angew. Chem. Int. Ed. 42:2758-2761(2003).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (1.46 ANGSTROMS) OF 21-147 IN COMPLEX WITH
RP   AMYLOIDOGENESIS INHIBITORS, AND FIBRIL FORMATION.
RX   PubMed=14583036; DOI=10.1021/ja030294z;
RA   Green N.S., Palaninathan S.K., Sacchettini J.C., Kelly J.W.;
RT   "Synthesis and characterization of potent bivalent amyloidosis
RT   inhibitors that bind prior to transthyretin tetramerization.";
RL   J. Am. Chem. Soc. 125:13404-13414(2003).
RN   [51]
RP   X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS) OF 21-147 IN COMPLEX WITH
RP   DIFLUNISAL ANALOGS, AND INHIBITION OF AMYLOID FORMATION.
RX   PubMed=14711308; DOI=10.1021/jm030347n;
RA   Adamski-Werner S.L., Palaninathan S.K., Sacchettini J.C., Kelly J.W.;
RT   "Diflunisal analogues stabilize the native state of transthyretin.
RT   Potent inhibition of amyloidogenesis.";
RL   J. Med. Chem. 47:355-374(2004).
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 21-147 OF VARIANT AMYL-TTR
RP   PHE-98 AND VARIANT HIS-124, AND SUBUNIT.
RX   PubMed=15735344; DOI=10.1107/S0907444904034316;
RA   Neto-Silva R.M., Macedo-Ribeiro S., Pereira P.J.B., Coll M.,
RA   Saraiva M.J., Damas A.M.;
RT   "X-ray crystallographic studies of two transthyretin variants: further
RT   insights into amyloidogenesis.";
RL   Acta Crystallogr. D 61:333-339(2005).
RN   [53]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 21-147 IN COMPLEXES WITH
RP   CHLORIDE AND IODIDE IONS.
RX   PubMed=15981995; DOI=10.1021/bi050249z;
RA   Hoernberg A., Hultdin U.W., Olofsson A., Sauer-Eriksson A.E.;
RT   "The effect of iodide and chloride on transthyretin structure and
RT   stability.";
RL   Biochemistry 44:9290-9299(2005).
RN   [54]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 21-147 OF VARIANT AMYL-TTR
RP   CYS-134.
RX   PubMed=16185074; DOI=10.1021/bi050795s;
RA   Karlsson A., Olofsson A., Eneqvist T., Sauer-Eriksson A.E.;
RT   "Cys114-linked dimers of transthyretin are compatible with amyloid
RT   formation.";
RL   Biochemistry 44:13063-13070(2005).
RN   [55]
RP   X-RAY CRYSTALLOGRAPHY (1.69 ANGSTROMS) OF 21-147 IN COMPLEX WITH
RP   THYROID HORMONE ANALOG, AND SUBUNIT.
RX   PubMed=15826192; DOI=10.1021/ja042929f;
RA   Wiseman R.L., Johnson S.M., Kelker M.S., Foss T., Wilson I.A.,
RA   Kelly J.W.;
RT   "Kinetic stabilization of an oligomeric protein by a single ligand
RT   binding event.";
RL   J. Am. Chem. Soc. 127:5540-5551(2005).
RN   [56]
RP   X-RAY CRYSTALLOGRAPHY (1.36 ANGSTROMS) OF 31-147, AND SUBUNIT.
RX   PubMed=15769474; DOI=10.1016/j.jmb.2005.01.050;
RA   Foss T.R., Kelker M.S., Wiseman R.L., Wilson I.A., Kelly J.W.;
RT   "Kinetic stabilization of the native state by protein engineering:
RT   implications for inhibition of transthyretin amyloidogenesis.";
RL   J. Mol. Biol. 347:841-854(2005).
RN   [57]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 21-147 OF WILD-TYPE AND
RP   VARIANTS AMYL-TTR PRO-75 AND PHE-98.
RX   PubMed=16627944; DOI=10.1107/S0907444906006962;
RA   Morais-de-Sa E., Neto-Silva R.M., Pereira P.J.B., Saraiva M.J.,
RA   Damas A.M.;
RT   "The binding of 2,4-dinitrophenol to wild-type and amyloidogenic
RT   transthyretin.";
RL   Acta Crystallogr. D 62:512-519(2006).
RN   [58]
RP   X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 21-147.
RX   PubMed=17175208; DOI=10.1016/j.bbapap.2006.10.015;
RA   Gales L., Saraiva M.J., Damas A.M.;
RT   "Structural basis for the protective role of sulfite against
RT   transthyretin amyloid formation.";
RL   Biochim. Biophys. Acta 1774:59-64(2007).
RN   [59]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 21-147.
RX   PubMed=17196219; DOI=10.1016/j.jmb.2006.11.076;
RA   Pasquato N., Berni R., Folli C., Alfieri B., Cendron L., Zanotti G.;
RT   "Acidic pH-induced conformational changes in amyloidogenic mutant
RT   transthyretin.";
RL   J. Mol. Biol. 366:711-719(2007).
RN   [60]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 21-147 IN COMPLEX WITH
RP   3,5-DIIODOSALICYLIC ACID, AND THYROXINE BINDING.
RX   PubMed=18155178; DOI=10.1016/j.bbapap.2007.11.014;
RA   Gales L., Almeida M.R., Arsequell G., Valencia G., Saraiva M.J.,
RA   Damas A.M.;
RT   "Iodination of salicylic acid improves its binding to transthyretin.";
RL   Biochim. Biophys. Acta 1784:512-517(2008).
RN   [61]
RP   X-RAY CRYSTALLOGRAPHY (3.38 ANGSTROMS) OF 21-147 IN COMPLEX WITH RBP4.
RX   PubMed=19021760; DOI=10.1111/j.1742-4658.2008.06705.x;
RA   Zanotti G., Folli C., Cendron L., Alfieri B., Nishida S.K.,
RA   Gliubich F., Pasquato N., Negro A., Berni R.;
RT   "Structural and mutational analyses of protein-protein interactions
RT   between transthyretin and retinol-binding protein.";
RL   FEBS J. 275:5841-5854(2008).
RN   [62]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 21-147 IN COMPLEX WITH
RP   2-ARYLBENZOXAZOLE-BASED TRANSTHYRETIN AMYLOIDOGENESIS INHIBITORS.
RX   PubMed=18095641; DOI=10.1021/jm0708735;
RA   Johnson S.M., Connelly S., Wilson I.A., Kelly J.W.;
RT   "Biochemical and structural evaluation of highly selective 2-
RT   arylbenzoxazole-based transthyretin amyloidogenesis inhibitors.";
RL   J. Med. Chem. 51:260-270(2008).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 21-147 IN COMPLEX WITH
RP   BISARYL AMYLOIDOGENESIS INHIBITORS.
RX   PubMed=18811132; DOI=10.1021/jm800435s;
RA   Johnson S.M., Connelly S., Wilson I.A., Kelly J.W.;
RT   "Toward optimization of the linker substructure common to
RT   transthyretin amyloidogenesis inhibitors using biochemical and
RT   structural studies.";
RL   J. Med. Chem. 51:6348-6358(2008).
RN   [64]
RP   X-RAY CRYSTALLOGRAPHY (1.72 ANGSTROMS) OF 21-147 AT PH 3.5 AND 4.5.
RX   PubMed=18662699; DOI=10.1016/j.jmb.2008.07.029;
RA   Palaninathan S.K., Mohamedmohaideen N.N., Snee W.C., Kelly J.W.,
RA   Sacchettini J.C.;
RT   "Structural insight into pH-induced conformational changes within the
RT   native human transthyretin tetramer.";
RL   J. Mol. Biol. 382:1157-1167(2008).
RN   [65]
RP   X-RAY CRYSTALLOGRAPHY (1.38 ANGSTROMS) OF 21-147.
RG   Mycobacterium tuberculosis structural genomics consortium (TB);
RT   "Crystal structure of the F87M/L110M mutant of human transthyretin at
RT   pH 4.6 soaked.";
RL   Submitted (JUL-2008) to the PDB data bank.
RN   [66]
RP   REVIEW ON VARIANTS.
RX   PubMed=7599630; DOI=10.1002/humu.1380050302;
RA   Saraiva M.J.M.;
RT   "Transthyretin mutations in health and disease.";
RL   Hum. Mutat. 5:191-196(1995).
RN   [67]
RP   VARIANT AMYL-TTR ILE-53.
RX   PubMed=6487335; DOI=10.1016/S0006-291X(84)80222-3;
RA   Nakazato M., Kangawa K., Minamino N., Tawara S., Matsuo H., Araki S.;
RT   "Revised analysis of amino acid replacement in a prealbumin variant
RT   (SKO-III) associated with familial amyloidotic polyneuropathy of
RT   Jewish origin.";
RL   Biochem. Biophys. Res. Commun. 123:921-928(1984).
RN   [68]
RP   VARIANT AMYL-TTR SER-104.
RX   PubMed=3722385; DOI=10.1172/JCI112573;
RA   Wallace M.R., Dwulet F.E., Conneally P.M., Benson M.D.;
RT   "Biochemical and molecular genetic characterization of a new variant
RT   prealbumin associated with hereditary amyloidosis.";
RL   J. Clin. Invest. 78:6-12(1986).
RN   [69]
RP   VARIANT VAL-136.
RX   PubMed=3675594; DOI=10.1016/0006-291X(87)91135-1;
RA   Strahler J.R., Rosenblum B.B., Hanash S.M.;
RT   "Identification and characterization of a human transthyretin
RT   variant.";
RL   Biochem. Biophys. Res. Commun. 148:471-477(1987).
RN   [70]
RP   VARIANT AMYL-TTR TYR-97.
RX   PubMed=2891727; DOI=10.1172/JCI113293;
RA   Wallace M.R., Dwulet F.E., Williams E.C., Conneally P.M., Benson M.D.;
RT   "Identification of a new hereditary amyloidosis prealbumin variant,
RT   Tyr-77, and detection of the gene by DNA analysis.";
RL   J. Clin. Invest. 81:189-193(1988).
RN   [71]
RP   VARIANT AMYL-TTR CYS-134.
RX   PubMed=2161654; DOI=10.1016/0006-291X(90)91445-X;
RA   Ueno S., Uemichi T., Yorifuji S., Tarui S.;
RT   "A novel variant of transthyretin (Tyr114 to Cys) deduced from the
RT   nucleotide sequences of gene fragments from familial amyloidotic
RT   polyneuropathy in Japanese sibling cases.";
RL   Biochem. Biophys. Res. Commun. 169:143-147(1990).
RN   [72]
RP   VARIANTS AMYL-TTR GLY-62 AND ARG-70.
RX   PubMed=2363717; DOI=10.1016/0006-291X(90)92011-N;
RA   Ueno S., Uemichi T., Takahashi N., Soga F., Yorifuji S., Tarui S.;
RT   "Two novel variants of transthyretin identified in Japanese cases with
RT   familial amyloidotic polyneuropathy: transthyretin (Glu42 to Gly) and
RT   transthyretin (Ser50 to Arg).";
RL   Biochem. Biophys. Res. Commun. 169:1117-1121(1990).
RN   [73]
RP   VARIANT CHICAGO MET-139.
RX   PubMed=1877623; DOI=10.1002/ajmg.1320390415;
RA   Harrison H.H., Gordon E.D., Nichols W.C., Benson M.D.;
RT   "Biochemical and clinical characterization of prealbuminCHICAGO: an
RT   apparently benign variant of serum prealbumin (transthyretin)
RT   discovered with high-resolution two-dimensional electrophoresis.";
RL   Am. J. Med. Genet. 39:442-452(1991).
RN   [74]
RP   VARIANT AMYL-TTR ARG-78.
RX   PubMed=1656975; DOI=10.1016/S0006-291X(05)81304-X;
RA   Saeki Y., Ueno S., Yorifuji S., Sugiyama Y., Ide Y., Matsuzawa Y.;
RT   "New mutant gene (transthyretin Arg 58) in cases with hereditary
RT   polyneuropathy detected by non-isotope method of single-strand
RT   conformation polymorphism analysis.";
RL   Biochem. Biophys. Res. Commun. 180:380-385(1991).
RN   [75]
RP   VARIANT ASN-110.
RX   PubMed=1997217;
RA   Skare J.C., Milunsky J.M., Milunsky A., Skare I.B., Cohen A.S.,
RA   Skinner M.;
RT   "A new transthyretin variant from a patient with familial amyloidotic
RT   polyneuropathy has asparagine substituted for histidine at position
RT   90.";
RL   Clin. Genet. 39:6-12(1991).
RN   [76]
RP   VARIANTS AMYL-TTR LEU-53 AND LEU-84.
RX   PubMed=2046936; DOI=10.1212/WNL.41.6.893;
RA   Li S., Minnerath S., Li K., Dyck P.J., Sommer S.S.;
RT   "Two-tiered DNA-based diagnosis of transthyretin amyloidosis reveals
RT   two novel point mutations.";
RL   Neurology 41:893-898(1991).
RN   [77]
RP   VARIANT AMYL-TTR THR-65.
RX   PubMed=1570831;
RA   Saraiva M.J.M., Almeida M.R., Sherman W., Gawinowicz M., Costa P.,
RA   Costa P.P., Goodman D.S.;
RT   "A new transthyretin mutation associated with amyloid
RT   cardiomyopathy.";
RL   Am. J. Hum. Genet. 50:1027-1030(1992).
RN   [78]
RP   VARIANT AMYL-TTR ARG-67.
RX   PubMed=1734866; DOI=10.1016/0006-291X(92)91763-G;
RA   Murakami T., Maeda S., Yi S., Ikegawa S., Kawashima E., Onodera S.,
RA   Shimada K., Araki S.;
RT   "A novel transthyretin mutation associated with familial amyloidotic
RT   polyneuropathy.";
RL   Biochem. Biophys. Res. Commun. 182:520-526(1992).
RN   [79]
RP   VARIANT AMYL-TTR LEU-50.
RX   PubMed=1520326; DOI=10.1016/S0006-291X(05)81506-2;
RA   Murakami T., Atsumi T., Maeda S., Tanase S., Ishikawa K., Mita S.,
RA   Kumamoto T., Araki S., Ando M.;
RT   "A novel transthyretin mutation at position 30 (Leu for Val)
RT   associated with familial amyloidotic polyneuropathy.";
RL   Biochem. Biophys. Res. Commun. 187:397-403(1992).
RN   [80]
RP   VARIANT AMYL-TTR ILE-70.
RX   PubMed=1520336; DOI=10.1016/S0006-291X(05)81516-5;
RA   Nishi H., Kimura A., Harada H., Hayashi Y., Nakamura M., Sasazuki T.;
RT   "Novel variant transthyretin gene (Ser50 to Ile) in familial cardiac
RT   amyloidosis.";
RL   Biochem. Biophys. Res. Commun. 187:460-466(1992).
RN   [81]
RP   VARIANT AMYL-TTR ALA-50.
RX   PubMed=1544214;
RA   Jones L.A., Skare J.C., Cohen A.S., Harding J.A., Milunsky A.,
RA   Skinner M.;
RT   "Familial amyloidotic polyneuropathy: a new transthyretin position 30
RT   mutation (alanine for valine) in a family of German descent.";
RL   Clin. Genet. 41:70-73(1992).
RN   [82]
RP   VARIANT AMYL-TTR PRO-75.
RX   PubMed=1351039; DOI=10.1007/BF00220559;
RA   Jacobson D.R., McFarlin D.E., Kane I., Buxbaum J.N.;
RT   "Transthyretin Pro55, a variant associated with early-onset,
RT   aggressive, diffuse amyloidosis with cardiac and neurologic
RT   involvement.";
RL   Hum. Genet. 89:353-356(1992).
RN   [83]
RP   VARIANTS AMYL-TTR ALA-69 AND GLN-109.
RX   PubMed=1301926; DOI=10.1002/humu.1380010306;
RA   Almeida M.R., Ferlini A., Forabosco A., Gawinowicz M.A., Costa P.P.,
RA   Salvi F., Plasmati R., Tassinari C.A., Altland K., Saraiva M.J.;
RT   "Two transthyretin variants (TTR Ala-49 and TTR Gln-89) in two
RT   Sicilian kindreds with hereditary amyloidosis.";
RL   Hum. Mutat. 1:211-215(1992).
RN   [84]
RP   VARIANT AMYL-TTR ARG-30.
RX   PubMed=1362222; DOI=10.1136/jmg.29.12.888;
RA   Uemichi T., Murrel J.R., Zeldenrust S., Benson M.D.;
RT   "A new mutant transthyretin (Arg 10) associated with familial amyloid
RT   polyneuropathy.";
RL   J. Med. Genet. 29:888-891(1992).
RN   [85]
RP   VARIANT AMYL-TTR ASN-90.
RX   PubMed=1436517; DOI=10.1212/WNL.42.11.2094;
RA   Izumoto S., Younger D., Hays A.P., Martone R.L., Smith R.T.,
RA   Herbert J.;
RT   "Familial amyloidotic polyneuropathy presenting with carpal tunnel
RT   syndrome and a new transthyretin mutation, asparagine 70.";
RL   Neurology 42:2094-2102(1992).
RN   [86]
RP   VARIANT AMYL-TTR LYS-81.
RX   PubMed=8352764; DOI=10.1006/bbrc.1993.1933;
RA   Shiomi K., Nakazato M., Matsukura S., Ohnishi A., Hatanaka H.,
RA   Tsuji S., Murai Y., Kojima M., Kangawa K., Matsuo H.;
RT   "A basic transthyretin variant (Glu61-->Lys) causes familial
RT   amyloidotic polyneuropathy: protein and DNA sequencing and PCR-induced
RT   mutation restriction analysis.";
RL   Biochem. Biophys. Res. Commun. 194:1090-1096(1993).
RN   [87]
RP   VARIANT AMYL-TTR LEU-88.
RX   PubMed=8038017; DOI=10.1136/hrt.70.2.111;
RA   Hesse A., Altland K., Linke R.P., Almeida M.R., Saraiva M.J.M.,
RA   Steinmetz A., Maisch B.;
RT   "Cardiac amyloidosis: a review and report of a new transthyretin
RT   (prealbumin) variant.";
RL   Br. Heart J. 70:111-115(1993).
RN   [88]
RP   VARIANT AMYL-TTR ALA-91.
RX   PubMed=8257997; DOI=10.1002/humu.1380020516;
RA   Almeida M.R., Lopez-Andreu F., Munar-Ques M., Costa P.P.,
RA   Saraiva M.J.;
RT   "Transthyretin Ala-71: a new transthyretin variant in a Spanish family
RT   with familial amyloidotic polyneuropathy.";
RL   Hum. Mutat. 2:420-421(1993).
RN   [89]
RP   VARIANT AMYL-TTR ALA-91.
RX   PubMed=8095302; DOI=10.1136/jmg.30.2.120;
RA   Benson M.D. II, Turpin J.C., Lucotte G., Zeldenrust S.,
RA   Lechevalier B., Benson M.D.;
RT   "A transthyretin variant (alanine 71) associated with familial
RT   amyloidotic polyneuropathy in a French family.";
RL   J. Med. Genet. 30:120-122(1993).
RN   [90]
RP   VARIANT AMYL-TTR ALA-67.
RA   Ferlini A., Salvi F., Patrosso C., Fini S., Vezzoni P., Forbasco A.;
RT   "Gly47Ala: a new transthyretin gene mutation in hereditary amyloidosis
RT   TTR-related.";
RL   J. Rheumatol. 20:187-187(1993).
RN   [91]
RP   VARIANT SER-26, AND VARIANT AMYL-TTR ILE-53.
RX   PubMed=8019560; DOI=10.1002/humu.1380030313;
RA   Jacobson D.R., Buxbaum J.N.;
RT   "A double-variant transthyretin allele (Ser 6, Ile 33) in the Israeli
RT   patient 'SKO' with familial amyloidotic polyneuropathy.";
RL   Hum. Mutat. 3:254-260(1994).
RN   [92]
RP   VARIANT AMYL-TTR VAL-127.
RX   PubMed=8081397; DOI=10.1002/humu.1380030414;
RA   Jacobson D., Gertz M.A., Buxbaum J.N.;
RT   "Transthyretin VAL107, a new variant associated with familial cardiac
RT   and neuropathic amyloidosis.";
RL   Hum. Mutat. 3:399-401(1994).
RN   [93]
RP   VARIANT SER-104, AND RBP BINDING STUDIES.
RX   PubMed=8089102;
RA   Berni R., Malpeli G., Folli C., Murrell J.R., Liepnieks J.J.,
RA   Benson M.D.;
RT   "The Ile-84-->Ser amino acid substitution in transthyretin interferes
RT   with the interaction with plasma retinol-binding protein.";
RL   J. Biol. Chem. 269:23395-23398(1994).
RN   [94]
RP   VARIANT AMYL-TTR VAL-127.
RX   PubMed=7914929; DOI=10.1136/jmg.31.5.416;
RA   Uemichi T., Gertz M.A., Benson M.D.;
RT   "Amyloid polyneuropathy in two German-American families: a new
RT   transthyretin variant (Val 107).";
RL   J. Med. Genet. 31:416-417(1994).
RN   [95]
RP   VARIANT AMYL-TTR GLY-117.
RX   PubMed=8133316; DOI=10.1016/0022-510X(94)90162-7;
RA   Yasuda T., Sobue G., Doyu M., Nakazato M., Shiomi K., Yanagi T.,
RA   Mitsuma T.;
RT   "Familial amyloidotic polyneuropathy with late-onset and well-
RT   preserved autonomic function: a Japanese kindred with novel mutant
RT   transthyretin (Ala97 to Gly).";
RL   J. Neurol. Sci. 121:97-102(1994).
RN   [96]
RP   VARIANT AMYL-TTR PRO-75.
RX   PubMed=7910950; DOI=10.1002/mus.880170611;
RA   Yamamoto K., Hsu S.P., Yoshida K., Ikeda S., Nakazato M., Shiomi K.,
RA   Cheng S.Y., Furihata K., Ueno I., Yanagisawa N.;
RT   "Familial amyloid polyneuropathy in Taiwan: identification of
RT   transthyretin variant (Leu55-->Pro).";
RL   Muscle Nerve 17:637-641(1994).
RN   [97]
RP   VARIANT CTS1 HIS-134.
RX   PubMed=8309582; DOI=10.1212/WNL.44.2.315;
RA   Murakami T., Tachibana S., Endo Y., Kawai R., Hara M., Tanase S.,
RA   Ando M.;
RT   "Familial carpal tunnel syndrome due to amyloidogenic transthyretin
RT   His 114 variant.";
RL   Neurology 44:315-318(1994).
RN   [98]
RP   VARIANTS AMYL-TTR MET-50; ASN-55; ALA-69; ARG-70; ALA-80; TYR-97 AND
RP   GLN-109.
RX   PubMed=7655883; DOI=10.1093/brain/118.4.849;
RA   Reilly M.M., Adams D., Booth D.R., Davis M.B., Said G.,
RA   Laubriat-Bianchin M., Pepys M.B., Thomas P.K., Harding A.E.;
RT   "Transthyretin gene analysis in European patients with suspected
RT   familial amyloid polyneuropathy.";
RL   Brain 118:849-856(1995).
RN   [99]
RP   VARIANT AMYL-TTR LYS-79.
RX   PubMed=7850982; DOI=10.1161/01.CIR.91.4.962;
RA   Booth D.R., Tan S.Y., Hawkins P.N., Pepys M.B., Frustaci A.;
RT   "A novel variant of transthyretin, 59Thr-->Lys, associated with
RT   autosomal dominant cardiac amyloidosis in an Italian family.";
RL   Circulation 91:962-967(1995).
RN   [100]
RP   VARIANT AMYL-TTR GLY-38.
RX   PubMed=8579098;
RA   Vidal R., Garzuly F., Budka H., Lalowski M., Linke R.P., Brittig F.,
RA   Frangione B., Wisniewski T.;
RT   "Meningocerebrovascular amyloidosis associated with a novel
RT   transthyretin mis-sense mutation at codon 18 (TTRD 18G).";
RL   Am. J. Pathol. 148:361-366(1996).
RN   [101]
RP   VARIANT AMYL-TTR GLY-50.
RX   PubMed=9066351; DOI=10.1002/ana.410410305;
RA   Petersen R.B., Goren H., Cohen M., Richardson S.L., Tresser N.,
RA   Lynn A., Gali M., Estes M., Gambetti P.;
RT   "Transthyretin amyloidosis: a new mutation associated with dementia.";
RL   Ann. Neurol. 41:307-313(1997).
RN   [102]
RP   VARIANT AMYL-TTR ILE-40.
RX   PubMed=8990019;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:1<83::AID-HUMU19>3.0.CO;2-L;
RA   Jacobson D.R., Pan T., Kyle R.A., Buxbaum J.N.;
RT   "Transthyretin ILE20, a new variant associated with late-onset cardiac
RT   amyloidosis.";
RL   Hum. Mutat. 9:83-85(1997).
RN   [103]
RP   VARIANT AMYL-TTR THR-54.
RX   PubMed=9605286;
RX   DOI=10.1002/(SICI)1096-8628(19980501)77:2<135::AID-AJMG5>3.0.CO;2-R;
RA   Patrosso M.C., Salvi F., De Grandis D., Vezzoni P., Jacobson D.R.,
RA   Ferlini A.;
RT   "Novel transthyretin missense mutation (Thr34) in an Italian family
RT   with hereditary amyloidosis.";
RL   Am. J. Med. Genet. 77:135-138(1998).
RN   [104]
RP   VARIANT AMYL-TTR ASP-62.
RX   PubMed=10036587; DOI=10.3109/13506129809007302;
RA   Dupuy O., Bletry O., Blanc A.S., Droz D., Viemont M., Delpech M.,
RA   Grateau G.;
RT   "A novel variant of transthyretin (Glu42Asp) associated with sporadic
RT   late-onset cardiac amyloidosis.";
RL   Amyloid 5:285-287(1998).
RN   [105]
RP   VARIANTS AMYL-TTR SER-111 AND SER-136.
RX   PubMed=10627135;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:1<71::AID-HUMU15>3.0.CO;2-7;
RA   Misrahi A.M., Plante V., Lalu T., Serre I., Adams D., Lacroix D.C.,
RA   Said G.;
RT   "New transthyretin variants Ser 91 and Ser 116 associated with
RT   familial amyloidotic polyneuropathy.";
RL   Hum. Mutat. 12:71-71(1998).
RN   [106]
RP   VARIANT AMYL-TTR VAL-93.
RX   PubMed=10694917;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:2<135::AID-HUMU9>3.0.CO;2-K;
RA   Booth D.R., Gillmore J.D., Persey M.R., Booth S.E., Cafferty K.D.,
RA   Tennent G.A., Madhoo S., Cochrane S.W., Whitehead T.C., Pasvol G.,
RA   Hawkins P.N.;
RT   "Transthyretin Ile73Val is associated with familial amyloidotic
RT   polyneuropathy in a Bangladeshi family.";
RL   Hum. Mutat. 12:135-135(1998).
RN   [107]
RP   VARIANT SER-121, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=10671063;
RA   Kishikawa M., Nakanishi T., Miyazaki A., Hatanaka M., Shimizu A.,
RA   Tamoto S., Ohsawa N., Hayashi H., Kanai M.;
RT   "A new nonamyloid transthyretin variant, G101S, detected by
RT   electrospray ionization/mass spectrometry.";
RL   Hum. Mutat. 12:363-363(1998).
RN   [108]
RP   VARIANT SER-64.
RX   PubMed=9818883; DOI=10.1212/WNL.51.5.1462;
RA   Klein C.J., Nakumura M., Jacobson D.R., Lacy M.Q., Benson M.D.,
RA   Petersen R.C.;
RT   "Transthyretin amyloidosis (serine 44) with headache, hearing loss,
RT   and peripheral neuropathy.";
RL   Neurology 51:1462-1464(1998).
RN   [109]
RP   VARIANT AMYL-TTR ALA-142, VARIANT SER-26, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=10211412; DOI=10.3109/13506129908993288;
RA   Theberge R., Connors L., Skare J., Skinner M., Falk R.H.,
RA   Costello C.E.;
RT   "A new amyloidogenic transthyretin variant (Val122Ala) found in a
RT   compound heterozygous patient.";
RL   Amyloid 6:54-58(1999).
RN   [110]
RP   VARIANT AMYL-TTR ASN-43, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=10439117; DOI=10.3109/13506129909007311;
RA   Connors L.H., Theberge R., Skare J., Costello C.E., Falk R.H.,
RA   Skinner M.;
RT   "A new transthyretin variant (Ser23Asn) associated with familial
RT   amyloidosis in a Portuguese patient.";
RL   Amyloid 6:114-118(1999).
RN   [111]
RP   VARIANTS AMYL-TTR LEU-50; VAL-53; ALA-58; ARG-70; GLY-117 AND SER-117,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=10611950; DOI=10.3109/13506129909007341;
RA   Tachibana N., Tokuda T., Yoshida K., Taketomi T., Nakazato M.,
RA   Li Y.F., Masuda Y., Ikeda S.;
RT   "Usefulness of MALDI/TOF mass spectrometry of immunoprecipitated serum
RT   variant transthyretin in the diagnosis of familial amyloid
RT   polyneuropathy.";
RL   Amyloid 6:282-288(1999).
RN   [112]
RP   VARIANT HIS-124, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=10529370; DOI=10.1006/bbrc.1999.1514;
RA   Terazaki H., Ando Y., Misumi S., Nakamura M., Ando E., Matsunaga N.,
RA   Shoji S., Okuyama M., Ideta H., Nakagawa K., Ishizaki T., Ando M.,
RA   Saraiva M.J.;
RT   "A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with
RT   high serum transthyretin (TTR) and retinol binding protein (RBP)
RT   levels.";
RL   Biochem. Biophys. Res. Commun. 264:365-370(1999).
RN   [113]
RP   VARIANT AMYL-TTR PRO-32.
RX   PubMed=10071047; DOI=10.1093/brain/122.2.183;
RA   Brett M., Persey M.R., Reilly M.M., Revesz T., Booth D.R., Booth S.E.,
RA   Hawkins P.N., Pepys M.B., Morgan-Hughes J.A.;
RT   "Transthyretin Leu12Pro is associated with systemic, neuropathic and
RT   leptomeningeal amyloidosis.";
RL   Brain 122:183-190(1999).
RN   [114]
RP   VARIANT AMYL-TTR ILE-69, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=10436378; DOI=10.1159/000022872;
RA   Nakamura M., Yamashita T., Ando Y., Hamidi Asl K., Tashima K.,
RA   Ohlsson P., Kususe Y., Benson M.D.;
RT   "Identification of a new transthyretin variant (Ile49) in familial
RT   amyloidotic polyneuropathy using electrospray ionization mass
RT   spectrometry and nonisotopic RNase cleavage assay.";
RL   Hum. Hered. 49:186-189(1999).
RN   [115]
RP   VARIANT AMYL-TTR LYS-109.
RX   PubMed=10842705; DOI=10.3109/13506120009146824;
RA   Nakamura M., Hamidi Asl K., Benson M.D.;
RT   "A novel variant of transthyretin (Glu89Lys) associated with familial
RT   amyloidotic polyneuropathy.";
RL   Amyloid 7:46-50(2000).
RN   [116]
RP   VARIANT AMYL-TTR SER-65, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=10842718; DOI=10.3109/13506120009146252;
RA   Janunger T., Anan I., Holmgren G., Lovheim O., Ohlsson P.I.,
RA   Suhr O.B., Tashima K.;
RT   "Heart failure caused by a novel amyloidogenic mutation of the
RT   transthyretin gene: ATTR Ala45Ser.";
RL   Amyloid 7:137-140(2000).
RN   [117]
RP   VARIANT AMYL-TTR MET-48.
RX   PubMed=10882995;
RX   DOI=10.1002/1097-4598(200007)23:7<1016::AID-MUS3>3.0.CO;2-W;
RA   de Carvalho M., Moreira P., Evangelista T., Ducla-Soares J.L.,
RA   Bento M., Fernandes R., Saraiva M.J.;
RT   "New transthyretin mutation V28M in a Portuguese kindred with amyloid
RT   polyneuropathy.";
RL   Muscle Nerve 23:1016-1021(2000).
RN   [118]
RP   VARIANT AMYL-TTR GLU-73.
RX   PubMed=11445644; DOI=10.1212/WNL.57.1.135;
RA   Ellie E., Camou F., Vital A., Rummens C., Grateau G., Delpech M.,
RA   Valleix S.;
RT   "Recurrent subarachnoid hemorrhage associated with a new transthyretin
RT   variant (Gly53Glu).";
RL   Neurology 57:135-137(2001).
RN   [119]
RP   VARIANT AMYL-TTR GLN-75.
RX   PubMed=12557757; DOI=10.3109/13506120209114105;
RA   Yazaki M., Varga J., Dyck P.J., Benson M.D.;
RT   "A new transthyretin variant Leu55Gln in a patient with systemic
RT   amyloidosis.";
RL   Amyloid 9:268-271(2002).
RN   [120]
RP   VARIANTS SER-26 AND MET-139, VARIANTS AMYL-TTR ALA-58; LEU-61; SER-64
RP   AND LEU-84, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=11866053; DOI=10.1021/ac010780+;
RA   Lim A., Prokaeva T., McComb M.E., O'Connor P.B., Theberge R.,
RA   Connors L.H., Skinner M., Costello C.E.;
RT   "Characterization of transthyretin variants in familial transthyretin
RT   amyloidosis by mass spectrometric peptide mapping and DNA sequence
RT   analysis.";
RL   Anal. Chem. 74:741-751(2002).
RN   [121]
RP   VARIANTS AMYL-TTR MET-50; LEU-53; VAL-53; VAL-58; GLU-67; ALA-80;
RP   SER-140 AND ILE-142.
RX   PubMed=12050338; DOI=10.1056/NEJMoa013354;
RA   Lachmann H.J., Booth D.R., Booth S.E., Bybee A., Gilbertson J.A.,
RA   Gillmore J.D., Pepys M.B., Hawkins P.N.;
RT   "Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.";
RL   N. Engl. J. Med. 346:1786-1791(2002).
RN   [122]
RP   VARIANT AMYL-TTR HIS-89.
RX   PubMed=12771253; DOI=10.1212/01.WNL.0000065901.18353.AB;
RA   Blevins G., Macaulay R., Harder S., Fladeland D., Yamashita T.,
RA   Yazaki M., Hamidi Asl K., Benson M.D., Donat J.R.;
RT   "Oculoleptomeningeal amyloidosis in a large kindred with a new
RT   transthyretin variant Tyr69His.";
RL   Neurology 60:1625-1630(2003).
RN   [123]
RP   VARIANT CYS-53, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12876326; DOI=10.1110/ps.0349703;
RA   Lim A., Prokaeva T., McComb M.E., Connors L.H., Skinner M.,
RA   Costello C.E.;
RT   "Identification of S-sulfonation and S-thiolation of a novel
RT   transthyretin Phe33Cys variant from a patient diagnosed with familial
RT   transthyretin amyloidosis.";
RL   Protein Sci. 12:1775-1785(2003).
RN   [124]
RP   VARIANT AMYL-TTR LYS-74.
RX   PubMed=15214015; DOI=10.1002/ajmg.a.30007;
RA   Busse A., Sanchez M.A., Monterroso V., Alvarado M.V., Leon P.;
RT   "A severe form of amyloidotic polyneuropathy in a Costa Rican family
RT   with a rare transthyretin mutation (Glu54Lys).";
RL   Am. J. Med. Genet. A 128:190-194(2004).
RN   [125]
RP   VARIANT AMYL-TTR VAL-53.
RX   PubMed=15478468; DOI=10.1080/13506120410001727767;
RA   Frigerio R., Fabrizi G.M., Ferrarini M., Cavallaro T., Brighina L.,
RA   Santoro P., Agostoni E., Cavaletti G., Rizzuto N., Ferrarese C.;
RT   "An unusual transthyretin gene missense mutation (TTR Phe33Val) linked
RT   to familial amyloidotic polyneuropathy.";
RL   Amyloid 11:121-124(2004).
RN   [126]
RP   VARIANTS SER-26; CYS-53 AND ALA-114, VARIANTS AMYL-TTR GLU-67; HIS-78;
RP   ALA-80 AND TYR-97, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15217993; DOI=10.1373/clinchem.2004.033266;
RA   Bergen H.R. III, Zeldenrust S.R., Butz M.L., Snow D.S., Dyck P.J.,
RA   Dyck P.J.B., Klein C.J., O'Brien J.F., Thibodeau S.N., Muddiman D.C.;
RT   "Identification of transthyretin variants by sequential proteomic and
RT   genomic analysis.";
RL   Clin. Chem. 50:1544-1552(2004).
RN   [127]
RP   VARIANT AMYL-TTR GLY-81.
RX   PubMed=17453626; DOI=10.1080/13506120601116625;
RA   Rosenzweig M., Skinner M., Prokaeva T., Theberge R., Costello C.,
RA   Drachman B.M., Connors L.H.;
RT   "A new transthyretin variant (Glu61Gly) associated with
RT   cardiomyopathy.";
RL   Amyloid 14:65-71(2007).
RN   [128]
RP   VARIANT AMYL-TTR SER-144.
RX   PubMed=17577687; DOI=10.1080/13506120701259895;
RA   Bergstroem J., Patrosso M.C., Colussi G., Salvadore M., Penco S.,
RA   Lando G., Marocchi A., Ueda A., Nakamura M., Ando Y.;
RT   "A novel type of familial transthyretin amyloidosis, ATTR Asn124Ser,
RT   with co-localization of kappa light chains.";
RL   Amyloid 14:141-145(2007).
RN   [129]
RP   VARIANTS AMYL-TTR PRO-32; ILE-40; SER-44; ALA-50; MET-50; LEU-53;
RP   VAL-53; PRO-56; THR-65; ALA-67; ALA-69; ILE-69; ALA-80; LEU-84;
RP   LEU-88; ALA-91; TYR-97; PHE-98; SER-104; ASN-104; THR-104; ALA-114;
RP   GLY-117; ASN-126; MET-127; VAL-127; MET-131 AND ILE-142, VARIANTS
RP   ILE-33; SER-121 AND THR-129, AND VARIANT CHICAGO MET-139.
RX   PubMed=17503405; DOI=10.1002/elps.200600840;
RA   Altland K., Benson M.D., Costello C.E., Ferlini A., Hazenberg B.P.C.,
RA   Hund E., Kristen A.V., Linke R.P., Merlini G., Salvi F., Saraiva M.J.,
RA   Singer R., Skinner M., Winter P.;
RT   "Genetic microheterogeneity of human transthyretin detected by IEF.";
RL   Electrophoresis 28:2053-2064(2007).
RN   [130]
RP   VARIANT AMYL-TTR VAL-58.
RX   PubMed=17635579; DOI=10.1111/j.1365-2362.2007.01836.x;
RA   Augustin S., Llige D., Andreu A., Gonzalez A., Genesca J.;
RT   "Familial amyloidosis in a large Spanish kindred resulting from a D38V
RT   mutation in the transthyretin gene.";
RL   Eur. J. Clin. Invest. 37:673-678(2007).
RN   [131]
RP   VARIANT AMYL-TTR ARG-70.
RX   PubMed=23317988; DOI=10.1016/j.jaad.2012.07.026;
RA   Dekmezian M.S., Tschen J.A., Cho-Vega J.H.;
RT   "Delayed diagnosis of transthyretin amyloidosis with a novel mutation
RT   (c.210T>A) in the transthyretin gene.";
RL   J. Am. Acad. Dermatol. 68:E49-E51(2013).
CC   -!- FUNCTION: Thyroid hormone-binding protein. Probably transports
CC       thyroxine from the bloodstream to the brain.
CC       {ECO:0000269|PubMed:3714052}.
CC   -!- SUBUNIT: Homotetramer. Dimer of dimers. In the homotetramer,
CC       subunits assemble around a central channel that can accommodate
CC       two ligand molecules. Interacts with RBP4.
CC       {ECO:0000269|PubMed:10052934, ECO:0000269|PubMed:11243784,
CC       ECO:0000269|PubMed:11560492, ECO:0000269|PubMed:12820260,
CC       ECO:0000269|PubMed:14583036, ECO:0000269|PubMed:14711308,
CC       ECO:0000269|PubMed:15735344, ECO:0000269|PubMed:15769474,
CC       ECO:0000269|PubMed:15826192, ECO:0000269|PubMed:18095641,
CC       ECO:0000269|PubMed:18155178, ECO:0000269|PubMed:18811132,
CC       ECO:0000269|PubMed:19021760}.
CC   -!- INTERACTION:
CC       Self; NbExp=11; IntAct=EBI-711909, EBI-711909;
CC       Q15109:AGER; NbExp=2; IntAct=EBI-711909, EBI-1646426;
CC       Q01850:CDR2; NbExp=3; IntAct=EBI-711909, EBI-1181367;
CC       P25713:MT3; NbExp=3; IntAct=EBI-711909, EBI-8084264;
CC       Q7Z6G3-2:NECAB2; NbExp=3; IntAct=EBI-711909, EBI-10172876;
CC   -!- SUBCELLULAR LOCATION: Secreted. Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Detected in serum and cerebrospinal fluid (at
CC       protein level). Highly expressed in choroid plexus epithelial
CC       cells. Detected in retina pigment epithelium and liver.
CC       {ECO:0000269|PubMed:10328977, ECO:0000269|PubMed:3714052}.
CC   -!- DOMAIN: Each monomer has two 4-stranded beta sheets and the shape
CC       of a prolate ellipsoid. Antiparallel beta-sheet interactions link
CC       monomers into dimers. A short loop from each monomer forms the
CC       main dimer-dimer interaction. These two pairs of loops separate
CC       the opposed, convex beta-sheets of the dimers to form an internal
CC       channel.
CC   -!- PTM: Not glycosylated under normal conditions. Following
CC       unfolding, caused for example by variant AMYL-TTR 'Gly-38', the
CC       cryptic Asn-118 site is exposed and glycosylated by STT3B-
CC       containing OST complex, leading to its degradation by the ER-
CC       associated degradation (ERAD) pathway.
CC       {ECO:0000269|PubMed:14760718, ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:19167329}.
CC   -!- DISEASE: Amyloidosis, transthyretin-related (AMYL-TTR)
CC       [MIM:105210]: A hereditary generalized amyloidosis due to
CC       transthyretin amyloid deposition. Protein fibrils can form in
CC       different tissues leading to amyloid polyneuropathies, amyloidotic
CC       cardiomyopathy, carpal tunnel syndrome, systemic senile
CC       amyloidosis. The disease includes leptomeningeal amyloidosis that
CC       is characterized by primary involvement of the central nervous
CC       system. Neuropathologic examination shows amyloid in the walls of
CC       leptomeningeal vessels, in pia arachnoid, and subpial deposits.
CC       Some patients also develop vitreous amyloid deposition that leads
CC       to visual impairment (oculoleptomeningeal amyloidosis). Clinical
CC       features include seizures, stroke-like episodes, dementia,
CC       psychomotor deterioration, variable amyloid deposition in the
CC       vitreous humor. {ECO:0000269|PubMed:10036587,
CC       ECO:0000269|PubMed:10071047, ECO:0000269|PubMed:10211412,
CC       ECO:0000269|PubMed:10436378, ECO:0000269|PubMed:10439117,
CC       ECO:0000269|PubMed:10611950, ECO:0000269|PubMed:10627135,
CC       ECO:0000269|PubMed:10694917, ECO:0000269|PubMed:10842705,
CC       ECO:0000269|PubMed:10842718, ECO:0000269|PubMed:10882995,
CC       ECO:0000269|PubMed:11243784, ECO:0000269|PubMed:11445644,
CC       ECO:0000269|PubMed:11866053, ECO:0000269|PubMed:12050338,
CC       ECO:0000269|PubMed:12403615, ECO:0000269|PubMed:12557757,
CC       ECO:0000269|PubMed:12771253, ECO:0000269|PubMed:1301926,
CC       ECO:0000269|PubMed:1351039, ECO:0000269|PubMed:1362222,
CC       ECO:0000269|PubMed:1436517, ECO:0000269|PubMed:1517749,
CC       ECO:0000269|PubMed:1520326, ECO:0000269|PubMed:1520336,
CC       ECO:0000269|PubMed:15214015, ECO:0000269|PubMed:15217993,
CC       ECO:0000269|PubMed:1544214, ECO:0000269|PubMed:15478468,
CC       ECO:0000269|PubMed:1570831, ECO:0000269|PubMed:15735344,
CC       ECO:0000269|PubMed:16185074, ECO:0000269|PubMed:1656975,
CC       ECO:0000269|PubMed:16627944, ECO:0000269|PubMed:1734866,
CC       ECO:0000269|PubMed:17453626, ECO:0000269|PubMed:17503405,
CC       ECO:0000269|PubMed:17577687, ECO:0000269|PubMed:17635579,
CC       ECO:0000269|PubMed:19167329, ECO:0000269|PubMed:1932142,
CC       ECO:0000269|PubMed:2046936, ECO:0000269|PubMed:2161654,
CC       ECO:0000269|PubMed:23317988, ECO:0000269|PubMed:2363717,
CC       ECO:0000269|PubMed:2891727, ECO:0000269|PubMed:3022108,
CC       ECO:0000269|PubMed:3135807, ECO:0000269|PubMed:3722385,
CC       ECO:0000269|PubMed:3818577, ECO:0000269|PubMed:6487335,
CC       ECO:0000269|PubMed:6583672, ECO:0000269|PubMed:6651852,
CC       ECO:0000269|PubMed:7655883, ECO:0000269|PubMed:7850982,
CC       ECO:0000269|PubMed:7910950, ECO:0000269|PubMed:7914929,
CC       ECO:0000269|PubMed:7923855, ECO:0000269|PubMed:8019560,
CC       ECO:0000269|PubMed:8038017, ECO:0000269|PubMed:8081397,
CC       ECO:0000269|PubMed:8095302, ECO:0000269|PubMed:8133316,
CC       ECO:0000269|PubMed:8257997, ECO:0000269|PubMed:8352764,
CC       ECO:0000269|PubMed:8382610, ECO:0000269|PubMed:8428915,
CC       ECO:0000269|PubMed:8579098, ECO:0000269|PubMed:8990019,
CC       ECO:0000269|PubMed:9066351, ECO:0000269|PubMed:9605286,
CC       ECO:0000269|PubMed:9733771, ECO:0000269|Ref.90}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Hyperthyroxinemia, dystransthyretinemic (DTTRH)
CC       [MIM:145680]: A condition characterized by elevation of total and
CC       free thyroxine in healthy, euthyroid persons without detectable
CC       binding protein abnormalities. {ECO:0000269|PubMed:1979335}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Carpal tunnel syndrome 1 (CTS1) [MIM:115430]: A condition
CC       characterized by entrapment of the median nerve within the carpal
CC       tunnel. Symptoms include burning pain and paresthesias involving
CC       the ventral surface of the hand and fingers which may radiate
CC       proximally. Impairment of sensation in the distribution of the
CC       median nerve and thenar muscle atrophy may occur. This condition
CC       may be associated with repetitive occupational trauma, wrist
CC       injuries, amyloid neuropathies, rheumatoid arthritis.
CC       {ECO:0000269|PubMed:8309582}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Tetramer dissociation and partial unfolding leads
CC       to the formation of aggregates and amyloid fibrils. Small
CC       molecules that occupy at least one of the thyroid hormone binding
CC       sites stabilize the tetramer, and thereby stabilize the native
CC       state and protect against misfolding and the formation of amyloid
CC       fibrils.
CC   -!- MISCELLANEOUS: Two binding sites for thyroxine are located in the
CC       channel. Less than 1% of plasma prealbumin molecules are normally
CC       involved in thyroxine transport. L-thyroxine binds to the
CC       transthyretin by an order of magnitude stronger than does the
CC       triiodo-L-thyronine. Thyroxine-binding globulin is the major
CC       carrier protein for thyroid hormones in man.
CC   -!- MISCELLANEOUS: About 40% of plasma transthyretin circulates in a
CC       tight protein-protein complex with the plasma retinol-binding
CC       protein (RBP). The formation of the complex with RBP stabilizes
CC       the binding of retinol to RBP and decreases the glomerular
CC       filtration and renal catabolism of the relatively small RBP
CC       molecule. There is evidence for 2 binding sites for RBP, one
CC       possibly being a region that includes Ile-104, located on the
CC       outer surface of the transthyretin molecule.
CC   -!- SIMILARITY: Belongs to the transthyretin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Transthyretin entry;
CC       URL="https://en.wikipedia.org/wiki/Transthyretin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K02091; AAA60011.1; -; mRNA.
DR   EMBL; M10605; AAA60012.1; -; mRNA.
DR   EMBL; M11518; AAA98771.1; -; Genomic_DNA.
DR   EMBL; M11844; AAA60013.1; -; Genomic_DNA.
DR   EMBL; X59498; CAA42087.1; -; mRNA.
DR   EMBL; D00096; BAA00059.1; -; mRNA.
DR   EMBL; M15517; AAA60018.1; -; Genomic_DNA.
DR   EMBL; M15515; AAA60018.1; JOINED; Genomic_DNA.
DR   EMBL; M15516; AAA60018.1; JOINED; Genomic_DNA.
DR   EMBL; U19780; AAA73473.1; -; mRNA.
DR   EMBL; AF162690; AAD45014.1; -; mRNA.
DR   EMBL; AK312051; BAG34987.1; -; mRNA.
DR   EMBL; BT007189; AAP35853.1; -; mRNA.
DR   EMBL; CR456908; CAG33189.1; -; mRNA.
DR   EMBL; CH471088; EAX01264.1; -; Genomic_DNA.
DR   EMBL; BC005310; AAH05310.1; -; mRNA.
DR   EMBL; BC020791; AAH20791.1; -; mRNA.
DR   EMBL; S63185; AAD14937.2; -; Genomic_DNA.
DR   EMBL; S72385; AAD14098.1; -; Genomic_DNA.
DR   EMBL; M11714; AAA61181.1; -; mRNA.
DR   EMBL; M63285; AAA36784.1; -; Genomic_DNA.
DR   CCDS; CCDS11899.1; -.
DR   PIR; A91532; VBHU.
DR   RefSeq; NP_000362.1; NM_000371.3.
DR   UniGene; Hs.427202; -.
DR   PDB; 1BM7; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 1BMZ; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 1BZ8; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 1BZD; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 1BZE; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 1DVQ; X-ray; 2.00 A; A/B=21-144.
DR   PDB; 1DVS; X-ray; 2.00 A; A/B=21-144.
DR   PDB; 1DVT; X-ray; 1.90 A; A/B=21-144.
DR   PDB; 1DVU; X-ray; 1.90 A; A/B=21-144.
DR   PDB; 1DVX; X-ray; 2.00 A; A/B=21-144.
DR   PDB; 1DVY; X-ray; 1.90 A; A/B=21-144.
DR   PDB; 1DVZ; X-ray; 1.90 A; A/B=21-144.
DR   PDB; 1E3F; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 1E4H; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 1E5A; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 1ETA; X-ray; 1.70 A; 1/2=21-147.
DR   PDB; 1ETB; X-ray; 1.70 A; 1/2=21-147.
DR   PDB; 1F41; X-ray; 1.30 A; A/B=21-147.
DR   PDB; 1F64; Model; -; A=21-147.
DR   PDB; 1F86; X-ray; 1.10 A; A/B=30-144.
DR   PDB; 1FH2; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 1FHN; X-ray; 1.75 A; A/B=21-147.
DR   PDB; 1G1O; X-ray; 2.30 A; A/B/C/D=21-147.
DR   PDB; 1GKO; X-ray; 2.10 A; A/B/C/D=21-147.
DR   PDB; 1ICT; X-ray; 3.00 A; A/B/C/D/E/F/G/H=21-147.
DR   PDB; 1III; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 1IIK; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 1IJN; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 1QAB; X-ray; 3.20 A; A/B/C/D=21-147.
DR   PDB; 1QWH; X-ray; 1.36 A; A/B=31-147.
DR   PDB; 1RLB; X-ray; 3.10 A; A/B/C/D=21-147.
DR   PDB; 1SOK; X-ray; 1.60 A; A/B=21-147.
DR   PDB; 1SOQ; X-ray; 2.10 A; A/B/C/D=21-147.
DR   PDB; 1THA; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 1THC; X-ray; 2.30 A; A/B=21-147.
DR   PDB; 1TLM; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 1TSH; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 1TT6; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 1TTA; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 1TTB; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 1TTC; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 1TTR; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 1TYR; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 1TZ8; X-ray; 1.85 A; A/B/C/D=21-147.
DR   PDB; 1U21; X-ray; 1.69 A; A/B=21-147.
DR   PDB; 1X7S; X-ray; 1.55 A; A/B=21-147.
DR   PDB; 1X7T; X-ray; 1.60 A; A/B=21-147.
DR   PDB; 1Y1D; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 1Z7J; X-ray; 2.20 A; A/B=21-147.
DR   PDB; 1ZCR; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 1ZD6; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 2B14; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 2B15; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 2B16; X-ray; 1.75 A; A/B=21-147.
DR   PDB; 2B77; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 2B9A; X-ray; 1.54 A; A/B=21-147.
DR   PDB; 2F7I; X-ray; 1.60 A; A/B=21-147.
DR   PDB; 2F8I; X-ray; 1.54 A; A/B=21-147.
DR   PDB; 2FBR; X-ray; 1.46 A; A/B=21-147.
DR   PDB; 2FLM; X-ray; 1.65 A; A/B=21-147.
DR   PDB; 2G3X; X-ray; 1.58 A; A/B=21-147.
DR   PDB; 2G3Z; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 2G4E; X-ray; 2.17 A; A/B=21-147.
DR   PDB; 2G4G; X-ray; 1.85 A; A/B=21-147.
DR   PDB; 2G5U; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 2G9K; X-ray; 1.85 A; A/B=21-147.
DR   PDB; 2GAB; X-ray; 1.85 A; A/B=21-147.
DR   PDB; 2H4E; X-ray; 1.45 A; A/B=21-147.
DR   PDB; 2M5N; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P=125-135.
DR   PDB; 2NBO; NMR; -; A=21-147.
DR   PDB; 2NBP; NMR; -; A=21-147.
DR   PDB; 2NOY; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 2PAB; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 2QEL; X-ray; 2.29 A; A/B/C/D=21-147.
DR   PDB; 2QGB; X-ray; 1.40 A; A/B=21-147.
DR   PDB; 2QGC; X-ray; 1.30 A; A/B=21-147.
DR   PDB; 2QGD; X-ray; 1.50 A; A/B=21-147.
DR   PDB; 2QGE; X-ray; 1.45 A; A/B=21-147.
DR   PDB; 2ROX; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 2ROY; X-ray; 2.20 A; A/B=21-147.
DR   PDB; 2TRH; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 2TRY; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 2WQA; X-ray; 2.85 A; A/B/C/D=21-147.
DR   PDB; 3A4D; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 3A4E; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 3A4F; X-ray; 1.99 A; A/B=21-147.
DR   PDB; 3B56; X-ray; 1.55 A; A/B=21-147.
DR   PDB; 3BSZ; X-ray; 3.38 A; A/B/C/D=21-147.
DR   PDB; 3BT0; X-ray; 1.59 A; A/B=21-147.
DR   PDB; 3CBR; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 3CFM; X-ray; 1.60 A; A/B=30-147.
DR   PDB; 3CFN; X-ray; 1.87 A; A/B=30-147.
DR   PDB; 3CFQ; X-ray; 2.09 A; A/B=30-147.
DR   PDB; 3CFT; X-ray; 1.87 A; A/B=30-147.
DR   PDB; 3CN0; X-ray; 1.52 A; A/B=21-147.
DR   PDB; 3CN1; X-ray; 1.52 A; A/B=21-147.
DR   PDB; 3CN2; X-ray; 1.52 A; A/B=21-147.
DR   PDB; 3CN3; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 3CN4; X-ray; 1.40 A; A/B=21-147.
DR   PDB; 3CXF; X-ray; 2.30 A; A/B=21-147.
DR   PDB; 3D2T; X-ray; 1.85 A; A/B=21-147.
DR   PDB; 3D7P; X-ray; 1.72 A; A/B=21-147.
DR   PDB; 3DGD; X-ray; 1.38 A; A/B/C/D=21-147.
DR   PDB; 3DID; X-ray; 1.78 A; A/B/C/D=21-147.
DR   PDB; 3DJR; X-ray; 2.02 A; A/B=21-147.
DR   PDB; 3DJS; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 3DJT; X-ray; 2.30 A; A/B=21-147.
DR   PDB; 3DJZ; X-ray; 1.82 A; A/B=21-147.
DR   PDB; 3DK0; X-ray; 1.87 A; A/B=21-147.
DR   PDB; 3DK2; X-ray; 2.35 A; A/B=21-147.
DR   PDB; 3DO4; X-ray; 2.40 A; A/B/C/D/E/F/G/H=21-147.
DR   PDB; 3ESN; X-ray; 1.35 A; A/B=21-147.
DR   PDB; 3ESO; X-ray; 1.31 A; A/B=21-147.
DR   PDB; 3ESP; X-ray; 1.31 A; A/B=21-147.
DR   PDB; 3FC8; X-ray; 1.85 A; A/B=21-144.
DR   PDB; 3FCB; X-ray; 1.80 A; A/B=21-144.
DR   PDB; 3GLZ; X-ray; 1.78 A; A/B=21-147.
DR   PDB; 3GPS; X-ray; 1.78 A; A/B/C/D=21-147.
DR   PDB; 3GRB; X-ray; 1.75 A; A/B/C/D=21-147.
DR   PDB; 3GRG; X-ray; 1.90 A; A/B/C/D=21-147.
DR   PDB; 3GS0; X-ray; 1.85 A; A/B=21-147.
DR   PDB; 3GS4; X-ray; 1.78 A; A/B=21-147.
DR   PDB; 3GS7; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 3HJ0; X-ray; 1.34 A; A/B=21-147.
DR   PDB; 3I9A; X-ray; 1.65 A; A/B=21-147.
DR   PDB; 3I9I; X-ray; 1.80 A; A/B=30-145.
DR   PDB; 3I9P; X-ray; 1.90 A; A/B=30-145.
DR   PDB; 3IMR; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 3IMS; X-ray; 1.40 A; A/B=21-147.
DR   PDB; 3IMT; X-ray; 1.40 A; A/B=21-147.
DR   PDB; 3IMU; X-ray; 1.40 A; A/B=21-147.
DR   PDB; 3IMV; X-ray; 1.47 A; A/B=21-147.
DR   PDB; 3IMW; X-ray; 1.31 A; A/B=21-147.
DR   PDB; 3IPB; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 3IPE; X-ray; 1.40 A; A/B=21-147.
DR   PDB; 3KGS; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 3KGT; X-ray; 1.95 A; A/B=21-147.
DR   PDB; 3KGU; X-ray; 1.85 A; A/B=21-147.
DR   PDB; 3M1O; X-ray; 1.20 A; A/B=21-147.
DR   PDB; 3NEE; X-ray; 1.55 A; A/B=30-145.
DR   PDB; 3NEO; X-ray; 2.00 A; A/B=30-145.
DR   PDB; 3NES; X-ray; 1.75 A; A/B=30-145.
DR   PDB; 3NEX; X-ray; 1.70 A; A/B=30-145.
DR   PDB; 3NG5; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 3OZK; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 3OZL; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 3P3R; X-ray; 1.25 A; A/B=21-147.
DR   PDB; 3P3S; X-ray; 1.60 A; A/B=21-147.
DR   PDB; 3P3T; X-ray; 1.45 A; A/B=21-147.
DR   PDB; 3P3U; X-ray; 1.50 A; A/B=21-147.
DR   PDB; 3SSG; X-ray; 2.00 A; A=21-147.
DR   PDB; 3TCT; X-ray; 1.30 A; A/B=21-147.
DR   PDB; 3TFB; X-ray; 2.03 A; A/B=30-145.
DR   PDB; 3U2I; X-ray; 1.70 A; A/B=32-147.
DR   PDB; 3U2J; Neutron; 2.00 A; A/B=32-147.
DR   PDB; 3W3B; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 4ABQ; X-ray; 1.70 A; A/B=21-144.
DR   PDB; 4ABU; X-ray; 1.86 A; A/B=21-144.
DR   PDB; 4ABV; X-ray; 1.80 A; A/B=21-144.
DR   PDB; 4ABW; X-ray; 1.70 A; A/B=21-144.
DR   PDB; 4AC2; X-ray; 1.81 A; A/B=21-144.
DR   PDB; 4AC4; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 4ACT; X-ray; 1.80 A; A/B=21-147.
DR   PDB; 4ANK; X-ray; 1.70 A; A/B=1-147.
DR   PDB; 4D7B; X-ray; 1.15 A; A/B=21-147.
DR   PDB; 4DER; X-ray; 1.90 A; A/B=30-145.
DR   PDB; 4DES; X-ray; 1.75 A; A/B=30-145.
DR   PDB; 4DET; X-ray; 2.05 A; A/B=30-145.
DR   PDB; 4DEU; X-ray; 1.60 A; A/B=30-145.
DR   PDB; 4DEW; X-ray; 1.90 A; A/B=1-147.
DR   PDB; 4FI6; X-ray; 1.46 A; A/B=21-147.
DR   PDB; 4FI7; X-ray; 1.40 A; A/B=21-147.
DR   PDB; 4FI8; X-ray; 1.22 A; A/B=21-147.
DR   PDB; 4HIQ; X-ray; 1.18 A; A/B=21-147.
DR   PDB; 4HIS; X-ray; 1.20 A; A/B=21-147.
DR   PDB; 4HJS; X-ray; 1.22 A; A/B=30-145.
DR   PDB; 4HJT; X-ray; 1.45 A; A/B=21-147.
DR   PDB; 4HJU; X-ray; 1.35 A; A/B=21-147.
DR   PDB; 4I85; X-ray; 1.67 A; A/B=21-147.
DR   PDB; 4I87; X-ray; 1.69 A; A/B=21-147.
DR   PDB; 4I89; X-ray; 1.69 A; A/B=21-147.
DR   PDB; 4IIZ; X-ray; 2.10 A; A/B=21-147.
DR   PDB; 4IK6; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 4IK7; X-ray; 2.10 A; A/B=21-147.
DR   PDB; 4IKI; X-ray; 2.00 A; A/B=21-147.
DR   PDB; 4IKJ; X-ray; 2.10 A; A/B=21-147.
DR   PDB; 4IKK; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 4IKL; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 4KY2; X-ray; 1.13 A; A/B=21-147.
DR   PDB; 4L1S; X-ray; 1.50 A; A/B=21-147.
DR   PDB; 4L1T; X-ray; 1.16 A; A/B=21-147.
DR   PDB; 4MAS; X-ray; 1.22 A; A/B=21-147.
DR   PDB; 4MRB; X-ray; 1.27 A; A/B=21-147.
DR   PDB; 4MRC; X-ray; 1.54 A; A/B=22-147.
DR   PDB; 4N85; X-ray; 1.60 A; A/B=1-147.
DR   PDB; 4N86; X-ray; 2.00 A; A/B=1-147.
DR   PDB; 4N87; X-ray; 1.79 A; A/B=1-147.
DR   PDB; 4PM1; X-ray; 1.23 A; A/B=21-147.
DR   PDB; 4PME; X-ray; 1.26 A; A/B=29-146.
DR   PDB; 4PMF; X-ray; 1.35 A; A/B=29-145.
DR   PDB; 4PVL; X-ray; 1.85 A; A/B=21-147.
DR   PDB; 4PVM; Other; 2.00 A; A/B=21-147.
DR   PDB; 4PVN; Other; 2.30 A; A/B=21-147.
DR   PDB; 4PWE; X-ray; 1.40 A; A/B=1-147.
DR   PDB; 4PWF; X-ray; 1.60 A; A/B=1-147.
DR   PDB; 4PWG; X-ray; 1.80 A; A/B=1-147.
DR   PDB; 4PWH; X-ray; 1.80 A; A/B=1-147.
DR   PDB; 4PWI; X-ray; 1.49 A; A/B=1-147.
DR   PDB; 4PWJ; X-ray; 1.55 A; A/B=1-147.
DR   PDB; 4PWK; X-ray; 1.59 A; A/B=1-147.
DR   PDB; 4QRF; X-ray; 1.80 A; A/B=1-147.
DR   PDB; 4QXV; X-ray; 1.12 A; A/B=21-147.
DR   PDB; 4QYA; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 4TKW; X-ray; 1.80 A; A/B=29-147.
DR   PDB; 4TL4; X-ray; 1.75 A; A/B=29-147.
DR   PDB; 4TL5; X-ray; 1.44 A; A/B=29-147.
DR   PDB; 4TLK; X-ray; 1.44 A; A/B=29-147.
DR   PDB; 4TLS; X-ray; 1.35 A; A/B=29-147.
DR   PDB; 4TLT; X-ray; 1.70 A; A/B=29-147.
DR   PDB; 4TLU; X-ray; 1.75 A; A/B=29-147.
DR   PDB; 4TM9; X-ray; 1.70 A; A/B=29-147.
DR   PDB; 4TNE; X-ray; 1.55 A; A/B=29-147.
DR   PDB; 4TNF; X-ray; 1.60 A; A/B=29-147.
DR   PDB; 4TNG; X-ray; 1.60 A; A/B=29-147.
DR   PDB; 4TQ8; X-ray; 1.52 A; A/B=21-147.
DR   PDB; 4TQH; X-ray; 1.51 A; A/B=21-147.
DR   PDB; 4TQI; X-ray; 1.25 A; A/B=21-147.
DR   PDB; 4TQP; X-ray; 1.58 A; A/B=21-147.
DR   PDB; 4WNJ; X-ray; 1.40 A; A/B=21-147.
DR   PDB; 4WNS; X-ray; 1.40 A; A/B=21-147.
DR   PDB; 4WO0; X-ray; 1.34 A; A/B=21-147.
DR   PDB; 4Y9B; X-ray; 1.40 A; A/B=1-147.
DR   PDB; 4Y9C; X-ray; 1.49 A; A/B=1-147.
DR   PDB; 4Y9E; X-ray; 1.49 A; A/B=1-147.
DR   PDB; 4Y9F; X-ray; 1.50 A; A/B=1-147.
DR   PDB; 4Y9G; X-ray; 1.89 A; A/B=1-147.
DR   PDB; 4YDM; X-ray; 1.25 A; A/B=21-147.
DR   PDB; 4YDN; X-ray; 1.35 A; A/B=21-147.
DR   PDB; 5A6I; X-ray; 1.86 A; A=21-147.
DR   PDB; 5AKS; X-ray; 1.25 A; A/B=21-147.
DR   PDB; 5AKT; X-ray; 1.35 A; A/B=21-147.
DR   PDB; 5AKV; X-ray; 1.52 A; A/B=21-147.
DR   PDB; 5AL0; X-ray; 1.39 A; A/B=21-147.
DR   PDB; 5AL8; X-ray; 1.50 A; A/B=21-147.
DR   PDB; 5AYT; X-ray; 1.40 A; A/B=1-147.
DR   PDB; 5BOJ; X-ray; 1.75 A; A/B=21-147.
DR   PDB; 5CLX; X-ray; 1.28 A; A/B=21-147.
DR   PDB; 5CLY; X-ray; 1.23 A; A/B=21-147.
DR   PDB; 5CLZ; X-ray; 1.22 A; A/B=21-147.
DR   PDB; 5CM1; X-ray; 1.22 A; A/B=21-147.
DR   PDB; 5CN3; X-ray; 1.30 A; A/B=21-147.
DR   PDB; 5CNH; X-ray; 1.42 A; A/B=21-147.
DR   PDB; 5CR1; X-ray; 1.54 A; A/B=30-145.
DR   PDB; 5DEJ; X-ray; 1.37 A; A/B=30-145.
DR   PDB; 5DWP; X-ray; 1.20 A; A/B=30-145.
DR   PDB; 5E23; X-ray; 1.41 A; A/B=21-147.
DR   PDB; 5E4A; X-ray; 1.33 A; A/B=10-146.
DR   PDB; 5E4O; X-ray; 1.50 A; A/B=30-146.
DR   PDB; 5EN3; X-ray; 1.25 A; A/B=21-147.
DR   PDB; 5EZP; X-ray; 2.50 A; A/B/C/D/E/F/G/H=26-147.
DR   PDB; 5FO2; X-ray; 1.45 A; A/B=21-147.
DR   PDB; 5FW6; X-ray; 1.30 A; A/B=21-147.
DR   PDB; 5FW7; X-ray; 1.20 A; A/B=21-147.
DR   PDB; 5FW8; X-ray; 1.60 A; A/B=21-147.
DR   PDB; 5H0V; X-ray; 1.58 A; A/B/C/D=31-147.
DR   PDB; 5H0W; X-ray; 1.90 A; A=31-147.
DR   PDB; 5H0X; X-ray; 1.57 A; A/B=31-147.
DR   PDB; 5H0Y; X-ray; 1.80 A; A=31-147.
DR   PDB; 5H0Z; X-ray; 1.74 A; A=31-147.
DR   PDB; 5HJG; X-ray; 1.40 A; A/B=21-147.
DR   PDB; 5IHH; X-ray; 1.35 A; A/B=21-147.
DR   PDB; 5JID; X-ray; 1.20 A; A/B=21-147.
DR   PDB; 5JIM; X-ray; 1.26 A; A/B=21-147.
DR   PDB; 5JIQ; X-ray; 1.45 A; A/B=21-147.
DR   PDB; 5K1J; X-ray; 1.69 A; A/B=30-145.
DR   PDB; 5K1N; X-ray; 1.81 A; A/B=30-147.
DR   PDB; 5L4F; X-ray; 1.48 A; A/B=21-147.
DR   PDB; 5L4I; X-ray; 1.45 A; A/B=21-147.
DR   PDB; 5L4J; X-ray; 1.62 A; A/B=21-147.
DR   PDB; 5L4M; X-ray; 1.58 A; A/B=21-147.
DR   PDB; 5LLL; X-ray; 1.42 A; A/B=21-147.
DR   PDB; 5LLV; X-ray; 1.70 A; A/B/C/D=21-147.
DR   PDB; 5N5Q; X-ray; 2.53 A; A/B=30-145.
DR   PDB; 5N62; X-ray; 1.80 A; A/B=30-146.
DR   PDB; 5N7C; X-ray; 2.45 A; A/B=30-145.
DR   PDB; 5OQ0; X-ray; 1.94 A; A=21-147.
DR   PDB; 5TTR; X-ray; 2.70 A; A/B/C/D/E/F/G/H=21-147.
DR   PDB; 5TZL; X-ray; 1.40 A; A/B=21-147.
DR   PDB; 5U48; X-ray; 1.50 A; A/B=21-147.
DR   PDB; 5U49; X-ray; 2.22 A; A=21-147.
DR   PDB; 5U4A; X-ray; 1.90 A; A/B=21-147.
DR   PDB; 5U4B; X-ray; 1.45 A; A/B=21-147.
DR   PDB; 5U4C; X-ray; 1.70 A; A/B=21-147.
DR   PDB; 5U4D; X-ray; 1.55 A; A/B=21-147.
DR   PDB; 5U4E; X-ray; 1.45 A; A/B=21-147.
DR   PDB; 5U4F; X-ray; 1.50 A; A/B=21-147.
DR   PDB; 5U4G; X-ray; 1.80 A; A/B=21-147.
DR   PDBsum; 1BM7; -.
DR   PDBsum; 1BMZ; -.
DR   PDBsum; 1BZ8; -.
DR   PDBsum; 1BZD; -.
DR   PDBsum; 1BZE; -.
DR   PDBsum; 1DVQ; -.
DR   PDBsum; 1DVS; -.
DR   PDBsum; 1DVT; -.
DR   PDBsum; 1DVU; -.
DR   PDBsum; 1DVX; -.
DR   PDBsum; 1DVY; -.
DR   PDBsum; 1DVZ; -.
DR   PDBsum; 1E3F; -.
DR   PDBsum; 1E4H; -.
DR   PDBsum; 1E5A; -.
DR   PDBsum; 1ETA; -.
DR   PDBsum; 1ETB; -.
DR   PDBsum; 1F41; -.
DR   PDBsum; 1F64; -.
DR   PDBsum; 1F86; -.
DR   PDBsum; 1FH2; -.
DR   PDBsum; 1FHN; -.
DR   PDBsum; 1G1O; -.
DR   PDBsum; 1GKO; -.
DR   PDBsum; 1ICT; -.
DR   PDBsum; 1III; -.
DR   PDBsum; 1IIK; -.
DR   PDBsum; 1IJN; -.
DR   PDBsum; 1QAB; -.
DR   PDBsum; 1QWH; -.
DR   PDBsum; 1RLB; -.
DR   PDBsum; 1SOK; -.
DR   PDBsum; 1SOQ; -.
DR   PDBsum; 1THA; -.
DR   PDBsum; 1THC; -.
DR   PDBsum; 1TLM; -.
DR   PDBsum; 1TSH; -.
DR   PDBsum; 1TT6; -.
DR   PDBsum; 1TTA; -.
DR   PDBsum; 1TTB; -.
DR   PDBsum; 1TTC; -.
DR   PDBsum; 1TTR; -.
DR   PDBsum; 1TYR; -.
DR   PDBsum; 1TZ8; -.
DR   PDBsum; 1U21; -.
DR   PDBsum; 1X7S; -.
DR   PDBsum; 1X7T; -.
DR   PDBsum; 1Y1D; -.
DR   PDBsum; 1Z7J; -.
DR   PDBsum; 1ZCR; -.
DR   PDBsum; 1ZD6; -.
DR   PDBsum; 2B14; -.
DR   PDBsum; 2B15; -.
DR   PDBsum; 2B16; -.
DR   PDBsum; 2B77; -.
DR   PDBsum; 2B9A; -.
DR   PDBsum; 2F7I; -.
DR   PDBsum; 2F8I; -.
DR   PDBsum; 2FBR; -.
DR   PDBsum; 2FLM; -.
DR   PDBsum; 2G3X; -.
DR   PDBsum; 2G3Z; -.
DR   PDBsum; 2G4E; -.
DR   PDBsum; 2G4G; -.
DR   PDBsum; 2G5U; -.
DR   PDBsum; 2G9K; -.
DR   PDBsum; 2GAB; -.
DR   PDBsum; 2H4E; -.
DR   PDBsum; 2M5N; -.
DR   PDBsum; 2NBO; -.
DR   PDBsum; 2NBP; -.
DR   PDBsum; 2NOY; -.
DR   PDBsum; 2PAB; -.
DR   PDBsum; 2QEL; -.
DR   PDBsum; 2QGB; -.
DR   PDBsum; 2QGC; -.
DR   PDBsum; 2QGD; -.
DR   PDBsum; 2QGE; -.
DR   PDBsum; 2ROX; -.
DR   PDBsum; 2ROY; -.
DR   PDBsum; 2TRH; -.
DR   PDBsum; 2TRY; -.
DR   PDBsum; 2WQA; -.
DR   PDBsum; 3A4D; -.
DR   PDBsum; 3A4E; -.
DR   PDBsum; 3A4F; -.
DR   PDBsum; 3B56; -.
DR   PDBsum; 3BSZ; -.
DR   PDBsum; 3BT0; -.
DR   PDBsum; 3CBR; -.
DR   PDBsum; 3CFM; -.
DR   PDBsum; 3CFN; -.
DR   PDBsum; 3CFQ; -.
DR   PDBsum; 3CFT; -.
DR   PDBsum; 3CN0; -.
DR   PDBsum; 3CN1; -.
DR   PDBsum; 3CN2; -.
DR   PDBsum; 3CN3; -.
DR   PDBsum; 3CN4; -.
DR   PDBsum; 3CXF; -.
DR   PDBsum; 3D2T; -.
DR   PDBsum; 3D7P; -.
DR   PDBsum; 3DGD; -.
DR   PDBsum; 3DID; -.
DR   PDBsum; 3DJR; -.
DR   PDBsum; 3DJS; -.
DR   PDBsum; 3DJT; -.
DR   PDBsum; 3DJZ; -.
DR   PDBsum; 3DK0; -.
DR   PDBsum; 3DK2; -.
DR   PDBsum; 3DO4; -.
DR   PDBsum; 3ESN; -.
DR   PDBsum; 3ESO; -.
DR   PDBsum; 3ESP; -.
DR   PDBsum; 3FC8; -.
DR   PDBsum; 3FCB; -.
DR   PDBsum; 3GLZ; -.
DR   PDBsum; 3GPS; -.
DR   PDBsum; 3GRB; -.
DR   PDBsum; 3GRG; -.
DR   PDBsum; 3GS0; -.
DR   PDBsum; 3GS4; -.
DR   PDBsum; 3GS7; -.
DR   PDBsum; 3HJ0; -.
DR   PDBsum; 3I9A; -.
DR   PDBsum; 3I9I; -.
DR   PDBsum; 3I9P; -.
DR   PDBsum; 3IMR; -.
DR   PDBsum; 3IMS; -.
DR   PDBsum; 3IMT; -.
DR   PDBsum; 3IMU; -.
DR   PDBsum; 3IMV; -.
DR   PDBsum; 3IMW; -.
DR   PDBsum; 3IPB; -.
DR   PDBsum; 3IPE; -.
DR   PDBsum; 3KGS; -.
DR   PDBsum; 3KGT; -.
DR   PDBsum; 3KGU; -.
DR   PDBsum; 3M1O; -.
DR   PDBsum; 3NEE; -.
DR   PDBsum; 3NEO; -.
DR   PDBsum; 3NES; -.
DR   PDBsum; 3NEX; -.
DR   PDBsum; 3NG5; -.
DR   PDBsum; 3OZK; -.
DR   PDBsum; 3OZL; -.
DR   PDBsum; 3P3R; -.
DR   PDBsum; 3P3S; -.
DR   PDBsum; 3P3T; -.
DR   PDBsum; 3P3U; -.
DR   PDBsum; 3SSG; -.
DR   PDBsum; 3TCT; -.
DR   PDBsum; 3TFB; -.
DR   PDBsum; 3U2I; -.
DR   PDBsum; 3U2J; -.
DR   PDBsum; 3W3B; -.
DR   PDBsum; 4ABQ; -.
DR   PDBsum; 4ABU; -.
DR   PDBsum; 4ABV; -.
DR   PDBsum; 4ABW; -.
DR   PDBsum; 4AC2; -.
DR   PDBsum; 4AC4; -.
DR   PDBsum; 4ACT; -.
DR   PDBsum; 4ANK; -.
DR   PDBsum; 4D7B; -.
DR   PDBsum; 4DER; -.
DR   PDBsum; 4DES; -.
DR   PDBsum; 4DET; -.
DR   PDBsum; 4DEU; -.
DR   PDBsum; 4DEW; -.
DR   PDBsum; 4FI6; -.
DR   PDBsum; 4FI7; -.
DR   PDBsum; 4FI8; -.
DR   PDBsum; 4HIQ; -.
DR   PDBsum; 4HIS; -.
DR   PDBsum; 4HJS; -.
DR   PDBsum; 4HJT; -.
DR   PDBsum; 4HJU; -.
DR   PDBsum; 4I85; -.
DR   PDBsum; 4I87; -.
DR   PDBsum; 4I89; -.
DR   PDBsum; 4IIZ; -.
DR   PDBsum; 4IK6; -.
DR   PDBsum; 4IK7; -.
DR   PDBsum; 4IKI; -.
DR   PDBsum; 4IKJ; -.
DR   PDBsum; 4IKK; -.
DR   PDBsum; 4IKL; -.
DR   PDBsum; 4KY2; -.
DR   PDBsum; 4L1S; -.
DR   PDBsum; 4L1T; -.
DR   PDBsum; 4MAS; -.
DR   PDBsum; 4MRB; -.
DR   PDBsum; 4MRC; -.
DR   PDBsum; 4N85; -.
DR   PDBsum; 4N86; -.
DR   PDBsum; 4N87; -.
DR   PDBsum; 4PM1; -.
DR   PDBsum; 4PME; -.
DR   PDBsum; 4PMF; -.
DR   PDBsum; 4PVL; -.
DR   PDBsum; 4PVM; -.
DR   PDBsum; 4PVN; -.
DR   PDBsum; 4PWE; -.
DR   PDBsum; 4PWF; -.
DR   PDBsum; 4PWG; -.
DR   PDBsum; 4PWH; -.
DR   PDBsum; 4PWI; -.
DR   PDBsum; 4PWJ; -.
DR   PDBsum; 4PWK; -.
DR   PDBsum; 4QRF; -.
DR   PDBsum; 4QXV; -.
DR   PDBsum; 4QYA; -.
DR   PDBsum; 4TKW; -.
DR   PDBsum; 4TL4; -.
DR   PDBsum; 4TL5; -.
DR   PDBsum; 4TLK; -.
DR   PDBsum; 4TLS; -.
DR   PDBsum; 4TLT; -.
DR   PDBsum; 4TLU; -.
DR   PDBsum; 4TM9; -.
DR   PDBsum; 4TNE; -.
DR   PDBsum; 4TNF; -.
DR   PDBsum; 4TNG; -.
DR   PDBsum; 4TQ8; -.
DR   PDBsum; 4TQH; -.
DR   PDBsum; 4TQI; -.
DR   PDBsum; 4TQP; -.
DR   PDBsum; 4WNJ; -.
DR   PDBsum; 4WNS; -.
DR   PDBsum; 4WO0; -.
DR   PDBsum; 4Y9B; -.
DR   PDBsum; 4Y9C; -.
DR   PDBsum; 4Y9E; -.
DR   PDBsum; 4Y9F; -.
DR   PDBsum; 4Y9G; -.
DR   PDBsum; 4YDM; -.
DR   PDBsum; 4YDN; -.
DR   PDBsum; 5A6I; -.
DR   PDBsum; 5AKS; -.
DR   PDBsum; 5AKT; -.
DR   PDBsum; 5AKV; -.
DR   PDBsum; 5AL0; -.
DR   PDBsum; 5AL8; -.
DR   PDBsum; 5AYT; -.
DR   PDBsum; 5BOJ; -.
DR   PDBsum; 5CLX; -.
DR   PDBsum; 5CLY; -.
DR   PDBsum; 5CLZ; -.
DR   PDBsum; 5CM1; -.
DR   PDBsum; 5CN3; -.
DR   PDBsum; 5CNH; -.
DR   PDBsum; 5CR1; -.
DR   PDBsum; 5DEJ; -.
DR   PDBsum; 5DWP; -.
DR   PDBsum; 5E23; -.
DR   PDBsum; 5E4A; -.
DR   PDBsum; 5E4O; -.
DR   PDBsum; 5EN3; -.
DR   PDBsum; 5EZP; -.
DR   PDBsum; 5FO2; -.
DR   PDBsum; 5FW6; -.
DR   PDBsum; 5FW7; -.
DR   PDBsum; 5FW8; -.
DR   PDBsum; 5H0V; -.
DR   PDBsum; 5H0W; -.
DR   PDBsum; 5H0X; -.
DR   PDBsum; 5H0Y; -.
DR   PDBsum; 5H0Z; -.
DR   PDBsum; 5HJG; -.
DR   PDBsum; 5IHH; -.
DR   PDBsum; 5JID; -.
DR   PDBsum; 5JIM; -.
DR   PDBsum; 5JIQ; -.
DR   PDBsum; 5K1J; -.
DR   PDBsum; 5K1N; -.
DR   PDBsum; 5L4F; -.
DR   PDBsum; 5L4I; -.
DR   PDBsum; 5L4J; -.
DR   PDBsum; 5L4M; -.
DR   PDBsum; 5LLL; -.
DR   PDBsum; 5LLV; -.
DR   PDBsum; 5N5Q; -.
DR   PDBsum; 5N62; -.
DR   PDBsum; 5N7C; -.
DR   PDBsum; 5OQ0; -.
DR   PDBsum; 5TTR; -.
DR   PDBsum; 5TZL; -.
DR   PDBsum; 5U48; -.
DR   PDBsum; 5U49; -.
DR   PDBsum; 5U4A; -.
DR   PDBsum; 5U4B; -.
DR   PDBsum; 5U4C; -.
DR   PDBsum; 5U4D; -.
DR   PDBsum; 5U4E; -.
DR   PDBsum; 5U4F; -.
DR   PDBsum; 5U4G; -.
DR   ProteinModelPortal; P02766; -.
DR   SMR; P02766; -.
DR   BioGrid; 113127; 51.
DR   CORUM; P02766; -.
DR   DIP; DIP-1083N; -.
DR   IntAct; P02766; 48.
DR   MINT; P02766; -.
DR   STRING; 9606.ENSP00000237014; -.
DR   BindingDB; P02766; -.
DR   ChEMBL; CHEMBL3194; -.
DR   DrugBank; DB07201; (2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid.
DR   DrugBank; DB04474; 1-Anilino-8-Naphthalene Sulfonate.
DR   DrugBank; DB07282; 3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid.
DR   DrugBank; DB07240; 3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid.
DR   DrugBank; DB06885; 3-[({(1E)-[2-(trifluoromethyl)phenyl]methylidene}amino)oxy]propanoic acid.
DR   DrugBank; DB07176; 5-aminonaphthalene-1-sulfonic acid.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB00255; Diethylstilbestrol.
DR   DrugBank; DB00861; Diflunisal.
DR   DrugBank; DB01093; Dimethyl sulfoxide.
DR   DrugBank; DB02266; Flufenamic Acid.
DR   DrugBank; DB05352; Fx-1006A.
DR   DrugBank; DB01645; Genistein.
DR   DrugBank; DB00451; Levothyroxine.
DR   DrugBank; DB00279; Liothyronine.
DR   DrugBank; DB01583; Liotrix.
DR   DrugBank; DB05235; NRP409.
DR   DrugBank; DB02179; O-Trifluoromethylphenyl Anthranilic Acid.
DR   DrugBank; DB03167; Pentabromophenol.
DR   DrugBank; DB02709; Resveratrol.
DR   GuidetoPHARMACOLOGY; 2851; -.
DR   CarbonylDB; P02766; -.
DR   iPTMnet; P02766; -.
DR   PhosphoSitePlus; P02766; -.
DR   BioMuta; TTR; -.
DR   DMDM; 136464; -.
DR   DOSAC-COBS-2DPAGE; P02766; -.
DR   REPRODUCTION-2DPAGE; P02766; -.
DR   SWISS-2DPAGE; P02766; -.
DR   UCD-2DPAGE; P02766; -.
DR   MaxQB; P02766; -.
DR   PaxDb; P02766; -.
DR   PeptideAtlas; P02766; -.
DR   PRIDE; P02766; -.
DR   TopDownProteomics; P02766; -.
DR   DNASU; 7276; -.
DR   Ensembl; ENST00000237014; ENSP00000237014; ENSG00000118271.
DR   GeneID; 7276; -.
DR   KEGG; hsa:7276; -.
DR   UCSC; uc002kwx.5; human.
DR   CTD; 7276; -.
DR   DisGeNET; 7276; -.
DR   EuPathDB; HostDB:ENSG00000118271.9; -.
DR   GeneCards; TTR; -.
DR   GeneReviews; TTR; -.
DR   HGNC; HGNC:12405; TTR.
DR   HPA; CAB002517; -.
DR   HPA; CAB062567; -.
DR   HPA; CAB073406; -.
DR   HPA; HPA002550; -.
DR   MalaCards; TTR; -.
DR   MIM; 105210; phenotype.
DR   MIM; 115430; phenotype.
DR   MIM; 145680; phenotype.
DR   MIM; 176300; gene.
DR   neXtProt; NX_P02766; -.
DR   OpenTargets; ENSG00000118271; -.
DR   Orphanet; 85447; Familial amyloid polyneuropathy.
DR   Orphanet; 85451; Transthyretin-related familial amyloid cardiomyopathy.
DR   PharmGKB; PA37069; -.
DR   eggNOG; KOG3006; Eukaryota.
DR   eggNOG; COG2351; LUCA.
DR   GeneTree; ENSGT00390000005321; -.
DR   HOGENOM; HOG000251776; -.
DR   HOVERGEN; HBG000285; -.
DR   InParanoid; P02766; -.
DR   KO; K20731; -.
DR   PhylomeDB; P02766; -.
DR   TreeFam; TF300210; -.
DR   Reactome; R-HSA-2453864; Retinoid cycle disease events.
DR   Reactome; R-HSA-2453902; The canonical retinoid cycle in rods (twilight vision).
DR   Reactome; R-HSA-3000171; Non-integrin membrane-ECM interactions.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   ChiTaRS; TTR; human.
DR   EvolutionaryTrace; P02766; -.
DR   GeneWiki; Transthyretin; -.
DR   GenomeRNAi; 7276; -.
DR   PMAP-CutDB; P02766; -.
DR   PRO; PR:P02766; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000118271; -.
DR   CleanEx; HS_TTR; -.
DR   ExpressionAtlas; P02766; baseline and differential.
DR   Genevisible; P02766; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0005179; F:hormone activity; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0070324; F:thyroid hormone binding; IBA:GO_Central.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0042572; P:retinol metabolic process; IEA:InterPro.
DR   GO; GO:0070327; P:thyroid hormone transport; IEA:InterPro.
DR   Gene3D; 2.60.40.180; -; 1.
DR   InterPro; IPR023418; Thyroxine_BS.
DR   InterPro; IPR030178; Transthyretin.
DR   InterPro; IPR000895; Transthyretin/HIU_hydrolase.
DR   InterPro; IPR023416; Transthyretin/HIU_hydrolase_d.
DR   InterPro; IPR036817; Transthyretin/HIU_hydrolase_sf.
DR   InterPro; IPR023419; Transthyretin_CS.
DR   PANTHER; PTHR10395; PTHR10395; 1.
DR   PANTHER; PTHR10395:SF12; PTHR10395:SF12; 1.
DR   Pfam; PF00576; Transthyretin; 1.
DR   PRINTS; PR00189; TRNSTHYRETIN.
DR   SMART; SM00095; TR_THY; 1.
DR   SUPFAM; SSF49472; SSF49472; 1.
DR   PROSITE; PS00768; TRANSTHYRETIN_1; 1.
DR   PROSITE; PS00769; TRANSTHYRETIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amyloid; Amyloidosis; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation;
KW   Gamma-carboxyglutamic acid; Glycoprotein; Hormone; Neuropathy;
KW   Phosphoprotein; Polymorphism; Reference proteome; Secreted; Signal;
KW   Thyroid hormone; Transport.
FT   SIGNAL        1     20       {ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:1517749,
FT                                ECO:0000269|PubMed:3135807,
FT                                ECO:0000269|PubMed:4607556,
FT                                ECO:0000269|PubMed:6583672,
FT                                ECO:0000269|PubMed:6651852}.
FT   CHAIN        21    147       Transthyretin.
FT                                /FTId=PRO_0000035755.
FT   REGION      135    139       Thyroid hormone binding.
FT   BINDING      35     35       Thyroid hormones.
FT   BINDING      74     74       Thyroid hormones.
FT   MOD_RES      62     62       4-carboxyglutamate; in a patient with
FT                                Moyamoya disease.
FT                                {ECO:0000269|PubMed:18221012}.
FT   MOD_RES      72     72       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P02767}.
FT   CARBOHYD    118    118       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19167329}.
FT   VARIANT      26     26       G -> S (common polymorphism;
FT                                dbSNP:rs1800458).
FT                                {ECO:0000269|PubMed:10211412,
FT                                ECO:0000269|PubMed:11866053,
FT                                ECO:0000269|PubMed:15217993,
FT                                ECO:0000269|PubMed:6300852,
FT                                ECO:0000269|PubMed:8019560}.
FT                                /FTId=VAR_007546.
FT   VARIANT      30     30       C -> R (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918083).
FT                                {ECO:0000269|PubMed:1362222}.
FT                                /FTId=VAR_007547.
FT   VARIANT      32     32       L -> P (in AMYL-TTR; dbSNP:rs121918094).
FT                                {ECO:0000269|PubMed:10071047,
FT                                ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_038959.
FT   VARIANT      33     33       M -> I. {ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_038960.
FT   VARIANT      38     38       D -> E (in AMYL-TTR; amyloid
FT                                polyneuropathy).
FT                                /FTId=VAR_007548.
FT   VARIANT      38     38       D -> G (in AMYL-TTR; leptomeningeal
FT                                amyloidosis; leads to unfolding and
FT                                exposure of N-118 to glycosylation by
FT                                STT3B and subsequent degradation by the
FT                                ERAD pathway; dbSNP:rs121918098).
FT                                {ECO:0000269|PubMed:19167329,
FT                                ECO:0000269|PubMed:8579098}.
FT                                /FTId=VAR_007549.
FT   VARIANT      40     40       V -> I (in AMYL-TTR; late-onset amyloid
FT                                polyneuropathy with carpal tunnel
FT                                syndrome; dbSNP:rs121918093).
FT                                {ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:8990019}.
FT                                /FTId=VAR_007550.
FT   VARIANT      43     43       S -> N (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:10439117}.
FT                                /FTId=VAR_038961.
FT   VARIANT      44     44       P -> S (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs11541790).
FT                                {ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_007551.
FT   VARIANT      48     48       V -> M (in AMYL-TTR; amyloid
FT                                polyneuropathy).
FT                                {ECO:0000269|PubMed:10882995}.
FT                                /FTId=VAR_010658.
FT   VARIANT      50     50       V -> A (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs79977247).
FT                                {ECO:0000269|PubMed:1544214,
FT                                ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_007552.
FT   VARIANT      50     50       V -> G (in AMYL-TTR; dbSNP:rs79977247).
FT                                {ECO:0000269|PubMed:9066351}.
FT                                /FTId=VAR_038962.
FT   VARIANT      50     50       V -> L (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs28933979).
FT                                {ECO:0000269|PubMed:10611950,
FT                                ECO:0000269|PubMed:1520326}.
FT                                /FTId=VAR_007553.
FT   VARIANT      50     50       V -> M (in AMYL-TTR; amyloid
FT                                polyneuropathy; by far the most frequent
FT                                mutation; dbSNP:rs28933979).
FT                                {ECO:0000269|PubMed:12050338,
FT                                ECO:0000269|PubMed:1517749,
FT                                ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:3022108,
FT                                ECO:0000269|PubMed:3818577,
FT                                ECO:0000269|PubMed:6583672,
FT                                ECO:0000269|PubMed:6651852,
FT                                ECO:0000269|PubMed:7655883,
FT                                ECO:0000269|PubMed:8382610,
FT                                ECO:0000269|PubMed:8428915}.
FT                                /FTId=VAR_007554.
FT   VARIANT      53     53       F -> C (in a patient with amyloidosis).
FT                                {ECO:0000269|PubMed:12876326,
FT                                ECO:0000269|PubMed:15217993}.
FT                                /FTId=VAR_038963.
FT   VARIANT      53     53       F -> I (in AMYL-TTR; Jewish 'SKO' amyloid
FT                                polyneuropathy; dbSNP:rs121918068).
FT                                {ECO:0000269|PubMed:6487335,
FT                                ECO:0000269|PubMed:8019560}.
FT                                /FTId=VAR_007555.
FT   VARIANT      53     53       F -> L (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918068).
FT                                {ECO:0000269|PubMed:12050338,
FT                                ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:1932142,
FT                                ECO:0000269|PubMed:2046936}.
FT                                /FTId=VAR_007556.
FT   VARIANT      53     53       F -> V (in AMYL-TTR; amyloid
FT                                polyneuropathy).
FT                                {ECO:0000269|PubMed:10611950,
FT                                ECO:0000269|PubMed:12050338,
FT                                ECO:0000269|PubMed:15478468,
FT                                ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_038964.
FT   VARIANT      54     54       R -> T (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:9605286}.
FT                                /FTId=VAR_038965.
FT   VARIANT      55     55       K -> N (in AMYL-TTR; amyloid
FT                                polyneuropathy).
FT                                {ECO:0000269|PubMed:7655883}.
FT                                /FTId=VAR_038966.
FT   VARIANT      56     56       A -> P (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918077).
FT                                {ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_007557.
FT   VARIANT      58     58       D -> A (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:10611950,
FT                                ECO:0000269|PubMed:11866053}.
FT                                /FTId=VAR_038967.
FT   VARIANT      58     58       D -> V (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:12050338,
FT                                ECO:0000269|PubMed:17635579}.
FT                                /FTId=VAR_038968.
FT   VARIANT      61     61       W -> L (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:11866053}.
FT                                /FTId=VAR_038969.
FT   VARIANT      62     62       E -> D (in AMYL-TTR; dbSNP:rs11541796).
FT                                {ECO:0000269|PubMed:10036587}.
FT                                /FTId=VAR_038970.
FT   VARIANT      62     62       E -> G (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs11541796).
FT                                {ECO:0000269|PubMed:2363717,
FT                                ECO:0000269|PubMed:7923855}.
FT                                /FTId=VAR_007558.
FT   VARIANT      64     64       F -> S (in AMYL-TTR; dbSNP:rs104894665).
FT                                {ECO:0000269|PubMed:11866053,
FT                                ECO:0000269|PubMed:9818883}.
FT                                /FTId=VAR_038971.
FT   VARIANT      65     65       A -> D (in AMYL-TTR; amyloid
FT                                cardiomyopathy; dbSNP:rs730881169).
FT                                /FTId=VAR_007559.
FT   VARIANT      65     65       A -> S (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:10842718}.
FT                                /FTId=VAR_038972.
FT   VARIANT      65     65       A -> T (in AMYL-TTR; amyloid
FT                                cardiomyopathy; dbSNP:rs121918078).
FT                                {ECO:0000269|PubMed:1570831,
FT                                ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_007560.
FT   VARIANT      67     67       G -> A (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918090).
FT                                {ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|Ref.90}.
FT                                /FTId=VAR_007561.
FT   VARIANT      67     67       G -> E (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:12050338,
FT                                ECO:0000269|PubMed:15217993}.
FT                                /FTId=VAR_038973.
FT   VARIANT      67     67       G -> R (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs387906523).
FT                                {ECO:0000269|PubMed:1734866}.
FT                                /FTId=VAR_007562.
FT   VARIANT      67     67       G -> V (in AMYL-TTR; amyloid
FT                                polyneuropathy with carpal tunnel
FT                                syndrome).
FT                                /FTId=VAR_007563.
FT   VARIANT      69     69       T -> A (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918081).
FT                                {ECO:0000269|PubMed:1301926,
FT                                ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:7655883}.
FT                                /FTId=VAR_007564.
FT   VARIANT      69     69       T -> I (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:10436378,
FT                                ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_038974.
FT   VARIANT      70     70       S -> I (in AMYL-TTR; amyloid
FT                                cardiomyopathy; dbSNP:rs121918080).
FT                                {ECO:0000269|PubMed:1520336}.
FT                                /FTId=VAR_007565.
FT   VARIANT      70     70       S -> R (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs386134269).
FT                                {ECO:0000269|PubMed:10611950,
FT                                ECO:0000269|PubMed:23317988,
FT                                ECO:0000269|PubMed:2363717,
FT                                ECO:0000269|PubMed:7655883}.
FT                                /FTId=VAR_007566.
FT   VARIANT      72     72       S -> P (in AMYL-TTR; amyloid
FT                                polyneuropathy).
FT                                /FTId=VAR_007567.
FT   VARIANT      73     73       G -> E (in AMYL-TTR; dbSNP:rs121918097).
FT                                {ECO:0000269|PubMed:11445644}.
FT                                /FTId=VAR_038975.
FT   VARIANT      74     74       E -> G (in AMYL-TTR; amyloid
FT                                polyneuropathy).
FT                                /FTId=VAR_007568.
FT   VARIANT      74     74       E -> K (in AMYL-TTR; early-onset amyloid
FT                                polyneuropathy).
FT                                {ECO:0000269|PubMed:15214015}.
FT                                /FTId=VAR_038976.
FT   VARIANT      75     75       L -> P (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918079).
FT                                {ECO:0000269|PubMed:1351039,
FT                                ECO:0000269|PubMed:16627944,
FT                                ECO:0000269|PubMed:7910950,
FT                                ECO:0000269|PubMed:9733771}.
FT                                /FTId=VAR_007569.
FT   VARIANT      75     75       L -> Q (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:12557757}.
FT                                /FTId=VAR_038977.
FT   VARIANT      78     78       L -> H (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918069).
FT                                {ECO:0000269|PubMed:15217993}.
FT                                /FTId=VAR_007570.
FT   VARIANT      78     78       L -> R (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918069).
FT                                {ECO:0000269|PubMed:1656975}.
FT                                /FTId=VAR_007571.
FT   VARIANT      79     79       T -> K (in AMYL-TTR; amyloid
FT                                cardiomyopathy; dbSNP:rs730881163).
FT                                {ECO:0000269|PubMed:7850982}.
FT                                /FTId=VAR_007572.
FT   VARIANT      80     80       T -> A (in AMYL-TTR; amyloid
FT                                polyneuropathy and cardiomyopathy;
FT                                dbSNP:rs121918070).
FT                                {ECO:0000269|PubMed:12050338,
FT                                ECO:0000269|PubMed:15217993,
FT                                ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:7655883}.
FT                                /FTId=VAR_007573.
FT   VARIANT      81     81       E -> G (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:17453626}.
FT                                /FTId=VAR_038978.
FT   VARIANT      81     81       E -> K (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918086).
FT                                {ECO:0000269|PubMed:8352764}.
FT                                /FTId=VAR_007574.
FT   VARIANT      84     84       F -> L (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918091).
FT                                {ECO:0000269|PubMed:11866053,
FT                                ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:2046936}.
FT                                /FTId=VAR_007575.
FT   VARIANT      88     88       I -> L (in AMYL-TTR; amyloid
FT                                cardiomyopathy; dbSNP:rs121918085).
FT                                {ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:8038017}.
FT                                /FTId=VAR_007576.
FT   VARIANT      89     89       Y -> H (in AMYL-TTR; leptomeningeal
FT                                amyloidosis; vitreous amyloid in some
FT                                patients; dbSNP:rs121918100).
FT                                {ECO:0000269|PubMed:12771253}.
FT                                /FTId=VAR_007577.
FT   VARIANT      90     90       K -> N (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs267607160).
FT                                {ECO:0000269|PubMed:1436517}.
FT                                /FTId=VAR_007578.
FT   VARIANT      91     91       V -> A (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918084).
FT                                {ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:8095302,
FT                                ECO:0000269|PubMed:8257997}.
FT                                /FTId=VAR_007579.
FT   VARIANT      93     93       I -> V (in AMYL-TTR; amyloid
FT                                polyneuropathy).
FT                                {ECO:0000269|PubMed:10694917}.
FT                                /FTId=VAR_007580.
FT   VARIANT      94     94       D -> H (in dbSNP:rs730881164).
FT                                /FTId=VAR_007581.
FT   VARIANT      97     97       S -> Y (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918071).
FT                                {ECO:0000269|PubMed:15217993,
FT                                ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:2891727,
FT                                ECO:0000269|PubMed:7655883}.
FT                                /FTId=VAR_007582.
FT   VARIANT      98     98       Y -> F (in AMYL-TTR; dbSNP:rs958191819).
FT                                {ECO:0000269|PubMed:16627944,
FT                                ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_038979.
FT   VARIANT     104    104       I -> N (in AMYL-TTR; vitrous amyloid).
FT                                {ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_007583.
FT   VARIANT     104    104       I -> S (in AMYL-TTR; amyloid
FT                                polyneuropathy; almost no RBP binding;
FT                                dbSNP:rs121918072).
FT                                {ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:3722385,
FT                                ECO:0000269|PubMed:8089102}.
FT                                /FTId=VAR_007584.
FT   VARIANT     104    104       I -> T (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_038980.
FT   VARIANT     109    109       E -> K (in AMYL-TTR; amyloid
FT                                polyneuropathy).
FT                                {ECO:0000269|PubMed:10842705}.
FT                                /FTId=VAR_010659.
FT   VARIANT     109    109       E -> Q (in AMYL-TTR; amyloid
FT                                polyneuropathy and cardiomyopathy;
FT                                dbSNP:rs121918082).
FT                                {ECO:0000269|PubMed:1301926,
FT                                ECO:0000269|PubMed:7655883}.
FT                                /FTId=VAR_007585.
FT   VARIANT     110    110       H -> N (in dbSNP:rs121918074).
FT                                {ECO:0000269|PubMed:1997217,
FT                                ECO:0000269|PubMed:7923855}.
FT                                /FTId=VAR_007586.
FT   VARIANT     111    111       A -> S (in AMYL-TTR; amyloid
FT                                polyneuropathy).
FT                                {ECO:0000269|PubMed:10627135}.
FT                                /FTId=VAR_007587.
FT   VARIANT     114    114       V -> A (in a patient with amyloidosis).
FT                                {ECO:0000269|PubMed:15217993,
FT                                ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_038981.
FT   VARIANT     117    117       A -> G (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918087).
FT                                {ECO:0000269|PubMed:10611950,
FT                                ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:8133316}.
FT                                /FTId=VAR_007588.
FT   VARIANT     117    117       A -> S (in AMYL-TTR; dbSNP:rs267607161).
FT                                {ECO:0000269|PubMed:10611950}.
FT                                /FTId=VAR_038982.
FT   VARIANT     121    121       G -> S (in dbSNP:rs755337715).
FT                                {ECO:0000269|PubMed:10671063,
FT                                ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_007589.
FT   VARIANT     122    122       P -> R.
FT                                /FTId=VAR_007590.
FT   VARIANT     124    124       R -> C (in dbSNP:rs745834030).
FT                                /FTId=VAR_007591.
FT   VARIANT     124    124       R -> H (in dbSNP:rs121918095).
FT                                {ECO:0000269|PubMed:10529370,
FT                                ECO:0000269|PubMed:15735344}.
FT                                /FTId=VAR_038983.
FT   VARIANT     126    126       T -> N (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_038984.
FT   VARIANT     127    127       I -> M (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_038985.
FT   VARIANT     127    127       I -> V (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918089).
FT                                {ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:7914929,
FT                                ECO:0000269|PubMed:8081397}.
FT                                /FTId=VAR_007592.
FT   VARIANT     129    129       A -> T (in DTTRH; increased affinity for
FT                                thyroxine; dbSNP:rs267607159).
FT                                {ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:1979335}.
FT                                /FTId=VAR_007593.
FT   VARIANT     131    131       L -> M (in AMYL-TTR; dbSNP:rs121918073).
FT                                {ECO:0000269|PubMed:17503405}.
FT                                /FTId=VAR_007594.
FT   VARIANT     134    134       Y -> C (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs121918075).
FT                                {ECO:0000269|PubMed:12403615,
FT                                ECO:0000269|PubMed:16185074,
FT                                ECO:0000269|PubMed:2161654}.
FT                                /FTId=VAR_007595.
FT   VARIANT     134    134       Y -> H (in CTS1; amyloid deposit on
FT                                carpal tunnel; patients show no other
FT                                abnormalities; dbSNP:rs121918088).
FT                                {ECO:0000269|PubMed:8309582}.
FT                                /FTId=VAR_007598.
FT   VARIANT     136    136       Y -> S (in AMYL-TTR; amyloid
FT                                polyneuropathy; dbSNP:rs730881167).
FT                                {ECO:0000269|PubMed:10627135}.
FT                                /FTId=VAR_007596.
FT   VARIANT     136    136       Y -> V (requires 2 nucleotide
FT                                substitutions).
FT                                {ECO:0000269|PubMed:3675594}.
FT                                /FTId=VAR_007597.
FT   VARIANT     139    139       T -> M (in Chicago variant;
FT                                dbSNP:rs28933981).
FT                                {ECO:0000269|PubMed:11866053,
FT                                ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:1877623}.
FT                                /FTId=VAR_007599.
FT   VARIANT     140    140       A -> S (in AMYL-TTR; dbSNP:rs876658108).
FT                                {ECO:0000269|PubMed:12050338}.
FT                                /FTId=VAR_038986.
FT   VARIANT     142    142       V -> A (in AMYL-TTR).
FT                                {ECO:0000269|PubMed:10211412}.
FT                                /FTId=VAR_038987.
FT   VARIANT     142    142       V -> I (in AMYL-TTR; dbSNP:rs76992529).
FT                                {ECO:0000269|PubMed:12050338,
FT                                ECO:0000269|PubMed:17503405,
FT                                ECO:0000269|PubMed:3135807}.
FT                                /FTId=VAR_007600.
FT   VARIANT     144    144       N -> S (in AMYL-TTR; dbSNP:rs144965179).
FT                                {ECO:0000269|PubMed:17577687}.
FT                                /FTId=VAR_038988.
FT   MUTAGEN     107    107       F->M: Loss of tetramerization; when
FT                                associated with M-130.
FT                                {ECO:0000269|PubMed:11560492}.
FT   MUTAGEN     130    130       L->M: Loss of tetramerization; when
FT                                associated with M-107.
FT                                {ECO:0000269|PubMed:11560492}.
FT   CONFLICT     41     41       R -> P (in Ref. 3; AAA98771).
FT                                {ECO:0000305}.
FT   CONFLICT    147    147       E -> D (in Ref. 12; CAG33189).
FT                                {ECO:0000305}.
FT   TURN         23     26       {ECO:0000244|PDB:1TSH}.
FT   STRAND       32     38       {ECO:0000244|PDB:1F86}.
FT   TURN         39     42       {ECO:0000244|PDB:1F86}.
FT   STRAND       49     55       {ECO:0000244|PDB:1F86}.
FT   STRAND       57     59       {ECO:0000244|PDB:2B77}.
FT   STRAND       61     68       {ECO:0000244|PDB:1F86}.
FT   STRAND       73     75       {ECO:0000244|PDB:1F86}.
FT   STRAND       77     80       {ECO:0000244|PDB:2QEL}.
FT   TURN         81     83       {ECO:0000244|PDB:1F86}.
FT   STRAND       86     93       {ECO:0000244|PDB:1F86}.
FT   HELIX        95    101       {ECO:0000244|PDB:1F86}.
FT   STRAND      107    118       {ECO:0000244|PDB:1F86}.
FT   STRAND      120    122       {ECO:0000244|PDB:5JIM}.
FT   STRAND      124    132       {ECO:0000244|PDB:1F86}.
FT   STRAND      135    143       {ECO:0000244|PDB:1F86}.
SQ   SEQUENCE   147 AA;  15887 MW;  3A6AEBCBBA56BC44 CRC64;
     MASHRLLLLC LAGLVFVSEA GPTGTGESKC PLMVKVLDAV RGSPAINVAV HVFRKAADDT
     WEPFASGKTS ESGELHGLTT EEEFVEGIYK VEIDTKSYWK ALGISPFHEH AEVVFTANDS
     GPRRYTIAAL LSPYSYSTTA VVTNPKE
//
ID   PFD1_HUMAN              Reviewed;         122 AA.
AC   O60925; B2RD02; Q53F95; Q96EX6;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-2002, sequence version 2.
DT   23-MAY-2018, entry version 151.
DE   RecName: Full=Prefoldin subunit 1;
GN   Name=PFDN1; Synonyms=PFD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9630229; DOI=10.1016/S0092-8674(00)81446-4;
RA   Vainberg I.E., Lewis S.A., Rommelaere H., Ampe C., Vandekerckhove J.,
RA   Klein H.L., Cowan N.J.;
RT   "Prefoldin, a chaperone that delivers unfolded proteins to cytosolic
RT   chaperonin.";
RL   Cell 93:863-873(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Binds specifically to cytosolic chaperonin (c-CPN) and
CC       transfers target proteins to it. Binds to nascent polypeptide
CC       chain and promotes folding in an environment in which there are
CC       many competing pathways for nonnative proteins.
CC   -!- SUBUNIT: Heterohexamer of two PFD-alpha type and four PFD-beta
CC       type subunits.
CC   -!- SIMILARITY: Belongs to the prefoldin subunit beta family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y17392; CAA76759.1; -; mRNA.
DR   EMBL; AK223394; BAD97114.1; -; mRNA.
DR   EMBL; AK315353; BAG37749.1; -; mRNA.
DR   EMBL; CH471062; EAW62071.1; -; Genomic_DNA.
DR   EMBL; BC003620; AAH03620.1; -; mRNA.
DR   EMBL; BC006202; AAH06202.1; -; mRNA.
DR   EMBL; BC011869; AAH11869.1; -; mRNA.
DR   CCDS; CCDS4222.1; -.
DR   RefSeq; NP_002613.2; NM_002622.4.
DR   UniGene; Hs.483564; -.
DR   ProteinModelPortal; O60925; -.
DR   SMR; O60925; -.
DR   BioGrid; 111223; 97.
DR   CORUM; O60925; -.
DR   IntAct; O60925; 60.
DR   MINT; O60925; -.
DR   STRING; 9606.ENSP00000261813; -.
DR   iPTMnet; O60925; -.
DR   PhosphoSitePlus; O60925; -.
DR   BioMuta; PFDN1; -.
DR   OGP; O60925; -.
DR   EPD; O60925; -.
DR   MaxQB; O60925; -.
DR   PaxDb; O60925; -.
DR   PeptideAtlas; O60925; -.
DR   PRIDE; O60925; -.
DR   TopDownProteomics; O60925; -.
DR   DNASU; 5201; -.
DR   Ensembl; ENST00000261813; ENSP00000261813; ENSG00000113068.
DR   GeneID; 5201; -.
DR   KEGG; hsa:5201; -.
DR   UCSC; uc003lff.2; human.
DR   CTD; 5201; -.
DR   DisGeNET; 5201; -.
DR   EuPathDB; HostDB:ENSG00000113068.9; -.
DR   GeneCards; PFDN1; -.
DR   HGNC; HGNC:8866; PFDN1.
DR   HPA; HPA006499; -.
DR   MIM; 604897; gene.
DR   neXtProt; NX_O60925; -.
DR   OpenTargets; ENSG00000113068; -.
DR   PharmGKB; PA33207; -.
DR   eggNOG; ENOG410ISJS; Eukaryota.
DR   eggNOG; ENOG4111Q46; LUCA.
DR   GeneTree; ENSGT00390000009786; -.
DR   HOGENOM; HOG000005946; -.
DR   HOVERGEN; HBG031813; -.
DR   InParanoid; O60925; -.
DR   KO; K09548; -.
DR   OMA; QSVGRMF; -.
DR   OrthoDB; EOG091G0X1V; -.
DR   PhylomeDB; O60925; -.
DR   TreeFam; TF106490; -.
DR   Reactome; R-HSA-389957; Prefoldin mediated transfer of substrate to CCT/TriC.
DR   ChiTaRS; PFDN1; human.
DR   GeneWiki; PFDN1; -.
DR   GenomeRNAi; 5201; -.
DR   PRO; PR:O60925; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113068; -.
DR   CleanEx; HS_PFDN1; -.
DR   ExpressionAtlas; O60925; baseline and differential.
DR   Genevisible; O60925; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016272; C:prefoldin complex; IEA:InterPro.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0044183; F:protein binding involved in protein folding; IPI:AgBase.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0007010; P:cytoskeleton organization; IBA:GO_Central.
DR   Gene3D; 1.10.287.370; -; 1.
DR   InterPro; IPR002777; PFD_beta-like.
DR   InterPro; IPR009053; Prefoldin.
DR   Pfam; PF01920; Prefoldin_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chaperone; Complete proteome; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    122       Prefoldin subunit 1.
FT                                /FTId=PRO_0000124830.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   CONFLICT     86     86       I -> V (in Ref. 3; BAD97114).
FT                                {ECO:0000305}.
FT   CONFLICT    104    105       SV -> RL (in Ref. 1; CAA76759).
FT                                {ECO:0000305}.
SQ   SEQUENCE   122 AA;  14210 MW;  4C88216612864F87 CRC64;
     MAAPVDLELK KAFTELQAKV IDTQQKVKLA DIQIEQLNRT KKHAHLTDTE IMTLVDETNM
     YEGVGRMFIL QSKEAIHSQL LEKQKIAEEK IKELEQKKSY LERSVKEAED NIREMLMARR
     AQ
//
ID   UB2J1_HUMAN             Reviewed;         318 AA.
AC   Q9Y385; A8K3F9; Q53F25; Q5W0N4; Q9BZ32; Q9NQL3; Q9NY66; Q9P011;
AC   Q9P0S0; Q9UF10;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 2.
DT   23-MAY-2018, entry version 156.
DE   RecName: Full=Ubiquitin-conjugating enzyme E2 J1;
DE            EC=2.3.2.23;
DE   AltName: Full=E2 ubiquitin-conjugating enzyme J1;
DE   AltName: Full=Non-canonical ubiquitin-conjugating enzyme 1;
DE            Short=NCUBE-1;
DE   AltName: Full=Yeast ubiquitin-conjugating enzyme UBC6 homolog E;
DE            Short=HsUBC6e;
GN   Name=UBE2J1; Synonyms=NCUBE1; ORFNames=CGI-76, HSPC153, HSPC205;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10708578; DOI=10.1006/bbrc.2000.2302;
RA   Lester D.H., Farquharson C., Russell G.C., Houston B.;
RT   "Identification of a family of non-canonical ubiquitin-conjugating
RT   enzymes structurally related to yeast UBC6.";
RL   Biochem. Biophys. Res. Commun. 269:474-480(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT VAL-55, FUNCTION, MUTAGENESIS OF
RP   CYS-91, AND SUBCELLULAR LOCATION.
RX   PubMed=12082160;
RA   Lenk U., Yu H., Walter J., Gelman M.S., Hartmann E., Kopito R.R.,
RA   Sommer T.;
RT   "A role for mammalian Ubc6 homologues in ER-associated protein
RT   degradation.";
RL   J. Cell Sci. 115:3007-3014(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-229.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-229.
RC   TISSUE=Spleen;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-229.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-229.
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   FUNCTION IN ERAD PATHWAY.
RX   PubMed=22607976; DOI=10.1016/j.molcel.2012.04.015;
RA   Sato T., Sako Y., Sho M., Momohara M., Suico M.A., Shuto T.,
RA   Nishitoh H., Okiyoneda T., Kokame K., Kaneko M., Taura M., Miyata M.,
RA   Chosa K., Koga T., Morino-Koga S., Wada I., Kai H.;
RT   "STT3B-dependent posttranslational N-glycosylation as a surveillance
RT   system for secretory protein.";
RL   Mol. Cell 47:99-110(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184; SER-266 AND
RP   SER-268, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the covalent attachment of ubiquitin to other
CC       proteins. Functions in the selective degradation of misfolded
CC       membrane proteins from the endoplasmic reticulum (ERAD).
CC       {ECO:0000255|PROSITE-ProRule:PRU00388,
CC       ECO:0000269|PubMed:12082160, ECO:0000269|PubMed:22607976}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine
CC       = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2
CC       ubiquitin-conjugating enzyme]-L-cysteine. {ECO:0000255|PROSITE-
CC       ProRule:PRU00388}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12082160}; Single-pass type IV membrane
CC       protein {ECO:0000269|PubMed:12082160}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD34071.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAF36125.1; Type=Frameshift; Positions=119; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ245898; CAB83212.1; -; mRNA.
DR   EMBL; U93243; AAF21505.1; -; mRNA.
DR   EMBL; AF151834; AAD34071.1; ALT_INIT; mRNA.
DR   EMBL; AF151039; AAF36125.1; ALT_FRAME; mRNA.
DR   EMBL; AF161502; AAF29117.1; -; mRNA.
DR   EMBL; AK290574; BAF83263.1; -; mRNA.
DR   EMBL; AK223464; BAD97184.1; -; mRNA.
DR   EMBL; AL138717; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL139804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48555.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48556.1; -; Genomic_DNA.
DR   EMBL; BC013973; AAH13973.1; -; mRNA.
DR   CCDS; CCDS5021.1; -.
DR   RefSeq; NP_057105.2; NM_016021.2.
DR   UniGene; Hs.163776; -.
DR   ProteinModelPortal; Q9Y385; -.
DR   SMR; Q9Y385; -.
DR   BioGrid; 119555; 37.
DR   CORUM; Q9Y385; -.
DR   DIP; DIP-45598N; -.
DR   IntAct; Q9Y385; 27.
DR   MINT; Q9Y385; -.
DR   STRING; 9606.ENSP00000451261; -.
DR   iPTMnet; Q9Y385; -.
DR   PhosphoSitePlus; Q9Y385; -.
DR   BioMuta; UBE2J1; -.
DR   DMDM; 52000881; -.
DR   OGP; Q9Y385; -.
DR   EPD; Q9Y385; -.
DR   MaxQB; Q9Y385; -.
DR   PaxDb; Q9Y385; -.
DR   PeptideAtlas; Q9Y385; -.
DR   PRIDE; Q9Y385; -.
DR   DNASU; 51465; -.
DR   Ensembl; ENST00000435041; ENSP00000451261; ENSG00000198833.
DR   GeneID; 51465; -.
DR   KEGG; hsa:51465; -.
DR   UCSC; uc003pnc.4; human.
DR   CTD; 51465; -.
DR   DisGeNET; 51465; -.
DR   EuPathDB; HostDB:ENSG00000198833.6; -.
DR   GeneCards; UBE2J1; -.
DR   HGNC; HGNC:17598; UBE2J1.
DR   HPA; CAB073419; -.
DR   HPA; HPA003509; -.
DR   MIM; 616175; gene.
DR   neXtProt; NX_Q9Y385; -.
DR   OpenTargets; ENSG00000198833; -.
DR   PharmGKB; PA134906541; -.
DR   eggNOG; KOG0428; Eukaryota.
DR   eggNOG; COG5078; LUCA.
DR   GeneTree; ENSGT00530000063379; -.
DR   HOVERGEN; HBG058959; -.
DR   InParanoid; Q9Y385; -.
DR   KO; K10578; -.
DR   OMA; DFCCEMC; -.
DR   OrthoDB; EOG091G0JU3; -.
DR   PhylomeDB; Q9Y385; -.
DR   TreeFam; TF101124; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q9Y385; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE2J1; human.
DR   GeneWiki; UBE2J1; -.
DR   GenomeRNAi; 51465; -.
DR   PRO; PR:Q9Y385; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000198833; -.
DR   CleanEx; HS_UBE2J1; -.
DR   Genevisible; Q9Y385; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; IMP:MGI.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:1904153; P:negative regulation of retrograde protein transport, ER to cytosol; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB.
DR   GO; GO:0042534; P:regulation of tumor necrosis factor biosynthetic process; IEA:Ensembl.
DR   GO; GO:0007286; P:spermatid development; IEA:Ensembl.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IMP:UniProtKB.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Endoplasmic reticulum; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix;
KW   Ubl conjugation pathway.
FT   CHAIN         1    318       Ubiquitin-conjugating enzyme E2 J1.
FT                                /FTId=PRO_0000082594.
FT   TOPO_DOM      1    282       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    283    303       Helical; Anchor for type IV membrane
FT                                protein. {ECO:0000255}.
FT   TOPO_DOM    304    318       Lumenal. {ECO:0000255}.
FT   ACT_SITE     91     91       Glycyl thioester intermediate.
FT   MOD_RES     184    184       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     266    266       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     268    268       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT      55     55       G -> V (in dbSNP:rs8099).
FT                                {ECO:0000269|PubMed:12082160}.
FT                                /FTId=VAR_019689.
FT   VARIANT     229    229       L -> V (in dbSNP:rs10502).
FT                                {ECO:0000269|PubMed:11042152,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.6, ECO:0000269|Ref.8}.
FT                                /FTId=VAR_019690.
FT   MUTAGEN      91     91       C->S: Loss of catalytic activity. Slows
FT                                down degradation of misfolded proteins
FT                                from the ER.
FT                                {ECO:0000269|PubMed:12082160}.
FT   CONFLICT     32     33       QP -> HA (in Ref. 3; AAD34071).
FT                                {ECO:0000305}.
FT   CONFLICT    276    276       Q -> H (in Ref. 2; AAF21505).
FT                                {ECO:0000305}.
SQ   SEQUENCE   318 AA;  35199 MW;  CFF5FE00C2BBD39E CRC64;
     METRYNLKSP AVKRLMKEAA ELKDPTDHYH AQPLEDNLFE WHFTVRGPPD SDFDGGVYHG
     RIVLPPEYPM KPPSIILLTA NGRFEVGKKI CLSISGHHPE TWQPSWSIRT ALLAIIGFMP
     TKGEGAIGSL DYTPEERRAL AKKSQDFCCE GCGSAMKDVL LPLKSGSDSS QADQEAKELA
     RQISFKAEVN SSGKTISESD LNHSFSLTDL QDDIPTTFQG ATASTSYGLQ NSSAASFHQP
     TQPVAKNTSM SPRQRRAQQQ SQRRLSTSPD VIQGHQPRDN HTDHGGSAVL IVILTLALAA
     LIFRRIYLAN EYIFDFEL
//
ID   SC61B_HUMAN             Reviewed;          96 AA.
AC   P60468; P38390; P38391; Q6IBC1;
DT   16-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   23-MAY-2018, entry version 141.
DE   RecName: Full=Protein transport protein Sec61 subunit beta;
GN   Name=SEC61B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8107851; DOI=10.1038/367654a0;
RA   Hartmann E., Sommer T., Prehn S., Goerlich D., Jentsch S.,
RA   Rapoport T.A.;
RT   "Evolutionary conservation of components of the protein translocation
RT   complex.";
RL   Nature 367:654-657(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-20, CLEAVAGE OF INITIATOR METHIONINE,
RP   PHOSPHORYLATION AT SER-7, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [6]
RP   IDENTIFICATION IN A COMPLEX WITH SEC62 AND SEC63, AND INTERACTION WITH
RP   SEC62.
RX   PubMed=10799540; DOI=10.1074/jbc.275.19.14550;
RA   Meyer H.-A., Grau H., Kraft R., Kostka S., Prehn S., Kalies K.-U.,
RA   Hartmann E.;
RT   "Mammalian Sec61 is associated with Sec62 and Sec63.";
RL   J. Biol. Chem. 275:14550-14557(2000).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13; SER-14 AND SER-17,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   MUTAGENESIS OF CYS-39, AND PALMITOYLATION AT CYS-39.
RX   PubMed=21044946; DOI=10.1194/jlr.D011106;
RA   Forrester M.T., Hess D.T., Thompson J.W., Hultman R., Moseley M.A.,
RA   Stamler J.S., Casey P.J.;
RT   "Site-specific analysis of protein S-acylation by resin-assisted
RT   capture.";
RL   J. Lipid Res. 52:393-398(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT PRO-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-17, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-9; SER-14 AND SER-17,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Necessary for protein translocation in the endoplasmic
CC       reticulum.
CC   -!- SUBUNIT: Heterotrimeric complex composed of SEC61-alpha, SEC61-
CC       beta and SEC61-gamma. Part of a complex composed of SEC61, SEC62
CC       and SEC63. Interacts with SEC62. {ECO:0000269|PubMed:10799540}.
CC   -!- INTERACTION:
CC       P51572:BCAP31; NbExp=7; IntAct=EBI-1788819, EBI-77683;
CC       Q12154:GET3 (xeno); NbExp=4; IntAct=EBI-1788819, EBI-2989;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the SEC61-beta family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L25085; AAA19706.1; -; mRNA.
DR   EMBL; CR456883; CAG33164.1; -; mRNA.
DR   EMBL; AL137067; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001734; AAH01734.1; -; mRNA.
DR   CCDS; CCDS6741.1; -.
DR   PIR; S42410; S42410.
DR   RefSeq; NP_006799.1; NM_006808.2.
DR   UniGene; Hs.191887; -.
DR   ProteinModelPortal; P60468; -.
DR   SMR; P60468; -.
DR   BioGrid; 116152; 50.
DR   CORUM; P60468; -.
DR   DIP; DIP-40997N; -.
DR   IntAct; P60468; 51.
DR   MINT; P60468; -.
DR   STRING; 9606.ENSP00000223641; -.
DR   TCDB; 3.A.5.9.1; the general secretory pathway (sec) family.
DR   iPTMnet; P60468; -.
DR   PhosphoSitePlus; P60468; -.
DR   SwissPalm; P60468; -.
DR   BioMuta; SEC61B; -.
DR   DMDM; 42560366; -.
DR   EPD; P60468; -.
DR   MaxQB; P60468; -.
DR   PaxDb; P60468; -.
DR   PeptideAtlas; P60468; -.
DR   PRIDE; P60468; -.
DR   TopDownProteomics; P60468; -.
DR   Ensembl; ENST00000223641; ENSP00000223641; ENSG00000106803.
DR   GeneID; 10952; -.
DR   KEGG; hsa:10952; -.
DR   UCSC; uc004azh.4; human.
DR   CTD; 10952; -.
DR   EuPathDB; HostDB:ENSG00000106803.9; -.
DR   GeneCards; SEC61B; -.
DR   HGNC; HGNC:16993; SEC61B.
DR   HPA; HPA049407; -.
DR   MIM; 609214; gene.
DR   neXtProt; NX_P60468; -.
DR   OpenTargets; ENSG00000106803; -.
DR   PharmGKB; PA134888963; -.
DR   eggNOG; KOG3457; Eukaryota.
DR   eggNOG; ENOG4111UAR; LUCA.
DR   GeneTree; ENSGT00390000003561; -.
DR   HOGENOM; HOG000211109; -.
DR   HOVERGEN; HBG061281; -.
DR   InParanoid; P60468; -.
DR   KO; K09481; -.
DR   OMA; NSGGMWR; -.
DR   OrthoDB; EOG091G17J4; -.
DR   PhylomeDB; P60468; -.
DR   TreeFam; TF313144; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   GeneWiki; SEC61B; -.
DR   GenomeRNAi; 10952; -.
DR   PRO; PR:P60468; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000106803; -.
DR   CleanEx; HS_SEC61B; -.
DR   ExpressionAtlas; P60468; baseline and differential.
DR   Genevisible; P60468; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0031205; C:endoplasmic reticulum Sec complex; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0005784; C:Sec61 translocon complex; IEA:InterPro.
DR   GO; GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0048408; F:epidermal growth factor binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031204; P:posttranslational protein targeting to membrane, translocation; IBA:GO_Central.
DR   GO; GO:0000060; P:protein import into nucleus, translocation; IMP:UniProtKB.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; IMP:UniProtKB.
DR   GO; GO:0006616; P:SRP-dependent cotranslational protein targeting to membrane, translocation; IBA:GO_Central.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:UniProtKB.
DR   InterPro; IPR030671; Sec61-beta/Sbh.
DR   InterPro; IPR016482; SecG/Sec61-beta/Sbh.
DR   PANTHER; PTHR13509; PTHR13509; 1.
DR   Pfam; PF03911; Sec61_beta; 1.
DR   PIRSF; PIRSF006398; Sec61_beta_euk; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Direct protein sequencing;
KW   Endoplasmic reticulum; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Protein transport; Reference proteome; Translocation;
KW   Transmembrane; Transmembrane helix; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.5}.
FT   CHAIN         2     96       Protein transport protein Sec61 subunit
FT                                beta.
FT                                /FTId=PRO_0000157254.
FT   TOPO_DOM      2     70       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     71     91       Helical. {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylproline.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES       7      7       Phosphoserine. {ECO:0000269|Ref.5}.
FT   MOD_RES       9      9       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      17     17       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   LIPID        39     39       S-palmitoyl cysteine.
FT                                {ECO:0000305|PubMed:21044946}.
FT   MUTAGEN      39     39       C->S: Abolishes S-acylation.
FT                                {ECO:0000269|PubMed:21044946}.
SQ   SEQUENCE   96 AA;  9974 MW;  5FAFF4197A62FA49 CRC64;
     MPGPTPSGTN VGSSGRSPSK AVAARAAGST VRQRKNASCG TRSAGRTTSA GTGGMWRFYT
     EDSPGLKVGP VPVLVMSLLF IASVFMLHIW GKYTRS
//
ID   B3KME8_HUMAN            Unreviewed;       170 AA.
AC   B3KME8;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   23-MAY-2018, entry version 71.
DE   SubName: Full=cDNA FLJ10827 fis, clone NT2RP4001117, highly similar to Protein transport protein Sec61 subunit alpha isoform 1 {ECO:0000313|EMBL:BAG50960.1};
DE   SubName: Full=cDNA FLJ14546 fis, clone NT2RM2001613, highly similar to Protein transport protein Sec61 subunit alpha isoform 1 {ECO:0000313|EMBL:BAG51323.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG50960.1};
RN   [1] {ECO:0000313|EMBL:BAG50960.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- SIMILARITY: Belongs to the SecY/SEC61-alpha family.
CC       {ECO:0000256|RuleBase:RU004349}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK001689; BAG50960.1; -; mRNA.
DR   EMBL; AK027452; BAG51323.1; -; mRNA.
DR   RefSeq; NP_037468.1; NM_013336.3.
DR   UniGene; Hs.518236; -.
DR   PeptideAtlas; B3KME8; -.
DR   PRIDE; B3KME8; -.
DR   DNASU; 29927; -.
DR   GeneID; 29927; -.
DR   KEGG; hsa:29927; -.
DR   CTD; 29927; -.
DR   PharmGKB; PA134901772; -.
DR   eggNOG; KOG1373; Eukaryota.
DR   eggNOG; COG0201; LUCA.
DR   HOGENOM; HOG000231249; -.
DR   HOVERGEN; HBG078361; -.
DR   KO; K10956; -.
DR   GenomeRNAi; 29927; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0015031; P:protein transport; IEA:InterPro.
DR   Gene3D; 1.10.3370.10; -; 1.
DR   InterPro; IPR002208; SecY/SEC61-alpha.
DR   InterPro; IPR023201; SecY_dom_sf.
DR   PANTHER; PTHR10906; PTHR10906; 1.
DR   Pfam; PF00344; SecY; 1.
DR   SUPFAM; SSF103491; SSF103491; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     53     74       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    107    125       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    131    152       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   170 AA;  18176 MW;  A9592F3C68619F26 CRC64;
     MLSARFSGNL LVSLLGTWSD TSSGGPARAY PVGGLCYYLS PPESFGSVLE DPVHAVVYIV
     FMLGSCAFFS KTWIEVSGSS AKDVAKQLKE QQMVMRGHRE TSMVHELNRY IPTAAAFGGL
     CIGALSVLAD FLGAIGSGTG ILLAVTIIYQ YFEIFVKEQS EVGSMGALLF
//
ID   B3KNF6_HUMAN            Unreviewed;       476 AA.
AC   B3KNF6;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   23-MAY-2018, entry version 86.
DE   SubName: Full=Sec61 alpha 1 subunit (S. cerevisiae), isoform CRA_c {ECO:0000313|EMBL:EAW79326.1};
DE   SubName: Full=cDNA FLJ14517 fis, clone NT2RM1000833, highly similar to Protein transport protein Sec61 subunit alpha isoform 1 {ECO:0000313|EMBL:BAG51318.1};
DE   SubName: Full=cDNA FLJ90225 fis, clone NT2RM1000855, highly similar to Protein transport protein Sec61 subunit alpha isoform 1 {ECO:0000313|EMBL:BAG51989.1};
GN   Name=SEC61A1 {ECO:0000313|EMBL:EAW79326.1};
GN   ORFNames=hCG_40108 {ECO:0000313|EMBL:EAW79326.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG51318.1};
RN   [1] {ECO:0000313|EMBL:EAW79326.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAG51318.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3] {ECO:0000313|EMBL:BAG51989.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [4] {ECO:0000313|EMBL:EAW79326.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU003484};
CC       Multi-pass membrane protein {ECO:0000256|RuleBase:RU003484}.
CC   -!- SIMILARITY: Belongs to the SecY/SEC61-alpha family.
CC       {ECO:0000256|RuleBase:RU004349}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK027423; BAG51318.1; -; mRNA.
DR   EMBL; AK074706; BAG51989.1; -; mRNA.
DR   EMBL; CH471052; EAW79326.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79327.1; -; Genomic_DNA.
DR   RefSeq; NP_037468.1; NM_013336.3.
DR   UniGene; Hs.518236; -.
DR   PRIDE; B3KNF6; -.
DR   DNASU; 29927; -.
DR   GeneID; 29927; -.
DR   KEGG; hsa:29927; -.
DR   CTD; 29927; -.
DR   EuPathDB; HostDB:ENSG00000058262.9; -.
DR   PharmGKB; PA134901772; -.
DR   eggNOG; KOG1373; Eukaryota.
DR   eggNOG; COG0201; LUCA.
DR   HOVERGEN; HBG055271; -.
DR   KO; K10956; -.
DR   ChiTaRS; SEC61A1; human.
DR   GenomeRNAi; 29927; -.
DR   Bgee; ENSG00000058262; -.
DR   ExpressionAtlas; B3KNF6; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0043022; F:ribosome binding; IEA:Ensembl.
DR   GO; GO:0039019; P:pronephric nephron development; IEA:Ensembl.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0034341; P:response to interferon-gamma; IEA:Ensembl.
DR   Gene3D; 1.10.3370.10; -; 1.
DR   InterPro; IPR002208; SecY/SEC61-alpha.
DR   InterPro; IPR030659; SecY_CS.
DR   InterPro; IPR023201; SecY_dom_sf.
DR   InterPro; IPR019561; Translocon_Sec61/SecY_plug_dom.
DR   PANTHER; PTHR10906; PTHR10906; 1.
DR   Pfam; PF10559; Plug_translocon; 1.
DR   Pfam; PF00344; SecY; 1.
DR   PIRSF; PIRSF004557; SecY; 1.
DR   SUPFAM; SSF103491; SSF103491; 1.
DR   TIGRFAMs; TIGR00967; 3a0501s007; 1.
DR   PROSITE; PS00755; SECY_1; 1.
DR   PROSITE; PS00756; SECY_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Protein transport {ECO:0000256|RuleBase:RU003484};
KW   Translocation {ECO:0000256|RuleBase:RU003484};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius};
KW   Transport {ECO:0000256|RuleBase:RU003484}.
FT   TRANSMEM     32     54       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     74     97       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    118    137       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    143    165       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    172    193       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    205    221       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    242    263       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    283    303       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    413    431       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    437    458       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       40     74       Plug_translocon.
FT                                {ECO:0000259|Pfam:PF10559}.
SQ   SEQUENCE   476 AA;  52265 MW;  44A9B7B37C7C82E4 CRC64;
     MAIKFLEVIK PFCVILPEIQ KPERKIQFKE KVLWTAITLF IFLVCCQIPL FGIMSSDSAD
     PFYWMRVILA SNRGTLMELG ISPIVTSGLI MQLLAGAKII EVGDTPKDRA LFNGAQKLFG
     MIITIGQSIV YVMTGMYGDP SEMGAGICLL ITIQLFVAGL IVLLLDELLQ KGYGLGSGIS
     LFIATNICET IVWKAFSPTT VNTGRGMEFE GAIIALFHLL ATRTDKVRAL REAFYRQNLP
     NLMNLIATIF VFAVVIYFQG FRVDLPIKSA RYRGQYNTYP IKLFYTSNIP IILQSALVSN
     LYVISQMLSA RFSGNLLVSL LGTWSDTSSG GPARAYPVGG LCYYLSPPES FGSVLEDPVH
     AVVYIVFMLG SCAFFSKTWI EVSGSSAKDV AKQLKEQQMV MRGHRETSMV HELNRYIPTA
     AAFGGLCIGA LSVLADFLGA IGSGTGILLA VTIIYQYFEI FVKEQSEVGS MGALLF
//
ID   S61A1_HUMAN             Reviewed;         476 AA.
AC   P61619; P38378; P57726; Q5JPF8; Q8N0Z4; Q8N3U3; Q8NC71; Q9BU16;
AC   Q9Y2R3;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   23-MAY-2018, entry version 142.
DE   RecName: Full=Protein transport protein Sec61 subunit alpha isoform 1;
DE            Short=Sec61 alpha-1;
GN   Name=SEC61A1; Synonyms=SEC61A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Liu T., Zhang J., Ye M., Zhang Q., Fu G., Zhou J., Wu J., Shen Y.,
RA   Yu M., Chen S., Mao M., Chen Z.;
RT   "Human sec61 homolog gene.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Li W., Liu T., Fu G., Zhang Q., Ye M., Zhou J., Wu J., Shen Y., Yu M.,
RA   Chen S., Mao M., Chen Z.;
RT   "Human sec61 homolog gene mRNA sequence.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Finke K., Prehn S., Hartmann E.;
RT   "Sec61 alpha isoforms.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Placenta, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow, and Lymph node;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   VARIANTS HNFJ4 GLY-67 AND ALA-185, CHARACTERIZATION OF VARIANTS HNFJ4
RP   GLY-67 AND ALA-185, INVOLVEMENT IN HNFJ4, AND SUBCELLULAR LOCATION.
RX   PubMed=27392076; DOI=10.1016/j.ajhg.2016.05.028;
RA   Bolar N.A., Golzio C., Zivna M., Hayot G., Van Hemelrijk C.,
RA   Schepers D., Vandeweyer G., Hoischen A., Huyghe J.R., Raes A.,
RA   Matthys E., Sys E., Azou M., Gubler M.C., Praet M., Van Camp G.,
RA   McFadden K., Pediaditakis I., Pristoupilova A., Hodanova K.,
RA   Vyletal P., Hartmannova H., Stranecky V., Hulkova H., Baresova V.,
RA   Jedlickova I., Sovova J., Hnizda A., Kidd K., Bleyer A.J., Spong R.S.,
RA   Vande Walle J., Mortier G., Brunner H., Van Laer L., Kmoch S.,
RA   Katsanis N., Loeys B.L.;
RT   "Heterozygous loss-of-function SEC61A1 mutations cause autosomal-
RT   dominant tubulo-interstitial and glomerulocystic kidney disease with
RT   anemia.";
RL   Am. J. Hum. Genet. 99:174-187(2016).
RN   [10]
RP   FUNCTION, VARIANT ASP-85, AND CHARACTERIZATION OF VARIANT ASP-85.
RX   PubMed=28782633; DOI=10.1016/j.jaci.2017.06.042;
RA   Schubert D., Klein M.C., Hassdenteufel S., Caballero-Oteyza A.,
RA   Yang L., Proietti M., Bulashevska A., Kemming J., Kuehn J., Winzer S.,
RA   Rusch S., Fliegauf M., Schaeffer A.A., Pfeffer S., Geiger R.,
RA   Cavalie A., Cao H., Yang F., Li Y., Rizzi M., Eibel H., Kobbe R.,
RA   Marks A.L., Peppers B.P., Hostoffer R.W., Puck J.M., Zimmermann R.,
RA   Grimbacher B.;
RT   "Plasma cell deficiency in human subjects with heterozygous mutations
RT   in Sec61 translocon alpha 1 subunit (SEC61A1).";
RL   J. Allergy Clin. Immunol. 141:1427-1438(2018).
CC   -!- FUNCTION: Plays a crucial role in the insertion of secretory and
CC       membrane polypeptides into the ER (PubMed:28782633). Required for
CC       assembly of membrane and secretory proteins. Tightly associated
CC       with membrane-bound ribosomes, either directly or through adapter
CC       proteins. Plays a role in pronephric kidney tubule development (By
CC       similarity). {ECO:0000250|UniProtKB:P61620,
CC       ECO:0000269|PubMed:28782633}.
CC   -!- SUBUNIT: Heterotrimeric complex composed of SEC61-alpha, SEC61-
CC       beta and SEC61-gamma.
CC   -!- INTERACTION:
CC       P27824:CANX; NbExp=4; IntAct=EBI-358919, EBI-355947;
CC       P11021:HSPA5; NbExp=3; IntAct=EBI-358919, EBI-354921;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:27392076}; Multi-pass membrane protein
CC       {ECO:0000305}. Note=Localizes exclusively in granular structures
CC       in the endoplasmic reticulum (ER). {ECO:0000269|PubMed:27392076}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P61619-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=P61619-3; Sequence=VSP_013747;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Familial juvenile hyperuricemic nephropathy 4 (HNFJ4)
CC       [MIM:617056]: An autosomal dominant renal disorder characterized
CC       by progressive chronic kidney disease, anemia, elevated serum
CC       creatinine levels, and hyperuricemia.
CC       {ECO:0000269|PubMed:27392076}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Defects in SEC61A1 may be a cause of autosomal
CC       dominant hypogammaglobulinemia, resulting in severe recurrent
CC       infections, mainly of the respiratory tract. Disease onset is
CC       mostly in the first year of life. Affected subjects manifest
CC       reduced antibodies production by plasma cells, in the presence of
CC       normal subpopulations of B and T cells in the peripheral blood.
CC       Patients respond well to immunoglobulin replacement therapy.
CC       {ECO:0000269|PubMed:28782633}.
CC   -!- SIMILARITY: Belongs to the SecY/SEC61-alpha family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11283.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC11434.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF077032; AAD27765.1; -; mRNA.
DR   EMBL; AF084458; AAD39847.1; -; mRNA.
DR   EMBL; AF346602; AAK29083.1; -; mRNA.
DR   EMBL; AK074907; BAC11283.1; ALT_INIT; mRNA.
DR   EMBL; AK074928; BAC11298.1; -; mRNA.
DR   EMBL; AK075148; BAC11434.1; ALT_INIT; mRNA.
DR   EMBL; AL831940; CAD38592.1; -; mRNA.
DR   EMBL; AL832821; CAI46127.1; -; mRNA.
DR   CCDS; CCDS3046.1; -. [P61619-1]
DR   RefSeq; NP_037468.1; NM_013336.3. [P61619-1]
DR   UniGene; Hs.518236; -.
DR   ProteinModelPortal; P61619; -.
DR   BioGrid; 118968; 70.
DR   IntAct; P61619; 39.
DR   MINT; P61619; -.
DR   STRING; 9606.ENSP00000243253; -.
DR   TCDB; 3.A.5.9.1; the general secretory pathway (sec) family.
DR   iPTMnet; P61619; -.
DR   PhosphoSitePlus; P61619; -.
DR   SwissPalm; P61619; -.
DR   BioMuta; SEC61A1; -.
DR   DMDM; 48429109; -.
DR   EPD; P61619; -.
DR   MaxQB; P61619; -.
DR   PaxDb; P61619; -.
DR   PeptideAtlas; P61619; -.
DR   PRIDE; P61619; -.
DR   DNASU; 29927; -.
DR   Ensembl; ENST00000243253; ENSP00000243253; ENSG00000058262. [P61619-1]
DR   Ensembl; ENST00000424880; ENSP00000411445; ENSG00000058262. [P61619-3]
DR   GeneID; 29927; -.
DR   KEGG; hsa:29927; -.
DR   UCSC; uc003ekb.4; human. [P61619-1]
DR   CTD; 29927; -.
DR   DisGeNET; 29927; -.
DR   EuPathDB; HostDB:ENSG00000058262.9; -.
DR   GeneCards; SEC61A1; -.
DR   HGNC; HGNC:18276; SEC61A1.
DR   HPA; CAB022076; -.
DR   MalaCards; SEC61A1; -.
DR   MIM; 609213; gene.
DR   MIM; 617056; phenotype.
DR   neXtProt; NX_P61619; -.
DR   OpenTargets; ENSG00000058262; -.
DR   PharmGKB; PA134901772; -.
DR   eggNOG; KOG1373; Eukaryota.
DR   eggNOG; COG0201; LUCA.
DR   GeneTree; ENSGT00390000003721; -.
DR   HOVERGEN; HBG055271; -.
DR   InParanoid; P61619; -.
DR   KO; K10956; -.
DR   PhylomeDB; P61619; -.
DR   TreeFam; TF300348; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   ChiTaRS; SEC61A1; human.
DR   GeneWiki; Sec61_alpha_1; -.
DR   GenomeRNAi; 29927; -.
DR   PRO; PR:P61619; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000058262; -.
DR   ExpressionAtlas; P61619; baseline and differential.
DR   Genevisible; P61619; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0043022; F:ribosome binding; ISS:UniProtKB.
DR   GO; GO:0006613; P:cotranslational protein targeting to membrane; IMP:UniProtKB.
DR   GO; GO:0007029; P:endoplasmic reticulum organization; IMP:MGI.
DR   GO; GO:0006620; P:posttranslational protein targeting to endoplasmic reticulum membrane; IMP:MGI.
DR   GO; GO:0039019; P:pronephric nephron development; ISS:UniProtKB.
DR   GO; GO:0045047; P:protein targeting to ER; ISS:UniProtKB.
DR   GO; GO:0034341; P:response to interferon-gamma; IEA:Ensembl.
DR   GO; GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; IMP:MGI.
DR   Gene3D; 1.10.3370.10; -; 1.
DR   InterPro; IPR002208; SecY/SEC61-alpha.
DR   InterPro; IPR030659; SecY_CS.
DR   InterPro; IPR023201; SecY_dom_sf.
DR   InterPro; IPR019561; Translocon_Sec61/SecY_plug_dom.
DR   PANTHER; PTHR10906; PTHR10906; 1.
DR   Pfam; PF10559; Plug_translocon; 1.
DR   Pfam; PF00344; SecY; 1.
DR   PIRSF; PIRSF004557; SecY; 1.
DR   SUPFAM; SSF103491; SSF103491; 1.
DR   TIGRFAMs; TIGR00967; 3a0501s007; 1.
DR   PROSITE; PS00755; SECY_1; 1.
DR   PROSITE; PS00756; SECY_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Membrane; Protein transport;
KW   Reference proteome; Translocation; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    476       Protein transport protein Sec61 subunit
FT                                alpha isoform 1.
FT                                /FTId=PRO_0000131791.
FT   TOPO_DOM      1     33       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     34     53       Helical. {ECO:0000255}.
FT   TOPO_DOM     54     76       Lumenal. {ECO:0000255}.
FT   TRANSMEM     77     96       Helical. {ECO:0000255}.
FT   TOPO_DOM     97    117       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    118    138       Helical. {ECO:0000255}.
FT   TOPO_DOM    139    144       Lumenal. {ECO:0000255}.
FT   TRANSMEM    145    165       Helical. {ECO:0000255}.
FT   TOPO_DOM    166    172       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    173    193       Helical. {ECO:0000255}.
FT   TOPO_DOM    194    240       Lumenal. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical. {ECO:0000255}.
FT   TOPO_DOM    262    288       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    289    309       Helical. {ECO:0000255}.
FT   TOPO_DOM    310    354       Lumenal. {ECO:0000255}.
FT   TRANSMEM    355    375       Helical. {ECO:0000255}.
FT   TOPO_DOM    376    420       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    421    441       Helical. {ECO:0000255}.
FT   TOPO_DOM    442    445       Lumenal. {ECO:0000255}.
FT   TRANSMEM    446    462       Helical. {ECO:0000255}.
FT   TOPO_DOM    463    476       Cytoplasmic. {ECO:0000255}.
FT   VAR_SEQ       1    120       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_013747.
FT   VARIANT      67     67       V -> G (in HNFJ4; decreases in protein
FT                                stability; partly confers novel Golgi
FT                                subcellular location; dbSNP:rs752745051).
FT                                {ECO:0000269|PubMed:27392076}.
FT                                /FTId=VAR_077059.
FT   VARIANT      85     85       V -> D (probable disease-associated
FT                                mutation found in a family with
FT                                hypogammaglobulinemia; decreased function
FT                                in cotranslational protein targeting to
FT                                endoplasmic reticulum).
FT                                {ECO:0000269|PubMed:28782633}.
FT                                /FTId=VAR_080231.
FT   VARIANT     185    185       T -> A (in HNFJ4; decreases in protein
FT                                stability; partly confers novel Golgi
FT                                subcellular location; dbSNP:rs879255648).
FT                                {ECO:0000269|PubMed:27392076}.
FT                                /FTId=VAR_077060.
FT   CONFLICT    135    135       G -> W (in Ref. 1; AAD27765).
FT                                {ECO:0000305}.
FT   CONFLICT    234    234       F -> L (in Ref. 4; BAC11298).
FT                                {ECO:0000305}.
FT   CONFLICT    278    278       T -> S (in Ref. 1; AAD27765).
FT                                {ECO:0000305}.
FT   CONFLICT    310    310       A -> V (in Ref. 1; AAD27765).
FT                                {ECO:0000305}.
FT   CONFLICT    316    316       L -> F (in Ref. 1; AAD27765).
FT                                {ECO:0000305}.
FT   CONFLICT    319    319       S -> N (in Ref. 1; AAD27765).
FT                                {ECO:0000305}.
FT   CONFLICT    323    329       TWSDTSS -> QWADVSG (in Ref. 1; AAD27765).
FT                                {ECO:0000305}.
FT   CONFLICT    335    335       A -> S (in Ref. 1; AAD27765).
FT                                {ECO:0000305}.
FT   CONFLICT    351    355       FGSVL -> MGAIF (in Ref. 1; AAD27765).
FT                                {ECO:0000305}.
SQ   SEQUENCE   476 AA;  52265 MW;  44A9B7B37C7C82E4 CRC64;
     MAIKFLEVIK PFCVILPEIQ KPERKIQFKE KVLWTAITLF IFLVCCQIPL FGIMSSDSAD
     PFYWMRVILA SNRGTLMELG ISPIVTSGLI MQLLAGAKII EVGDTPKDRA LFNGAQKLFG
     MIITIGQSIV YVMTGMYGDP SEMGAGICLL ITIQLFVAGL IVLLLDELLQ KGYGLGSGIS
     LFIATNICET IVWKAFSPTT VNTGRGMEFE GAIIALFHLL ATRTDKVRAL REAFYRQNLP
     NLMNLIATIF VFAVVIYFQG FRVDLPIKSA RYRGQYNTYP IKLFYTSNIP IILQSALVSN
     LYVISQMLSA RFSGNLLVSL LGTWSDTSSG GPARAYPVGG LCYYLSPPES FGSVLEDPVH
     AVVYIVFMLG SCAFFSKTWI EVSGSSAKDV AKQLKEQQMV MRGHRETSMV HELNRYIPTA
     AAFGGLCIGA LSVLADFLGA IGSGTGILLA VTIIYQYFEI FVKEQSEVGS MGALLF
//
ID   F8WCA0_HUMAN            Unreviewed;       118 AA.
AC   F8WCA0;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   21-SEP-2011, sequence version 1.
DT   25-APR-2018, entry version 52.
DE   SubName: Full=Vesicle-associated membrane protein 2 {ECO:0000313|Ensembl:ENSP00000418572};
GN   Name=VAMP2 {ECO:0000313|Ensembl:ENSP00000418572};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000418572, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000418572, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000418572}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC129492; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317054.1; NM_001330125.1.
DR   UniGene; Hs.25348; -.
DR   ProteinModelPortal; F8WCA0; -.
DR   EPD; F8WCA0; -.
DR   MaxQB; F8WCA0; -.
DR   PeptideAtlas; F8WCA0; -.
DR   PRIDE; F8WCA0; -.
DR   Ensembl; ENST00000488857; ENSP00000418572; ENSG00000220205.
DR   GeneID; 6844; -.
DR   UCSC; uc060ayt.1; human.
DR   CTD; 6844; -.
DR   EuPathDB; HostDB:ENSG00000220205.8; -.
DR   HGNC; HGNC:12643; VAMP2.
DR   OpenTargets; ENSG00000220205; -.
DR   eggNOG; KOG0860; Eukaryota.
DR   eggNOG; COG5143; LUCA.
DR   GeneTree; ENSGT00550000074449; -.
DR   OrthoDB; EOG091G0MPE; -.
DR   PhylomeDB; F8WCA0; -.
DR   ChiTaRS; VAMP2; human.
DR   GenomeRNAi; 6844; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000220205; -.
DR   ExpressionAtlas; F8WCA0; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016192; P:vesicle-mediated transport; IEA:InterPro.
DR   InterPro; IPR001388; Synaptobrevin.
DR   InterPro; IPR016444; Synaptobrevin/VAMP.
DR   InterPro; IPR028717; VAMP2.
DR   PANTHER; PTHR21136:SF91; PTHR21136:SF91; 1.
DR   Pfam; PF00957; Synaptobrevin; 1.
DR   PIRSF; PIRSF005409; Synaptobrevin_euk; 1.
DR   PRINTS; PR00219; SYNAPTOBREVN.
DR   PROSITE; PS00417; SYNAPTOBREVIN; 1.
DR   PROSITE; PS50892; V_SNARE; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU00290,
KW   ECO:0000256|SAAS:SAAS00119457};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     95    116       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       33     93       V-SNARE coiled-coil homology.
FT                                {ECO:0000259|PROSITE:PS50892}.
SQ   SEQUENCE   118 AA;  12934 MW;  CCC93D81D8785143 CRC64;
     MDRSATAATA PPAAPAGEGG PPAPPPNLTS NRRLQQTQAQ VDEVVDIMRV NVDKVLERDQ
     KLSELDDRAD ALQAGASQFE TSAAKLKRKY WWKNLKMMII LGVICAIILI IIIVYFST
//
ID   VAMP2_HUMAN             Reviewed;         116 AA.
AC   P63027; P19065; Q9BUC2;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   09-FEB-2010, sequence version 3.
DT   23-MAY-2018, entry version 140.
DE   RecName: Full=Vesicle-associated membrane protein 2;
DE            Short=VAMP-2;
DE   AltName: Full=Synaptobrevin-2;
GN   Name=VAMP2; Synonyms=SYB2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1976629;
RA   Archer B.T. III, Oezcelik T., Jahn R., Francke U., Suedhof T.C.;
RT   "Structures and chromosomal localizations of two human genes encoding
RT   synaptobrevins 1 and 2.";
RL   J. Biol. Chem. 265:17267-17273(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Peripheral blood;
RA   Nabokina S.M., Lazo P.A., Mollinedo F.;
RT   "Expression of VAMP genes in human neutrophils.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RA   Taruscio D., Zoraqi K.G., Falbo V.;
RT   "Genomic structure of human SYB2 gene.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Neuroblastoma, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=8760387; DOI=10.1042/bj3170945;
RA   Jagadish M.N., Fernandez C.S., Hewish D.R., Macaulay S.L., Gough K.H.,
RA   Grusovin J., Verkuylen A., Cosgrove L., Alafaci A., Frenkel M.J.,
RA   Ward C.W.;
RT   "Insulin-responsive tissues contain the core complex protein SNAP-25
RT   (synaptosomal-associated protein 25) A and B isoforms in addition to
RT   syntaxin 4 and synaptobrevins 1 and 2.";
RL   Biochem. J. 317:945-954(1996).
RN   [8]
RP   TOPOLOGY.
RX   PubMed=7835332;
RA   Kutay U., Ahnert-Hilger G., Hartmann E., Wiedenmann B., Rapoport T.A.;
RT   "Transport route for synaptobrevin via a novel pathway of insertion
RT   into the endoplasmic reticulum membrane.";
RL   EMBO J. 14:217-223(1995).
RN   [9]
RP   INTERACTION WITH WDFY2; PRKCZ AND PRKCI, COMPLEX FORMATION WITH WDFY2
RP   AND PRKCZ, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND MUTAGENESIS OF
RP   SER-28; SER-61; SER-75 AND SER-80.
RX   PubMed=17313651; DOI=10.1111/j.1742-4658.2007.05702.x;
RA   Fritzius T., Frey A.D., Schweneker M., Mayer D., Moelling K.;
RT   "WD-repeat-propeller-FYVE protein, ProF, binds VAMP2 and protein
RT   kinase Czeta.";
RL   FEBS J. 274:1552-1566(2007).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 34-89 IN COMPLEX WITH BOTB.
RX   PubMed=10932255; DOI=10.1038/77997;
RA   Hanson M.A., Stevens R.C.;
RT   "Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin
RT   type B at 2.0 A resolution.";
RL   Nat. Struct. Biol. 7:687-692(2000).
CC   -!- FUNCTION: Involved in the targeting and/or fusion of transport
CC       vesicles to their target membrane. Modulates the gating
CC       characteristics of the delayed rectifier voltage-dependent
CC       potassium channel KCNB1. {ECO:0000250|UniProtKB:P63045}.
CC   -!- SUBUNIT: Interacts (via N-terminus) with KCNB1 (via N-terminus and
CC       C-terminus); stimulates the channel inactivation rate of KCNB1 (By
CC       similarity). Part of the SNARE core complex containing SNAP25,
CC       VAMP2 and STX1A. This complex binds to CPLX1. Interacts with BVES
CC       and STX4 (By similarity). Interacts with VAPA and VAPB. Interacts
CC       with WDFY2, PRKCZ and PRKCI (PubMed:17313651). Forms a complex
CC       with WDFY2 and PRKCZ (PubMed:17313651).
CC       {ECO:0000250|UniProtKB:P63044, ECO:0000250|UniProtKB:P63045,
CC       ECO:0000269|PubMed:10932255, ECO:0000269|PubMed:17313651}.
CC   -!- INTERACTION:
CC       D2KHQ9:- (xeno); NbExp=2; IntAct=EBI-520113, EBI-7604762;
CC       Q57236:bont (xeno); NbExp=3; IntAct=EBI-520113, EBI-15790260;
CC       A7GBG3:F (xeno); NbExp=2; IntAct=EBI-520113, EBI-7604673;
CC       O55012:Picalm (xeno); NbExp=2; IntAct=EBI-520113, EBI-915601;
CC       O94806:PRKD3; NbExp=7; IntAct=EBI-520113, EBI-1255366;
CC       O95721:SNAP29; NbExp=5; IntAct=EBI-520113, EBI-490676;
CC       Q12846:STX4; NbExp=5; IntAct=EBI-520113, EBI-744942;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle,
CC       synaptic vesicle membrane; Single-pass type IV membrane protein.
CC       Cell junction, synapse, synaptosome. Cell membrane
CC       {ECO:0000250|UniProtKB:P63045}. Note=Neuronal synaptic vesicles.
CC       Colocalizes with PRKCZ and WDFY2 in intracellular vesicles
CC       (PubMed:17313651). {ECO:0000269|PubMed:17313651}.
CC   -!- TISSUE SPECIFICITY: Nervous system and skeletal muscle.
CC       {ECO:0000269|PubMed:8760387}.
CC   -!- PTM: Phosphorylated by PRKCZ in vitro and this phosphorylation is
CC       increased in the presence of WDFY2. {ECO:0000269|PubMed:17313651}.
CC   -!- SIMILARITY: Belongs to the synaptobrevin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M36205; AAA60604.1; -; Genomic_DNA.
DR   EMBL; M36201; AAA60604.1; JOINED; Genomic_DNA.
DR   EMBL; M36202; AAA60604.1; JOINED; Genomic_DNA.
DR   EMBL; M36203; AAA60604.1; JOINED; Genomic_DNA.
DR   EMBL; M36204; AAA60604.1; JOINED; Genomic_DNA.
DR   EMBL; AJ225044; CAA12385.1; -; mRNA.
DR   EMBL; AF135372; AAF15551.1; -; Genomic_DNA.
DR   EMBL; AK289555; BAF82244.1; -; mRNA.
DR   EMBL; CH471108; EAW90087.1; -; Genomic_DNA.
DR   EMBL; BC002737; AAH02737.3; -; mRNA.
DR   EMBL; BC019608; AAH19608.1; -; mRNA.
DR   EMBL; BC033870; AAH33870.1; -; mRNA.
DR   CCDS; CCDS32561.1; -.
DR   PIR; B38315; B38315.
DR   RefSeq; NP_055047.2; NM_014232.2.
DR   UniGene; Hs.25348; -.
DR   PDB; 3FIE; X-ray; 2.10 A; C/D=22-57.
DR   PDB; 3FII; X-ray; 2.17 A; B=27-57.
DR   PDB; 3RK2; X-ray; 2.20 A; A/E=28-60.
DR   PDB; 3RK3; X-ray; 3.50 A; A=28-60.
DR   PDB; 3RL0; X-ray; 3.80 A; A/E/I/M/Q/U/Y/c=28-60.
DR   PDBsum; 3FIE; -.
DR   PDBsum; 3FII; -.
DR   PDBsum; 3RK2; -.
DR   PDBsum; 3RK3; -.
DR   PDBsum; 3RL0; -.
DR   DisProt; DP00069; -.
DR   ProteinModelPortal; P63027; -.
DR   SMR; P63027; -.
DR   BioGrid; 112711; 79.
DR   CORUM; P63027; -.
DR   DIP; DIP-39072N; -.
DR   IntAct; P63027; 24.
DR   MINT; P63027; -.
DR   STRING; 9606.ENSP00000314214; -.
DR   ChEMBL; CHEMBL2364160; -.
DR   DrugBank; DB00042; Botulinum Toxin Type B.
DR   TCDB; 1.F.1.1.1; the synaptosomal vesicle fusion pore (svf-pore) family.
DR   iPTMnet; P63027; -.
DR   PhosphoSitePlus; P63027; -.
DR   SwissPalm; P63027; -.
DR   BioMuta; VAMP2; -.
DR   DMDM; 288558837; -.
DR   EPD; P63027; -.
DR   MaxQB; P63027; -.
DR   PaxDb; P63027; -.
DR   PeptideAtlas; P63027; -.
DR   PRIDE; P63027; -.
DR   TopDownProteomics; P63027; -.
DR   DNASU; 6844; -.
DR   Ensembl; ENST00000316509; ENSP00000314214; ENSG00000220205.
DR   GeneID; 6844; -.
DR   KEGG; hsa:6844; -.
DR   UCSC; uc010cnt.2; human.
DR   CTD; 6844; -.
DR   DisGeNET; 6844; -.
DR   EuPathDB; HostDB:ENSG00000220205.8; -.
DR   GeneCards; VAMP2; -.
DR   HGNC; HGNC:12643; VAMP2.
DR   HPA; CAB078785; -.
DR   MIM; 185881; gene.
DR   neXtProt; NX_P63027; -.
DR   OpenTargets; ENSG00000220205; -.
DR   PharmGKB; PA37267; -.
DR   eggNOG; KOG0860; Eukaryota.
DR   eggNOG; COG5143; LUCA.
DR   GeneTree; ENSGT00550000074449; -.
DR   HOGENOM; HOG000042711; -.
DR   HOVERGEN; HBG006675; -.
DR   InParanoid; P63027; -.
DR   KO; K13504; -.
DR   PhylomeDB; P63027; -.
DR   TreeFam; TF313666; -.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-181429; Serotonin Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-181430; Norepinephrine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-210500; Glutamate Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-212676; Dopamine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-264642; Acetylcholine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-264876; Insulin processing.
DR   Reactome; R-HSA-421837; Clathrin derived vesicle budding.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-449836; Other interleukin signaling.
DR   Reactome; R-HSA-5250955; Toxicity of botulinum toxin type D (BoNT/D).
DR   Reactome; R-HSA-5250958; Toxicity of botulinum toxin type B (BoNT/B).
DR   Reactome; R-HSA-5250981; Toxicity of botulinum toxin type F (BoNT/F).
DR   Reactome; R-HSA-5250982; Toxicity of tetanus toxin (TeNT).
DR   Reactome; R-HSA-5250989; Toxicity of botulinum toxin type G (BoNT/G).
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-888590; GABA synthesis, release, reuptake and degradation.
DR   ChiTaRS; VAMP2; human.
DR   EvolutionaryTrace; P63027; -.
DR   GeneWiki; VAMP2; -.
DR   GenomeRNAi; 6844; -.
DR   PRO; PR:P63027; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000220205; -.
DR   CleanEx; HS_VAMP2; -.
DR   ExpressionAtlas; P63027; baseline and differential.
DR   Genevisible; P63027; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IDA:UniProtKB.
DR   GO; GO:0030665; C:clathrin-coated vesicle membrane; TAS:Reactome.
DR   GO; GO:0061202; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0060203; C:clathrin-sculpted glutamate transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0070083; C:clathrin-sculpted monoamine transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0044306; C:neuron projection terminus; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0030141; C:secretory granule; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0030667; C:secretory granule membrane; TAS:Reactome.
DR   GO; GO:0031201; C:SNARE complex; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0008021; C:synaptic vesicle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0030672; C:synaptic vesicle membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0070044; C:synaptobrevin 2-SNAP-25-syntaxin-1a complex; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0070032; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0070033; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005802; C:trans-Golgi network; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0031982; C:vesicle; IDA:UniProtKB.
DR   GO; GO:0042589; C:zymogen granule membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048306; F:calcium-dependent protein binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005516; F:calmodulin binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005543; F:phospholipid binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0043621; F:protein self-association; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005484; F:SNAP receptor activity; IBA:GO_Central.
DR   GO; GO:0000149; F:SNARE binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0019905; F:syntaxin binding; IPI:UniProtKB.
DR   GO; GO:0017075; F:syntaxin-1 binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0017156; P:calcium ion regulated exocytosis; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0043308; P:eosinophil degranulation; IMP:UniProtKB.
DR   GO; GO:0006887; P:exocytosis; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0014047; P:glutamate secretion; TAS:Reactome.
DR   GO; GO:0043001; P:Golgi to plasma membrane protein transport; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0061025; P:membrane fusion; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0015031; P:protein transport; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0065003; P:protein-containing complex assembly; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1902259; P:regulation of delayed rectifier potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0017157; P:regulation of exocytosis; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0060627; P:regulation of vesicle-mediated transport; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0009749; P:response to glucose; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0016079; P:synaptic vesicle exocytosis; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0006906; P:vesicle fusion; IBA:GO_Central.
DR   GO; GO:0016192; P:vesicle-mediated transport; ISS:ParkinsonsUK-UCL.
DR   InterPro; IPR001388; Synaptobrevin.
DR   InterPro; IPR016444; Synaptobrevin/VAMP.
DR   InterPro; IPR028717; VAMP2.
DR   PANTHER; PTHR21136:SF91; PTHR21136:SF91; 1.
DR   Pfam; PF00957; Synaptobrevin; 1.
DR   PIRSF; PIRSF005409; Synaptobrevin_euk; 1.
DR   PRINTS; PR00219; SYNAPTOBREVN.
DR   PROSITE; PS00417; SYNAPTOBREVIN; 1.
DR   PROSITE; PS50892; V_SNARE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell junction; Cell membrane; Coiled coil;
KW   Complete proteome; Cytoplasmic vesicle; Membrane; Phosphoprotein;
KW   Reference proteome; Synapse; Synaptosome; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P63026}.
FT   CHAIN         2    116       Vesicle-associated membrane protein 2.
FT                                /FTId=PRO_0000206723.
FT   TOPO_DOM      2     94       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     95    114       Helical; Anchor for type IV membrane
FT                                protein. {ECO:0000255}.
FT   TOPO_DOM    115    116       Vesicular. {ECO:0000255}.
FT   DOMAIN       31     91       v-SNARE coiled-coil homology.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00290}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000250|UniProtKB:P63026}.
FT   MUTAGEN      28     28       S->A: Significant loss of
FT                                phosphorylation; when associated with A-
FT                                61, A-75 and A-80.
FT                                {ECO:0000269|PubMed:17313651}.
FT   MUTAGEN      61     61       S->A: Significant loss of
FT                                phosphorylation; when associated with A-
FT                                28, A-75 and A-80.
FT                                {ECO:0000269|PubMed:17313651}.
FT   MUTAGEN      75     75       S->A: Significant loss of
FT                                phosphorylation; when associated with A-
FT                                28, A-61 and A-80.
FT                                {ECO:0000269|PubMed:17313651}.
FT   MUTAGEN      80     80       S->A: Significant loss of
FT                                phosphorylation; when associated with A-
FT                                28, A-61 and A-75.
FT                                {ECO:0000269|PubMed:17313651}.
FT   CONFLICT    116    116       T -> S (in Ref. 1; AAA60604, 2; CAA12385
FT                                and 3; AAF15551). {ECO:0000305}.
FT   STRAND       34     36       {ECO:0000244|PDB:3FIE}.
FT   TURN         47     49       {ECO:0000244|PDB:3FIE}.
FT   HELIX        50     53       {ECO:0000244|PDB:3FIE}.
SQ   SEQUENCE   116 AA;  12663 MW;  9CD679C4F6F1B5A8 CRC64;
     MSATAATAPP AAPAGEGGPP APPPNLTSNR RLQQTQAQVD EVVDIMRVNV DKVLERDQKL
     SELDDRADAL QAGASQFETS AAKLKRKYWW KNLKMMIILG VICAIILIII IVYFST
//
ID   B4DKR0_HUMAN            Unreviewed;       259 AA.
AC   B4DKR0;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   23-MAY-2018, entry version 87.
DE   SubName: Full=Syntaxin 5A, isoform CRA_c {ECO:0000313|EMBL:EAW74110.1};
DE   SubName: Full=cDNA FLJ57518, highly similar to Syntaxin-5 {ECO:0000313|EMBL:BAG59272.1};
GN   Name=STX5A {ECO:0000313|EMBL:EAW74110.1};
GN   ORFNames=hCG_1734926 {ECO:0000313|EMBL:EAW74110.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59272.1};
RN   [1] {ECO:0000313|EMBL:EAW74110.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW74110.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAG59272.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cord blood {ECO:0000313|EMBL:BAG59272.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the syntaxin family.
CC       {ECO:0000256|SAAS:SAAS00569153}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK296675; BAG59272.1; -; mRNA.
DR   EMBL; CH471076; EAW74110.1; -; Genomic_DNA.
DR   RefSeq; XP_011543526.1; XM_011545224.2.
DR   UniGene; Hs.654602; -.
DR   MaxQB; B4DKR0; -.
DR   PeptideAtlas; B4DKR0; -.
DR   PRIDE; B4DKR0; -.
DR   GeneID; 6811; -.
DR   CTD; 6811; -.
DR   eggNOG; KOG0812; Eukaryota.
DR   eggNOG; ENOG410Y2MB; LUCA.
DR   HOGENOM; HOG000194860; -.
DR   HOVERGEN; HBG001973; -.
DR   ChiTaRS; STX5; human.
DR   GenomeRNAi; 6811; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005484; F:SNAP receptor activity; IEA:InterPro.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:InterPro.
DR   GO; GO:0016192; P:vesicle-mediated transport; IEA:InterPro.
DR   InterPro; IPR010989; SNARE.
DR   InterPro; IPR006012; Syntaxin/epimorphin_CS.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   Pfam; PF05739; SNARE; 1.
DR   SMART; SM00397; t_SNARE; 1.
DR   SUPFAM; SSF47661; SSF47661; 1.
DR   PROSITE; PS00914; SYNTAXIN; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU00202,
KW   ECO:0000256|SAAS:SAAS00569180, ECO:0000256|SAM:Coils};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    238    258       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      167    229       T-SNARE coiled-coil homology.
FT                                {ECO:0000259|PROSITE:PS50192}.
FT   COILED      191    211       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   259 AA;  29234 MW;  A68A11B6122D7950 CRC64;
     MAKRIGKDLS NTFAKLEKLT ILAKRKSLFD DKAVEIEELT YIIKQDINSL NKQIAQLQDF
     VRAKGSQSGR HLQTHSNTIV VSLQSKLASM SNDFKSVLEV RTENLKQQRS RREQFSRAPV
     SALPLAPNHL GGGAVVLGAE SHASKDVAID MMDSRTSQQL QLIDEQDSYI QSRADTMQNI
     ESTIVELGSI FQQLAHMVKE QEETIQRIDE NVLGAQLDVE AAHSEILKYF QSVTSNRWLM
     VKIFLILIVF FIIFVVFLA
//
ID   STX5_HUMAN              Reviewed;         355 AA.
AC   Q13190; B2R8T2; F8W8Q9; Q5U0D4; Q7Z3T6; Q9BUG1;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 2.
DT   23-MAY-2018, entry version 168.
DE   RecName: Full=Syntaxin-5;
GN   Name=STX5; Synonyms=STX5A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=B-cell;
RX   PubMed=9188044; DOI=10.1007/BF02736780;
RA   Ravichandran V., Roche P.A.;
RT   "Cloning and identification of human syntaxin 5 as a
RT   synaptobrevin/VAMP binding protein.";
RL   J. Mol. Neurosci. 8:159-161(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Kidney, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   INTERACTION WITH COG4.
RX   PubMed=19536132; DOI=10.1038/emboj.2009.168;
RA   Laufman O., Kedan A., Hong W., Lev S.;
RT   "Direct interaction between the COG complex and the SM protein, Sly1,
RT   is required for Golgi SNARE pairing.";
RL   EMBO J. 28:2006-2017(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12] {ECO:0000244|PDB:3EFO}
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 242-248 IN COMPLEX WITH
RP   SEC23A AND SEC24D, INTERACTION WITH SEC24C AND SEC24D, MOTIF, AND
RP   MUTAGENESIS OF ILE-245 AND MET-247.
RX   PubMed=18843296; DOI=10.1038/emboj.2008.208;
RA   Mancias J.D., Goldberg J.;
RT   "Structural basis of cargo membrane protein discrimination by the
RT   human COPII coat machinery.";
RL   EMBO J. 27:2918-2928(2008).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-79.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Mediates endoplasmic reticulum to Golgi transport.
CC       Together with p115/USO1 and GM130/GOLGA2, involved in vesicle
CC       tethering and fusion at the cis-Golgi membrane to maintain the
CC       stacked and inter-connected structure of the Golgi apparatus.
CC       {ECO:0000250|UniProtKB:Q08851}.
CC   -!- SUBUNIT: Part of a ternary complex containing STX5A, NSFL1C and
CC       VCP (By similarity). Identified in a unique SNARE complex composed
CC       of the Golgi SNAREs GOSR1, GOSR2, YKT6 and VTI1A (By similarity).
CC       Interacts with COG4 (PubMed:19536132). Interacts with GM130/GOLGA2
CC       (By similarity). Interacts (via IxM motif) with SEC24C and SEC24D;
CC       mediates STX5 packaging into COPII-coated vesicles
CC       (PubMed:18843296). {ECO:0000250|UniProtKB:Q08851,
CC       ECO:0000250|UniProtKB:Q8K1E0, ECO:0000269|PubMed:18843296,
CC       ECO:0000269|PubMed:19536132}.
CC   -!- INTERACTION:
CC       Q8N6L0:CCDC155; NbExp=5; IntAct=EBI-714206, EBI-749265;
CC       Q9H9E3:COG4; NbExp=2; IntAct=EBI-714206, EBI-368382;
CC       P43360:MAGEA6; NbExp=3; IntAct=EBI-714206, EBI-1045155;
CC       Q9H115:NAPB; NbExp=5; IntAct=EBI-714206, EBI-3921185;
CC       Q13277:STX3; NbExp=4; IntAct=EBI-714206, EBI-1394295;
CC       Q12846:STX4; NbExp=5; IntAct=EBI-714206, EBI-744942;
CC       P61764:STXBP1; NbExp=5; IntAct=EBI-714206, EBI-960169;
CC       O75410:TACC1; NbExp=3; IntAct=EBI-714206, EBI-624237;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum-Golgi intermediate
CC       compartment membrane {ECO:0000250|UniProtKB:Q08851}; Single-pass
CC       type IV membrane protein {ECO:0000255}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q08851}. Note=Localizes throughout the
CC       Golgi apparatus, but most abundant in the cis-most cisternae.
CC       {ECO:0000250|UniProtKB:Q08851}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q13190-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13190-2; Sequence=VSP_020119;
CC         Note=Produced by alternative initiation at Met-55 of isoform 1.;
CC       Name=3;
CC         IsoId=Q13190-3; Sequence=VSP_020119, VSP_020120;
CC         Note=Produced by alternative splicing and alternative
CC         initiation.;
CC       Name=4;
CC         IsoId=Q13190-4; Sequence=VSP_020120;
CC         Note=Gene prediction based on EST data.;
CC   -!- SIMILARITY: Belongs to the syntaxin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U26648; AAC71078.1; -; mRNA.
DR   EMBL; BX537426; CAD97668.1; -; mRNA.
DR   EMBL; AK313497; BAG36279.1; -; mRNA.
DR   EMBL; BT019646; AAV38452.1; -; mRNA.
DR   EMBL; BT019647; AAV38453.1; -; mRNA.
DR   EMBL; AP001160; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002645; AAH02645.1; -; mRNA.
DR   EMBL; BC012137; AAH12137.2; -; mRNA.
DR   CCDS; CCDS58140.1; -. [Q13190-4]
DR   CCDS; CCDS8038.2; -. [Q13190-1]
DR   CCDS; CCDS81578.1; -. [Q13190-2]
DR   PIR; G01817; G01817.
DR   RefSeq; NP_001231595.1; NM_001244666.1. [Q13190-4]
DR   RefSeq; NP_001317223.1; NM_001330294.1. [Q13190-2]
DR   RefSeq; NP_003155.2; NM_003164.4. [Q13190-1]
DR   UniGene; Hs.654602; -.
DR   PDB; 3EFO; X-ray; 2.70 A; C=242-248.
DR   PDBsum; 3EFO; -.
DR   ProteinModelPortal; Q13190; -.
DR   SMR; Q13190; -.
DR   BioGrid; 112680; 81.
DR   DIP; DIP-56987N; -.
DR   IntAct; Q13190; 42.
DR   MINT; Q13190; -.
DR   STRING; 9606.ENSP00000294179; -.
DR   iPTMnet; Q13190; -.
DR   PhosphoSitePlus; Q13190; -.
DR   BioMuta; STX5; -.
DR   DMDM; 114152881; -.
DR   EPD; Q13190; -.
DR   MaxQB; Q13190; -.
DR   PaxDb; Q13190; -.
DR   PeptideAtlas; Q13190; -.
DR   PRIDE; Q13190; -.
DR   DNASU; 6811; -.
DR   Ensembl; ENST00000294179; ENSP00000294179; ENSG00000162236. [Q13190-1]
DR   Ensembl; ENST00000377897; ENSP00000367129; ENSG00000162236. [Q13190-4]
DR   Ensembl; ENST00000394690; ENSP00000378182; ENSG00000162236. [Q13190-2]
DR   GeneID; 6811; -.
DR   KEGG; hsa:6811; -.
DR   UCSC; uc001nvh.4; human. [Q13190-1]
DR   CTD; 6811; -.
DR   DisGeNET; 6811; -.
DR   EuPathDB; HostDB:ENSG00000162236.11; -.
DR   GeneCards; STX5; -.
DR   HGNC; HGNC:11440; STX5.
DR   HPA; HPA001358; -.
DR   MIM; 603189; gene.
DR   neXtProt; NX_Q13190; -.
DR   OpenTargets; ENSG00000162236; -.
DR   PharmGKB; PA36237; -.
DR   eggNOG; KOG0812; Eukaryota.
DR   eggNOG; ENOG410Y2MB; LUCA.
DR   GeneTree; ENSGT00390000000652; -.
DR   HOGENOM; HOG000194860; -.
DR   HOVERGEN; HBG001973; -.
DR   InParanoid; Q13190; -.
DR   KO; K08490; -.
DR   OMA; QDRTNEF; -.
DR   OrthoDB; EOG091G0HR8; -.
DR   PhylomeDB; Q13190; -.
DR   TreeFam; TF315068; -.
DR   Reactome; R-HSA-204005; COPII-mediated vesicle transport.
DR   Reactome; R-HSA-5694530; Cargo concentration in the ER.
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-HSA-6811438; Intra-Golgi traffic.
DR   ChiTaRS; STX5; human.
DR   EvolutionaryTrace; Q13190; -.
DR   GeneWiki; STX5; -.
DR   GenomeRNAi; 6811; -.
DR   PRO; PR:Q13190; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000162236; -.
DR   CleanEx; HS_STX5; -.
DR   ExpressionAtlas; Q13190; baseline and differential.
DR   Genevisible; Q13190; HS.
DR   GO; GO:0005829; C:cytosol; IEA:GOC.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0031201; C:SNARE complex; TAS:HGNC.
DR   GO; GO:0031982; C:vesicle; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0005484; F:SNAP receptor activity; IDA:HGNC.
DR   GO; GO:0000149; F:SNARE binding; IBA:GO_Central.
DR   GO; GO:0048208; P:COPII vesicle coating; TAS:Reactome.
DR   GO; GO:0034498; P:early endosome to Golgi transport; IMP:UniProtKB.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IBA:GO_Central.
DR   GO; GO:0090166; P:Golgi disassembly; IDA:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; IBA:GO_Central.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; IMP:UniProtKB.
DR   GO; GO:1903358; P:regulation of Golgi organization; IDA:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IDA:HGNC.
DR   GO; GO:0048278; P:vesicle docking; IBA:GO_Central.
DR   GO; GO:0006906; P:vesicle fusion; IBA:GO_Central.
DR   GO; GO:0048280; P:vesicle fusion with Golgi apparatus; IEA:Ensembl.
DR   InterPro; IPR010989; SNARE.
DR   InterPro; IPR021538; Syntaxin-5_N.
DR   InterPro; IPR006012; Syntaxin/epimorphin_CS.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   Pfam; PF05739; SNARE; 1.
DR   Pfam; PF11416; Syntaxin-5_N; 1.
DR   SMART; SM00397; t_SNARE; 1.
DR   SUPFAM; SSF47661; SSF47661; 1.
DR   PROSITE; PS00914; SYNTAXIN; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Alternative splicing;
KW   Coiled coil; Complete proteome; Golgi apparatus; Membrane;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    355       Syntaxin-5.
FT                                /FTId=PRO_0000210205.
FT   TOPO_DOM      1    333       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    334    354       Helical; Anchor for type IV membrane
FT                                protein. {ECO:0000255}.
FT   TOPO_DOM    355    355       Vesicular. {ECO:0000255}.
FT   DOMAIN      263    325       t-SNARE coiled-coil homology.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00202}.
FT   COILED      287    318       {ECO:0000255}.
FT   MOTIF       245    247       IxM motif; signal for cargo packaging
FT                                into COPII-coated vesicles.
FT                                {ECO:0000269|PubMed:18843296}.
FT   VAR_SEQ       1     54       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9188044,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_020119.
FT   VAR_SEQ     303    355       RIDENVLGAQLDVEAAHSEILKYFQSVTSNRWLMVKIFLIL
FT                                IVFFIIFVVFLA -> SVLLFPLLPALSPGSTRTC (in
FT                                isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020120.
FT   VARIANT      51     51       P -> L (in dbSNP:rs3802945).
FT                                /FTId=VAR_052248.
FT   VARIANT      72     72       Q -> H (in dbSNP:rs11231241).
FT                                /FTId=VAR_052249.
FT   VARIANT      79     79       Q -> H (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035642.
FT   MUTAGEN     245    245       I->A: Loss of interaction with SEC24C.
FT                                {ECO:0000269|PubMed:18843296}.
FT   MUTAGEN     247    247       M->A: Loss of interaction with SEC24C.
FT                                {ECO:0000269|PubMed:18843296}.
FT   STRAND      243    246       {ECO:0000244|PDB:3EFO}.
SQ   SEQUENCE   355 AA;  39673 MW;  EE8616A226888501 CRC64;
     MIPRKRYGSK NTDQGVYLGL SKTQVLSPAT AGSSSSDIAP LPPPVTLVPP PPDTMSCRDR
     TQEFLSACKS LQTRQNGIQT NKPALRAVRQ RSEFTLMAKR IGKDLSNTFA KLEKLTILAK
     RKSLFDDKAV EIEELTYIIK QDINSLNKQI AQLQDFVRAK GSQSGRHLQT HSNTIVVSLQ
     SKLASMSNDF KSVLEVRTEN LKQQRSRREQ FSRAPVSALP LAPNHLGGGA VVLGAESHAS
     KDVAIDMMDS RTSQQLQLID EQDSYIQSRA DTMQNIESTI VELGSIFQQL AHMVKEQEET
     IQRIDENVLG AQLDVEAAHS EILKYFQSVT SNRWLMVKIF LILIVFFIIF VVFLA
//
ID   A0A1U9X7A6_HUMAN        Unreviewed;      1126 AA.
AC   A0A1U9X7A6;
DT   07-JUN-2017, integrated into UniProtKB/TrEMBL.
DT   07-JUN-2017, sequence version 1.
DT   23-MAY-2018, entry version 10.
DE   SubName: Full=BAG6 {ECO:0000313|EMBL:AQY76674.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AQY76674.1};
RN   [1] {ECO:0000313|EMBL:AQY76674.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Norman P.J., Norberg S.J., Nemat-Gorgani N., Ronaghi M., Parham P.;
RT   "CDS alleles of MHC region genes derived from homozygous
RT   individuals.";
RL   Submitted (MAR-2017) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KY500163; AQY76667.1; -; Genomic_DNA.
DR   EMBL; KY500166; AQY76670.1; -; Genomic_DNA.
DR   EMBL; KY500168; AQY76672.1; -; Genomic_DNA.
DR   EMBL; KY500170; AQY76674.1; -; Genomic_DNA.
DR   RefSeq; NP_001092004.1; NM_001098534.1.
DR   RefSeq; NP_542433.1; NM_080702.2.
DR   RefSeq; NP_542434.1; NM_080703.2.
DR   UniGene; Hs.440900; -.
DR   SMR; A0A1U9X7A6; -.
DR   GeneID; 7917; -.
DR   CTD; 7917; -.
DR   ExpressionAtlas; A0A1U9X7A6; baseline and differential.
DR   InterPro; IPR021925; BAG6.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF12057; DUF3538; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00299; UBIQUITIN_1; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   4: Predicted;
FT   DOMAIN       17     77       Ubiquitin-like.
FT                                {ECO:0000259|PROSITE:PS50053}.
SQ   SEQUENCE   1126 AA;  118693 MW;  8A67290BC8176ABA CRC64;
     MEPNDSTSTA VEEPDSLEVL VKTLDSQTRT FIVGAQMNVK EFKEHIAASV SIPSEKQRLI
     YQGRVLQDDK KLQEYNVGGK VIHLVERAPP QTHLPSGASS GTGSASATHG GGSPPGTRGP
     GASVHDRNAN SYVMVGTFNL PSDGSAVDVH INMEQAPIQS EPRVRLVMAQ HMIRDIQTLL
     SRMECRGGPQ PQHSQPPPQP PAVTPEPVAL SSQTSEPVES EAPPREPMEA EEVEERAPAQ
     NPELTPGPAP AGPTPAPETN APNHPSPAEY VEVLQELQRL ESRLQPFLQR YYEVLGAAAT
     TDYNNNHEGR EEDQRLINLV GESLRLLGNT FVALSDLRCN LACTPPRHLH VVRPMSHYTT
     PMVLQQAAIP IQINVGTTVT MTGNGTRPPP TPNAEAPPPG PGQASSVAPS STNVESSAEG
     APPPGPAPPP ATSHPRVIRI SHQSVEPVVM MHMNIQDSGT QPGGVPSAPT GPLGPPGHGQ
     TLGQQVPGFP TAPTRVVIAR PTPPQARPSH PGGPPVSGTL QGAGLGTNAS LAQMVSGLVG
     QLLMQPVLVA QGTPGMAPPP APATASASAG TTNTATTAGP APGGPAQPPP TPQPSMADLQ
     FSQLLGNLLG PAGPGAGGSG VASPTITVAM PGVPAFLQGM TDFLQATQTA PPPPPPPPPP
     PPAPEQQTMP PPGSPSGGAG SPGGLGLESL SPEFFTSVVQ GVLSSLLGSL GARAGSSESI
     AAFIQRLSGS SNIFEPGADG ALGFFGALLS LLCQNFSMVD VVMLLHGHFQ PLQRLQPQLR
     SFFHQHYLGG QEPTPSNIRM ATHTLITGLE EYVRESFSLV QVQPGVDIIR TNLEFLQEQF
     NSIAAHVLHC TDSGFGARLL ELCNQGLFEC LALNLHCLGG QQMELAAVIN GRIRRMSRGV
     NPSLVSWLTT MMGLRLQVVL EHMPVGPDAI LRYVRRVGDP PQPLPEEPME VQGAERASPE
     PQRENASPAP GTTAEEAMSR GPPPAPEGGS RDEQDGASAE TEPWAAAVPP EWVPIIQQDI
     QSQRKVKPQP PLSDAYLSGM PAKRRKTMQG EGPQLLLSEA VSRAAKAAGA RPLTSPESLS
     RDLEAPEVQE SYRQQLRSDI QKRLQEDPNY SPQRFPNAQR AFADDP
//
ID   BAG6_HUMAN              Reviewed;        1132 AA.
AC   P46379; A2ADJ7; A3KQ42; A3KQ44; A6NGY6; A6PWF7; B0UX84; B4DZ12;
AC   B4E3V4; E7EMZ4; F8VXY4; O95874; Q5HYL9; Q5SQ35; Q5SQ36; Q5SQ37;
AC   Q5SQ41; Q5SRP8; Q5SRP9; Q5STC1; Q5STX1; Q5STX3; Q96SA6; Q9BCN4;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 2.
DT   23-MAY-2018, entry version 175.
DE   RecName: Full=Large proline-rich protein BAG6 {ECO:0000305};
DE   AltName: Full=BAG family molecular chaperone regulator 6;
DE   AltName: Full=BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};
DE            Short=BAG-6;
DE   AltName: Full=HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};
DE   AltName: Full=Protein G3;
DE   AltName: Full=Protein Scythe {ECO:0000303|PubMed:17403783};
GN   Name=BAG6 {ECO:0000312|HGNC:HGNC:13919};
GN   Synonyms=BAT3 {ECO:0000303|PubMed:2156268}, G3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), VARIANT PRO-625,
RP   AND REPEAT.
RC   TISSUE=T-cell;
RX   PubMed=2156268; DOI=10.1073/pnas.87.6.2374;
RA   Banerji J., Sands J., Strominger J.L., Spies T.;
RT   "A gene pair from the human major histocompatibility complex encodes
RT   large proline-rich proteins with multiple repeated motifs and a single
RT   ubiquitin-like domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2374-2378(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5), AND VARIANT
RP   PRO-625.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S.,
RA   Campbell R.D., Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-625.
RA   Hirakawa M., Yamaguchi H., Imai K., Shimada J., Shiina S., Tamiya G.,
RA   Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-625.
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-625.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH RICIN A CHAIN,
RP   MUTAGENESIS OF ASP-1001, AND CLEAVAGE BY CASP3.
RX   PubMed=14960581; DOI=10.1074/jbc.M307049200;
RA   Wu Y.-H., Shih S.-F., Lin J.-Y.;
RT   "Ricin triggers apoptotic morphological changes through caspase-3
RT   cleavage of BAT3.";
RL   J. Biol. Chem. 279:19264-19275(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1117, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH EP300.
RX   PubMed=17403783; DOI=10.1101/gad.1534107;
RA   Sasaki T., Gan E.C., Wakeham A., Kornbluth S., Mak T.W., Okada H.;
RT   "HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-
RT   mediated acetylation of p53.";
RL   Genes Dev. 21:848-861(2007).
RN   [13]
RP   FUNCTION IN NK CELL ACTIVATION, AND SUBCELLULAR LOCATION.
RX   PubMed=18055229; DOI=10.1016/j.immuni.2007.10.010;
RA   Pogge von Strandmann E., Simhadri V.R., von Tresckow B., Sasse S.,
RA   Reiners K.S., Hansen H.P., Rothe A., Boll B., Simhadri V.L.,
RA   Borchmann P., McKinnon P.J., Hallek M., Engert A.;
RT   "Human leukocyte antigen-B-associated transcript 3 is released from
RT   tumor cells and engages the NKp30 receptor on natural killer cells.";
RL   Immunity 27:965-974(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-973, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH CTCFL.
RX   PubMed=18765639; DOI=10.1128/MCB.00568-08;
RA   Nguyen P., Bar-Sela G., Sun L., Bisht K.S., Cui H., Kohn E.,
RA   Feinberg A.P., Gius D.;
RT   "BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4
RT   histone dimethylation and gene expression.";
RL   Mol. Cell. Biol. 28:6720-6729(2008).
RN   [17]
RP   FUNCTION IN NK CELL ACTIVATION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=18852879; DOI=10.1371/journal.pone.0003377;
RA   Simhadri V.R., Reiners K.S., Hansen H.P., Topolar D., Simhadri V.L.,
RA   Nohroudi K., Kufer T.A., Engert A., Pogge von Strandmann E.;
RT   "Dendritic cells release HLA-B-associated transcript-3 positive
RT   exosomes to regulate natural killer function.";
RL   PLoS ONE 3:E3377-E3377(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-973; SER-1081
RP   AND SER-1117, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-832
RP   (ISOFORM 4), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-964 AND SER-973, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   UBIQUITINATION IN CASE OF INFECTION BY L.PNEUMOPHILA (MICROBIAL
RP   INFECTION), AND INTERACTION WITH LPG2160 AND LEGU1 (MICROBIAL
RP   INFECTION).
RX   PubMed=20547746; DOI=10.1128/IAI.00344-10;
RA   Ensminger A.W., Isberg R.R.;
RT   "E3 ubiquitin ligase activity and targeting of BAT3 by multiple
RT   Legionella pneumophila translocated substrates.";
RL   Infect. Immun. 78:3905-3919(2010).
RN   [22]
RP   FUNCTION.
RX   PubMed=20516149; DOI=10.1242/jcs.066738;
RA   Leznicki P., Clancy A., Schwappach B., High S.;
RT   "Bat3 promotes the membrane integration of tail-anchored proteins.";
RL   J. Cell Sci. 123:2170-2178(2010).
RN   [23]
RP   FUNCTION, SUBCELLULAR LOCATION, RIBOSOME-BINDING, IDENTIFICATION BY
RP   MASS SPECTROMETRY, AND IDENTIFICATION IN THE BAG6/BAT3 COMPLEX.
RX   PubMed=20676083; DOI=10.1038/nature09296;
RA   Mariappan M., Li X., Stefanovic S., Sharma A., Mateja A., Keenan R.J.,
RA   Hegde R.S.;
RT   "A ribosome-associating factor chaperones tail-anchored membrane
RT   proteins.";
RL   Nature 466:1120-1124(2010).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-350; SER-964; SER-973
RP   AND SER-1117, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   FUNCTION, INTERACTION WITH AMFR; SYVN1 AND VCP, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=21636303; DOI=10.1016/j.molcel.2011.05.010;
RA   Wang Q., Liu Y., Soetandyo N., Baek K., Hegde R., Ye Y.;
RT   "A ubiquitin ligase-associated chaperone holdase maintains
RT   polypeptides in soluble states for proteasome degradation.";
RL   Mol. Cell 42:758-770(2011).
RN   [27]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=21743475; DOI=10.1038/nature10181;
RA   Hessa T., Sharma A., Mariappan M., Eshleman H.D., Gutierrez E.,
RA   Hegde R.S.;
RT   "Protein targeting and degradation are coupled for elimination of
RT   mislocalized proteins.";
RL   Nature 475:394-397(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-964 AND SER-973, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [29]
RP   FUNCTION, AND INTERACTION WITH SGTA.
RX   PubMed=23129660; DOI=10.1073/pnas.1209997109;
RA   Leznicki P., High S.;
RT   "SGTA antagonizes BAG6-mediated protein triage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:19214-19219(2012).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-964; SER-973;
RP   THR-1053; SER-1081 AND SER-1117, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [31]
RP   INTERACTION WITH ZFAND2B.
RX   PubMed=24160817; DOI=10.1042/BJ20130710;
RA   Glinka T., Alter J., Braunstein I., Tzach L., Wei Sheng C.,
RA   Geifman S., Edelmann M.J., Kessler B.M., Stanhill A.;
RT   "Signal-peptide-mediated translocation is regulated by a p97-AIRAPL
RT   complex.";
RL   Biochem. J. 457:253-261(2014).
RN   [32]
RP   INTERACTION WITH SGTA AND USP13.
RX   PubMed=24424410; DOI=10.7554/eLife.01369;
RA   Liu Y., Soetandyo N., Lee J.G., Liu L., Xu Y., Clemons W.M. Jr.,
RA   Ye Y.;
RT   "USP13 antagonizes gp78 to maintain functionality of a chaperone in
RT   ER-associated degradation.";
RL   Elife 3:E01369-E01369(2014).
RN   [33]
RP   FUNCTION, AND INTERACTION WITH SGTA.
RX   PubMed=25179605; DOI=10.1242/jcs.155648;
RA   Wunderley L., Leznicki P., Payapilly A., High S.;
RT   "SGTA regulates the cytosolic quality control of hydrophobic
RT   substrates.";
RL   J. Cell Sci. 127:4728-4739(2014).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96 AND THR-117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   FUNCTION, INTERACTION WITH RNF126, AND DOMAIN.
RX   PubMed=24981174; DOI=10.1016/j.molcel.2014.05.025;
RA   Rodrigo-Brenni M.C., Gutierrez E., Hegde R.S.;
RT   "Cytosolic quality control of mislocalized proteins requires RNF126
RT   recruitment to Bag6.";
RL   Mol. Cell 55:227-237(2014).
RN   [36]
RP   FUNCTION.
RX   PubMed=26565908; DOI=10.1016/j.celrep.2015.09.047;
RA   Kadowaki H., Nagai A., Maruyama T., Takami Y., Satrimafitrah P.,
RA   Kato H., Honda A., Hatta T., Natsume T., Sato T., Kai H., Ichijo H.,
RA   Nishitoh H.;
RT   "Pre-emptive quality control protects the ER from protein overload via
RT   the proximity of ERAD components and SRP.";
RL   Cell Rep. 13:944-956(2015).
RN   [37]
RP   INTERACTION WITH ZFAND2B.
RX   PubMed=26337389; DOI=10.1091/mbc.E15-02-0085;
RA   Braunstein I., Zach L., Allan S., Kalies K.U., Stanhill A.;
RT   "Proteasomal degradation of preemptive quality control (pQC)
RT   substrates is mediated by an AIRAPL-p97 complex.";
RL   Mol. Biol. Cell 26:3719-3727(2015).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [39]
RP   FUNCTION.
RX   PubMed=26692333; DOI=10.1038/nm.4013;
RA   Osorio F.G., Soria-Valles C., Santiago-Fernandez O., Bernal T.,
RA   Mittelbrunn M., Colado E., Rodriguez F., Bonzon-Kulichenko E.,
RA   Vazquez J., Porta-de-la-Riva M., Ceron J., Fueyo A., Li J.,
RA   Green A.R., Freije J.M., Lopez-Otin C.;
RT   "Loss of the proteostasis factor AIRAPL causes myeloid transformation
RT   by deregulating IGF-1 signaling.";
RL   Nat. Med. 22:91-96(2016).
RN   [40]
RP   FUNCTION, DOMAIN, AND REGION.
RX   PubMed=28104892; DOI=10.1126/science.aah6130;
RA   Shao S., Rodrigo-Brenni M.C., Kivlen M.H., Hegde R.S.;
RT   "Mechanistic basis for a molecular triage reaction.";
RL   Science 355:298-302(2017).
RN   [41]
RP   STRUCTURE BY NMR OF 17-89.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminal ubiquitin-like domain in the
RT   human BAT3 protein.";
RL   Submitted (JUL-2005) to the PDB data bank.
RN   [42]
RP   STRUCTURE BY NMR OF 17-101 IN COMPLEX WITH RNF126, FUNCTION,
RP   INTERACTION WITH RNF126 AND SGTA, AND DOMAIN.
RX   PubMed=27193484; DOI=10.1038/srep26433;
RA   Krysztofinska E.M., Martinez-Lumbreras S., Thapaliya A., Evans N.J.,
RA   High S., Isaacson R.L.;
RT   "Structural and functional insights into the E3 ligase, RNF126.";
RL   Sci. Rep. 6:26433-26433(2016).
CC   -!- FUNCTION: ATP-independent molecular chaperone preventing the
CC       aggregation of misfolded and hydrophobic patches-containing
CC       proteins (PubMed:21636303). Functions as part of a cytosolic
CC       protein quality control complex, the BAG6/BAT3 complex, which
CC       maintains these client proteins in a soluble state and
CC       participates to their proper delivery to the endoplasmic reticulum
CC       or alternatively can promote their sorting to the proteasome where
CC       they undergo degradation (PubMed:20516149, PubMed:21636303,
CC       PubMed:21743475, PubMed:28104892). The BAG6/BAT3 complex is
CC       involved in the post-translational delivery of tail-anchored/type
CC       II transmembrane proteins to the endoplasmic reticulum membrane.
CC       Recruited to ribosomes, it interacts with the transmembrane region
CC       of newly synthesized tail-anchored proteins and together with SGTA
CC       and ASNA1 mediates their delivery to the endoplasmic reticulum
CC       (PubMed:20516149, PubMed:20676083, PubMed:28104892). Client
CC       proteins that cannot be properly delivered to the endoplasmic
CC       reticulum are ubiquitinated by RNF126, an E3 ubiquitin-protein
CC       ligase associated with BAG6 and are sorted to the proteasome
CC       (PubMed:24981174, PubMed:28104892, PubMed:27193484). SGTA which
CC       prevents the recruitment of RNF126 to BAG6 may negatively regulate
CC       the ubiquitination and the proteasomal degradation of client
CC       proteins (PubMed:23129660, PubMed:25179605, PubMed:27193484).
CC       Similarly, the BAG6/BAT3 complex also functions as a sorting
CC       platform for proteins of the secretory pathway that are
CC       mislocalized to the cytosol either delivering them to the
CC       proteasome for degradation or to the endoplasmic reticulum
CC       (PubMed:21743475). The BAG6/BAT3 complex also plays a role in the
CC       endoplasmic reticulum-associated degradation (ERAD), a quality
CC       control mechanism that eliminates unwanted proteins of the
CC       endoplasmic reticulum through their retrotranslocation to the
CC       cytosol and their targeting to the proteasome. It maintains these
CC       retrotranslocated proteins in an unfolded yet soluble state
CC       condition in the cytosol to ensure their proper delivery to the
CC       proteasome (PubMed:21636303). BAG6 is also required for selective
CC       ubiquitin-mediated degradation of defective nascent chain
CC       polypeptides by the proteasome. In this context, it may
CC       participate to the production of antigenic peptides and play a
CC       role in antigen presentation in immune response (By similarity).
CC       BAG6 is also involved in endoplasmic reticulum stress-induced pre-
CC       emptive quality control, a mechanism that selectively attenuates
CC       the translocation of newly synthesized proteins into the
CC       endoplasmic reticulum and reroutes them to the cytosol for
CC       proteasomal degradation. BAG6 may ensure the proper degradation of
CC       these proteins and thereby protects the endoplasmic reticulum from
CC       protein overload upon stress (PubMed:26565908). By inhibiting the
CC       polyubiquitination and subsequent proteasomal degradation of HSPA2
CC       it may also play a role in the assembly of the synaptonemal
CC       complex during spermatogenesis (By similarity). Also positively
CC       regulates apoptosis by interacting with and stabilizing the
CC       proapoptotic factor AIFM1 (By similarity). By controlling the
CC       steady-state expression of the IGF1R receptor, indirectly
CC       regulates the insulin-like growth factor receptor signaling
CC       pathway (PubMed:26692333). {ECO:0000250|UniProtKB:Q9Z1R2,
CC       ECO:0000269|PubMed:20516149, ECO:0000269|PubMed:20676083,
CC       ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:21743475,
CC       ECO:0000269|PubMed:23129660, ECO:0000269|PubMed:24981174,
CC       ECO:0000269|PubMed:25179605, ECO:0000269|PubMed:26565908,
CC       ECO:0000269|PubMed:26692333, ECO:0000269|PubMed:27193484,
CC       ECO:0000269|PubMed:28104892}.
CC   -!- FUNCTION: Involved in DNA damage-induced apoptosis: following DNA
CC       damage, accumulates in the nucleus and forms a complex with
CC       p300/EP300, enhancing p300/EP300-mediated p53/TP53 acetylation
CC       leading to increase p53/TP53 transcriptional activity
CC       (PubMed:17403783). When nuclear, may also act as a component of
CC       some chromatin regulator complex that regulates histone 3 'Lys-4'
CC       dimethylation (H3K4me2) (PubMed:18765639).
CC       {ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:18765639}.
CC   -!- FUNCTION: Released extracellularly via exosomes, it is a ligand of
CC       the natural killer/NK cells receptor NCR3 and stimulates NK cells
CC       cytotoxicity. It may thereby trigger NK cells cytotoxicity against
CC       neighboring tumor cells and immature myeloid dendritic cells (DC).
CC       {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879}.
CC   -!- FUNCTION: Mediates ricin-induced apoptosis.
CC       {ECO:0000269|PubMed:14960581}.
CC   -!- SUBUNIT: Component of the BAG6/BAT3 complex, also named BAT3
CC       complex, at least composed of BAG6, UBL4A and GET4/TRC35
CC       (PubMed:20676083). Interacts with GET4; the interaction is direct
CC       and localizes BAG6 in the cytosol (PubMed:21636303). Interacts
CC       with AIFM1 (By similarity). Interacts with HSPA2 (By similarity).
CC       Interacts with CTCFL (PubMed:18765639). Interacts with p300/EP300
CC       (PubMed:17403783). Interacts (via ubiquitin-like domain) with
CC       RNF126; required for BAG6-dependent ubiquitination of proteins
CC       mislocalized to the cytosol (PubMed:24981174, PubMed:27193484).
CC       Interacts (via ubiquitin-like domain) with SGTA; SGTA competes
CC       with RNF126 by binding the same region of BAG6, thereby promoting
CC       deubiquitination of BAG6-target proteins and rescuing them from
CC       degradation (PubMed:23129660, PubMed:24424410, PubMed:25179605,
CC       PubMed:27193484). Interacts with ricin A chain (PubMed:14960581).
CC       Interacts with VCP and AMFR; both form the VCP/p97-AMFR/gp78
CC       complex (PubMed:21636303). Interacts with SYVN1 (PubMed:21636303).
CC       Interacts with USP13; the interaction is direct and may mediate
CC       UBL4A deubiquitination (PubMed:24424410). Interacts with ZFAND2B
CC       (PubMed:24160817, PubMed:26337389). {ECO:0000250|UniProtKB:Q9Z1R2,
CC       ECO:0000269|PubMed:14960581, ECO:0000269|PubMed:17403783,
CC       ECO:0000269|PubMed:18765639, ECO:0000269|PubMed:20676083,
CC       ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:23129660,
CC       ECO:0000269|PubMed:24160817, ECO:0000269|PubMed:24424410,
CC       ECO:0000269|PubMed:24981174, ECO:0000269|PubMed:25179605,
CC       ECO:0000269|PubMed:26337389, ECO:0000269|PubMed:27193484}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with L. pneumophila
CC       Lpg2160 and LegU1 proteins. {ECO:0000269|PubMed:20547746}.
CC   -!- INTERACTION:
CC       Q12805:EFEMP1; NbExp=3; IntAct=EBI-347552, EBI-536772;
CC       Q8IZU0:FAM9B; NbExp=3; IntAct=EBI-347552, EBI-10175124;
CC       Q53G59:KLHL12; NbExp=4; IntAct=EBI-347552, EBI-740929;
CC       Q7Z434:MAVS; NbExp=2; IntAct=EBI-347552, EBI-995373;
CC       O14931:NCR3; NbExp=6; IntAct=EBI-347552, EBI-14989262;
CC       O14931-1:NCR3; NbExp=5; IntAct=EBI-9640181, EBI-15013584;
CC       Q9BV68:RNF126; NbExp=4; IntAct=EBI-347552, EBI-357322;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-347552, EBI-347996;
CC       Q12800:TFCP2; NbExp=3; IntAct=EBI-347552, EBI-717422;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-10988864, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:20676083,
CC       ECO:0000269|PubMed:21636303}. Nucleus
CC       {ECO:0000269|PubMed:14960581, ECO:0000269|PubMed:17403783,
CC       ECO:0000269|PubMed:21636303}. Secreted, exosome
CC       {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879}.
CC       Note=Normally localized in cytosol and nucleus, it can also be
CC       released extracellularly, in exosomes, by tumor and myeloid
CC       dendritic cells. {ECO:0000269|PubMed:18055229,
CC       ECO:0000269|PubMed:18852879}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P46379-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P46379-2; Sequence=VSP_015695;
CC       Name=3;
CC         IsoId=P46379-3; Sequence=VSP_015695, VSP_030519;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P46379-4; Sequence=VSP_015695, VSP_045910, VSP_045911,
CC                                  VSP_045912, VSP_045913;
CC         Note=No experimental confirmation available. Contains a
CC         phosphoserine at position 832.;
CC       Name=5;
CC         IsoId=P46379-5; Sequence=VSP_015695, VSP_045913;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed by immature dendritic cells (at
CC       protein level). {ECO:0000269|PubMed:18852879}.
CC   -!- DOMAIN: The ubiquitin-like domain mediates interaction with the E3
CC       ubiquitin-protein ligase RNF126 which is responsible for the BAG6-
CC       dependent ubiquitination of client proteins (PubMed:21743475,
CC       PubMed:24981174, PubMed:28104892, PubMed:27193484). SGTA also
CC       binds this domain and competes with RNF126 to antagonize client
CC       protein ubiquitination and degradation (PubMed:28104892). The
CC       ubiquitin-like domain also mediates the interaction with USP13
CC       (PubMed:24424410). {ECO:0000269|PubMed:21743475,
CC       ECO:0000269|PubMed:24424410, ECO:0000269|PubMed:24981174,
CC       ECO:0000269|PubMed:27193484, ECO:0000269|PubMed:28104892}.
CC   -!- PTM: Ricin can induce a cleavage by the caspase CASP3. The
CC       released C-terminal peptide induces apoptosis.
CC       {ECO:0000269|PubMed:14960581}.
CC   -!- PTM: (Microbial infection) In case of infection by L.pneumophila,
CC       ubiquitinated by the SCF(LegU1) complex.
CC       {ECO:0000269|PubMed:20547746}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD18085.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAB63390.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAI18318.2; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M33519; AAA35587.1; -; mRNA.
DR   EMBL; M33521; AAA35588.1; -; Genomic_DNA.
DR   EMBL; M33520; AAA35588.1; JOINED; Genomic_DNA.
DR   EMBL; BX647244; CAI46045.1; -; mRNA.
DR   EMBL; AK302695; BAG63924.1; -; mRNA.
DR   EMBL; AK304879; BAG65616.1; -; mRNA.
DR   EMBL; AF129756; AAD18085.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BA000025; BAB63390.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL662801; CAI18314.1; -; Genomic_DNA.
DR   EMBL; AL662801; CAI18315.1; -; Genomic_DNA.
DR   EMBL; AL662801; CAI18316.2; -; Genomic_DNA.
DR   EMBL; AL662801; CAI18318.2; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL662847; CAI17658.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAI17658.1; JOINED; Genomic_DNA.
DR   EMBL; AL662847; CAI17659.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAI17659.1; JOINED; Genomic_DNA.
DR   EMBL; AL670886; CAI17784.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAI17784.1; JOINED; Genomic_DNA.
DR   EMBL; AL670886; CAI17785.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAI17785.1; JOINED; Genomic_DNA.
DR   EMBL; AL670886; CAI17786.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAI17786.1; JOINED; Genomic_DNA.
DR   EMBL; AL805934; CAI18501.1; -; Genomic_DNA.
DR   EMBL; AL805934; CAI18504.1; -; Genomic_DNA.
DR   EMBL; AL805934; CAI18508.2; -; Genomic_DNA.
DR   EMBL; AL805934; CAI18509.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAM25014.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAM25014.1; JOINED; Genomic_DNA.
DR   EMBL; BX511262; CAM45799.1; -; Genomic_DNA.
DR   EMBL; BX511262; CAM45800.1; -; Genomic_DNA.
DR   EMBL; BX511262; CAM45801.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAO72072.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAO72072.1; JOINED; Genomic_DNA.
DR   EMBL; CR753842; CAQ06558.1; -; Genomic_DNA.
DR   EMBL; CR753892; CAQ06558.1; JOINED; Genomic_DNA.
DR   EMBL; CR753892; CAQ06931.1; -; Genomic_DNA.
DR   EMBL; CR753842; CAQ06931.1; JOINED; Genomic_DNA.
DR   EMBL; CR354443; CAQ06977.1; -; Genomic_DNA.
DR   EMBL; CR759761; CAQ10854.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03455.1; -; Genomic_DNA.
DR   EMBL; BC003133; AAH03133.1; -; mRNA.
DR   CCDS; CCDS4709.1; -. [P46379-2]
DR   CCDS; CCDS47403.1; -. [P46379-1]
DR   CCDS; CCDS56414.1; -. [P46379-4]
DR   CCDS; CCDS56415.1; -. [P46379-5]
DR   PIR; A35098; A35098.
DR   RefSeq; NP_001092004.1; NM_001098534.1. [P46379-2]
DR   RefSeq; NP_001186626.1; NM_001199697.1. [P46379-4]
DR   RefSeq; NP_001186627.1; NM_001199698.1. [P46379-5]
DR   RefSeq; NP_004630.3; NM_004639.3. [P46379-1]
DR   RefSeq; NP_542433.1; NM_080702.2. [P46379-2]
DR   RefSeq; NP_542434.1; NM_080703.2. [P46379-2]
DR   RefSeq; XP_016866776.1; XM_017011287.1. [P46379-3]
DR   UniGene; Hs.440900; -.
DR   PDB; 1WX9; NMR; -; A=17-89.
DR   PDB; 2N9P; NMR; -; C=17-101.
DR   PDB; 4DWF; X-ray; 1.80 A; A/B=13-101.
DR   PDB; 4EEW; X-ray; 1.30 A; A/B=1-87.
DR   PDB; 4WWR; X-ray; 2.00 A; A/C/E/G=1060-1111.
DR   PDB; 4X86; X-ray; 1.85 A; B=1048-1123.
DR   PDB; 6AU8; X-ray; 1.80 A; C=1008-1050.
DR   PDBsum; 1WX9; -.
DR   PDBsum; 2N9P; -.
DR   PDBsum; 4DWF; -.
DR   PDBsum; 4EEW; -.
DR   PDBsum; 4WWR; -.
DR   PDBsum; 4X86; -.
DR   PDBsum; 6AU8; -.
DR   ProteinModelPortal; P46379; -.
DR   SMR; P46379; -.
DR   BioGrid; 113647; 294.
DR   CORUM; P46379; -.
DR   DIP; DIP-31191N; -.
DR   IntAct; P46379; 260.
DR   MINT; P46379; -.
DR   STRING; 9606.ENSP00000365131; -.
DR   iPTMnet; P46379; -.
DR   PhosphoSitePlus; P46379; -.
DR   SwissPalm; P46379; -.
DR   BioMuta; BAG6; -.
DR   DMDM; 76800648; -.
DR   EPD; P46379; -.
DR   MaxQB; P46379; -.
DR   PaxDb; P46379; -.
DR   PeptideAtlas; P46379; -.
DR   PRIDE; P46379; -.
DR   Ensembl; ENST00000211379; ENSP00000211379; ENSG00000204463. [P46379-2]
DR   Ensembl; ENST00000361076; ENSP00000354368; ENSG00000096155. [P46379-1]
DR   Ensembl; ENST00000362049; ENSP00000354875; ENSG00000204463. [P46379-5]
DR   Ensembl; ENST00000375964; ENSP00000365131; ENSG00000204463. [P46379-1]
DR   Ensembl; ENST00000375976; ENSP00000365143; ENSG00000204463. [P46379-2]
DR   Ensembl; ENST00000383446; ENSP00000372938; ENSG00000096155. [P46379-2]
DR   Ensembl; ENST00000383448; ENSP00000372940; ENSG00000096155. [P46379-2]
DR   Ensembl; ENST00000417144; ENSP00000412110; ENSG00000229524. [P46379-2]
DR   Ensembl; ENST00000419847; ENSP00000389121; ENSG00000233348. [P46379-2]
DR   Ensembl; ENST00000439687; ENSP00000402856; ENSG00000204463. [P46379-4]
DR   Ensembl; ENST00000442479; ENSP00000413698; ENSG00000229524. [P46379-2]
DR   Ensembl; ENST00000443182; ENSP00000410156; ENSG00000233348. [P46379-2]
DR   Ensembl; ENST00000449450; ENSP00000397894; ENSG00000229524. [P46379-1]
DR   Ensembl; ENST00000451932; ENSP00000390966; ENSG00000233348. [P46379-1]
DR   Ensembl; ENST00000551350; ENSP00000447546; ENSG00000229524. [P46379-5]
DR   Ensembl; ENST00000552116; ENSP00000447946; ENSG00000233348. [P46379-5]
DR   Ensembl; ENST00000552605; ENSP00000446525; ENSG00000096155. [P46379-5]
DR   Ensembl; ENST00000613474; ENSP00000478966; ENSG00000227761. [P46379-4]
DR   Ensembl; ENST00000615143; ENSP00000482413; ENSG00000229524. [P46379-4]
DR   Ensembl; ENST00000615224; ENSP00000477951; ENSG00000228760. [P46379-4]
DR   Ensembl; ENST00000615725; ENSP00000479238; ENSG00000233348. [P46379-4]
DR   Ensembl; ENST00000617635; ENSP00000484238; ENSG00000096155. [P46379-4]
DR   Ensembl; ENST00000621056; ENSP00000477867; ENSG00000234651. [P46379-4]
DR   GeneID; 7917; -.
DR   KEGG; hsa:7917; -.
DR   UCSC; uc003nvf.4; human. [P46379-1]
DR   CTD; 7917; -.
DR   DisGeNET; 7917; -.
DR   EuPathDB; HostDB:ENSG00000204463.12; -.
DR   GeneCards; BAG6; -.
DR   H-InvDB; HIX0165051; -.
DR   H-InvDB; HIX0166179; -.
DR   H-InvDB; HIX0166289; -.
DR   H-InvDB; HIX0166578; -.
DR   H-InvDB; HIX0166832; -.
DR   H-InvDB; HIX0167081; -.
DR   H-InvDB; HIX0167222; -.
DR   H-InvDB; HIX0167321; -.
DR   H-InvDB; HIX0167461; -.
DR   H-InvDB; HIX0167568; -.
DR   HGNC; HGNC:13919; BAG6.
DR   HPA; CAB020704; -.
DR   HPA; HPA045116; -.
DR   HPA; HPA053291; -.
DR   MIM; 142590; gene.
DR   neXtProt; NX_P46379; -.
DR   OpenTargets; ENSG00000204463; -.
DR   PharmGKB; PA25264; -.
DR   eggNOG; KOG4248; Eukaryota.
DR   eggNOG; ENOG410XS9P; LUCA.
DR   GeneTree; ENSGT00390000016199; -.
DR   HOVERGEN; HBG002193; -.
DR   InParanoid; P46379; -.
DR   OMA; PMVAPNA; -.
DR   OrthoDB; EOG091G0XSR; -.
DR   PhylomeDB; P46379; -.
DR   TreeFam; TF328437; -.
DR   ChiTaRS; BAG6; human.
DR   EvolutionaryTrace; P46379; -.
DR   GeneWiki; HLA-B_associated_transcript_3; -.
DR   GenomeRNAi; 7917; -.
DR   PMAP-CutDB; B0UX84; -.
DR   PRO; PR:P46379; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000204463; -.
DR   ExpressionAtlas; P46379; baseline and differential.
DR   Genevisible; P46379; HS.
DR   GO; GO:0071818; C:BAT3 complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030544; F:Hsp70 protein binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051787; F:misfolded protein binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; ISS:UniProtKB.
DR   GO; GO:0070628; F:proteasome binding; ISS:UniProtKB.
DR   GO; GO:0043022; F:ribosome binding; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0006915; P:apoptotic process; IDA:UniProtKB.
DR   GO; GO:0007420; P:brain development; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0009790; P:embryo development; ISS:UniProtKB.
DR   GO; GO:0061857; P:endoplasmic reticulum stress-induced pre-emptive quality control; IMP:UniProtKB.
DR   GO; GO:0071712; P:ER-associated misfolded protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0002429; P:immune response-activating cell surface receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0018393; P:internal peptidyl-lysine acetylation; IDA:UniProtKB.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; ISS:UniProtKB.
DR   GO; GO:0030324; P:lung development; ISS:UniProtKB.
DR   GO; GO:1904378; P:maintenance of unfolded protein involved in ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030101; P:natural killer cell activation; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0045861; P:negative regulation of proteolysis; ISS:UniProtKB.
DR   GO; GO:1904294; P:positive regulation of ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0010498; P:proteasomal protein catabolic process; IMP:UniProtKB.
DR   GO; GO:1904379; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   GO; GO:0007130; P:synaptonemal complex assembly; ISS:UniProtKB.
DR   GO; GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; IDA:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   InterPro; IPR021925; BAG6.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF12057; DUF3538; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00299; UBIQUITIN_1; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis; Chaperone;
KW   Chromatin regulator; Complete proteome; Cytoplasm; Differentiation;
KW   Immunity; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Secreted; Spermatogenesis; Transport; Ubl conjugation.
FT   CHAIN         1   1132       Large proline-rich protein BAG6.
FT                                /FTId=PRO_0000114897.
FT   DOMAIN       17     92       Ubiquitin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   REPEAT      242    270       1. {ECO:0000303|PubMed:2156268}.
FT   REPEAT      415    443       2. {ECO:0000303|PubMed:2156268}.
FT   REPEAT      574    602       3. {ECO:0000303|PubMed:2156268}.
FT   REPEAT      608    636       4. {ECO:0000303|PubMed:2156268}.
FT   REGION      242    636       4 X 29 AA approximate repeats.
FT                                {ECO:0000303|PubMed:2156268}.
FT   REGION     1022   1132       Mediates interaction with UBL4A and GET4
FT                                and is sufficient for the delivery of
FT                                client proteins to the endoplasmic
FT                                reticulum. {ECO:0000269|PubMed:28104892}.
FT   COMPBIAS    195    273       Pro-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00015}.
FT   COMPBIAS    394    681       Pro-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00015}.
FT   SITE       1001   1002       Cleavage; by CASP3.
FT                                {ECO:0000269|PubMed:14960581}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      96     96       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     113    113       Phosphoserine.
FT                                {ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     117    117       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     350    350       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     964    964       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     973    973       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1053   1053       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1081   1081       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1117   1117       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     185    190       Missing (in isoform 2, isoform 3, isoform
FT                                4 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_015695.
FT   VAR_SEQ     489    489       G -> GSTLIQLPSLPPEFMHAVAHQITHQAMVAAVASAAA
FT                                G (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_030519.
FT   VAR_SEQ     527    527       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045910.
FT   VAR_SEQ     561    685       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045911.
FT   VAR_SEQ     969   1016       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045912.
FT   VAR_SEQ    1053   1101       Missing (in isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045913.
FT   VARIANT     625    625       S -> P (in dbSNP:rs1052486).
FT                                {ECO:0000269|PubMed:14574404,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:2156268,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_023531.
FT   VARIANT     728    728       A -> V (in dbSNP:rs11548856).
FT                                /FTId=VAR_037150.
FT   MUTAGEN    1001   1001       D->A: Abolishes cleavage by the caspase
FT                                CASP3. {ECO:0000269|PubMed:14960581}.
FT   CONFLICT     43     43       K -> R (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT     47     47       A -> R (in Ref. 1; AAA35587).
FT                                {ECO:0000305}.
FT   CONFLICT    150    150       H -> D (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    511    511       Q -> R (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    561    561       G -> D (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    617    617       P -> L (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    679    679       G -> R (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    839    839       L -> R (in Ref. 3; BAG63924).
FT                                {ECO:0000305}.
FT   CONFLICT    842    842       L -> P (in Ref. 3; BAG63924).
FT                                {ECO:0000305}.
FT   CONFLICT    853    853       V -> M (in Ref. 2; CAI46045).
FT                                {ECO:0000305}.
FT   CONFLICT    854    854       L -> Q (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    927    927       E -> D (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   STRAND       16     23       {ECO:0000244|PDB:4EEW}.
FT   STRAND       28     34       {ECO:0000244|PDB:4EEW}.
FT   STRAND       35     37       {ECO:0000244|PDB:2N9P}.
FT   HELIX        39     50       {ECO:0000244|PDB:4EEW}.
FT   HELIX        54     56       {ECO:0000244|PDB:4EEW}.
FT   STRAND       57     61       {ECO:0000244|PDB:4EEW}.
FT   STRAND       64     66       {ECO:0000244|PDB:2N9P}.
FT   STRAND       68     71       {ECO:0000244|PDB:1WX9}.
FT   HELIX        72     75       {ECO:0000244|PDB:4EEW}.
FT   STRAND       80     86       {ECO:0000244|PDB:4EEW}.
FT   TURN         91     93       {ECO:0000244|PDB:2N9P}.
FT   HELIX      1009   1013       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1016   1018       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1019   1028       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1040   1043       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1063   1074       {ECO:0000244|PDB:4X86}.
FT   HELIX      1082   1089       {ECO:0000244|PDB:4X86}.
FT   HELIX      1092   1110       {ECO:0000244|PDB:4X86}.
SQ   SEQUENCE   1132 AA;  119409 MW;  625B5F86321367ED CRC64;
     MEPNDSTSTA VEEPDSLEVL VKTLDSQTRT FIVGAQMNVK EFKEHIAASV SIPSEKQRLI
     YQGRVLQDDK KLQEYNVGGK VIHLVERAPP QTHLPSGASS GTGSASATHG GGSPPGTRGP
     GASVHDRNAN SYVMVGTFNL PSDGSAVDVH INMEQAPIQS EPRVRLVMAQ HMIRDIQTLL
     SRMETLPYLQ CRGGPQPQHS QPPPQPPAVT PEPVALSSQT SEPVESEAPP REPMEAEEVE
     ERAPAQNPEL TPGPAPAGPT PAPETNAPNH PSPAEYVEVL QELQRLESRL QPFLQRYYEV
     LGAAATTDYN NNHEGREEDQ RLINLVGESL RLLGNTFVAL SDLRCNLACT PPRHLHVVRP
     MSHYTTPMVL QQAAIPIQIN VGTTVTMTGN GTRPPPTPNA EAPPPGPGQA SSVAPSSTNV
     ESSAEGAPPP GPAPPPATSH PRVIRISHQS VEPVVMMHMN IQDSGTQPGG VPSAPTGPLG
     PPGHGQTLGQ QVPGFPTAPT RVVIARPTPP QARPSHPGGP PVSGTLQGAG LGTNASLAQM
     VSGLVGQLLM QPVLVAQGTP GMAPPPAPAT ASASAGTTNT ATTAGPAPGG PAQPPPTPQP
     SMADLQFSQL LGNLLGPAGP GAGGSGVASP TITVAMPGVP AFLQGMTDFL QATQTAPPPP
     PPPPPPPPAP EQQTMPPPGS PSGGAGSPGG LGLESLSPEF FTSVVQGVLS SLLGSLGARA
     GSSESIAAFI QRLSGSSNIF EPGADGALGF FGALLSLLCQ NFSMVDVVML LHGHFQPLQR
     LQPQLRSFFH QHYLGGQEPT PSNIRMATHT LITGLEEYVR ESFSLVQVQP GVDIIRTNLE
     FLQEQFNSIA AHVLHCTDSG FGARLLELCN QGLFECLALN LHCLGGQQME LAAVINGRIR
     RMSRGVNPSL VSWLTTMMGL RLQVVLEHMP VGPDAILRYV RRVGDPPQPL PEEPMEVQGA
     ERASPEPQRE NASPAPGTTA EEAMSRGPPP APEGGSRDEQ DGASAETEPW AAAVPPEWVP
     IIQQDIQSQR KVKPQPPLSD AYLSGMPAKR RKTMQGEGPQ LLLSEAVSRA AKAAGARPLT
     SPESLSRDLE APEVQESYRQ QLRSDIQKRL QEDPNYSPQR FPNAQRAFAD DP
//
ID   IF6_HUMAN               Reviewed;         245 AA.
AC   P56537; B7ZBG9; Q6IBN8; Q96TD5;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 1.
DT   23-MAY-2018, entry version 179.
DE   RecName: Full=Eukaryotic translation initiation factor 6 {ECO:0000255|HAMAP-Rule:MF_03132};
DE            Short=eIF-6 {ECO:0000255|HAMAP-Rule:MF_03132};
DE   AltName: Full=B(2)GCN homolog;
DE   AltName: Full=B4 integrin interactor;
DE   AltName: Full=CAB;
DE   AltName: Full=p27(BBP);
GN   Name=EIF6 {ECO:0000255|HAMAP-Rule:MF_03132,
GN   ECO:0000312|HGNC:HGNC:6159};
GN   Synonyms=EIF3A, ITGB4BP {ECO:0000255|HAMAP-Rule:MF_03132};
GN   ORFNames=OK/SW-cl.27;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=9405604; DOI=10.1073/pnas.94.26.14285;
RA   Si K., Chaudhuri J., Chevesich J., Maitra U.;
RT   "Molecular cloning and functional expression of a human cDNA encoding
RT   translation initiation factor 6.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14285-14290(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=9374518; DOI=10.1074/jbc.272.48.30314;
RA   Biffo S., Sanvito F., Costa S., Preve L., Pignatelli R., Spinardi L.,
RA   Marchisio P.C.;
RT   "Isolation of a novel beta4 integrin-binding protein (p27(BBP)) highly
RT   expressed in epithelial cells.";
RL   J. Biol. Chem. 272:30314-30321(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=11290417; DOI=10.1016/S0378-1119(01)00370-5;
RA   Donadini A., Giodini A., Sanvito F., Marchisio P.C., Biffo S.;
RT   "The human ITGB4BP gene is constitutively expressed in vitro, but
RT   highly modulated in vivo.";
RL   Gene 266:35-43(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=9653160; DOI=10.1073/pnas.95.14.8175;
RA   Mao M., Fu G., Wu J.-S., Zhang Q.-H., Zhou J., Kan L.-X., Huang Q.-H.,
RA   He K.-L., Gu B.-W., Han Z.-G., Shen Y., Gu J., Yu Y.-P., Xu S.-H.,
RA   Wang Y.-X., Chen S.-J., Chen Z.;
RT   "Identification of genes expressed in human CD34(+) hematopoietic
RT   stem/progenitor cells by expressed sequence tags and efficient full-
RT   length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:8175-8180(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-
RT   reactive CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, Muscle, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10085284; DOI=10.1083/jcb.144.5.823;
RA   Sanvito F., Piatti S., Villa A., Bossi M., Lucchini G.,
RA   Marchisio P.C., Biffo S.;
RT   "The beta4 integrin interactor p27(BBP/eIF6) is an essential nuclear
RT   matrix protein involved in 60S ribosomal subunit assembly.";
RL   J. Cell Biol. 144:823-837(1999).
RN   [12]
RP   PHOSPHORYLATION AT SER-174 AND SER-175, SUBCELLULAR LOCATION, AND
RP   NUCLEOCYTOPLASMIC SHUTTLING.
RX   PubMed=12917340; DOI=10.1128/MCB.23.17.6187-6199.2003;
RA   Basu U., Si K., Deng H., Maitra U.;
RT   "Phosphorylation of mammalian eukaryotic translation initiation factor
RT   6 and its Saccharomyces cerevisiae homologue Tif6p: evidence that
RT   phosphorylation of Tif6p regulates its nucleocytoplasmic distribution
RT   and is required for yeast cell growth.";
RL   Mol. Cell. Biol. 23:6187-6199(2003).
RN   [13]
RP   FUNCTION, SUBUNIT, PHOSPHORYLATION AT SER-235, AND INTERACTION WITH
RP   RACK1.
RX   PubMed=14654845; DOI=10.1038/nature02160;
RA   Ceci M., Gaviraghi C., Gorrini C., Sala L.A., Offenhauser N.,
RA   Marchisio P.C., Biffo S.;
RT   "Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome
RT   assembly.";
RL   Nature 426:579-584(2003).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-113, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH AGO2; DICER1; MOV10; RPL7A AND TARBP2.
RX   PubMed=17507929; DOI=10.1038/nature05841;
RA   Chendrimada T.P., Finn K.J., Ji X., Baillat D., Gregory R.I.,
RA   Liebhaber S.A., Pasquinelli A.E., Shiekhattar R.;
RT   "MicroRNA silencing through RISC recruitment of eIF6.";
RL   Nature 447:823-828(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239 AND SER-243, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   FUNCTION.
RX   PubMed=21536732; DOI=10.1101/gad.623011;
RA   Finch A.J., Hilcenko C., Basse N., Drynan L.F., Goyenechea B.,
RA   Menne T.F., Gonzalez Fernandez A., Simpson P., D'Santos C.S.,
RA   Arends M.J., Donadieu J., Bellanne-Chantelot C., Costanzo M.,
RA   Boone C., McKenzie A.N., Freund S.M., Warren A.J.;
RT   "Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes
RT   Shwachman-Diamond syndrome.";
RL   Genes Dev. 25:917-929(2011).
RN   [21]
RP   PHOSPHORYLATION AT SER-174 AND SER-175 BY CSNK1D/CK1, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=21084295; DOI=10.1074/jbc.M110.188565;
RA   Biswas A., Mukherjee S., Das S., Shields D., Chow C.W., Maitra U.;
RT   "Opposing action of casein kinase 1 and calcineurin in nucleo-
RT   cytoplasmic shuttling of mammalian translation initiation factor
RT   eIF6.";
RL   J. Biol. Chem. 286:3129-3138(2011).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Binds to the 60S ribosomal subunit and prevents its
CC       association with the 40S ribosomal subunit to form the 80S
CC       initiation complex in the cytoplasm. Behaves as a stimulatory
CC       translation initiation factor downstream insulin/growth factors.
CC       Is also involved in ribosome biogenesis. Associates with pre-60S
CC       subunits in the nucleus and is involved in its nuclear export.
CC       Cytoplasmic release of TIF6 from 60S subunits and nuclear
CC       relocalization is promoted by a RACK1 (RACK1)-dependent protein
CC       kinase C activity (PubMed:10085284, PubMed:14654845,
CC       PubMed:21536732). In tissues responsive to insulin, controls fatty
CC       acid synthesis and glycolysis by exerting translational control of
CC       adipogenic transcription factors such as CEBPB, CEBPD and ATF4
CC       that have G/C rich or uORF in their 5'UTR. Required for ROS-
CC       dependent megakaryocyte maturation and platelets formation,
CC       controls the expression of mitochondrial respiratory chain genes
CC       involved in reactive oxygen species (ROS) synthesis (By
CC       similarity). Involved in miRNA-mediated gene silencing by the RNA-
CC       induced silencing complex (RISC). Required for both miRNA-mediated
CC       translational repression and miRNA-mediated cleavage of
CC       complementary mRNAs by RISC (PubMed:17507929). Modulates cell
CC       cycle progression and global translation of pre-B cells, its
CC       activation seems to be rate-limiting in tumorigenesis and tumor
CC       growth (By similarity). {ECO:0000255|HAMAP-Rule:MF_03132,
CC       ECO:0000269|PubMed:10085284, ECO:0000269|PubMed:14654845,
CC       ECO:0000269|PubMed:17507929, ECO:0000269|PubMed:21536732}.
CC   -!- SUBUNIT: Monomer. Associates with the 60S ribosomal subunit.
CC       Interacts with RACK1. Interacts with DICER1, AGO2, TARBP2, MOV10
CC       and RPL7A; they form a large RNA-induced silencing complex (RISC)
CC       (PubMed:17507929). {ECO:0000255|HAMAP-Rule:MF_03132,
CC       ECO:0000269|PubMed:14654845, ECO:0000269|PubMed:17507929}.
CC   -!- INTERACTION:
CC       Q96C10:DHX58; NbExp=2; IntAct=EBI-372243, EBI-744193;
CC       P19525:EIF2AK2; NbExp=2; IntAct=EBI-372243, EBI-640775;
CC       Q16612:NREP; NbExp=5; IntAct=EBI-372243, EBI-718657;
CC       Q9Y6K5:OAS3; NbExp=2; IntAct=EBI-372243, EBI-6115729;
CC       P68404:Prkcb (xeno); NbExp=2; IntAct=EBI-372243, EBI-397048;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus, nucleolus. Note=Shuttles
CC       between cytoplasm and nucleus/nucleolus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P56537-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P56537-2; Sequence=VSP_046747;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- TISSUE SPECIFICITY: Expressed at very high levels in colon
CC       carcinoma with lower levels in normal colon and ileum and lowest
CC       levels in kidney and muscle (at protein level).
CC       {ECO:0000269|PubMed:11290417}.
CC   -!- PTM: Phosphorylation at Ser-174 and Ser-175 by CSNK1D/CK1 promotes
CC       nuclear export. {ECO:0000269|PubMed:12917340,
CC       ECO:0000269|PubMed:14654845, ECO:0000269|PubMed:21084295}.
CC   -!- SIMILARITY: Belongs to the eIF-6 family. {ECO:0000255|HAMAP-
CC       Rule:MF_03132}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF022229; AAB97735.1; -; mRNA.
DR   EMBL; Y11435; CAA72243.1; -; mRNA.
DR   EMBL; AF289541; AAK39426.1; -; Genomic_DNA.
DR   EMBL; AF289540; AAK39426.1; JOINED; Genomic_DNA.
DR   EMBL; AF047433; AAC39897.1; -; mRNA.
DR   EMBL; AK314969; BAG37470.1; -; mRNA.
DR   EMBL; AB062289; BAB93472.1; -; mRNA.
DR   EMBL; CR456764; CAG33045.1; -; mRNA.
DR   EMBL; AL121753; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW76221.1; -; Genomic_DNA.
DR   EMBL; BC001119; AAH01119.1; -; mRNA.
DR   EMBL; BC011845; AAH11845.1; -; mRNA.
DR   EMBL; BC019305; AAH19305.1; -; mRNA.
DR   CCDS; CCDS13249.1; -. [P56537-1]
DR   CCDS; CCDS13250.1; -. [P56537-2]
DR   RefSeq; NP_001254739.1; NM_001267810.1. [P56537-1]
DR   RefSeq; NP_002203.1; NM_002212.3. [P56537-1]
DR   RefSeq; NP_852131.1; NM_181466.2. [P56537-2]
DR   RefSeq; NP_852133.1; NM_181468.2. [P56537-1]
DR   UniGene; Hs.743992; -.
DR   ProteinModelPortal; P56537; -.
DR   SMR; P56537; -.
DR   BioGrid; 109898; 147.
DR   CORUM; P56537; -.
DR   IntAct; P56537; 29.
DR   MINT; P56537; -.
DR   STRING; 9606.ENSP00000363559; -.
DR   Allergome; 8361; Hom s eIF6.
DR   iPTMnet; P56537; -.
DR   PhosphoSitePlus; P56537; -.
DR   SwissPalm; P56537; -.
DR   BioMuta; EIF6; -.
DR   OGP; P56537; -.
DR   REPRODUCTION-2DPAGE; IPI00010105; -.
DR   SWISS-2DPAGE; P56537; -.
DR   EPD; P56537; -.
DR   MaxQB; P56537; -.
DR   PaxDb; P56537; -.
DR   PeptideAtlas; P56537; -.
DR   PRIDE; P56537; -.
DR   TopDownProteomics; P56537-1; -. [P56537-1]
DR   DNASU; 3692; -.
DR   Ensembl; ENST00000374436; ENSP00000363559; ENSG00000242372. [P56537-1]
DR   Ensembl; ENST00000374443; ENSP00000363566; ENSG00000242372. [P56537-2]
DR   Ensembl; ENST00000374450; ENSP00000363574; ENSG00000242372. [P56537-1]
DR   Ensembl; ENST00000621148; ENSP00000483289; ENSG00000242372. [P56537-1]
DR   GeneID; 3692; -.
DR   KEGG; hsa:3692; -.
DR   UCSC; uc002xbv.3; human. [P56537-1]
DR   CTD; 3692; -.
DR   DisGeNET; 3692; -.
DR   EuPathDB; HostDB:ENSG00000242372.6; -.
DR   GeneCards; EIF6; -.
DR   HGNC; HGNC:6159; EIF6.
DR   HPA; HPA040873; -.
DR   MIM; 602912; gene.
DR   neXtProt; NX_P56537; -.
DR   OpenTargets; ENSG00000242372; -.
DR   PharmGKB; PA29958; -.
DR   eggNOG; KOG3185; Eukaryota.
DR   eggNOG; COG1976; LUCA.
DR   GeneTree; ENSGT00390000015972; -.
DR   HOGENOM; HOG000230605; -.
DR   HOVERGEN; HBG001300; -.
DR   InParanoid; P56537; -.
DR   KO; K03264; -.
DR   OMA; NDWCAFT; -.
DR   OrthoDB; EOG091G0HYF; -.
DR   PhylomeDB; P56537; -.
DR   TreeFam; TF105396; -.
DR   SIGNOR; P56537; -.
DR   ChiTaRS; EIF6; human.
DR   GeneWiki; EIF6; -.
DR   GenomeRNAi; 3692; -.
DR   PRO; PR:P56537; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000242372; -.
DR   CleanEx; HS_EIF3A; -.
DR   CleanEx; HS_EIF6; -.
DR   ExpressionAtlas; P56537; baseline and differential.
DR   Genevisible; P56537; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030687; C:preribosome, large subunit precursor; IBA:GO_Central.
DR   GO; GO:0043023; F:ribosomal large subunit binding; IBA:GO_Central.
DR   GO; GO:0043022; F:ribosome binding; IDA:UniProtKB.
DR   GO; GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:1902626; P:assembly of large subunit precursor of preribosome; IBA:GO_Central.
DR   GO; GO:0035195; P:gene silencing by miRNA; IMP:UniProtKB.
DR   GO; GO:0000460; P:maturation of 5.8S rRNA; IBA:GO_Central.
DR   GO; GO:0000470; P:maturation of LSU-rRNA; IBA:GO_Central.
DR   GO; GO:0042256; P:mature ribosome assembly; IMP:UniProtKB.
DR   GO; GO:0035278; P:miRNA mediated inhibition of translation; IMP:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; ISS:UniProtKB.
DR   GO; GO:0042304; P:regulation of fatty acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0006110; P:regulation of glycolytic process; ISS:UniProtKB.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; ISS:UniProtKB.
DR   GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; ISS:UniProtKB.
DR   GO; GO:0032868; P:response to insulin; ISS:UniProtKB.
DR   GO; GO:0000054; P:ribosomal subunit export from nucleus; IBA:GO_Central.
DR   CDD; cd00527; IF6; 1.
DR   HAMAP; MF_00032; eIF_6; 1.
DR   InterPro; IPR002769; eIF6.
DR   PANTHER; PTHR10784; PTHR10784; 1.
DR   Pfam; PF01912; eIF-6; 1.
DR   PIRSF; PIRSF006413; IF-6; 1.
DR   SMART; SM00654; eIF6; 1.
DR   TIGRFAMs; TIGR00323; eIF-6; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm; Initiation factor;
KW   Nucleus; Phosphoprotein; Protein biosynthesis; Reference proteome;
KW   Ribosome biogenesis.
FT   CHAIN         1    245       Eukaryotic translation initiation factor
FT                                6.
FT                                /FTId=PRO_0000153734.
FT   MOD_RES     113    113       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES     165    165       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O55135,
FT                                ECO:0000255|HAMAP-Rule:MF_03132}.
FT   MOD_RES     166    166       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O55135,
FT                                ECO:0000255|HAMAP-Rule:MF_03132}.
FT   MOD_RES     174    174       Phosphoserine; by CK1.
FT                                {ECO:0000255|HAMAP-Rule:MF_03132,
FT                                ECO:0000269|PubMed:12917340,
FT                                ECO:0000269|PubMed:21084295}.
FT   MOD_RES     175    175       Phosphoserine; by CK1.
FT                                {ECO:0000255|HAMAP-Rule:MF_03132,
FT                                ECO:0000269|PubMed:12917340,
FT                                ECO:0000269|PubMed:21084295}.
FT   MOD_RES     235    235       Phosphoserine; by PKC.
FT                                {ECO:0000255|HAMAP-Rule:MF_03132,
FT                                ECO:0000269|PubMed:14654845}.
FT   MOD_RES     239    239       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     243    243       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ      36    123       SVFEGELSDTIPVVHASIAGCRIIGRMCVGNRHGLLVPNNT
FT                                TDQELQHIRNSLPDTVQIRRVEERLSALGNVTTCNDYVALV
FT                                HPDLDR -> RCGGSPGAYGGGEACAGVKSSGSGRVPAPLP
FT                                RHHRVHVPTVCSRASSPIPSPWCTRLSPAAASSGACVW
FT                                (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_046747.
FT   CONFLICT     35     36       Missing (in Ref. 3; AAK39426).
FT                                {ECO:0000305}.
SQ   SEQUENCE   245 AA;  26599 MW;  5BA97CD5DB0C17C3 CRC64;
     MAVRASFENN CEIGCFAKLT NTYCLVAIGG SENFYSVFEG ELSDTIPVVH ASIAGCRIIG
     RMCVGNRHGL LVPNNTTDQE LQHIRNSLPD TVQIRRVEER LSALGNVTTC NDYVALVHPD
     LDRETEEILA DVLKVEVFRQ TVADQVLVGS YCVFSNQGGL VHPKTSIEDQ DELSSLLQVP
     LVAGTVNRGS EVIAAGMVVN DWCAFCGLDT TSTELSVVES VFKLNEAQPS TIATSMRDSL
     IDSLT
//
ID   HSP7C_HUMAN             Reviewed;         646 AA.
AC   P11142; Q9H3R6;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   23-MAY-2018, entry version 222.
DE   RecName: Full=Heat shock cognate 71 kDa protein;
DE   AltName: Full=Heat shock 70 kDa protein 8;
DE   AltName: Full=Lipopolysaccharide-associated protein 1;
DE            Short=LAP-1;
DE            Short=LPS-associated protein 1;
GN   Name=HSPA8; Synonyms=HSC70, HSP73, HSPA10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=3037489; DOI=10.1093/nar/15.13.5181;
RA   Dworniczak B.P., Mirault M.-E.;
RT   "Structure and expression of a human gene coding for a 71 kd heat
RT   shock 'cognate' protein.";
RL   Nucleic Acids Res. 15:5181-5197(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=11093761;
RA   Tsukahara F., Yoshioka T., Muraki T.;
RT   "Molecular and functional characterization of HSC54, a novel variant
RT   of human heat shock cognate protein 70.";
RL   Mol. Pharmacol. 58:1257-1263(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Niswonger M.L., Berk L.R., Srivastava P.K.;
RT   "Complete coding sequence of human HSC70.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-49; 57-71; 77-102; 103-155; 160-188; 221-247;
RP   273-311; 326-342; 349-416; 424-447; 452-493; 510-517; 540-550; 570-597
RP   AND 602-646, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [6]
RP   PROTEIN SEQUENCE OF 2-49; 57-72; 78-88; 113-188; 221-247; 300-319;
RP   326-342; 349-357; 362-384; 424-447; 452-469; 510-517; 540-550 AND
RP   584-609, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.,
RA   Bilsland A.E., Keith W.N.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 4-49; 57-71; 77-88; 113-126; 129-155; 160-187;
RP   221-246; 300-311; 329-342; 362-384; 424-447; 540-550 AND 574-583, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 50-55; 103-107 AND 580-596.
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [9]
RP   PROTEIN SEQUENCE OF 77-86; 221-236 AND 302-311.
RX   PubMed=8713105; DOI=10.1006/bbrc.1996.1082;
RA   Egerton M., Moritz R.L., Druker B., Kelso A., Simpson R.J.;
RT   "Identification of the 70kD heat shock cognate protein (Hsc70) and
RT   alpha-actinin-1 as novel phosphotyrosine-containing proteins in T
RT   lymphocytes.";
RL   Biochem. Biophys. Res. Commun. 224:666-674(1996).
RN   [10]
RP   PROTEIN SEQUENCE OF 551-567, METHYLATION AT LYS-561, MUTAGENESIS OF
RP   LYS-561, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine
RT   methyltransferases preferentially interact with molecular chaperones
RT   to regulate their activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=1586970;
RA   Hattori H., Liu Y.-C., Tohnai I., Ueda M., Kaneda T., Kobayashi T.,
RA   Tanabe K., Ohtsuka K.;
RT   "Intracellular localization and partial amino acid sequence of a
RT   stress-inducible 40-kDa protein in HeLa cells.";
RL   Cell Struct. Funct. 17:77-86(1992).
RN   [12]
RP   INTERACTION WITH BAG1, AND DOMAIN.
RX   PubMed=9305631; DOI=10.1093/emboj/16.16.4887;
RA   Takayama S., Bimston D.N., Matsuzawa S.-I., Freeman B.C.,
RA   Aime-Sempe C., Xie Z., Morimoto R.I., Reed J.C.;
RT   "BAG-1 modulates the chaperone activity of Hsp70/Hsc70.";
RL   EMBO J. 16:4887-4896(1997).
RN   [13]
RP   INTERACTION WITH BAG1.
RX   PubMed=9679980;
RA   Takayama S., Krajewski S., Krajewska M., Kitada S., Zapata J.M.,
RA   Kochel K., Knee D., Scudiero D., Tudor G., Miller G.J., Miyashita T.,
RA   Yamada M., Reed J.C.;
RT   "Expression and location of Hsp70/Hsc-binding anti-apoptotic protein
RT   BAG-1 and its variants in normal tissues and tumor cell lines.";
RL   Cancer Res. 58:3116-3131(1998).
RN   [14]
RP   INTERACTION WITH HSF1.
RX   PubMed=9499401; DOI=10.1101/gad.12.5.654;
RA   Shi Y., Mosser D.D., Morimoto R.I.;
RT   "Molecular chaperones as HSF1-specific transcriptional repressors.";
RL   Genes Dev. 12:654-666(1998).
RN   [15]
RP   INTERACTION WITH SV40 VP1.
RX   PubMed=11147964; DOI=10.1379/1466-1268(2000)005<0132:HIWSVP>2.0.CO;2;
RA   Sainis L., Angelidis C., Pagoulatos G.N., Lazaridis L.;
RT   "HSC70 interactions with SV40 viral proteins differ between permissive
RT   and nonpermissive mammalian cells.";
RL   Cell Stress Chaperones 5:132-138(2000).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH CITED1.
RX   PubMed=10722728; DOI=10.1074/jbc.275.12.8825;
RA   Yahata T., de Caestecker M.P., Lechleider R.J., Andriole S.,
RA   Roberts A.B., Isselbacher K.J., Shioda T.;
RT   "The MSG1 non-DNA-binding transactivator binds to the p300/CBP
RT   coactivators, enhancing their functional link to the Smad
RT   transcription factors.";
RL   J. Biol. Chem. 275:8825-8834(2000).
RN   [17]
RP   FUNCTION, IDENTIFICATION AS LPS RECEPTOR, INTERACTION WITH CXCR4; GDF5
RP   AND HSP90AA1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11276205; DOI=10.1038/86342;
RA   Triantafilou K., Triantafilou M., Dedrick R.L.;
RT   "A CD14-independent LPS receptor cluster.";
RL   Nat. Immunol. 2:338-345(2001).
RN   [18]
RP   INTERACTION WITH PACRG.
RX   PubMed=14532270; DOI=10.1074/jbc.M309655200;
RA   Imai Y., Soda M., Murakami T., Shoji M., Abe K., Takahashi R.;
RT   "A product of the human gene adjacent to parkin is a component of Lewy
RT   bodies and suppresses Pael receptor-induced cell death.";
RL   J. Biol. Chem. 278:51901-51910(2003).
RN   [19]
RP   INTERACTION WITH TTC1.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [20]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [21]
RP   INTERACTION WITH TSC2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15963462; DOI=10.1016/j.bbrc.2005.05.175;
RA   Nellist M., Burgers P.C., van den Ouweland A.M.W., Halley D.J.J.,
RA   Luider T.M.;
RT   "Phosphorylation and binding partner analysis of the TSC1-TSC2
RT   complex.";
RL   Biochem. Biophys. Res. Commun. 333:818-826(2005).
RN   [22]
RP   INTERACTION WITH DNAJB2.
RX   PubMed=15936278; DOI=10.1016/j.cub.2005.04.058;
RA   Westhoff B., Chapple J.P., van der Spuy J., Hoehfeld J.,
RA   Cheetham M.E.;
RT   "HSJ1 is a neuronal shuttling factor for the sorting of chaperone
RT   clients to the proteasome.";
RL   Curr. Biol. 15:1058-1064(2005).
RN   [23]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [24]
RP   INTERACTION WITH HERC5, AND ISGYLATION.
RX   PubMed=16815975; DOI=10.1073/pnas.0600397103;
RA   Wong J.J., Pung Y.F., Sze N.S., Chin K.C.;
RT   "HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates
RT   type I IFN-induced ISGylation of protein targets.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:10735-10740(2006).
RN   [25]
RP   INTERACTION WITH DNAJC9.
RX   PubMed=17182002; DOI=10.1016/j.bbrc.2006.12.013;
RA   Han C., Chen T., Li N., Yang M., Wan T., Cao X.;
RT   "HDJC9, a novel human type C DnaJ/HSP40 member interacts with and
RT   cochaperones HSP70 through the J domain.";
RL   Biochem. Biophys. Res. Commun. 353:280-285(2007).
RN   [26]
RP   IDENTIFICATION IN A MRNP GRANULE COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.M600346-MCP200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [29]
RP   IDENTIFICATION IN A COMPLEX WITH HCFC1; MKI67; EMSY; MATR3; ZNF335;
RP   TUBB2A; CCAR2; ASCL2; RBBP5 AND WDR5.
RX   PubMed=19131338; DOI=10.1074/jbc.M805872200;
RA   Garapaty S., Xu C.F., Trojer P., Mahajan M.A., Neubert T.A.,
RA   Samuels H.H.;
RT   "Identification and characterization of a novel nuclear protein
RT   complex involved in nuclear hormone receptor-mediated gene
RT   regulation.";
RL   J. Biol. Chem. 284:7542-7552(2009).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-246; LYS-319; LYS-589;
RP   LYS-597 AND LYS-601, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [32]
RP   INTERACTION WITH DNAJB12.
RX   PubMed=21150129; DOI=10.1247/csf.10023;
RA   Yamamoto Y.H., Kimura T., Momohara S., Takeuchi M., Tani T.,
RA   Kimata Y., Kadokura H., Kohno K.;
RT   "A novel ER J-protein DNAJB12 accelerates ER-associated degradation of
RT   membrane proteins including CFTR.";
RL   Cell Struct. Funct. 35:107-116(2010).
RN   [33]
RP   INTERACTION WITH TRIM5.
RX   PubMed=20053985; DOI=10.1074/jbc.M109.040618;
RA   Hwang C.Y., Holl J., Rajan D., Lee Y., Kim S., Um M., Kwon K.S.,
RA   Song B.;
RT   "Hsp70 interacts with the retroviral restriction factor TRIM5alpha and
RT   assists the folding of TRIM5alpha.";
RL   J. Biol. Chem. 285:7827-7837(2010).
RN   [34]
RP   IDENTIFICATION AS A COMPONENT OF THE PRP19-CDC5L COMPLEX, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=20176811; DOI=10.1128/MCB.01505-09;
RA   Grote M., Wolf E., Will C.L., Lemm I., Agafonov D.E., Schomburg A.,
RA   Fischle W., Urlaub H., Luhrmann R.;
RT   "Molecular architecture of the human Prp19/CDC5L complex.";
RL   Mol. Cell. Biol. 30:2105-2119(2010).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [37]
RP   INTERACTION WITH DNAJB12.
RX   PubMed=21148293; DOI=10.1091/mbc.E10-09-0760;
RA   Grove D.E., Fan C.Y., Ren H.Y., Cyr D.M.;
RT   "The endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70
RT   cooperate to facilitate RMA1 E3-dependent degradation of nascent
RT   CFTRDeltaF508.";
RL   Mol. Biol. Cell 22:301-314(2011).
RN   [38]
RP   INTERACTION WITH DNAJB14.
RX   PubMed=23018488; DOI=10.1247/csf.12017;
RA   Sopha P., Kadokura H., Yamamoto Y.H., Takeuchi M., Saito M., Tsuru A.,
RA   Kohno K.;
RT   "A novel mammalian ER-located J-protein, DNAJB14, can accelerate ERAD
RT   of misfolded membrane proteins.";
RL   Cell Struct. Funct. 37:177-187(2012).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [40]
RP   REVIEW.
RX   PubMed=24121476; DOI=10.4161/auto.26448;
RA   Stricher F., Macri C., Ruff M., Muller S.;
RT   "HSPA8/HSC70 chaperone protein: structure, function, and chemical
RT   targeting.";
RL   Autophagy 9:1937-1954(2013).
RN   [41]
RP   SUBUNIT, AND INTERACTION WITH STUB1.
RX   PubMed=23865999; DOI=10.1021/bi4009209;
RA   Smith M.C., Scaglione K.M., Assimon V.A., Patury S., Thompson A.D.,
RA   Dickey C.A., Southworth D.R., Paulson H.L., Gestwicki J.E.,
RA   Zuiderweg E.R.;
RT   "The E3 ubiquitin ligase CHIP and the molecular chaperone Hsc70 form a
RT   dynamic, tethered complex.";
RL   Biochemistry 52:5354-5364(2013).
RN   [42]
RP   INTERACTION WITH FOXP3.
RX   PubMed=23973223; DOI=10.1016/j.immuni.2013.08.006;
RA   Chen Z., Barbi J., Bu S., Yang H.Y., Li Z., Gao Y., Jinasena D.,
RA   Fu J., Lin F., Chen C., Zhang J., Yu N., Li X., Shan Z., Nie J.,
RA   Gao Z., Tian H., Li Y., Yao Z., Zheng Y., Park B.V., Pan Z., Zhang J.,
RA   Dang E., Li Z., Wang H., Luo W., Li L., Semenza G.L., Zheng S.G.,
RA   Loser K., Tsun A., Greene M.I., Pardoll D.M., Pan F., Li B.;
RT   "The ubiquitin ligase Stub1 negatively modulates regulatory T cell
RT   suppressive activity by promoting degradation of the transcription
RT   factor Foxp3.";
RL   Immunity 39:272-285(2013).
RN   [43]
RP   METHYLATION AT LYS-561, MUTAGENESIS OF LYS-561, AND INTERACTION WITH
RP   METTL21A.
RX   PubMed=23921388; DOI=10.1074/jbc.M113.483248;
RA   Jakobsson M.E., Moen A., Bousset L., Egge-Jacobsen W., Kernstock S.,
RA   Melki R., Falnes P.O.;
RT   "Identification and characterization of a novel human
RT   methyltransferase modulating Hsp70 function through lysine
RT   methylation.";
RL   J. Biol. Chem. 288:27752-27763(2013).
RN   [44]
RP   FUNCTION IN ERAD, AND INTERACTION WITH STUB1.
RX   PubMed=23990462; DOI=10.1074/jbc.M113.479345;
RA   Matsumura Y., Sakai J., Skach W.R.;
RT   "Endoplasmic reticulum protein quality control is determined by
RT   cooperative interactions between Hsp/c70 protein and the CHIP E3
RT   ligase.";
RL   J. Biol. Chem. 288:31069-31079(2013).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329 AND SER-541, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [46]
RP   INTERACTION WITH PRKN.
RX   PubMed=24270810; DOI=10.1038/nature12748;
RA   Hasson S.A., Kane L.A., Yamano K., Huang C.H., Sliter D.A.,
RA   Buehler E., Wang C., Heman-Ackah S.M., Hessa T., Guha R., Martin S.E.,
RA   Youle R.J.;
RT   "High-content genome-wide RNAi screens identify regulators of parkin
RT   upstream of mitophagy.";
RL   Nature 504:291-295(2013).
RN   [47]
RP   INTERACTION WITH DNAJC12.
RX   PubMed=24122553; DOI=10.1007/s12192-013-0471-6;
RA   Choi J., Djebbar S., Fournier A., Labrie C.;
RT   "The co-chaperone DNAJC12 binds to Hsc70 and is upregulated by
RT   endoplasmic reticulum stress.";
RL   Cell Stress Chaperones 19:439-446(2014).
RN   [48]
RP   INTERACTION WITH MLLT11.
RX   PubMed=24880125; DOI=10.1016/j.yexcr.2014.05.013;
RA   Li P., Ji M., Lu F., Zhang J., Li H., Cui T., Li Wang X., Tang D.,
RA   Ji C.;
RT   "Degradation of AF1Q by chaperone-mediated autophagy.";
RL   Exp. Cell Res. 327:48-56(2014).
RN   [49]
RP   FUNCTION, AND INTERACTION WITH BAG1; BAG2; BAG3 AND HSPH1.
RX   PubMed=24318877; DOI=10.1074/jbc.M113.521997;
RA   Rauch J.N., Gestwicki J.E.;
RT   "Binding of human nucleotide exchange factors to heat shock protein 70
RT   (Hsp70) generates functionally distinct complexes in vitro.";
RL   J. Biol. Chem. 289:1402-1414(2014).
RN   [50]
RP   INTERACTION WITH RNF207.
RX   PubMed=25281747; DOI=10.1074/jbc.M114.592295;
RA   Roder K., Werdich A.A., Li W., Liu M., Kim T.Y., Organ-Darling L.E.,
RA   Moshal K.S., Hwang J.M., Lu Y., Choi B.R., MacRae C.A., Koren G.;
RT   "RING finger protein RNF207, a novel regulator of cardiac
RT   excitation.";
RL   J. Biol. Chem. 289:33730-33740(2014).
RN   [51]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [52]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-469 AND LYS-561, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [53]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-512, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [54]
RP   INTERACTION WITH DNAJB12 AND DNAJB14.
RX   PubMed=24732912; DOI=10.1371/journal.pone.0094322;
RA   Goodwin E.C., Motamedi N., Lipovsky A., Fernandez-Busnadiego R.,
RA   DiMaio D.;
RT   "Expression of DNAJB12 or DNAJB14 causes coordinate invasion of the
RT   nucleus by membranes associated with a novel nuclear pore structure.";
RL   PLoS ONE 9:E94322-E94322(2014).
RN   [55]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-512, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [56]
RP   INTERACTION WITH HSPA8.
RX   PubMed=25760597; DOI=10.1107/S1399004714026881;
RA   Song J., Kose S., Watanabe A., Son S.Y., Choi S., Hong H.,
RA   Yamashita E., Park I.Y., Imamoto N., Lee S.J.;
RT   "Structural and functional analysis of Hikeshi, a new nuclear
RT   transport receptor of Hsp70s.";
RL   Acta Crystallogr. D 71:473-483(2015).
RN   [57]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [58]
RP   INTERACTION WITH DNAJC21.
RX   PubMed=27346687; DOI=10.1016/j.ajhg.2016.05.002;
RA   Tummala H., Walne A.J., Williams M., Bockett N., Collopy L.,
RA   Cardoso S., Ellison A., Wynn R., Leblanc T., Fitzgibbon J.,
RA   Kelsell D.P., van Heel D.A., Payne E., Plagnol V., Dokal I.,
RA   Vulliamy T.;
RT   "DNAJC21 mutations link a cancer-prone bone marrow failure syndrome to
RT   corruption in 60S ribosome subunit maturation.";
RL   Am. J. Hum. Genet. 99:115-124(2016).
RN   [59]
RP   REVIEW.
RX   PubMed=26865365; DOI=10.1007/s12192-016-0676-6;
RA   Radons J.;
RT   "The human HSP70 family of chaperones: where do we stand?";
RL   Cell Stress Chaperones 21:379-404(2016).
RN   [60]
RP   FUNCTION, INTERACTION WITH BAG1 AND BAG3, REGION NBD, AND REGION SBD.
RX   PubMed=27474739; DOI=10.1074/jbc.M116.742502;
RA   Rauch J.N., Zuiderweg E.R., Gestwicki J.E.;
RT   "Non-canonical interactions between heat shock cognate protein 70
RT   (Hsc70) and Bcl2-associated anthanogene (BAG) co-chaperones are
RT   important for client release.";
RL   J. Biol. Chem. 291:19848-19857(2016).
RN   [61]
RP   INTERACTION WITH HOPX; STUB1; HSP40 AND HSP90.
RX   PubMed=27708256; DOI=10.1038/ncomms12882;
RA   Seo J.H., Park J.H., Lee E.J., Vo T.T., Choi H., Kim J.Y., Jang J.K.,
RA   Wee H.J., Lee H.S., Jang S.H., Park Z.Y., Jeong J., Lee K.J.,
RA   Seok S.H., Park J.Y., Lee B.J., Lee M.N., Oh G.T., Kim K.W.;
RT   "ARD1-mediated Hsp70 acetylation balances stress-induced protein
RT   refolding and degradation.";
RL   Nat. Commun. 7:12882-12882(2016).
RN   [62]
RP   INTERACTION WITH DNAJB12 AND DNAJB14.
RX   PubMed=27916661; DOI=10.1016/j.molcel.2016.10.027;
RA   Li K., Jiang Q., Bai X., Yang Y.F., Ruan M.Y., Cai S.Q.;
RT   "Tetrameric assembly of K(+) channels requires ER-located chaperone
RT   proteins.";
RL   Mol. Cell 65:52-65(2017).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 1-634.
RX   PubMed=19586912; DOI=10.1074/jbc.M109.033894;
RA   Kajander T., Sachs J.N., Goldman A., Regan L.;
RT   "Electrostatic interactions of Hsp-organizing protein
RT   tetratricopeptide domains with Hsp70 and Hsp90: computational analysis
RT   and protein engineering.";
RL   J. Biol. Chem. 284:25364-25374(2009).
RN   [64]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 4-381 IN COMPLEXES WITH ATP
RP   AND ATP ANALOGS.
RX   PubMed=19256508; DOI=10.1021/jm801627a;
RA   Williamson D.S., Borgognoni J., Clay A., Daniels Z., Dokurno P.,
RA   Drysdale M.J., Foloppe N., Francis G.L., Graham C.J., Howes R.,
RA   Macias A.T., Murray J.B., Parsons R., Shaw T., Surgenor A.E.,
RA   Terry L., Wang Y., Wood M., Massey A.J.;
RT   "Novel adenosine-derived inhibitors of 70 kDa heat shock protein,
RT   discovered through structure-based design.";
RL   J. Med. Chem. 52:1510-1513(2009).
RN   [65]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 4-381 IN COMPLEXES WITH ATP
RP   ANALOGS.
RX   PubMed=21526763; DOI=10.1021/jm101625x;
RA   Macias A.T., Williamson D.S., Allen N., Borgognoni J., Clay A.,
RA   Daniels Z., Dokurno P., Drysdale M.J., Francis G.L., Graham C.J.,
RA   Howes R., Matassova N., Murray J.B., Parsons R., Shaw T.,
RA   Surgenor A.E., Terry L., Wang Y., Wood M., Massey A.J.;
RT   "Adenosine-derived inhibitors of 78 kDa glucose regulated protein
RT   (Grp78) ATPase: insights into isoform selectivity.";
RL   J. Med. Chem. 54:4034-4041(2011).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of
CC       cellular processes, including protection of the proteome from
CC       stress, folding and transport of newly synthesized polypeptides,
CC       activation of proteolysis of misfolded proteins and the formation
CC       and dissociation of protein complexes. Plays a pivotal role in the
CC       protein quality control system, ensuring the correct folding of
CC       proteins, the re-folding of misfolded proteins and controlling the
CC       targeting of proteins for subsequent degradation (PubMed:21150129,
CC       PubMed:21148293, PubMed:24732912, PubMed:27916661,
CC       PubMed:23018488). This is achieved through cycles of ATP binding,
CC       ATP hydrolysis and ADP release, mediated by co-chaperones
CC       (PubMed:21150129, PubMed:21148293, PubMed:24732912,
CC       PubMed:27916661, PubMed:23018488). The co-chaperones have been
CC       shown to not only regulate different steps of the ATPase cycle of
CC       HSP70, but they also have an individual specificity such that one
CC       co-chaperone may promote folding of a substrate while another may
CC       promote degradation (PubMed:21150129, PubMed:21148293,
CC       PubMed:24732912, PubMed:27916661, PubMed:23018488). The affinity
CC       of HSP70 for polypeptides is regulated by its nucleotide bound
CC       state. In the ATP-bound form, it has a low affinity for substrate
CC       proteins. However, upon hydrolysis of the ATP to ADP, it undergoes
CC       a conformational change that increases its affinity for substrate
CC       proteins. HSP70 goes through repeated cycles of ATP hydrolysis and
CC       nucleotide exchange, which permits cycles of substrate binding and
CC       release. The HSP70-associated co-chaperones are of three types: J-
CC       domain co-chaperones HSP40s (stimulate ATPase hydrolysis by
CC       HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3
CC       (facilitate conversion of HSP70 from the ADP-bound to the ATP-
CC       bound state thereby promoting substrate release), and the TPR
CC       domain chaperones such as HOPX and STUB1 (PubMed:24318877,
CC       PubMed:27474739, PubMed:24121476, PubMed:26865365). Acts as a
CC       repressor of transcriptional activation. Inhibits the
CC       transcriptional coactivator activity of CITED1 on Smad-mediated
CC       transcription. Component of the PRP19-CDC5L complex that forms an
CC       integral part of the spliceosome and is required for activating
CC       pre-mRNA splicing. May have a scaffolding role in the spliceosome
CC       assembly as it contacts all other components of the core complex.
CC       Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced
CC       inflammatory response, including TNF secretion by monocytes
CC       (PubMed:10722728, PubMed:11276205). Participates in the ER-
CC       associated degradation (ERAD) quality control pathway in
CC       conjunction with J domain-containing co-chaperones and the E3
CC       ligase STUB1 (PubMed:23990462). {ECO:0000269|PubMed:10722728,
CC       ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:21148293,
CC       ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488,
CC       ECO:0000269|PubMed:23990462, ECO:0000269|PubMed:24318877,
CC       ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27474739,
CC       ECO:0000269|PubMed:27916661, ECO:0000303|PubMed:24121476,
CC       ECO:0000303|PubMed:26865365}.
CC   -!- SUBUNIT: Identified in a IGF2BP1-dependent mRNP granule complex
CC       containing untranslated mRNAs. Interacts with PACRG. Interacts
CC       with HSPH1/HSP105. Interacts with IRAK1BP1 and BAG1. Interacts
CC       with DNAJC7. Interacts with DNAJB12 (via J domain)
CC       (PubMed:21150129, PubMed:21148293, PubMed:24732912,
CC       PubMed:27916661). Interacts with DNAJB14 (via J domain)
CC       (PubMed:23018488, PubMed:24732912, PubMed:27916661). Interacts
CC       (via C-terminus) with the E3 ligase CHIP forming a 210 kDa complex
CC       of one CHIP and two HSPA8 molecules. Interacts with CITED1 (via N-
CC       terminus); the interaction suppresses the association of CITED1 to
CC       p300/CBP and Smad-mediated transcription transactivation.
CC       Component of the PRP19-CDC5L splicing complex composed of a core
CC       complex comprising a homotetramer of PRPF19, CDC5L, PLRG1 and
CC       BCAS2, and at least three less stably associated proteins CTNNBL1,
CC       CWC15 and HSPA8. Interacts with SV40 VP1. Interacts with TRIM5.
CC       Part of a complex composed at least of ASCL2, EMSY, HCFC1, HSPA8,
CC       CCAR2, MATR3, MKI67, RBBP5, TUBB2A, WDR5 and ZNF335; this complex
CC       may have a histone H3-specific methyltransferase activity.
CC       Interacts with METTL21A. Following LPS binding, may form a complex
CC       with CXCR4, GDF5 and HSP90AA1. Interacts with PRKN. Interacts with
CC       FOXP3. Interacts with DNAJC9 (via J domain) (PubMed:17182002).
CC       Interacts with MLLT11 (PubMed:24880125). Interacts with RNF207
CC       (PubMed:25281747). Interacts with DNAJC21 (PubMed:27346687).
CC       Interacts with DNAJB2 (PubMed:15936278). Interacts with TTC1 (via
CC       TPR repeats) (PubMed:15708368). Interacts with SGTA (via TPR
CC       repeats) (By similarity). Interacts with HSF1 (via transactivation
CC       domain) (PubMed:9499401). Interacts with HOPX, HSP40 and HSP90
CC       (PubMed:27708256). Interacts with STUB1 (PubMed:27708256).
CC       Interacts with BAG2 (PubMed:24318877). Interacts with BAG3
CC       (PubMed:27474739, PubMed:24318877). Interacts with DNAJC12
CC       (PubMed:24122553). Interacts with HSPC138 (PubMed:25760597).
CC       {ECO:0000250|UniProtKB:P63018, ECO:0000269|PubMed:10722728,
CC       ECO:0000269|PubMed:11147964, ECO:0000269|PubMed:11276205,
CC       ECO:0000269|PubMed:14532270, ECO:0000269|PubMed:15708368,
CC       ECO:0000269|PubMed:15936278, ECO:0000269|PubMed:15963462,
CC       ECO:0000269|PubMed:16815975, ECO:0000269|PubMed:17182002,
CC       ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:19131338,
CC       ECO:0000269|PubMed:20053985, ECO:0000269|PubMed:21148293,
CC       ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488,
CC       ECO:0000269|PubMed:23865999, ECO:0000269|PubMed:23921388,
CC       ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:23990462,
CC       ECO:0000269|PubMed:24122553, ECO:0000269|PubMed:24270810,
CC       ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24732912,
CC       ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:25281747,
CC       ECO:0000269|PubMed:25760597, ECO:0000269|PubMed:27346687,
CC       ECO:0000269|PubMed:27474739, ECO:0000269|PubMed:27708256,
CC       ECO:0000269|PubMed:27916661, ECO:0000269|PubMed:9305631,
CC       ECO:0000269|PubMed:9499401, ECO:0000269|PubMed:9679980}.
CC   -!- INTERACTION:
CC       Q99IB8:- (xeno); NbExp=3; IntAct=EBI-351896, EBI-6927928;
CC       P60709:ACTB; NbExp=2; IntAct=EBI-351896, EBI-353944;
CC       Q9GZX7:AICDA; NbExp=2; IntAct=EBI-351896, EBI-3834328;
CC       P49407:ARRB1; NbExp=4; IntAct=EBI-351896, EBI-743313;
CC       P32121:ARRB2; NbExp=4; IntAct=EBI-351896, EBI-714559;
CC       Q9NQ11:ATP13A2; NbExp=2; IntAct=EBI-351896, EBI-6308763;
CC       Q99933:BAG1; NbExp=13; IntAct=EBI-351896, EBI-1030678;
CC       O95816:BAG2; NbExp=7; IntAct=EBI-351896, EBI-355275;
CC       O95429:BAG4; NbExp=3; IntAct=EBI-351896, EBI-2949658;
CC       Q8AZK7:EBNA-LP (xeno); NbExp=3; IntAct=EBI-351896, EBI-1185167;
CC       P00533:EGFR; NbExp=5; IntAct=EBI-351896, EBI-297353;
CC       O14976:GAK; NbExp=6; IntAct=EBI-351896, EBI-714707;
CC       P34932:HSPA4; NbExp=5; IntAct=EBI-351896, EBI-356933;
CC       Q9NZL4:HSPBP1; NbExp=11; IntAct=EBI-351896, EBI-356763;
CC       P05412:JUN; NbExp=3; IntAct=EBI-351896, EBI-852823;
CC       P00338:LDHA; NbExp=4; IntAct=EBI-351896, EBI-372327;
CC       Q5S007:LRRK2; NbExp=5; IntAct=EBI-351896, EBI-5323863;
CC       P03485:M (xeno); NbExp=4; IntAct=EBI-351896, EBI-2547543;
CC       P14598:NCF1; NbExp=2; IntAct=EBI-351896, EBI-395044;
CC       Q9UNE7:STUB1; NbExp=8; IntAct=EBI-351896, EBI-357085;
CC       Q9UNE7-1:STUB1; NbExp=4; IntAct=EBI-351908, EBI-15687717;
CC       P61764:STXBP1; NbExp=2; IntAct=EBI-351896, EBI-960169;
CC       O00635:TRIM38; NbExp=5; IntAct=EBI-351896, EBI-2130415;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Melanosome. Nucleus, nucleolus.
CC       Cell membrane. Note=Localized in cytoplasmic mRNP granules
CC       containing untranslated mRNAs. Translocates rapidly from the
CC       cytoplasm to the nuclei, and especially to the nucleoli, upon heat
CC       shock.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11142-1; Sequence=Displayed;
CC       Name=2; Synonyms=HSC54;
CC         IsoId=P11142-2; Sequence=VSP_002427;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11276205}.
CC   -!- INDUCTION: Constitutively synthesized.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known
CC       as the ATPase domain) is responsible for binding and hydrolyzing
CC       ATP. The C-terminal substrate-binding domain (SBD) (also known as
CC       peptide-binding domain) binds to the client/substrate proteins.
CC       The two domains are allosterically coupled so that, when ATP is
CC       bound to the NBD, the SBD binds relatively weakly to clients. When
CC       ADP is bound in the NBD, a conformational change enhances the
CC       affinity of the SBD for client proteins.
CC       {ECO:0000269|PubMed:9305631}.
CC   -!- PTM: Acetylated. {ECO:0000269|Ref.5, ECO:0000269|Ref.6}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798,
CC       ECO:0000269|PubMed:16815975}.
CC   -!- PTM: Trimethylation at Lys-561 reduces fibrillar SNCA binding.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00371; CAA68445.1; -; Genomic_DNA.
DR   EMBL; AB034951; BAB18615.1; -; mRNA.
DR   EMBL; AF352832; AAK17898.1; -; mRNA.
DR   EMBL; BC016179; AAH16179.1; -; mRNA.
DR   EMBL; BC016660; AAH16660.1; -; mRNA.
DR   EMBL; BC019816; AAH19816.1; -; mRNA.
DR   CCDS; CCDS44754.1; -. [P11142-2]
DR   CCDS; CCDS8440.1; -. [P11142-1]
DR   PIR; A27077; A27077.
DR   RefSeq; NP_006588.1; NM_006597.5. [P11142-1]
DR   RefSeq; NP_694881.1; NM_153201.3. [P11142-2]
DR   RefSeq; XP_011541100.1; XM_011542798.1. [P11142-1]
DR   UniGene; Hs.180414; -.
DR   PDB; 3AGY; X-ray; 1.85 A; C/D/F=639-646.
DR   PDB; 3AGZ; X-ray; 2.51 A; C/D/E/F=639-646.
DR   PDB; 3ESK; X-ray; 2.05 A; B=635-646.
DR   PDB; 3FZF; X-ray; 2.20 A; A=4-381.
DR   PDB; 3FZH; X-ray; 2.00 A; A=4-381.
DR   PDB; 3FZK; X-ray; 2.10 A; A=4-381.
DR   PDB; 3FZL; X-ray; 2.20 A; A=4-381.
DR   PDB; 3FZM; X-ray; 2.30 A; A=4-381.
DR   PDB; 3LDQ; X-ray; 1.90 A; A=4-381.
DR   PDB; 3M3Z; X-ray; 2.10 A; A=4-381.
DR   PDB; 4H5N; X-ray; 1.86 A; A/B=2-384.
DR   PDB; 4H5R; X-ray; 1.64 A; A/B=2-384.
DR   PDB; 4H5T; X-ray; 1.90 A; A=2-384.
DR   PDB; 4H5V; X-ray; 1.75 A; A=2-384.
DR   PDB; 4H5W; X-ray; 1.94 A; A/B=2-384.
DR   PDB; 4HWI; X-ray; 2.27 A; A=5-381.
DR   PDB; 4KBQ; X-ray; 2.91 A; C/D=541-646.
DR   PDB; 5AQF; X-ray; 1.88 A; A/C=1-381.
DR   PDB; 5AQG; X-ray; 2.24 A; A/C/E=1-381.
DR   PDB; 5AQH; X-ray; 2.00 A; A=1-381.
DR   PDB; 5AQI; X-ray; 1.98 A; A/C=1-381.
DR   PDB; 5AQJ; X-ray; 1.96 A; A/C/E=1-381.
DR   PDB; 5AQK; X-ray; 2.09 A; A=1-381.
DR   PDB; 5AQL; X-ray; 1.69 A; A/C=1-381.
DR   PDB; 5AQM; X-ray; 1.63 A; A/C=1-381.
DR   PDB; 5AQN; X-ray; 2.45 A; A/C/E=1-381.
DR   PDB; 5AQO; X-ray; 2.12 A; A/C/E=1-381.
DR   PDB; 5AQP; X-ray; 2.08 A; A/C/E=1-381.
DR   PDB; 5AQQ; X-ray; 2.72 A; A/C/E=1-381.
DR   PDB; 5AQR; X-ray; 1.91 A; A/C/E=1-381.
DR   PDB; 5AQS; X-ray; 2.00 A; A/C=1-381.
DR   PDB; 5AQT; X-ray; 1.90 A; A=1-381.
DR   PDB; 5AQU; X-ray; 1.92 A; A=1-381.
DR   PDB; 5AQV; X-ray; 1.75 A; A=1-381.
DR   PDB; 6B1I; X-ray; 2.30 A; A/B=5-381.
DR   PDB; 6B1M; X-ray; 1.90 A; A/B=5-381.
DR   PDB; 6B1N; X-ray; 1.80 A; A/B=5-381.
DR   PDBsum; 3AGY; -.
DR   PDBsum; 3AGZ; -.
DR   PDBsum; 3ESK; -.
DR   PDBsum; 3FZF; -.
DR   PDBsum; 3FZH; -.
DR   PDBsum; 3FZK; -.
DR   PDBsum; 3FZL; -.
DR   PDBsum; 3FZM; -.
DR   PDBsum; 3LDQ; -.
DR   PDBsum; 3M3Z; -.
DR   PDBsum; 4H5N; -.
DR   PDBsum; 4H5R; -.
DR   PDBsum; 4H5T; -.
DR   PDBsum; 4H5V; -.
DR   PDBsum; 4H5W; -.
DR   PDBsum; 4HWI; -.
DR   PDBsum; 4KBQ; -.
DR   PDBsum; 5AQF; -.
DR   PDBsum; 5AQG; -.
DR   PDBsum; 5AQH; -.
DR   PDBsum; 5AQI; -.
DR   PDBsum; 5AQJ; -.
DR   PDBsum; 5AQK; -.
DR   PDBsum; 5AQL; -.
DR   PDBsum; 5AQM; -.
DR   PDBsum; 5AQN; -.
DR   PDBsum; 5AQO; -.
DR   PDBsum; 5AQP; -.
DR   PDBsum; 5AQQ; -.
DR   PDBsum; 5AQR; -.
DR   PDBsum; 5AQS; -.
DR   PDBsum; 5AQT; -.
DR   PDBsum; 5AQU; -.
DR   PDBsum; 5AQV; -.
DR   PDBsum; 6B1I; -.
DR   PDBsum; 6B1M; -.
DR   PDBsum; 6B1N; -.
DR   ProteinModelPortal; P11142; -.
DR   SMR; P11142; -.
DR   BioGrid; 109544; 573.
DR   CORUM; P11142; -.
DR   DIP; DIP-32874N; -.
DR   IntAct; P11142; 216.
DR   MINT; P11142; -.
DR   STRING; 9606.ENSP00000227378; -.
DR   BindingDB; P11142; -.
DR   ChEMBL; CHEMBL1275223; -.
DR   iPTMnet; P11142; -.
DR   PhosphoSitePlus; P11142; -.
DR   SwissPalm; P11142; -.
DR   DMDM; 123648; -.
DR   DOSAC-COBS-2DPAGE; P11142; -.
DR   OGP; P11142; -.
DR   REPRODUCTION-2DPAGE; IPI00003865; -.
DR   SWISS-2DPAGE; P11142; -.
DR   UCD-2DPAGE; P11142; -.
DR   EPD; P11142; -.
DR   PaxDb; P11142; -.
DR   PeptideAtlas; P11142; -.
DR   PRIDE; P11142; -.
DR   TopDownProteomics; P11142-1; -. [P11142-1]
DR   TopDownProteomics; P11142-2; -. [P11142-2]
DR   DNASU; 3312; -.
DR   Ensembl; ENST00000227378; ENSP00000227378; ENSG00000109971. [P11142-1]
DR   Ensembl; ENST00000453788; ENSP00000404372; ENSG00000109971. [P11142-2]
DR   Ensembl; ENST00000532636; ENSP00000437125; ENSG00000109971. [P11142-1]
DR   Ensembl; ENST00000534624; ENSP00000432083; ENSG00000109971. [P11142-1]
DR   GeneID; 3312; -.
DR   KEGG; hsa:3312; -.
DR   UCSC; uc001pyp.5; human. [P11142-1]
DR   CTD; 3312; -.
DR   DisGeNET; 3312; -.
DR   EuPathDB; HostDB:ENSG00000109971.13; -.
DR   GeneCards; HSPA8; -.
DR   H-InvDB; HIX0033867; -.
DR   HGNC; HGNC:5241; HSPA8.
DR   HPA; CAB002056; -.
DR   HPA; HPA052504; -.
DR   MIM; 600816; gene.
DR   neXtProt; NX_P11142; -.
DR   OpenTargets; ENSG00000109971; -.
DR   PharmGKB; PA29507; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   GeneTree; ENSGT00910000144045; -.
DR   HOGENOM; HOG000228135; -.
DR   HOVERGEN; HBG051845; -.
DR   InParanoid; P11142; -.
DR   KO; K03283; -.
DR   OMA; AYTKNQD; -.
DR   OrthoDB; EOG091G03SF; -.
DR   PhylomeDB; P11142; -.
DR   TreeFam; TF105042; -.
DR   BRENDA; 3.6.3.51; 2681.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-447041; CHL1 interactions.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8876725; Protein methylation.
DR   Reactome; R-HSA-888590; GABA synthesis, release, reuptake and degradation.
DR   SIGNOR; P11142; -.
DR   ChiTaRS; HSPA8; human.
DR   EvolutionaryTrace; P11142; -.
DR   GeneWiki; HSPA8; -.
DR   GenomeRNAi; 3312; -.
DR   PMAP-CutDB; P11142; -.
DR   PRO; PR:P11142; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000109971; -.
DR   CleanEx; HS_HSPA8; -.
DR   ExpressionAtlas; P11142; baseline and differential.
DR   Genevisible; P11142; HS.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0101031; C:chaperone complex; IPI:ARUK-UCL.
DR   GO; GO:0061202; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005770; C:late endosome; IEA:Ensembl.
DR   GO; GO:0098575; C:lumenal side of lysosomal membrane; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005765; C:lysosomal membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0000974; C:Prp19 complex; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005681; C:spliceosomal complex; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IDA:BHF-UCL.
DR   GO; GO:0016887; F:ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0042623; F:ATPase activity, coupled; TAS:Reactome.
DR   GO; GO:0055131; F:C3HC4-type RING finger domain binding; IPI:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:ARUK-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0001786; F:phosphatidylserine binding; IEA:Ensembl.
DR   GO; GO:0030674; F:protein binding, bridging; IPI:ARUK-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0046034; P:ATP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0009267; P:cellular response to starvation; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IEA:Ensembl.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1904764; P:chaperone-mediated autophagy translocation complex disassembly; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0061741; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0072318; P:clathrin coat disassembly; IEA:Ensembl.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0061738; P:late endosomal microautophagy; IEA:Ensembl.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:1902904; P:negative regulation of supramolecular fiber organization; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; IEA:Ensembl.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:0006457; P:protein folding; NAS:UniProtKB.
DR   GO; GO:0042026; P:protein refolding; IDA:UniProtKB.
DR   GO; GO:0061740; P:protein targeting to lysosome involved in chaperone-mediated autophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0043254; P:regulation of protein complex assembly; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0061635; P:regulation of protein complex stability; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1904589; P:regulation of protein import; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell membrane; Chaperone; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Host-virus interaction; Isopeptide bond;
KW   Membrane; Methylation; mRNA processing; mRNA splicing;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repressor; Spliceosome; Stress response;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.6}.
FT   CHAIN         2    646       Heat shock cognate 71 kDa protein.
FT                                /FTId=PRO_0000078270.
FT   NP_BIND      12     15       ATP.
FT   NP_BIND     202    204       ATP.
FT   NP_BIND     268    275       ATP.
FT   NP_BIND     339    342       ATP.
FT   REGION        2    386       Nucleotide-binding domain (NBD).
FT                                {ECO:0000305|PubMed:27474739}.
FT   REGION      186    377       Interaction with BAG1.
FT   REGION      394    509       Substrate-binding domain (SBD).
FT                                {ECO:0000305|PubMed:27474739}.
FT   BINDING      71     71       ATP.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.6}.
FT   MOD_RES     108    108       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     153    153       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     246    246       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     319    319       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     319    319       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     328    328       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     329    329       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     362    362       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     469    469       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     512    512       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     512    512       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     524    524       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     541    541       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     561    561       N6,N6,N6-trimethyllysine; by METTL21A;
FT                                alternate. {ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   MOD_RES     561    561       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     589    589       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     597    597       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     601    601       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CROSSLNK    512    512       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    512    512       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447}.
FT   VAR_SEQ     464    616       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11093761}.
FT                                /FTId=VSP_002427.
FT   VARIANT      32     32       D -> Y (in dbSNP:rs11551602).
FT                                /FTId=VAR_049619.
FT   VARIANT     459    459       F -> L (in dbSNP:rs11551598).
FT                                /FTId=VAR_049620.
FT   MUTAGEN     561    561       K->R: Complete loss of in vitro
FT                                methylation by METTL21A.
FT                                {ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   STRAND        7     10       {ECO:0000244|PDB:5AQM}.
FT   STRAND       13     22       {ECO:0000244|PDB:5AQM}.
FT   STRAND       25     28       {ECO:0000244|PDB:5AQM}.
FT   STRAND       36     39       {ECO:0000244|PDB:5AQM}.
FT   STRAND       42     44       {ECO:0000244|PDB:5AQM}.
FT   STRAND       49     51       {ECO:0000244|PDB:5AQM}.
FT   HELIX        53     57       {ECO:0000244|PDB:5AQM}.
FT   TURN         58     61       {ECO:0000244|PDB:5AQM}.
FT   HELIX        63     65       {ECO:0000244|PDB:5AQM}.
FT   HELIX        70     72       {ECO:0000244|PDB:5AQM}.
FT   TURN         73     75       {ECO:0000244|PDB:5AQM}.
FT   HELIX        81     87       {ECO:0000244|PDB:5AQM}.
FT   STRAND       91     97       {ECO:0000244|PDB:5AQM}.
FT   STRAND      100    107       {ECO:0000244|PDB:5AQM}.
FT   STRAND      110    114       {ECO:0000244|PDB:5AQM}.
FT   HELIX       116    135       {ECO:0000244|PDB:5AQM}.
FT   STRAND      136    138       {ECO:0000244|PDB:5AQF}.
FT   STRAND      141    146       {ECO:0000244|PDB:5AQM}.
FT   HELIX       152    164       {ECO:0000244|PDB:5AQM}.
FT   STRAND      168    174       {ECO:0000244|PDB:5AQM}.
FT   HELIX       175    182       {ECO:0000244|PDB:5AQM}.
FT   HELIX       185    187       {ECO:0000244|PDB:5AQM}.
FT   STRAND      188    191       {ECO:0000244|PDB:5AQL}.
FT   STRAND      193    201       {ECO:0000244|PDB:5AQM}.
FT   STRAND      204    213       {ECO:0000244|PDB:5AQM}.
FT   STRAND      216    225       {ECO:0000244|PDB:5AQM}.
FT   HELIX       230    249       {ECO:0000244|PDB:5AQM}.
FT   HELIX       253    255       {ECO:0000244|PDB:3LDQ}.
FT   HELIX       257    276       {ECO:0000244|PDB:5AQM}.
FT   STRAND      278    288       {ECO:0000244|PDB:5AQM}.
FT   STRAND      291    298       {ECO:0000244|PDB:5AQM}.
FT   HELIX       299    305       {ECO:0000244|PDB:5AQM}.
FT   HELIX       307    312       {ECO:0000244|PDB:5AQM}.
FT   HELIX       314    324       {ECO:0000244|PDB:5AQM}.
FT   HELIX       328    330       {ECO:0000244|PDB:5AQM}.
FT   STRAND      333    338       {ECO:0000244|PDB:5AQM}.
FT   HELIX       339    342       {ECO:0000244|PDB:5AQM}.
FT   HELIX       344    353       {ECO:0000244|PDB:5AQM}.
FT   TURN        354    356       {ECO:0000244|PDB:5AQM}.
FT   STRAND      357    360       {ECO:0000244|PDB:3FZF}.
FT   TURN        365    367       {ECO:0000244|PDB:5AQM}.
FT   HELIX       368    380       {ECO:0000244|PDB:5AQM}.
FT   HELIX       541    556       {ECO:0000244|PDB:4KBQ}.
FT   HELIX       564    582       {ECO:0000244|PDB:4KBQ}.
FT   HELIX       594    612       {ECO:0000244|PDB:4KBQ}.
FT   HELIX       613    616       {ECO:0000244|PDB:4KBQ}.
FT   STRAND      641    644       {ECO:0000244|PDB:3AGY}.
SQ   SEQUENCE   646 AA;  70898 MW;  9AA27B210730670C CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVM TVLIKRNTTI
     PTKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGIPPAPRG VPQIEVTFDI
     DANGILNVSA VDKSTGKENK ITITNDKGRL SKEDIERMVQ EAEKYKAEDE KQRDKVSSKN
     SLESYAFNMK ATVEDEKLQG KINDEDKQKI LDKCNEIINW LDKNQTAEKE EFEHQQKELE
     KVCNPIITKL YQSAGGMPGG MPGGFPGGGA PPSGGASSGP TIEEVD
//
ID   Q53HF2_HUMAN            Unreviewed;       493 AA.
AC   Q53HF2;
DT   24-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   24-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 82.
DE   SubName: Full=Heat shock 70kDa protein 8 isoform 2 variant {ECO:0000313|EMBL:BAD96348.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD96348.1};
RN   [1] {ECO:0000313|EMBL:BAD96348.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAD96348.1};
RX   PubMed=8125298; DOI=10.1016/0378-1119(94)90802-8;
RA   Maruyama K., Sugano S.;
RT   "Oligo-capping: a simple method to replace the cap structure of
RT   eukaryotic mRNAs with oligoribonucleotides.";
RL   Gene 138:171-174(1994).
RN   [2] {ECO:0000313|EMBL:BAD96348.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAD96348.1};
RX   PubMed=9373149; DOI=10.1016/S0378-1119(97)00411-3;
RA   Suzuki Y., Yoshitomo K., Maruyama K., Suyama A., Sugano S.;
RT   "Construction and characterization of a full length-enriched and a 5'-
RT   end-enriched cDNA library.";
RL   Gene 200:149-156(1997).
RN   [3] {ECO:0000313|EMBL:BAD96348.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAD96348.1};
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       Q13387:MAPK8IP2; NbExp=2; IntAct=EBI-877761, EBI-722813;
CC       O14796:SH2D1B; NbExp=3; IntAct=EBI-877761, EBI-3923013;
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK222628; BAD96348.1; -; mRNA.
DR   RefSeq; NP_006588.1; NM_006597.5.
DR   RefSeq; NP_694881.1; NM_153201.3.
DR   UniGene; Hs.180414; -.
DR   IntAct; Q53HF2; 2.
DR   PeptideAtlas; Q53HF2; -.
DR   PRIDE; Q53HF2; -.
DR   DNASU; 3312; -.
DR   GeneID; 3312; -.
DR   KEGG; hsa:3312; -.
DR   CTD; 3312; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOGENOM; HOG000228135; -.
DR   HOVERGEN; HBG051845; -.
DR   KO; K03283; -.
DR   GenomeRNAi; 3312; -.
DR   Genevisible; Q53HF2; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 2.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Stress response {ECO:0000313|EMBL:BAD96348.1}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAD96348.1}.
SQ   SEQUENCE   493 AA;  53500 MW;  518CE1F703509AFA CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVT TVLIKRNTTI
     PIKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGMPGGMPG GFPGGGAPPS
     GGASSGPTIE EVD
//
ID   V9HW22_HUMAN            Unreviewed;       646 AA.
AC   V9HW22;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   23-MAY-2018, entry version 46.
DE   SubName: Full=Epididymis luminal protein 33 {ECO:0000313|EMBL:ACF94502.1};
DE   SubName: Full=Epididymis secretory sperm binding protein Li 72p {ECO:0000313|EMBL:ACI45986.1};
DE   SubName: Full=Heat shock 70kDa protein 8, isoform CRA_a {ECO:0000313|EMBL:EAW67539.1};
GN   Name=HEL-S-72p {ECO:0000313|EMBL:ACI45986.1};
GN   Synonyms=HEL-33 {ECO:0000313|EMBL:ACF94502.1},
GN   HSPA8 {ECO:0000313|EMBL:EAW67539.1};
GN   ORFNames=hCG_2032950 {ECO:0000313|EMBL:EAW67539.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI45986.1};
RN   [1] {ECO:0000313|EMBL:EAW67539.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW67539.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACF94502.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (APR-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ACI45986.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu J., Liu F.J.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU668349; ACF94502.1; -; mRNA.
DR   EMBL; FJ224294; ACI45986.1; -; mRNA.
DR   EMBL; CH471065; EAW67539.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67540.1; -; Genomic_DNA.
DR   RefSeq; NP_006588.1; NM_006597.5.
DR   RefSeq; XP_011541100.1; XM_011542798.1.
DR   UniGene; Hs.180414; -.
DR   SMR; V9HW22; -.
DR   MaxQB; V9HW22; -.
DR   PRIDE; V9HW22; -.
DR   GeneID; 3312; -.
DR   KEGG; hsa:3312; -.
DR   UCSC; uc001pyo.5; human.
DR   CTD; 3312; -.
DR   EuPathDB; HostDB:ENSG00000109971.13; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   KO; K03283; -.
DR   OMA; AYTKNQD; -.
DR   OrthoDB; EOG091G03SF; -.
DR   ChiTaRS; HSPA8; human.
DR   GenomeRNAi; 3312; -.
DR   Bgee; ENSG00000109971; -.
DR   ExpressionAtlas; V9HW22; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0005770; C:late endosome; IEA:Ensembl.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042623; F:ATPase activity, coupled; IEA:Ensembl.
DR   GO; GO:0001786; F:phosphatidylserine binding; IEA:Ensembl.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:Ensembl.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IEA:Ensembl.
DR   GO; GO:0072318; P:clathrin coat disassembly; IEA:Ensembl.
DR   GO; GO:0061738; P:late endosomal microautophagy; IEA:Ensembl.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; IEA:Ensembl.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Stress response {ECO:0000313|EMBL:EAW67539.1}.
FT   COILED      512    535       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   646 AA;  70898 MW;  9AA27B210730670C CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVM TVLIKRNTTI
     PTKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGIPPAPRG VPQIEVTFDI
     DANGILNVSA VDKSTGKENK ITITNDKGRL SKEDIERMVQ EAEKYKAEDE KQRDKVSSKN
     SLESYAFNMK ATVEDEKLQG KINDEDKQKI LDKCNEIINW LDKNQTAEKE EFEHQQKELE
     KVCNPIITKL YQSAGGMPGG MPGGFPGGGA PPSGGASSGP TIEEVD
//
ID   SYRC_HUMAN              Reviewed;         660 AA.
AC   P54136; B2RBS9; Q53GY4; Q9BWA1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2002, sequence version 2.
DT   23-MAY-2018, entry version 185.
DE   RecName: Full=Arginine--tRNA ligase, cytoplasmic;
DE            EC=6.1.1.19 {ECO:0000269|PubMed:16055448, ECO:0000269|PubMed:25288775};
DE   AltName: Full=Arginyl-tRNA synthetase;
DE            Short=ArgRS;
GN   Name=RARS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7590355; DOI=10.1016/0378-1119(95)00502-W;
RA   Girjes A.A., Hobson K., Chen P., Lavin M.F.;
RT   "Cloning and characterization of cDNA encoding a human arginyl-tRNA
RT   synthetase.";
RL   Gene 164:347-350(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-11.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   INTERACTION WITH AIMP1.
RX   PubMed=10358004; DOI=10.1074/jbc.274.24.16673;
RA   Park S.G., Jung K.H., Lee J.S., Jo Y.J., Motegi H., Kim S., Shiba K.;
RT   "Precursor of pro-apoptotic cytokine modulates aminoacylation activity
RT   of tRNA synthetase.";
RL   J. Biol. Chem. 274:16673-16676(1999).
RN   [8]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH LARS2.
RX   PubMed=16055448; DOI=10.1074/jbc.M413511200;
RA   Ling C., Yao Y.N., Zheng Y.G., Wei H., Wang L., Wu X.F., Wang E.D.;
RT   "The C-terminal appended domain of human cytosolic leucyl-tRNA
RT   synthetase is indispensable in its interaction with arginyl-tRNA
RT   synthetase in the multi-tRNA synthetase complex.";
RL   J. Biol. Chem. 280:34755-34763(2005).
RN   [9]
RP   SUBCELLULAR LOCATION, AND ALTERNATIVE INITIATION.
RX   PubMed=16430231; DOI=10.1021/bi051675n;
RA   Zheng Y.-G., Wei H., Ling C., Xu M.-G., Wang E.-D.;
RT   "Two forms of human cytoplasmic arginyl-tRNA synthetase produced from
RT   two translation initiations by a single mRNA.";
RL   Biochemistry 45:1338-1344(2006).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH AIMP1.
RX   PubMed=17443684; DOI=10.1002/jcp.21083;
RA   Bottoni A., Vignali C., Piccin D., Tagliati F., Luchin A.,
RA   Zatelli M.C., Uberti E.C.;
RT   "Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer
RT   cell lines.";
RL   J. Cell. Physiol. 212:293-297(2007).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   SUBUNIT, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19131329; DOI=10.1074/jbc.M809636200;
RA   Kaminska M., Havrylenko S., Decottignies P., Gillet S.,
RA   Le Marechal P., Negrutskii B., Mirande M.;
RT   "Dissection of the structural organization of the aminoacyl-tRNA
RT   synthetase complex.";
RL   J. Biol. Chem. 284:6053-6060(2009).
RN   [13]
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=19289464; DOI=10.1074/jbc.M900480200;
RA   Kaminska M., Havrylenko S., Decottignies P., Le Marechal P.,
RA   Negrutskii B., Mirande M.;
RT   "Dynamic Organization of Aminoacyl-tRNA Synthetase Complexes in the
RT   Cytoplasm of Human Cells.";
RL   J. Biol. Chem. 284:13746-13754(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   INTERACTION WITH QARS.
RX   PubMed=24656866; DOI=10.1016/j.ajhg.2014.03.003;
RA   Zhang X., Ling J., Barcia G., Jing L., Wu J., Barry B.J.,
RA   Mochida G.H., Hill R.S., Weimer J.M., Stein Q., Poduri A.,
RA   Partlow J.N., Ville D., Dulac O., Yu T.W., Lam A.T., Servattalab S.,
RA   Rodriguez J., Boddaert N., Munnich A., Colleaux L., Zon L.I., Soll D.,
RA   Walsh C.A., Nabbout R.;
RT   "Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause
RT   progressive microcephaly, cerebral-cerebellar atrophy, and intractable
RT   seizures.";
RL   Am. J. Hum. Genet. 94:547-558(2014).
RN   [19]
RP   INVOLVEMENT IN HLD9, AND VARIANTS HLD9 GLY-2 AND GLN-512.
RX   PubMed=24777941; DOI=10.1002/ana.24167;
RA   Wolf N.I., Salomons G.S., Rodenburg R.J., Pouwels P.J.,
RA   Schieving J.H., Derks T.G., Fock J.M., Rump P., van Beek D.M.,
RA   van der Knaap M.S., Waisfisz Q.;
RT   "Mutations in RARS cause hypomyelination.";
RL   Ann. Neurol. 76:134-139(2014).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21] {ECO:0000244|PDB:4Q2T, ECO:0000244|PDB:4Q2X, ECO:0000244|PDB:4Q2Y}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 73-660 IN COMPLEXES WIT
RP   ARGNINE AND CANAVANINE, AND SUBUNIT.
RX   PubMed=24859084; DOI=10.1016/j.febslet.2014.05.027;
RA   Kim H.S., Cha S.Y., Jo C.H., Han A., Hwang K.Y.;
RT   "The crystal structure of arginyl-tRNA synthetase from Homo sapiens.";
RL   FEBS Lett. 588:2328-2334(2014).
RN   [22] {ECO:0000244|PDB:4R3Z}
RP   X-RAY CRYSTALLOGRAPHY (4.03 ANGSTROMS) IN COMPLEX WITH QARS AND AIMP1,
RP   SUBUNIT, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=25288775; DOI=10.1073/pnas.1408836111;
RA   Fu Y., Kim Y., Jin K.S., Kim H.S., Kim J.H., Wang D., Park M.,
RA   Jo C.H., Kwon N.H., Kim D., Kim M.H., Jeon Y.H., Hwang K.Y., Kim S.,
RA   Cho Y.;
RT   "Structure of the ArgRS-GlnRS-AIMP1 complex and its implications for
RT   mammalian translation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:15084-15089(2014).
CC   -!- FUNCTION: Forms part of a macromolecular complex that catalyzes
CC       the attachment of specific amino acids to cognate tRNAs during
CC       protein synthesis (PubMed:25288775). Modulates the secretion of
CC       AIMP1 and may be involved in generation of the inflammatory
CC       cytokine EMAP2 from AIMP1 (PubMed:17443684).
CC       {ECO:0000269|PubMed:17443684, ECO:0000269|PubMed:25288775}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-arginine + tRNA(Arg) = AMP +
CC       diphosphate + L-arginyl-tRNA(Arg). {ECO:0000269|PubMed:16055448,
CC       ECO:0000269|PubMed:25288775}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.9 uM for arginine (ATP-PPi exchange at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:16055448};
CC         KM=3.5 uM for arginine (arginylation at 37 degrees Celsius)
CC         {ECO:0000269|PubMed:16055448};
CC         KM=1183 uM for ATP (ATP-PPi exchange at 37 Celsius)
CC         {ECO:0000269|PubMed:16055448};
CC         KM=910 uM for ATP (arginylation at 37 Celsius)
CC         {ECO:0000269|PubMed:16055448};
CC         KM=0.05 uM for calf liver tRNA-Arg (ATP-PPi exchange at 37
CC         Celsius) {ECO:0000269|PubMed:16055448};
CC         KM=0.41 uM for calf liver tRNA-Arg (arginylation at 37 Celsius)
CC         {ECO:0000269|PubMed:16055448};
CC   -!- SUBUNIT: Interacts (via N-terminus) with AIMP1 (via N-terminus);
CC       this stimulates its catalytic activity (PubMed:10358004,
CC       PubMed:25288775). Interacts (via N-terminus) with LARS2 (via C-
CC       terminus) (PubMed:16055448, PubMed:17443684). Monomer
CC       (PubMed:24859084). Part of a multisubunit complex that groups tRNA
CC       ligases for Arg (RARS), Asp (DARS), Gln (QARS), Ile (IARS), Leu
CC       (LARS), Lys (KARS), Met (MARS) the bifunctional ligase for Glu and
CC       Pro (EPRS) and the auxiliary subunits AIMP1/p43, AIMP2/p38 and
CC       EEF1E1/p18 (PubMed:19131329, PubMed:19289464). Interacts with QARS
CC       (PubMed:24656866). Part of a complex composed of RARS, QARS and
CC       AIMP1 (PubMed:25288775). {ECO:0000269|PubMed:10358004,
CC       ECO:0000269|PubMed:16055448, ECO:0000269|PubMed:17443684,
CC       ECO:0000269|PubMed:19131329, ECO:0000269|PubMed:19289464,
CC       ECO:0000269|PubMed:24656866, ECO:0000269|PubMed:24859084,
CC       ECO:0000269|PubMed:25288775}.
CC   -!- INTERACTION:
CC       Q9P2J5:LARS; NbExp=3; IntAct=EBI-355482, EBI-356077;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16055448,
CC       ECO:0000269|PubMed:16430231}. Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:19289464}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Complexed;
CC         IsoId=P54136-1; Sequence=Displayed;
CC       Name=Monomeric;
CC         IsoId=P54136-2; Sequence=VSP_018905;
CC   -!- DOMAIN: The alpha-helical N-terminus (residues 1-72) mediates
CC       interaction with AIMP1 and thereby contributes to the assembly of
CC       the multisynthetase complex. {ECO:0000269|PubMed:25288775}.
CC   -!- DISEASE: Leukodystrophy, hypomyelinating, 9 (HLD9) [MIM:616140]:
CC       An autosomal recessive neurodegenerative disorder characterized by
CC       delayed psychomotor development, severe spasticity, nystagmus, and
CC       ataxia associated with diffuse hypomyelination apparent on brain
CC       MRI. {ECO:0000269|PubMed:24777941}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S80343; AAB35627.1; -; mRNA.
DR   EMBL; BT007394; AAP36058.1; -; mRNA.
DR   EMBL; AK314795; BAG37326.1; -; mRNA.
DR   EMBL; AK222797; BAD96517.1; -; mRNA.
DR   EMBL; BC000528; AAH00528.1; -; mRNA.
DR   EMBL; BC014619; AAH14619.1; -; mRNA.
DR   CCDS; CCDS4367.1; -. [P54136-1]
DR   PIR; JC4365; JC4365.
DR   RefSeq; NP_002878.2; NM_002887.3. [P54136-1]
DR   UniGene; Hs.654907; -.
DR   PDB; 4Q2T; X-ray; 2.40 A; A/B=73-660.
DR   PDB; 4Q2X; X-ray; 2.80 A; A/B=73-660.
DR   PDB; 4Q2Y; X-ray; 2.80 A; A/B=73-660.
DR   PDB; 4R3Z; X-ray; 4.03 A; B=1-660.
DR   PDB; 4ZAJ; X-ray; 2.22 A; A=73-660.
DR   PDBsum; 4Q2T; -.
DR   PDBsum; 4Q2X; -.
DR   PDBsum; 4Q2Y; -.
DR   PDBsum; 4R3Z; -.
DR   PDBsum; 4ZAJ; -.
DR   ProteinModelPortal; P54136; -.
DR   SMR; P54136; -.
DR   BioGrid; 111852; 73.
DR   CORUM; P54136; -.
DR   IntAct; P54136; 18.
DR   MINT; P54136; -.
DR   STRING; 9606.ENSP00000231572; -.
DR   BindingDB; P54136; -.
DR   ChEMBL; CHEMBL2824; -.
DR   iPTMnet; P54136; -.
DR   PhosphoSitePlus; P54136; -.
DR   SwissPalm; P54136; -.
DR   BioMuta; RARS; -.
DR   DMDM; 20178331; -.
DR   EPD; P54136; -.
DR   MaxQB; P54136; -.
DR   PaxDb; P54136; -.
DR   PeptideAtlas; P54136; -.
DR   PRIDE; P54136; -.
DR   DNASU; 5917; -.
DR   Ensembl; ENST00000231572; ENSP00000231572; ENSG00000113643. [P54136-1]
DR   GeneID; 5917; -.
DR   KEGG; hsa:5917; -.
DR   UCSC; uc003lzx.4; human. [P54136-1]
DR   CTD; 5917; -.
DR   DisGeNET; 5917; -.
DR   EuPathDB; HostDB:ENSG00000113643.8; -.
DR   GeneCards; RARS; -.
DR   HGNC; HGNC:9870; RARS.
DR   HPA; HPA003979; -.
DR   HPA; HPA004130; -.
DR   MalaCards; RARS; -.
DR   MIM; 107820; gene.
DR   MIM; 616140; phenotype.
DR   neXtProt; NX_P54136; -.
DR   OpenTargets; ENSG00000113643; -.
DR   PharmGKB; PA34231; -.
DR   eggNOG; KOG1195; Eukaryota.
DR   eggNOG; COG0018; LUCA.
DR   GeneTree; ENSGT00530000063407; -.
DR   HOGENOM; HOG000247212; -.
DR   HOVERGEN; HBG029238; -.
DR   InParanoid; P54136; -.
DR   KO; K01887; -.
DR   OMA; NKPLHLG; -.
DR   OrthoDB; EOG091G03A6; -.
DR   PhylomeDB; P54136; -.
DR   TreeFam; TF106111; -.
DR   Reactome; R-HSA-2408517; SeMet incorporation into proteins.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   ChiTaRS; RARS; human.
DR   GeneWiki; RARS_(gene); -.
DR   GenomeRNAi; 5917; -.
DR   PRO; PR:P54136; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113643; -.
DR   CleanEx; HS_RARS; -.
DR   ExpressionAtlas; P54136; baseline and differential.
DR   Genevisible; P54136; HS.
DR   GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:CAFA.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:CAFA.
DR   GO; GO:0034618; F:arginine binding; IEA:Ensembl.
DR   GO; GO:0004814; F:arginine-tRNA ligase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0000049; F:tRNA binding; IEA:Ensembl.
DR   GO; GO:0006420; P:arginyl-tRNA aminoacylation; IDA:UniProtKB.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   CDD; cd00671; ArgRS_core; 1.
DR   Gene3D; 3.30.1360.70; -; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   HAMAP; MF_00123; Arg_tRNA_synth; 1.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR001278; Arg-tRNA-ligase.
DR   InterPro; IPR005148; Arg-tRNA-synth_N.
DR   InterPro; IPR036695; Arg-tRNA-synth_N_sf.
DR   InterPro; IPR035684; ArgRS_core.
DR   InterPro; IPR008909; DALR_anticod-bd.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR11956; PTHR11956; 1.
DR   Pfam; PF03485; Arg_tRNA_synt_N; 1.
DR   Pfam; PF05746; DALR_1; 1.
DR   Pfam; PF00750; tRNA-synt_1d; 1.
DR   PRINTS; PR01038; TRNASYNTHARG.
DR   SMART; SM01016; Arg_tRNA_synt_N; 1.
DR   SMART; SM00836; DALR_1; 1.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   SUPFAM; SSF55190; SSF55190; 1.
DR   TIGRFAMs; TIGR00456; argS; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Leukodystrophy; Ligase;
KW   Nucleotide-binding; Polymorphism; Protein biosynthesis;
KW   Reference proteome.
FT   CHAIN         1    660       Arginine--tRNA ligase, cytoplasmic.
FT                                /FTId=PRO_0000035797.
FT   REGION        1     72       Could be involved in the assembly of the
FT                                multisynthetase complex.
FT   REGION      200    202       L-arginine binding.
FT                                {ECO:0000244|PDB:4Q2T,
FT                                ECO:0000269|PubMed:24859084}.
FT   REGION      529    543       Interaction with tRNA.
FT                                {ECO:0000250|UniProtKB:Q05506}.
FT   MOTIF       201    212       "HIGH" region.
FT   BINDING     211    211       L-arginine. {ECO:0000244|PDB:4Q2T,
FT                                ECO:0000269|PubMed:24859084}.
FT   BINDING     384    384       L-arginine. {ECO:0000244|PDB:4Q2T,
FT                                ECO:0000269|PubMed:24859084}.
FT   BINDING     388    388       L-arginine. {ECO:0000244|PDB:4Q2T,
FT                                ECO:0000269|PubMed:24859084}.
FT   BINDING     412    412       L-arginine. {ECO:0000244|PDB:4Q2T,
FT                                ECO:0000269|PubMed:24859084}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   VAR_SEQ       1     72       Missing (in isoform Monomeric).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018905.
FT   VARIANT       2      2       D -> G (in HLD9; dbSNP:rs672601372).
FT                                {ECO:0000269|PubMed:24777941}.
FT                                /FTId=VAR_072666.
FT   VARIANT       3      3       V -> I (in dbSNP:rs244903).
FT                                /FTId=VAR_020106.
FT   VARIANT     135    135       R -> G (in dbSNP:rs1059443).
FT                                /FTId=VAR_052635.
FT   VARIANT     397    397       F -> Y (in dbSNP:rs2305734).
FT                                /FTId=VAR_020107.
FT   VARIANT     512    512       R -> Q (in HLD9; dbSNP:rs369398935).
FT                                {ECO:0000269|PubMed:24777941}.
FT                                /FTId=VAR_072667.
FT   CONFLICT     39     39       P -> S (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    130    131       QK -> PE (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    135    137       REI -> GEF (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    147    156       DNECIEKVEI -> AMDVLKRVEF (in Ref. 1;
FT                                AAB35627). {ECO:0000305}.
FT   CONFLICT    164    164       V -> G (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    278    278       K -> N (in Ref. 3; BAG37326).
FT                                {ECO:0000305}.
FT   CONFLICT    308    312       WKLIC -> YLLMS (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    341    341       R -> G (in Ref. 4; BAD96517).
FT                                {ECO:0000305}.
FT   CONFLICT    358    358       D -> G (in Ref. 3; BAG37326).
FT                                {ECO:0000305}.
FT   CONFLICT    487    487       T -> A (in Ref. 4; BAD96517).
FT                                {ECO:0000305}.
FT   CONFLICT    567    567       D -> V (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    635    640       MLLCEA -> ILCET (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    651    651       I -> T (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   CONFLICT    657    660       VQRM -> GPRV (in Ref. 1; AAB35627).
FT                                {ECO:0000305}.
FT   HELIX        76     91       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      102    104       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      108    110       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      112    115       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       117    123       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       134    143       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      149    155       {ECO:0000244|PDB:4ZAJ}.
FT   TURN        158    160       {ECO:0000244|PDB:4Q2T}.
FT   STRAND      162    166       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       168    181       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      193    197       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       209    227       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      231    236       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      241    243       {ECO:0000244|PDB:4Q2T}.
FT   HELIX       244    255       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       257    260       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       269    282       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       285    298       {ECO:0000244|PDB:4ZAJ}.
FT   TURN        302    304       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       305    325       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       335    341       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       342    351       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      355    358       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      361    364       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      373    376       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       384    397       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      402    409       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       410    412       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       413    425       {ECO:0000244|PDB:4ZAJ}.
FT   TURN        431    433       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      434    441       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      449    451       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      455    458       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       462    478       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      482    485       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       487    490       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       493    508       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      512    514       {ECO:0000244|PDB:4Q2X}.
FT   HELIX       520    523       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      526    530       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       531    546       {ECO:0000244|PDB:4ZAJ}.
FT   TURN        547    549       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       552    561       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       569    578       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       581    591       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       595    614       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      617    620       {ECO:0000244|PDB:4ZAJ}.
FT   TURN        622    624       {ECO:0000244|PDB:4ZAJ}.
FT   STRAND      627    630       {ECO:0000244|PDB:4ZAJ}.
FT   HELIX       632    652       {ECO:0000244|PDB:4ZAJ}.
SQ   SEQUENCE   660 AA;  75379 MW;  FE9FB5C910709956 CRC64;
     MDVLVSECSA RLLQQEEEIK SLTAEIDRLK NCGCLGASPN LEQLQEENLK LKYRLNILRK
     SLQAERNKPT KNMINIISRL QEVFGHAIKA AYPDLENPPL LVTPSQQAKF GDYQCNSAMG
     ISQMLKTKEQ KVNPREIAEN ITKHLPDNEC IEKVEIAGPG FINVHLRKDF VSEQLTSLLV
     NGVQLPALGE NKKVIVDFSS PNIAKEMHVG HLRSTIIGES ISRLFEFAGY DVLRLNHVGD
     WGTQFGMLIA HLQDKFPDYL TVSPPIGDLQ VFYKESKKRF DTEEEFKKRA YQCVVLLQGK
     NPDITKAWKL ICDVSRQELN KIYDALDVSL IERGESFYQD RMNDIVKEFE DRGFVQVDDG
     RKIVFVPGCS IPLTIVKSDG GYTYDTSDLA AIKQRLFEEK ADMIIYVVDN GQSVHFQTIF
     AAAQMIGWYD PKVTRVFHAG FGVVLGEDKK KFKTRSGETV RLMDLLGEGL KRSMDKLKEK
     ERDKVLTAEE LNAAQTSVAY GCIKYADLSH NRLNDYIFSF DKMLDDRGNT AAYLLYAFTR
     IRSIARLANI DEEMLQKAAR ETKILLDHEK EWKLGRCILR FPEILQKILD DLFLHTLCDY
     IYELATAFTE FYDSCYCVEK DRQTGKILKV NMWRMLLCEA VAAVMAKGFD ILGIKPVQRM
//
ID   B3KNL2_HUMAN            Unreviewed;       429 AA.
AC   B3KNL2;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   23-MAY-2018, entry version 64.
DE   RecName: Full=RuvB-like helicase {ECO:0000256|RuleBase:RU363048};
DE            EC=3.6.4.12 {ECO:0000256|RuleBase:RU363048};
GN   Name=RUVBL2 {ECO:0000313|EMBL:EAW52429.1};
GN   ORFNames=hCG_16214 {ECO:0000313|EMBL:EAW52429.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG51374.1};
RN   [1] {ECO:0000313|EMBL:EAW52429.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAG51374.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAG51374.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3] {ECO:0000313|EMBL:EAW52429.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Proposed core component of the chromatin remodeling
CC       INO80 complex which is involved in transcriptional regulation, DNA
CC       replication and probably DNA repair.
CC       {ECO:0000256|RuleBase:RU363048}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC       {ECO:0000256|RuleBase:RU363048, ECO:0000256|SAAS:SAAS00005495}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU363048,
CC       ECO:0000256|SAAS:SAAS00005491}.
CC   -!- SIMILARITY: Belongs to the RuvB family.
CC       {ECO:0000256|RuleBase:RU363048, ECO:0000256|SAAS:SAAS00536598}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK027762; BAG51374.1; -; mRNA.
DR   EMBL; CH471177; EAW52429.1; -; Genomic_DNA.
DR   RefSeq; NP_001308119.1; NM_001321190.1.
DR   UniGene; Hs.515846; -.
DR   SMR; B3KNL2; -.
DR   PeptideAtlas; B3KNL2; -.
DR   PRIDE; B3KNL2; -.
DR   GeneID; 10856; -.
DR   CTD; 10856; -.
DR   eggNOG; KOG2680; Eukaryota.
DR   eggNOG; COG1224; LUCA.
DR   HOVERGEN; HBG054186; -.
DR   ChiTaRS; RUVBL2; human.
DR   GenomeRNAi; 10856; -.
DR   GO; GO:0031011; C:Ino80 complex; IEA:InterPro.
DR   GO; GO:0035267; C:NuA4 histone acetyltransferase complex; IEA:InterPro.
DR   GO; GO:0097255; C:R2TP complex; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0043141; F:ATP-dependent 5'-3' DNA helicase activity; IEA:InterPro.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR027238; RuvB-like.
DR   InterPro; IPR037942; RUVBL2.
DR   InterPro; IPR010339; TIP49_C.
DR   PANTHER; PTHR11093; PTHR11093; 1.
DR   PANTHER; PTHR11093:SF2; PTHR11093:SF2; 1.
DR   Pfam; PF06068; TIP49; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU363048,
KW   ECO:0000256|SAAS:SAAS00418363};
KW   DNA damage {ECO:0000256|RuleBase:RU363048};
KW   DNA recombination {ECO:0000256|RuleBase:RU363048};
KW   DNA repair {ECO:0000256|RuleBase:RU363048};
KW   Helicase {ECO:0000256|RuleBase:RU363048,
KW   ECO:0000256|SAAS:SAAS00418363};
KW   Hydrolase {ECO:0000256|RuleBase:RU363048,
KW   ECO:0000256|SAAS:SAAS00418363};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU363048,
KW   ECO:0000256|SAAS:SAAS00418363};
KW   Nucleus {ECO:0000256|RuleBase:RU363048,
KW   ECO:0000256|SAAS:SAAS00418356};
KW   Transcription {ECO:0000256|RuleBase:RU363048};
KW   Transcription regulation {ECO:0000256|RuleBase:RU363048}.
FT   DOMAIN       35    327       AAA. {ECO:0000259|SMART:SM00382}.
SQ   SEQUENCE   429 AA;  47404 MW;  6280330793DD67CD CRC64;
     MCASHPQASQ GMVGQLAARR AAGVVLEMIR EGKIAGRAVL IAGQPGTGKT AIAMGMAQAL
     GPDTPFTAIA GSEIFSLEMS KTEALTQAFR RSIGVRIKEE TEIIEGEVVE IQIDRPATGT
     GSKVGKLTLK TTEMETIYDL GTKMIESLTK DKVQAGDVIT IDKATGKISK LGRSFTRARD
     YDAMGSQTKF VQCPDGELQK RKEVVHTVSL HEIDVINSRT QGFLALFSGD TGEIKSEVRE
     QINAKVAEWR EEGKAEIIPG VLFIDEVHML DIESFSFLNR ALESDMAPVL IMATNRGITR
     IRGTSYQSPH GIPIDLLDRL LIVSTTPYSE KDTKQILRIR CEEEDVEMSE DAYTVLTRIG
     LETSLRYAIQ LITAASLVCR KRKGTEVQVD DIKRVYSLFL DESRSTQYMK EYQDAFLFNE
     LKGETMDTS
//
ID   RUVB2_HUMAN             Reviewed;         463 AA.
AC   Q9Y230; B3KQ59; E7ETE5; Q6FIB9; Q6PK27; Q9Y361;
DT   01-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   23-MAY-2018, entry version 206.
DE   RecName: Full=RuvB-like 2;
DE            EC=3.6.4.12;
DE   AltName: Full=48 kDa TATA box-binding protein-interacting protein;
DE            Short=48 kDa TBP-interacting protein;
DE   AltName: Full=51 kDa erythrocyte cytosolic protein;
DE            Short=ECP-51;
DE   AltName: Full=INO80 complex subunit J;
DE   AltName: Full=Repressing pontin 52;
DE            Short=Reptin 52;
DE   AltName: Full=TIP49b;
DE   AltName: Full=TIP60-associated protein 54-beta;
DE            Short=TAP54-beta;
GN   Name=RUVBL2; Synonyms=INO80J, TIP48, TIP49B; ORFNames=CGI-46;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 72-83;
RP   131-144; 212-223; 369-372 AND 440-457.
RC   TISSUE=Bone marrow;
RX   PubMed=10524211; DOI=10.1016/S0167-4781(99)00104-9;
RA   Salzer U., Kubicek M., Prohaska R.;
RT   "Isolation, molecular characterization, and tissue-specific expression
RT   of ECP-51 and ECP-54 (TIP49), two homologous, interacting erythroid
RT   cytosolic proteins.";
RL   Biochim. Biophys. Acta 1446:365-370(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHARACTERIZATION, AND
RP   INTERACTION WITH RUVBL1.
RC   TISSUE=Liver;
RX   PubMed=10428817; DOI=10.1074/jbc.274.32.22437;
RA   Kanemaki M., Kurokawa Y., Matsu-ura T., Makino Y., Masani A.,
RA   Okazaki K., Morishita T., Tamura T.-A.;
RT   "TIP49b, a new RuvB-like DNA helicase, is included in a complex
RT   together with another RuvB-like DNA helicase, TIP49a.";
RL   J. Biol. Chem. 274:22437-22444(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=10998447; DOI=10.1016/S0003-3995(00)01016-9;
RA   Parfait B., Giovangrandi Y., Asheuer M., Laurendeau I., Olivi M.,
RA   Vodovar N., Vidaud D., Vidaud M., Bieche I.;
RT   "Human TIP49b/RUVBL2 gene: genomic structure, expression pattern,
RT   physical link to the human CGB/LHB gene cluster on chromosome
RT   19q13.3.";
RL   Ann. Genet. 43:69-74(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal liver;
RX   PubMed=11080158; DOI=10.1093/emboj/19.22.6121;
RA   Bauer A., Chauvet S., Huber O., Usseglio F., Rothbaecher U.,
RA   Aragnol D., Kemler R., Pradel J.;
RT   "Pontin52 and reptin52 function as antagonistic regulators of beta-
RT   catenin signalling activity.";
RL   EMBO J. 19:6121-6130(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 73-83;
RP   116-124; 237-253 AND 254-269, AND INTERACTION WITH MYC.
RX   PubMed=10882073; DOI=10.1016/S1097-2765(00)80427-X;
RA   Wood M.A., McMahon S.B., Cole M.D.;
RT   "An ATPase/helicase complex is an essential cofactor for oncogenic
RT   transformation by c-Myc.";
RL   Mol. Cell 5:321-330(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Embryo, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PROTEIN SEQUENCE OF 2-14.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [14]
RP   PROTEIN SEQUENCE OF 2-18; 30-53; 55-64; 72-83; 116-124; 165-177;
RP   237-269; 335-368; 393-400 AND 418-438, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [15]
RP   PROTEIN SEQUENCE OF 30-40; 185-197; 354-365 AND 417-427,
RP   IDENTIFICATION IN THE NUA4 COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=10966108; DOI=10.1016/S0092-8674(00)00051-9;
RA   Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J.,
RA   Horikoshi M., Scully R., Qin J., Nakatani Y.;
RT   "Involvement of the TIP60 histone acetylase complex in DNA repair and
RT   apoptosis.";
RL   Cell 102:463-473(2000).
RN   [16]
RP   PROTEIN SEQUENCE OF 30-40; 72-83; 165-177; 187-197; 254-269; 354-365;
RP   418-438 AND 445-463, IDENTIFICATION IN NUA4 COMPLEX, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12963728; DOI=10.1074/jbc.C300389200;
RA   Cai Y., Jin J., Tomomori-Sato C., Sato S., Sorokina I., Parmely T.J.,
RA   Conaway R.C., Conaway J.W.;
RT   "Identification of new subunits of the multiprotein mammalian
RT   TRRAP/TIP60-containing histone acetyltransferase complex.";
RL   J. Biol. Chem. 278:42733-42736(2003).
RN   [17]
RP   INTERACTION WITH ATF2.
RX   PubMed=11713276; DOI=10.1128/MCB.21.24.8398-8413.2001;
RA   Cho S.-G., Bhoumik A., Broday L., Ivanov V., Rosenstein B., Ronai Z.;
RT   "TIP49b, a regulator of activating transcription factor 2 response to
RT   stress and DNA damage.";
RL   Mol. Cell. Biol. 21:8398-8413(2001).
RN   [18]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN NUA4
RP   COMPLEX, AND IDENTIFICATION IN A NUA4-RELATED SRCAP-CONTAINING
RP   COMPLEX.
RX   PubMed=14966270; DOI=10.1128/MCB.24.5.1884-1896.2004;
RA   Doyon Y., Selleck W., Lane W.S., Tan S., Cote J.;
RT   "Structural and functional conservation of the NuA4 histone
RT   acetyltransferase complex from yeast to humans.";
RL   Mol. Cell. Biol. 24:1884-1896(2004).
RN   [19]
RP   IDENTIFICATION IN THE MLL1/MLL COMPLEX.
RX   PubMed=15960975; DOI=10.1016/j.cell.2005.04.031;
RA   Dou Y., Milne T.A., Tackett A.J., Smith E.R., Fukuda A., Wysocka J.,
RA   Allis C.D., Chait B.T., Hess J.L., Roeder R.G.;
RT   "Physical association and coordinate function of the H3 K4
RT   methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.";
RL   Cell 121:873-885(2005).
RN   [20]
RP   IDENTIFICATION IN INO80 COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16230350; DOI=10.1074/jbc.M509128200;
RA   Jin J., Cai Y., Yao T., Gottschalk A.J., Florens L., Swanson S.K.,
RA   Gutierrez J.L., Coleman M.K., Workman J.L., Mushegian A.,
RA   Washburn M.P., Conaway R.C., Conaway J.W.;
RT   "A mammalian chromatin remodeling complex with similarities to the
RT   yeast INO80 complex.";
RL   J. Biol. Chem. 280:41207-41212(2005).
RN   [21]
RP   INTERACTION WITH HINT1, AND FUNCTION.
RX   PubMed=16014379; DOI=10.1242/jcs.02437;
RA   Weiske J., Huber O.;
RT   "The histidine triad protein Hint1 interacts with Pontin and Reptin
RT   and inhibits TCF-beta-catenin-mediated transcription.";
RL   J. Cell Sci. 118:3117-3129(2005).
RN   [22]
RP   SUBUNIT, MUTAGENESIS OF ASP-299, AND ELECTRON MICROSCOPY OF THE
RP   RUVBL1-RUVBL2 HETEROMER.
RX   PubMed=17157868; DOI=10.1016/j.jmb.2006.11.030;
RA   Puri T., Wendler P., Sigala B., Saibil H., Tsaneva I.R.;
RT   "Dodecameric structure and ATPase activity of the human TIP48/TIP49
RT   complex.";
RL   J. Mol. Biol. 366:179-192(2007).
RN   [23]
RP   IDENTIFICATION IN THE INO80 COMPLEX, AND PROTEIN INTERACTION.
RX   PubMed=18026119; DOI=10.1038/nsmb1332;
RA   Wu S., Shi Y., Mulligan P., Gay F., Landry J., Liu H., Lu J., Qi H.H.,
RA   Wang W., Nickoloff J.A., Wu C., Shi Y.;
RT   "A YY1-INO80 complex regulates genomic stability through homologous
RT   recombination-based repair.";
RL   Nat. Struct. Mol. Biol. 14:1165-1172(2007).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH NPAT.
RX   PubMed=17967892; DOI=10.1128/MCB.00607-07;
RA   DeRan M., Pulvino M., Greene E., Su C., Zhao J.;
RT   "Transcriptional activation of histone genes requires NPAT-dependent
RT   recruitment of TRRAP-Tip60 complex to histone promoters during the
RT   G1/S phase transition.";
RL   Mol. Cell. Biol. 28:435-447(2008).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [26]
RP   INTERACTION WITH IGHMBP2.
RX   PubMed=19299493; DOI=10.1093/hmg/ddp134;
RA   de Planell-Saguer M., Schroeder D.G., Rodicio M.C., Cox G.A.,
RA   Mourelatos Z.;
RT   "Biochemical and genetic evidence for a role of IGHMBP2 in the
RT   translational machinery.";
RL   Hum. Mol. Genet. 18:2115-2126(2009).
RN   [27]
RP   INTERACTION WITH TELO2.
RX   PubMed=20801936; DOI=10.1101/gad.1956410;
RA   Takai H., Xie Y., de Lange T., Pavletich N.P.;
RT   "Tel2 structure and function in the Hsp90-dependent maturation of mTOR
RT   and ATR complexes.";
RL   Genes Dev. 24:2019-2030(2010).
RN   [28]
RP   IDENTIFICATION IN THE R2TP COMPLEX.
RX   PubMed=20864032; DOI=10.1016/j.molcel.2010.08.037;
RA   Horejsi Z., Takai H., Adelman C.A., Collis S.J., Flynn H., Maslen S.,
RA   Skehel J.M., de Lange T., Boulton S.J.;
RT   "CK2 phospho-dependent binding of R2TP complex to TEL2 is essential
RT   for mTOR and SMG1 stability.";
RL   Mol. Cell 39:839-850(2010).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [30]
RP   IDENTIFICATION IN THE INO80 COMPLEX.
RX   PubMed=21303910; DOI=10.1074/jbc.M111.222505;
RA   Chen L., Cai Y., Jin J., Florens L., Swanson S.K., Washburn M.P.,
RA   Conaway J.W., Conaway R.C.;
RT   "Subunit organization of the human INO80 chromatin remodeling complex:
RT   An evolutionarily conserved core complex catalyzes ATP-dependent
RT   nucleosome remodeling.";
RL   J. Biol. Chem. 286:11283-11289(2011).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-437, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   INTERACTION WITH ITFG1.
RX   PubMed=25437307; DOI=10.7554/eLife.04449;
RA   Kato M., Chou T.F., Yu C.Z., DeModena J., Sternberg P.W.;
RT   "LINKIN, a new transmembrane protein necessary for cell adhesion.";
RL   Elife 3:E04449-E04449(2014).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   FUNCTION, AND IDENTIFICATION IN THE SWR1-LIKE COMPLEX.
RX   PubMed=24463511; DOI=10.1038/nature12922;
RA   Obri A., Ouararhni K., Papin C., Diebold M.L., Padmanabhan K.,
RA   Marek M., Stoll I., Roy L., Reilly P.T., Mak T.W., Dimitrov S.,
RA   Romier C., Hamiche A.;
RT   "ANP32E is a histone chaperone that removes H2A.Z from chromatin.";
RL   Nature 505:648-653(2014).
RN   [36]
RP   FUNCTION.
RX   PubMed=25652260; DOI=10.15252/embr.201439123;
RA   Marza E., Taouji S., Barroso K., Raymond A.A., Guignard L., Bonneu M.,
RA   Pallares-Lupon N., Dupuy J.W., Fernandez-Zapico M.E., Rosenbaum J.,
RA   Palladino F., Dupuy D., Chevet E.;
RT   "Genome-wide screen identifies a novel p97/CDC-48-dependent pathway
RT   regulating ER-stress-induced gene transcription.";
RL   EMBO Rep. 16:332-340(2015).
RN   [37]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [38]
RP   INTERACTION WITH WAC.
RX   PubMed=26812014; DOI=10.1016/j.devcel.2015.12.019;
RA   David-Morrison G., Xu Z., Rui Y.N., Charng W.L., Jaiswal M.,
RA   Yamamoto S., Xiong B., Zhang K., Sandoval H., Duraine L., Zuo Z.,
RA   Zhang S., Bellen H.J.;
RT   "WAC regulates mTOR activity by acting as an adaptor for the TTT and
RT   Pontin/Reptin complexes.";
RL   Dev. Cell 36:139-151(2016).
RN   [39]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-9; LYS-444 AND LYS-456, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [40]
RP   STRUCTURE BY NMR OF 132-213.
RG   Mycobacterium tuberculosis structural genomics consortium (TB);
RT   "Solution structure of RSGI RUH-039, a fragment of C-terminal domain
RT   of RuvB-like 2 from human cDNA.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Possesses single-stranded DNA-stimulated ATPase and ATP-
CC       dependent DNA helicase (5' to 3') activity; hexamerization is
CC       thought to be critical for ATP hydrolysis and adjacent subunits in
CC       the ring-like structure contribute to the ATPase activity.
CC   -!- FUNCTION: Component of the NuA4 histone acetyltransferase complex
CC       which is involved in transcriptional activation of select genes
CC       principally by acetylation of nucleosomal histones H4 and H2A.
CC       This modification may both alter nucleosome - DNA interactions and
CC       promote interaction of the modified histones with other proteins
CC       which positively regulate transcription. This complex may be
CC       required for the activation of transcriptional programs associated
CC       with oncogene and proto-oncogene mediated growth induction, tumor
CC       suppressor mediated growth arrest and replicative senescence,
CC       apoptosis, and DNA repair. The NuA4 complex ATPase and helicase
CC       activities seem to be, at least in part, contributed by the
CC       association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a
CC       direct role in DNA repair when recruited to sites of DNA damage.
CC       Component of a SWR1-like complex that specifically mediates the
CC       removal of histone H2A.Z/H2AFZ from the nucleosome.
CC   -!- FUNCTION: Proposed core component of the chromatin remodeling
CC       INO80 complex which is involved in transcriptional regulation, DNA
CC       replication and probably DNA repair.
CC   -!- FUNCTION: Plays an essential role in oncogenic transformation by
CC       MYC and also modulates transcriptional activation by the
CC       LEF1/TCF1-CTNNB1 complex. May also inhibit the transcriptional
CC       activity of ATF2.
CC   -!- FUNCTION: Involved in the endoplasmic reticulum (ER)-associated
CC       degradation (ERAD) pathway where it negatively regulates
CC       expression of ER stress response genes.
CC       {ECO:0000269|PubMed:25652260}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC   -!- SUBUNIT: Forms homohexameric rings (Probable). Can form a
CC       dodecamer with RUVBL1 made of two stacked hexameric rings;
CC       however, even though RUVBL1 and RUVBL2 are present in equimolar
CC       ratio, the oligomeric status of each hexamer is not known.
CC       Oligomerization may regulate binding to nucleic acids and
CC       conversely, binding to nucleic acids may affect the dodecameric
CC       assembly. Interacts with the transcriptional activation domain of
CC       MYC. Interacts With ATF2. Component of the RNA polymerase II
CC       holoenzyme complex. May also act to bridge the LEF1/TCF1-CTNNB1
CC       complex and TBP. Component of the NuA4 histone acetyltransferase
CC       complex which contains the catalytic subunit KAT5/TIP60 and the
CC       subunits EP400, TRRAP/PAF400, BRD8/SMAP, EPC1, DMAP1/DNMAP1,
CC       RUVBL1/TIP49, RUVBL2, ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15,
CC       MORF4L2/MRGX, MRGBP, YEATS4/GAS41, VPS72/YL1 and MEAF6. The NuA4
CC       complex interacts with MYC and the adenovirus E1A protein. RUVBL2
CC       interacts with EP400. Component of a NuA4-related complex which
CC       contains EP400, TRRAP/PAF400, SRCAP, BRD8/SMAP, EPC1,
CC       DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2, actin, ACTL6A/BAF53A, VPS72
CC       and YEATS4/GAS41. Interacts with NPAT. Component of the chromatin-
CC       remodeling INO80 complex; specifically part of a complex module
CC       associated with the helicase ATP-binding and the helicase C-
CC       terminal domain of INO80. Component of some MLL1/MLL complex, at
CC       least composed of the core components KMT2A/MLL1, ASH2L,
CC       HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative components
CC       BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MGA,
CC       MYST1/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B,
CC       SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. Interacts with
CC       IGHMBP2. Interacts with TELO2. Interacts with HINT1. Component of
CC       a SWR1-like complex. Component of the R2TP complex composed at
CC       least of PIHD1, RUVBL1, RUVBL2 and RPAP3 (PubMed:20864032).
CC       Interacts with ITFG1 (PubMed:25437307). Interacts with WAC; WAC
CC       positively regulates MTOR activity by promoting the assembly of
CC       the TTT complex composed of TELO2, TTI1 and TTI2 and the RUVBL
CC       complex composed of RUVBL1 and RUVBL2 into the TTT-RUVBL complex
CC       which leads to the dimerization of the mTORC1 complex and its
CC       subsequent activation (PubMed:26812014).
CC       {ECO:0000269|PubMed:10428817, ECO:0000269|PubMed:10882073,
CC       ECO:0000269|PubMed:10966108, ECO:0000269|PubMed:11713276,
CC       ECO:0000269|PubMed:12963728, ECO:0000269|PubMed:14966270,
CC       ECO:0000269|PubMed:15960975, ECO:0000269|PubMed:16014379,
CC       ECO:0000269|PubMed:16230350, ECO:0000269|PubMed:17157868,
CC       ECO:0000269|PubMed:17967892, ECO:0000269|PubMed:18026119,
CC       ECO:0000269|PubMed:19299493, ECO:0000269|PubMed:20801936,
CC       ECO:0000269|PubMed:20864032, ECO:0000269|PubMed:21303910,
CC       ECO:0000269|PubMed:24463511, ECO:0000269|PubMed:25437307,
CC       ECO:0000269|PubMed:26812014, ECO:0000305}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-352939, EBI-352939;
CC       Q8IW40:CCDC103; NbExp=3; IntAct=EBI-352939, EBI-10261970;
CC       Q9BVM2:DPCD; NbExp=6; IntAct=EBI-352939, EBI-749988;
CC       Q8TBB1:LNX1; NbExp=5; IntAct=EBI-352939, EBI-739832;
CC       Q9Y265:RUVBL1; NbExp=29; IntAct=EBI-352939, EBI-353675;
CC       P25490:YY1; NbExp=6; IntAct=EBI-352939, EBI-765538;
CC   -!- SUBCELLULAR LOCATION: Nucleus matrix. Nucleus, nucleoplasm.
CC       Cytoplasm. Membrane. Note=Mainly localized in the nucleus,
CC       associated with nuclear matrix or in the nuclear cytosol. Although
CC       it is also present in the cytoplasm and associated with the cell
CC       membranes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y230-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y230-2; Sequence=VSP_056584;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Highly expressed in
CC       testis and thymus.
CC   -!- DOMAIN: The C-terminal domain is required for association with
CC       ATF2.
CC   -!- SIMILARITY: Belongs to the RuvB family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD34041.1; Type=Frameshift; Positions=401; Evidence={ECO:0000305};
CC       Sequence=AAH08355.1; Type=Frameshift; Positions=191; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RUVBL2ID42185ch19q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y18417; CAB46270.1; -; mRNA.
DR   EMBL; AB024301; BAA76708.1; -; mRNA.
DR   EMBL; AF155138; AAD38073.1; -; mRNA.
DR   EMBL; AF124607; AAF87087.1; -; mRNA.
DR   EMBL; AF151804; AAD34041.1; ALT_FRAME; mRNA.
DR   EMBL; AL136743; CAB66677.1; -; mRNA.
DR   EMBL; AK057498; BAG51921.1; -; mRNA.
DR   EMBL; AK074542; BAC11048.1; -; mRNA.
DR   EMBL; CR533507; CAG38538.1; -; mRNA.
DR   EMBL; AC008687; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471177; EAW52426.1; -; Genomic_DNA.
DR   EMBL; CH471177; EAW52430.1; -; Genomic_DNA.
DR   EMBL; BC000428; AAH00428.1; -; mRNA.
DR   EMBL; BC004531; AAH04531.1; -; mRNA.
DR   EMBL; BC008355; AAH08355.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS42588.1; -. [Q9Y230-1]
DR   PIR; T46313; T46313.
DR   RefSeq; NP_001308120.1; NM_001321191.1. [Q9Y230-2]
DR   RefSeq; NP_006657.1; NM_006666.2. [Q9Y230-1]
DR   RefSeq; XP_011524632.1; XM_011526330.1. [Q9Y230-2]
DR   UniGene; Hs.515846; -.
DR   PDB; 2CQA; NMR; -; A=132-213.
DR   PDB; 2XSZ; X-ray; 3.00 A; D/E/F=2-133, D/E/F=238-463.
DR   PDB; 3UK6; X-ray; 2.95 A; A/B/C/D/E/F/G/H/I/J/K/L=1-132, A/B/C/D/E/F/G/H/I/J/K/L=239-463.
DR   PDB; 5N7R; X-ray; 2.87 A; A=2-463.
DR   PDB; 5OAF; EM; 4.06 A; B/D/F=1-463.
DR   PDB; 6FO1; EM; 3.57 A; D/E/F=1-463.
DR   PDBsum; 2CQA; -.
DR   PDBsum; 2XSZ; -.
DR   PDBsum; 3UK6; -.
DR   PDBsum; 5N7R; -.
DR   PDBsum; 5OAF; -.
DR   PDBsum; 6FO1; -.
DR   ProteinModelPortal; Q9Y230; -.
DR   SMR; Q9Y230; -.
DR   BioGrid; 116067; 277.
DR   CORUM; Q9Y230; -.
DR   DIP; DIP-28153N; -.
DR   IntAct; Q9Y230; 121.
DR   MINT; Q9Y230; -.
DR   STRING; 9606.ENSP00000473172; -.
DR   ChEMBL; CHEMBL2062349; -.
DR   iPTMnet; Q9Y230; -.
DR   PhosphoSitePlus; Q9Y230; -.
DR   SwissPalm; Q9Y230; -.
DR   BioMuta; RUVBL2; -.
DR   DMDM; 28201890; -.
DR   REPRODUCTION-2DPAGE; IPI00009104; -.
DR   EPD; Q9Y230; -.
DR   PaxDb; Q9Y230; -.
DR   PeptideAtlas; Q9Y230; -.
DR   PRIDE; Q9Y230; -.
DR   DNASU; 10856; -.
DR   Ensembl; ENST00000595090; ENSP00000473172; ENSG00000183207. [Q9Y230-1]
DR   GeneID; 10856; -.
DR   KEGG; hsa:10856; -.
DR   UCSC; uc002plr.2; human. [Q9Y230-1]
DR   CTD; 10856; -.
DR   DisGeNET; 10856; -.
DR   EuPathDB; HostDB:ENSG00000183207.12; -.
DR   GeneCards; RUVBL2; -.
DR   HGNC; HGNC:10475; RUVBL2.
DR   HPA; CAB012432; -.
DR   HPA; HPA042880; -.
DR   HPA; HPA067966; -.
DR   MIM; 604788; gene.
DR   neXtProt; NX_Q9Y230; -.
DR   OpenTargets; ENSG00000183207; -.
DR   PharmGKB; PA34888; -.
DR   eggNOG; KOG2680; Eukaryota.
DR   eggNOG; COG1224; LUCA.
DR   GeneTree; ENSGT00890000139527; -.
DR   HOGENOM; HOG000190885; -.
DR   HOVERGEN; HBG054186; -.
DR   InParanoid; Q9Y230; -.
DR   KO; K11338; -.
DR   OMA; VPFTMIA; -.
DR   OrthoDB; EOG091G07C9; -.
DR   PhylomeDB; Q9Y230; -.
DR   TreeFam; TF300469; -.
DR   Reactome; R-HSA-171319; Telomere Extension By Telomerase.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   ChiTaRS; RUVBL2; human.
DR   EvolutionaryTrace; Q9Y230; -.
DR   GeneWiki; RUVBL2; -.
DR   GenomeRNAi; 10856; -.
DR   PRO; PR:Q9Y230; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000183207; -.
DR   CleanEx; HS_RUVBL2; -.
DR   ExpressionAtlas; Q9Y230; baseline and differential.
DR   Genevisible; Q9Y230; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031011; C:Ino80 complex; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IDA:LIFEdb.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0071339; C:MLL1 complex; IDA:UniProtKB.
DR   GO; GO:0035267; C:NuA4 histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0005719; C:nuclear euchromatin; IDA:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0097255; C:R2TP complex; IDA:UniProtKB.
DR   GO; GO:0000812; C:Swr1 complex; IDA:UniProtKB.
DR   GO; GO:0043531; F:ADP binding; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0043141; F:ATP-dependent 5'-3' DNA helicase activity; IEA:InterPro.
DR   GO; GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc.
DR   GO; GO:0051117; F:ATPase binding; IEA:Ensembl.
DR   GO; GO:0008013; F:beta-catenin binding; IDA:UniProtKB.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:UniProtKB.
DR   GO; GO:0003678; F:DNA helicase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0017025; F:TBP-class protein binding; IDA:UniProtKB.
DR   GO; GO:0001094; F:TFIID-class transcription factor binding; IEA:Ensembl.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:ProtInc.
DR   GO; GO:0000492; P:box C/D snoRNP assembly; IBA:GO_Central.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IMP:UniProtKB.
DR   GO; GO:0034644; P:cellular response to UV; IMP:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; IMP:UniProtKB.
DR   GO; GO:0006310; P:DNA recombination; TAS:ProtInc.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0071169; P:establishment of protein localization to chromatin; IMP:UniProtKB.
DR   GO; GO:0043968; P:histone H2A acetylation; IDA:UniProtKB.
DR   GO; GO:0043967; P:histone H4 acetylation; IDA:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0071899; P:negative regulation of estrogen receptor binding; IMP:UniProtKB.
DR   GO; GO:0035066; P:positive regulation of histone acetylation; IMP:UniProtKB.
DR   GO; GO:1904874; P:positive regulation of telomerase RNA localization to Cajal body; HMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0006457; P:protein folding; TAS:ProtInc.
DR   GO; GO:0040008; P:regulation of growth; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0071733; P:transcriptional activation by promoter-enhancer looping; IMP:UniProtKB.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR027238; RuvB-like.
DR   InterPro; IPR037942; RUVBL2.
DR   InterPro; IPR010339; TIP49_C.
DR   PANTHER; PTHR11093; PTHR11093; 1.
DR   PANTHER; PTHR11093:SF2; PTHR11093:SF2; 1.
DR   Pfam; PF06068; TIP49; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   ATP-binding; Chromatin regulator; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; DNA damage; DNA recombination; DNA repair;
KW   Growth regulation; Helicase; Hydrolase; Isopeptide bond; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|Ref.14}.
FT   CHAIN         2    463       RuvB-like 2.
FT                                /FTId=PRO_0000165644.
FT   NP_BIND      77     84       ATP.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.14}.
FT   MOD_RES     437    437       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK      9      9       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    444    444       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    456    456       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1     45       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056584.
FT   MUTAGEN     299    299       D->N: Abolishes ATPase activity.
FT                                {ECO:0000269|PubMed:17157868}.
FT   CONFLICT    214    214       D -> N (in Ref. 6; AAD34041).
FT                                {ECO:0000305}.
FT   CONFLICT    257    258       FL -> YV (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   TURN         19     22       {ECO:0000244|PDB:3UK6}.
FT   TURN         24     27       {ECO:0000244|PDB:2XSZ}.
FT   STRAND       41     43       {ECO:0000244|PDB:3UK6}.
FT   STRAND       46     48       {ECO:0000244|PDB:3UK6}.
FT   HELIX        50     64       {ECO:0000244|PDB:3UK6}.
FT   STRAND       72     78       {ECO:0000244|PDB:3UK6}.
FT   HELIX        83     94       {ECO:0000244|PDB:3UK6}.
FT   STRAND      100    104       {ECO:0000244|PDB:3UK6}.
FT   HELIX       105    108       {ECO:0000244|PDB:3UK6}.
FT   STRAND      111    113       {ECO:0000244|PDB:3UK6}.
FT   HELIX       115    125       {ECO:0000244|PDB:3UK6}.
FT   STRAND      126    129       {ECO:0000244|PDB:3UK6}.
FT   STRAND      136    148       {ECO:0000244|PDB:2CQA}.
FT   STRAND      152    156       {ECO:0000244|PDB:2CQA}.
FT   STRAND      158    164       {ECO:0000244|PDB:2CQA}.
FT   STRAND      166    174       {ECO:0000244|PDB:2CQA}.
FT   HELIX       177    184       {ECO:0000244|PDB:2CQA}.
FT   STRAND      191    196       {ECO:0000244|PDB:2CQA}.
FT   TURN        197    200       {ECO:0000244|PDB:2CQA}.
FT   STRAND      201    206       {ECO:0000244|PDB:2CQA}.
FT   STRAND      241    243       {ECO:0000244|PDB:2XSZ}.
FT   HELIX       244    250       {ECO:0000244|PDB:3UK6}.
FT   HELIX       270    286       {ECO:0000244|PDB:3UK6}.
FT   STRAND      290    293       {ECO:0000244|PDB:2XSZ}.
FT   STRAND      295    300       {ECO:0000244|PDB:3UK6}.
FT   HELIX       301    303       {ECO:0000244|PDB:3UK6}.
FT   HELIX       306    315       {ECO:0000244|PDB:3UK6}.
FT   STRAND      323    329       {ECO:0000244|PDB:3UK6}.
FT   STRAND      331    334       {ECO:0000244|PDB:3UK6}.
FT   STRAND      341    343       {ECO:0000244|PDB:3UK6}.
FT   HELIX       348    351       {ECO:0000244|PDB:3UK6}.
FT   STRAND      354    359       {ECO:0000244|PDB:3UK6}.
FT   HELIX       364    377       {ECO:0000244|PDB:3UK6}.
FT   HELIX       384    396       {ECO:0000244|PDB:3UK6}.
FT   HELIX       399    415       {ECO:0000244|PDB:3UK6}.
FT   STRAND      419    421       {ECO:0000244|PDB:3UK6}.
FT   HELIX       423    432       {ECO:0000244|PDB:3UK6}.
FT   HELIX       436    443       {ECO:0000244|PDB:3UK6}.
SQ   SEQUENCE   463 AA;  51157 MW;  54C78E9C587D975A CRC64;
     MATVTATTKV PEIRDVTRIE RIGAHSHIRG LGLDDALEPR QASQGMVGQL AARRAAGVVL
     EMIREGKIAG RAVLIAGQPG TGKTAIAMGM AQALGPDTPF TAIAGSEIFS LEMSKTEALT
     QAFRRSIGVR IKEETEIIEG EVVEIQIDRP ATGTGSKVGK LTLKTTEMET IYDLGTKMIE
     SLTKDKVQAG DVITIDKATG KISKLGRSFT RARDYDAMGS QTKFVQCPDG ELQKRKEVVH
     TVSLHEIDVI NSRTQGFLAL FSGDTGEIKS EVREQINAKV AEWREEGKAE IIPGVLFIDE
     VHMLDIESFS FLNRALESDM APVLIMATNR GITRIRGTSY QSPHGIPIDL LDRLLIVSTT
     PYSEKDTKQI LRIRCEEEDV EMSEDAYTVL TRIGLETSLR YAIQLITAAS LVCRKRKGTE
     VQVDDIKRVY SLFLDESRST QYMKEYQDAF LFNELKGETM DTS
//
ID   B4DMJ5_HUMAN            Unreviewed;       242 AA.
AC   B4DMJ5;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 74.
DE   SubName: Full=cDNA FLJ53012, highly similar to Tubulin beta-7 chain {ECO:0000313|EMBL:BAG59907.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59907.1};
RN   [1] {ECO:0000313|EMBL:BAG59907.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG59907.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules. It
CC       binds two moles of GTP, one at an exchangeable site on the beta
CC       chain and one at a non-exchangeable site on the alpha chain.
CC       {ECO:0000256|SAAS:SAAS00031082}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000256|SAAS:SAAS00361597}.
CC   -!- SIMILARITY: Belongs to the tubulin family.
CC       {ECO:0000256|SAAS:SAAS00576975}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK297489; BAG59907.1; -; mRNA.
DR   RefSeq; NP_001280142.1; NM_001293213.1.
DR   UniGene; Hs.636480; -.
DR   ProteinModelPortal; B4DMJ5; -.
DR   SMR; B4DMJ5; -.
DR   PeptideAtlas; B4DMJ5; -.
DR   PRIDE; B4DMJ5; -.
DR   GeneID; 203068; -.
DR   CTD; 203068; -.
DR   eggNOG; KOG1375; Eukaryota.
DR   eggNOG; COG5023; LUCA.
DR   HOGENOM; HOG000165712; -.
DR   HOVERGEN; HBG000089; -.
DR   GenomeRNAi; 203068; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro.
DR   GO; GO:0007017; P:microtubule-based process; IEA:InterPro.
DR   Gene3D; 1.10.287.600; -; 1.
DR   Gene3D; 3.40.50.1440; -; 1.
DR   InterPro; IPR013838; Beta-tubulin_BS.
DR   InterPro; IPR002453; Beta_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; PTHR11588; 2.
DR   PANTHER; PTHR11588:SF256; PTHR11588:SF256; 2.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01163; BETATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SUPFAM; SSF52490; SSF52490; 1.
DR   SUPFAM; SSF55307; SSF55307; 1.
DR   PROSITE; PS00228; TUBULIN_B_AUTOREG; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Cytoplasm {ECO:0000256|SAAS:SAAS00045377};
KW   Cytoskeleton {ECO:0000256|SAAS:SAAS00045377};
KW   GTP-binding {ECO:0000256|SAAS:SAAS00596730};
KW   Microtubule {ECO:0000256|SAAS:SAAS00576796};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00596730}.
FT   DOMAIN       47    191       Tubulin. {ECO:0000259|SMART:SM00864}.
FT   COILED      206    233       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   242 AA;  27307 MW;  0E58CE262055F9E2 CRC64;
     MREIVHIQAG QCGNQIGAKF WEVISDEHGI DPTGTYHGDS DLQLDRISVY YNEATGGKYV
     PRAILVDLEP GTMDSVRSGP FGQIFRPDNF VFGQSGAGNN WAKGHYTEGA ELVDSVLDVV
     RKEVDEQMLN VQNKNSSYFV EWIPNNVKTA VCDIPPRGLK MAVTFIGNST AIQELFKRIS
     EQFTAMFRRK AFLHWYTGEG MDEMEFTEAE SNMNDLVSEY QQYQDATAEE EEDFGEEAEE
     EA
//
ID   B4DQN9_HUMAN            Unreviewed;       372 AA.
AC   B4DQN9;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 69.
DE   RecName: Full=Tubulin beta chain {ECO:0000256|RuleBase:RU000352};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG61001.1};
RN   [1] {ECO:0000313|EMBL:BAG61001.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules. It
CC       binds two moles of GTP, one at an exchangeable site on the beta
CC       chain and one at a non-exchangeable site on the alpha chain.
CC       {ECO:0000256|RuleBase:RU000352}.
CC   -!- SUBUNIT: Dimer of alpha and beta chains. A typical microtubule is
CC       a hollow water-filled tube with an outer diameter of 25 nm and an
CC       inner diameter of 15 nM. Alpha-beta heterodimers associate head-
CC       to-tail to form protofilaments running lengthwise along the
CC       microtubule wall with the beta-tubulin subunit facing the
CC       microtubule plus end conferring a structural polarity.
CC       Microtubules usually have 13 protofilaments but different
CC       protofilament numbers can be found in some organisms and
CC       specialized cells. {ECO:0000256|RuleBase:RU000352}.
CC   -!- SIMILARITY: Belongs to the tubulin family.
CC       {ECO:0000256|RuleBase:RU000352, ECO:0000256|SAAS:SAAS00576975}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK298889; BAG61001.1; -; mRNA.
DR   RefSeq; NP_001280144.1; NM_001293215.1.
DR   UniGene; Hs.636480; -.
DR   IntAct; B4DQN9; 1.
DR   PeptideAtlas; B4DQN9; -.
DR   PRIDE; B4DQN9; -.
DR   GeneID; 203068; -.
DR   CTD; 203068; -.
DR   eggNOG; KOG1375; Eukaryota.
DR   eggNOG; COG5023; LUCA.
DR   HOGENOM; HOG000165710; -.
DR   HOVERGEN; HBG000089; -.
DR   GenomeRNAi; 203068; -.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003924; F:GTPase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro.
DR   GO; GO:0007017; P:microtubule-based process; IEA:InterPro.
DR   Gene3D; 1.10.287.600; -; 1.
DR   Gene3D; 3.30.1330.20; -; 1.
DR   Gene3D; 3.40.50.1440; -; 1.
DR   InterPro; IPR002453; Beta_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR037103; Tubulin/FtsZ_C_sf.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR017975; Tubulin_CS.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; PTHR11588; 1.
DR   PANTHER; PTHR11588:SF256; PTHR11588:SF256; 1.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01163; BETATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SMART; SM00865; Tubulin_C; 1.
DR   SUPFAM; SSF52490; SSF52490; 1.
DR   SUPFAM; SSF55307; SSF55307; 1.
DR   PROSITE; PS00227; TUBULIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   GTP-binding {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00977278};
KW   Microtubule {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00576796};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00977278}.
FT   DOMAIN        1    172       Tubulin. {ECO:0000259|SMART:SM00864}.
FT   DOMAIN      174    311       Tubulin_C. {ECO:0000259|SMART:SM00865}.
FT   COILED      336    363       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   372 AA;  41724 MW;  DE7F78305733C76E CRC64;
     MDSVRSGPFG QIFRPDNFVF GQSGAGNNWA KGHYTEGAEL VDPVLDVVRK EAESCDCLQG
     FQLTHSLGGG TGSGMGTLLI SKIREEYPDR IMNTFSVVPS PKVSDTVVEP YNATLSVHQL
     VENTDETYCI DNEALYDICF RTLKLTTPTY GDLNHLVSAT MSGVTTCLRF PGQLNADLRK
     LAVNMVPFPR LHFFMPGFAP LTSRGSQQYR ALTVPELTQQ VFDAKNMMAA CDPRHGRYLT
     AAAVFRGRMS MKEVDEQMLN VQNKNSSYFV EWIPNNVKTA VCDIPPRGLK MAVTFIGNST
     AIQELFKRIS EQFTAMFRRK AFLHWYTGEG MDEMEFTEAE SNMNDLVSEY QQYQDATAEE
     EEDFGEEAEE EA
//
ID   B4DY90_HUMAN            Unreviewed;       464 AA.
AC   B4DY90;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 69.
DE   RecName: Full=Tubulin beta chain {ECO:0000256|RuleBase:RU000352};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG63652.1};
RN   [1] {ECO:0000313|EMBL:BAG63652.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAG63652.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules. It
CC       binds two moles of GTP, one at an exchangeable site on the beta
CC       chain and one at a non-exchangeable site on the alpha chain.
CC       {ECO:0000256|RuleBase:RU000352}.
CC   -!- SUBUNIT: Dimer of alpha and beta chains. A typical microtubule is
CC       a hollow water-filled tube with an outer diameter of 25 nm and an
CC       inner diameter of 15 nM. Alpha-beta heterodimers associate head-
CC       to-tail to form protofilaments running lengthwise along the
CC       microtubule wall with the beta-tubulin subunit facing the
CC       microtubule plus end conferring a structural polarity.
CC       Microtubules usually have 13 protofilaments but different
CC       protofilament numbers can be found in some organisms and
CC       specialized cells. {ECO:0000256|RuleBase:RU000352}.
CC   -!- SIMILARITY: Belongs to the tubulin family.
CC       {ECO:0000256|RuleBase:RU000352, ECO:0000256|SAAS:SAAS00576975}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK302314; BAG63652.1; -; mRNA.
DR   RefSeq; NP_001280141.1; NM_001293212.1.
DR   UniGene; Hs.636480; -.
DR   PeptideAtlas; B4DY90; -.
DR   PRIDE; B4DY90; -.
DR   GeneID; 203068; -.
DR   CTD; 203068; -.
DR   eggNOG; KOG1375; Eukaryota.
DR   eggNOG; COG5023; LUCA.
DR   HOGENOM; HOG000165710; -.
DR   HOVERGEN; HBG000089; -.
DR   GenomeRNAi; 203068; -.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003924; F:GTPase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro.
DR   GO; GO:0007017; P:microtubule-based process; IEA:InterPro.
DR   Gene3D; 1.10.287.600; -; 1.
DR   Gene3D; 3.30.1330.20; -; 1.
DR   Gene3D; 3.40.50.1440; -; 1.
DR   InterPro; IPR002453; Beta_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR037103; Tubulin/FtsZ_C_sf.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR017975; Tubulin_CS.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; PTHR11588; 1.
DR   PANTHER; PTHR11588:SF256; PTHR11588:SF256; 1.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01163; BETATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SMART; SM00865; Tubulin_C; 1.
DR   SUPFAM; SSF52490; SSF52490; 1.
DR   SUPFAM; SSF55307; SSF55307; 1.
DR   PROSITE; PS00227; TUBULIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   GTP-binding {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00977278};
KW   Microtubule {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00576796};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00977278}.
FT   DOMAIN       67    264       Tubulin. {ECO:0000259|SMART:SM00864}.
FT   DOMAIN      266    403       Tubulin_C. {ECO:0000259|SMART:SM00865}.
FT   COILED      428    455       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   464 AA;  52048 MW;  1E0C5424F23274C9 CRC64;
     MGDVGPRWAN WDPSRSGVRD HPGQQSETLP HATFLQKIKF WEVISDEHGI DPTGTYHGDS
     DLQLDRISVY YNEATGGKYV PRAILVDLEP GTMDSVRSGP FGQIFRPDNF VFGQSGAGNN
     WAKGHYTEGA ELVDSVLDVV WKEAESCDCL QGFQLTHSLG GGTGSGMGTL LISKIREEYP
     DRIMNTFSVV PSPKVSDTVV EPYNATLSVH QLVENTDETY CIDNEALYDI CFRTLKLTTP
     TYGDLNHLVS ATMSGVTTCL RFPGQLNADL RKLAVNMVPF PRLHFFMPGF APLTSRGSQQ
     YRALTVPELT QQVFDAKNMM AACDPRHGRY LTVAAVFRGR MSMKEVDEQM LNVQNKNSSY
     FVEWIPNNVK TAVCDIPPRG LKMAVTFIGN STAIQELFKR ISEQFTAMFR RKAFLHWYTG
     EGMDEMEFTE AESNMNDLVS EYQQYQDATA EEEEDFGEEA EEEA
//
ID   TBB5_HUMAN              Reviewed;         444 AA.
AC   P07437; P05218; Q8WUC1; Q9CY33;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 2.
DT   23-MAY-2018, entry version 213.
DE   RecName: Full=Tubulin beta chain;
DE   AltName: Full=Tubulin beta-5 chain;
GN   Name=TUBB; Synonyms=TUBB5; ORFNames=OK/SW-cl.56;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6688039; DOI=10.1016/0092-8674(83)90429-4;
RA   Lee M.G.-S., Lewis S.A., Wilde C.D., Cowan N.J.;
RT   "Evolutionary history of a multigene family: an expressed human beta-
RT   tubulin gene and three processed pseudogenes.";
RL   Cell 33:477-487(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6865944; DOI=10.1128/MCB.3.5.854;
RA   Hall J.L., Dudley L., Dobner P.R., Lewis S.A., Cowan N.J.;
RT   "Identification of two human beta-tubulin isotypes.";
RL   Mol. Cell. Biol. 3:854-862(1983).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=11504633; DOI=10.1016/S0968-0896(01)00103-1;
RA   Crabtree D.V., Ojima I., Geng X., Adler A.J.;
RT   "Tubulins in the primate retina: evidence that xanthophylls may be
RT   endogenous ligands for the paclitaxel-binding site.";
RL   Bioorg. Med. Chem. 9:1967-1976(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Shiina T., Ota M., Katsuyama Y., Hashimoto N., Inoko H.;
RT   "Genome diversity in HLA: a new strategy for detection of genetic
RT   polymorphisms in expressed genes within the HLA class III and class I
RT   regions.";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-
RT   reactive CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Eye, Lung, Muscle, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 1-19; 47-77; 104-174; 242-276; 283-297; 310-359
RP   AND 363-390, METHYLATION AT ARG-318, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Foreskin fibroblast, and Mammary carcinoma;
RA   Bienvenut W.V., Campbell A., Ozanne B.W., Lourenco F., Olson M.F.;
RL   Submitted (DEC-2009) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 3-19; 47-58; 63-77; 104-121; 163-174; 242-251;
RP   253-276; 283-297; 310-318; 325-336 AND 381-390, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [12]
RP   PHOSPHORYLATION AT SER-172.
RX   PubMed=16371510; DOI=10.1091/mbc.E05-07-0621;
RA   Fourest-Lieuvin A., Peris L., Gache V., Garcia-Saez I.,
RA   Juillan-Binard C., Lantez V., Job D.;
RT   "Microtubule regulation in mitosis: tubulin phosphorylation by the
RT   cyclin-dependent kinase Cdk1.";
RL   Mol. Biol. Cell 17:1041-1050(2006).
RN   [13]
RP   GLYCYLATION.
RX   PubMed=19524510; DOI=10.1016/j.cell.2009.05.020;
RA   Rogowski K., Juge F., van Dijk J., Wloga D., Strub J.-M.,
RA   Levilliers N., Thomas D., Bre M.-H., Van Dorsselaer A., Gaertig J.,
RA   Janke C.;
RT   "Evolutionary divergence of enzymatic mechanisms for posttranslational
RT   polyglycylation.";
RL   Cell 137:1076-1087(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-58, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   TISSUE SPECIFICITY.
RX   PubMed=20191564; DOI=10.1002/cm.20436;
RA   Leandro-Garcia L.J., Leskela S., Landa I., Montero-Conde C.,
RA   Lopez-Jimenez E., Leton R., Cascon A., Robledo M.,
RA   Rodriguez-Antona C.;
RT   "Tumoral and tissue-specific expression of the major human beta-
RT   tubulin isotypes.";
RL   Cytoskeleton 67:214-223(2010).
RN   [16]
RP   INTERACTION WITH PIFO.
RX   PubMed=20643351; DOI=10.1016/j.devcel.2010.06.005;
RA   Kinzel D., Boldt K., Davis E.E., Burtscher I., Trumbach D., Diplas B.,
RA   Attie-Bitach T., Wurst W., Katsanis N., Ueffing M., Lickert H.;
RT   "Pitchfork regulates primary cilia disassembly and left-right
RT   asymmetry.";
RL   Dev. Cell 19:66-77(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-55; THR-285 AND THR-290,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   INTERACTION WITH DIAPH1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23325789; DOI=10.1091/mbc.E12-08-0597;
RA   Li D., Dammer E.B., Lucki N.C., Sewer M.B.;
RT   "cAMP-stimulated phosphorylation of diaphanous 1 regulates protein
RT   stability and interaction with binding partners in adrenocortical
RT   cells.";
RL   Mol. Biol. Cell 24:848-857(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   GLUTAMYLATION.
RX   PubMed=26875866; DOI=10.1016/j.cell.2016.01.019;
RA   Valenstein M.L., Roll-Mecak A.;
RT   "Graded control of microtubule severing by tubulin glutamylation.";
RL   Cell 164:911-921(2016).
RN   [23]
RP   VARIANTS CDCBM6 VAL-299; ILE-353 AND LYS-401, AND CHARACTERIZATION OF
RP   VARIANTS CDCBM6 VAL-299 AND LYS-401.
RX   PubMed=23246003; DOI=10.1016/j.celrep.2012.11.017;
RA   Breuss M., Heng J.I., Poirier K., Tian G., Jaglin X.H., Qu Z.,
RA   Braun A., Gstrein T., Ngo L., Haas M., Bahi-Buisson N., Moutard M.L.,
RA   Passemard S., Verloes A., Gressens P., Xie Y., Robson K.J., Rani D.S.,
RA   Thangaraj K., Clausen T., Chelly J., Cowan N.J., Keays D.A.;
RT   "Mutations in the beta-tubulin gene TUBB5 cause microcephaly with
RT   structural brain abnormalities.";
RL   Cell Rep. 2:1554-1562(2012).
RN   [24]
RP   INVOLVEMENT IN CSCSC1, VARIANTS CSCSC1 LYS-15 AND PHE-222,
RP   CHARACTERIZATION OF VARIANTS CSCSC1 LYS-15 AND PHE-222, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=26637975; DOI=10.1016/j.ajhg.2015.10.014;
RA   Isrie M., Breuss M., Tian G., Hansen A.H., Cristofoli F.,
RA   Morandell J., Kupchinsky Z.A., Sifrim A., Rodriguez-Rodriguez C.M.,
RA   Dapena E.P., Doonanco K., Leonard N., Tinsa F., Moortgat S.,
RA   Ulucan H., Koparir E., Karaca E., Katsanis N., Marton V.,
RA   Vermeesch J.R., Davis E.E., Cowan N.J., Keays D.A., Van Esch H.;
RT   "Mutations in Either TUBB or MAPRE2 Cause Circumferential Skin Creases
RT   Kunze Type.";
RL   Am. J. Hum. Genet. 97:790-800(2015).
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules. It
CC       binds two moles of GTP, one at an exchangeable site on the beta
CC       chain and one at a non-exchangeable site on the alpha chain.
CC   -!- SUBUNIT: Heterodimer of alpha and beta chains (PubMed:26637975). A
CC       typical microtubule is a hollow water-filled tube with an outer
CC       diameter of 25 nm and an inner diameter of 15 nM. Alpha-beta
CC       heterodimers associate head-to-tail to form protofilaments running
CC       lengthwise along the microtubule wall with the beta-tubulin
CC       subunit facing the microtubule plus end conferring a structural
CC       polarity. Microtubules usually have 13 protofilaments but
CC       different protofilament numbers can be found in some organisms and
CC       specialized cells. Interacts with PIFO (PubMed:20643351).
CC       Interacts with DIAPH1 (PubMed:23325789). Interacts with MX1 (By
CC       similarity). May interact with RNABP10 (By similarity). Interacts
CC       with CFAP157 (By similarity). {ECO:0000250|UniProtKB:P69893,
CC       ECO:0000250|UniProtKB:P99024, ECO:0000269|PubMed:20643351,
CC       ECO:0000269|PubMed:23325789, ECO:0000269|PubMed:26637975}.
CC   -!- INTERACTION:
CC       Q8AZK7:EBNA-LP (xeno); NbExp=3; IntAct=EBI-350864, EBI-1185167;
CC       P05412:JUN; NbExp=3; IntAct=EBI-350864, EBI-852823;
CC       Q5S007:LRRK2; NbExp=4; IntAct=EBI-350864, EBI-5323863;
CC       Q9BSI4:TINF2; NbExp=2; IntAct=EBI-350864, EBI-717399;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:26637975}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed with highest levels in
CC       spleen, thymus and immature brain. {ECO:0000269|PubMed:20191564}.
CC   -!- DOMAIN: The highly acidic C-terminal region may bind cations such
CC       as calcium.
CC   -!- PTM: Some glutamate residues at the C-terminus are
CC       polyglutamylated, resulting in polyglutamate chains on the gamma-
CC       carboxyl group (PubMed:26875866). Polyglutamylation plays a key
CC       role in microtubule severing by spastin (SPAST). SPAST
CC       preferentially recognizes and acts on microtubules decorated with
CC       short polyglutamate tails: severing activity by SPAST increases as
CC       the number of glutamates per tubulin rises from one to eight, but
CC       decreases beyond this glutamylation threshold (PubMed:26875866).
CC       {ECO:0000269|PubMed:26875866}.
CC   -!- PTM: Some glutamate residues at the C-terminus are monoglycylated
CC       but not polyglycylated due to the absence of functional TTLL10 in
CC       human. Monoglycylation is mainly limited to tubulin incorporated
CC       into axonemes (cilia and flagella). Both polyglutamylation and
CC       monoglycylation can coexist on the same protein on adjacent
CC       residues, and lowering glycylation levels increases
CC       polyglutamylation, and reciprocally. The precise function of
CC       monoglycylation is still unclear (Probable).
CC       {ECO:0000305|PubMed:19524510}.
CC   -!- PTM: Phosphorylated on Ser-172 by CDK1 during the cell cycle, from
CC       metaphase to telophase, but not in interphase. This
CC       phosphorylation inhibits tubulin incorporation into microtubules.
CC       {ECO:0000269|PubMed:16371510}.
CC   -!- DISEASE: Cortical dysplasia, complex, with other brain
CC       malformations 6 (CDCBM6) [MIM:615771]: A disorder of aberrant
CC       neuronal migration and disturbed axonal guidance. Affected
CC       individuals have microcephaly, ataxia, and severe delayed
CC       psychomotor development. Brain imaging shows variable
CC       malformations of cortical development, including white matter
CC       streaks, dysmorphic basal ganglia, corpus callosum abnormalities,
CC       brainstem and cerebellar hypoplasia, cortical dysplasia,
CC       polymicrogyria. {ECO:0000269|PubMed:23246003}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Skin creases, congenital symmetric circumferential, 1
CC       (CSCSC1) [MIM:156610]: An autosomal dominant disease characterized
CC       by multiple, symmetric, circumferential rings of folded skin,
CC       affecting primarily the limbs. Affected individuals also exhibit
CC       intellectual disability, cleft palate, and dysmorphic features.
CC       {ECO:0000269|PubMed:26637975}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the tubulin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Tubulin entry;
CC       URL="https://en.wikipedia.org/wiki/Tubulin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J00314; AAB59507.1; -; Genomic_DNA.
DR   EMBL; AF141349; AAD33873.1; -; mRNA.
DR   EMBL; AF070561; AAC28642.1; -; mRNA.
DR   EMBL; AF070593; AAC28650.1; -; mRNA.
DR   EMBL; AF070600; AAC28654.1; -; mRNA.
DR   EMBL; BA000025; BAB63321.1; -; Genomic_DNA.
DR   EMBL; AB088100; BAC54932.1; -; Genomic_DNA.
DR   EMBL; AB062393; BAB93480.1; -; mRNA.
DR   EMBL; BC001938; AAH01938.1; -; mRNA.
DR   EMBL; BC002347; AAH02347.1; -; mRNA.
DR   EMBL; BC005838; AAH05838.1; -; mRNA.
DR   EMBL; BC007605; AAH07605.1; -; mRNA.
DR   EMBL; BC013374; AAH13374.1; -; mRNA.
DR   EMBL; BC019924; AAH19924.1; -; mRNA.
DR   EMBL; BC020946; AAH20946.1; -; mRNA.
DR   EMBL; BC021909; AAH21909.1; -; mRNA.
DR   EMBL; BC070326; AAH70326.1; -; mRNA.
DR   CCDS; CCDS4687.1; -.
DR   PIR; A26561; A26561.
DR   RefSeq; NP_001280141.1; NM_001293212.1.
DR   RefSeq; NP_001280142.1; NM_001293213.1.
DR   RefSeq; NP_001280143.1; NM_001293214.1.
DR   RefSeq; NP_001280144.1; NM_001293215.1.
DR   RefSeq; NP_001280145.1; NM_001293216.1.
DR   RefSeq; NP_821133.1; NM_178014.3.
DR   UniGene; Hs.636480; -.
DR   PDB; 3QNZ; X-ray; 2.20 A; C=429-438.
DR   PDB; 3QO0; X-ray; 2.30 A; C=422-441.
DR   PDB; 5N5N; EM; 4.00 A; A/B/C/D/E/F=1-426.
DR   PDBsum; 3QNZ; -.
DR   PDBsum; 3QO0; -.
DR   PDBsum; 5N5N; -.
DR   ProteinModelPortal; P07437; -.
DR   SMR; P07437; -.
DR   BioGrid; 128444; 270.
DR   CORUM; P07437; -.
DR   DIP; DIP-32772N; -.
DR   IntAct; P07437; 113.
DR   MINT; P07437; -.
DR   STRING; 9606.ENSP00000339001; -.
DR   ChEMBL; CHEMBL5444; -.
DR   DrugBank; DB05284; CA4P.
DR   DrugBank; DB01394; Colchicine.
DR   DrugBank; DB05147; CYT997.
DR   DrugBank; DB03010; Epothilone B.
DR   DrugBank; DB01873; Epothilone D.
DR   DrugBank; DB01179; Podofilox.
DR   DrugBank; DB00570; Vinblastine.
DR   DrugBank; DB00541; Vincristine.
DR   DrugBank; DB00361; Vinorelbine.
DR   DrugBank; DB06042; ZEN-012.
DR   GuidetoPHARMACOLOGY; 2640; -.
DR   iPTMnet; P07437; -.
DR   PhosphoSitePlus; P07437; -.
DR   SwissPalm; P07437; -.
DR   BioMuta; TUBB; -.
DR   DMDM; 56757569; -.
DR   OGP; P07437; -.
DR   REPRODUCTION-2DPAGE; P07437; -.
DR   SWISS-2DPAGE; P07437; -.
DR   UCD-2DPAGE; P07437; -.
DR   EPD; P07437; -.
DR   PaxDb; P07437; -.
DR   PeptideAtlas; P07437; -.
DR   PRIDE; P07437; -.
DR   TopDownProteomics; P07437; -.
DR   Ensembl; ENST00000327892; ENSP00000339001; ENSG00000196230.
DR   Ensembl; ENST00000383564; ENSP00000373058; ENSG00000183311.
DR   Ensembl; ENST00000419792; ENSP00000401317; ENSG00000235067.
DR   Ensembl; ENST00000421473; ENSP00000399155; ENSG00000224156.
DR   Ensembl; ENST00000422650; ENSP00000400663; ENSG00000229684.
DR   Ensembl; ENST00000422674; ENSP00000406811; ENSG00000227739.
DR   Ensembl; ENST00000432462; ENSP00000410829; ENSG00000232421.
DR   Ensembl; ENST00000436628; ENSP00000410071; ENSG00000232575.
DR   GeneID; 203068; -.
DR   KEGG; hsa:203068; -.
DR   CTD; 203068; -.
DR   DisGeNET; 203068; -.
DR   EuPathDB; HostDB:ENSG00000196230.12; -.
DR   GeneCards; TUBB; -.
DR   HGNC; HGNC:20778; TUBB.
DR   HPA; CAB005417; -.
DR   HPA; CAB012406; -.
DR   HPA; HPA043640; -.
DR   HPA; HPA046280; -.
DR   MalaCards; TUBB; -.
DR   MIM; 156610; phenotype.
DR   MIM; 191130; gene.
DR   MIM; 615771; phenotype.
DR   neXtProt; NX_P07437; -.
DR   OpenTargets; ENSG00000196230; -.
DR   PharmGKB; PA358; -.
DR   eggNOG; KOG1375; Eukaryota.
DR   eggNOG; COG5023; LUCA.
DR   GeneTree; ENSGT00760000119061; -.
DR   HOVERGEN; HBG000089; -.
DR   InParanoid; P07437; -.
DR   KO; K07375; -.
DR   OMA; ESEKMRE; -.
DR   OrthoDB; EOG09370T84; -.
DR   PhylomeDB; P07437; -.
DR   TreeFam; TF300298; -.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; P07437; -.
DR   ChiTaRS; TUBB; human.
DR   GeneWiki; TUBB; -.
DR   GenomeRNAi; 203068; -.
DR   PRO; PR:P07437; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000196230; -.
DR   CleanEx; HS_TUBB; -.
DR   ExpressionAtlas; P07437; baseline and differential.
DR   Genevisible; P07437; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0044297; C:cell body; IDA:DFLAT.
DR   GO; GO:0005737; C:cytoplasm; IDA:CAFA.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005856; C:cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0005641; C:nuclear envelope lumen; IDA:DFLAT.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0042288; F:MHC class I protein binding; IDA:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005198; F:structural molecule activity; TAS:BHF-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051301; P:cell division; TAS:BHF-UCL.
DR   GO; GO:0009987; P:cellular process; IDA:DFLAT.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; TAS:BHF-UCL.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0007017; P:microtubule-based process; TAS:BHF-UCL.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; NAS:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0051225; P:spindle assembly; IEA:Ensembl.
DR   Gene3D; 1.10.287.600; -; 1.
DR   Gene3D; 3.30.1330.20; -; 1.
DR   Gene3D; 3.40.50.1440; -; 1.
DR   InterPro; IPR013838; Beta-tubulin_BS.
DR   InterPro; IPR002453; Beta_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR037103; Tubulin/FtsZ_C_sf.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR017975; Tubulin_CS.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; PTHR11588; 1.
DR   PANTHER; PTHR11588:SF256; PTHR11588:SF256; 1.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01163; BETATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SMART; SM00865; Tubulin_C; 1.
DR   SUPFAM; SSF52490; SSF52490; 1.
DR   SUPFAM; SSF55307; SSF55307; 1.
DR   PROSITE; PS00227; TUBULIN; 1.
DR   PROSITE; PS00228; TUBULIN_B_AUTOREG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disease mutation; GTP-binding;
KW   Isopeptide bond; Methylation; Microtubule; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN         1    444       Tubulin beta chain.
FT                                /FTId=PRO_0000048243.
FT   NP_BIND     140    146       GTP. {ECO:0000255}.
FT   MOD_RES      40     40       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P99024}.
FT   MOD_RES      55     55       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      58     58       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      58     58       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P99024}.
FT   MOD_RES     172    172       Phosphoserine; by CDK1.
FT                                {ECO:0000269|PubMed:16371510}.
FT   MOD_RES     285    285       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     290    290       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     318    318       Omega-N-methylarginine.
FT                                {ECO:0000269|Ref.9}.
FT   MOD_RES     438    438       5-glutamyl polyglutamate.
FT                                {ECO:0000250|UniProtKB:Q2T9S0}.
FT   CROSSLNK     58     58       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin);
FT                                alternate.
FT   CROSSLNK    324    324       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   VARIANT      15     15       Q -> K (in CSCSC1; disrupts heterodimer
FT                                assembly and microtubule dynamics;
FT                                dbSNP:rs864321676).
FT                                {ECO:0000269|PubMed:26637975}.
FT                                /FTId=VAR_076543.
FT   VARIANT     222    222       Y -> F (in CSCSC1; disrupts heterodimer
FT                                assembly and microtubule dynamics;
FT                                dbSNP:rs864321677).
FT                                {ECO:0000269|PubMed:26637975}.
FT                                /FTId=VAR_076544.
FT   VARIANT     299    299       M -> V (in CDCBM6; decreases the ability
FT                                of the protein to assemble into tubulin
FT                                heterodimers; dbSNP:rs587777355).
FT                                {ECO:0000269|PubMed:23246003}.
FT                                /FTId=VAR_071763.
FT   VARIANT     353    353       V -> I (in CDCBM6; does not affect the
FT                                ability of the mutant polypeptides to
FT                                assemble into heterodimers and
FT                                incorporate into microtubules;
FT                                dbSNP:rs587777356).
FT                                {ECO:0000269|PubMed:23246003}.
FT                                /FTId=VAR_071764.
FT   VARIANT     401    401       E -> K (in CDCBM6; arrests the assembly
FT                                pathway of alpha/beta-tubulin; the mutant
FT                                protein is unable to coassemble into a
FT                                tubulin heterodimer but is instead
FT                                distributed throughout the cytoplasm;
FT                                dbSNP:rs587777357).
FT                                {ECO:0000269|PubMed:23246003}.
FT                                /FTId=VAR_071765.
FT   CONFLICT    216    216       K -> R (in Ref. 1; no nucleotide entry
FT                                and 2; AAB59507). {ECO:0000305}.
FT   CONFLICT    231    231       A -> G (in Ref. 1; no nucleotide entry
FT                                and 2; AAB59507). {ECO:0000305}.
FT   CONFLICT    234    235       SG -> EC (in Ref. 1; no nucleotide entry
FT                                and 2; AAB59507). {ECO:0000305}.
FT   CONFLICT    288    288       E -> D (in Ref. 1; no nucleotide entry
FT                                and 2; AAB59507). {ECO:0000305}.
FT   CONFLICT    298    298       N -> D (in Ref. 8; AAH20946).
FT                                {ECO:0000305}.
SQ   SEQUENCE   444 AA;  49671 MW;  1E6CD0A36773A103 CRC64;
     MREIVHIQAG QCGNQIGAKF WEVISDEHGI DPTGTYHGDS DLQLDRISVY YNEATGGKYV
     PRAILVDLEP GTMDSVRSGP FGQIFRPDNF VFGQSGAGNN WAKGHYTEGA ELVDSVLDVV
     RKEAESCDCL QGFQLTHSLG GGTGSGMGTL LISKIREEYP DRIMNTFSVV PSPKVSDTVV
     EPYNATLSVH QLVENTDETY CIDNEALYDI CFRTLKLTTP TYGDLNHLVS ATMSGVTTCL
     RFPGQLNADL RKLAVNMVPF PRLHFFMPGF APLTSRGSQQ YRALTVPELT QQVFDAKNMM
     AACDPRHGRY LTVAAVFRGR MSMKEVDEQM LNVQNKNSSY FVEWIPNNVK TAVCDIPPRG
     LKMAVTFIGN STAIQELFKR ISEQFTAMFR RKAFLHWYTG EGMDEMEFTE AESNMNDLVS
     EYQQYQDATA EEEEDFGEEA EEEA
//
ID   Q5ST81_HUMAN            Unreviewed;       372 AA.
AC   Q5ST81;
DT   21-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   21-DEC-2004, sequence version 1.
DT   23-MAY-2018, entry version 130.
DE   RecName: Full=Tubulin beta chain {ECO:0000256|RuleBase:RU000352};
GN   Name=TUBB {ECO:0000313|Ensembl:ENSP00000379668};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000379668, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000379668, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000379668}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [5] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [6] {ECO:0000313|Ensembl:ENSP00000383374}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUN-2015) to UniProtKB.
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules. It
CC       binds two moles of GTP, one at an exchangeable site on the beta
CC       chain and one at a non-exchangeable site on the alpha chain.
CC       {ECO:0000256|RuleBase:RU000352}.
CC   -!- SUBUNIT: Dimer of alpha and beta chains. A typical microtubule is
CC       a hollow water-filled tube with an outer diameter of 25 nm and an
CC       inner diameter of 15 nM. Alpha-beta heterodimers associate head-
CC       to-tail to form protofilaments running lengthwise along the
CC       microtubule wall with the beta-tubulin subunit facing the
CC       microtubule plus end conferring a structural polarity.
CC       Microtubules usually have 13 protofilaments but different
CC       protofilament numbers can be found in some organisms and
CC       specialized cells. {ECO:0000256|RuleBase:RU000352}.
CC   -!- SIMILARITY: Belongs to the tubulin family.
CC       {ECO:0000256|RuleBase:RU000352, ECO:0000256|SAAS:SAAS00576975}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL662797; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662848; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL845353; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX248307; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX927283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR759873; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR788240; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR936878; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001280144.1; NM_001293215.1.
DR   RefSeq; NP_001280145.1; NM_001293216.1.
DR   UniGene; Hs.636480; -.
DR   Ensembl; ENST00000330914; ENSP00000365578; ENSG00000196230.
DR   Ensembl; ENST00000396384; ENSP00000379668; ENSG00000196230.
DR   Ensembl; ENST00000400530; ENSP00000383374; ENSG00000183311.
DR   Ensembl; ENST00000400531; ENSP00000383375; ENSG00000183311.
DR   Ensembl; ENST00000413547; ENSP00000414479; ENSG00000224156.
DR   Ensembl; ENST00000420618; ENSP00000392914; ENSG00000232421.
DR   Ensembl; ENST00000425102; ENSP00000394841; ENSG00000232575.
DR   Ensembl; ENST00000427480; ENSP00000407673; ENSG00000232421.
DR   Ensembl; ENST00000435546; ENSP00000399046; ENSG00000227739.
DR   Ensembl; ENST00000436335; ENSP00000416480; ENSG00000235067.
DR   Ensembl; ENST00000437490; ENSP00000391515; ENSG00000232575.
DR   Ensembl; ENST00000444441; ENSP00000393340; ENSG00000235067.
DR   Ensembl; ENST00000446385; ENSP00000395838; ENSG00000229684.
DR   Ensembl; ENST00000453350; ENSP00000406981; ENSG00000227739.
DR   Ensembl; ENST00000454454; ENSP00000403213; ENSG00000229684.
DR   Ensembl; ENST00000454620; ENSP00000394124; ENSG00000224156.
DR   GeneID; 203068; -.
DR   UCSC; uc011dmq.3; human.
DR   CTD; 203068; -.
DR   EuPathDB; HostDB:ENSG00000196230.12; -.
DR   HGNC; HGNC:20778; TUBB.
DR   OpenTargets; ENSG00000196230; -.
DR   eggNOG; KOG1375; Eukaryota.
DR   eggNOG; COG5023; LUCA.
DR   GeneTree; ENSGT00760000119061; -.
DR   HOVERGEN; HBG000089; -.
DR   ChiTaRS; TUBB; human.
DR   GenomeRNAi; 203068; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000196230; -.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003924; F:GTPase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro.
DR   GO; GO:0007017; P:microtubule-based process; IEA:InterPro.
DR   Gene3D; 1.10.287.600; -; 1.
DR   Gene3D; 3.30.1330.20; -; 1.
DR   Gene3D; 3.40.50.1440; -; 1.
DR   InterPro; IPR002453; Beta_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR037103; Tubulin/FtsZ_C_sf.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR017975; Tubulin_CS.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; PTHR11588; 1.
DR   PANTHER; PTHR11588:SF256; PTHR11588:SF256; 1.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01163; BETATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SMART; SM00865; Tubulin_C; 1.
DR   SUPFAM; SSF52490; SSF52490; 1.
DR   SUPFAM; SSF55307; SSF55307; 1.
DR   PROSITE; PS00227; TUBULIN; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   GTP-binding {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00977278};
KW   Microtubule {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00576796};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00977278};
KW   Proteomics identification {ECO:0000213|EPD:Q5ST81,
KW   ECO:0000213|MaxQB:Q5ST81, ECO:0000213|PeptideAtlas:Q5ST81};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        1    172       Tubulin. {ECO:0000259|SMART:SM00864}.
FT   DOMAIN      174    311       Tubulin_C. {ECO:0000259|SMART:SM00865}.
FT   COILED      336    363       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   372 AA;  41742 MW;  1C31F252FFD2B86F CRC64;
     MDSVRSGPFG QIFRPDNFVF GQSGAGNNWA KGHYTEGAEL VDSVLDVVRK EAESCDCLQG
     FQLTHSLGGG TGSGMGTLLI SKIREEYPDR IMNTFSVVPS PKVSDTVVEP YNATLSVHQL
     VENTDETYCI DNEALYDICF RTLKLTTPTY GDLNHLVSAT MSGVTTCLRF PGQLNADLRK
     LAVNMVPFPR LHFFMPGFAP LTSRGSQQYR ALTVPELTQQ VFDAKNMMAA CDPRHGRYLT
     VAAVFRGRMS MKEVDEQMLN VQNKNSSYFV EWIPNNVKTA VCDIPPRGLK MAVTFIGNST
     AIQELFKRIS EQFTAMFRRK AFLHWYTGEG MDEMEFTEAE SNMNDLVSEY QQYQDATAEE
     EEDFGEEAEE EA
//
ID   Q5SU16_HUMAN            Unreviewed;       444 AA.
AC   Q5SU16;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   23-MAY-2018, entry version 147.
DE   RecName: Full=Tubulin beta chain {ECO:0000256|RuleBase:RU000352};
GN   Name=TUBB {ECO:0000313|EMBL:BAF31267.1};
GN   Synonyms=OK/SW-cl.56 {ECO:0000313|EMBL:BAE78618.1};
GN   ORFNames=hCG_26016 {ECO:0000313|EMBL:EAX03322.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF31267.1};
RN   [1] {ECO:0000313|EMBL:EAX03322.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAI03747.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus {ECO:0000313|EMBL:AAI03747.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000313|EMBL:EAX03322.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAF31267.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Peripheral blood leukocyte {ECO:0000313|EMBL:BAE78618.1};
RX   PubMed=16702430; DOI=10.1534/genetics.106.057034;
RA   Shiina T., Ota M., Shimizu S., Katsuyama Y., Hashimoto N., Takasu M.,
RA   Anzai T., Kulski J.K., Kikkawa E., Naruse T., Kimura N., Yanagiya K.,
RA   Watanabe A., Hosomichi K., Kohara S., Iwamoto C., Umehara Y.,
RA   Meyer A., Wanner V., Sano K., Macquin C., Ikeo K., Tokunaga K.,
RA   Gojobori T., Inoko H., Bahram S.;
RT   "Rapid evolution of major histocompatibility complex class I genes in
RT   primates generates new disease alleles in humans via hitchhiking
RT   diversity.";
RL   Genetics 173:1555-1570(2006).
CC   -!- FUNCTION: Tubulin is the major constituent of microtubules. It
CC       binds two moles of GTP, one at an exchangeable site on the beta
CC       chain and one at a non-exchangeable site on the alpha chain.
CC       {ECO:0000256|RuleBase:RU000352, ECO:0000256|SAAS:SAAS00031082}.
CC   -!- SUBUNIT: Dimer of alpha and beta chains. A typical microtubule is
CC       a hollow water-filled tube with an outer diameter of 25 nm and an
CC       inner diameter of 15 nM. Alpha-beta heterodimers associate head-
CC       to-tail to form protofilaments running lengthwise along the
CC       microtubule wall with the beta-tubulin subunit facing the
CC       microtubule plus end conferring a structural polarity.
CC       Microtubules usually have 13 protofilaments but different
CC       protofilament numbers can be found in some organisms and
CC       specialized cells. {ECO:0000256|RuleBase:RU000352}.
CC   -!- INTERACTION:
CC       Q96DZ9:CMTM5; NbExp=3; IntAct=EBI-10245038, EBI-2548702;
CC       Q96E03:MAGEA2B; NbExp=3; IntAct=EBI-10245038, EBI-10239285;
CC       Q969L2:MAL2; NbExp=3; IntAct=EBI-10245038, EBI-944295;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000256|SAAS:SAAS00361597}.
CC   -!- SIMILARITY: Belongs to the tubulin family.
CC       {ECO:0000256|RuleBase:RU000352, ECO:0000256|SAAS:SAAS00576975}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC103746; AAI03747.1; -; mRNA.
DR   EMBL; AB202098; BAE78618.1; -; Genomic_DNA.
DR   EMBL; AB103606; BAF31267.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03322.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03323.1; -; Genomic_DNA.
DR   RefSeq; NP_821133.1; NM_178014.3.
DR   UniGene; Hs.636480; -.
DR   SMR; Q5SU16; -.
DR   IntAct; Q5SU16; 3.
DR   MaxQB; Q5SU16; -.
DR   PRIDE; Q5SU16; -.
DR   GeneID; 203068; -.
DR   KEGG; hsa:203068; -.
DR   UCSC; uc003nrl.4; human.
DR   CTD; 203068; -.
DR   EuPathDB; HostDB:ENSG00000196230.12; -.
DR   PharmGKB; PA358; -.
DR   eggNOG; KOG1375; Eukaryota.
DR   eggNOG; COG5023; LUCA.
DR   HOVERGEN; HBG000089; -.
DR   KO; K07375; -.
DR   OMA; ESEKMRE; -.
DR   OrthoDB; EOG09370A7Z; -.
DR   ChiTaRS; TUBB; human.
DR   GenomeRNAi; 203068; -.
DR   Bgee; ENSG00000196230; -.
DR   ExpressionAtlas; Q5SU16; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003924; F:GTPase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IEA:Ensembl.
DR   GO; GO:0051225; P:spindle assembly; IEA:Ensembl.
DR   Gene3D; 1.10.287.600; -; 1.
DR   Gene3D; 3.30.1330.20; -; 1.
DR   Gene3D; 3.40.50.1440; -; 1.
DR   InterPro; IPR013838; Beta-tubulin_BS.
DR   InterPro; IPR002453; Beta_tubulin.
DR   InterPro; IPR008280; Tub_FtsZ_C.
DR   InterPro; IPR000217; Tubulin.
DR   InterPro; IPR018316; Tubulin/FtsZ_2-layer-sand-dom.
DR   InterPro; IPR037103; Tubulin/FtsZ_C_sf.
DR   InterPro; IPR036525; Tubulin/FtsZ_GTPase_sf.
DR   InterPro; IPR023123; Tubulin_C.
DR   InterPro; IPR017975; Tubulin_CS.
DR   InterPro; IPR003008; Tubulin_FtsZ_GTPase.
DR   PANTHER; PTHR11588; PTHR11588; 1.
DR   PANTHER; PTHR11588:SF256; PTHR11588:SF256; 1.
DR   Pfam; PF00091; Tubulin; 1.
DR   Pfam; PF03953; Tubulin_C; 1.
DR   PRINTS; PR01163; BETATUBULIN.
DR   PRINTS; PR01161; TUBULIN.
DR   SMART; SM00864; Tubulin; 1.
DR   SMART; SM00865; Tubulin_C; 1.
DR   SUPFAM; SSF52490; SSF52490; 1.
DR   SUPFAM; SSF55307; SSF55307; 1.
DR   PROSITE; PS00227; TUBULIN; 1.
DR   PROSITE; PS00228; TUBULIN_B_AUTOREG; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Cytoplasm {ECO:0000256|SAAS:SAAS00045377};
KW   Cytoskeleton {ECO:0000256|SAAS:SAAS00045377};
KW   GTP-binding {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00977278};
KW   Microtubule {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00576796};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000352,
KW   ECO:0000256|SAAS:SAAS00977278}.
FT   DOMAIN       47    244       Tubulin. {ECO:0000259|SMART:SM00864}.
FT   DOMAIN      246    383       Tubulin_C. {ECO:0000259|SMART:SM00865}.
FT   COILED      408    435       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   444 AA;  49671 MW;  1E6CD0A36773A103 CRC64;
     MREIVHIQAG QCGNQIGAKF WEVISDEHGI DPTGTYHGDS DLQLDRISVY YNEATGGKYV
     PRAILVDLEP GTMDSVRSGP FGQIFRPDNF VFGQSGAGNN WAKGHYTEGA ELVDSVLDVV
     RKEAESCDCL QGFQLTHSLG GGTGSGMGTL LISKIREEYP DRIMNTFSVV PSPKVSDTVV
     EPYNATLSVH QLVENTDETY CIDNEALYDI CFRTLKLTTP TYGDLNHLVS ATMSGVTTCL
     RFPGQLNADL RKLAVNMVPF PRLHFFMPGF APLTSRGSQQ YRALTVPELT QQVFDAKNMM
     AACDPRHGRY LTVAAVFRGR MSMKEVDEQM LNVQNKNSSY FVEWIPNNVK TAVCDIPPRG
     LKMAVTFIGN STAIQELFKR ISEQFTAMFR RKAFLHWYTG EGMDEMEFTE AESNMNDLVS
     EYQQYQDATA EEEEDFGEEA EEEA
//
ID   VAPB_HUMAN              Reviewed;         243 AA.
AC   O95292; A2A2F2; O95293; Q9P0H0;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   23-MAY-2018, entry version 179.
DE   RecName: Full=Vesicle-associated membrane protein-associated protein B/C;
DE            Short=VAMP-B/VAMP-C;
DE            Short=VAMP-associated protein B/C;
DE            Short=VAP-B/VAP-C;
GN   Name=VAPB; ORFNames=UNQ484/PRO983;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND INTERACTION WITH
RP   VAPA; VAMP1 AND VAMP2.
RC   TISSUE=Brain, and Heart;
RX   PubMed=9920726; DOI=10.1006/bbrc.1998.9876;
RA   Nishimura Y., Hayashi M., Inada H., Tanaka T.;
RT   "Molecular cloning and characterization of mammalian homologues of
RT   vesicle-associated membrane protein-associated (VAMP-associated)
RT   proteins.";
RL   Biochem. Biophys. Res. Commun. 254:21-26(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Adrenal gland;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-19.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   INTERACTION WITH HCV NS5A AND NS5B (MICROBIAL INFECTION).
RX   PubMed=16227268; DOI=10.1128/JVI.79.21.13473-13482.2005;
RA   Hamamoto I., Nishimura Y., Okamoto T., Aizaki H., Liu M., Mori Y.,
RA   Abe T., Suzuki T., Lai M.M., Miyamura T., Moriishi K., Matsuura Y.;
RT   "Human VAP-B is involved in hepatitis C virus replication through
RT   interaction with NS5A and NS5B.";
RL   J. Virol. 79:13473-13482(2005).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   FUNCTION IN ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE, AND
RP   CHARACTERIZATION OF VARIANT ALS8 SER-56.
RX   PubMed=16891305; DOI=10.1074/jbc.M605049200;
RA   Kanekura K., Nishimoto I., Aiso S., Matsuoka M.;
RT   "Characterization of amyotrophic lateral sclerosis-linked P56S
RT   mutation of vesicle-associated membrane protein-associated protein B
RT   (VAPB/ALS8).";
RL   J. Biol. Chem. 281:30223-30233(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-150; SER-156 AND
RP   SER-160, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   INTERACTION WITH ZFYVE27.
RX   PubMed=19289470; DOI=10.1074/jbc.M807938200;
RA   Saita S., Shirane M., Natume T., Iemura S., Nakayama K.I.;
RT   "Promotion of neurite extension by protrudin requires its interaction
RT   with vesicle-associated membrane protein-associated protein.";
RL   J. Biol. Chem. 284:13766-13777(2009).
RN   [14]
RP   FUNCTION IN ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE, VARIANT
RP   ALS8 ILE-46, CHARACTERIZATION OF VARIANTS ALS8 ILE-46 AND SER-56,
RP   SUBUNIT, AND INTERACTION WITH VAPA; VAMP1 AND VAMP2.
RX   PubMed=20940299; DOI=10.1074/jbc.M110.161398;
RA   Chen H.J., Anagnostou G., Chai A., Withers J., Morris A.,
RA   Adhikaree J., Pennetta G., de Belleroche J.S.;
RT   "Characterization of the properties of a novel mutation in VAPB in
RT   familial amyotrophic lateral sclerosis.";
RL   J. Biol. Chem. 285:40266-40281(2010).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-150; SER-156 AND
RP   SER-160, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   INTERACTION WITH ZFYVE27 AND KIF5A.
RX   PubMed=21976701; DOI=10.1091/mbc.E11-01-0068;
RA   Matsuzaki F., Shirane M., Matsumoto M., Nakayama K.I.;
RT   "Protrudin serves as an adaptor molecule that connects KIF5 and its
RT   cargoes in vesicular transport during process formation.";
RL   Mol. Biol. Cell 22:4602-4620(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   FUNCTION IN CELLULAR CALCIUM HOMEOSTASIS REGULATION, SUBCELLULAR
RP   LOCATION, INTERACTION WITH RMDN3, AND CHARACTERIZATION OF VARIANT ALS8
RP   SER-56.
RX   PubMed=22131369; DOI=10.1093/hmg/ddr559;
RA   De Vos K.J., Morotz G.M., Stoica R., Tudor E.L., Lau K.F.,
RA   Ackerley S., Warley A., Shaw C.E., Miller C.C.;
RT   "VAPB interacts with the mitochondrial protein PTPIP51 to regulate
RT   calcium homeostasis.";
RL   Hum. Mol. Genet. 21:1299-1311(2012).
RN   [20]
RP   INTERACTION WITH STARD3 AND STARD3NL.
RX   PubMed=24105263; DOI=10.1242/jcs.139295;
RA   Alpy F., Rousseau A., Schwab Y., Legueux F., Stoll I., Wendling C.,
RA   Spiegelhalter C., Kessler P., Mathelin C., Rio M.C., Levine T.P.,
RA   Tomasetto C.;
RT   "STARD3 or STARD3NL and VAP form a novel molecular tether between late
RT   endosomes and the ER.";
RL   J. Cell Sci. 126:5500-5512(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; THR-150; SER-156;
RP   SER-158; SER-159; SER-160 AND SER-206, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158 AND SER-160, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-147, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [25]
RP   VARIANT ALS8 SER-56, AND VARIANT SMAPAD SER-56.
RX   PubMed=15372378; DOI=10.1086/425287;
RA   Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A.,
RA   Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T.,
RA   Webb J., Skehel P., Zatz M.;
RT   "A mutation in the vesicle-trafficking protein VAPB causes late-onset
RT   spinal muscular atrophy and amyotrophic lateral sclerosis.";
RL   Am. J. Hum. Genet. 75:822-831(2004).
CC   -!- FUNCTION: Participates in the endoplasmic reticulum unfolded
CC       protein response (UPR) by inducing ERN1/IRE1 activity. Involved in
CC       cellular calcium homeostasis regulation.
CC       {ECO:0000269|PubMed:16891305, ECO:0000269|PubMed:20940299,
CC       ECO:0000269|PubMed:22131369}.
CC   -!- SUBUNIT: Homodimer, and heterodimer with VAPA (PubMed:20940299).
CC       Interacts with VAMP1 and VAMP2 (PubMed:9920726, PubMed:20940299).
CC       Interacts (via MSP domain) with ZFYVE27 (PubMed:21976701,
CC       PubMed:19289470). Interacts with RMDN3 (PubMed:22131369).
CC       Interacts with KIF5A in a ZFYVE27-dependent manner
CC       (PubMed:21976701). Interacts with STARD3 (via FFAT motif)
CC       (PubMed:24105263). Interacts with STARD3NL (via FFAT motif)
CC       (PubMed:24105263). {ECO:0000269|PubMed:16227268,
CC       ECO:0000269|PubMed:19289470, ECO:0000269|PubMed:20940299,
CC       ECO:0000269|PubMed:21976701, ECO:0000269|PubMed:22131369,
CC       ECO:0000269|PubMed:24105263, ECO:0000269|PubMed:9920726}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HCV protein NS5A and
CC       NS5B. {ECO:0000269|PubMed:16227268}.
CC   -!- INTERACTION:
CC       Q03463:- (xeno); NbExp=3; IntAct=EBI-9350855, EBI-8803474;
CC       Q99IB8:- (xeno); NbExp=2; IntAct=EBI-1188298, EBI-9096996;
CC       P50402:EMD; NbExp=5; IntAct=EBI-1188298, EBI-489887;
CC       Q03137:Epha4 (xeno); NbExp=2; IntAct=EBI-1188298, EBI-1539152;
CC       Q9P0L0:VAPA; NbExp=2; IntAct=EBI-9350848, EBI-1059156;
CC       O95070:YIF1A; NbExp=9; IntAct=EBI-1188298, EBI-2799703;
CC       Q5T4F4:ZFYVE27; NbExp=2; IntAct=EBI-1188298, EBI-3892947;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Single-pass type IV membrane protein {ECO:0000250}.
CC       Note=Present in mitochondria-associated membranes that are
CC       endoplasmic reticulum membrane regions closely apposed to the
CC       outer mitochondrial membrane. {ECO:0000269|PubMed:22131369}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=VAP-B;
CC         IsoId=O95292-1; Sequence=Displayed;
CC       Name=2; Synonyms=VAP-C;
CC         IsoId=O95292-2; Sequence=VSP_003277, VSP_003278;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Isoform 1 predominates.
CC   -!- DISEASE: Amyotrophic lateral sclerosis 8 (ALS8) [MIM:608627]: A
CC       neurodegenerative disorder affecting upper motor neurons in the
CC       brain and lower motor neurons in the brain stem and spinal cord,
CC       resulting in fatal paralysis. Sensory abnormalities are absent.
CC       The pathologic hallmarks of the disease include pallor of the
CC       corticospinal tract due to loss of motor neurons, presence of
CC       ubiquitin-positive inclusions within surviving motor neurons, and
CC       deposition of pathologic aggregates. The etiology of amyotrophic
CC       lateral sclerosis is likely to be multifactorial, involving both
CC       genetic and environmental factors. The disease is inherited in 5-
CC       10% of the cases. {ECO:0000269|PubMed:15372378,
CC       ECO:0000269|PubMed:16891305, ECO:0000269|PubMed:20940299,
CC       ECO:0000269|PubMed:22131369}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Spinal muscular atrophy, proximal, adult, autosomal
CC       dominant (SMAPAD) [MIM:182980]: A form of spinal muscular atrophy,
CC       a neuromuscular disorder characterized by degeneration of the
CC       anterior horn cells of the spinal cord, leading to symmetrical
CC       muscle weakness and atrophy. SMAPAD is characterized by proximal
CC       muscle weakness that begins in the lower limbs and then progresses
CC       to upper limbs, onset in late adulthood (after third decade) and a
CC       benign course. Most of the patients remain ambulatory 10 to 40
CC       years after clinical onset. {ECO:0000269|PubMed:15372378}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the VAMP-associated protein (VAP) (TC
CC       9.B.17) family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Alsod; Note=ALS genetic mutations db;
CC       URL="http://alsod.iop.kcl.ac.uk/Als/";
CC   -!- WEB RESOURCE: Name=Mendelian genes VAMP (vesicle-associated
CC       membrane protein)-associated protein B and C (VAPB); Note=Leiden
CC       Open Variation Database (LOVD);
CC       URL="http://www.lovd.nl/VAPB";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF086628; AAD13577.1; -; mRNA.
DR   EMBL; AF086629; AAD13578.1; -; mRNA.
DR   EMBL; AF160212; AAF67013.1; -; mRNA.
DR   EMBL; AY358464; AAQ88829.1; -; mRNA.
DR   EMBL; AL035455; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001712; AAH01712.1; -; mRNA.
DR   CCDS; CCDS33498.1; -. [O95292-1]
DR   CCDS; CCDS56198.1; -. [O95292-2]
DR   PIR; JG0186; JG0186.
DR   RefSeq; NP_001182606.1; NM_001195677.1. [O95292-2]
DR   RefSeq; NP_004729.1; NM_004738.4. [O95292-1]
DR   UniGene; Hs.182625; -.
DR   PDB; 2MDK; NMR; -; A=1-125.
DR   PDB; 3IKK; X-ray; 2.50 A; A/B=1-125.
DR   PDBsum; 2MDK; -.
DR   PDBsum; 3IKK; -.
DR   ProteinModelPortal; O95292; -.
DR   SMR; O95292; -.
DR   BioGrid; 114650; 167.
DR   CORUM; O95292; -.
DR   DIP; DIP-39816N; -.
DR   IntAct; O95292; 60.
DR   MINT; O95292; -.
DR   STRING; 9606.ENSP00000417175; -.
DR   TCDB; 9.B.17.1.1; the vamp-associated protein (vap) family.
DR   iPTMnet; O95292; -.
DR   PhosphoSitePlus; O95292; -.
DR   SwissPalm; O95292; -.
DR   BioMuta; VAPB; -.
DR   EPD; O95292; -.
DR   PaxDb; O95292; -.
DR   PeptideAtlas; O95292; -.
DR   PRIDE; O95292; -.
DR   DNASU; 9217; -.
DR   Ensembl; ENST00000395802; ENSP00000379147; ENSG00000124164. [O95292-2]
DR   Ensembl; ENST00000475243; ENSP00000417175; ENSG00000124164. [O95292-1]
DR   GeneID; 9217; -.
DR   KEGG; hsa:9217; -.
DR   UCSC; uc002xzd.3; human. [O95292-1]
DR   CTD; 9217; -.
DR   DisGeNET; 9217; -.
DR   EuPathDB; HostDB:ENSG00000124164.15; -.
DR   GeneCards; VAPB; -.
DR   GeneReviews; VAPB; -.
DR   HGNC; HGNC:12649; VAPB.
DR   HPA; CAB013722; -.
DR   HPA; HPA013144; -.
DR   MalaCards; VAPB; -.
DR   MIM; 182980; phenotype.
DR   MIM; 605704; gene.
DR   MIM; 608627; phenotype.
DR   neXtProt; NX_O95292; -.
DR   OpenTargets; ENSG00000124164; -.
DR   Orphanet; 209335; Adult-onset proximal spinal muscular atrophy, autosomal dominant.
DR   Orphanet; 803; Amyotrophic lateral sclerosis.
DR   PharmGKB; PA37273; -.
DR   eggNOG; KOG0439; Eukaryota.
DR   eggNOG; COG5066; LUCA.
DR   GeneTree; ENSGT00390000006947; -.
DR   HOGENOM; HOG000293182; -.
DR   HOVERGEN; HBG028551; -.
DR   InParanoid; O95292; -.
DR   KO; K10707; -.
DR   OMA; PHDIEIN; -.
DR   OrthoDB; EOG091G0KJ2; -.
DR   PhylomeDB; O95292; -.
DR   TreeFam; TF317024; -.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   ChiTaRS; VAPB; human.
DR   EvolutionaryTrace; O95292; -.
DR   GeneWiki; VAPB; -.
DR   GenomeRNAi; 9217; -.
DR   PRO; PR:O95292; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000124164; -.
DR   CleanEx; HS_VAPB; -.
DR   ExpressionAtlas; O95292; baseline and differential.
DR   Genevisible; O95292; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0048487; F:beta-tubulin binding; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0033149; F:FFAT motif binding; IMP:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; IDA:UniProtKB.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IMP:UniProtKB.
DR   GO; GO:0090114; P:COPII-coated vesicle budding; IMP:UniProtKB.
DR   GO; GO:0007029; P:endoplasmic reticulum organization; IMP:UniProtKB.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IMP:UniProtKB.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IMP:UniProtKB.
DR   GO; GO:0044830; P:modulation by host of viral RNA genome replication; IDA:AgBase.
DR   GO; GO:0019048; P:modulation by virus of host morphology or physiology; IDA:UniProtKB.
DR   GO; GO:0044828; P:negative regulation by host of viral genome replication; IDA:AgBase.
DR   GO; GO:0044790; P:negative regulation by host of viral release from host cell; IDA:AgBase.
DR   GO; GO:0046725; P:negative regulation by virus of viral protein levels in host cell; IDA:AgBase.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; IDA:AgBase.
DR   GO; GO:0044791; P:positive regulation by host of viral release from host cell; IDA:AgBase.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR000535; MSP_dom.
DR   InterPro; IPR008962; PapD-like_sf.
DR   InterPro; IPR016763; VAP.
DR   InterPro; IPR030226; VapB.
DR   PANTHER; PTHR10809; PTHR10809; 1.
DR   PANTHER; PTHR10809:SF12; PTHR10809:SF12; 1.
DR   Pfam; PF00635; Motile_Sperm; 1.
DR   PIRSF; PIRSF019693; VAMP-associated; 1.
DR   SUPFAM; SSF49354; SSF49354; 1.
DR   PROSITE; PS50202; MSP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Amyotrophic lateral sclerosis; Coiled coil; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Endoplasmic reticulum;
KW   Host-virus interaction; Isopeptide bond; Membrane; Neurodegeneration;
KW   Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Ubl conjugation; Unfolded protein response.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801}.
FT   CHAIN         2    243       Vesicle-associated membrane protein-
FT                                associated protein B/C.
FT                                /FTId=PRO_0000213473.
FT   TOPO_DOM      2    222       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    223    243       Helical; Anchor for type IV membrane
FT                                protein. {ECO:0000255}.
FT   DOMAIN        7    124       MSP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00132}.
FT   COILED      159    196       {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712}.
FT   MOD_RES     146    146       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     150    150       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     156    156       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     158    158       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     160    160       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     206    206       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    147    147       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000244|PubMed:25114211}.
FT   VAR_SEQ      71     99       VMLQPFDYDPNEKSKHKFMVQSMFAPTDT -> GRRWTADE
FT                                EDSAEQQPHFSISPNWEGRRP (in isoform 2).
FT                                {ECO:0000303|PubMed:9920726}.
FT                                /FTId=VSP_003277.
FT   VAR_SEQ     100    243       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9920726}.
FT                                /FTId=VSP_003278.
FT   VARIANT      46     46       T -> I (in ALS8; it forms insoluble
FT                                cytosolic aggregates; cannot activate the
FT                                UPR pathway through ERN1/IRE1 induction;
FT                                results in ubiquitinated aggregates
FT                                accumulation and cell death;
FT                                dbSNP:rs281875284).
FT                                {ECO:0000269|PubMed:20940299}.
FT                                /FTId=VAR_067964.
FT   VARIANT      56     56       P -> S (in ALS8 and SMAPAD; it forms
FT                                insoluble cytosolic aggregates; cannot
FT                                activate the UPR pathway; affects
FT                                interaction with RMDN3; affects cellular
FT                                calcium homeostasis; induces
FT                                mislocalization to the non-ER
FT                                compartments; enhances homodimerization;
FT                                dbSNP:rs74315431).
FT                                {ECO:0000269|PubMed:15372378,
FT                                ECO:0000269|PubMed:16891305,
FT                                ECO:0000269|PubMed:20940299,
FT                                ECO:0000269|PubMed:22131369}.
FT                                /FTId=VAR_026743.
FT   CONFLICT     60     60       I -> V (in Ref. 2; AAF67013).
FT                                {ECO:0000305}.
FT   CONFLICT     67     67       I -> L (in Ref. 2; AAF67013).
FT                                {ECO:0000305}.
FT   CONFLICT     97     97       T -> P (in Ref. 2; AAF67013).
FT                                {ECO:0000305}.
FT   CONFLICT    103    106       EAVW -> DGTR (in Ref. 2; AAF67013).
FT                                {ECO:0000305}.
FT   TURN          4      7       {ECO:0000244|PDB:2MDK}.
FT   STRAND        8     20       {ECO:0000244|PDB:3IKK}.
FT   STRAND       26     33       {ECO:0000244|PDB:3IKK}.
FT   STRAND       36     38       {ECO:0000244|PDB:3IKK}.
FT   STRAND       40     47       {ECO:0000244|PDB:3IKK}.
FT   TURN         49     51       {ECO:0000244|PDB:3IKK}.
FT   STRAND       52     61       {ECO:0000244|PDB:3IKK}.
FT   STRAND       66     73       {ECO:0000244|PDB:3IKK}.
FT   TURN         82     84       {ECO:0000244|PDB:2MDK}.
FT   STRAND       88     94       {ECO:0000244|PDB:3IKK}.
FT   TURN        104    108       {ECO:0000244|PDB:3IKK}.
FT   STRAND      111    113       {ECO:0000244|PDB:3IKK}.
FT   STRAND      115    124       {ECO:0000244|PDB:3IKK}.
SQ   SEQUENCE   243 AA;  27228 MW;  22AEEF9EC7FC0B3F CRC64;
     MAKVEQVLSL EPQHELKFRG PFTDVVTTNL KLGNPTDRNV CFKVKTTAPR RYCVRPNSGI
     IDAGASINVS VMLQPFDYDP NEKSKHKFMV QSMFAPTDTS DMEAVWKEAK PEDLMDSKLR
     CVFELPAEND KPHDVEINKI ISTTASKTET PIVSKSLSSS LDDTEVKKVM EECKRLQGEV
     QRLREENKQF KEEDGLRMRK TVQSNSPISA LAPTGKEEGL STRLLALVVL FFIVGVIIGK
     IAL
//
ID   Q53XM7_HUMAN            Unreviewed;       243 AA.
AC   Q53XM7;
DT   24-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   24-MAY-2005, sequence version 1.
DT   23-MAY-2018, entry version 118.
DE   SubName: Full=VAMP (Vesicle-associated membrane protein)-associated protein B and C {ECO:0000313|EMBL:AAP88813.1};
DE   SubName: Full=VAMP (Vesicle-associated membrane protein)-associated protein B and C, isoform CRA_b {ECO:0000313|EMBL:EAW75494.1};
DE   SubName: Full=cDNA FLJ13179 fis, clone NT2RP3003918, highly similar to Vesicle-associated membrane protein-associated protein B/C {ECO:0000313|EMBL:BAG51174.1};
GN   Name=VAPB {ECO:0000313|EMBL:EAW75494.1};
GN   ORFNames=hCG_26693 {ECO:0000313|EMBL:EAW75494.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAP88813.1};
RN   [1] {ECO:0000313|EMBL:EAW75494.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAP88813.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAG51174.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000313|EMBL:EAW75494.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       O00155:GPR25; NbExp=3; IntAct=EBI-10178947, EBI-10178951;
CC       Q9H1P3:OSBPL2; NbExp=3; IntAct=EBI-10178947, EBI-2828285;
CC       Q96LZ7:RMDN2; NbExp=3; IntAct=EBI-10178947, EBI-2806908;
CC       Q9Y2K6:USP20; NbExp=3; IntAct=EBI-10178947, EBI-2511991;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BT009811; AAP88813.1; -; mRNA.
DR   EMBL; AK023241; BAG51174.1; -; mRNA.
DR   EMBL; CH471077; EAW75494.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75495.1; -; Genomic_DNA.
DR   RefSeq; NP_004729.1; NM_004738.4.
DR   UniGene; Hs.182625; -.
DR   SMR; Q53XM7; -.
DR   IntAct; Q53XM7; 4.
DR   MaxQB; Q53XM7; -.
DR   PRIDE; Q53XM7; -.
DR   DNASU; 9217; -.
DR   GeneID; 9217; -.
DR   KEGG; hsa:9217; -.
DR   UCSC; uc002xza.4; human.
DR   CTD; 9217; -.
DR   EuPathDB; HostDB:ENSG00000124164.15; -.
DR   PharmGKB; PA37273; -.
DR   eggNOG; KOG0439; Eukaryota.
DR   eggNOG; COG5066; LUCA.
DR   HOVERGEN; HBG028551; -.
DR   KO; K10707; -.
DR   OMA; PHDIEIN; -.
DR   OrthoDB; EOG091G0KJ2; -.
DR   ChiTaRS; VAPB; human.
DR   GenomeRNAi; 9217; -.
DR   Bgee; ENSG00000124164; -.
DR   ExpressionAtlas; Q53XM7; baseline and differential.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:InterPro.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:InterPro.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IEA:InterPro.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR000535; MSP_dom.
DR   InterPro; IPR008962; PapD-like_sf.
DR   InterPro; IPR016763; VAP.
DR   InterPro; IPR030226; VapB.
DR   PANTHER; PTHR10809; PTHR10809; 1.
DR   PANTHER; PTHR10809:SF12; PTHR10809:SF12; 1.
DR   Pfam; PF00635; Motile_Sperm; 1.
DR   PIRSF; PIRSF019693; VAMP-associated; 1.
DR   SUPFAM; SSF49354; SSF49354; 1.
DR   PROSITE; PS50202; MSP; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    224    242       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN        7    124       MSP. {ECO:0000259|PROSITE:PS50202}.
FT   COILED      166    193       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   243 AA;  27228 MW;  22AEEF9EC7FC0B3F CRC64;
     MAKVEQVLSL EPQHELKFRG PFTDVVTTNL KLGNPTDRNV CFKVKTTAPR RYCVRPNSGI
     IDAGASINVS VMLQPFDYDP NEKSKHKFMV QSMFAPTDTS DMEAVWKEAK PEDLMDSKLR
     CVFELPAEND KPHDVEINKI ISTTASKTET PIVSKSLSSS LDDTEVKKVM EECKRLQGEV
     QRLREENKQF KEEDGLRMRK TVQSNSPISA LAPTGKEEGL STRLLALVVL FFIVGVIIGK
     IAL
//
ID   FAF1_HUMAN              Reviewed;         650 AA.
AC   Q9UNN5; Q549F0; Q9UF34; Q9UNT3; Q9Y2Z3;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 2.
DT   23-MAY-2018, entry version 166.
DE   RecName: Full=FAS-associated factor 1;
DE            Short=hFAF1;
DE   AltName: Full=UBX domain-containing protein 12;
DE   AltName: Full=UBX domain-containing protein 3A;
GN   Name=FAF1; Synonyms=UBXD12, UBXN3A; ORFNames=CGI-03;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT), INTERACTION WITH
RP   FAS, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain, and Liver;
RX   PubMed=10462485; DOI=10.1006/bbrc.1999.1217;
RA   Ryu S.-W., Chae S.-K., Lee K.-J., Kim E.;
RT   "Identification and characterization of human Fas associated factor 1,
RT   hFAF1.";
RL   Biochem. Biophys. Res. Commun. 262:388-394(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RA   Ding J.B., Yu L., Zhao S.Y.;
RT   "Cloning of a new human cDNA homologous to Mus musculus FAF1.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RA   Boldyreff B.;
RT   "Full length cDNA sequence and chromosomal localization of the human
RT   Fas-associated factor 1 gene, hFaf1.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Brain, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 97-650 (ISOFORM LONG).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   INTERACTION WITH NLRP12.
RX   PubMed=21978668; DOI=10.1016/j.jmb.2011.09.024;
RA   Pinheiro A.S., Eibl C., Ekman-Vural Z., Schwarzenbacher R., Peti W.;
RT   "The NLRP12 pyrin domain: structure, dynamics, and functional
RT   insights.";
RL   J. Mol. Biol. 413:790-803(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-580 AND SER-582, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   FUNCTION, INTERACTION WITH CDT1 AND VCP, AND SUBCELLULAR LOCATION.
RX   PubMed=26842564; DOI=10.1038/ncomms10612;
RA   Franz A., Pirson P.A., Pilger D., Halder S., Achuthankutty D.,
RA   Kashkar H., Ramadan K., Hoppe T.;
RT   "Chromatin-associated degradation is defined by UBXN-3/FAF1 to
RT   safeguard DNA replication fork progression.";
RL   Nat. Commun. 7:10612-10612(2016).
RN   [16]
RP   STRUCTURE BY NMR OF 569-650.
RX   PubMed=11243799; DOI=10.1006/jmbi.2000.4462;
RA   Buchberger A., Howard M.J., Proctor M., Bycroft M.M.;
RT   "The UBX domain: a widespread ubiquitin-like module.";
RL   J. Mol. Biol. 307:17-24(2001).
RN   [17]
RP   STRUCTURE BY NMR OF 99-191.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the ubiquitin-like domain in human FAS-
RT   associated factor 1 (hFAF1).";
RL   Submitted (OCT-2007) to the PDB data bank.
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.73 ANGSTROMS) OF 5-47, FUNCTION, AND DOMAIN
RP   UBA.
RX   PubMed=19722279; DOI=10.1002/pro.237;
RA   Song J., Park J.K., Lee J.J., Choi Y.S., Ryu K.S., Kim J.H., Kim E.,
RA   Lee K.J., Jeon Y.H., Kim E.E.;
RT   "Structure and interaction of ubiquitin-associated domain of human
RT   Fas-associated factor 1.";
RL   Protein Sci. 18:2265-2276(2009).
CC   -!- FUNCTION: Ubiquitin-binding protein (PubMed:19722279). Required
CC       for the progression of DNA replication forks by targeting DNA
CC       replication licensing factor CDT1 for degradation
CC       (PubMed:26842564). Potentiates but cannot initiate FAS-induced
CC       apoptosis (By similarity). {ECO:0000250|UniProtKB:P54731,
CC       ECO:0000269|PubMed:19722279, ECO:0000269|PubMed:26842564}.
CC   -!- SUBUNIT: Interacts with CDT1 and ATPase VCP/p97 (PubMed:26842564).
CC       Interacts (via UBA domain) with FAS (via death domain)
CC       (PubMed:10462485). Interacts (via UBA domain) with NLRP12 (via
CC       DAPIN/PYRIN domain) (PubMed:21978668).
CC       {ECO:0000269|PubMed:10462485, ECO:0000269|PubMed:21978668,
CC       ECO:0000269|PubMed:26842564}.
CC   -!- INTERACTION:
CC       P55072:VCP; NbExp=4; IntAct=EBI-15930546, EBI-355164;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26842564}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q9UNN5-1; Sequence=Displayed;
CC       Name=Short; Synonyms=hFAF1(s);
CC         IsoId=Q9UNN5-2; Sequence=VSP_006704;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Most abundant in testis, slightly less
CC       abundant in skeletal muscle and heart, followed by prostate,
CC       thymus, ovary, small intestine, and colon. Not detected in the
CC       peripheral blood leukocytes. {ECO:0000269|PubMed:10462485}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD51876.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF106798; AAD51886.1; -; mRNA.
DR   EMBL; AF094700; AAD51876.1; ALT_INIT; mRNA.
DR   EMBL; AF136173; AAP97263.1; -; mRNA.
DR   EMBL; AJ271408; CAB67705.1; -; mRNA.
DR   EMBL; AF132938; AAD27713.1; -; mRNA.
DR   EMBL; AC091610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC118557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL049637; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359977; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL603746; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06837.1; -; Genomic_DNA.
DR   EMBL; BC004970; AAH04970.1; -; mRNA.
DR   EMBL; BC067100; AAH67100.1; -; mRNA.
DR   EMBL; AL133631; CAB63755.1; -; mRNA.
DR   CCDS; CCDS554.1; -. [Q9UNN5-1]
DR   PIR; JC7093; JC7093.
DR   PIR; T43466; T43466.
DR   RefSeq; NP_008982.1; NM_007051.2. [Q9UNN5-1]
DR   UniGene; Hs.530402; -.
DR   PDB; 1H8C; NMR; -; A=569-650.
DR   PDB; 2DZM; NMR; -; A=99-191.
DR   PDB; 2EC4; NMR; -; A=325-495.
DR   PDB; 3E21; X-ray; 1.73 A; A=5-47.
DR   PDB; 3QC8; X-ray; 2.20 A; B=571-650.
DR   PDB; 3QCA; X-ray; 2.90 A; A/B/C/D=571-650.
DR   PDB; 3QQ8; X-ray; 2.00 A; B=568-650.
DR   PDB; 3QWZ; X-ray; 2.00 A; B=571-650.
DR   PDB; 3QX1; X-ray; 1.60 A; A/B=571-650.
DR   PDB; 3R3M; X-ray; 3.00 A; A/B/C/D=568-650.
DR   PDBsum; 1H8C; -.
DR   PDBsum; 2DZM; -.
DR   PDBsum; 2EC4; -.
DR   PDBsum; 3E21; -.
DR   PDBsum; 3QC8; -.
DR   PDBsum; 3QCA; -.
DR   PDBsum; 3QQ8; -.
DR   PDBsum; 3QWZ; -.
DR   PDBsum; 3QX1; -.
DR   PDBsum; 3R3M; -.
DR   ProteinModelPortal; Q9UNN5; -.
DR   SMR; Q9UNN5; -.
DR   BioGrid; 116298; 132.
DR   DIP; DIP-38245N; -.
DR   IntAct; Q9UNN5; 50.
DR   MINT; Q9UNN5; -.
DR   STRING; 9606.ENSP00000360843; -.
DR   ChEMBL; CHEMBL3758063; -.
DR   iPTMnet; Q9UNN5; -.
DR   PhosphoSitePlus; Q9UNN5; -.
DR   BioMuta; FAF1; -.
DR   DMDM; 20454906; -.
DR   EPD; Q9UNN5; -.
DR   PaxDb; Q9UNN5; -.
DR   PeptideAtlas; Q9UNN5; -.
DR   PRIDE; Q9UNN5; -.
DR   DNASU; 11124; -.
DR   Ensembl; ENST00000396153; ENSP00000379457; ENSG00000185104. [Q9UNN5-1]
DR   GeneID; 11124; -.
DR   KEGG; hsa:11124; -.
DR   UCSC; uc001cse.2; human. [Q9UNN5-1]
DR   CTD; 11124; -.
DR   DisGeNET; 11124; -.
DR   EuPathDB; HostDB:ENSG00000185104.19; -.
DR   GeneCards; FAF1; -.
DR   HGNC; HGNC:3578; FAF1.
DR   HPA; CAB072814; -.
DR   HPA; HPA018253; -.
DR   MIM; 604460; gene.
DR   neXtProt; NX_Q9UNN5; -.
DR   OpenTargets; ENSG00000185104; -.
DR   PharmGKB; PA27976; -.
DR   eggNOG; ENOG410IPG5; Eukaryota.
DR   eggNOG; ENOG410Z9BT; LUCA.
DR   GeneTree; ENSGT00530000063422; -.
DR   HOGENOM; HOG000043073; -.
DR   HOVERGEN; HBG002876; -.
DR   InParanoid; Q9UNN5; -.
DR   KO; K20703; -.
DR   OMA; MEIFSAQ; -.
DR   OrthoDB; EOG091G04LQ; -.
DR   PhylomeDB; Q9UNN5; -.
DR   TreeFam; TF314172; -.
DR   SignaLink; Q9UNN5; -.
DR   SIGNOR; Q9UNN5; -.
DR   ChiTaRS; FAF1; human.
DR   EvolutionaryTrace; Q9UNN5; -.
DR   GeneWiki; FAF1; -.
DR   GenomeRNAi; 11124; -.
DR   PRO; PR:Q9UNN5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000185104; -.
DR   CleanEx; HS_FAF1; -.
DR   ExpressionAtlas; Q9UNN5; baseline and differential.
DR   Genevisible; Q9UNN5; HS.
DR   GO; GO:0031265; C:CD95 death-inducing signaling complex; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0034098; C:VCP-NPL4-UFD1 AAA ATPase complex; IDA:BHF-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IDA:UniProtKB.
DR   GO; GO:0051059; F:NF-kappaB binding; IPI:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IDA:UniProtKB.
DR   GO; GO:0019887; F:protein kinase regulator activity; NAS:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; IDA:BHF-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IDA:BHF-UCL.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0008219; P:cell death; IMP:UniProtKB.
DR   GO; GO:0007253; P:cytoplasmic sequestering of NF-kappaB; IMP:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; NAS:UniProtKB.
DR   GO; GO:0010942; P:positive regulation of cell death; IDA:CACAO.
DR   GO; GO:1903364; P:positive regulation of cellular protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0045740; P:positive regulation of DNA replication; IMP:UniProtKB.
DR   GO; GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl.
DR   GO; GO:0031334; P:positive regulation of protein complex assembly; IMP:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; NAS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IEA:Ensembl.
DR   GO; GO:0042176; P:regulation of protein catabolic process; IMP:UniProtKB.
DR   CDD; cd01771; Faf1_UBX; 1.
DR   InterPro; IPR033043; FAF1_UBX.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR006577; UAS.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR001012; UBX_dom.
DR   Pfam; PF00789; UBX; 1.
DR   SMART; SM00594; UAS; 1.
DR   SMART; SM00166; UBX; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   SUPFAM; SSF54236; SSF54236; 3.
DR   PROSITE; PS50033; UBX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Complete proteome;
KW   Nucleus; Phosphoprotein; Reference proteome.
FT   CHAIN         1    650       FAS-associated factor 1.
FT                                /FTId=PRO_0000211038.
FT   DOMAIN        1     57       UBA. {ECO:0000269|PubMed:19722279}.
FT   DOMAIN      569    646       UBX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00215}.
FT   MOD_RES     320    320       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     580    580       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     582    582       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     188    339       Missing (in isoform Short).
FT                                {ECO:0000303|PubMed:10462485}.
FT                                /FTId=VSP_006704.
FT   CONFLICT    448    448       F -> K (in Ref. 1; AAD51886/AAD51876).
FT                                {ECO:0000305}.
FT   CONFLICT    498    498       E -> G (in Ref. 1; AAD51886/AAD51876).
FT                                {ECO:0000305}.
FT   CONFLICT    529    529       H -> R (in Ref. 1; AAD51886/AAD51876).
FT                                {ECO:0000305}.
FT   HELIX         7     18       {ECO:0000244|PDB:3E21}.
FT   HELIX        23     32       {ECO:0000244|PDB:3E21}.
FT   TURN         33     35       {ECO:0000244|PDB:3E21}.
FT   HELIX        37     41       {ECO:0000244|PDB:3E21}.
FT   STRAND      100    106       {ECO:0000244|PDB:2DZM}.
FT   STRAND      111    117       {ECO:0000244|PDB:2DZM}.
FT   HELIX       122    133       {ECO:0000244|PDB:2DZM}.
FT   TURN        137    139       {ECO:0000244|PDB:2DZM}.
FT   STRAND      146    148       {ECO:0000244|PDB:2DZM}.
FT   HELIX       156    159       {ECO:0000244|PDB:2DZM}.
FT   STRAND      163    169       {ECO:0000244|PDB:2DZM}.
FT   STRAND      172    174       {ECO:0000244|PDB:2DZM}.
FT   HELIX       330    345       {ECO:0000244|PDB:2EC4}.
FT   HELIX       357    362       {ECO:0000244|PDB:2EC4}.
FT   STRAND      365    367       {ECO:0000244|PDB:2EC4}.
FT   TURN        369    371       {ECO:0000244|PDB:2EC4}.
FT   STRAND      374    380       {ECO:0000244|PDB:2EC4}.
FT   HELIX       386    393       {ECO:0000244|PDB:2EC4}.
FT   TURN        394    396       {ECO:0000244|PDB:2EC4}.
FT   HELIX       398    406       {ECO:0000244|PDB:2EC4}.
FT   STRAND      408    414       {ECO:0000244|PDB:2EC4}.
FT   HELIX       418    431       {ECO:0000244|PDB:2EC4}.
FT   HELIX       434    442       {ECO:0000244|PDB:2EC4}.
FT   STRAND      449    454       {ECO:0000244|PDB:2EC4}.
FT   STRAND      463    467       {ECO:0000244|PDB:2EC4}.
FT   HELIX       473    490       {ECO:0000244|PDB:2EC4}.
FT   STRAND      573    579       {ECO:0000244|PDB:3QX1}.
FT   STRAND      585    591       {ECO:0000244|PDB:3QX1}.
FT   HELIX       596    605       {ECO:0000244|PDB:3QX1}.
FT   TURN        610    612       {ECO:0000244|PDB:3QX1}.
FT   STRAND      613    616       {ECO:0000244|PDB:3QX1}.
FT   STRAND      618    620       {ECO:0000244|PDB:3QX1}.
FT   HELIX       624    626       {ECO:0000244|PDB:3QX1}.
FT   TURN        633    637       {ECO:0000244|PDB:3QX1}.
FT   STRAND      640    648       {ECO:0000244|PDB:3QX1}.
SQ   SEQUENCE   650 AA;  73954 MW;  7FB9018B9A230488 CRC64;
     MASNMDREMI LADFQACTGI ENIDEAITLL EQNNWDLVAA INGVIPQENG ILQSEYGGET
     IPGPAFNPAS HPASAPTSSS SSAFRPVMPS RQIVERQPRM LDFRVEYRDR NVDVVLEDTC
     TVGEIKQILE NELQIPVSKM LLKGWKTGDV EDSTVLKSLH LPKNNSLYVL TPDLPPPSSS
     SHAGALQESL NQNFMLIITH REVQREYNLN FSGSSTIQEV KRNVYDLTSI PVRHQLWEGW
     PTSATDDSMC LAESGLSYPC HRLTVGRRSS PAQTREQSEE QITDVHMVSD SDGDDFEDAT
     EFGVDDGEVF GMASSALRKS PMMPENAENE GDALLQFTAE FSSRYGDCHP VFFIGSLEAA
     FQEAFYVKAR DRKLLAIYLH HDESVLTNVF CSQMLCAESI VSYLSQNFIT WAWDLTKDSN
     RARFLTMCNR HFGSVVAQTI RTQKTDQFPL FLIIMGKRSS NEVLNVIQGN TTVDELMMRL
     MAAMEIFTAQ QQEDIKDEDE REARENVKRE QDEAYRLSLE ADRAKREAHE REMAEQFRLE
     QIRKEQEEER EAIRLSLEQA LPPEPKEENA EPVSKLRIRT PSGEFLERRF LASNKLQIVF
     DFVASKGFPW DEYKLLSTFP RRDVTQLDPN KSLLEVKLFP QETLFLEAKE
//
ID   UBC_HUMAN               Reviewed;         685 AA.
AC   P0CG48; P02248; P02249; P02250; P62988; Q29120; Q6LBL4; Q6LDU5;
AC   Q8WYN8; Q91887; Q91888; Q9BWD6; Q9BX98; Q9UEF2; Q9UEG1; Q9UEK8;
AC   Q9UPK7;
DT   10-AUG-2010, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2012, sequence version 3.
DT   23-MAY-2018, entry version 90.
DE   RecName: Full=Polyubiquitin-C;
DE   Contains:
DE     RecName: Full=Ubiquitin;
DE   Flags: Precursor;
GN   Name=UBC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2988935;
RA   Wiborg O., Pedersen M.S., Wind A., Berglund L.E., Marcker K.A.,
RA   Vuust J.;
RT   "The human ubiquitin multigene family: some genes contain multiple
RT   directly repeated ubiquitin coding sequences.";
RL   EMBO J. 4:755-759(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9644242; DOI=10.1093/oxfordjournals.jbchem.a022093;
RA   Kim N.S., Yamaguchi T., Sekine S., Saeki M., Iwamuro S., Kato S.;
RT   "Cloning of human polyubiquitin cDNAs and a ubiquitin-binding assay
RT   involving its in vitro translation product.";
RL   J. Biochem. 124:35-39(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=14745543; DOI=10.1007/s00239-003-2532-4;
RA   Tachikui H., Saitou N., Nakajima T., Hayasaka I., Ishida T., Inoue I.;
RT   "Lineage-specific homogenization of the polyubiquitin gene among human
RT   and great apes.";
RL   J. Mol. Evol. 57:737-744(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Liver, Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-611.
RX   PubMed=8917096; DOI=10.1016/0378-1119(96)00145-X;
RA   Nenoi M., Mita K., Ichimura S., Cartwright I.L., Takahashi E.,
RA   Yamauchi M., Tsuji H.;
RT   "Heterogeneous structure of the polyubiquitin gene UbC of HeLa S3
RT   cells.";
RL   Gene 175:179-185(1996).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-74.
RX   PubMed=1128706; DOI=10.1038/255423a0;
RA   Schlesinger D.H., Goldstein G.;
RT   "Molecular conservation of 74 amino acid sequence of ubiquitin between
RT   cattle and man.";
RL   Nature 255:423-424(1975).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-27; 30-42 AND 55-72, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 1-27 AND 43-54, UBIQUITINATION AT LYS-6; LYS-11
RP   AND LYS-48, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16443603; DOI=10.1074/jbc.M512786200;
RA   Cripps D., Thomas S.N., Jeng Y., Yang F., Davies P., Yang A.J.;
RT   "Alzheimer disease-specific conformation of hyperphosphorylated paired
RT   helical filament-tau is polyubiquitinated through Lys-48, Lys-11, and
RT   Lys-6 ubiquitin conjugation.";
RL   J. Biol. Chem. 281:10825-10838(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 77-685.
RX   PubMed=9504932;
RA   Nenoi M., Mita K., Ichimura S., Kawano A.;
RT   "Higher frequency of concerted evolutionary events in rodents than in
RT   man at the polyubiquitin gene VNTR locus.";
RL   Genetics 148:867-876(1998).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 417-685.
RX   PubMed=2820408; DOI=10.1016/0006-291X(87)90970-3;
RA   Einspanier R., Sharma H.S., Scheit K.H.;
RT   "Cloning and sequence analysis of a cDNA encoding poly-ubiquitin in
RT   human ovarian granulosa cells.";
RL   Biochem. Biophys. Res. Commun. 147:581-587(1987).
RN   [12]
RP   FUNCTION, UBIQUITINATION AT LYS-11; LYS-29; LYS-48 AND LYS-63, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16543144; DOI=10.1016/j.molcel.2006.02.018;
RA   Huang F., Kirkpatrick D., Jiang X., Gygi S.P., Sorkin A.;
RT   "Differential regulation of EGF receptor internalization and
RT   degradation by multiubiquitination within the kinase domain.";
RL   Mol. Cell 21:737-748(2006).
RN   [13]
RP   UBIQUITINATION AT LYS-27.
RX   PubMed=15466860; DOI=10.1074/jbc.M402916200;
RA   Okumura F., Hatakeyama S., Matsumoto M., Kamura T., Nakayama K.;
RT   "Functional regulation of FEZ1 by the U-box-type ubiquitin ligase E4B
RT   contributes to neuritogenesis.";
RL   J. Biol. Chem. 279:53533-53543(2004).
RN   [14]
RP   UBIQUITINATION AT LYS-63, AND MUTAGENESIS OF LYS-48 AND LYS-63.
RX   PubMed=18719106; DOI=10.1073/pnas.0805685105;
RA   Motegi A., Liaw H.-J., Lee K.-Y., Roest H.P., Maas A., Wu X.,
RA   Moinova H., Markowitz S.D., Ding H., Hoeijmakers J.H.J., Myung K.;
RT   "Polyubiquitination of proliferating cell nuclear antigen by HLTF and
RT   SHPRH prevents genomic instability from stalled replication forks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12411-12416(2008).
RN   [15]
RP   REVIEW, AND FUNCTION.
RX   PubMed=19754430; DOI=10.1042/BST0370937;
RA   Komander D.;
RT   "The emerging complexity of protein ubiquitination.";
RL   Biochem. Soc. Trans. 37:937-953(2009).
RN   [16]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24660806; DOI=10.1042/BJ20140334;
RA   Kazlauskaite A., Kondapalli C., Gourlay R., Campbell D.G.,
RA   Ritorto M.S., Hofmann K., Alessi D.R., Knebel A., Trost M.,
RA   Muqit M.M.;
RT   "Parkin is activated by PINK1-dependent phosphorylation of ubiquitin
RT   at Ser65.";
RL   Biochem. J. 460:127-139(2014).
RN   [17]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24751536; DOI=10.1083/jcb.201402104;
RA   Kane L.A., Lazarou M., Fogel A.I., Li Y., Yamano K., Sarraf S.A.,
RA   Banerjee S., Youle R.J.;
RT   "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase
RT   activity.";
RL   J. Cell Biol. 205:143-153(2014).
RN   [18]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24784582; DOI=10.1038/nature13392;
RA   Koyano F., Okatsu K., Kosako H., Tamura Y., Go E., Kimura M.,
RA   Kimura Y., Tsuchiya H., Yoshihara H., Hirokawa T., Endo T., Fon E.A.,
RA   Trempe J.F., Saeki Y., Tanaka K., Matsuda N.;
RT   "Ubiquitin is phosphorylated by PINK1 to activate parkin.";
RL   Nature 510:162-166(2014).
RN   [19]
RP   ADP-RIBOSYLATION, AND MUTAGENESIS OF HIS-68; ARG-72; ARG-74 AND
RP   GLY-76.
RX   PubMed=28525742; DOI=10.1016/j.molcel.2017.04.028;
RA   Yang C.S., Jividen K., Spencer A., Dworak N., Ni L., Oostdyk L.T.,
RA   Chatterjee M., Kusmider B., Reon B., Parlak M., Gorbunova V.,
RA   Abbas T., Jeffery E., Sherman N.E., Paschal B.M.;
RT   "Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase
RT   Dtx3L/Parp9.";
RL   Mol. Cell 66:503-516(2017).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=3041007; DOI=10.1016/0022-2836(87)90679-6;
RA   Vijay-Kumar S., Bugg C.E., Cook W.J.;
RT   "Structure of ubiquitin refined at 1.8-A resolution.";
RL   J. Mol. Biol. 194:531-544(1987).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=8166633; DOI=10.1042/bj2990151;
RA   Ramage R., Green J., Muir T.W., Ogunjobi O.M., Love S., Shaw K.;
RT   "Synthetic, structural and biological studies of the ubiquitin system:
RT   the total chemical synthesis of ubiquitin.";
RL   Biochem. J. 299:151-158(1994).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=8107144; DOI=10.1006/jmbi.1994.1169;
RA   Cook W.J., Jeffrey L.C., Kasperek E., Pickart C.M.;
RT   "Structure of tetraubiquitin shows how multiubiquitin chains can be
RT   formed.";
RL   J. Mol. Biol. 236:601-609(1994).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=11173499; DOI=10.1107/S090744490001800X;
RA   Phillips C.L., Thrower J., Pickart C.M., Hill C.P.;
RT   "Structure of a new crystal form of tetraubiquitin.";
RL   Acta Crystallogr. D 57:341-344(2001).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-75 IN COMPLEX WITH USP7.
RX   PubMed=12507430; DOI=10.1016/S0092-8674(02)01199-6;
RA   Hu M., Li P., Li M., Li W., Yao T., Wu J.-W., Gu W., Cohen R.E.,
RA   Shi Y.;
RT   "Crystal structure of a UBP-family deubiquitinating enzyme in
RT   isolation and in complex with ubiquitin aldehyde.";
RL   Cell 111:1041-1054(2002).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) OF 1-75 IN COMPLEX WITH USP21.
RX   PubMed=21399617; DOI=10.1038/embor.2011.17;
RA   Ye Y., Akutsu M., Reyes-Turcu F., Enchev R.I., Wilkinson K.D.,
RA   Komander D.;
RT   "Polyubiquitin binding and cross-reactivity in the USP domain
RT   deubiquitinase USP21.";
RL   EMBO Rep. 12:350-357(2011).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-76.
RX   PubMed=20622874; DOI=10.1038/nsmb.1873;
RA   Bremm A., Freund S.M., Komander D.;
RT   "Lys11-linked ubiquitin chains adopt compact conformations and are
RT   preferentially hydrolyzed by the deubiquitinase Cezanne.";
RL   Nat. Struct. Mol. Biol. 17:939-947(2010).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (3.03 ANGSTROMS) OF 1-76 IN COMPLEX WITH YOD1.
RX   PubMed=23827681; DOI=10.1016/j.cell.2013.05.046;
RA   Mevissen T.E., Hospenthal M.K., Geurink P.P., Elliott P.R., Akutsu M.,
RA   Arnaudo N., Ekkebus R., Kulathu Y., Wauer T., El Oualid F.,
RA   Freund S.M., Ovaa H., Komander D.;
RT   "OTU deubiquitinases reveal mechanisms of linkage specificity and
RT   enable ubiquitin chain restriction analysis.";
RL   Cell 154:169-184(2013).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 153-228 PHOSPHORYLATED AT
RP   SER-65, AND PHOSPHORYLATION AT SER-65.
RX   PubMed=25527291; DOI=10.15252/embj.201489847;
RA   Wauer T., Swatek K.N., Wagstaff J.L., Gladkova C., Pruneda J.N.,
RA   Michel M.A., Gersch M., Johnson C.M., Freund S.M., Komander D.;
RT   "Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain
RT   assembly and hydrolysis.";
RL   EMBO J. 34:307-325(2015).
CC   -!- FUNCTION: Ubiquitin: Exists either covalently attached to another
CC       protein, or free (unanchored). When covalently bound, it is
CC       conjugated to target proteins via an isopeptide bond either as a
CC       monomer (monoubiquitin), a polymer linked via different Lys
CC       residues of the ubiquitin (polyubiquitin chains) or a linear
CC       polymer linked via the initiator Met of the ubiquitin (linear
CC       polyubiquitin chains). Polyubiquitin chains, when attached to a
CC       target protein, have different functions depending on the Lys
CC       residue of the ubiquitin that is linked: Lys-6-linked may be
CC       involved in DNA repair; Lys-11-linked is involved in ERAD
CC       (endoplasmic reticulum-associated degradation) and in cell-cycle
CC       regulation; Lys-29-linked is involved in lysosomal degradation;
CC       Lys-33-linked is involved in kinase modification; Lys-48-linked is
CC       involved in protein degradation via the proteasome; Lys-63-linked
CC       is involved in endocytosis, DNA-damage responses as well as in
CC       signaling processes leading to activation of the transcription
CC       factor NF-kappa-B. Linear polymer chains formed via attachment by
CC       the initiator Met lead to cell signaling. Ubiquitin is usually
CC       conjugated to Lys residues of target proteins, however, in rare
CC       cases, conjugation to Cys or Ser residues has been observed. When
CC       polyubiquitin is free (unanchored-polyubiquitin), it also has
CC       distinct roles, such as in activation of protein kinases, and in
CC       signaling. {ECO:0000269|PubMed:16543144,
CC       ECO:0000269|PubMed:19754430}.
CC   -!- INTERACTION:
CC       Q9UNQ0:ABCG2; NbExp=2; IntAct=EBI-3390054, EBI-1569435;
CC       Q16186:ADRM1; NbExp=10; IntAct=EBI-3390054, EBI-954387;
CC       Q9ULH1:ASAP1; NbExp=2; IntAct=EBI-3390054, EBI-346622;
CC       O43150:ASAP2; NbExp=2; IntAct=EBI-3390054, EBI-310968;
CC       P54252-1:ATXN3; NbExp=2; IntAct=EBI-3390054, EBI-946068;
CC       Q9HB09-1:BCL2L12; NbExp=3; IntAct=EBI-3390054, EBI-6968951;
CC       P35226:BMI1; NbExp=2; IntAct=EBI-3390054, EBI-2341576;
CC       O60566:BUB1B; NbExp=3; IntAct=EBI-3390054, EBI-1001438;
CC       P06493:CDK1; NbExp=6; IntAct=EBI-3390054, EBI-444308;
CC       Q99062:CSF3R; NbExp=2; IntAct=EBI-3390054, EBI-7331284;
CC       Q9UER7:DAXX; NbExp=2; IntAct=EBI-3390054, EBI-77321;
CC       Q15038:DAZAP2; NbExp=4; IntAct=EBI-3390054, EBI-724310;
CC       P40087:DDI1 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-5717;
CC       O43583:DENR; NbExp=3; IntAct=EBI-3390054, EBI-716083;
CC       Q6ICB0:DESI1; NbExp=4; IntAct=EBI-3390054, EBI-2806959;
CC       P48510:DSK2 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-6174;
CC       Q86Y01:DTX1; NbExp=2; IntAct=EBI-3390054, EBI-1755174;
CC       Q15717:ELAVL1; NbExp=4; IntAct=EBI-3390054, EBI-374260;
CC       Q92567-2:FAM168A; NbExp=4; IntAct=EBI-3390054, EBI-11978259;
CC       Q61088:Fzd4 (xeno); NbExp=3; IntAct=EBI-3390054, EBI-7987880;
CC       P25098:GRK2; NbExp=3; IntAct=EBI-3390054, EBI-3904795;
CC       Q9Y6K9:IKBKG; NbExp=4; IntAct=EBI-3390054, EBI-81279;
CC       O88522:Ikbkg (xeno); NbExp=3; IntAct=EBI-3390054, EBI-998011;
CC       Q13887:KLF5; NbExp=2; IntAct=EBI-3390054, EBI-2696013;
CC       P06239:LCK; NbExp=2; IntAct=EBI-3390054, EBI-1348;
CC       P48357-3:LEPR; NbExp=2; IntAct=EBI-3390054, EBI-7886448;
CC       Q9UDY8:MALT1; NbExp=4; IntAct=EBI-3390054, EBI-1047372;
CC       Q9Y6R4:MAP3K4; NbExp=2; IntAct=EBI-3390054, EBI-448104;
CC       O43318:MAP3K7; NbExp=4; IntAct=EBI-3390054, EBI-358684;
CC       Q9NX47:MARCH5; NbExp=2; IntAct=EBI-3390054, EBI-2341610;
CC       Q00987:MDM2; NbExp=6; IntAct=EBI-3390054, EBI-389668;
CC       P01106:MYC; NbExp=5; IntAct=EBI-3390054, EBI-447544;
CC       O43639:NCK2; NbExp=2; IntAct=EBI-3390054, EBI-713635;
CC       Q14934:NFATC4; NbExp=3; IntAct=EBI-3390054, EBI-3905796;
CC       P25963:NFKBIA; NbExp=3; IntAct=EBI-3390054, EBI-307386;
CC       P09874:PARP1; NbExp=2; IntAct=EBI-3390054, EBI-355676;
CC       P35227:PCGF2; NbExp=2; IntAct=EBI-3390054, EBI-2129767;
CC       Q9Y253:POLH; NbExp=4; IntAct=EBI-3390054, EBI-2827270;
CC       Q9UNA4:POLI; NbExp=4; IntAct=EBI-3390054, EBI-741774;
CC       P17252:PRKCA; NbExp=2; IntAct=EBI-3390054, EBI-1383528;
CC       P55036:PSMD4; NbExp=8; IntAct=EBI-3390054, EBI-359318;
CC       P32628:RAD23 (xeno); NbExp=4; IntAct=EBI-3390054, EBI-14668;
CC       P54727:RAD23B; NbExp=6; IntAct=EBI-3390054, EBI-954531;
CC       Q84L31:RAD23C (xeno); NbExp=2; IntAct=EBI-3390054, EBI-4437395;
CC       Q62921:Rbck1 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-7266339;
CC       Q96NR8:RDH12; NbExp=2; IntAct=EBI-3390054, EBI-3916363;
CC       Q04206:RELA; NbExp=6; IntAct=EBI-3390054, EBI-73886;
CC       P04325:rev (xeno); NbExp=2; IntAct=EBI-3390054, EBI-7061954;
CC       P55034:RPN10 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-2620423;
CC       O48726:RPN13 (xeno); NbExp=9; IntAct=EBI-3390054, EBI-7710745;
CC       Q8N488:RYBP; NbExp=3; IntAct=EBI-3390054, EBI-752324;
CC       Q9H4L4:SENP3; NbExp=2; IntAct=EBI-3390054, EBI-2880236;
CC       Q96B97:SH3KBP1; NbExp=6; IntAct=EBI-3390054, EBI-346595;
CC       Q9Y5X1:SNX9; NbExp=2; IntAct=EBI-3390054, EBI-77848;
CC       Q13501:SQSTM1; NbExp=3; IntAct=EBI-3390054, EBI-307104;
CC       Q92783:STAM; NbExp=2; IntAct=EBI-3390054, EBI-752333;
CC       Q86VP1:TAX1BP1; NbExp=7; IntAct=EBI-3390054, EBI-529518;
CC       P04637:TP53; NbExp=15; IntAct=EBI-3390054, EBI-366083;
CC       Q9Y4K3:TRAF6; NbExp=3; IntAct=EBI-3390054, EBI-359276;
CC       Q9EPK8:Trpv4 (xeno); NbExp=3; IntAct=EBI-3390054, EBI-7091763;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-3390054, EBI-741480;
CC       P98170:XIAP; NbExp=3; IntAct=EBI-3390054, EBI-517127;
CC       O76080:ZFAND5; NbExp=3; IntAct=EBI-3390054, EBI-8028844;
CC       Q9UGI0:ZRANB1; NbExp=2; IntAct=EBI-3390054, EBI-527853;
CC   -!- SUBCELLULAR LOCATION: Ubiquitin: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitin: Phosphorylated at Ser-65 by PINK1 during
CC       mitophagy. Phosphorylated ubiquitin specifically binds and
CC       activates parkin (PRKN), triggering mitophagy (PubMed:24660806,
CC       PubMed:24751536, PubMed:24784582, PubMed:25527291).
CC       Phosphorylation does not affect E1-mediated E2 charging of
CC       ubiquitin but affects discharging of E2 enzymes to form
CC       polyubiquitin chains. It also affects deubiquitination by
CC       deubiquitinase enzymes such as USP30 (PubMed:25527291).
CC       {ECO:0000269|PubMed:24660806, ECO:0000269|PubMed:24751536,
CC       ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:25527291}.
CC   -!- PTM: Ubiquitin: Mono-ADP-riblosylated at the C-terminus by PARP9,
CC       a component of the PPAR9-DTX3L complex. ADP-ribosylation requires
CC       processing by E1 and E2 enzymes and prevents ubiquitin conjugation
CC       to substrates such as histones. {ECO:0000269|PubMed:28525742}.
CC   -!- MISCELLANEOUS: Ubiquitin is encoded by 4 different genes. UBA52
CC       and RPS27A genes code for a single copy of ubiquitin fused to the
CC       ribosomal proteins L40 and S27a, respectively. UBB and UBC genes
CC       code for a polyubiquitin precursor with exact head to tail
CC       repeats, the number of repeats differ between species and strains.
CC   -!- MISCELLANEOUS: For the sake of clarity sequence features are
CC       annotated only for the first chain, and are not repeated for each
CC       of the following chains.
CC   -!- SIMILARITY: Belongs to the ubiquitin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26880; AAA36789.1; -; mRNA.
DR   EMBL; AB009010; BAA23632.1; -; mRNA.
DR   EMBL; AB089613; BAC56951.1; -; Genomic_DNA.
DR   EMBL; AC126309; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC039193; AAH39193.1; -; mRNA.
DR   EMBL; D63791; BAA09860.1; -; Genomic_DNA.
DR   EMBL; AB003730; BAA23486.1; -; Genomic_DNA.
DR   EMBL; M17597; AAA36787.1; -; mRNA.
DR   CCDS; CCDS9260.1; -.
DR   PIR; A02574; UQHU.
DR   PIR; A22005; UQHUC.
DR   PIR; A29526; A29526.
DR   RefSeq; NP_066289.3; NM_021009.6.
DR   UniGene; Hs.520348; -.
DR   UniGene; Hs.707528; -.
DR   UniGene; Hs.731841; -.
DR   PDB; 1C3T; NMR; -; A=1-76.
DR   PDB; 1CMX; X-ray; 2.25 A; B/D=1-76.
DR   PDB; 1D3Z; NMR; -; A=1-76.
DR   PDB; 1F9J; X-ray; 2.70 A; A/B=1-76.
DR   PDB; 1FXT; NMR; -; B=1-76.
DR   PDB; 1G6J; NMR; -; A=1-76.
DR   PDB; 1GJZ; NMR; -; A/B=1-51.
DR   PDB; 1NBF; X-ray; 2.30 A; C/D=1-76.
DR   PDB; 1OGW; X-ray; 1.32 A; A=1-76.
DR   PDB; 1Q5W; NMR; -; B=1-76.
DR   PDB; 1S1Q; X-ray; 2.00 A; B/D=1-76.
DR   PDB; 1SIF; X-ray; 2.18 A; A=6-76.
DR   PDB; 1TBE; X-ray; 2.40 A; A/B=1-76.
DR   PDB; 1UBI; X-ray; 1.80 A; A=1-76.
DR   PDB; 1UBQ; X-ray; 1.80 A; A=1-76.
DR   PDB; 1UD7; NMR; -; A=1-76.
DR   PDB; 1XD3; X-ray; 1.45 A; B/D=1-75.
DR   PDB; 1XQQ; NMR; -; A=1-76.
DR   PDB; 1YX5; NMR; -; B=1-76.
DR   PDB; 1YX6; NMR; -; B=1-76.
DR   PDB; 1ZGU; NMR; -; B=1-76.
DR   PDB; 1ZO6; Model; -; B/C=1-76.
DR   PDB; 2AYO; X-ray; 3.50 A; B=1-76.
DR   PDB; 2BGF; NMR; -; A/B=1-76.
DR   PDB; 2DEN; NMR; -; B=1-76.
DR   PDB; 2FUH; NMR; -; B=1-76.
DR   PDB; 2G45; X-ray; 1.99 A; B/E=1-76.
DR   PDB; 2GBJ; X-ray; 1.35 A; A/B=1-76.
DR   PDB; 2GBK; X-ray; 1.99 A; A/B/C/D=10-76.
DR   PDB; 2GBM; X-ray; 1.55 A; A/B/C/D=1-76.
DR   PDB; 2GBN; X-ray; 1.60 A; A=1-76.
DR   PDB; 2GBR; X-ray; 2.00 A; A/B/C=1-76.
DR   PDB; 2GMI; X-ray; 2.50 A; C=1-76.
DR   PDB; 2HTH; X-ray; 2.70 A; A=1-76.
DR   PDB; 2IBI; X-ray; 2.20 A; B=1-75.
DR   PDB; 2J7Q; X-ray; 1.80 A; B/D=1-75.
DR   PDB; 2JF5; X-ray; 1.95 A; A/B=1-76.
DR   PDB; 2JRI; NMR; -; B/C=1-76.
DR   PDB; 2JY6; NMR; -; A=1-76.
DR   PDB; 2JZZ; NMR; -; A=1-76.
DR   PDB; 2K25; NMR; -; A=1-75.
DR   PDB; 2K6D; NMR; -; B=1-75.
DR   PDB; 2K8B; NMR; -; A=1-76.
DR   PDB; 2K8C; NMR; -; A=1-76.
DR   PDB; 2KDF; NMR; -; B/C=1-76.
DR   PDB; 2KHW; NMR; -; B=1-76.
DR   PDB; 2KJH; NMR; -; B=1-75.
DR   PDB; 2KLG; NMR; -; A=1-76.
DR   PDB; 2KN5; NMR; -; A=1-76.
DR   PDB; 2KX0; NMR; -; A=74-151.
DR   PDB; 2L3Z; NMR; -; A=1-76.
DR   PDB; 2LD9; NMR; -; A=76-152.
DR   PDB; 2LVO; NMR; -; A=1-76.
DR   PDB; 2LVP; NMR; -; A/B=1-76.
DR   PDB; 2LVQ; NMR; -; A/B=1-76.
DR   PDB; 2LZ6; NMR; -; A=609-684.
DR   PDB; 2MBO; NMR; -; A/B=609-684.
DR   PDB; 2MBQ; NMR; -; A/B=609-684.
DR   PDB; 2MCN; NMR; -; B=609-684.
DR   PDB; 2MI8; NMR; -; A=609-684.
DR   PDB; 2MJ5; NMR; -; A=609-684.
DR   PDB; 2MOR; NMR; -; A=609-684.
DR   PDB; 2MRE; NMR; -; A=609-684.
DR   PDB; 2MWS; NMR; -; A=609-684.
DR   PDB; 2N2K; NMR; -; A=609-684, B=609-679.
DR   PDB; 2NR2; NMR; -; A=1-76.
DR   PDB; 2O6V; X-ray; 2.20 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 2OJR; X-ray; 2.60 A; A=1-76.
DR   PDB; 2PE9; NMR; -; A/B=1-76.
DR   PDB; 2PEA; NMR; -; A/B=1-76.
DR   PDB; 2RR9; NMR; -; A/B=1-76.
DR   PDB; 2RU6; NMR; -; A=609-684.
DR   PDB; 2W9N; X-ray; 2.25 A; A=1-152.
DR   PDB; 2WDT; X-ray; 2.30 A; B/D=1-75.
DR   PDB; 2XEW; X-ray; 2.20 A; A/B/C/D/E/F/G/H/I/J/K/L=1-76.
DR   PDB; 2Y5B; X-ray; 2.70 A; B/F=1-152.
DR   PDB; 2Z59; NMR; -; B=1-76.
DR   PDB; 2ZCB; X-ray; 1.60 A; A/B/C=1-76.
DR   PDB; 2ZVN; X-ray; 3.00 A; A/C/E/G=1-152.
DR   PDB; 2ZVO; X-ray; 2.90 A; A/G=1-152.
DR   PDB; 3A33; X-ray; 2.20 A; B=1-76.
DR   PDB; 3ALB; X-ray; 1.85 A; A/B/C/D=1-76.
DR   PDB; 3AUL; X-ray; 2.39 A; A/B=1-76.
DR   PDB; 3B08; X-ray; 1.70 A; A/D/G/J=1-152.
DR   PDB; 3B0A; X-ray; 1.90 A; A/D=1-152.
DR   PDB; 3BY4; X-ray; 1.55 A; B=1-75.
DR   PDB; 3C0R; X-ray; 2.31 A; B/D=1-75.
DR   PDB; 3DVG; X-ray; 2.60 A; X/Y=1-76.
DR   PDB; 3DVN; X-ray; 2.70 A; U/V/X/Y=1-76.
DR   PDB; 3EEC; X-ray; 3.00 A; A/B=1-76.
DR   PDB; 3EFU; X-ray; 1.84 A; A=1-76.
DR   PDB; 3EHV; X-ray; 1.81 A; A/B/C=1-76.
DR   PDB; 3H7P; X-ray; 1.90 A; A/B=1-76.
DR   PDB; 3H7S; X-ray; 2.30 A; A/B=1-76.
DR   PDB; 3HM3; X-ray; 1.96 A; A/B/C/D=1-76.
DR   PDB; 3I3T; X-ray; 2.59 A; B/D/F/H=1-75.
DR   PDB; 3IFW; X-ray; 2.40 A; B=1-75.
DR   PDB; 3IHP; X-ray; 2.80 A; C/D=1-75.
DR   PDB; 3JSV; X-ray; 2.70 A; A/B=1-76.
DR   PDB; 3JVZ; X-ray; 3.30 A; X/Y=1-76.
DR   PDB; 3JW0; X-ray; 3.10 A; X/Y=1-76.
DR   PDB; 3K9O; X-ray; 1.80 A; B=76-151.
DR   PDB; 3K9P; X-ray; 2.80 A; B=1-76.
DR   PDB; 3KVF; X-ray; 2.80 A; B=1-75.
DR   PDB; 3KW5; X-ray; 2.83 A; B=1-75.
DR   PDB; 3LDZ; X-ray; 2.60 A; E/F/G=1-73.
DR   PDB; 3MHS; X-ray; 1.89 A; D=1-76.
DR   PDB; 3MTN; X-ray; 2.70 A; B/D=1-76.
DR   PDB; 3N30; X-ray; 3.00 A; A/B=1-76.
DR   PDB; 3N32; X-ray; 1.80 A; A=1-76.
DR   PDB; 3N3K; X-ray; 2.60 A; B=5-76.
DR   PDB; 3NS8; X-ray; 1.71 A; A/B=1-76.
DR   PDB; 3O65; X-ray; 2.70 A; B/D/F/H=1-75.
DR   PDB; 3OFI; X-ray; 2.35 A; C/D=1-76.
DR   PDB; 3OJ3; X-ray; 2.50 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 3OJ4; X-ray; 3.40 A; B/E=1-76.
DR   PDB; 3ONS; X-ray; 1.80 A; A=1-72.
DR   PDB; 3PRM; X-ray; 2.30 A; B/D=1-75.
DR   PDB; 3PT2; X-ray; 2.50 A; B=1-75.
DR   PDB; 3PTF; X-ray; 2.70 A; C/D=1-76.
DR   PDB; 3Q3F; X-ray; 2.17 A; A=2-76.
DR   PDB; 3RUL; X-ray; 2.50 A; A/B/C/D=1-75.
DR   PDB; 3TMP; X-ray; 1.91 A; B/D/F/H=1-76.
DR   PDB; 3U30; X-ray; 2.43 A; A/D=1-152.
DR   PDB; 3UGB; X-ray; 2.35 A; B=1-76.
DR   PDB; 3V6C; X-ray; 1.70 A; B=74-150.
DR   PDB; 3V6E; X-ray; 2.10 A; B=74-150.
DR   PDB; 3VFK; X-ray; 2.80 A; A=1-75.
DR   PDB; 3VUW; X-ray; 1.95 A; A/B/C=1-76.
DR   PDB; 3VUX; X-ray; 1.70 A; A/B/C=1-76.
DR   PDB; 3VUY; X-ray; 1.98 A; A/B/C=1-76.
DR   PDB; 3WXE; X-ray; 2.50 A; B=533-680.
DR   PDB; 3WXF; X-ray; 2.30 A; B/D=533-680.
DR   PDB; 3ZLZ; X-ray; 2.90 A; A/B=1-76.
DR   PDB; 3ZNH; X-ray; 2.30 A; B=1-75.
DR   PDB; 3ZNI; X-ray; 2.21 A; D/H/L/P=1-76.
DR   PDB; 3ZNZ; X-ray; 1.90 A; B=1-152.
DR   PDB; 4AP4; X-ray; 2.21 A; C/F=608-684.
DR   PDB; 4AUQ; X-ray; 2.18 A; C/F=1-76.
DR   PDB; 4BOS; X-ray; 2.35 A; C/E=609-684, F=612-625.
DR   PDB; 4BOZ; X-ray; 3.03 A; B/C/E=1-76.
DR   PDB; 4BVU; X-ray; 2.70 A; C=609-684.
DR   PDB; 4DDG; X-ray; 3.30 A; D/E/F/G/H/I/M/N/O/P/Q/R=1-76.
DR   PDB; 4DDI; X-ray; 3.80 A; G/H/I/J/K/L=1-76.
DR   PDB; 4DHJ; X-ray; 2.35 A; B/F/J/M=1-76, D/H=1-75.
DR   PDB; 4DHZ; X-ray; 3.11 A; B=1-76, E=1-75.
DR   PDB; 4FJV; X-ray; 2.05 A; B/D=1-76.
DR   PDB; 4HK2; X-ray; 1.40 A; A/B/C/D=1-76.
DR   PDB; 4HXD; X-ray; 2.85 A; A/C=1-75.
DR   PDB; 4I6L; X-ray; 2.49 A; B=77-150.
DR   PDB; 4I6N; X-ray; 1.70 A; B/D=1-75.
DR   PDB; 4IG7; X-ray; 2.00 A; B=1-75.
DR   PDB; 4IUM; X-ray; 1.45 A; B=1-75.
DR   PDB; 4JQW; X-ray; 2.90 A; C=609-684.
DR   PDB; 4K1R; X-ray; 1.63 A; B/D=607-684.
DR   PDB; 4K7S; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4K7U; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4K7W; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4KSK; X-ray; 2.40 A; C/D=76-152.
DR   PDB; 4KSL; X-ray; 2.83 A; C/D/F/H/J/L/N/P/R/T/V/X=76-228.
DR   PDB; 4LCD; X-ray; 3.10 A; E/F=609-683.
DR   PDB; 4LDT; X-ray; 1.90 A; B/D=609-684.
DR   PDB; 4MDK; X-ray; 2.61 A; E/F/G/H=608-684.
DR   PDB; 4MM3; X-ray; 2.75 A; A=609-684.
DR   PDB; 4MSM; X-ray; 1.74 A; B/D=609-684.
DR   PDB; 4MSQ; X-ray; 1.95 A; B/D=609-684.
DR   PDB; 4NQK; X-ray; 3.70 A; E/F/G/H/I/J=608-684.
DR   PDB; 4UN2; X-ray; 1.51 A; A=609-684.
DR   PDB; 4V3K; X-ray; 2.04 A; B/E=609-684.
DR   PDB; 4V3L; X-ray; 1.53 A; B/D=609-684.
DR   PDB; 4WZP; X-ray; 1.90 A; A/B/C/D/E/F/G/H=153-228.
DR   PDB; 4XOK; X-ray; 2.20 A; A/B/C=1-76.
DR   PDB; 4XOL; X-ray; 2.91 A; A/B=1-76.
DR   PDB; 4ZQS; X-ray; 1.80 A; A/B=533-684.
DR   PDB; 5A5B; EM; 9.50 A; 9=609-684.
DR   PDB; 5AF4; X-ray; 1.85 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 5AF5; X-ray; 1.68 A; A=1-73.
DR   PDB; 5AF6; X-ray; 3.40 A; A/B/C/D/E=1-76.
DR   PDB; 5AIT; X-ray; 3.40 A; C/F=609-684.
DR   PDB; 5AIU; X-ray; 2.21 A; C/F=609-684.
DR   PDB; 5B83; X-ray; 2.69 A; A/D=1-304.
DR   PDB; 5C7J; X-ray; 3.00 A; C/D=1-74.
DR   PDB; 5C7M; X-ray; 3.03 A; B/C=1-75.
DR   PDB; 5E6J; X-ray; 2.85 A; B/E=609-683.
DR   PDB; 5H07; X-ray; 2.59 A; A=1-228.
DR   PDB; 5NL4; X-ray; 1.32 A; A/B/C=1-76.
DR   PDB; 5NLF; X-ray; 1.50 A; A/B/C=1-76.
DR   PDB; 5NLI; X-ray; 1.53 A; A/B/C=1-76.
DR   PDB; 5NMC; X-ray; 1.70 A; A/B/C=1-76.
DR   PDB; 5OE7; X-ray; 2.95 A; B=1-146.
DR   PDB; 5OHV; X-ray; 2.80 A; A/C=1-76.
DR   PDB; 5OXH; X-ray; 1.60 A; A=1-76.
DR   PDB; 5OXI; X-ray; 1.63 A; A/B=1-76.
DR   PDB; 5UDH; X-ray; 3.24 A; E=1-76.
DR   PDB; 5WQ4; X-ray; 3.00 A; A/B=1-152.
DR   PDB; 6EQI; X-ray; 3.10 A; A=1-76.
DR   PDBsum; 1C3T; -.
DR   PDBsum; 1CMX; -.
DR   PDBsum; 1D3Z; -.
DR   PDBsum; 1F9J; -.
DR   PDBsum; 1FXT; -.
DR   PDBsum; 1G6J; -.
DR   PDBsum; 1GJZ; -.
DR   PDBsum; 1NBF; -.
DR   PDBsum; 1OGW; -.
DR   PDBsum; 1Q5W; -.
DR   PDBsum; 1S1Q; -.
DR   PDBsum; 1SIF; -.
DR   PDBsum; 1TBE; -.
DR   PDBsum; 1UBI; -.
DR   PDBsum; 1UBQ; -.
DR   PDBsum; 1UD7; -.
DR   PDBsum; 1XD3; -.
DR   PDBsum; 1XQQ; -.
DR   PDBsum; 1YX5; -.
DR   PDBsum; 1YX6; -.
DR   PDBsum; 1ZGU; -.
DR   PDBsum; 1ZO6; -.
DR   PDBsum; 2AYO; -.
DR   PDBsum; 2BGF; -.
DR   PDBsum; 2DEN; -.
DR   PDBsum; 2FUH; -.
DR   PDBsum; 2G45; -.
DR   PDBsum; 2GBJ; -.
DR   PDBsum; 2GBK; -.
DR   PDBsum; 2GBM; -.
DR   PDBsum; 2GBN; -.
DR   PDBsum; 2GBR; -.
DR   PDBsum; 2GMI; -.
DR   PDBsum; 2HTH; -.
DR   PDBsum; 2IBI; -.
DR   PDBsum; 2J7Q; -.
DR   PDBsum; 2JF5; -.
DR   PDBsum; 2JRI; -.
DR   PDBsum; 2JY6; -.
DR   PDBsum; 2JZZ; -.
DR   PDBsum; 2K25; -.
DR   PDBsum; 2K6D; -.
DR   PDBsum; 2K8B; -.
DR   PDBsum; 2K8C; -.
DR   PDBsum; 2KDF; -.
DR   PDBsum; 2KHW; -.
DR   PDBsum; 2KJH; -.
DR   PDBsum; 2KLG; -.
DR   PDBsum; 2KN5; -.
DR   PDBsum; 2KX0; -.
DR   PDBsum; 2L3Z; -.
DR   PDBsum; 2LD9; -.
DR   PDBsum; 2LVO; -.
DR   PDBsum; 2LVP; -.
DR   PDBsum; 2LVQ; -.
DR   PDBsum; 2LZ6; -.
DR   PDBsum; 2MBO; -.
DR   PDBsum; 2MBQ; -.
DR   PDBsum; 2MCN; -.
DR   PDBsum; 2MI8; -.
DR   PDBsum; 2MJ5; -.
DR   PDBsum; 2MOR; -.
DR   PDBsum; 2MRE; -.
DR   PDBsum; 2MWS; -.
DR   PDBsum; 2N2K; -.
DR   PDBsum; 2NR2; -.
DR   PDBsum; 2O6V; -.
DR   PDBsum; 2OJR; -.
DR   PDBsum; 2PE9; -.
DR   PDBsum; 2PEA; -.
DR   PDBsum; 2RR9; -.
DR   PDBsum; 2RU6; -.
DR   PDBsum; 2W9N; -.
DR   PDBsum; 2WDT; -.
DR   PDBsum; 2XEW; -.
DR   PDBsum; 2Y5B; -.
DR   PDBsum; 2Z59; -.
DR   PDBsum; 2ZCB; -.
DR   PDBsum; 2ZVN; -.
DR   PDBsum; 2ZVO; -.
DR   PDBsum; 3A33; -.
DR   PDBsum; 3ALB; -.
DR   PDBsum; 3AUL; -.
DR   PDBsum; 3B08; -.
DR   PDBsum; 3B0A; -.
DR   PDBsum; 3BY4; -.
DR   PDBsum; 3C0R; -.
DR   PDBsum; 3DVG; -.
DR   PDBsum; 3DVN; -.
DR   PDBsum; 3EEC; -.
DR   PDBsum; 3EFU; -.
DR   PDBsum; 3EHV; -.
DR   PDBsum; 3H7P; -.
DR   PDBsum; 3H7S; -.
DR   PDBsum; 3HM3; -.
DR   PDBsum; 3I3T; -.
DR   PDBsum; 3IFW; -.
DR   PDBsum; 3IHP; -.
DR   PDBsum; 3JSV; -.
DR   PDBsum; 3JVZ; -.
DR   PDBsum; 3JW0; -.
DR   PDBsum; 3K9O; -.
DR   PDBsum; 3K9P; -.
DR   PDBsum; 3KVF; -.
DR   PDBsum; 3KW5; -.
DR   PDBsum; 3LDZ; -.
DR   PDBsum; 3MHS; -.
DR   PDBsum; 3MTN; -.
DR   PDBsum; 3N30; -.
DR   PDBsum; 3N32; -.
DR   PDBsum; 3N3K; -.
DR   PDBsum; 3NS8; -.
DR   PDBsum; 3O65; -.
DR   PDBsum; 3OFI; -.
DR   PDBsum; 3OJ3; -.
DR   PDBsum; 3OJ4; -.
DR   PDBsum; 3ONS; -.
DR   PDBsum; 3PRM; -.
DR   PDBsum; 3PT2; -.
DR   PDBsum; 3PTF; -.
DR   PDBsum; 3Q3F; -.
DR   PDBsum; 3RUL; -.
DR   PDBsum; 3TMP; -.
DR   PDBsum; 3U30; -.
DR   PDBsum; 3UGB; -.
DR   PDBsum; 3V6C; -.
DR   PDBsum; 3V6E; -.
DR   PDBsum; 3VFK; -.
DR   PDBsum; 3VUW; -.
DR   PDBsum; 3VUX; -.
DR   PDBsum; 3VUY; -.
DR   PDBsum; 3WXE; -.
DR   PDBsum; 3WXF; -.
DR   PDBsum; 3ZLZ; -.
DR   PDBsum; 3ZNH; -.
DR   PDBsum; 3ZNI; -.
DR   PDBsum; 3ZNZ; -.
DR   PDBsum; 4AP4; -.
DR   PDBsum; 4AUQ; -.
DR   PDBsum; 4BOS; -.
DR   PDBsum; 4BOZ; -.
DR   PDBsum; 4BVU; -.
DR   PDBsum; 4DDG; -.
DR   PDBsum; 4DDI; -.
DR   PDBsum; 4DHJ; -.
DR   PDBsum; 4DHZ; -.
DR   PDBsum; 4FJV; -.
DR   PDBsum; 4HK2; -.
DR   PDBsum; 4HXD; -.
DR   PDBsum; 4I6L; -.
DR   PDBsum; 4I6N; -.
DR   PDBsum; 4IG7; -.
DR   PDBsum; 4IUM; -.
DR   PDBsum; 4JQW; -.
DR   PDBsum; 4K1R; -.
DR   PDBsum; 4K7S; -.
DR   PDBsum; 4K7U; -.
DR   PDBsum; 4K7W; -.
DR   PDBsum; 4KSK; -.
DR   PDBsum; 4KSL; -.
DR   PDBsum; 4LCD; -.
DR   PDBsum; 4LDT; -.
DR   PDBsum; 4MDK; -.
DR   PDBsum; 4MM3; -.
DR   PDBsum; 4MSM; -.
DR   PDBsum; 4MSQ; -.
DR   PDBsum; 4NQK; -.
DR   PDBsum; 4UN2; -.
DR   PDBsum; 4V3K; -.
DR   PDBsum; 4V3L; -.
DR   PDBsum; 4WZP; -.
DR   PDBsum; 4XOK; -.
DR   PDBsum; 4XOL; -.
DR   PDBsum; 4ZQS; -.
DR   PDBsum; 5A5B; -.
DR   PDBsum; 5AF4; -.
DR   PDBsum; 5AF5; -.
DR   PDBsum; 5AF6; -.
DR   PDBsum; 5AIT; -.
DR   PDBsum; 5AIU; -.
DR   PDBsum; 5B83; -.
DR   PDBsum; 5C7J; -.
DR   PDBsum; 5C7M; -.
DR   PDBsum; 5E6J; -.
DR   PDBsum; 5H07; -.
DR   PDBsum; 5NL4; -.
DR   PDBsum; 5NLF; -.
DR   PDBsum; 5NLI; -.
DR   PDBsum; 5NMC; -.
DR   PDBsum; 5OE7; -.
DR   PDBsum; 5OHV; -.
DR   PDBsum; 5OXH; -.
DR   PDBsum; 5OXI; -.
DR   PDBsum; 5UDH; -.
DR   PDBsum; 5WQ4; -.
DR   PDBsum; 6EQI; -.
DR   ProteinModelPortal; P0CG48; -.
DR   SMR; P0CG48; -.
DR   BioGrid; 113164; 1580.
DR   IntAct; P0CG48; 183.
DR   MINT; P0CG48; -.
DR   STRING; 9606.ENSP00000344818; -.
DR   DrugBank; DB04464; N-Formylmethionine.
DR   iPTMnet; P0CG48; -.
DR   PhosphoSitePlus; P0CG48; -.
DR   SwissPalm; P0CG48; -.
DR   DMDM; 391358178; -.
DR   EPD; P0CG48; -.
DR   MaxQB; P0CG48; -.
DR   PaxDb; P0CG48; -.
DR   PeptideAtlas; P0CG48; -.
DR   PRIDE; P0CG48; -.
DR   TopDownProteomics; P0CG48; -.
DR   Ensembl; ENST00000339647; ENSP00000344818; ENSG00000150991.
DR   Ensembl; ENST00000536769; ENSP00000441543; ENSG00000150991.
DR   GeneID; 7316; -.
DR   KEGG; hsa:7316; -.
DR   UCSC; uc001ugs.5; human.
DR   CTD; 7316; -.
DR   DisGeNET; 7316; -.
DR   EuPathDB; HostDB:ENSG00000150991.14; -.
DR   GeneCards; UBC; -.
DR   HGNC; HGNC:12468; UBC.
DR   HPA; CAB000362; -.
DR   HPA; CAB005419; -.
DR   HPA; HPA041344; -.
DR   HPA; HPA049132; -.
DR   MIM; 191340; gene.
DR   neXtProt; NX_P0CG48; -.
DR   OpenTargets; ENSG00000150991; -.
DR   eggNOG; KOG0001; Eukaryota.
DR   eggNOG; COG5272; LUCA.
DR   GeneTree; ENSGT00810000125435; -.
DR   InParanoid; P0CG48; -.
DR   KO; K08770; -.
DR   OMA; HINTATF; -.
DR   OrthoDB; EOG091G178I; -.
DR   TreeFam; TF354256; -.
DR   Reactome; R-HSA-110312; Translesion synthesis by REV1.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-110320; Translesion Synthesis by POLH.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236382; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1253288; Downregulation of ERBB4 signaling.
DR   Reactome; R-HSA-1295596; Spry regulation of FGF signaling.
DR   Reactome; R-HSA-1358803; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; R-HSA-162588; Budding and maturation of HIV virion.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-168927; TICAM1, RIP1-mediated IKK complex recruitment.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-174048; APC/C:Cdc20 mediated degradation of Cyclin B.
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-174490; Membrane binding and targetting of GAG proteins.
DR   Reactome; R-HSA-175474; Assembly Of The HIV Virion.
DR   Reactome; R-HSA-179409; APC-Cdc20 mediated degradation of Nek2A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-182971; EGFR downregulation.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-201681; TCF dependent signaling in response to WNT.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-HSA-209543; p75NTR recruits signalling complexes.
DR   Reactome; R-HSA-209560; NF-kB is activated and signals survival.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2173788; Downregulation of TGF-beta receptor signaling.
DR   Reactome; R-HSA-2173791; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition).
DR   Reactome; R-HSA-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-2691232; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-3134975; Regulation of innate immune responses to cytosolic DNA.
DR   Reactome; R-HSA-3322077; Glycogen synthesis.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-3769402; Deactivation of the beta-catenin transactivating complex.
DR   Reactome; R-HSA-3785653; Myoclonic epilepsy of Lafora.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-445989; TAK1 activates NFkB by phosphorylation and activation of IKKs complex.
DR   Reactome; R-HSA-450302; activated TAK1 mediates p38 MAPK activation.
DR   Reactome; R-HSA-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-4641263; Regulation of FZD by ubiquitination.
DR   Reactome; R-HSA-5205685; Pink/Parkin Mediated Mitophagy.
DR   Reactome; R-HSA-532668; N-glycan trimming in the ER and Calnexin/Calreticulin cycle.
DR   Reactome; R-HSA-5357905; Regulation of TNFR1 signaling.
DR   Reactome; R-HSA-5357956; TNFR1-induced NFkappaB signaling pathway.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5654726; Negative regulation of FGFR1 signaling.
DR   Reactome; R-HSA-5654727; Negative regulation of FGFR2 signaling.
DR   Reactome; R-HSA-5654732; Negative regulation of FGFR3 signaling.
DR   Reactome; R-HSA-5654733; Negative regulation of FGFR4 signaling.
DR   Reactome; R-HSA-5655862; Translesion synthesis by POLK.
DR   Reactome; R-HSA-5656121; Translesion synthesis by POLI.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-5675482; Regulation of necroptotic cell death.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5684264; MAP3K8 (TPL2)-dependent MAPK1/3 activation.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689877; Josephin domain DUBs.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689896; Ovarian tumor domain proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-5696394; DNA Damage Recognition in GG-NER.
DR   Reactome; R-HSA-5696395; Formation of Incision Complex in GG-NER.
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6783310; Fanconi Anemia Pathway.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-HSA-6804760; Regulation of TP53 Activity through Methylation.
DR   Reactome; R-HSA-6807004; Negative regulation of MET activity.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69229; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69541; Stabilization of p53.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-8849469; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   Reactome; R-HSA-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8875360; InlB-mediated entry of Listeria monocytogenes into host cell.
DR   Reactome; R-HSA-8876493; InlA-mediated entry of Listeria monocytogenes into host cells.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948747; Regulation of PTEN localization.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9013507; NOTCH3 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-9013973; TICAM1-dependent activation of IRF3/IRF7.
DR   Reactome; R-HSA-9014325; TICAM1,TRAF6-dependent induction of TAK1 complex.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-9033241; Peroxisomal protein import.
DR   Reactome; R-HSA-912631; Regulation of signaling by CBL.
DR   Reactome; R-HSA-917729; Endosomal Sorting Complex Required For Transport (ESCRT).
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   Reactome; R-HSA-936440; Negative regulators of DDX58/IFIH1 signaling.
DR   Reactome; R-HSA-936964; Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon.
DR   Reactome; R-HSA-937039; IRAK1 recruits IKK complex.
DR   Reactome; R-HSA-937041; IKK complex recruitment mediated by RIP1.
DR   Reactome; R-HSA-937042; IRAK2 mediated activation of TAK1 complex.
DR   Reactome; R-HSA-937072; TRAF6-mediated induction of TAK1 complex within TLR4 complex.
DR   Reactome; R-HSA-975110; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling.
DR   Reactome; R-HSA-975144; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-HSA-975163; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SIGNOR; P0CG48; -.
DR   ChiTaRS; UBC; human.
DR   EvolutionaryTrace; P0CG48; -.
DR   GeneWiki; Ubiquitin_C; -.
DR   GenomeRNAi; 7316; -.
DR   PRO; PR:P0CG48; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000150991; -.
DR   ExpressionAtlas; P0CG48; baseline and differential.
DR   Genevisible; P0CG48; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0043657; C:host cell; IEA:GOC.
DR   GO; GO:0005741; C:mitochondrial outer membrane; TAS:Reactome.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000187; P:activation of MAPK activity; TAS:Reactome.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; TAS:Reactome.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; TAS:Reactome.
DR   GO; GO:0016197; P:endosomal transport; TAS:Reactome.
DR   GO; GO:0070987; P:error-free translesion synthesis; TAS:Reactome.
DR   GO; GO:0042276; P:error-prone translesion synthesis; TAS:Reactome.
DR   GO; GO:0070911; P:global genome nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0036297; P:interstrand cross-link repair; TAS:Reactome.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0007254; P:JNK cascade; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome.
DR   GO; GO:0000715; P:nucleotide-excision repair, DNA damage recognition; TAS:Reactome.
DR   GO; GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome.
DR   GO; GO:0033683; P:nucleotide-excision repair, DNA incision; TAS:Reactome.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; TAS:Reactome.
DR   GO; GO:0006294; P:nucleotide-excision repair, preincision complex assembly; TAS:Reactome.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0006625; P:protein targeting to peroxisome; TAS:Reactome.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019985; P:translesion synthesis; TAS:Reactome.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019058; P:viral life cycle; TAS:Reactome.
DR   GO; GO:0019068; P:virion assembly; TAS:Reactome.
DR   GO; GO:0016055; P:Wnt signaling pathway; TAS:Reactome.
DR   InterPro; IPR019956; Ubiquitin.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF00240; ubiquitin; 9.
DR   PRINTS; PR00348; UBIQUITIN.
DR   SMART; SM00213; UBQ; 9.
DR   SUPFAM; SSF54236; SSF54236; 9.
DR   PROSITE; PS00299; UBIQUITIN_1; 9.
DR   PROSITE; PS50053; UBIQUITIN_2; 9.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN         1     76       Ubiquitin.
FT                                /FTId=PRO_0000396178.
FT   CHAIN        77    152       Ubiquitin.
FT                                /FTId=PRO_0000396179.
FT   CHAIN       153    228       Ubiquitin.
FT                                /FTId=PRO_0000396180.
FT   CHAIN       229    304       Ubiquitin.
FT                                /FTId=PRO_0000396181.
FT   CHAIN       305    380       Ubiquitin.
FT                                /FTId=PRO_0000396182.
FT   CHAIN       381    456       Ubiquitin.
FT                                /FTId=PRO_0000396183.
FT   CHAIN       457    532       Ubiquitin.
FT                                /FTId=PRO_0000396184.
FT   CHAIN       533    608       Ubiquitin.
FT                                /FTId=PRO_0000396185.
FT   CHAIN       609    684       Ubiquitin.
FT                                /FTId=PRO_0000396186.
FT   PROPEP      685    685
FT                                /FTId=PRO_0000396187.
FT   DOMAIN        1     76       Ubiquitin-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN       77    152       Ubiquitin-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      153    228       Ubiquitin-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      229    304       Ubiquitin-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      305    380       Ubiquitin-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      381    456       Ubiquitin-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      457    532       Ubiquitin-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      533    608       Ubiquitin-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      609    684       Ubiquitin-like 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   BINDING      54     54       Activating enzyme.
FT   BINDING      72     72       Activating enzyme.
FT   SITE         68     68       Essential for function.
FT   MOD_RES      65     65       Phosphoserine; by PINK1.
FT                                {ECO:0000269|PubMed:24660806,
FT                                ECO:0000269|PubMed:24751536,
FT                                ECO:0000269|PubMed:24784582,
FT                                ECO:0000269|PubMed:25527291}.
FT   CROSSLNK      6      6       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16443603}.
FT   CROSSLNK     11     11       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:16543144}.
FT   CROSSLNK     27     27       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000305|PubMed:15466860}.
FT   CROSSLNK     29     29       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144}.
FT   CROSSLNK     48     48       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:16543144}.
FT   CROSSLNK     63     63       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144,
FT                                ECO:0000269|PubMed:18719106}.
FT   CROSSLNK     76     76       Glycyl lysine isopeptide (Gly-Lys)
FT                                (interchain with K-? in acceptor
FT                                proteins).
FT   MUTAGEN      48     48       K->R: No effect on HLTF-mediated
FT                                polyubiquitination of PCNA.
FT                                {ECO:0000269|PubMed:18719106}.
FT   MUTAGEN      63     63       K->R: Abolishes HLTF-mediated
FT                                polyubiquitination of PCNA.
FT                                {ECO:0000269|PubMed:18719106}.
FT   MUTAGEN      65     65       S->A: Prevents phosphorylation in case of
FT                                mitophagy. {ECO:0000269|PubMed:24660806,
FT                                ECO:0000269|PubMed:24751536,
FT                                ECO:0000269|PubMed:24784582}.
FT   MUTAGEN      65     65       S->D: Phosphomimetic mutant that binds
FT                                and activates PRKN.
FT                                {ECO:0000269|PubMed:24751536}.
FT   MUTAGEN      68     68       H->G: Loss of DTX3L-mediated
FT                                polyubiquitination of histone H3 and H4.
FT                                {ECO:0000269|PubMed:28525742}.
FT   MUTAGEN      72     72       R->G: No effect on ADP-ribosylation.
FT                                {ECO:0000269|PubMed:28525742}.
FT   MUTAGEN      72     72       R->K: No effect on ADP-ribosylation, when
FT                                associated with K-74.
FT                                {ECO:0000269|PubMed:28525742}.
FT   MUTAGEN      74     74       R->G: No effect on ADP-ribosylation.
FT                                {ECO:0000269|PubMed:28525742}.
FT   MUTAGEN      74     74       R->K: No effect on ADP-ribosylation, when
FT                                associated with K-72.
FT                                {ECO:0000269|PubMed:28525742}.
FT   MUTAGEN      76     76       G->A: Loss of ADP-ribosylation.
FT                                {ECO:0000269|PubMed:28525742}.
FT   CONFLICT    190    190       P -> S (in Ref. 4; AC126309).
FT                                {ECO:0000305}.
FT   CONFLICT    397    397       V -> G (in Ref. 6; BAA09860).
FT                                {ECO:0000305}.
FT   STRAND      383    386       {ECO:0000244|PDB:5B83}.
FT   STRAND      392    395       {ECO:0000244|PDB:5B83}.
FT   HELIX       403    411       {ECO:0000244|PDB:5B83}.
FT   HELIX       418    420       {ECO:0000244|PDB:5B83}.
FT   STRAND      421    425       {ECO:0000244|PDB:5B83}.
FT   STRAND      428    430       {ECO:0000244|PDB:5B83}.
FT   HELIX       436    438       {ECO:0000244|PDB:5B83}.
FT   STRAND      446    451       {ECO:0000244|PDB:5B83}.
FT   STRAND      458    463       {ECO:0000244|PDB:5H07}.
FT   STRAND      468    472       {ECO:0000244|PDB:5H07}.
FT   HELIX       479    490       {ECO:0000244|PDB:5H07}.
FT   HELIX       494    496       {ECO:0000244|PDB:5H07}.
FT   STRAND      497    501       {ECO:0000244|PDB:5H07}.
FT   HELIX       513    515       {ECO:0000244|PDB:5H07}.
FT   STRAND      522    527       {ECO:0000244|PDB:5H07}.
FT   STRAND      534    539       {ECO:0000244|PDB:3B08}.
FT   STRAND      540    542       {ECO:0000244|PDB:2W9N}.
FT   STRAND      544    548       {ECO:0000244|PDB:3B08}.
FT   HELIX       555    566       {ECO:0000244|PDB:3B08}.
FT   HELIX       570    572       {ECO:0000244|PDB:3B08}.
FT   STRAND      573    577       {ECO:0000244|PDB:3B08}.
FT   STRAND      579    581       {ECO:0000244|PDB:3N3K}.
FT   STRAND      586    588       {ECO:0000244|PDB:3WXE}.
FT   HELIX       589    591       {ECO:0000244|PDB:3B08}.
FT   STRAND      598    603       {ECO:0000244|PDB:3B08}.
FT   STRAND      610    615       {ECO:0000244|PDB:1OGW}.
FT   STRAND      616    618       {ECO:0000244|PDB:4K1R}.
FT   STRAND      620    624       {ECO:0000244|PDB:1OGW}.
FT   STRAND      627    630       {ECO:0000244|PDB:1G6J}.
FT   HELIX       631    642       {ECO:0000244|PDB:1OGW}.
FT   HELIX       646    648       {ECO:0000244|PDB:1OGW}.
FT   STRAND      649    653       {ECO:0000244|PDB:1OGW}.
FT   STRAND      654    657       {ECO:0000244|PDB:4BVU}.
FT   STRAND      660    663       {ECO:0000244|PDB:3JSV}.
FT   HELIX       664    667       {ECO:0000244|PDB:1OGW}.
FT   TURN        668    670       {ECO:0000244|PDB:5OXH}.
FT   STRAND      671    673       {ECO:0000244|PDB:6EQI}.
FT   STRAND      674    679       {ECO:0000244|PDB:1OGW}.
SQ   SEQUENCE   685 AA;  77039 MW;  B6E7BC06FEE77196 CRC64;
     MQIFVKTLTG KTITLEVEPS DTIENVKAKI QDKEGIPPDQ QRLIFAGKQL EDGRTLSDYN
     IQKESTLHLV LRLRGGMQIF VKTLTGKTIT LEVEPSDTIE NVKAKIQDKE GIPPDQQRLI
     FAGKQLEDGR TLSDYNIQKE STLHLVLRLR GGMQIFVKTL TGKTITLEVE PSDTIENVKA
     KIQDKEGIPP DQQRLIFAGK QLEDGRTLSD YNIQKESTLH LVLRLRGGMQ IFVKTLTGKT
     ITLEVEPSDT IENVKAKIQD KEGIPPDQQR LIFAGKQLED GRTLSDYNIQ KESTLHLVLR
     LRGGMQIFVK TLTGKTITLE VEPSDTIENV KAKIQDKEGI PPDQQRLIFA GKQLEDGRTL
     SDYNIQKEST LHLVLRLRGG MQIFVKTLTG KTITLEVEPS DTIENVKAKI QDKEGIPPDQ
     QRLIFAGKQL EDGRTLSDYN IQKESTLHLV LRLRGGMQIF VKTLTGKTIT LEVEPSDTIE
     NVKAKIQDKE GIPPDQQRLI FAGKQLEDGR TLSDYNIQKE STLHLVLRLR GGMQIFVKTL
     TGKTITLEVE PSDTIENVKA KIQDKEGIPP DQQRLIFAGK QLEDGRTLSD YNIQKESTLH
     LVLRLRGGMQ IFVKTLTGKT ITLEVEPSDT IENVKAKIQD KEGIPPDQQR LIFAGKQLED
     GRTLSDYNIQ KESTLHLVLR LRGGV
//
ID   APEL_HUMAN              Reviewed;          77 AA.
AC   Q9ULZ1; Q4VY08; Q8WU89;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   23-MAY-2018, entry version 127.
DE   RecName: Full=Apelin;
DE   AltName: Full=APJ endogenous ligand;
DE   Contains:
DE     RecName: Full=Apelin-36;
DE   Contains:
DE     RecName: Full=Apelin-31;
DE   Contains:
DE     RecName: Full=Apelin-28;
DE   Contains:
DE     RecName: Full=Apelin-13;
DE   Flags: Precursor;
GN   Name=APLN; Synonyms=APEL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=9792798; DOI=10.1006/bbrc.1998.9489;
RA   Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.-X.,
RA   Kawamata Y., Fukusumi S., Hinuma S., Kitada C., Kurokawa T., Onda H.,
RA   Fujino M.;
RT   "Isolation and characterization of a novel endogenous peptide ligand
RT   for the human APJ receptor.";
RL   Biochem. Biophys. Res. Commun. 251:471-476(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=10525157; DOI=10.1016/S0167-4889(99)00114-7;
RA   Habata Y., Fujii R., Hosoya M., Fukusumi S., Kawamata Y., Hinuma S.,
RA   Kitada C., Nishizawa N., Murosaki S., Kurokawa T., Onda H.,
RA   Tatemoto K., Fujino M.;
RT   "Apelin, the natural ligand of the orphan receptor APJ, is abundantly
RT   secreted in the colostrum.";
RL   Biochim. Biophys. Acta 1452:25-35(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Hypothalamus;
RX   PubMed=10617103; DOI=10.1046/j.1471-4159.2000.0740034.x;
RA   Lee D.K., Cheng R., Nguyen T., Fan T., Kariyawasam A.P., Liu Y.,
RA   Osmond D.H., George S.R., O'Dowd B.F.;
RT   "Characterization of apelin, the ligand for the APJ receptor.";
RL   J. Neurochem. 74:34-41(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=11090199; DOI=10.1128/JVI.74.24.11972-11976.2000;
RA   Cayabyab M., Hinuma S., Farzan M., Choe H., Fukusumi S., Kitada C.,
RA   Nishizawa N., Hosoya M., Nishimura O., Messele T., Pollakis G.,
RA   Goudsmit J., Fujino M., Sodroski J.;
RT   "Apelin, the natural ligand of the orphan seven-transmembrane receptor
RT   APJ, inhibits human immunodeficiency virus type 1 entry.";
RL   J. Virol. 74:11972-11976(2000).
CC   -!- FUNCTION: Endogenous ligand for the apelin receptor (APLNR)
CC       (PubMed:10525157). Drives internalization of the apelin receptor
CC       (By similarity). Apelin-36 dissociates more hardly than
CC       (pyroglu)apelin-13 from APLNR (By similarity). Hormone involved in
CC       the regulation of cardiac precursor cell movements during
CC       gastrulation and heart morphogenesis (By similarity). Has an
CC       inhibitory effect on cytokine production in response to T-cell
CC       receptor/CD3 cross-linking; the oral intake of apelin in the
CC       colostrum and the milk might therefore modulate immune responses
CC       in neonates (By similarity). Plays a role in early coronary blood
CC       vessels formation (By similarity). Mediates myocardial
CC       contractility in an ERK1/2-dependent manner (By similarity). May
CC       also have a role in the central control of body fluid homeostasis
CC       by influencing vasopressin release and drinking behavior (By
CC       similarity). {ECO:0000250|UniProtKB:Q4TTN8,
CC       ECO:0000250|UniProtKB:Q9R0R3, ECO:0000250|UniProtKB:Q9R0R4,
CC       ECO:0000269|PubMed:10525157}.
CC   -!- FUNCTION: (Microbial infection) Endogenous ligand for the apelin
CC       receptor (APLNR), an alternative coreceptor with CD4 for HIV-1
CC       infection (PubMed:11090199). Inhibits HIV-1 entry in cells
CC       coexpressing CD4 and APLNR (PubMed:11090199). Apelin-36 has a
CC       greater inhibitory activity on HIV infection than other synthetic
CC       apelin derivatives (PubMed:11090199).
CC       {ECO:0000269|PubMed:11090199}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q9TUI9}.
CC       Secreted, extracellular space {ECO:0000250|UniProtKB:Q9TUI9}.
CC       Note=Abundantly secreted in the colostrum. Lower level in milk.
CC       Decreases rapidly within several days after parturition in milk,
CC       but is still detectable even in commercial milk.
CC       {ECO:0000250|UniProtKB:Q9TUI9}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain with highest levels in
CC       the frontal cortex, thalamus, hypothalamus and midbrain
CC       (PubMed:10617103). Secreted by the mammary gland into the
CC       colostrum and the milk. {ECO:0000269|PubMed:10617103}.
CC   -!- PTM: Several active peptides may be produced by proteolytic
CC       processing of the peptide precursor.
CC       {ECO:0000250|UniProtKB:Q9TUI9}.
CC   -!- SIMILARITY: Belongs to the apelin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI95697.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB023493; BAA84975.1; -; mRNA.
DR   EMBL; AF179680; AAF25815.1; -; Genomic_DNA.
DR   EMBL; AL022162; CAI95697.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC021104; AAH21104.2; -; mRNA.
DR   CCDS; CCDS48165.1; -.
DR   RefSeq; NP_059109.3; NM_017413.4.
DR   UniGene; Hs.303084; -.
DR   ProteinModelPortal; Q9ULZ1; -.
DR   SMR; Q9ULZ1; -.
DR   BioGrid; 114385; 5.
DR   IntAct; Q9ULZ1; 1.
DR   STRING; 9606.ENSP00000305464; -.
DR   BindingDB; Q9ULZ1; -.
DR   ChEMBL; CHEMBL3232687; -.
DR   PaxDb; Q9ULZ1; -.
DR   PRIDE; Q9ULZ1; -.
DR   DNASU; 8862; -.
DR   Ensembl; ENST00000429967; ENSP00000391800; ENSG00000171388.
DR   GeneID; 8862; -.
DR   KEGG; hsa:8862; -.
DR   UCSC; uc004eus.4; human.
DR   CTD; 8862; -.
DR   DisGeNET; 8862; -.
DR   EuPathDB; HostDB:ENSG00000171388.11; -.
DR   GeneCards; APLN; -.
DR   HGNC; HGNC:16665; APLN.
DR   MIM; 300297; gene.
DR   neXtProt; NX_Q9ULZ1; -.
DR   OpenTargets; ENSG00000171388; -.
DR   PharmGKB; PA134984493; -.
DR   eggNOG; ENOG410J5ST; Eukaryota.
DR   eggNOG; ENOG410ZHPP; LUCA.
DR   GeneTree; ENSGT00390000014020; -.
DR   HOGENOM; HOG000033992; -.
DR   HOVERGEN; HBG018249; -.
DR   InParanoid; Q9ULZ1; -.
DR   KO; K05225; -.
DR   OMA; PMASTEH; -.
DR   OrthoDB; EOG091G19F6; -.
DR   PhylomeDB; Q9ULZ1; -.
DR   TreeFam; TF339660; -.
DR   Reactome; R-HSA-375276; Peptide ligand-binding receptors.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   ChiTaRS; APLN; human.
DR   GeneWiki; Apelin; -.
DR   GenomeRNAi; 8862; -.
DR   PRO; PR:Q9ULZ1; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000171388; -.
DR   CleanEx; HS_APLN; -.
DR   Genevisible; Q9ULZ1; HS.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0031704; F:apelin receptor binding; IDA:UniProtKB.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IBA:GO_Central.
DR   GO; GO:0005179; F:hormone activity; IMP:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; TAS:ProtInc.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0060183; P:apelin receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0060976; P:coronary vasculature development; ISS:UniProtKB.
DR   GO; GO:0042756; P:drinking behavior; ISS:UniProtKB.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007369; P:gastrulation; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0007595; P:lactation; TAS:ProtInc.
DR   GO; GO:0045776; P:negative regulation of blood pressure; ISS:UniProtKB.
DR   GO; GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; IGI:BHF-UCL.
DR   GO; GO:0010629; P:negative regulation of gene expression; IGI:BHF-UCL.
DR   GO; GO:1904706; P:negative regulation of vascular smooth muscle cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0045906; P:negative regulation of vasoconstriction; IEA:Ensembl.
DR   GO; GO:0051461; P:positive regulation of corticotropin secretion; IEA:Ensembl.
DR   GO; GO:0051466; P:positive regulation of corticotropin-releasing hormone secretion; IEA:Ensembl.
DR   GO; GO:1904022; P:positive regulation of G-protein coupled receptor internalization; IDA:UniProtKB.
DR   GO; GO:0045823; P:positive regulation of heart contraction; ISS:UniProtKB.
DR   GO; GO:0031652; P:positive regulation of heat generation; IEA:Ensembl.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IEA:Ensembl.
DR   GO; GO:1902895; P:positive regulation of pri-miRNA transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:1905564; P:positive regulation of vascular endothelial cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0043576; P:regulation of respiratory gaseous exchange; IEA:Ensembl.
DR   GO; GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0023052; P:signaling; IBA:GO_Central.
DR   InterPro; IPR026155; Apelin.
DR   PANTHER; PTHR15953; PTHR15953; 1.
DR   Pfam; PF15360; Apelin; 1.
PE   2: Evidence at transcript level;
KW   Angiogenesis; Cleavage on pair of basic residues; Complete proteome;
KW   Developmental protein; Gastrulation; Hormone; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   PROPEP       23     41       {ECO:0000250}.
FT                                /FTId=PRO_0000001759.
FT   PEPTIDE      42     77       Apelin-36. {ECO:0000250}.
FT                                /FTId=PRO_0000001760.
FT   PEPTIDE      47     77       Apelin-31. {ECO:0000250}.
FT                                /FTId=PRO_0000001761.
FT   PEPTIDE      50     77       Apelin-28. {ECO:0000250}.
FT                                /FTId=PRO_0000001762.
FT   PEPTIDE      65     77       Apelin-13. {ECO:0000250}.
FT                                /FTId=PRO_0000001763.
SQ   SEQUENCE   77 AA;  8569 MW;  41521E0DBE97BFDA CRC64;
     MNLRLCVQAL LLLWLSLTAV CGGSLMPLPD GNGLEDGNVR HLVQPRGSRN GPGPWQGGRR
     KFRRQRPRLS HKGPMPF
//
ID   STAT_HUMAN              Reviewed;          62 AA.
AC   P02808; A6NKE9; B2R4F8;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 2.
DT   25-APR-2018, entry version 146.
DE   RecName: Full=Statherin;
DE   Flags: Precursor;
GN   Name=STATH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3502720;
RA   Sabatinai L., Carlock L., Johnson G., Azen E.;
RT   "cDNA cloning and chromosomal localization (4q11-13) of a gene for
RT   statherin, a regulator of calcium in saliva.";
RL   Am. J. Hum. Genet. 41:1048-1060(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3426601; DOI=10.1016/0006-291X(87)90436-0;
RA   Dickinson D.P., Ridall A.L., Levine M.J.;
RT   "Human submandibular gland statherin and basic histidine-rich peptide
RT   are encoded by highly abundant mRNA's derived from a common ancestral
RT   sequence.";
RL   Biochem. Biophys. Res. Commun. 149:784-790(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2373369; DOI=10.1016/0378-1119(90)90012-G;
RA   Sabatini L.M., He Y.-Z., Azen E.A.;
RT   "Structure and sequence determination of the gene encoding human
RT   salivary statherin.";
RL   Gene 89:245-251(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thyroid;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 20-62 (ISOFORM 1), AND PHOSPHORYLATION AT SER-21
RP   AND SER-22.
RX   PubMed=838735;
RA   Schlesinger D.H., Hay D.I.;
RT   "Complete covalent structure of statherin, a tyrosine-rich acidic
RT   peptide which inhibits calcium phosphate precipitation from human
RT   parotid saliva.";
RL   J. Biol. Chem. 252:1689-1695(1977).
RN   [9]
RP   PROTEIN SEQUENCE OF 20-62 (ISOFORMS 1 AND 2), VARIANT PHE-62 DEL, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=1663737; DOI=10.1016/0003-9969(91)90147-M;
RA   Jensen J.L., Lamkin M.S., Troxler R.F., Oppenheim F.G.;
RT   "Multiple forms of statherin in human salivary secretions.";
RL   Arch. Oral Biol. 36:529-534(1991).
RN   [10]
RP   PARTIAL PROTEIN SEQUENCE OF 1-16.
RX   PubMed=3476566; DOI=10.1177/00220345870660021301;
RA   Oppenheim F.G., Hay D.I., Smith D.J., Offner G.D., Troxler R.F.;
RT   "Molecular basis of salivary proline-rich protein and peptide
RT   synthesis: cell-free translations and processing of human and macaque
RT   statherin mRNAs and partial amino acid sequence of their signal
RT   peptides.";
RL   J. Dent. Res. 66:462-466(1987).
RN   [11]
RP   PROTEIN SEQUENCE OF 20-62 (ISOFORM 1), AND SULFATION.
RX   PubMed=17389930; DOI=10.7150/ijbs.3.237;
RA   Kasinathan C., Gandhi N., Ramaprasad P., Sundaram P., Ramasubbu N.;
RT   "Tyrosine sulfation of statherin.";
RL   Int. J. Biol. Sci. 3:237-241(2007).
RN   [12]
RP   TRANSGLUTAMINATION, AND MASS SPECTROMETRY.
RX   PubMed=17313100; DOI=10.1002/jssc.200600244;
RA   Cabras T., Inzitari R., Fanali C., Scarano E., Patamia M., Sanna M.T.,
RA   Pisano E., Giardina B., Castagnola M., Messana I.;
RT   "HPLC-MS characterization of cyclo-statherin Q-37, a specific
RT   cyclization product of human salivary statherin generated by
RT   transglutaminase 2.";
RL   J. Sep. Sci. 29:2600-2608(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Salivary protein that stabilizes saliva supersaturated
CC       with calcium salts by inhibiting the precipitation of calcium
CC       phosphate salts. It also modulates hydroxyapatite crystal
CC       formation on the tooth surface.
CC   -!- INTERACTION:
CC       Q8TAX7:MUC7; NbExp=2; IntAct=EBI-738687, EBI-738582;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Both isoforms can occur with the Phe-62 deletion.;
CC       Name=1;
CC         IsoId=P02808-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P02808-2; Sequence=VSP_045744;
CC   -!- TISSUE SPECIFICITY: Secreted by parotid and submandibular glands.
CC   -!- PTM: Substrate for transglutaminase-2. More than 95% of the
CC       cyclized peptide is cyclo-statherin Q-37, and less than 5% is
CC       cyclo-statherin Q-39. Cyclized forms account for about 1% of total
CC       statherin in saliva. {ECO:0000269|PubMed:17313100}.
CC   -!- PTM: Sulfated on tyrosine residues. {ECO:0000269|PubMed:17389930}.
CC   -!- MASS SPECTROMETRY: Mass=5380.0; Mass_error=0.3;
CC       Method=Electrospray; Range=20-62; Note=With phosphorylated Ser-21
CC       and Ser-22.; Evidence={ECO:0000269|PubMed:17313100};
CC   -!- MASS SPECTROMETRY: Mass=5363.0; Mass_error=0.3;
CC       Method=Electrospray; Range=20-62; Note=With phosphorylated Ser-21
CC       and Ser-22 and transglutamine cross-link.;
CC       Evidence={ECO:0000269|PubMed:17313100};
CC   -!- SIMILARITY: Belongs to the histatin/statherin family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M18078; AAA60594.1; -; mRNA.
DR   EMBL; M18371; AAA60600.1; -; mRNA.
DR   EMBL; M32639; AAA60593.1; -; Genomic_DNA.
DR   EMBL; AK311812; BAG34755.1; -; mRNA.
DR   EMBL; AC063956; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471057; EAX05604.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX05605.1; -; Genomic_DNA.
DR   EMBL; BC067219; AAH67219.1; -; mRNA.
DR   CCDS; CCDS33998.1; -. [P02808-2]
DR   CCDS; CCDS3533.1; -. [P02808-1]
DR   PIR; JH0153; SBHUP.
DR   RefSeq; NP_001009181.1; NM_001009181.1. [P02808-2]
DR   RefSeq; NP_003145.1; NM_003154.2. [P02808-1]
DR   UniGene; Hs.654495; -.
DR   ProteinModelPortal; P02808; -.
DR   BioGrid; 112656; 3.
DR   IntAct; P02808; 2.
DR   STRING; 9606.ENSP00000246895; -.
DR   TCDB; 1.C.79.1.2; the channel-forming histatin antimicrobial peptide (histatin) family.
DR   iPTMnet; P02808; -.
DR   PhosphoSitePlus; P02808; -.
DR   BioMuta; STATH; -.
DR   EPD; P02808; -.
DR   MaxQB; P02808; -.
DR   PaxDb; P02808; -.
DR   PeptideAtlas; P02808; -.
DR   PRIDE; P02808; -.
DR   TopDownProteomics; P02808-1; -. [P02808-1]
DR   TopDownProteomics; P02808-2; -. [P02808-2]
DR   Ensembl; ENST00000246895; ENSP00000246895; ENSG00000126549. [P02808-1]
DR   Ensembl; ENST00000381060; ENSP00000370448; ENSG00000126549. [P02808-2]
DR   Ensembl; ENST00000615994; ENSP00000484341; ENSG00000126549. [P02808-1]
DR   Ensembl; ENST00000634727; ENSP00000489107; ENSG00000282891. [P02808-2]
DR   Ensembl; ENST00000635437; ENSP00000489569; ENSG00000282891. [P02808-1]
DR   Ensembl; ENST00000635686; ENSP00000489243; ENSG00000282891. [P02808-1]
DR   GeneID; 6779; -.
DR   KEGG; hsa:6779; -.
DR   UCSC; uc003heu.2; human. [P02808-1]
DR   CTD; 6779; -.
DR   DisGeNET; 6779; -.
DR   EuPathDB; HostDB:ENSG00000126549.9; -.
DR   GeneCards; STATH; -.
DR   HGNC; HGNC:11369; STATH.
DR   HPA; HPA044569; -.
DR   MIM; 184470; gene.
DR   neXtProt; NX_P02808; -.
DR   OpenTargets; ENSG00000126549; -.
DR   PharmGKB; PA36187; -.
DR   eggNOG; ENOG410KCI1; Eukaryota.
DR   eggNOG; ENOG4110NY1; LUCA.
DR   GeneTree; ENSGT00390000011757; -.
DR   HOGENOM; HOG000293326; -.
DR   InParanoid; P02808; -.
DR   KO; K13914; -.
DR   OMA; GPYQPFV; -.
DR   OrthoDB; EOG091G1BYD; -.
DR   PhylomeDB; P02808; -.
DR   TreeFam; TF341588; -.
DR   ChiTaRS; STATH; human.
DR   GeneWiki; STATH; -.
DR   GenomeRNAi; 6779; -.
DR   PRO; PR:P02808; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000126549; -.
DR   CleanEx; HS_STATH; -.
DR   Genevisible; P02808; HS.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0030197; F:extracellular matrix constituent, lubricant activity; NAS:UniProtKB.
DR   GO; GO:0046848; F:hydroxyapatite binding; NAS:UniProtKB.
DR   GO; GO:0030345; F:structural constituent of tooth enamel; NAS:UniProtKB.
DR   GO; GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:InterPro.
DR   GO; GO:0030502; P:negative regulation of bone mineralization; NAS:UniProtKB.
DR   GO; GO:0001503; P:ossification; TAS:ProtInc.
DR   GO; GO:0046541; P:saliva secretion; NAS:UniProtKB.
DR   InterPro; IPR030773; Histatin/statherin.
DR   InterPro; IPR005575; Statherin.
DR   PANTHER; PTHR15057; PTHR15057; 1.
DR   Pfam; PF03875; Statherin; 1.
DR   PIRSF; PIRSF002565; Statherin; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Biomineralization; Complete proteome;
KW   Direct protein sequencing; Isopeptide bond; Phosphoprotein;
KW   Polymorphism; Reference proteome; Secreted; Signal; Sulfation.
FT   SIGNAL        1     19       {ECO:0000269|PubMed:3476566}.
FT   CHAIN        20     62       Statherin.
FT                                /FTId=PRO_0000022422.
FT   REGION       20     25       Hydroxyapatite-binding; inhibits crystal
FT                                growth.
FT   REGION       38     62       Hydrophobic; inhibits precipitation of
FT                                calcium phosphate salts.
FT   MOD_RES      21     21       Phosphoserine.
FT                                {ECO:0000269|PubMed:838735}.
FT   MOD_RES      22     22       Phosphoserine.
FT                                {ECO:0000269|PubMed:838735}.
FT   CROSSLNK     25     58       Isoglutamyl lysine isopeptide (Lys-Gln);
FT                                in form cyclo-statherin Q-39.
FT   CROSSLNK     25     56       Isoglutamyl lysine isopeptide (Lys-Gln);
FT                                in form cyclo-statherin Q-37.
FT   VAR_SEQ      25     34       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_045744.
FT   VARIANT      62     62       Missing. {ECO:0000269|PubMed:1663737}.
FT                                /FTId=VAR_069065.
SQ   SEQUENCE   62 AA;  7304 MW;  CFE32EC235CA3A22 CRC64;
     MKFLVFAFIL ALMVSMIGAD SSEEKFLRRI GRFGYGYGPY QPVPEQPLYP QPYQPQYQQY
     TF
//
ID   SGTA_HUMAN              Reviewed;         313 AA.
AC   O43765; D6W610; Q6FIA9; Q9BTZ9;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   23-MAY-2018, entry version 180.
DE   RecName: Full=Small glutamine-rich tetratricopeptide repeat-containing protein alpha;
DE   AltName: Full=Alpha-SGT;
DE   AltName: Full=Vpu-binding protein;
DE            Short=UBP;
GN   Name=SGTA; Synonyms=SGT, SGT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9740675; DOI=10.1006/geno.1998.5385;
RA   Kordes E., Savelyeva L., Schwab M., Rommelaere J., Jauniaux J.-C.,
RA   Cziepluch C.;
RT   "Isolation and characterization of human SGT and identification of
RT   homologues in Saccharomyces cerevisiae and Caenorhabditis elegans.";
RL   Genomics 52:90-94(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10567422; DOI=10.1074/jbc.274.48.34425;
RA   Liu F.H., Wu S.J., Hu S.M., Hsiao C.D., Wang C.;
RT   "Specific interaction of the 70-kDa heat shock cognate protein with
RT   the tetratricopeptide repeats.";
RL   J. Biol. Chem. 274:34425-34432(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH HIV-1V PU AND GAG
RP   (MICROBIAL INFECTION).
RX   PubMed=9573291;
RA   Callahan M.A., Handley M.A., Lee Y.H., Talbot K.J., Harper J.W.,
RA   Panganiban A.T.;
RT   "Functional interaction of human immunodeficiency virus type 1 Vpu and
RT   Gag with a novel member of the tetratricopeptide repeat protein
RT   family.";
RL   J. Virol. 72:5189-5197(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Tobaben S., Stahl B.;
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, Muscle, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 138-160; 165-174 AND 185-196.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   SUBUNIT, AND INTERACTION WITH HSP90AA1 AND SLC2A1.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [12]
RP   INTERACTION WITH HSP90AB1, AND SUBCELLULAR LOCATION.
RX   PubMed=16580629; DOI=10.1016/j.bbrc.2006.03.090;
RA   Yin H., Wang H., Zong H., Chen X., Wang Y., Yun X., Wu Y., Wang J.,
RA   Gu J.;
RT   "SGT, a Hsp90beta binding partner, is accumulated in the nucleus
RT   during cell apoptosis.";
RL   Biochem. Biophys. Res. Commun. 343:1153-1158(2006).
RN   [13]
RP   INTERACTION WITH SARS-COV ACCESSORY PROTEIN 7A (MICROBIAL INFECTION).
RX   PubMed=16580632; DOI=10.1016/j.bbrc.2006.03.091;
RA   Fielding B.C., Gunalan V., Tan T.H.P., Chou C.-F., Shen S., Khan S.,
RA   Lim S.G., Hong W., Tan Y.-J.;
RT   "Severe acute respiratory syndrome coronavirus protein 7a interacts
RT   with hSGT.";
RL   Biochem. Biophys. Res. Commun. 343:1201-1208(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-305, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [15]
RP   INTERACTION WITH DNAJC5 AND DNAJC5B.
RX   PubMed=17034881; DOI=10.1016/j.bbamcr.2006.08.054;
RA   Boal F., Le Pevelen S., Cziepluch C., Scotti P., Lang J.;
RT   "Cysteine-string protein isoform beta (Cspbeta) is targeted to the
RT   trans-Golgi network as a non-palmitoylated CSP in clonal beta-cells.";
RL   Biochim. Biophys. Acta 1773:109-119(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; THR-81; SER-301;
RP   THR-303 AND SER-305, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; THR-81 AND SER-305,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-137, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-303, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301 AND SER-305, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH BAG6.
RX   PubMed=23129660; DOI=10.1073/pnas.1209997109;
RA   Leznicki P., High S.;
RT   "SGTA antagonizes BAG6-mediated protein triage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:19214-19219(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; THR-81 AND SER-301,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   FUNCTION, AND INTERACTION WITH BAG6.
RX   PubMed=25179605; DOI=10.1242/jcs.155648;
RA   Wunderley L., Leznicki P., Payapilly A., High S.;
RT   "SGTA regulates the cytosolic quality control of hydrophobic
RT   substrates.";
RL   J. Cell Sci. 127:4728-4739(2014).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-81; THR-303 AND SER-305,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   FUNCTION (MICROBIAL INFECTION), IDENTIFICATION IN A COMPLEX WITH
RP   DNAJB12 AND DNAJB14, AND INTERACTION WITH HSPA8.
RX   PubMed=24675744; DOI=10.1371/journal.ppat.1004007;
RA   Walczak C.P., Ravindran M.S., Inoue T., Tsai B.;
RT   "A cytosolic chaperone complexes with dynamic membrane J-proteins and
RT   mobilizes a nonenveloped virus out of the endoplasmic reticulum.";
RL   PLoS Pathog. 10:E1004007-E1004007(2014).
RN   [27]
RP   FUNCTION, AND INTERACTION WITH BAG6.
RX   PubMed=27193484; DOI=10.1038/srep26433;
RA   Krysztofinska E.M., Martinez-Lumbreras S., Thapaliya A., Evans N.J.,
RA   High S., Isaacson R.L.;
RT   "Structural and functional insights into the E3 ligase, RNF126.";
RL   Sci. Rep. 6:26433-26433(2016).
RN   [28]
RP   FUNCTION.
RX   PubMed=28104892; DOI=10.1126/science.aah6130;
RA   Shao S., Rodrigo-Brenni M.C., Kivlen M.H., Hegde R.S.;
RT   "Mechanistic basis for a molecular triage reaction.";
RL   Science 355:298-302(2017).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 84-210, SUBUNIT (MICROBIAL
RP   INFECTION), AND FUNCTION.
RX   PubMed=18759457; DOI=10.1021/bi800758a;
RA   Dutta S., Tan Y.J.;
RT   "Structural and functional characterization of human SGT and its
RT   interaction with Vpu of the human immunodeficiency virus type 1.";
RL   Biochemistry 47:10123-10131(2008).
CC   -!- FUNCTION: Co-chaperone that binds misfolded and hydrophobic
CC       patches-containing client proteins in the cytosol. Mediates their
CC       targeting to the endoplasmic reticulum but also regulates their
CC       sorting to the proteasome when targeting fails (PubMed:28104892).
CC       Functions in tail-anchored/type II transmembrane proteins membrane
CC       insertion constituting with ASNA1 and the BAG6 complex a targeting
CC       module (PubMed:28104892). Probably functions upstream of the BAG6
CC       complex and ASNA1, binding more rapidly the transmembrane domain
CC       of newly synthesized proteins (PubMed:28104892). It is also
CC       involved in the regulation of the endoplasmic reticulum-associated
CC       misfolded protein catabolic process via its interaction with BAG6:
CC       collaborates with the BAG6 complex to maintain hydrophobic
CC       substrates in non-ubiquitinated states (PubMed:23129660,
CC       PubMed:25179605). Competes with RNF126 for interaction with BAG6,
CC       preventing the ubiquitination of client proteins associated with
CC       the BAG6 complex (PubMed:27193484). Binds directly to HSC70 and
CC       HSP70 and regulates their ATPase activity (PubMed:18759457).
CC       {ECO:0000269|PubMed:18759457, ECO:0000269|PubMed:23129660,
CC       ECO:0000269|PubMed:25179605, ECO:0000269|PubMed:27193484,
CC       ECO:0000269|PubMed:28104892}.
CC   -!- FUNCTION: (Microbial infection) In case of infection by
CC       polyomavirus, involved in the virus endoplasmic reticulum membrane
CC       penetration and infection via interaction with DNAJB12, DNAJB14
CC       and HSPA8/Hsc70 (PubMed:24675744). {ECO:0000269|PubMed:24675744}.
CC   -!- SUBUNIT: Homodimer (PubMed:15708368). Homooligomer (By
CC       similarity). Interacts with DNAJC5 and DNAJC5B. Interacts (via TPR
CC       repeats) with HSP90AA1 (PubMed:15708368). Interacts (via Gln-rich
CC       region) with SLC2A1 (PubMed:15708368). Interacts with HSP90AB1
CC       (PubMed:16580629). Interacts (via TPR repeats) with HSPA8/Hsc70;
CC       the interaction is direct (PubMed:24675744). Interacts with BAG6
CC       (via ubiquitin-like domain); interaction prevents interaction
CC       between BAG6 and RNF126 (PubMed:23129660, PubMed:25179605,
CC       PubMed:27193484). Forms a multiprotein complex, at least composed
CC       of DNAJB12, DNAJB14, HSPA8/Hsc70 and SGTA; interaction with
CC       DNAJB14 and HSPA8/Hsc70 is direct (PubMed:24675744).
CC       {ECO:0000250|UniProtKB:O70593, ECO:0000269|PubMed:15708368,
CC       ECO:0000269|PubMed:16580629, ECO:0000269|PubMed:17034881,
CC       ECO:0000269|PubMed:18759457, ECO:0000269|PubMed:23129660,
CC       ECO:0000269|PubMed:24675744, ECO:0000269|PubMed:25179605,
CC       ECO:0000269|PubMed:27193484}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Vpu and Gag from
CC       HIV-1. {ECO:0000269|PubMed:18759457, ECO:0000269|PubMed:9573291}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with SARS-CoV accessory
CC       protein 7a. {ECO:0000269|PubMed:16580632}.
CC   -!- INTERACTION:
CC       A8K660:ADIPOQ; NbExp=3; IntAct=EBI-347996, EBI-10174479;
CC       Q15848:ADIPOQ; NbExp=5; IntAct=EBI-347996, EBI-10827839;
CC       Q8TD06:AGR3; NbExp=5; IntAct=EBI-347996, EBI-3925742;
CC       O95816:BAG2; NbExp=2; IntAct=EBI-347996, EBI-355275;
CC       P46379:BAG6; NbExp=5; IntAct=EBI-347996, EBI-347552;
CC       P35070:BTC; NbExp=5; IntAct=EBI-347996, EBI-6590057;
CC       Q9BXJ1:C1QTNF1; NbExp=4; IntAct=EBI-347996, EBI-750200;
CC       Q9BXI9:C1QTNF6; NbExp=3; IntAct=EBI-347996, EBI-10301084;
CC       Q8N6L0:CCDC155; NbExp=9; IntAct=EBI-347996, EBI-749265;
CC       P40259:CD79B; NbExp=6; IntAct=EBI-347996, EBI-2873732;
CC       Q8TCZ2:CD99L2; NbExp=5; IntAct=EBI-347996, EBI-2824782;
CC       P55291:CDH15; NbExp=5; IntAct=EBI-347996, EBI-10215061;
CC       A0A0S2Z3K0:COL1A2; NbExp=3; IntAct=EBI-347996, EBI-16431143;
CC       P08123:COL1A2; NbExp=8; IntAct=EBI-347996, EBI-983038;
CC       Q4VAQ0:COL8A2; NbExp=3; IntAct=EBI-347996, EBI-10241815;
CC       P09603:CSF1; NbExp=5; IntAct=EBI-347996, EBI-2872294;
CC       P01037:CST1; NbExp=3; IntAct=EBI-347996, EBI-1056240;
CC       P78358:CTAG1B; NbExp=4; IntAct=EBI-347996, EBI-1188472;
CC       P07711:CTSL; NbExp=3; IntAct=EBI-347996, EBI-1220160;
CC       A0A0S2Z3V1:EFEMP1; NbExp=3; IntAct=EBI-347996, EBI-16434097;
CC       Q12805:EFEMP1; NbExp=12; IntAct=EBI-347996, EBI-536772;
CC       O95967:EFEMP2; NbExp=6; IntAct=EBI-347996, EBI-743414;
CC       Q96DN0:ERP27; NbExp=5; IntAct=EBI-347996, EBI-953772;
CC       Q9NVM1:EVA1B; NbExp=5; IntAct=EBI-347996, EBI-10314666;
CC       Q9Y624:F11R; NbExp=9; IntAct=EBI-347996, EBI-742600;
CC       Q96RJ6:FERD3L; NbExp=3; IntAct=EBI-347996, EBI-10183007;
CC       Q9Y680:FKBP7; NbExp=3; IntAct=EBI-347996, EBI-3918971;
CC       P58549:FXYD7; NbExp=7; IntAct=EBI-347996, EBI-10216171;
CC       P22466:GAL; NbExp=3; IntAct=EBI-347996, EBI-6624768;
CC       P09681:GIP; NbExp=7; IntAct=EBI-347996, EBI-8588553;
CC       Q14440:GPErik; NbExp=3; IntAct=EBI-347996, EBI-10232920;
CC       Q96SL4:GPX7; NbExp=5; IntAct=EBI-347996, EBI-749411;
CC       P28799:GRN; NbExp=6; IntAct=EBI-347996, EBI-747754;
CC       Q02747:GUCA2A; NbExp=4; IntAct=EBI-347996, EBI-12244272;
CC       A0A0C4DFT7:GYPA; NbExp=3; IntAct=EBI-347996, EBI-12044847;
CC       B8Q183:GYPA; NbExp=4; IntAct=EBI-347996, EBI-10176190;
CC       P48723:HSPA13; NbExp=5; IntAct=EBI-347996, EBI-750892;
CC       P46695:IER3; NbExp=4; IntAct=EBI-347996, EBI-1748945;
CC       Q6PIQ7:IGL@; NbExp=3; IntAct=EBI-347996, EBI-6677651;
CC       Q8N355:IGL@; NbExp=4; IntAct=EBI-347996, EBI-748681;
CC       Q14653:IRF3; NbExp=3; IntAct=EBI-347996, EBI-2650369;
CC       Q13568:IRF5; NbExp=3; IntAct=EBI-347996, EBI-3931258;
CC       Q6GPH6:ITPRIPL1; NbExp=3; IntAct=EBI-347996, EBI-953819;
CC       P02538:KRT6A; NbExp=3; IntAct=EBI-347996, EBI-702198;
CC       Q86UP2:KTN1; NbExp=3; IntAct=EBI-347996, EBI-359761;
CC       Q6ISS4:LAIR2; NbExp=5; IntAct=EBI-347996, EBI-10250491;
CC       O43561:LAT; NbExp=3; IntAct=EBI-347996, EBI-1222766;
CC       P80188:LCN2; NbExp=4; IntAct=EBI-347996, EBI-11911016;
CC       P08118:MSMB; NbExp=3; IntAct=EBI-347996, EBI-10195681;
CC       Q969H8:MYDGF; NbExp=5; IntAct=EBI-347996, EBI-718622;
CC       Q8IW45:NAXD; NbExp=6; IntAct=EBI-347996, EBI-8650724;
CC       Q13232:NME3; NbExp=8; IntAct=EBI-347996, EBI-713684;
CC       C3PTT6:PAUF; NbExp=3; IntAct=EBI-347996, EBI-3505892;
CC       Q96AQ6:PBXIP1; NbExp=3; IntAct=EBI-347996, EBI-740845;
CC       Q9UN74:PCDHA4; NbExp=3; IntAct=EBI-347996, EBI-712273;
CC       P23284:PPIB; NbExp=5; IntAct=EBI-347996, EBI-359252;
CC       P45877:PPIC; NbExp=5; IntAct=EBI-347996, EBI-953909;
CC       Q96NZ9:PRAP1; NbExp=5; IntAct=EBI-347996, EBI-2116102;
CC       Q9UL19:RARRES3; NbExp=3; IntAct=EBI-347996, EBI-10323452;
CC       Q96K19-5:RNF170; NbExp=4; IntAct=EBI-347996, EBI-12055631;
CC       P04843:RPN1; NbExp=5; IntAct=EBI-347996, EBI-355963;
CC       P31431:SDC4; NbExp=5; IntAct=EBI-347996, EBI-3913237;
CC       P05121:SERPINE1; NbExp=5; IntAct=EBI-347996, EBI-953978;
CC       Q16586:SGCA; NbExp=12; IntAct=EBI-347996, EBI-5663553;
CC       Q16586-2:SGCA; NbExp=4; IntAct=EBI-347996, EBI-16434133;
CC       P03973:SLPI; NbExp=3; IntAct=EBI-347996, EBI-355293;
CC       Q0VAQ4:SMAGP; NbExp=3; IntAct=EBI-347996, EBI-10226799;
CC       Q71RC9:SMIM5; NbExp=4; IntAct=EBI-347996, EBI-12334905;
CC       P08294:SOD3; NbExp=3; IntAct=EBI-347996, EBI-10195782;
CC       P10451:SPP1; NbExp=8; IntAct=EBI-347996, EBI-723648;
CC       Q8TCT8:SPPL2A; NbExp=6; IntAct=EBI-347996, EBI-750784;
CC       P10124:SRGN; NbExp=8; IntAct=EBI-347996, EBI-744915;
CC       Q9BT88:SYT11; NbExp=6; IntAct=EBI-347996, EBI-751770;
CC       Q9H2B2:SYT4; NbExp=6; IntAct=EBI-347996, EBI-751132;
CC       Q07654:TFF3; NbExp=3; IntAct=EBI-347996, EBI-10224676;
CC       P02786:TFRC; NbExp=5; IntAct=EBI-347996, EBI-355727;
CC       P01135:TGFA; NbExp=3; IntAct=EBI-347996, EBI-1034374;
CC       Q8WUU8:TMEM174; NbExp=5; IntAct=EBI-347996, EBI-10276729;
CC       Q5JXX7:TMEM31; NbExp=3; IntAct=EBI-347996, EBI-10244617;
CC       Q71RG4:TMUB2; NbExp=3; IntAct=EBI-347996, EBI-2820477;
CC       O14836:TNFRSF13B; NbExp=3; IntAct=EBI-347996, EBI-519160;
CC       O14836-2:TNFRSF13B; NbExp=5; IntAct=EBI-347996, EBI-12023110;
CC       Q5BVD1:TTMP; NbExp=5; IntAct=EBI-347996, EBI-10243654;
CC       Q9GZX9:TWSG1; NbExp=3; IntAct=EBI-347996, EBI-10304067;
CC       O95881:TXNDC12; NbExp=3; IntAct=EBI-347996, EBI-2564581;
CC       P11441:UBL4A; NbExp=4; IntAct=EBI-347996, EBI-356983;
CC       O75631:UPK3A; NbExp=3; IntAct=EBI-347996, EBI-10188907;
CC       P01282:VIP; NbExp=3; IntAct=EBI-347996, EBI-751454;
CC       Q9NX94:WBP1L; NbExp=3; IntAct=EBI-347996, EBI-10316321;
CC       O60844:ZG16; NbExp=8; IntAct=EBI-347996, EBI-746479;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16580629}.
CC       Nucleus {ECO:0000269|PubMed:16580629}. Note=Co-localizes with
CC       HSP90AB1 in the cytoplasm. Increased nuclear accumulation seen
CC       during cell apoptosis. {ECO:0000269|PubMed:16580629}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The second tetratricopeptide repeat (TPR 2) mediates the
CC       interaction with SARS-CoV accessory protein 7a.
CC   -!- SIMILARITY: Belongs to the SGT family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ223828; CAA11565.1; -; mRNA.
DR   EMBL; AJ133129; CAB39725.1; -; mRNA.
DR   EMBL; AF408399; AAL01051.1; -; mRNA.
DR   EMBL; AF368279; AAP29457.1; -; mRNA.
DR   EMBL; AL050156; CAB43297.2; -; mRNA.
DR   EMBL; CR533517; CAG38548.1; -; mRNA.
DR   EMBL; CR542282; CAG47077.1; -; mRNA.
DR   EMBL; AC006538; AAD13117.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69366.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69367.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69368.1; -; Genomic_DNA.
DR   EMBL; BC000390; AAH00390.1; -; mRNA.
DR   EMBL; BC002989; AAH02989.2; -; mRNA.
DR   EMBL; BC005165; AAH05165.1; -; mRNA.
DR   EMBL; BC008885; AAH08885.1; -; mRNA.
DR   CCDS; CCDS12094.1; -.
DR   RefSeq; NP_003012.1; NM_003021.3.
DR   RefSeq; XP_011526480.1; XM_011528178.2.
DR   UniGene; Hs.203910; -.
DR   PDB; 2VYI; X-ray; 2.40 A; A/B=84-210.
DR   PDB; 4CPG; NMR; -; A/B=1-69.
DR   PDB; 4GOD; X-ray; 1.40 A; A/B=4-54.
DR   PDB; 4GOE; X-ray; 1.45 A; A/B=4-54.
DR   PDB; 4GOF; X-ray; 1.35 A; A/B=4-54.
DR   PDBsum; 2VYI; -.
DR   PDBsum; 4CPG; -.
DR   PDBsum; 4GOD; -.
DR   PDBsum; 4GOE; -.
DR   PDBsum; 4GOF; -.
DR   ProteinModelPortal; O43765; -.
DR   SMR; O43765; -.
DR   BioGrid; 112347; 141.
DR   IntAct; O43765; 188.
DR   MINT; O43765; -.
DR   STRING; 9606.ENSP00000221566; -.
DR   iPTMnet; O43765; -.
DR   PhosphoSitePlus; O43765; -.
DR   BioMuta; SGTA; -.
DR   EPD; O43765; -.
DR   MaxQB; O43765; -.
DR   PaxDb; O43765; -.
DR   PeptideAtlas; O43765; -.
DR   PRIDE; O43765; -.
DR   TopDownProteomics; O43765; -.
DR   DNASU; 6449; -.
DR   Ensembl; ENST00000221566; ENSP00000221566; ENSG00000104969.
DR   GeneID; 6449; -.
DR   KEGG; hsa:6449; -.
DR   UCSC; uc002lwi.2; human.
DR   CTD; 6449; -.
DR   DisGeNET; 6449; -.
DR   EuPathDB; HostDB:ENSG00000104969.9; -.
DR   GeneCards; SGTA; -.
DR   HGNC; HGNC:10819; SGTA.
DR   HPA; HPA056309; -.
DR   MIM; 603419; gene.
DR   neXtProt; NX_O43765; -.
DR   OpenTargets; ENSG00000104969; -.
DR   PharmGKB; PA35727; -.
DR   eggNOG; KOG0553; Eukaryota.
DR   eggNOG; COG0457; LUCA.
DR   GeneTree; ENSGT00730000110724; -.
DR   HOGENOM; HOG000208193; -.
DR   HOVERGEN; HBG000885; -.
DR   InParanoid; O43765; -.
DR   KO; K16365; -.
DR   OMA; EAVVYYK; -.
DR   OrthoDB; EOG091G0C0Q; -.
DR   PhylomeDB; O43765; -.
DR   TreeFam; TF313092; -.
DR   ChiTaRS; SGTA; human.
DR   EvolutionaryTrace; O43765; -.
DR   GeneWiki; SGTA; -.
DR   GenomeRNAi; 6449; -.
DR   PRO; PR:O43765; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000104969; -.
DR   CleanEx; HS_SGTA; -.
DR   ExpressionAtlas; O43765; baseline and differential.
DR   Genevisible; O43765; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0016020; C:membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:1904288; F:BAT3 complex binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0043621; F:protein self-association; IDA:UniProtKB.
DR   GO; GO:1903070; P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:2000059; P:negative regulation of ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:1903071; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR032374; SGTA_dimer.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR001440; TPR_1.
DR   InterPro; IPR019734; TPR_repeat.
DR   Pfam; PF16546; SGTA_dimer; 1.
DR   Pfam; PF00515; TPR_1; 2.
DR   Pfam; PF13181; TPR_8; 1.
DR   SMART; SM00028; TPR; 3.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   PROSITE; PS50005; TPR; 3.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chaperone; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Host-virus interaction; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; TPR repeat.
FT   CHAIN         1    313       Small glutamine-rich tetratricopeptide
FT                                repeat-containing protein alpha.
FT                                /FTId=PRO_0000106365.
FT   REPEAT       91    124       TPR 1.
FT   REPEAT      125    158       TPR 2.
FT   REPEAT      159    192       TPR 3.
FT   COMPBIAS    275    287       Gln-rich.
FT   MOD_RES      77     77       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      81     81       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      84     84       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70593}.
FT   MOD_RES     137    137       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     301    301       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     303    303       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     305    305       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   HELIX         5     21       {ECO:0000244|PDB:4GOF}.
FT   HELIX        26     43       {ECO:0000244|PDB:4GOF}.
FT   HELIX        48     51       {ECO:0000244|PDB:4CPG}.
FT   HELIX        58     65       {ECO:0000244|PDB:4CPG}.
FT   HELIX        87    103       {ECO:0000244|PDB:2VYI}.
FT   HELIX       107    120       {ECO:0000244|PDB:2VYI}.
FT   HELIX       125    137       {ECO:0000244|PDB:2VYI}.
FT   HELIX       141    154       {ECO:0000244|PDB:2VYI}.
FT   HELIX       159    171       {ECO:0000244|PDB:2VYI}.
FT   HELIX       175    188       {ECO:0000244|PDB:2VYI}.
FT   HELIX       193    206       {ECO:0000244|PDB:2VYI}.
SQ   SEQUENCE   313 AA;  34063 MW;  80B3C71B41F3CB55 CRC64;
     MDNKKRLAYA IIQFLHDQLR HGGLSSDAQE SLEVAIQCLE TAFGVTVEDS DLALPQTLPE
     IFEAAATGKE MPQDLRSPAR TPPSEEDSAE AERLKTEGNE QMKVENFEAA VHFYGKAIEL
     NPANAVYFCN RAAAYSKLGN YAGAVQDCER AICIDPAYSK AYGRMGLALS SLNKHVEAVA
     YYKKALELDP DNETYKSNLK IAELKLREAP SPTGGVGSFD IAGLLNNPGF MSMASNLMNN
     PQIQQLMSGM ISGGNNPLGT PGTSPSQNDL ASLIQAGQQF AQQMQQQNPE LIEQLRSQIR
     SRTPSASNDD QQE
//
ID   A0A024R9W5_HUMAN        Unreviewed;      4374 AA.
AC   A0A024R9W5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 37.
DE   SubName: Full=HECT, UBA and WWE domain containing 1, isoform CRA_b {ECO:0000313|EMBL:EAW93166.1};
GN   Name=HUWE1 {ECO:0000313|EMBL:EAW93166.1};
GN   ORFNames=hCG_2000770 {ECO:0000313|EMBL:EAW93166.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW93166.1};
RN   [1] {ECO:0000313|EMBL:EAW93166.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW93166.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000256|SAAS:SAAS00628607}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471154; EAW93161.1; -; Genomic_DNA.
DR   EMBL; CH471154; EAW93166.1; -; Genomic_DNA.
DR   RefSeq; NP_113584.3; NM_031407.6.
DR   RefSeq; XP_005262022.1; XM_005261965.3.
DR   UniGene; Hs.136905; -.
DR   SMR; A0A024R9W5; -.
DR   PRIDE; A0A024R9W5; -.
DR   GeneID; 10075; -.
DR   KEGG; hsa:10075; -.
DR   CTD; 10075; -.
DR   EuPathDB; HostDB:ENSG00000086758.15; -.
DR   eggNOG; KOG0939; Eukaryota.
DR   eggNOG; COG5021; LUCA.
DR   KO; K10592; -.
DR   OMA; GDLYHWI; -.
DR   OrthoDB; EOG091G01V1; -.
DR   ChiTaRS; HUWE1; human.
DR   GenomeRNAi; 10075; -.
DR   Bgee; ENSG00000086758; -.
DR   ExpressionAtlas; A0A024R9W5; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IEA:InterPro.
DR   CDD; cd00078; HECTc; 1.
DR   Gene3D; 3.30.720.50; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR025527; DUF4414.
DR   InterPro; IPR010309; E3_Ub_ligase_DUF908.
DR   InterPro; IPR010314; E3_Ub_ligase_DUF913.
DR   InterPro; IPR000569; HECT_dom.
DR   InterPro; IPR035983; Hect_E3_ubiquitin_ligase.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like_sf.
DR   InterPro; IPR004170; WWE-dom.
DR   InterPro; IPR037197; WWE_dom_sf.
DR   Pfam; PF14377; DUF4414; 1.
DR   Pfam; PF06012; DUF908; 1.
DR   Pfam; PF06025; DUF913; 1.
DR   Pfam; PF00632; HECT; 1.
DR   Pfam; PF00627; UBA; 1.
DR   Pfam; PF02825; WWE; 1.
DR   SMART; SM00119; HECTc; 1.
DR   SMART; SM00165; UBA; 1.
DR   SUPFAM; SSF117839; SSF117839; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF48371; SSF48371; 3.
DR   SUPFAM; SSF56204; SSF56204; 1.
DR   PROSITE; PS50237; HECT; 1.
DR   PROSITE; PS50030; UBA; 1.
DR   PROSITE; PS50918; WWE; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Transferase {ECO:0000256|SAAS:SAAS00628615};
KW   Ubl conjugation pathway {ECO:0000256|PROSITE-ProRule:PRU00104,
KW   ECO:0000256|SAAS:SAAS00593691}.
FT   DOMAIN     1316   1355       UBA. {ECO:0000259|PROSITE:PS50030}.
FT   DOMAIN     1603   1680       WWE. {ECO:0000259|PROSITE:PS50918}.
FT   DOMAIN     4038   4374       HECT. {ECO:0000259|PROSITE:PS50237}.
FT   COILED     1402   1423       {ECO:0000256|SAM:Coils}.
FT   COILED     2425   2445       {ECO:0000256|SAM:Coils}.
FT   COILED     2681   2703       {ECO:0000256|SAM:Coils}.
FT   COILED     3029   3049       {ECO:0000256|SAM:Coils}.
FT   COILED     3090   3110       {ECO:0000256|SAM:Coils}.
FT   ACT_SITE   4341   4341       Glycyl thioester intermediate.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00104}.
SQ   SEQUENCE   4374 AA;  481891 MW;  FA9D3A7712F6393B CRC64;
     MKVDRTKLKK TPTEAPADCR ALIDKLKVCN DEQLLLELQQ IKTWNIGKCE LYHWVDLLDR
     FDGILADAGQ TVENMSWMLV CDRPEREQLK MLLLAVLNFT ALLIEYSFSR HLYSSIEHLT
     TLLASSDMQV VLAVLNLLYV FSKRSNYITR LGSDKRTPLL TRLQHLAESW GGKENGFGLA
     ECCRDLHMMK YPPSATTLHF EFYADPGAEV KIEKRTTSNT LHYIHIEQLD KISESPSEIM
     ESLTKMYSIP KDKQMLLFTH IRLAHGFSNH RKRLQAVQAR LHAISILVYS NALQESANSI
     LYNGLIEELV DVLQITDKQL MEIKAASLRT LTSIVHLERT PKLSSIIDCT GTASYHGFLP
     VLVRNCIQAM IDPSMDPYPH QFATALFSFL YHLASYDAGG EALVSCGMME ALLKVIKFLG
     DEQDQITFVT RAVRVVDLIT NLDMAAFQSH SGLSIFIYRL EHEVDLCRKE CPFVIKPKIQ
     RPNTTQEGEE METDMDGVQC IPQRAALLKS MLNFLKKAIQ DPAFSDGIRH VMDGSLPTSL
     KHIISNAEYY GPSLFLLATE VVTVFVFQEP SLLSSLQDNG LTDVMLHALL IKDVPATREV
     LGSLPNVFSA LCLNARGLQS FVQCQPFERL FKVLLSPDYL PAMRRRRSSD PLGDTASNLG
     SAVDELMRHQ PTLKTDATTA IIKLLEEICN LGRDPKYICQ KPSIQKADGT ATAPPPRSNH
     AAEEASSEDE EEEEVQAMQS FNSTQQNETE PNQQVVGTEE RIPIPLMDYI LNVMKFVESI
     LSNNTTDDHC QEFVNQKGLL PLVTILGLPN LPIDFPTSAA CQAVAGVCKS ILTLSHEPKV
     LQEGLLQLDS ILSSLEPLHR PIESPGGSVL LRELACAGNV ADATLSAQAT PLLHALTAAH
     AYIMMFVHTC RVGQSEIRSI SVNQWGSQLG LSVLSKLSQL YCSLVWESTV LLSLCTPNSL
     PSGCEFGQAD MQKLVPKDEK AGTTQGGKRS DGEQDGAAGS MDASTQGLLE GIGLDGDTLA
     PMETDEPTAS DSKGKSKITP AMAARIKQIK PLLSASSRLG RALAELFGLL VKLCVGSPVR
     QRRSHHAAST TTAPTPAARS TASALTKLLT KGLSWQPPPY TPTPRFRLTF FICSVGFTSP
     MLFDERKYPY HLMLQKFLCS GGHNALFETF NWALSMGGKV PVSEGLEHSD LPDGTGEFLD
     AWLMLVEKMV NPTTVLESPH SLPAKLPGGV QNFPQFSALR FLVVTQKAAF TCIKNLWNRK
     PLKVYGGRMA ESMLAILCHI LRGEPVIRER LSKEKEGSRG EEDTGQEEGG SRREPQVNQQ
     QLQQLMDMGF TREHAMEALL NTSTMEQATE YLLTHPPPIM GGVVRDLSMS EEDQMMRAIA
     MSLGQDIPMD QRAESPEEVA CRKEEEERKA REKQEEEEAK CLEKFQDADP LEQDELHTFT
     DTMLPGCFHL LDELPDTVYR VCDLIMTAIK RNGADYRDMI LKQVVNQVWE AADVLIKAAL
     PLTTSDTKTV SEWISQMATL PQASNLATRI LLLTLLFEEL KLPCAWVVES SGILNVLIKL
     LEVVQPCLQA AKEQKEVQTP KWITPVLLLI DFYEKTAISS KRRAQMTKYL QSNSNNWRWF
     DDRSGRWCSY SASNNSTIDS AWKSGETSVR FTAGRRRYTV QFTTMVQVNE ETGNRRPVML
     TLLRVPRLNK NSKNSNGQEL EKTLEESKEM DIKRKENKGN DTPLALESTN TEKETSLEET
     KIGEILIQGL TEDMVTVLIR ACVSMLGVPV DPDTLHATLR LCLRLTRDHK YAMMFAELKS
     TRMILNLTQS SGFNGFTPLV TLLLRHIIED PCTLRHTMEK VVRSAATSGA GSTTSGVVSG
     SLGSREINYI LRVLGPAACR NPDIFTEVAN CCIRIALPAP RGSGTASDDE FENLRIKGPN
     AVQLVKTTPL KPSPLPVIPD TIKEVIYDML NALAAYHAPE EADKSDPKPG VMTQEVGQLL
     QDMGDDVYQQ YRSLTRQSSD FDTQSGFSIN SQVFAADGAS TETSASGTSQ GEASTPEESR
     DGKKDKEGDR ASEEGKQKGK GSKPLMPTST ILRLLAELVR SYVGIATLIA NYSYTVGQSE
     LIKEDCSVLA FVLDHLLPHT QNAEDKDTPA LARLFLASLA AAGSGTDAQV ALVNEVKAAL
     GRALAMAEST EKHARLQAVM CIISTIMESC PSTSSFYSSA TAKTQHNGMN NIIRLFLKKG
     LVNDLARVPH SLDLSSPNMA NTVNAALKPL ETLSRIVNQP SSLFGSKSAS SKNKSEQDAQ
     GASQDSSSNQ QDPGEPGEAE VQEEDHDVTQ TEVADGDIMD GEAETDSVVI AGQPEVLSSQ
     EMQVENELED LIDELLERDG GSGNSTIIVS RSGEDESQED VLMDEAPSNL SQASTLQANR
     EDSMNILDPE DEEEHTQEED SSGSNEDEDD SQDEEEEEEE DEEDDQEDDE GEEGDEDDDD
     DGSEMELDED YPDMNASPLV RFERFDREDD LIIEFDNMFS SATDIPPSPG NIPTTHPLMV
     RHADHSSLTL GSGSSTTRLT QGIGRSQRTL RQLTANTGHT IHVHYPGNRQ PNPPLILQRL
     LGPSAAADIL QLSSSLPLQS RGRARLLVGN DDVHIIARSD DELLDDFFHD QSTATSQAGT
     LSSIPTALTR WTEECKVLDA ESMHDCVSVV KVSIVNHLEF LRDEELEERR EKRRKQLAEE
     ETKITDKGKE DKENRDQSAQ CTASKSNDST EQNLSDGTPM PDSYPTTPSS TDAATSESKE
     TLGTLQSSQQ QPTLPTPPAL GEVPQELQSP AGEGGSSTQL LMPVEPEELG PTRPSGEAET
     TQMELSPAPT ITSLSPERAE DSDALTAVSS QLEGSPMDTS SLASCTLEEA VGDTSAAGSS
     EQPRAGSSTP GDAPPAVAEV QGRSDGSGES AQPPEDSSPP ASSESSSTRD SAVAISGADS
     RGILEEPLPS TSSEEEDPLA GISLPEGVDP SFLAALPDDI RREVLQNQLG IRPPTRTAPS
     TNSSAPAVVG NPGVTEVSPE FLAALPPAIQ EEVLAQQRAE QQRRELAQNA SSDTPMDPVT
     FIQTLPSDLR RSVLEDMEDS VLAVMPPDIA AEAQALRREQ EARQRQLMHE RLFGHSSTSA
     LSAILRSPAF TSRLSGNRGV QYTRLAVQRG GTFQMGGSSS HNRPSGSNVD TLLRLRGRLL
     LDHEALSCLL VLLFVDEPKL NTSRLHRVLR NLCYHAQTRH WVIRSLLSIL QRSSESELCI
     ETPKLTTSEE KGKKSSKSCG SSSHENRPLD LLHKMESKSS NQLSWLSVSM DAALGCRTNI
     FQIQRSGGRK HTEKHASGGS TVHIHPQAAP VVCRHVLDTL IQLAKVFPSH FTQQRTKETN
     CESDRERGNK ACSPCSSQSS SSGICTDFWD LLVKLDNMNV SRKGKNSVKS VPVSAGGEGE
     TSPYSLEASP LGQLMNMLSH PVIRRSSLLT EKLLRLLSLI SIALPENKVS EAQANSGSGA
     SSTTTATSTT STTTTTAAST TPTPPTAPTP VTSAPALVAA TAISTIVVAA STTVTTPTTA
     TTTVSISPTT KGSKSPAKVS DGGSSSTDFK MVSSGLTENQ LQLSVEVLTS HSCSEEGLED
     AANVLLQLSR GDSGTRDTVL KLLLNGARHL GYTLCKQIGT LLAELREYNL EQQRRAQCET
     LSPDGLPEEQ PQTTKLKGKM QSRFDMAENV VIVASQKRPL GGRELQLPSM SMLTSKTSTQ
     KFFLRVLQVI IQLRDDTRRA NKKAKQTGRL GSSGLGSASS IQAAVRQLEA EADAIIQMVR
     EGQRARRQQQ AATSESSQSE ASVRREESPM DVDQPSPSAQ DTQSIASDGT PQGEKEKEER
     PPELPLLSEQ LSLDELWDML GECLKELEES HDQHAVLVLQ PAVEAFFLVH ATERESKPPV
     RDTRESQLAH IKDEPPPLSP APLTPATPSS LDPFFSREPS SMHISSSLPP DTQKFLRFAE
     THRTVLNQIL RQSTTHLADG PFAVLVDYIR VLDFDVKRKY FRQELERLDE GLRKEDMAVH
     VRRDHVFEDS YRELHRKSPE EMKNRLYIVF EGEEGQDAGG LLREWYMIIS REMFNPMYAL
     FRTSPGDRVT YTINPSSHCN PNHLSYFKFV GRIVAKAVYD NRLLECYFTR SFYKHILGKS
     VRYTDMESED YHFYQGLVYL LENDVSTLGY DLTFSTEVQE FGVCEVRDLK PNGANILVTE
     ENKKEYVHLV CQMRMTGAIR KQLAAFLEGF YEIIPKRLIS IFTEQELELL ISGLPTIDID
     DLKSNTEYHK YQSNSIQIQW FWRALRSFDQ ADRAKFLQFV TGTSKVPLQG FAALEGMNGI
     QKFQIHRDDR STDRLPSAHT CFNQLDLPAY ESFEKLRHML LLAIQECSEG FGLA
//
ID   HUWE1_HUMAN             Reviewed;        4374 AA.
AC   Q7Z6Z7; O15029; Q4G2Z2; Q5H961; Q6P4D0; Q8NG67; Q9BUI0; Q9HCJ4;
AC   Q9NSL6; Q9P0A9;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 3.
DT   23-MAY-2018, entry version 168.
DE   RecName: Full=E3 ubiquitin-protein ligase HUWE1;
DE            EC=2.3.2.26;
DE   AltName: Full=ARF-binding protein 1;
DE            Short=ARF-BP1;
DE   AltName: Full=HECT, UBA and WWE domain-containing protein 1;
DE   AltName: Full=HECT-type E3 ubiquitin transferase HUWE1;
DE   AltName: Full=Homologous to E6AP carboxyl terminus homologous protein 9;
DE            Short=HectH9;
DE   AltName: Full=Large structure of UREB1;
DE            Short=LASU1;
DE   AltName: Full=Mcl-1 ubiquitin ligase E3;
DE            Short=Mule;
DE   AltName: Full=Upstream regulatory element-binding protein 1;
DE            Short=URE-B1;
DE            Short=URE-binding protein 1;
GN   Name=HUWE1; Synonyms=KIAA0312, KIAA1578, UREB1; ORFNames=HSPC272;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   CDKN2A, AND MUTAGENESIS OF CYS-4341.
RX   PubMed=15989956; DOI=10.1016/j.cell.2005.03.037;
RA   Chen D., Kon N., Li M., Zhang W., Qin J., Gu W.;
RT   "ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.";
RL   Cell 121:1071-1083(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND MUTAGENESIS OF
RP   CYS-4341.
RX   PubMed=15989957; DOI=10.1016/j.cell.2005.06.009;
RA   Zhong Q., Gao W., Du F., Wang X.;
RT   "Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the
RT   polyubiquitination of Mcl-1 and regulates apoptosis.";
RL   Cell 121:1085-1095(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=15767685; DOI=10.1128/MCB.25.7.2819-2831.2005;
RA   Liu Z., Oughtred R., Wing S.S.;
RT   "Characterization of E3Histone, a novel testis ubiquitin protein
RT   ligase which ubiquitinates histones.";
RL   Mol. Cell. Biol. 25:2819-2831(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 959-4374 (ISOFORM 3).
RC   TISSUE=Brain;
RA   Miyazaki K., Okamoto Y., Sakamoto M., Kato C., Ozaki T., Watanabe K.,
RA   Nakagawara A.;
RT   "Homo sapiens LASU1 (large structure of UREB1) mRNA, complete cds.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1166-4374 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [7]
RP   SEQUENCE REVISION TO 2310.
RA   Ohara O., Nagase T., Kikuno R., Nomura N.;
RL   Submitted (SEP-2011) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1246-2418.
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2451-4374.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3953-4374.
RC   TISSUE=Ovary, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4029-4374.
RA   Kim J.W., Lee Y., Hong Y.M., Hong M., Choe I.S.;
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4067-4374.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4320-4374.
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [14]
RP   FUNCTION, TISSUE SPECIFICITY, AND MUTAGENESIS OF TYR-4268 AND
RP   CYS-4341.
RX   PubMed=15567145; DOI=10.1016/j.bbrc.2004.11.004;
RA   Yoon S.Y., Lee Y., Kim J.H., Chung A.-S., Joo J.H., Kim C.-N.,
RA   Kim N.-S., Choe I.S., Kim J.W.;
RT   "Over-expression of human UREB1 in colorectal cancer: HECT domain of
RT   human UREB1 inhibits the activity of tumor suppressor p53 protein.";
RL   Biochem. Biophys. Res. Commun. 326:7-17(2005).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1395; SER-1907;
RP   SER-2362; SER-2887 AND SER-2918, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH CDC6.
RX   PubMed=17567951; DOI=10.1091/mbc.E07-02-0173;
RA   Hall J.R., Kow E., Nevis K.R., Lu C.K., Luce K.S., Zhong Q.,
RA   Cook J.G.;
RT   "Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA
RT   damage.";
RL   Mol. Biol. Cell 18:3340-3350(2007).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [22]
RP   FUNCTION, INTERACTION WITH MYCN, AND MUTAGENESIS OF CYS-4341.
RX   PubMed=18488021; DOI=10.1038/ncb1727;
RA   Zhao X., Heng J.I.-T., Guardavaccaro D., Jiang R., Pagano M.,
RA   Guillemot F., Iavarone A., Lasorella A.;
RT   "The HECT-domain ubiquitin ligase Huwe1 controls neural
RT   differentiation and proliferation by destabilizing the N-Myc
RT   oncoprotein.";
RL   Nat. Cell Biol. 10:643-653(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1368; SER-1907;
RP   SER-2362; SER-2365; SER-2887; SER-3662; SER-3919; THR-3924 AND
RP   THR-3927, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [25]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH POLB.
RX   PubMed=19713937; DOI=10.1038/emboj.2009.243;
RA   Parsons J.L., Tait P.S., Finch D., Dianova I.I., Edelmann M.J.,
RA   Khoronenkova S.V., Kessler B.M., Sharma R.A., McKenna W.G.,
RA   Dianov G.L.;
RT   "Ubiquitin ligase ARF-BP1/Mule modulates base excision repair.";
RL   EMBO J. 28:3207-3215(2009).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH PA2G4.
RX   PubMed=19037095; DOI=10.1091/mbc.E08-09-0983;
RA   Liu Z., Oh S.M., Okada M., Liu X., Cheng D., Peng J., Brat D.J.,
RA   Sun S.Y., Zhou W., Gu W., Ye K.;
RT   "Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor.";
RL   Mol. Biol. Cell 20:757-768(2009).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1370; SER-1395;
RP   SER-1907; SER-2362; SER-2391; SER-2595; SER-2619; THR-2751; SER-2887;
RP   SER-3116; SER-3752; SER-3757; SER-3808; SER-3816; SER-3919 AND
RP   THR-3924, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084; SER-1368;
RP   SER-1395; THR-1722; SER-1907; SER-2362; SER-2365; SER-2595; SER-3127;
RP   SER-3662; SER-3757; SER-3760 AND SER-3919, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084; SER-1907; SER-2362
RP   AND SER-2365, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1368; SER-1382;
RP   SER-1395; THR-1722; SER-1907; SER-2266; SER-2362; SER-2365; SER-2527;
RP   SER-2532; SER-2535; THR-2554; SER-2595; SER-2887; SER-2888; THR-2889;
RP   SER-3116; SER-3117; SER-3122; SER-3127; SER-3135; SER-3555; SER-3662;
RP   SER-3752; SER-3757; SER-3760; SER-3808; SER-3816; SER-3827 AND
RP   THR-3830, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-740; SER-1368; SER-1395;
RP   THR-2035; SER-2584; SER-2826; SER-2833; SER-2835; SER-2861; SER-3757;
RP   SER-3759; SER-3816; SER-3827; SER-3906; SER-3919; THR-3924 AND
RP   THR-3927, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [34]
RP   STRUCTURE BY NMR OF 1317-1356.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RSGI RUH-074, a human UBA domain.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 4005-4374.
RG   Structural genomics consortium (SGC);
RT   "Hect domain of human huwe1/mule.";
RL   Submitted (MAY-2009) to the PDB data bank.
RN   [36]
RP   VARIANTS MRXST HIS-2981; TRP-4013 AND CYS-4187, INVOLVEMENT IN MRX17,
RP   AND INVOLVEMENT IN MRXST.
RX   PubMed=18252223; DOI=10.1016/j.ajhg.2007.11.002;
RA   Froyen G., Corbett M., Vandewalle J., Jarvela I., Lawrence O.,
RA   Meldrum C., Bauters M., Govaerts K., Vandeleur L., Van Esch H.,
RA   Chelly J., Sanlaville D., van Bokhoven H., Ropers H.-H.,
RA   Laumonnier F., Ranieri E., Schwartz C.E., Abidi F., Tarpey P.S.,
RA   Futreal P.A., Whibley A., Raymond F.L., Stratton M.R., Fryns J.-P.,
RA   Scott R., Peippo M., Sipponen M., Partington M., Mowat D., Field M.,
RA   Hackett A., Marynen P., Turner G., Gecz J.;
RT   "Submicroscopic duplications of the hydroxysteroid dehydrogenase
RT   HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental
RT   retardation.";
RL   Am. J. Hum. Genet. 82:432-443(2008).
RN   [37]
RP   VARIANT ASP-950.
RX   PubMed=23092983; DOI=10.1038/tp.2012.102;
RA   Nava C., Lamari F., Heron D., Mignot C., Rastetter A., Keren B.,
RA   Cohen D., Faudet A., Bouteiller D., Gilleron M., Jacquette A.,
RA   Whalen S., Afenjar A., Perisse D., Laurent C., Dupuits C., Gautier C.,
RA   Gerard M., Huguet G., Caillet S., Leheup B., Leboyer M., Gillberg C.,
RA   Delorme R., Bourgeron T., Brice A., Depienne C.;
RT   "Analysis of the chromosome X exome in patients with autism spectrum
RT   disorders identified novel candidate genes, including TMLHE.";
RL   Transl. Psychiatry 2:E179-E179(2012).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which mediates
CC       ubiquitination and subsequent proteasomal degradation of target
CC       proteins. Regulates apoptosis by catalyzing the polyubiquitination
CC       and degradation of MCL1. Mediates monoubiquitination of DNA
CC       polymerase beta (POLB) at 'Lys-41', 'Lys-61' and 'Lys-81', thereby
CC       playing a role in base-excision repair. Also ubiquitinates the
CC       p53/TP53 tumor suppressor and core histones including H1, H2A,
CC       H2B, H3 and H4. Binds to an upstream initiator-like sequence in
CC       the preprodynorphin gene. Regulates neural differentiation and
CC       proliferation by catalyzing the polyubiquitination and degradation
CC       of MYCN. May regulate abundance of CDC6 after DNA damage by
CC       polyubiquitinating and targeting CDC6 to degradation. Mediates
CC       polyubiquitination of isoform 2 of PA2G4.
CC       {ECO:0000269|PubMed:15567145, ECO:0000269|PubMed:15767685,
CC       ECO:0000269|PubMed:15989956, ECO:0000269|PubMed:15989957,
CC       ECO:0000269|PubMed:17567951, ECO:0000269|PubMed:18488021,
CC       ECO:0000269|PubMed:19037095, ECO:0000269|PubMed:19713937}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with isoform p14ARF of CDKN2A which strongly
CC       inhibits HUWE1 ubiquitin ligase activity. Interacts with MYCN,
CC       POLB and CDC6. Interacts with isoform 2 of PA2G4.
CC       {ECO:0000269|PubMed:15989956, ECO:0000269|PubMed:17567951,
CC       ECO:0000269|PubMed:18488021, ECO:0000269|PubMed:19037095,
CC       ECO:0000269|PubMed:19713937}.
CC   -!- INTERACTION:
CC       Q8N726:CDKN2A; NbExp=5; IntAct=EBI-625934, EBI-625922;
CC       P04792:HSPB1; NbExp=3; IntAct=EBI-625934, EBI-352682;
CC       Q07820:MCL1; NbExp=6; IntAct=EBI-625934, EBI-1003422;
CC       P20393:NR1D1; NbExp=3; IntAct=EBI-625934, EBI-2811738;
CC       P04637:TP53; NbExp=3; IntAct=EBI-625934, EBI-366083;
CC       Q13107:USP4; NbExp=4; IntAct=EBI-625934, EBI-723290;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19713937}.
CC       Nucleus {ECO:0000269|PubMed:19713937}. Note=Mainly expressed in
CC       the cytoplasm of most tissues, except in the nucleus of
CC       spermatogonia, primary spermatocytes and neuronal cells (By
CC       similarity). Predominantly cytosolic or perinuclear in some
CC       colorectal carcinoma cells. {ECO:0000250|UniProtKB:Q7TMY8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=LASU1, Large structure of UREB1;
CC         IsoId=Q7Z6Z7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z6Z7-2; Sequence=VSP_011146;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q7Z6Z7-3; Sequence=VSP_015272;
CC   -!- TISSUE SPECIFICITY: Weakly expressed in heart, brain and placenta
CC       but not in other tissues. Expressed in a number of cell lines,
CC       predominantly in those from colorectal carcinomas.
CC       {ECO:0000269|PubMed:15567145}.
CC   -!- DOMAIN: The HECT domain mediates inhibition of the transcriptional
CC       activity of p53.
CC   -!- PTM: Phosphorylated on tyrosine; phosphorylation is probably
CC       required for its ability to inhibit TP53 transactivation.
CC       {ECO:0000250|UniProtKB:Q7TMY8}.
CC   -!- DISEASE: Mental retardation, X-linked, syndromic, Turner type
CC       (MRXST) [MIM:300706]: A syndrome characterized by the association
CC       of mental retardation with macrocephaly and variable contractures.
CC       {ECO:0000269|PubMed:18252223}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Mental retardation, X-linked 17 (MRX17) [MIM:300705]: A
CC       disorder characterized by significantly below average general
CC       intellectual functioning associated with impairments in adaptive
CC       behavior and manifested during the developmental period.
CC       Intellectual deficiency is the only primary symptom of non-
CC       syndromic X-linked mental retardation, while syndromic mental
CC       retardation presents with associated physical, neurological and/or
CC       psychiatric manifestations. {ECO:0000269|PubMed:18252223}.
CC       Note=The gene represented in this entry is involved in disease
CC       pathogenesis. A chromosomal microduplication involving HSD17B10
CC       and HUWE1 has been found in patients with mental retardation.
CC   -!- SIMILARITY: Belongs to the UPL family. TOM1/PTR1 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC62492.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAF28950.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAF28950.1; Type=Frameshift; Positions=4356; Evidence={ECO:0000305};
CC       Sequence=BAB13404.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA, contains the C-terminal part of ATP5I.; Evidence={ECO:0000305};
CC       Sequence=BAC06833.1; Type=Frameshift; Positions=982, 1055; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY772009; AAV90838.1; -; mRNA.
DR   EMBL; DQ097177; AAY98258.1; -; mRNA.
DR   EMBL; AY929612; AAX24125.1; -; mRNA.
DR   EMBL; AL592046; CAI39580.1; -; Genomic_DNA.
DR   EMBL; Z94044; CAI39580.1; JOINED; Genomic_DNA.
DR   EMBL; Z97054; CAI39580.1; JOINED; Genomic_DNA.
DR   EMBL; Z94044; CAI42354.1; -; Genomic_DNA.
DR   EMBL; AL592046; CAI42354.1; JOINED; Genomic_DNA.
DR   EMBL; Z97054; CAI42354.1; JOINED; Genomic_DNA.
DR   EMBL; Z97054; CAI42654.1; -; Genomic_DNA.
DR   EMBL; AL592046; CAI42654.1; JOINED; Genomic_DNA.
DR   EMBL; Z94044; CAI42654.1; JOINED; Genomic_DNA.
DR   EMBL; AB071605; BAC06833.1; ALT_FRAME; mRNA.
DR   EMBL; AB002310; BAA20771.3; -; mRNA.
DR   EMBL; AB046798; BAB13404.1; ALT_SEQ; mRNA.
DR   EMBL; AF161390; AAF28950.1; ALT_SEQ; mRNA.
DR   EMBL; BC002602; AAH02602.2; -; mRNA.
DR   EMBL; BC063505; AAH63505.1; -; mRNA.
DR   EMBL; AF057569; AAC62492.1; ALT_INIT; mRNA.
DR   EMBL; CR456813; CAG33094.1; -; mRNA.
DR   EMBL; AL162050; CAB82393.1; -; mRNA.
DR   CCDS; CCDS35301.1; -. [Q7Z6Z7-1]
DR   PIR; T47165; T47165.
DR   RefSeq; NP_113584.3; NM_031407.6. [Q7Z6Z7-1]
DR   RefSeq; XP_005262022.1; XM_005261965.3. [Q7Z6Z7-1]
DR   UniGene; Hs.136905; -.
DR   PDB; 2EKK; NMR; -; A=1317-1356.
DR   PDB; 2MUL; NMR; -; A=2951-3003.
DR   PDB; 3G1N; X-ray; 2.60 A; A/B=4005-4374.
DR   PDB; 3H1D; X-ray; 1.89 A; A=3993-4374.
DR   PDB; 5C6H; X-ray; 2.05 A; B/D/F/H/J/L/N/P/R/T/V/X=1969-1994.
DR   PDB; 5LP8; X-ray; 2.70 A; A/B=3951-4374.
DR   PDBsum; 2EKK; -.
DR   PDBsum; 2MUL; -.
DR   PDBsum; 3G1N; -.
DR   PDBsum; 3H1D; -.
DR   PDBsum; 5C6H; -.
DR   PDBsum; 5LP8; -.
DR   ProteinModelPortal; Q7Z6Z7; -.
DR   SMR; Q7Z6Z7; -.
DR   BioGrid; 115385; 477.
DR   CORUM; Q7Z6Z7; -.
DR   DIP; DIP-34362N; -.
DR   ELM; Q7Z6Z7; -.
DR   IntAct; Q7Z6Z7; 89.
DR   MINT; Q7Z6Z7; -.
DR   STRING; 9606.ENSP00000262854; -.
DR   CarbonylDB; Q7Z6Z7; -.
DR   iPTMnet; Q7Z6Z7; -.
DR   PhosphoSitePlus; Q7Z6Z7; -.
DR   BioMuta; HUWE1; -.
DR   DMDM; 73915353; -.
DR   EPD; Q7Z6Z7; -.
DR   MaxQB; Q7Z6Z7; -.
DR   PaxDb; Q7Z6Z7; -.
DR   PeptideAtlas; Q7Z6Z7; -.
DR   PRIDE; Q7Z6Z7; -.
DR   Ensembl; ENST00000262854; ENSP00000262854; ENSG00000086758. [Q7Z6Z7-1]
DR   Ensembl; ENST00000342160; ENSP00000340648; ENSG00000086758. [Q7Z6Z7-1]
DR   Ensembl; ENST00000612484; ENSP00000479451; ENSG00000086758. [Q7Z6Z7-3]
DR   GeneID; 10075; -.
DR   KEGG; hsa:10075; -.
DR   UCSC; uc033eew.2; human. [Q7Z6Z7-1]
DR   CTD; 10075; -.
DR   DisGeNET; 10075; -.
DR   EuPathDB; HostDB:ENSG00000086758.15; -.
DR   GeneCards; HUWE1; -.
DR   HGNC; HGNC:30892; HUWE1.
DR   HPA; CAB022718; -.
DR   HPA; HPA002548; -.
DR   MalaCards; HUWE1; -.
DR   MIM; 300697; gene.
DR   MIM; 300705; phenotype.
DR   MIM; 300706; phenotype.
DR   neXtProt; NX_Q7Z6Z7; -.
DR   OpenTargets; ENSG00000086758; -.
DR   Orphanet; 85328; X-linked intellectual disability, Turner type.
DR   PharmGKB; PA128394567; -.
DR   eggNOG; KOG0939; Eukaryota.
DR   eggNOG; COG5021; LUCA.
DR   GeneTree; ENSGT00850000132302; -.
DR   HOVERGEN; HBG080254; -.
DR   InParanoid; Q7Z6Z7; -.
DR   KO; K10592; -.
DR   OMA; GDLYHWI; -.
DR   OrthoDB; EOG091G01V1; -.
DR   PhylomeDB; Q7Z6Z7; -.
DR   TreeFam; TF323417; -.
DR   BRENDA; 6.3.2.19; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; HUWE1; human.
DR   EvolutionaryTrace; Q7Z6Z7; -.
DR   GeneWiki; HUWE1; -.
DR   GenomeRNAi; 10075; -.
DR   PRO; PR:Q7Z6Z7; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000086758; -.
DR   ExpressionAtlas; Q7Z6Z7; baseline and differential.
DR   Genevisible; Q7Z6Z7; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0006284; P:base-excision repair; IMP:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0016574; P:histone ubiquitination; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; HMP:ParkinsonsUK-UCL.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   CDD; cd00078; HECTc; 1.
DR   Gene3D; 3.30.720.50; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR025527; DUF4414.
DR   InterPro; IPR010309; E3_Ub_ligase_DUF908.
DR   InterPro; IPR010314; E3_Ub_ligase_DUF913.
DR   InterPro; IPR000569; HECT_dom.
DR   InterPro; IPR035983; Hect_E3_ubiquitin_ligase.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like_sf.
DR   InterPro; IPR004170; WWE-dom.
DR   InterPro; IPR037197; WWE_dom_sf.
DR   Pfam; PF14377; DUF4414; 1.
DR   Pfam; PF06012; DUF908; 1.
DR   Pfam; PF06025; DUF913; 1.
DR   Pfam; PF00632; HECT; 1.
DR   Pfam; PF00627; UBA; 1.
DR   Pfam; PF02825; WWE; 1.
DR   SMART; SM00119; HECTc; 1.
DR   SMART; SM00165; UBA; 1.
DR   SUPFAM; SSF117839; SSF117839; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF48371; SSF48371; 3.
DR   SUPFAM; SSF56204; SSF56204; 1.
DR   PROSITE; PS50237; HECT; 1.
DR   PROSITE; PS50030; UBA; 1.
DR   PROSITE; PS50918; WWE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm;
KW   Differentiation; Disease mutation; DNA damage; DNA repair;
KW   DNA-binding; Mental retardation; Methylation; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase;
KW   Ubl conjugation pathway.
FT   CHAIN         1   4374       E3 ubiquitin-protein ligase HUWE1.
FT                                /FTId=PRO_0000120340.
FT   DOMAIN     1316   1355       UBA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00212}.
FT   DOMAIN     1370   1389       UIM. {ECO:0000305}.
FT   DOMAIN     1603   1680       WWE. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00248}.
FT   DOMAIN     4038   4374       HECT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00104}.
FT   COMPBIAS   2295   2469       Glu-rich.
FT   COMPBIAS   2427   2490       Asp-rich.
FT   COMPBIAS   3483   3550       Thr-rich.
FT   ACT_SITE   4341   4341       Glycyl thioester intermediate.
FT   MOD_RES     648    648       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7TMY8}.
FT   MOD_RES     649    649       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7TMY8}.
FT   MOD_RES     740    740       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1084   1084       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1368   1368       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1370   1370       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES    1382   1382       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1395   1395       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1722   1722       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1907   1907       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2035   2035       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2266   2266       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2267   2267       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q7TMY8}.
FT   MOD_RES    2362   2362       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2365   2365       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2391   2391       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES    2527   2527       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2532   2532       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2535   2535       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2554   2554       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2584   2584       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2595   2595       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2619   2619       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES    2751   2751       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES    2826   2826       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2833   2833       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2835   2835       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2861   2861       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2887   2887       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2888   2888       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2889   2889       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2918   2918       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243}.
FT   MOD_RES    3116   3116       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3117   3117       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3122   3122       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3127   3127       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3135   3135       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3149   3149       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q7TMY8}.
FT   MOD_RES    3555   3555       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3662   3662       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3752   3752       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3757   3757       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    3759   3759       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    3760   3760       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3808   3808       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3816   3816       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    3827   3827       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    3830   3830       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3906   3906       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    3919   3919       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    3924   3924       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    3927   3927       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    4271   4271       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P51593}.
FT   VAR_SEQ     982    990       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_015272.
FT   VAR_SEQ    3016   3031       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9205841}.
FT                                /FTId=VSP_011146.
FT   VARIANT     483    483       N -> S (in dbSNP:rs41307640).
FT                                /FTId=VAR_061986.
FT   VARIANT     950    950       V -> D (found in patients with autism
FT                                spectrum disorders; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23092983}.
FT                                /FTId=VAR_076253.
FT   VARIANT    2981   2981       R -> H (in MRXST; dbSNP:rs121918526).
FT                                {ECO:0000269|PubMed:18252223}.
FT                                /FTId=VAR_045670.
FT   VARIANT    4013   4013       R -> W (in MRXST; dbSNP:rs121918525).
FT                                {ECO:0000269|PubMed:18252223}.
FT                                /FTId=VAR_045671.
FT   VARIANT    4187   4187       R -> C (in MRXST; dbSNP:rs121918527).
FT                                {ECO:0000269|PubMed:18252223}.
FT                                /FTId=VAR_045672.
FT   MUTAGEN    4268   4268       Y->S: Loss of activity.
FT                                {ECO:0000269|PubMed:15567145}.
FT   MUTAGEN    4341   4341       C->A,D: Loss of activity.
FT                                {ECO:0000269|PubMed:15567145,
FT                                ECO:0000269|PubMed:15989956,
FT                                ECO:0000269|PubMed:15989957,
FT                                ECO:0000269|PubMed:18488021}.
FT   CONFLICT   1111   1111       K -> N (in Ref. 5; BAC06833).
FT                                {ECO:0000305}.
FT   CONFLICT   1124   1124       P -> L (in Ref. 1; AAV90838 and 5;
FT                                BAC06833). {ECO:0000305}.
FT   CONFLICT   1190   1190       D -> H (in Ref. 5; BAC06833).
FT                                {ECO:0000305}.
FT   CONFLICT   1962   1962       Missing (in Ref. 6; BAA20771).
FT                                {ECO:0000305}.
FT   CONFLICT   2525   2525       H -> Y (in Ref. 5; BAC06833 and 9;
FT                                AAF28950). {ECO:0000305}.
FT   CONFLICT   4022   4022       R -> L (in Ref. 10; AAH02602).
FT                                {ECO:0000305}.
FT   HELIX      1319   1329       {ECO:0000244|PDB:2EKK}.
FT   HELIX      1332   1341       {ECO:0000244|PDB:2EKK}.
FT   HELIX      1345   1353       {ECO:0000244|PDB:2EKK}.
FT   HELIX      1976   1991       {ECO:0000244|PDB:5C6H}.
FT   HELIX      2958   2960       {ECO:0000244|PDB:2MUL}.
FT   HELIX      2970   2975       {ECO:0000244|PDB:2MUL}.
FT   HELIX      2978   2988       {ECO:0000244|PDB:2MUL}.
FT   HELIX      3952   3972       {ECO:0000244|PDB:5LP8}.
FT   TURN       3977   3979       {ECO:0000244|PDB:5LP8}.
FT   HELIX      3983   3991       {ECO:0000244|PDB:5LP8}.
FT   HELIX      3994   4008       {ECO:0000244|PDB:3H1D}.
FT   TURN       4009   4011       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4016   4021       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4023   4025       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4026   4034       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4041   4043       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4044   4050       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4061   4072       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4076   4078       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4080   4083       {ECO:0000244|PDB:3H1D}.
FT   TURN       4085   4087       {ECO:0000244|PDB:3G1N}.
FT   STRAND     4088   4093       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4095   4099       {ECO:0000244|PDB:3G1N}.
FT   HELIX      4103   4120       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4130   4137       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4143   4145       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4146   4149       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4151   4162       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4165   4167       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4168   4170       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4172   4175       {ECO:0000244|PDB:3H1D}.
FT   TURN       4176   4178       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4181   4183       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4186   4189       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4193   4197       {ECO:0000244|PDB:3H1D}.
FT   TURN       4200   4202       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4203   4215       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4217   4219       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4220   4233       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4236   4239       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4244   4252       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4259   4264       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4266   4271       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4276   4287       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4290   4301       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4302   4304       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4311   4313       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4317   4320       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4323   4328       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4337   4339       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4340   4342       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4344   4348       {ECO:0000244|PDB:3H1D}.
FT   HELIX      4353   4365       {ECO:0000244|PDB:3H1D}.
FT   STRAND     4370   4372       {ECO:0000244|PDB:5LP8}.
SQ   SEQUENCE   4374 AA;  481891 MW;  FA9D3A7712F6393B CRC64;
     MKVDRTKLKK TPTEAPADCR ALIDKLKVCN DEQLLLELQQ IKTWNIGKCE LYHWVDLLDR
     FDGILADAGQ TVENMSWMLV CDRPEREQLK MLLLAVLNFT ALLIEYSFSR HLYSSIEHLT
     TLLASSDMQV VLAVLNLLYV FSKRSNYITR LGSDKRTPLL TRLQHLAESW GGKENGFGLA
     ECCRDLHMMK YPPSATTLHF EFYADPGAEV KIEKRTTSNT LHYIHIEQLD KISESPSEIM
     ESLTKMYSIP KDKQMLLFTH IRLAHGFSNH RKRLQAVQAR LHAISILVYS NALQESANSI
     LYNGLIEELV DVLQITDKQL MEIKAASLRT LTSIVHLERT PKLSSIIDCT GTASYHGFLP
     VLVRNCIQAM IDPSMDPYPH QFATALFSFL YHLASYDAGG EALVSCGMME ALLKVIKFLG
     DEQDQITFVT RAVRVVDLIT NLDMAAFQSH SGLSIFIYRL EHEVDLCRKE CPFVIKPKIQ
     RPNTTQEGEE METDMDGVQC IPQRAALLKS MLNFLKKAIQ DPAFSDGIRH VMDGSLPTSL
     KHIISNAEYY GPSLFLLATE VVTVFVFQEP SLLSSLQDNG LTDVMLHALL IKDVPATREV
     LGSLPNVFSA LCLNARGLQS FVQCQPFERL FKVLLSPDYL PAMRRRRSSD PLGDTASNLG
     SAVDELMRHQ PTLKTDATTA IIKLLEEICN LGRDPKYICQ KPSIQKADGT ATAPPPRSNH
     AAEEASSEDE EEEEVQAMQS FNSTQQNETE PNQQVVGTEE RIPIPLMDYI LNVMKFVESI
     LSNNTTDDHC QEFVNQKGLL PLVTILGLPN LPIDFPTSAA CQAVAGVCKS ILTLSHEPKV
     LQEGLLQLDS ILSSLEPLHR PIESPGGSVL LRELACAGNV ADATLSAQAT PLLHALTAAH
     AYIMMFVHTC RVGQSEIRSI SVNQWGSQLG LSVLSKLSQL YCSLVWESTV LLSLCTPNSL
     PSGCEFGQAD MQKLVPKDEK AGTTQGGKRS DGEQDGAAGS MDASTQGLLE GIGLDGDTLA
     PMETDEPTAS DSKGKSKITP AMAARIKQIK PLLSASSRLG RALAELFGLL VKLCVGSPVR
     QRRSHHAAST TTAPTPAARS TASALTKLLT KGLSWQPPPY TPTPRFRLTF FICSVGFTSP
     MLFDERKYPY HLMLQKFLCS GGHNALFETF NWALSMGGKV PVSEGLEHSD LPDGTGEFLD
     AWLMLVEKMV NPTTVLESPH SLPAKLPGGV QNFPQFSALR FLVVTQKAAF TCIKNLWNRK
     PLKVYGGRMA ESMLAILCHI LRGEPVIRER LSKEKEGSRG EEDTGQEEGG SRREPQVNQQ
     QLQQLMDMGF TREHAMEALL NTSTMEQATE YLLTHPPPIM GGVVRDLSMS EEDQMMRAIA
     MSLGQDIPMD QRAESPEEVA CRKEEEERKA REKQEEEEAK CLEKFQDADP LEQDELHTFT
     DTMLPGCFHL LDELPDTVYR VCDLIMTAIK RNGADYRDMI LKQVVNQVWE AADVLIKAAL
     PLTTSDTKTV SEWISQMATL PQASNLATRI LLLTLLFEEL KLPCAWVVES SGILNVLIKL
     LEVVQPCLQA AKEQKEVQTP KWITPVLLLI DFYEKTAISS KRRAQMTKYL QSNSNNWRWF
     DDRSGRWCSY SASNNSTIDS AWKSGETSVR FTAGRRRYTV QFTTMVQVNE ETGNRRPVML
     TLLRVPRLNK NSKNSNGQEL EKTLEESKEM DIKRKENKGN DTPLALESTN TEKETSLEET
     KIGEILIQGL TEDMVTVLIR ACVSMLGVPV DPDTLHATLR LCLRLTRDHK YAMMFAELKS
     TRMILNLTQS SGFNGFTPLV TLLLRHIIED PCTLRHTMEK VVRSAATSGA GSTTSGVVSG
     SLGSREINYI LRVLGPAACR NPDIFTEVAN CCIRIALPAP RGSGTASDDE FENLRIKGPN
     AVQLVKTTPL KPSPLPVIPD TIKEVIYDML NALAAYHAPE EADKSDPKPG VMTQEVGQLL
     QDMGDDVYQQ YRSLTRQSSD FDTQSGFSIN SQVFAADGAS TETSASGTSQ GEASTPEESR
     DGKKDKEGDR ASEEGKQKGK GSKPLMPTST ILRLLAELVR SYVGIATLIA NYSYTVGQSE
     LIKEDCSVLA FVLDHLLPHT QNAEDKDTPA LARLFLASLA AAGSGTDAQV ALVNEVKAAL
     GRALAMAEST EKHARLQAVM CIISTIMESC PSTSSFYSSA TAKTQHNGMN NIIRLFLKKG
     LVNDLARVPH SLDLSSPNMA NTVNAALKPL ETLSRIVNQP SSLFGSKSAS SKNKSEQDAQ
     GASQDSSSNQ QDPGEPGEAE VQEEDHDVTQ TEVADGDIMD GEAETDSVVI AGQPEVLSSQ
     EMQVENELED LIDELLERDG GSGNSTIIVS RSGEDESQED VLMDEAPSNL SQASTLQANR
     EDSMNILDPE DEEEHTQEED SSGSNEDEDD SQDEEEEEEE DEEDDQEDDE GEEGDEDDDD
     DGSEMELDED YPDMNASPLV RFERFDREDD LIIEFDNMFS SATDIPPSPG NIPTTHPLMV
     RHADHSSLTL GSGSSTTRLT QGIGRSQRTL RQLTANTGHT IHVHYPGNRQ PNPPLILQRL
     LGPSAAADIL QLSSSLPLQS RGRARLLVGN DDVHIIARSD DELLDDFFHD QSTATSQAGT
     LSSIPTALTR WTEECKVLDA ESMHDCVSVV KVSIVNHLEF LRDEELEERR EKRRKQLAEE
     ETKITDKGKE DKENRDQSAQ CTASKSNDST EQNLSDGTPM PDSYPTTPSS TDAATSESKE
     TLGTLQSSQQ QPTLPTPPAL GEVPQELQSP AGEGGSSTQL LMPVEPEELG PTRPSGEAET
     TQMELSPAPT ITSLSPERAE DSDALTAVSS QLEGSPMDTS SLASCTLEEA VGDTSAAGSS
     EQPRAGSSTP GDAPPAVAEV QGRSDGSGES AQPPEDSSPP ASSESSSTRD SAVAISGADS
     RGILEEPLPS TSSEEEDPLA GISLPEGVDP SFLAALPDDI RREVLQNQLG IRPPTRTAPS
     TNSSAPAVVG NPGVTEVSPE FLAALPPAIQ EEVLAQQRAE QQRRELAQNA SSDTPMDPVT
     FIQTLPSDLR RSVLEDMEDS VLAVMPPDIA AEAQALRREQ EARQRQLMHE RLFGHSSTSA
     LSAILRSPAF TSRLSGNRGV QYTRLAVQRG GTFQMGGSSS HNRPSGSNVD TLLRLRGRLL
     LDHEALSCLL VLLFVDEPKL NTSRLHRVLR NLCYHAQTRH WVIRSLLSIL QRSSESELCI
     ETPKLTTSEE KGKKSSKSCG SSSHENRPLD LLHKMESKSS NQLSWLSVSM DAALGCRTNI
     FQIQRSGGRK HTEKHASGGS TVHIHPQAAP VVCRHVLDTL IQLAKVFPSH FTQQRTKETN
     CESDRERGNK ACSPCSSQSS SSGICTDFWD LLVKLDNMNV SRKGKNSVKS VPVSAGGEGE
     TSPYSLEASP LGQLMNMLSH PVIRRSSLLT EKLLRLLSLI SIALPENKVS EAQANSGSGA
     SSTTTATSTT STTTTTAAST TPTPPTAPTP VTSAPALVAA TAISTIVVAA STTVTTPTTA
     TTTVSISPTT KGSKSPAKVS DGGSSSTDFK MVSSGLTENQ LQLSVEVLTS HSCSEEGLED
     AANVLLQLSR GDSGTRDTVL KLLLNGARHL GYTLCKQIGT LLAELREYNL EQQRRAQCET
     LSPDGLPEEQ PQTTKLKGKM QSRFDMAENV VIVASQKRPL GGRELQLPSM SMLTSKTSTQ
     KFFLRVLQVI IQLRDDTRRA NKKAKQTGRL GSSGLGSASS IQAAVRQLEA EADAIIQMVR
     EGQRARRQQQ AATSESSQSE ASVRREESPM DVDQPSPSAQ DTQSIASDGT PQGEKEKEER
     PPELPLLSEQ LSLDELWDML GECLKELEES HDQHAVLVLQ PAVEAFFLVH ATERESKPPV
     RDTRESQLAH IKDEPPPLSP APLTPATPSS LDPFFSREPS SMHISSSLPP DTQKFLRFAE
     THRTVLNQIL RQSTTHLADG PFAVLVDYIR VLDFDVKRKY FRQELERLDE GLRKEDMAVH
     VRRDHVFEDS YRELHRKSPE EMKNRLYIVF EGEEGQDAGG LLREWYMIIS REMFNPMYAL
     FRTSPGDRVT YTINPSSHCN PNHLSYFKFV GRIVAKAVYD NRLLECYFTR SFYKHILGKS
     VRYTDMESED YHFYQGLVYL LENDVSTLGY DLTFSTEVQE FGVCEVRDLK PNGANILVTE
     ENKKEYVHLV CQMRMTGAIR KQLAAFLEGF YEIIPKRLIS IFTEQELELL ISGLPTIDID
     DLKSNTEYHK YQSNSIQIQW FWRALRSFDQ ADRAKFLQFV TGTSKVPLQG FAALEGMNGI
     QKFQIHRDDR STDRLPSAHT CFNQLDLPAY ESFEKLRHML LLAIQECSEG FGLA
//
ID   B4DQ07_HUMAN            Unreviewed;       285 AA.
AC   B4DQ07;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   07-JUN-2017, entry version 41.
DE   SubName: Full=cDNA FLJ54075, highly similar to Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) {ECO:0000313|EMBL:BAG60769.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG60769.1};
RN   [1] {ECO:0000313|EMBL:BAG60769.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK298577; BAG60769.1; -; mRNA.
DR   RefSeq; NP_001158226.1; NM_001164754.1.
DR   UniGene; Hs.332422; -.
DR   MaxQB; B4DQ07; -.
DR   PeptideAtlas; B4DQ07; -.
DR   PRIDE; B4DQ07; -.
DR   DNASU; 444; -.
DR   GeneID; 444; -.
DR   CTD; 444; -.
DR   PharmGKB; PA25056; -.
DR   HOVERGEN; HBG062244; -.
DR   GenomeRNAi; 444; -.
DR   Genevisible; B4DQ07; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR007943; Asp-B-hydro/Triadin_dom.
DR   Pfam; PF05279; Asp-B-Hydro_N; 2.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     45     66       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       34    211       Asp-B-Hydro_N.
FT                                {ECO:0000259|Pfam:PF05279}.
FT   DOMAIN      208    282       Asp-B-Hydro_N.
FT                                {ECO:0000259|Pfam:PF05279}.
SQ   SEQUENCE   285 AA;  31759 MW;  740E04134899A7B2 CRC64;
     MAQRKNAKSS GNSSSSSSSS PGARRETKHG GHENGRKGGL SGTSFFTWFM VIALLGVWTS
     VAVVWFDLVD YEEVLGKLGI YDADGDGDFD VDDAKVLLGL KERSTSEPAV PPEEAEPHTE
     PEEQVPVEAE PQNIEDEAKE QIQSLLHEMV HAEHVEGEDL QQEDGPTGEP QQEDDEFLMA
     TDVDDRFETL EPEVSHEETE HSYHVEETDS SEPVVEDERL HHDTDDVTYQ VYEEQAVYEP
     LENEGIEITE VTAPPEDNPV EDSQVIVEEV SIFPVEEQQE VPPDT
//
ID   B7ZM96_HUMAN            Unreviewed;       279 AA.
AC   B7ZM96;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 49.
DE   SubName: Full=ASPH protein {ECO:0000313|EMBL:AAI44364.1};
GN   Name=ASPH {ECO:0000313|EMBL:AAI44364.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI44364.1};
RN   [1] {ECO:0000313|EMBL:AAI44364.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAI44364.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC144363; AAI44364.1; -; mRNA.
DR   RefSeq; NP_001158224.1; NM_001164752.1.
DR   UniGene; Hs.332422; -.
DR   ProteinModelPortal; B7ZM96; -.
DR   MaxQB; B7ZM96; -.
DR   PeptideAtlas; B7ZM96; -.
DR   DNASU; 444; -.
DR   GeneID; 444; -.
DR   CTD; 444; -.
DR   PharmGKB; PA25056; -.
DR   HOVERGEN; HBG062244; -.
DR   ChiTaRS; ASPH; human.
DR   GenomeRNAi; 444; -.
DR   Genevisible; B7ZM96; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR007943; Asp-B-hydro/Triadin_dom.
DR   Pfam; PF05279; Asp-B-Hydro_N; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     25     49       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       14    276       Asp-B-Hydro_N.
FT                                {ECO:0000259|Pfam:PF05279}.
SQ   SEQUENCE   279 AA;  31518 MW;  966814F02AAE2186 CRC64;
     MAEDKETKHG GHKNGRKGGL SGTSFFTWFM VIALLGVWTS VAVVWFDLVD YEEVLAKAKD
     FRYNLSEVLQ GKLGIYDADG DGDFDVDDAK VLLGLKERST SEPAVPPEEA EPHTEPEEQV
     PVEAEPQNIE DEAKEQIQSL LHEMVHAEHV EGEDLQQEDG PTGEPQQEDD EFLMATDVDD
     RFETLEPEVS HEETEHSYHV EETDSSEPVV EDERLHHDTD DVTYQVYEEQ VYEPLENEGI
     EITEVTAPPE DNPVEDSQVI VEEVSIFPVE EQQEVPPDT
//
ID   ASPH_HUMAN              Reviewed;         758 AA.
AC   Q12797; A0A0A0MSK8; A6NDF4; A6NHI2; B4DIC9; B4E2K4; B7ZM95; E5RGP5;
AC   F5H667; Q6NXR7; Q8TB28; Q9H291; Q9H2C4; Q9NRI0; Q9NRI1; Q9Y4J0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 3.
DT   23-MAY-2018, entry version 182.
DE   RecName: Full=Aspartyl/asparaginyl beta-hydroxylase;
DE            EC=1.14.11.16 {ECO:0000269|PubMed:11773073};
DE   AltName: Full=Aspartate beta-hydroxylase;
DE            Short=ASP beta-hydroxylase;
DE   AltName: Full=Peptide-aspartate beta-dioxygenase;
GN   Name=ASPH; Synonyms=BAH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7821814; DOI=10.1016/0378-1119(94)90460-X;
RA   Korioth F., Gieffers C., Frey J.;
RT   "Cloning and characterization of the human gene encoding aspartyl
RT   beta-hydroxylase.";
RL   Gene 150:395-399(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8823296; DOI=10.1172/JCI118918;
RA   Lavaissiere L., Jia S., Nishiyama M., de la Monte S., Stern A.M.,
RA   Wands J.R., Friedman P.A.;
RT   "Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in
RT   hepatocellular carcinoma and cholangiocarcinoma.";
RL   J. Clin. Invest. 98:1313-1323(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Heart;
RX   PubMed=10974562; DOI=10.1016/S0378-1119(00)00299-7;
RA   Lim K.Y., Hong C.-S., Kim D.H.;
RT   "cDNA cloning and characterization of human cardiac junctin.";
RL   Gene 255:35-42(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=10956665; DOI=10.1074/jbc.M006753200;
RA   Dinchuk J.E., Henderson N.L., Burn T.C., Huber R., Ho S.P., Link J.,
RA   O'Neil K.T., Focht R.J., Scully M.S., Hollis J.M., Hollis G.F.,
RA   Friedman P.A.;
RT   "Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved
RT   isoform of Asph missing the catalytic domain share exons with
RT   junctin.";
RL   J. Biol. Chem. 275:39543-39554(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8), CALCIUM-BINDING, ALTERNATIVE
RP   SPLICING, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Muscle;
RX   PubMed=11007777; DOI=10.1074/jbc.M005473200;
RA   Treves S., Feriotto G., Moccagatta L., Gambari R., Zorzato F.;
RT   "Molecular cloning, expression, functional characterization,
RT   chromosomal localization, and gene structure of junctate, a novel
RT   integral calcium binding protein of sarco(endo)plasmic reticulum
RT   membrane.";
RL   J. Biol. Chem. 275:39555-39568(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Heart;
RX   PubMed=10767180; DOI=10.1006/mgme.2000.2966;
RA   Wetzel G.T., Ding S., Chen F.;
RT   "Molecular cloning of junctin from human and developing rabbit
RT   heart.";
RL   Mol. Genet. Metab. 69:252-258(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 9 AND 10).
RC   TISSUE=Hippocampus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5; 6 AND 7).
RC   TISSUE=Brain, and Pancreatic carcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   FUNCTION, CALCIUM-BINDING DOMAIN, INTERACTION WITH ORAI1 AND STIM1
RP   (ISOFORM 8), MUTAGENESIS OF 91-ASP--ASP-93, AND SUBCELLULAR LOCATION.
RX   PubMed=22586105; DOI=10.1073/pnas.1200667109;
RA   Srikanth S., Jew M., Kim K.D., Yee M.K., Abramson J., Gwack Y.;
RT   "Junctate is a Ca2+-sensing structural component of Orai1 and stromal
RT   interaction molecule 1 (STIM1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:8682-8687(2012).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-452, AND GLYCOSYLATION
RP   [LARGE SCALE ANALYSIS] AT ASN-64 (ISOFORM 3).
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   INTERACTION WITH CASQ2 (ISOFORM 4), AND SUBCELLULAR LOCATION.
RX   PubMed=15485681; DOI=10.1016/j.cardiores.2004.09.009;
RA   Houle T.D., Ram M.L., Cala S.E.;
RT   "Calsequestrin mutant D307H exhibits depressed binding to its protein
RT   targets and a depressed response to calcium.";
RL   Cardiovasc. Res. 64:227-233(2004).
RN   [16]
RP   FUNCTION (ISOFORM 1), AND CATALYTIC ACTIVITY.
RX   PubMed=11773073; DOI=10.1074/jbc.M110389200;
RA   Dinchuk J.E., Focht R.J., Kelley J.A., Henderson N.L.,
RA   Zolotarjova N.I., Wynn R., Neff N.T., Link J., Huber R.M., Burn T.C.,
RA   Rupar M.J., Cunningham M.R., Selling B.H., Ma J., Stern A.A.,
RA   Hollis G.F., Stein R.B., Friedman P.A.;
RT   "Absence of post-translational aspartyl beta-hydroxylation of
RT   epidermal growth factor domains in mice leads to developmental defects
RT   and an increased incidence of intestinal neoplasia.";
RL   J. Biol. Chem. 277:12970-12977(2002).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 562-758 IN COMPLEX WITH
RP   N-OXALYOLGLYCINE AND ZINC IONS, AND DISULFIDE BOND.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human aspartate beta-hydroxylase isoform A.";
RL   Submitted (MAY-2011) to the PDB data bank.
RN   [19]
RP   INVOLVEMENT IN FDLAB, AND VARIANT FDLAB TRP-735.
RX   PubMed=24768550; DOI=10.1016/j.ajhg.2014.04.002;
RA   Patel N., Khan A.O., Mansour A., Mohamed J.Y., Al-Assiri A.,
RA   Haddad R., Jia X., Xiong Y., Megarbane A., Traboulsi E.I.,
RA   Alkuraya F.S.;
RT   "Mutations in ASPH cause facial dysmorphism, lens dislocation,
RT   anterior-segment abnormalities, and spontaneous filtering blebs, or
RT   Traboulsi syndrome.";
RL   Am. J. Hum. Genet. 94:755-759(2014).
CC   -!- FUNCTION: Isoform 1: specifically hydroxylates an Asp or Asn
CC       residue in certain epidermal growth factor-like (EGF) domains of a
CC       number of proteins. {ECO:0000269|PubMed:11773073}.
CC   -!- FUNCTION: Isoform 8: membrane-bound Ca(2+)-sensing protein, which
CC       is a structural component of the ER-plasma membrane junctions.
CC       Isoform 8 regulates the activity of Ca(+2) released-activated
CC       Ca(+2) (CRAC) channels in T-cells. {ECO:0000269|PubMed:22586105}.
CC   -!- CATALYTIC ACTIVITY: Peptide L-aspartate + 2-oxoglutarate + O(2) =
CC       peptide 3-hydroxy-L-aspartate + succinate + CO(2).
CC       {ECO:0000269|PubMed:11773073}.
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000250|UniProtKB:Q28056};
CC   -!- SUBUNIT: Monomer (By similarity). Isoform 8 interacts with ORAI1
CC       and STIM1. Isoform 4 interacts with CASQ2.
CC       {ECO:0000250|UniProtKB:Q28056, ECO:0000269|PubMed:15485681,
CC       ECO:0000269|PubMed:22586105}.
CC   -!- INTERACTION:
CC       O43681:ASNA1; NbExp=4; IntAct=EBI-12092171, EBI-2515857;
CC       P60022:DEFB1; NbExp=4; IntAct=EBI-12092171, EBI-7200390;
CC       Q8NFU4:FDCSP; NbExp=4; IntAct=EBI-12092171, EBI-12210457;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane;
CC       Single-pass type II membrane protein
CC       {ECO:0000250|UniProtKB:Q28056}.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Sarcoplasmic reticulum membrane;
CC       Single-pass type II membrane protein
CC       {ECO:0000305|PubMed:15485681}.
CC   -!- SUBCELLULAR LOCATION: Isoform 8: Endoplasmic reticulum membrane;
CC       Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:22586105}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=11;
CC         Comment=Comment: 3 functionally distinct proteins are produced
CC         by alternative splicing: Aspartyl/asparaginyl beta-hydroxylase,
CC         Junctin and Junctate. Additional isoforms are produced by
CC         alternative splicing. {ECO:0000269|PubMed:11007777};
CC       Name=1;
CC         IsoId=Q12797-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12797-2; Sequence=VSP_039169, VSP_039170;
CC       Name=3; Synonyms=Junctin-1, Cardiac junctin;
CC         IsoId=Q12797-3; Sequence=VSP_039165, VSP_039166, VSP_039167,
CC                                  VSP_039168;
CC         Note=Contains a N-linked (GlcNAc...) asparagine at position 64.;
CC       Name=4; Synonyms=Junctin-2, Junctin;
CC         IsoId=Q12797-4; Sequence=VSP_039165, VSP_039167, VSP_039168;
CC       Name=5;
CC         IsoId=Q12797-5; Sequence=VSP_039165, VSP_039166, VSP_044238,
CC                                  VSP_039169, VSP_039170;
CC       Name=10;
CC         IsoId=Q12797-10; Sequence=VSP_039165;
CC       Name=6;
CC         IsoId=Q12797-6; Sequence=VSP_044236, VSP_039169, VSP_039170;
CC       Name=7;
CC         IsoId=Q12797-7; Sequence=VSP_039166, VSP_044235, VSP_044237;
CC       Name=8; Synonyms=Junctate;
CC         IsoId=Q12797-8; Sequence=VSP_039165, VSP_039166, VSP_039169,
CC                                  VSP_039170;
CC       Name=9;
CC         IsoId=Q12797-9; Sequence=VSP_039165, VSP_039166, VSP_044236,
CC                                  VSP_039169, VSP_039170;
CC       Name=11;
CC         IsoId=Q12797-11; Sequence=VSP_059345, VSP_039169, VSP_039170;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is detected in all tissues tested.
CC       Isoform 8 is mainly expressed in pancreas, heart, brain, kidney
CC       and liver. Isoform 8 is expressed in kidney (at protein level).
CC       {ECO:0000269|PubMed:11007777}.
CC   -!- DISEASE: Facial dysmorphism, lens dislocation, anterior segment
CC       abnormalities, and spontaneous filtering blebs (FDLAB)
CC       [MIM:601552]: A syndrome characterized by dislocated crystalline
CC       lenses and anterior segment abnormalities in association with a
CC       distinctive facies involving flat cheeks and a beaked nose. Some
CC       affected individuals develop highly unusual non-traumatic
CC       conjunctival cysts (filtering blebs).
CC       {ECO:0000269|PubMed:24768550}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the aspartyl/asparaginyl beta-hydroxylase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03109; AAA82108.1; -; mRNA.
DR   EMBL; S83325; AAB50779.1; -; mRNA.
DR   EMBL; AF224468; AAF82246.1; -; mRNA.
DR   EMBL; AF224469; AAF82247.1; -; mRNA.
DR   EMBL; AF289489; AAG40811.1; -; mRNA.
DR   EMBL; AF306765; AAG42257.1; -; mRNA.
DR   EMBL; AF184241; AAG16983.1; -; mRNA.
DR   EMBL; AK295528; BAG58441.1; -; mRNA.
DR   EMBL; AK304314; BAG65166.1; -; mRNA.
DR   EMBL; AC067881; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090094; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471068; EAW86841.1; -; Genomic_DNA.
DR   EMBL; CH471068; EAW86840.1; -; Genomic_DNA.
DR   EMBL; CH471068; EAW86847.1; -; Genomic_DNA.
DR   EMBL; CH471068; EAW86848.1; -; Genomic_DNA.
DR   EMBL; CH471068; EAW86849.1; -; Genomic_DNA.
DR   EMBL; BC025236; AAH25236.1; -; mRNA.
DR   EMBL; BC066929; AAH66929.1; -; mRNA.
DR   EMBL; BC142967; AAI42968.1; -; mRNA.
DR   EMBL; BC144362; AAI44363.1; -; mRNA.
DR   CCDS; CCDS34898.1; -. [Q12797-1]
DR   CCDS; CCDS34899.1; -. [Q12797-4]
DR   CCDS; CCDS34900.1; -. [Q12797-3]
DR   CCDS; CCDS43742.1; -. [Q12797-2]
DR   CCDS; CCDS47866.1; -. [Q12797-8]
DR   CCDS; CCDS55234.1; -. [Q12797-10]
DR   CCDS; CCDS55235.1; -. [Q12797-9]
DR   CCDS; CCDS55236.1; -. [Q12797-5]
DR   CCDS; CCDS55237.1; -. [Q12797-6]
DR   CCDS; CCDS55238.1; -. [Q12797-7]
DR   CCDS; CCDS75746.1; -. [Q12797-11]
DR   PIR; I38423; I38423.
DR   RefSeq; NP_001158222.1; NM_001164750.1. [Q12797-10]
DR   RefSeq; NP_001158223.1; NM_001164751.1. [Q12797-5]
DR   RefSeq; NP_001158225.1; NM_001164753.1. [Q12797-9]
DR   RefSeq; NP_001158227.1; NM_001164755.1. [Q12797-6]
DR   RefSeq; NP_001158228.1; NM_001164756.1. [Q12797-7]
DR   RefSeq; NP_004309.2; NM_004318.3. [Q12797-1]
DR   RefSeq; NP_064549.1; NM_020164.4. [Q12797-3]
DR   RefSeq; NP_115855.1; NM_032466.3. [Q12797-2]
DR   RefSeq; NP_115856.1; NM_032467.3. [Q12797-4]
DR   RefSeq; NP_115857.1; NM_032468.4. [Q12797-8]
DR   UniGene; Hs.332422; -.
DR   PDB; 5APA; X-ray; 2.05 A; A=562-758.
DR   PDB; 5JQY; X-ray; 1.99 A; A=330-758.
DR   PDB; 5JTC; X-ray; 2.24 A; A=330-758.
DR   PDB; 5JZ6; X-ray; 2.35 A; A=330-758.
DR   PDB; 5JZ8; X-ray; 2.10 A; A=330-758.
DR   PDB; 5JZA; X-ray; 2.14 A; A=330-758.
DR   PDB; 5JZU; X-ray; 2.50 A; A=330-758.
DR   PDB; 5JZZ; X-ray; 2.29 A; A/C=330-758.
DR   PDBsum; 5APA; -.
DR   PDBsum; 5JQY; -.
DR   PDBsum; 5JTC; -.
DR   PDBsum; 5JZ6; -.
DR   PDBsum; 5JZ8; -.
DR   PDBsum; 5JZA; -.
DR   PDBsum; 5JZU; -.
DR   PDBsum; 5JZZ; -.
DR   ProteinModelPortal; Q12797; -.
DR   SMR; Q12797; -.
DR   BioGrid; 106936; 44.
DR   IntAct; Q12797; 48.
DR   MINT; Q12797; -.
DR   STRING; 9606.ENSP00000368767; -.
DR   DrugBank; DB00128; L-Aspartic Acid.
DR   DrugBank; DB00139; Succinic acid.
DR   TCDB; 8.A.28.1.5; the ankyrin (ankyrin) family.
DR   iPTMnet; Q12797; -.
DR   PhosphoSitePlus; Q12797; -.
DR   SwissPalm; Q12797; -.
DR   BioMuta; ASPH; -.
DR   DMDM; 145559444; -.
DR   EPD; Q12797; -.
DR   MaxQB; Q12797; -.
DR   PaxDb; Q12797; -.
DR   PeptideAtlas; Q12797; -.
DR   PRIDE; Q12797; -.
DR   TopDownProteomics; Q12797-1; -. [Q12797-1]
DR   TopDownProteomics; Q12797-2; -. [Q12797-2]
DR   DNASU; 444; -.
DR   Ensembl; ENST00000356457; ENSP00000348841; ENSG00000198363. [Q12797-2]
DR   Ensembl; ENST00000379449; ENSP00000368762; ENSG00000198363. [Q12797-7]
DR   Ensembl; ENST00000379454; ENSP00000368767; ENSG00000198363. [Q12797-1]
DR   Ensembl; ENST00000389204; ENSP00000373856; ENSG00000198363. [Q12797-3]
DR   Ensembl; ENST00000445642; ENSP00000394013; ENSG00000198363. [Q12797-11]
DR   Ensembl; ENST00000517847; ENSP00000429954; ENSG00000198363. [Q12797-8]
DR   Ensembl; ENST00000517903; ENSP00000430245; ENSG00000198363. [Q12797-5]
DR   Ensembl; ENST00000518068; ENSP00000429286; ENSG00000198363. [Q12797-6]
DR   Ensembl; ENST00000522603; ENSP00000436188; ENSG00000198363. [Q12797-4]
DR   Ensembl; ENST00000522835; ENSP00000429160; ENSG00000198363. [Q12797-9]
DR   Ensembl; ENST00000541428; ENSP00000437864; ENSG00000198363. [Q12797-10]
DR   GeneID; 444; -.
DR   KEGG; hsa:444; -.
DR   UCSC; uc003xuj.4; human. [Q12797-1]
DR   CTD; 444; -.
DR   DisGeNET; 444; -.
DR   EuPathDB; HostDB:ENSG00000198363.15; -.
DR   GeneCards; ASPH; -.
DR   HGNC; HGNC:757; ASPH.
DR   HPA; HPA055161; -.
DR   HPA; HPA059303; -.
DR   MalaCards; ASPH; -.
DR   MIM; 600582; gene.
DR   MIM; 601552; phenotype.
DR   neXtProt; NX_Q12797; -.
DR   OpenTargets; ENSG00000198363; -.
DR   PharmGKB; PA25056; -.
DR   eggNOG; KOG3696; Eukaryota.
DR   eggNOG; COG3555; LUCA.
DR   GeneTree; ENSGT00530000063281; -.
DR   HOGENOM; HOG000231622; -.
DR   HOVERGEN; HBG004290; -.
DR   InParanoid; Q12797; -.
DR   KO; K00476; -.
DR   OMA; RNENACK; -.
DR   OrthoDB; EOG091G0H5R; -.
DR   PhylomeDB; Q12797; -.
DR   TreeFam; TF312799; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   ChiTaRS; ASPH; human.
DR   EvolutionaryTrace; Q12797; -.
DR   GeneWiki; ASPH; -.
DR   GenomeRNAi; 444; -.
DR   PRO; PR:Q12797; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000198363; -.
DR   CleanEx; HS_ASPH; -.
DR   ExpressionAtlas; Q12797; baseline and differential.
DR   Genevisible; Q12797; HS.
DR   GO; GO:0034704; C:calcium channel complex; TAS:BHF-UCL.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0032541; C:cortical endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0014701; C:junctional sarcoplasmic reticulum membrane; TAS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0033018; C:sarcoplasmic reticulum lumen; TAS:BHF-UCL.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; TAS:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0009055; F:electron transfer activity; TAS:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; TAS:BHF-UCL.
DR   GO; GO:0004597; F:peptide-aspartate beta-dioxygenase activity; TAS:ProtInc.
DR   GO; GO:0008307; F:structural constituent of muscle; TAS:ProtInc.
DR   GO; GO:0005198; F:structural molecule activity; TAS:ProtInc.
DR   GO; GO:0097202; P:activation of cysteine-type endopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:0032237; P:activation of store-operated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0005513; P:detection of calcium ion; TAS:BHF-UCL.
DR   GO; GO:0060325; P:face morphogenesis; IEA:Ensembl.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0035108; P:limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0007389; P:pattern specification process; IEA:Ensembl.
DR   GO; GO:0042264; P:peptidyl-aspartic acid hydroxylation; IEA:Ensembl.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; IDA:UniProtKB.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; IDA:UniProtKB.
DR   GO; GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL.
DR   GO; GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; ISS:BHF-UCL.
DR   GO; GO:0010649; P:regulation of cell communication by electrical coupling; TAS:BHF-UCL.
DR   GO; GO:0031585; P:regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IDA:UniProtKB.
DR   GO; GO:1901879; P:regulation of protein depolymerization; IEA:Ensembl.
DR   GO; GO:0031647; P:regulation of protein stability; IEA:Ensembl.
DR   GO; GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; TAS:BHF-UCL.
DR   GO; GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL.
DR   GO; GO:0033198; P:response to ATP; IDA:UniProtKB.
DR   GO; GO:0060021; P:roof of mouth development; IEA:Ensembl.
DR   Gene3D; 1.25.40.10; -; 1.
DR   Gene3D; 2.60.120.330; -; 1.
DR   InterPro; IPR007943; Asp-B-hydro/Triadin_dom.
DR   InterPro; IPR007803; Asp/Arg/Pro-Hydrxlase.
DR   InterPro; IPR027443; IPNS-like.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   Pfam; PF05279; Asp-B-Hydro_N; 1.
DR   Pfam; PF05118; Asp_Arg_Hydrox; 1.
DR   SMART; SM00028; TPR; 2.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   PROSITE; PS50005; TPR; 2.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Complete proteome;
KW   Dioxygenase; Disease mutation; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Iron; Membrane; Metal-binding; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Sarcoplasmic reticulum; Signal-anchor; TPR repeat; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    758       Aspartyl/asparaginyl beta-hydroxylase.
FT                                /FTId=PRO_0000064706.
FT   TOPO_DOM      1     53       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     54     74       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     75    758       Lumenal. {ECO:0000255}.
FT   REPEAT      341    374       TPR 1.
FT   REPEAT      454    487       TPR 2.
FT   REPEAT      489    521       TPR 3.
FT   REPEAT      525    557       TPR 4.
FT   CA_BIND      90    102       {ECO:0000305|PubMed:22586105}.
FT   REGION      688    690       2-oxoglutarate binding.
FT                                {ECO:0000269|Ref.18}.
FT   COMPBIAS      9     29       Ser-rich.
FT   COMPBIAS    111    312       Glu-rich.
FT   COMPBIAS    323    332       Poly-Lys.
FT   METAL       679    679       Iron. {ECO:0000305}.
FT   METAL       725    725       Iron. {ECO:0000305}.
FT   BINDING     625    625       2-oxoglutarate. {ECO:0000269|Ref.18}.
FT   BINDING     668    668       2-oxoglutarate. {ECO:0000269|Ref.18}.
FT   BINDING     735    735       2-oxoglutarate. {ECO:0000269|Ref.18}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    452    452       N-linked (GlcNAc...) asparagine.
FT   CARBOHYD    706    706       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    641    648       {ECO:0000269|Ref.18}.
FT   VAR_SEQ       1     34       MAQRKNAKSSGNSSSSGSGSGSTSAGSSSPGARR -> MAE
FT                                DK (in isoform 3, isoform 4, isoform 5,
FT                                isoform 8, isoform 9 and isoform 10).
FT                                {ECO:0000303|PubMed:10767180,
FT                                ECO:0000303|PubMed:10974562,
FT                                ECO:0000303|PubMed:11007777,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039165.
FT   VAR_SEQ      84     84       L -> LAKAKDFRYNLSEVLQ (in isoform 3,
FT                                isoform 5, isoform 7, isoform 8 and
FT                                isoform 9). {ECO:0000303|PubMed:10767180,
FT                                ECO:0000303|PubMed:10974562,
FT                                ECO:0000303|PubMed:11007777,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039166.
FT   VAR_SEQ     108    239       GLKERSTSEPAVPPEEAEPHTEPEEQVPVEAEPQNIEDEAK
FT                                EQIQSLLHEMVHAEHVEGEDLQQEDGPTGEPQQEDDEFLMA
FT                                TDVDDRFETLEPEVSHEETEHSYHVEETVSQDCNQDMEEMM
FT                                SEQENPDSS -> EGPSGVAKRKTKAKVKELTKEELKKEKE
FT                                KPESRKESKNEERKKGKKEDVRKDKKIADADLSRKESPKGK
FT                                KDREKEKVDLEKSAKTKENRKKSTNMKDVSSKMASRDKDDR
FT                                KESRSSTRYAHLTKGNTQKRNG (in isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:10767180,
FT                                ECO:0000303|PubMed:10974562}.
FT                                /FTId=VSP_039167.
FT   VAR_SEQ     110    188       KERSTSEPAVPPEEAEPHTEPEEQVPVEAEPQNIEDEAKEQ
FT                                IQSLLHEMVHAEHVEGEDLQQEDGPTGEPQQEDDEFLM ->
FT                                TKDGSNENIDSLEEVLNILAEESSDWFYGFLSFLYDIMTPF
FT                                EMLEEEEEESETADGVDGTSQNEGVQGKTCVILDLHNQ
FT                                (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044235.
FT   VAR_SEQ     164    206       Missing (in isoform 6 and isoform 9).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044236.
FT   VAR_SEQ     189    758       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044237.
FT   VAR_SEQ     218    236       Missing (in isoform 11).
FT                                /FTId=VSP_059345.
FT   VAR_SEQ     240    758       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:10767180,
FT                                ECO:0000303|PubMed:10974562}.
FT                                /FTId=VSP_039168.
FT   VAR_SEQ     264    264       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044238.
FT   VAR_SEQ     312    313       ET -> DT (in isoform 2, isoform 5,
FT                                isoform 6, isoform 8, isoform 9 and
FT                                isoform 11).
FT                                {ECO:0000303|PubMed:10956665,
FT                                ECO:0000303|PubMed:11007777,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039169.
FT   VAR_SEQ     314    758       Missing (in isoform 2, isoform 5, isoform
FT                                6, isoform 8, isoform 9 and isoform 11).
FT                                {ECO:0000303|PubMed:10956665,
FT                                ECO:0000303|PubMed:11007777,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039170.
FT   VARIANT     354    354       R -> M (in dbSNP:rs6995412).
FT                                /FTId=VAR_053781.
FT   VARIANT     735    735       R -> W (in FDLAB; dbSNP:rs374385878).
FT                                {ECO:0000269|PubMed:24768550}.
FT                                /FTId=VAR_071821.
FT   MUTAGEN      91     93       DAD->AAA: Increase in cytoplasmic Ca(2+)
FT                                via activation of endogenous CRAC
FT                                channels. {ECO:0000269|PubMed:22586105}.
FT   CONFLICT    519    519       D -> N (in Ref. 7; BAG65166).
FT                                {ECO:0000305}.
FT   CONFLICT    565    565       Y -> I (in Ref. 1; AAA82108).
FT                                {ECO:0000305}.
FT   CONFLICT    575    577       WWT -> CG (in Ref. 1; AAA82108).
FT                                {ECO:0000305}.
FT   CONFLICT    585    585       E -> Q (in Ref. 1; AAA82108).
FT                                {ECO:0000305}.
FT   CONFLICT    599    599       D -> Y (in Ref. 7; BAG65166).
FT                                {ECO:0000305}.
FT   CONFLICT    709    709       K -> R (in Ref. 2; AAB50779).
FT                                {ECO:0000305}.
FT   CONFLICT    734    734       F -> L (in Ref. 7; BAG65166).
FT                                {ECO:0000305}.
FT   HELIX       336    339       {ECO:0000244|PDB:5JQY}.
FT   HELIX       342    353       {ECO:0000244|PDB:5JQY}.
FT   HELIX       357    370       {ECO:0000244|PDB:5JQY}.
FT   HELIX       375    392       {ECO:0000244|PDB:5JQY}.
FT   HELIX       395    410       {ECO:0000244|PDB:5JQY}.
FT   STRAND      411    413       {ECO:0000244|PDB:5JZ8}.
FT   HELIX       416    433       {ECO:0000244|PDB:5JQY}.
FT   HELIX       436    449       {ECO:0000244|PDB:5JQY}.
FT   HELIX       454    466       {ECO:0000244|PDB:5JQY}.
FT   HELIX       470    483       {ECO:0000244|PDB:5JQY}.
FT   HELIX       488    500       {ECO:0000244|PDB:5JQY}.
FT   HELIX       504    517       {ECO:0000244|PDB:5JQY}.
FT   HELIX       525    538       {ECO:0000244|PDB:5JQY}.
FT   HELIX       543    552       {ECO:0000244|PDB:5JQY}.
FT   STRAND      555    561       {ECO:0000244|PDB:5JQY}.
FT   STRAND      574    576       {ECO:0000244|PDB:5JQY}.
FT   HELIX       578    581       {ECO:0000244|PDB:5JQY}.
FT   HELIX       584    592       {ECO:0000244|PDB:5JQY}.
FT   HELIX       594    607       {ECO:0000244|PDB:5JQY}.
FT   HELIX       609    611       {ECO:0000244|PDB:5JQY}.
FT   STRAND      612    614       {ECO:0000244|PDB:5JQY}.
FT   HELIX       617    619       {ECO:0000244|PDB:5JZA}.
FT   STRAND      620    623       {ECO:0000244|PDB:5JQY}.
FT   STRAND      625    632       {ECO:0000244|PDB:5JQY}.
FT   HELIX       638    641       {ECO:0000244|PDB:5JQY}.
FT   HELIX       645    651       {ECO:0000244|PDB:5JQY}.
FT   HELIX       655    658       {ECO:0000244|PDB:5JQY}.
FT   STRAND      664    670       {ECO:0000244|PDB:5JQY}.
FT   STRAND      672    679       {ECO:0000244|PDB:5JQY}.
FT   STRAND      686    694       {ECO:0000244|PDB:5JQY}.
FT   STRAND      697    704       {ECO:0000244|PDB:5JQY}.
FT   STRAND      707    709       {ECO:0000244|PDB:5JQY}.
FT   STRAND      716    719       {ECO:0000244|PDB:5JQY}.
FT   STRAND      725    729       {ECO:0000244|PDB:5JQY}.
FT   STRAND      731    733       {ECO:0000244|PDB:5JQY}.
FT   STRAND      735    743       {ECO:0000244|PDB:5JQY}.
FT   HELIX       749    754       {ECO:0000244|PDB:5JQY}.
SQ   SEQUENCE   758 AA;  85863 MW;  4AE56D1D8DF0AF0C CRC64;
     MAQRKNAKSS GNSSSSGSGS GSTSAGSSSP GARRETKHGG HKNGRKGGLS GTSFFTWFMV
     IALLGVWTSV AVVWFDLVDY EEVLGKLGIY DADGDGDFDV DDAKVLLGLK ERSTSEPAVP
     PEEAEPHTEP EEQVPVEAEP QNIEDEAKEQ IQSLLHEMVH AEHVEGEDLQ QEDGPTGEPQ
     QEDDEFLMAT DVDDRFETLE PEVSHEETEH SYHVEETVSQ DCNQDMEEMM SEQENPDSSE
     PVVEDERLHH DTDDVTYQVY EEQAVYEPLE NEGIEITEVT APPEDNPVED SQVIVEEVSI
     FPVEEQQEVP PETNRKTDDP EQKAKVKKKK PKLLNKFDKT IKAELDAAEK LRKRGKIEEA
     VNAFKELVRK YPQSPRARYG KAQCEDDLAE KRRSNEVLRG AIETYQEVAS LPDVPADLLK
     LSLKRRSDRQ QFLGHMRGSL LTLQRLVQLF PNDTSLKNDL GVGYLLIGDN DNAKKVYEEV
     LSVTPNDGFA KVHYGFILKA QNKIAESIPY LKEGIESGDP GTDDGRFYFH LGDAMQRVGN
     KEAYKWYELG HKRGHFASVW QRSLYNVNGL KAQPWWTPKE TGYTELVKSL ERNWKLIRDE
     GLAVMDKAKG LFLPEDENLR EKGDWSQFTL WQQGRRNENA CKGAPKTCTL LEKFPETTGC
     RRGQIKYSIM HPGTHVWPHT GPTNCRLRMH LGLVIPKEGC KIRCANETKT WEEGKVLIFD
     DSFEHEVWQD ASSFRLIFIV DVWHPELTPQ QRRSLPAI
//
ID   GPX7_HUMAN              Reviewed;         187 AA.
AC   Q96SL4; O95337; Q5T501;
DT   04-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   28-FEB-2018, entry version 149.
DE   RecName: Full=Glutathione peroxidase 7;
DE            Short=GPx-7;
DE            Short=GSHPx-7;
DE            EC=1.11.1.9;
DE   AltName: Full=CL683;
DE   Flags: Precursor;
GN   Name=GPX7; Synonyms=GPX6; ORFNames=UNQ469/PRO828;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RA   Gu S., Lin S., Ying K., Xie Y., Mao Y.;
RT   "Cloning and characterizing a novel human glutathione peroxidase-
RT   GPX6.";
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 75-187.
RA   Barrow I.K.-P., Boguski M.S., Touchman J.W., Spencer F.;
RT   "Full-insert sequence of mapped XREF EST.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND INVOLVEMENT IN BE.
RX   PubMed=22157330; DOI=10.1136/gutjnl-2011-301078;
RA   Peng D., Belkhiri A., Hu T., Chaturvedi R., Asim M., Wilson K.T.,
RA   Zaika A., El-Rifai W.;
RT   "Glutathione peroxidase 7 protects against oxidative DNA damage in
RT   oesophageal cells.";
RL   Gut 61:1250-1260(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 20-177.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human glutathione peroxidase 7.";
RL   Submitted (MAR-2007) to the PDB data bank.
CC   -!- FUNCTION: It protects esophageal epithelia from hydrogen peroxide-
CC       induced oxidative stress. It suppresses acidic bile acid-induced
CC       reactive oxigen species (ROS) and protects against oxidative DNA
CC       damage and double-strand breaks. {ECO:0000269|PubMed:22157330}.
CC   -!- CATALYTIC ACTIVITY: 2 glutathione + H(2)O(2) = glutathione
CC       disulfide + 2 H(2)O.
CC   -!- INTERACTION:
CC       O43681:ASNA1; NbExp=5; IntAct=EBI-749411, EBI-2515857;
CC       Q8NHQ1:CEP70; NbExp=3; IntAct=EBI-749411, EBI-739624;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-749411, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=4; IntAct=EBI-749411, EBI-744081;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-749411, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in esophageal epithelial cells;
CC       expression is up-regulated after exposure to acidic bile acids.
CC       {ECO:0000269|PubMed:22157330}.
CC   -!- DISEASE: Barrett esophagus (BE) [MIM:614266]: A condition
CC       characterized by a metaplastic change in which normal esophageal
CC       squamous epithelium is replaced by a columnar and intestinal-type
CC       epithelium. Patients with Barrett esophagus have an increased risk
CC       of esophageal adenocarcinoma. The main cause of Barrett esophagus
CC       is gastroesophageal reflux. The retrograde movement of acid and
CC       bile salts from the stomach into the esophagus causes prolonged
CC       injury to the esophageal epithelium and induces chronic
CC       esophagitis, which in turn is believed to trigger the pathologic
CC       changes. {ECO:0000269|PubMed:22157330}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry. The
CC       pathologic mechanisms leading to Barrett esophagus involve GPX7
CC       dysfunction that results in higher levels of hydrogen peroxide and
CC       ROS-induced oxidative stress and DNA damage in esophageal cells.
CC   -!- SIMILARITY: Belongs to the glutathione peroxidase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC72961.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/gpx7/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF320068; AAN76501.1; -; mRNA.
DR   EMBL; AY358402; AAQ88768.1; -; mRNA.
DR   EMBL; AK027683; BAB55294.1; -; mRNA.
DR   EMBL; DQ096732; AAY88741.1; -; Genomic_DNA.
DR   EMBL; AL356976; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032788; AAH32788.1; -; mRNA.
DR   EMBL; AF091092; AAC72961.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS569.1; -.
DR   RefSeq; NP_056511.2; NM_015696.4.
DR   UniGene; Hs.43728; -.
DR   PDB; 2P31; X-ray; 2.00 A; A/B=20-177.
DR   PDBsum; 2P31; -.
DR   ProteinModelPortal; Q96SL4; -.
DR   SMR; Q96SL4; -.
DR   BioGrid; 109139; 45.
DR   IntAct; Q96SL4; 11.
DR   STRING; 9606.ENSP00000354677; -.
DR   DrugBank; DB00143; Glutathione.
DR   PeroxiBase; 3606; HsGPx07.
DR   iPTMnet; Q96SL4; -.
DR   PhosphoSitePlus; Q96SL4; -.
DR   BioMuta; GPX7; -.
DR   DMDM; 33516901; -.
DR   EPD; Q96SL4; -.
DR   MaxQB; Q96SL4; -.
DR   PaxDb; Q96SL4; -.
DR   PeptideAtlas; Q96SL4; -.
DR   PRIDE; Q96SL4; -.
DR   DNASU; 2882; -.
DR   Ensembl; ENST00000361314; ENSP00000354677; ENSG00000116157.
DR   GeneID; 2882; -.
DR   KEGG; hsa:2882; -.
DR   UCSC; uc001cue.4; human.
DR   CTD; 2882; -.
DR   DisGeNET; 2882; -.
DR   EuPathDB; HostDB:ENSG00000116157.5; -.
DR   GeneCards; GPX7; -.
DR   HGNC; HGNC:4559; GPX7.
DR   HPA; HPA025829; -.
DR   MIM; 614266; phenotype.
DR   MIM; 615784; gene.
DR   neXtProt; NX_Q96SL4; -.
DR   OpenTargets; ENSG00000116157; -.
DR   PharmGKB; PA28955; -.
DR   eggNOG; KOG1651; Eukaryota.
DR   eggNOG; COG0386; LUCA.
DR   GeneTree; ENSGT00760000119230; -.
DR   HOGENOM; HOG000277054; -.
DR   HOVERGEN; HBG004333; -.
DR   InParanoid; Q96SL4; -.
DR   KO; K00432; -.
DR   OMA; IAQTCHI; -.
DR   OrthoDB; EOG091G0OJG; -.
DR   PhylomeDB; Q96SL4; -.
DR   TreeFam; TF331942; -.
DR   BRENDA; 1.11.1.9; 2681.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   ChiTaRS; GPX7; human.
DR   EvolutionaryTrace; Q96SL4; -.
DR   GeneWiki; GPX7; -.
DR   GenomeRNAi; 2882; -.
DR   PRO; PR:Q96SL4; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116157; -.
DR   CleanEx; HS_GPX6; -.
DR   CleanEx; HS_GPX7; -.
DR   Genevisible; Q96SL4; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004096; F:catalase activity; IDA:CACAO.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004601; F:peroxidase activity; EXP:Reactome.
DR   GO; GO:0034599; P:cellular response to oxidative stress; TAS:Reactome.
DR   CDD; cd00340; GSH_Peroxidase; 1.
DR   InterPro; IPR013376; Glut_perox_Gpx7.
DR   InterPro; IPR000889; Glutathione_peroxidase.
DR   InterPro; IPR029759; GPX_AS.
DR   InterPro; IPR029760; GPX_CS.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PANTHER; PTHR11592; PTHR11592; 1.
DR   Pfam; PF00255; GSHPx; 1.
DR   PIRSF; PIRSF000303; Glutathion_perox; 1.
DR   PRINTS; PR01011; GLUTPROXDASE.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   TIGRFAMs; TIGR02540; gpx7; 1.
DR   PROSITE; PS00460; GLUTATHIONE_PEROXID_1; 1.
DR   PROSITE; PS00763; GLUTATHIONE_PEROXID_2; 1.
DR   PROSITE; PS51355; GLUTATHIONE_PEROXID_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Oxidoreductase; Peroxidase;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    187       Glutathione peroxidase 7.
FT                                /FTId=PRO_0000013084.
FT   ACT_SITE     57     57       {ECO:0000250}.
FT   CONFLICT     75     77       GPH -> HED (in Ref. 7). {ECO:0000305}.
FT   HELIX        25     27       {ECO:0000244|PDB:2P31}.
FT   STRAND       29     32       {ECO:0000244|PDB:2P31}.
FT   STRAND       37     39       {ECO:0000244|PDB:2P31}.
FT   HELIX        40     43       {ECO:0000244|PDB:2P31}.
FT   STRAND       46     53       {ECO:0000244|PDB:2P31}.
FT   STRAND       55     57       {ECO:0000244|PDB:2P31}.
FT   HELIX        60     74       {ECO:0000244|PDB:2P31}.
FT   HELIX        75     77       {ECO:0000244|PDB:2P31}.
FT   STRAND       79     85       {ECO:0000244|PDB:2P31}.
FT   HELIX        97    108       {ECO:0000244|PDB:2P31}.
FT   HELIX       127    136       {ECO:0000244|PDB:2P31}.
FT   STRAND      146    149       {ECO:0000244|PDB:2P31}.
FT   STRAND      155    159       {ECO:0000244|PDB:2P31}.
FT   HELIX       165    173       {ECO:0000244|PDB:2P31}.
SQ   SEQUENCE   187 AA;  20996 MW;  0ACB80AC2522EFCD CRC64;
     MVAATVAAAW LLLWAAACAQ QEQDFYDFKA VNIRGKLVSL EKYRGSVSLV VNVASECGFT
     DQHYRALQQL QRDLGPHHFN VLAFPCNQFG QQEPDSNKEI ESFARRTYSV SFPMFSKIAV
     TGTGAHPAFK YLAQTSGKEP TWNFWKYLVA PDGKVVGAWD PTVSVEEVRP QITALVRKLI
     LLKREDL
//
ID   HLPDA_HUMAN             Reviewed;          63 AA.
AC   Q9Y5L2; A4D0Z5; Q52LY5; Q53HJ7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   23-MAY-2018, entry version 123.
DE   RecName: Full=Hypoxia-inducible lipid droplet-associated protein;
DE   AltName: Full=Hypoxia-inducible gene 2 protein;
GN   Name=HILPDA; Synonyms=C7orf68, HIG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10690527;
RA   Denko N.C., Schindler C., Koong A., Laderoute K., Green C.,
RA   Giaccia A.J.;
RT   "Epigenetic regulation of gene expression in cervical cancer cells by
RT   the tumor microenvironment.";
RL   Clin. Cancer Res. 6:480-487(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Coronary artery;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum, and Lung carcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15930302; DOI=10.1158/0008-5472.CAN-05-0120;
RA   Togashi A., Katagiri T., Ashida S., Fujioka T., Maruyama O.,
RA   Wakumoto Y., Sakamoto Y., Fujime M., Kawachi Y., Shuin T.,
RA   Nakamura Y.;
RT   "Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for
RT   renal cell carcinoma and potential target for molecular therapy.";
RL   Cancer Res. 65:4817-4826(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INDUCTION, AND
RP   MUTAGENESIS OF 8-TYR-LEU-9; THR-41 AND SER-44.
RX   PubMed=20624928; DOI=10.1096/fj.10-159806;
RA   Gimm T., Wiese M., Teschemacher B., Deggerich A., Schodel J.,
RA   Knaup K.X., Hackenbeck T., Hellerbrand C., Amann K., Wiesener M.S.,
RA   Honing S., Eckardt K.U., Warnecke C.;
RT   "Hypoxia-inducible protein 2 is a novel lipid droplet protein and a
RT   specific target gene of hypoxia-inducible factor-1.";
RL   FASEB J. 24:4443-4458(2010).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=21614900;
RA   Nishimura S., Tsuda H., Nomura H., Kataoka F., Chiyoda T., Tanaka H.,
RA   Tanaka K., Susumu N., Aoki D.;
RT   "Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer.";
RL   Eur. J. Gynaecol. Oncol. 32:146-149(2011).
CC   -!- FUNCTION: Increases intracellular lipid accumulation. Stimulates
CC       expression of cytokines including IL6, MIF and VEGFA. Enhances
CC       cell growth and proliferation. {ECO:0000269|PubMed:15930302,
CC       ECO:0000269|PubMed:20624928}.
CC   -!- INTERACTION:
CC       O43681:ASNA1; NbExp=3; IntAct=EBI-8803836, EBI-2515857;
CC       Q9ULW2:FZD10; NbExp=2; IntAct=EBI-8803836, EBI-8803802;
CC   -!- SUBCELLULAR LOCATION: Lipid droplet. Secreted. Membrane
CC       {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in renal cell carcinoma cells
CC       but barely detectable in adjacent normal kidney tissue. Detected
CC       in some cervical and endometrial cancers. Expression also detected
CC       in fetal kidney with little or no expression observed in normal
CC       adult heart, liver, lung, pancreas, prostate or spinal cord (at
CC       protein level). {ECO:0000269|PubMed:15930302,
CC       ECO:0000269|PubMed:20624928, ECO:0000269|PubMed:21614900}.
CC   -!- INDUCTION: By hypoxia but highly abundant under normoxic
CC       conditions (at protein level). {ECO:0000269|PubMed:10690527,
CC       ECO:0000269|PubMed:20624928}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF144755; AAD37585.1; -; mRNA.
DR   EMBL; AK222583; BAD96303.1; -; mRNA.
DR   EMBL; CH236947; EAL24309.1; -; Genomic_DNA.
DR   EMBL; BC001863; AAH01863.1; -; mRNA.
DR   EMBL; BC093742; AAH93742.1; -; mRNA.
DR   EMBL; BC112183; AAI12184.1; -; mRNA.
DR   CCDS; CCDS5802.1; -.
DR   RefSeq; NP_001092256.1; NM_001098786.1.
DR   RefSeq; NP_037464.1; NM_013332.3.
DR   UniGene; Hs.706124; -.
DR   ProteinModelPortal; Q9Y5L2; -.
DR   BioGrid; 118964; 1.
DR   IntAct; Q9Y5L2; 2.
DR   STRING; 9606.ENSP00000257696; -.
DR   iPTMnet; Q9Y5L2; -.
DR   PhosphoSitePlus; Q9Y5L2; -.
DR   BioMuta; HILPDA; -.
DR   MaxQB; Q9Y5L2; -.
DR   PaxDb; Q9Y5L2; -.
DR   PeptideAtlas; Q9Y5L2; -.
DR   PRIDE; Q9Y5L2; -.
DR   Ensembl; ENST00000257696; ENSP00000257696; ENSG00000135245.
DR   Ensembl; ENST00000435296; ENSP00000388871; ENSG00000135245.
DR   GeneID; 29923; -.
DR   KEGG; hsa:29923; -.
DR   UCSC; uc003vne.5; human.
DR   CTD; 29923; -.
DR   DisGeNET; 29923; -.
DR   EuPathDB; HostDB:ENSG00000135245.9; -.
DR   GeneCards; HILPDA; -.
DR   HGNC; HGNC:28859; HILPDA.
DR   HPA; HPA010515; -.
DR   neXtProt; NX_Q9Y5L2; -.
DR   OpenTargets; ENSG00000135245; -.
DR   PharmGKB; PA164717457; -.
DR   eggNOG; ENOG410JJ0P; Eukaryota.
DR   eggNOG; ENOG41114TU; LUCA.
DR   GeneTree; ENSGT00390000014201; -.
DR   HOGENOM; HOG000112896; -.
DR   HOVERGEN; HBG001634; -.
DR   InParanoid; Q9Y5L2; -.
DR   OMA; PGSSWTT; -.
DR   OrthoDB; EOG091G1900; -.
DR   PhylomeDB; Q9Y5L2; -.
DR   Reactome; R-HSA-8964572; Lipid particle organization.
DR   ChiTaRS; HILPDA; human.
DR   GenomeRNAi; 29923; -.
DR   PRO; PR:Q9Y5L2; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000135245; -.
DR   Genevisible; Q9Y5L2; HS.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005811; C:lipid droplet; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0030141; C:secretory granule; IDA:BHF-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:BHF-UCL.
DR   GO; GO:0035425; P:autocrine signaling; IDA:BHF-UCL.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB.
DR   GO; GO:0034389; P:lipid particle organization; TAS:Reactome.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0001819; P:positive regulation of cytokine production; IDA:UniProtKB.
DR   GO; GO:0010884; P:positive regulation of lipid storage; IDA:UniProtKB.
DR   InterPro; IPR026190; Hipoxia_HILPDA.
DR   PANTHER; PTHR16886; PTHR16886; 1.
DR   Pfam; PF15220; HILPDA; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Lipid droplet; Membrane; Phosphoprotein;
KW   Reference proteome; Secreted; Stress response; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1     63       Hypoxia-inducible lipid droplet-
FT                                associated protein.
FT                                /FTId=PRO_0000083976.
FT   TRANSMEM      7     23       Helical. {ECO:0000255}.
FT   REGION        1     37       Required for targeting to lipid droplets.
FT   MOD_RES      44     44       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MUTAGEN       8      9       YL->DD: Loss of targeting to lipid
FT                                droplets and elimination of protein.
FT                                {ECO:0000269|PubMed:20624928}.
FT   MUTAGEN      41     41       T->K: No effect on lipid droplet
FT                                targeting or protein expression; when
FT                                associated with K-44.
FT                                {ECO:0000269|PubMed:20624928}.
FT   MUTAGEN      44     44       S->K: No effect on lipid droplet
FT                                targeting or protein expression; when
FT                                associated with K-41.
FT                                {ECO:0000269|PubMed:20624928}.
FT   CONFLICT     21     21       V -> T (in Ref. 2; BAD96303).
FT                                {ECO:0000305}.
SQ   SEQUENCE   63 AA;  6950 MW;  91EA626A511FC8B7 CRC64;
     MKHVLNLYLL GVVLTLLSIF VRVMESLEGL LESPSPGTSW TTRSQLANTE PTKGLPDHPS
     RSM
//
ID   CUL7_HUMAN              Reviewed;        1698 AA.
AC   Q14999; B4DYZ0; F5H0L1; Q5T654;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   23-MAY-2018, entry version 179.
DE   RecName: Full=Cullin-7;
DE            Short=CUL-7;
GN   Name=CUL7; Synonyms=KIAA0076;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-813.
RC   TISSUE=Bone marrow;
RX   PubMed=7584044; DOI=10.1093/dnares/1.5.223;
RA   Nomura N., Nagase T., Miyajima N., Sazuka T., Tanaka A., Sato S.,
RA   Seki N., Kawarabayasi Y., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. II.
RT   The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 1:223-229(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   ARG-813.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-813.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION IN A COMPLEX WITH SKP1; FBXW8 AND RBX1.
RX   PubMed=12481031; DOI=10.1073/pnas.252646399;
RA   Dias D.C., Dolios G., Wang R., Pan Z.Q.;
RT   "CUL7: a DOC domain-containing cullin selectively binds Skp1.Fbx29 to
RT   form an SCF-like complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:16601-16606(2002).
RN   [6]
RP   INTERACTION WITH RBX1, AND IDENTIFICATION IN A COMPLEX WITH SKP1;
RP   FBXW8; RBX1 AND GLMN.
RX   PubMed=12904573; DOI=10.1073/pnas.1733908100;
RA   Arai T., Kasper J.S., Skaar J.R., Ali S.H., Takahashi C.,
RA   DeCaprio J.A.;
RT   "Targeted disruption of p185/Cul7 gene results in abnormal vascular
RT   morphogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:9855-9860(2003).
RN   [7]
RP   INTERACTION WITH SV40 LARGE ANTIGEN, AND IDENTIFICATION IN A
RP   SFC(CUL7)-LIKE COMPLEX.
RX   PubMed=16140746; DOI=10.1128/JVI.79.18.11685-11692.2005;
RA   Kasper J.S., Kuwabara H., Arai T., Ali S.H., DeCaprio J.A.;
RT   "Simian virus 40 large T antigen's association with the CUL7 SCF
RT   complex contributes to cellular transformation.";
RL   J. Virol. 79:11685-11692(2005).
RN   [8]
RP   INTERACTION WITH CUL9.
RX   PubMed=15964813; DOI=10.1128/MCB.25.13.5579-5589.2005;
RA   Skaar J.R., Arai T., DeCaprio J.A.;
RT   "Dimerization of CUL7 and PARC is not required for all CUL7 functions
RT   and mouse development.";
RL   Mol. Cell. Biol. 25:5579-5589(2005).
RN   [9]
RP   FUNCTION, INTERACTION WITH RBX1 AND TP53, AND SUBCELLULAR LOCATION.
RX   PubMed=16547496; DOI=10.1038/sj.onc.1209490;
RA   Andrews P., He Y.J., Xiong Y.;
RT   "Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and
RT   promotes cell growth by antagonizing p53 function.";
RL   Oncogene 25:4534-4548(2006).
RN   [10]
RP   FUNCTION, INTERACTION WITH CUL9; SKP1; FBXW8; RBX1 AND TP53, AND LACK
RP   OF NEDDYLATION.
RX   PubMed=17332328; DOI=10.1158/0008-5472.CAN-06-3241;
RA   Skaar J.R., Florens L., Tsutsumi T., Arai T., Tron A., Swanson S.K.,
RA   Washburn M.P., DeCaprio J.A.;
RT   "PARC and CUL7 form atypical cullin RING ligase complexes.";
RL   Cancer Res. 67:2006-2014(2007).
RN   [11]
RP   INVOLVEMENT IN 3M1.
RX   PubMed=17675530; DOI=10.1136/jmg.2007.051979;
RA   Maksimova N., Hara K., Miyashia A., Nikolaeva I., Shiga A.,
RA   Nogovicina A., Sukhomyasova A., Argunov V., Shvedova A., Ikeuchi T.,
RA   Nishizawa M., Kuwano R., Onodera O.;
RT   "Clinical, molecular and histopathological features of short stature
RT   syndrome with novel CUL7 mutation in Yakuts: new population isolate in
RT   Asia.";
RL   J. Med. Genet. 44:772-778(2007).
RN   [12]
RP   FUNCTION.
RX   PubMed=18498745; DOI=10.1016/j.molcel.2008.03.009;
RA   Xu X., Sarikas A., Dias-Santagata D.C., Dolios G., Lafontant P.J.,
RA   Tsai S.C., Zhu W., Nakajima H., Nakajima H.O., Field L.J., Wang R.,
RA   Pan Z.Q.;
RT   "The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for
RT   ubiquitin-dependent degradation.";
RL   Mol. Cell 30:403-414(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   INTERACTION WITH OBSL1.
RX   PubMed=21737058; DOI=10.1016/j.ajhg.2011.05.028;
RA   Hanson D., Murray P.G., O'Sullivan J., Urquhart J., Daly S.,
RA   Bhaskar S.S., Biesecker L.G., Skae M., Smith C., Cole T., Kirk J.,
RA   Chandler K., Kingston H., Donnai D., Clayton P.E., Black G.C.;
RT   "Exome sequencing identifies CCDC8 mutations in 3-M syndrome,
RT   Suggesting that CCDC8 Contributes in a Pathway with CUL7 and OBSL1 to
RT   Control Human Growth.";
RL   Am. J. Hum. Genet. 89:148-153(2011).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   FUNCTION, INTERACTION WITH FBXW8 AND OBSL1, AND SUBCELLULAR LOCATION.
RX   PubMed=21572988; DOI=10.1371/journal.pbio.1001060;
RA   Litterman N., Ikeuchi Y., Gallardo G., O'Connell B.C., Sowa M.E.,
RA   Gygi S.P., Harper J.W., Bonni A.;
RT   "An OBSL1-Cul7Fbxw8 ubiquitin ligase signaling mechanism regulates
RT   Golgi morphology and dendrite patterning.";
RL   PLoS Biol. 9:E1001060-E1001060(2011).
RN   [18]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=20139075; DOI=10.1074/jbc.M109.004200;
RA   Fu J., Lv X., Lin H., Wu L., Wang R., Zhou Z., Zhang B., Wang Y.L.,
RA   Tsang B.K., Zhu C., Wang H.;
RT   "Ubiquitin ligase cullin 7 induces epithelial-mesenchymal transition
RT   in human choriocarcinoma cells.";
RL   J. Biol. Chem. 285:10870-10879(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH FBXW8.
RX   PubMed=24362026; DOI=10.1074/jbc.M113.520106;
RA   Wang H., Chen Y., Lin P., Li L., Zhou G., Liu G., Logsdon C., Jin J.,
RA   Abbruzzese J.L., Tan T.H., Wang H.;
RT   "The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8)
RT   ubiquitin ligase promotes degradation of hematopoietic progenitor
RT   kinase 1.";
RL   J. Biol. Chem. 289:4009-4017(2014).
RN   [21]
RP   FUNCTION, IDENTIFICATION IN THE 3M COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=24793695; DOI=10.1016/j.molcel.2014.03.047;
RA   Yan J., Yan F., Li Z., Sinnott B., Cappell K.M., Yu Y., Mo J.,
RA   Duncan J.A., Chen X., Cormier-Daire V., Whitehurst A.W., Xiong Y.;
RT   "The 3M complex maintains microtubule and genome integrity.";
RL   Mol. Cell 54:791-804(2014).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH CUL9.
RX   PubMed=24793696; DOI=10.1016/j.molcel.2014.03.046;
RA   Li Z., Pei X.H., Yan J., Yan F., Cappell K.M., Whitehurst A.W.,
RA   Xiong Y.;
RT   "CUL9 mediates the functions of the 3M complex and ubiquitylates
RT   survivin to maintain genome integrity.";
RL   Mol. Cell 54:805-819(2014).
RN   [23]
RP   INTERACTION WITH HDAC4 AND HDAC5.
RX   PubMed=25752541; DOI=10.1016/j.str.2015.02.001;
RA   Nie J., Xu C., Jin J., Aka J.A., Tempel W., Nguyen V., You L.,
RA   Weist R., Min J., Pawson T., Yang X.J.;
RT   "Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome
RT   protein CCDC8.";
RL   Structure 23:700-712(2015).
RN   [24]
RP   STRUCTURE BY NMR OF 360-460, AND INTERACTION WITH TP53.
RX   PubMed=17298945; DOI=10.1074/jbc.M611297200;
RA   Kaustov L., Lukin J., Lemak A., Duan S., Ho M., Doherty R., Penn L.Z.,
RA   Arrowsmith C.H.;
RT   "The conserved CPH domains of Cul7 and PARC are protein-protein
RT   interaction modules that bind the tetramerization domain of p53.";
RL   J. Biol. Chem. 282:11300-11307(2007).
RN   [25]
RP   VARIANTS 3M1 ARG-1014; GLY-1246 AND PRO-1464, AND TISSUE SPECIFICITY.
RX   PubMed=16142236; DOI=10.1038/ng1628;
RA   Huber C., Dias-Santagata D., Glaser A., O'Sullivan J., Brauner R.,
RA   Wu K., Xu X., Pearce K., Wang R., Giovannucci Uzielli M.L.,
RA   Dagoneau N., Chemaitilly W., Superti-Furga A., Dos Santos H.,
RA   Megarbane A., Morin G., Gillessen-Kaesbach G., Hennekam R.C.M.,
RA   Van der Burgt I., Black G.C.M., Clayton P.E., Read A., Le Merrer M.,
RA   Scambler P.J., Munnich A., Pan Z.-Q., Winter R., Cormier-Daire V.;
RT   "Identification of mutations in CUL7 in 3-M syndrome.";
RL   Nat. Genet. 37:1119-1124(2005).
RN   [26]
RP   VARIANT 3M1 PRO-1588.
RX   PubMed=23018678; DOI=10.1530/JME-12-0034;
RA   Hanson D., Murray P.G., Coulson T., Sud A., Omokanye A., Stratta E.,
RA   Sakhinia F., Bonshek C., Wilson L.C., Wakeling E., Temtamy S.A.,
RA   Aglan M., Rosser E.M., Mansour S., Carcavilla A., Nampoothiri S.,
RA   Khan W.I., Banerjee I., Chandler K.E., Black G.C., Clayton P.E.;
RT   "Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered
RT   growth factor signalling.";
RL   J. Mol. Endocrinol. 49:267-275(2012).
CC   -!- FUNCTION: Core component of the 3M and Cul7-RING(FBXW8) complexes,
CC       which mediates the ubiquitination of target proteins. Core
CC       component of the 3M complex, a complex required to regulate
CC       microtubule dynamics and genome integrity. It is unclear how the
CC       3M complex regulates microtubules, it could act by controlling the
CC       level of a microtubule stabilizer (PubMed:24793695). Interaction
CC       with CUL9 is required to inhibit CUL9 activity and ubiquitination
CC       of BIRC5 (PubMed:24793696). Core component of a Cul7-RING
CC       ubiquitin-protein ligase with FBXW8, which mediates ubiquitination
CC       and consequent degradation of target proteins such as GORASP1,
CC       IRS1 and MAP4K1/HPK1 (PubMed:21572988, PubMed:24362026).
CC       Ubiquitination of GORASP1 regulates Golgi morphogenesis and
CC       dendrite patterning in brain (PubMed:21572988). Mediates
CC       ubiquitination and degradation of IRS1 in a mTOR-dependent manner:
CC       the Cul7-RING(FBXW8) complex recognizes and binds IRS1 previously
CC       phosphorylated by S6 kinase (RPS6KB1 or RPS6KB2)
CC       (PubMed:18498745). The Cul7-RING(FBXW8) complex also mediates
CC       ubiquitination of MAP4K1/HPK1: recognizes and binds
CC       autophosphorylated MAP4K1/HPK1, leading to its degradation,
CC       thereby affecting cell proliferation and differentiation
CC       (PubMed:24362026). Acts as a regulator in trophoblast cell
CC       epithelial-mesenchymal transition and placental development
CC       (PubMed:20139075). Does not promote polyubiquitination and
CC       proteasomal degradation of p53/TP53 (PubMed:16547496,
CC       PubMed:17332328). While the Cul7-RING(FBXW8) and the 3M complexes
CC       are associated and involved in common processes, CUL7 and the
CC       Cul7-RING(FBXW8) complex may be have additional functions.
CC       {ECO:0000269|PubMed:16547496, ECO:0000269|PubMed:17332328,
CC       ECO:0000269|PubMed:18498745, ECO:0000269|PubMed:20139075,
CC       ECO:0000269|PubMed:21572988, ECO:0000269|PubMed:24362026,
CC       ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Component of the 3M complex, composed of core components
CC       CUL7, CCDC8 and OBSL1. Part of a Cul7-RING complex consisting of
CC       CUL7, RBX1, SKP1 and FBXW8. Interacts with a complex of SKP1 and
CC       FBXW8, but not with SKP1 alone. Interacts with CUL9; leading to
CC       inhibit CUL9 activity. Interacts with FBXW8; interaction is
CC       mutually exclusive of binding to CUL9 or p53/TP53. Interacts with
CC       p53/TP53; the interaction preferentially involves tetrameric and
CC       dimeric p53/TP53. The CUL7-CUL9 heterodimer seems to interact
CC       specifically with p53/TP53. Interacts with CUL1; the interactions
CC       seems to be mediated by FBXW8. Interacts with SV40 Large T
CC       antigen; this interaction seems to inhibit CUL7. Interacts with
CC       OBSL1. Interacts (as part of the 3M complex) with HDAC4 and HDAC5;
CC       it is negatively regulated by ANKRA2.
CC       {ECO:0000269|PubMed:12481031, ECO:0000269|PubMed:12904573,
CC       ECO:0000269|PubMed:15964813, ECO:0000269|PubMed:16140746,
CC       ECO:0000269|PubMed:16547496, ECO:0000269|PubMed:17298945,
CC       ECO:0000269|PubMed:17332328, ECO:0000269|PubMed:21572988,
CC       ECO:0000269|PubMed:21737058, ECO:0000269|PubMed:24362026,
CC       ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696,
CC       ECO:0000269|PubMed:25752541}.
CC   -!- INTERACTION:
CC       O75147-2:OBSL1; NbExp=4; IntAct=EBI-308606, EBI-15927144;
CC       P04637:TP53; NbExp=5; IntAct=EBI-308606, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome. Cytoplasm, perinuclear
CC       region. Golgi apparatus. Note=Colocalizes with FBXW8 at the Golgi
CC       apparatus in neurons; localization to Golgi is mediated by OBSL1.
CC       During mitosis, localizes to the mitotic apparatus
CC       (PubMed:24793695). CCDC8 is required for centrosomal location
CC       (PubMed:24793695). {ECO:0000269|PubMed:24793695}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14999-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14999-2; Sequence=VSP_046105, VSP_046106;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in fetal kidney and adult
CC       skeletal muscle. Also abundant in fetal brain, as well as in adult
CC       pancreas, kidney, placenta and heart. Detected in trophoblasts,
CC       lymphoblasts, osteoblasts, chondrocytes and skin fibroblasts.
CC       {ECO:0000269|PubMed:16142236}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in invasive placental villi
CC       during first trimester. {ECO:0000269|PubMed:20139075}.
CC   -!- PTM: According to a report, may not be neddylated despite the
CC       conserved consensus site for neddylation at Lys-1576.
CC       {ECO:0000269|PubMed:17332328}.
CC   -!- DISEASE: 3M syndrome 1 (3M1) [MIM:273750]: An autosomal recessive
CC       disorder characterized by severe pre- and postnatal growth
CC       retardation, facial dysmorphism, large head circumference, and
CC       normal intelligence and endocrine function. Skeletal changes
CC       include long slender tubular bones and tall vertebral bodies.
CC       {ECO:0000269|PubMed:16142236, ECO:0000269|PubMed:17675530,
CC       ECO:0000269|PubMed:23018678}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00330}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA07551.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D38548; BAA07551.2; ALT_INIT; mRNA.
DR   EMBL; AK302668; BAG63902.1; -; mRNA.
DR   EMBL; AL355385; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136304; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC033647; AAH33647.1; -; mRNA.
DR   CCDS; CCDS4881.1; -. [Q14999-1]
DR   CCDS; CCDS55003.1; -. [Q14999-2]
DR   RefSeq; NP_001161842.1; NM_001168370.1. [Q14999-2]
DR   RefSeq; NP_055595.2; NM_014780.4. [Q14999-1]
DR   UniGene; Hs.520136; -.
DR   PDB; 2JNG; NMR; -; A=360-460.
DR   PDBsum; 2JNG; -.
DR   ProteinModelPortal; Q14999; -.
DR   SMR; Q14999; -.
DR   BioGrid; 115159; 661.
DR   CORUM; Q14999; -.
DR   DIP; DIP-31618N; -.
DR   DIP; DIP-60187N; -.
DR   IntAct; Q14999; 16.
DR   MINT; Q14999; -.
DR   STRING; 9606.ENSP00000438788; -.
DR   iPTMnet; Q14999; -.
DR   PhosphoSitePlus; Q14999; -.
DR   BioMuta; CUL7; -.
DR   DMDM; 160370003; -.
DR   EPD; Q14999; -.
DR   MaxQB; Q14999; -.
DR   PaxDb; Q14999; -.
DR   PeptideAtlas; Q14999; -.
DR   PRIDE; Q14999; -.
DR   Ensembl; ENST00000265348; ENSP00000265348; ENSG00000044090. [Q14999-1]
DR   Ensembl; ENST00000535468; ENSP00000438788; ENSG00000044090. [Q14999-2]
DR   GeneID; 9820; -.
DR   KEGG; hsa:9820; -.
DR   UCSC; uc003otq.4; human. [Q14999-1]
DR   CTD; 9820; -.
DR   DisGeNET; 9820; -.
DR   EuPathDB; HostDB:ENSG00000044090.8; -.
DR   GeneCards; CUL7; -.
DR   GeneReviews; CUL7; -.
DR   HGNC; HGNC:21024; CUL7.
DR   HPA; CAB015449; -.
DR   HPA; HPA030095; -.
DR   HPA; HPA030096; -.
DR   MalaCards; CUL7; -.
DR   MIM; 273750; phenotype.
DR   MIM; 609577; gene.
DR   neXtProt; NX_Q14999; -.
DR   OpenTargets; ENSG00000044090; -.
DR   Orphanet; 2616; 3M syndrome.
DR   PharmGKB; PA134897835; -.
DR   eggNOG; KOG1815; Eukaryota.
DR   eggNOG; ENOG410XP9Y; LUCA.
DR   GeneTree; ENSGT00890000139411; -.
DR   HOGENOM; HOG000024831; -.
DR   HOVERGEN; HBG103792; -.
DR   InParanoid; Q14999; -.
DR   KO; K10613; -.
DR   OMA; EHILLWM; -.
DR   OrthoDB; EOG091G0053; -.
DR   PhylomeDB; Q14999; -.
DR   TreeFam; TF101154; -.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SIGNOR; Q14999; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; CUL7; human.
DR   EvolutionaryTrace; Q14999; -.
DR   GeneWiki; CUL7; -.
DR   GenomeRNAi; 9820; -.
DR   PRO; PR:Q14999; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000044090; -.
DR   CleanEx; HS_CUL7; -.
DR   Genevisible; Q14999; HS.
DR   GO; GO:1990393; C:3M complex; IDA:UniProtKB.
DR   GO; GO:0005680; C:anaphase-promoting complex; NAS:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0031467; C:Cul7-RING ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:InterPro.
DR   GO; GO:0001837; P:epithelial to mesenchymal transition; IDA:UniProtKB.
DR   GO; GO:0007030; P:Golgi organization; ISS:UniProtKB.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0000281; P:mitotic cytokinesis; IMP:UniProtKB.
DR   GO; GO:0001890; P:placenta development; IDA:UniProtKB.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; IGI:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; NAS:UniProtKB.
DR   GO; GO:0007088; P:regulation of mitotic nuclear division; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   GO; GO:0001570; P:vasculogenesis; ISS:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.30.30.30; -; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR004939; APC_su10/DOC_dom.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR021097; CPH_domain.
DR   InterPro; IPR031223; CUL7.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR014722; Rib_L2_dom2.
DR   PANTHER; PTHR22771:SF3; PTHR22771:SF3; 1.
DR   Pfam; PF03256; ANAPC10; 1.
DR   Pfam; PF11515; Cul7; 1.
DR   Pfam; PF00888; Cullin; 1.
DR   SMART; SM01337; APC10; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF48371; SSF48371; 3.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF75632; SSF75632; 2.
DR   PROSITE; PS50069; CULLIN_2; 1.
DR   PROSITE; PS51284; DOC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Disease mutation; Dwarfism; Golgi apparatus;
KW   Host-virus interaction; Isopeptide bond; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN         1   1698       Cullin-7.
FT                                /FTId=PRO_0000119802.
FT   DOMAIN      814    993       DOC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00614}.
FT   REGION      360    460       Interaction with TP53.
FT   MOD_RES     339    339       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CROSSLNK   1576   1576       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in NEDD8).
FT                                {ECO:0000255}.
FT   VAR_SEQ       1      1       M -> MSRGFWLAEPLAGTGPHPAPVAADSRGCSSVPRRHA
FT                                PSRLSVSTPSRGPGARM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046105.
FT   VAR_SEQ     194    194       G -> GEGQCGEEGKAGEGLGRLRDSQDTVAGASDLIR
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046106.
FT   VARIANT     616    616       S -> G (in dbSNP:rs7774330).
FT                                /FTId=VAR_048841.
FT   VARIANT     813    813       Q -> R (in dbSNP:rs9381231).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7584044}.
FT                                /FTId=VAR_026121.
FT   VARIANT     852    852       R -> Q (in dbSNP:rs34574340).
FT                                /FTId=VAR_048842.
FT   VARIANT    1014   1014       L -> R (in 3M1; unknown pathological
FT                                significance; dbSNP:rs61752334).
FT                                {ECO:0000269|PubMed:16142236}.
FT                                /FTId=VAR_026122.
FT   VARIANT    1246   1246       Q -> G (in 3M1; requires 2 nucleotide
FT                                substitutions).
FT                                {ECO:0000269|PubMed:16142236}.
FT                                /FTId=VAR_026123.
FT   VARIANT    1246   1246       Q -> H (in dbSNP:rs36071170).
FT                                /FTId=VAR_048843.
FT   VARIANT    1464   1464       H -> P (in 3M1; impairs the ability to
FT                                interact with RBX1, thus hampers the
FT                                assembly of polyubiquitin chains;
FT                                dbSNP:rs121918229).
FT                                {ECO:0000269|PubMed:16142236}.
FT                                /FTId=VAR_026124.
FT   VARIANT    1588   1588       L -> P (in 3M1; dbSNP:rs759300846).
FT                                {ECO:0000269|PubMed:23018678}.
FT                                /FTId=VAR_071120.
FT   HELIX       360    362       {ECO:0000244|PDB:2JNG}.
FT   STRAND      363    366       {ECO:0000244|PDB:2JNG}.
FT   HELIX       367    376       {ECO:0000244|PDB:2JNG}.
FT   STRAND      382    385       {ECO:0000244|PDB:2JNG}.
FT   STRAND      397    403       {ECO:0000244|PDB:2JNG}.
FT   STRAND      407    414       {ECO:0000244|PDB:2JNG}.
FT   TURN        415    418       {ECO:0000244|PDB:2JNG}.
FT   STRAND      419    424       {ECO:0000244|PDB:2JNG}.
FT   HELIX       425    427       {ECO:0000244|PDB:2JNG}.
FT   STRAND      428    430       {ECO:0000244|PDB:2JNG}.
SQ   SEQUENCE   1698 AA;  191161 MW;  EC9EED17E98FC9A1 CRC64;
     MVGELRYREF RVPLGPGLHA YPDELIRQRV GHDGHPEYQI RWLILRRGDE GDGGSGQVDC
     KAEHILLWMS KDEIYANCHK MLGEDGQVIG PSQESAGEVG ALDKSVLEEM ETDVKSLIQR
     ALRQLEECVG TIPPAPLLHT VHVLSAYASI EPLTGVFKDP RVLDLLMHML SSPDYQIRWS
     AGRMIQALSS HDAGTRTQIL LSLSQQEAIE KHLDFDSRCA LLALFAQATL SEHPMSFEGI
     QLPQVPGRVL FSLVKRYLHV TSLLDQLNDS AAEPGAQNTS APEELSGERG QLELEFSMAM
     GTLISELVQA MRWDQASDRP RSSARSPGSI FQPQLADVSP GLPAAQAQPS FRRSRRFRPR
     SEFASGNTYA LYVRDTLQPG MRVRMLDDYE EISAGDEGEF RQSNNGVPPV QVFWESTGRT
     YWVHWHMLEI LGFEEDIEDM VEADEYQGAV ASRVLGRALP AWRWRPMTEL YAVPYVLPED
     EDTEECEHLT LAEWWELLFF IKKLDGPDHQ EVLQILQENL DGEILDDEIL AELAVPIELA
     QDLLLTLPQR LNDSALRDLI NCHVYKKYGP EALAGNQAYP SLLEAQEDVL LLDAQAQAKD
     SEDAAKVEAK EPPSQSPNTP LQRLVEGYGP AGKILLDLEQ ALSSEGTQEN KVKPLLLQLQ
     RQPQPFLALM QSLDTPETNR TLHLTVLRIL KQLVDFPEAL LLPWHEAVDA CMACLRSPNT
     DREVLQELIF FLHRLTSVSR DYAVVLNQLG ARDAISKALE KHLGKLELAQ ELRDMVFKCE
     KHAHLYRKLI TNILGGCIQM VLGQIEDHRR THQPINIPFF DVFLRYLCQG SSVEVKEDKC
     WEKVEVSSNP HRASKLTDHN PKTYWESNGS AGSHYITLHM RRGILIRQLT LLVASEDSSY
     MPARVVVCGG DSTSSLHTEL NSVNVMPSAS RVILLENLTR FWPIIQIRIK RCQQGGIDTR
     IRGLEILGPK PTFWPVFREQ LCRHTRLFYM VRAQAWSQDM AEDRRSLLHL SSRLNGALRQ
     EQNFADRFLP DDEAAQALGK TCWEALVSPV VQNITSPDED GISPLGWLLD QYLECQEAVF
     NPQSRGPAFF SRVRRLTHLL VHVEPCEAPP PVVATPRPKG RNRSHDWSSL ATRGLPSSIM
     RNLTRCWRAV VEKQVNNFLT SSWRDDDFVP RYCEHFNILQ NSSSELFGPR AAFLLALQNG
     CAGALLKLPF LKAAHVSEQF ARHIDQQIQG SRIGGAQEME RLAQLQQCLQ AVLIFSGLEI
     ATTFEHYYQH YMADRLLGVV SSWLEGAVLE QIGPCFPNRL PQQMLQSLST SKELQRQFHV
     YQLQQLDQEL LKLEDTEKKI QVGLGASGKE HKSEKEEEAG AAAVVDVAEG EEEEEENEDL
     YYEGAMPEVS VLVLSRHSWP VASICHTLNP RTCLPSYLRG TLNRYSNFYN KSQSHPALER
     GSQRRLQWTW LGWAELQFGN QTLHVSTVQM WLLLYLNDLK AVSVESLLAF SGLSADMLNQ
     AIGPLTSSRG PLDLHEQKDI PGGVLKIRDG SKEPRSRWDI VRLIPPQTYL QAEGEDGQNL
     EKRRNLLNCL IVRILKAHGD EGLHIDQLVC LVLEAWQKGP CPPRGLVSSL GKGSACSSTD
     VLSCILHLLG KGTLRRHDDR PQVLSYAVPV TVMEPHTESL NPGSSGPNPP LTFHTLQIRS
     RGVPYASCTA TQSFSTFR
//
ID   GET4_HUMAN              Reviewed;         327 AA.
AC   Q7L5D6; A4D2Q1; B3KNC7; Q9UFC9; Q9Y309;
DT   21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   23-MAY-2018, entry version 121.
DE   RecName: Full=Golgi to ER traffic protein 4 homolog;
DE   AltName: Full=Conserved edge-expressed protein;
DE   AltName: Full=Transmembrane domain recognition complex 35 kDa subunit;
DE            Short=TRC35;
GN   Name=GET4; Synonyms=C7orf20, CEE, TRC35; ORFNames=CGI-20;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Ovary, Testis, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-14 AND 111-122, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RA   Bienvenut W.V., Vousden K.H., Lukashchuk N.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 8-327 (ISOFORM 1).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [7]
RP   IDENTIFICATION.
RX   PubMed=18249086; DOI=10.1016/j.ygeno.2007.10.017;
RA   Fernandes J.M.O., Macqueen D.J., Lee H.-T., Johnston I.A.;
RT   "Genomic, evolutionary, and expression analyses of cee, an ancient
RT   gene involved in normal growth and development.";
RL   Genomics 91:315-325(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND IDENTIFICATION IN THE BAG6/BAT3 COMPLEX.
RX   PubMed=20676083; DOI=10.1038/nature09296;
RA   Mariappan M., Li X., Stefanovic S., Sharma A., Mateja A., Keenan R.J.,
RA   Hegde R.S.;
RT   "A ribosome-associating factor chaperones tail-anchored membrane
RT   proteins.";
RL   Nature 466:1120-1124(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, INTERACTION WITH BAG6, AND SUBCELLULAR LOCATION.
RX   PubMed=21636303; DOI=10.1016/j.molcel.2011.05.010;
RA   Wang Q., Liu Y., Soetandyo N., Baek K., Hegde R., Ye Y.;
RT   "A ubiquitin ligase-associated chaperone holdase maintains
RT   polypeptides in soluble states for proteasome degradation.";
RL   Mol. Cell 42:758-770(2011).
RN   [12]
RP   FUNCTION.
RX   PubMed=21743475; DOI=10.1038/nature10181;
RA   Hessa T., Sharma A., Mariappan M., Eshleman H.D., Gutierrez E.,
RA   Hegde R.S.;
RT   "Protein targeting and degradation are coupled for elimination of
RT   mislocalized proteins.";
RL   Nature 475:394-397(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   FUNCTION.
RX   PubMed=28104892; DOI=10.1126/science.aah6130;
RA   Shao S., Rodrigo-Brenni M.C., Kivlen M.H., Hegde R.S.;
RT   "Mechanistic basis for a molecular triage reaction.";
RL   Science 355:298-302(2017).
CC   -!- FUNCTION: As part of a cytosolic protein quality control complex,
CC       the BAG6/BAT3 complex, maintains misfolded and hydrophobic
CC       patches-containing proteins in a soluble state and participates to
CC       their proper delivery to the endoplasmic reticulum or
CC       alternatively can promote their sorting to the proteasome where
CC       they undergo degradation (PubMed:20676083, PubMed:21636303,
CC       PubMed:21743475, PubMed:28104892). The BAG6/BAT3 complex is
CC       involved in the post-translational delivery of tail-anchored/type
CC       II transmembrane proteins to the endoplasmic reticulum membrane.
CC       Recruited to ribosomes, it interacts with the transmembrane region
CC       of newly synthesized tail-anchored proteins and together with SGTA
CC       and ASNA1 mediates their delivery to the endoplasmic reticulum
CC       (PubMed:20676083, PubMed:28104892). Client proteins that cannot be
CC       properly delivered to the endoplasmic reticulum are ubiquitinated
CC       and sorted to the proteasome (PubMed:28104892). Similarly, the
CC       BAG6/BAT3 complex also functions as a sorting platform for
CC       proteins of the secretory pathway that are mislocalized to the
CC       cytosol either delivering them to the proteasome for degradation
CC       or to the endoplasmic reticulum (PubMed:21743475). The BAG6/BAT3
CC       complex also plays a role in the endoplasmic reticulum-associated
CC       degradation (ERAD), a quality control mechanism that eliminates
CC       unwanted proteins of the endoplasmic reticulum through their
CC       retrotranslocation to the cytosol and their targeting to the
CC       proteasome. It maintains these retrotranslocated proteins in an
CC       unfolded yet soluble state condition in the cytosol to ensure
CC       their proper delivery to the proteasome (PubMed:21636303).
CC       {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303,
CC       ECO:0000269|PubMed:21743475, ECO:0000269|PubMed:28104892}.
CC   -!- SUBUNIT: Component of the BAG6/BAT3 complex, at least composed of
CC       BAG6, UBL4A and GET4/TRC35 (PubMed:20676083). Interacts with BAG6;
CC       the interaction is direct and localizes BAG6 to the cytosol
CC       (PubMed:21636303). {ECO:0000269|PubMed:20676083,
CC       ECO:0000269|PubMed:21636303}.
CC   -!- INTERACTION:
CC       O43681:ASNA1; NbExp=3; IntAct=EBI-711823, EBI-2515857;
CC       O43741:PRKAB2; NbExp=6; IntAct=EBI-711823, EBI-1053424;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7L5D6-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=2;
CC         IsoId=Q7L5D6-2; Sequence=VSP_017652;
CC   -!- SIMILARITY: Belongs to the GET4 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK024305; BAG51289.1; -; mRNA.
DR   EMBL; AK097899; BAG53546.1; -; mRNA.
DR   EMBL; AK125863; BAG54258.1; -; mRNA.
DR   EMBL; AL133014; CAB61355.1; -; mRNA.
DR   EMBL; CH236965; EAL23708.1; -; Genomic_DNA.
DR   EMBL; BC003550; AAH03550.2; -; mRNA.
DR   EMBL; AF132954; AAD27729.1; -; mRNA.
DR   CCDS; CCDS5317.1; -. [Q7L5D6-1]
DR   PIR; T42648; T42648.
DR   RefSeq; NP_057033.2; NM_015949.2. [Q7L5D6-1]
DR   UniGene; Hs.107387; -.
DR   UniGene; Hs.743756; -.
DR   PDB; 6AU8; X-ray; 1.80 A; A=23-305.
DR   PDBsum; 6AU8; -.
DR   ProteinModelPortal; Q7L5D6; -.
DR   SMR; Q7L5D6; -.
DR   BioGrid; 119636; 64.
DR   IntAct; Q7L5D6; 46.
DR   MINT; Q7L5D6; -.
DR   STRING; 9606.ENSP00000265857; -.
DR   iPTMnet; Q7L5D6; -.
DR   PhosphoSitePlus; Q7L5D6; -.
DR   BioMuta; GET4; -.
DR   DMDM; 74738593; -.
DR   EPD; Q7L5D6; -.
DR   MaxQB; Q7L5D6; -.
DR   PaxDb; Q7L5D6; -.
DR   PeptideAtlas; Q7L5D6; -.
DR   PRIDE; Q7L5D6; -.
DR   DNASU; 51608; -.
DR   Ensembl; ENST00000265857; ENSP00000265857; ENSG00000239857. [Q7L5D6-1]
DR   Ensembl; ENST00000407192; ENSP00000385646; ENSG00000239857. [Q7L5D6-2]
DR   GeneID; 51608; -.
DR   KEGG; hsa:51608; -.
DR   UCSC; uc003sjl.2; human. [Q7L5D6-1]
DR   CTD; 51608; -.
DR   EuPathDB; HostDB:ENSG00000239857.6; -.
DR   GeneCards; GET4; -.
DR   H-InvDB; HIX0033841; -.
DR   H-InvDB; HIX0201122; -.
DR   HGNC; HGNC:21690; GET4.
DR   HPA; HPA019765; -.
DR   MIM; 612056; gene.
DR   neXtProt; NX_Q7L5D6; -.
DR   OpenTargets; ENSG00000239857; -.
DR   PharmGKB; PA165618100; -.
DR   eggNOG; KOG3024; Eukaryota.
DR   eggNOG; ENOG410XRWE; LUCA.
DR   GeneTree; ENSGT00390000015750; -.
DR   HOGENOM; HOG000264232; -.
DR   HOVERGEN; HBG059877; -.
DR   InParanoid; Q7L5D6; -.
DR   OMA; QMYRTLF; -.
DR   OrthoDB; EOG091G0DTD; -.
DR   PhylomeDB; Q7L5D6; -.
DR   TreeFam; TF315163; -.
DR   GeneWiki; C7orf20; -.
DR   GenomeRNAi; 51608; -.
DR   PRO; PR:Q7L5D6; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000239857; -.
DR   CleanEx; HS_C7orf20; -.
DR   ExpressionAtlas; Q7L5D6; baseline and differential.
DR   Genevisible; Q7L5D6; HS.
DR   GO; GO:0071818; C:BAT3 complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0051087; F:chaperone binding; IPI:BHF-UCL.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1904378; P:maintenance of unfolded protein involved in ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; IMP:UniProtKB.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR007317; UPF0363.
DR   PANTHER; PTHR12875; PTHR12875; 1.
DR   Pfam; PF04190; DUF410; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Phosphoprotein;
KW   Reference proteome; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.5}.
FT   CHAIN         2    327       Golgi to ER traffic protein 4 homolog.
FT                                /FTId=PRO_0000228104.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.5}.
FT   MOD_RES      12     12       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     53       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_017652.
FT   CONFLICT      9     22       EQESARNGGRNRGG -> DRRAPATALQPRA (in Ref.
FT                                6; AAD27729). {ECO:0000305}.
FT   CONFLICT    177    177       N -> D (in Ref. 6; AAD27729).
FT                                {ECO:0000305}.
FT   HELIX        26     35       {ECO:0000244|PDB:6AU8}.
FT   HELIX        39     55       {ECO:0000244|PDB:6AU8}.
FT   HELIX        59     75       {ECO:0000244|PDB:6AU8}.
FT   HELIX        79     95       {ECO:0000244|PDB:6AU8}.
FT   HELIX       102    114       {ECO:0000244|PDB:6AU8}.
FT   HELIX       120    133       {ECO:0000244|PDB:6AU8}.
FT   HELIX       143    155       {ECO:0000244|PDB:6AU8}.
FT   HELIX       159    167       {ECO:0000244|PDB:6AU8}.
FT   HELIX       172    186       {ECO:0000244|PDB:6AU8}.
FT   HELIX       189    191       {ECO:0000244|PDB:6AU8}.
FT   HELIX       192    205       {ECO:0000244|PDB:6AU8}.
FT   HELIX       209    222       {ECO:0000244|PDB:6AU8}.
FT   HELIX       235    248       {ECO:0000244|PDB:6AU8}.
FT   HELIX       252    261       {ECO:0000244|PDB:6AU8}.
FT   HELIX       263    266       {ECO:0000244|PDB:6AU8}.
FT   HELIX       272    284       {ECO:0000244|PDB:6AU8}.
FT   HELIX       294    298       {ECO:0000244|PDB:6AU8}.
FT   HELIX       301    303       {ECO:0000244|PDB:6AU8}.
SQ   SEQUENCE   327 AA;  36504 MW;  4D6C4233181B0512 CRC64;
     MAAAAAMAEQ ESARNGGRNR GGVQRVEGKL RASVEKGDYY EAHQMYRTLF FRYMSQSKHT
     EARELMYSGA LLFFSHGQQN SAADLSMLVL ESLEKAEVEV ADELLENLAK VFSLMDPNSP
     ERVTFVSRAL KWSSGGSGKL GHPRLHQLLA LTLWKEQNYC ESRYHFLHSA DGEGCANMLV
     EYSTSRGFRS EVDMFVAQAV LQFLCLKNKS SASVVFTTYT QKHPSIEDGP PFVEPLLNFI
     WFLLLAVDGG KLTVFTVLCE QYQPSLRRDP MYNEYLDRIG QLFFGVPPKQ TSSYGGLLGN
     LLTSLMGSSE QEDGEESPSD GSPIELD
//
ID   A0A024R206_HUMAN        Unreviewed;       311 AA.
AC   A0A024R206;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 34.
DE   SubName: Full=Ring finger protein 126, isoform CRA_b {ECO:0000313|EMBL:EAW61173.1};
GN   Name=RNF126 {ECO:0000313|EMBL:EAW61173.1};
GN   ORFNames=hCG_20566 {ECO:0000313|EMBL:EAW61173.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW61173.1};
RN   [1] {ECO:0000313|EMBL:EAW61173.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW61173.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471242; EAW61168.1; -; Genomic_DNA.
DR   EMBL; CH471242; EAW61173.1; -; Genomic_DNA.
DR   RefSeq; NP_919442.1; NM_194460.2.
DR   UniGene; Hs.69554; -.
DR   SMR; A0A024R206; -.
DR   GeneID; 55658; -.
DR   KEGG; hsa:55658; -.
DR   CTD; 55658; -.
DR   EuPathDB; HostDB:ENSG00000070423.17; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   eggNOG; ENOG41121N2; LUCA.
DR   KO; K11982; -.
DR   OMA; WGMLHSN; -.
DR   OrthoDB; EOG091G0SOO; -.
DR   ChiTaRS; RNF126; human.
DR   GenomeRNAi; 55658; -.
DR   Bgee; ENSG00000070423; -.
DR   ExpressionAtlas; A0A024R206; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IEA:Ensembl.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:Ensembl.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IEA:Ensembl.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   4: Predicted;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00175};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00175};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00175}.
FT   DOMAIN      229    270       RING-type. {ECO:0000259|PROSITE:PS50089}.
SQ   SEQUENCE   311 AA;  33861 MW;  0C748E78E6719C3E CRC64;
     MAEASPHPGR YFCHCCSVEI VPRLPDYICP RCESGFIEEL PEETRSTENG SAPSTAPTDQ
     SRPPLEHVDQ HLFTLPQGYG QFAFGIFDDS FEIPTFPPGA QADDGRDPES RRERDHPSRH
     RYGARQPRAR LTTRRATGRH EGVPTLEGII QQLVNGIITP ATIPSLGPWG VLHSNPMDYA
     WGANGLDAII TQLLNQFENT GPPPADKEKI QALPTVPVTE EHVGSGLECP VCKDDYALGE
     RVRQLPCNHL FHDGCIVPWL EQHDSCPVCR KSLTGQNTAT NPPGLTGVSF SSSSSSSSSS
     SPSNENATSN S
//
ID   A8K0Q1_HUMAN            Unreviewed;       311 AA.
AC   A8K0Q1;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   31-JAN-2018, entry version 55.
DE   SubName: Full=cDNA FLJ77001, highly similar to Homo sapiens ring finger protein 126 (RNF126), transcript variant 2, mRNA {ECO:0000313|EMBL:BAF82305.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF82305.1};
RN   [1] {ECO:0000313|EMBL:BAF82305.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:BAF82305.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK289616; BAF82305.1; -; mRNA.
DR   RefSeq; NP_919442.1; NM_194460.2.
DR   UniGene; Hs.69554; -.
DR   ProteinModelPortal; A8K0Q1; -.
DR   PeptideAtlas; A8K0Q1; -.
DR   GeneID; 55658; -.
DR   KEGG; hsa:55658; -.
DR   CTD; 55658; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   eggNOG; ENOG41121N2; LUCA.
DR   HOGENOM; HOG000116417; -.
DR   HOVERGEN; HBG059832; -.
DR   KO; K11982; -.
DR   GenomeRNAi; 55658; -.
DR   Genevisible; A8K0Q1; HS.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00175};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00175};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00175}.
FT   DOMAIN      229    270       RING-type. {ECO:0000259|PROSITE:PS50089}.
SQ   SEQUENCE   311 AA;  33909 MW;  2B60B63B16DDD021 CRC64;
     MAEASPHPGR YFCHCCSVEI VPRLPDYICP RCESDFIEEL PEETRSTENG SAPSTAPTDQ
     SRPPLEHVDQ HLFTLPQGYG QFAFGIFDDS FEIPTFPPGA QADDGRDPES RRERDHPSRH
     RYGARQPRAR LTTRRATGRH EGVPTLEGII QQLVNGIITP ATIPSLGPWG VLHSNPMDYA
     WGANGLDAII TQLLNQFENT GPPSADKEKI QALPTVPVTE EHVGSGLECP VCKDDYALGE
     RVRQLPCNHL FHDGCIVPWL EQHDSCPVCR KSLTGQNTAT NPPGLTGVSF SSSSSSSSSS
     SPSNENATSN S
//
ID   RN126_HUMAN             Reviewed;         326 AA.
AC   Q9BV68; Q9NWX1;
DT   27-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   23-MAY-2018, entry version 141.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF126 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:23026136, ECO:0000269|PubMed:24981174};
DE   AltName: Full=RING finger protein 126 {ECO:0000312|HGNC:HGNC:21151};
GN   Name=RNF126 {ECO:0000312|HGNC:HGNC:21151};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [4]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-5, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, INTERACTION WITH CDKN1A,
RP   SUBCELLULAR LOCATION, UBIQUITINATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF CYS-229 AND CYS-232.
RX   PubMed=23026136; DOI=10.1158/0008-5472.CAN-12-0562;
RA   Zhi X., Zhao D., Wang Z., Zhou Z., Wang C., Chen W., Liu R., Chen C.;
RT   "E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by
RT   targeting the tumor suppressor p21 for ubiquitin-mediated
RT   degradation.";
RL   Cancer Res. 73:385-394(2013).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH CCDC50; EGFR; FLT3 AND SCAMP3.
RX   PubMed=23418353; DOI=10.1242/jcs.116129;
RA   Smith C.J., Berry D.M., McGlade C.J.;
RT   "The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal
RT   sorting of the epidermal growth factor receptor.";
RL   J. Cell Sci. 126:1366-1380(2013).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH AICDA.
RX   PubMed=23277564; DOI=10.1073/pnas.1214538110;
RA   Delker R.K., Zhou Y., Strikoudis A., Stebbins C.E., Papavasiliou F.N.;
RT   "Solubility-based genetic screen identifies RING finger protein 126 as
RT   an E3 ligase for activation-induced cytidine deaminase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:1029-1034(2013).
RN   [9]
RP   FUNCTION.
RX   PubMed=24275455; DOI=10.1016/j.yexcr.2013.11.013;
RA   Smith C.J., McGlade C.J.;
RT   "The ubiquitin ligase RNF126 regulates the retrograde sorting of the
RT   cation-independent mannose 6-phosphate receptor.";
RL   Exp. Cell Res. 320:219-232(2014).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND INTERACTION WITH BAG6.
RX   PubMed=24981174; DOI=10.1016/j.molcel.2014.05.025;
RA   Rodrigo-Brenni M.C., Gutierrez E., Hegde R.S.;
RT   "Cytosolic quality control of mislocalized proteins requires RNF126
RT   recruitment to Bag6.";
RL   Mol. Cell 55:227-237(2014).
RN   [11] {ECO:0000244|PDB:2N9O, ECO:0000244|PDB:2N9P}
RP   STRUCTURE BY NMR OF 1-40 IN COMPLEX WITH BAG6 AND ZINC, DOMAIN,
RP   INTERACTION WITH BAG6, ZINC-BINDING, AND MUTAGENESIS OF HIS-14; PHE-36
RP   AND 38-GLU-GLU-39.
RX   PubMed=27193484; DOI=10.1038/srep26433;
RA   Krysztofinska E.M., Martinez-Lumbreras S., Thapaliya A., Evans N.J.,
RA   High S., Isaacson R.L.;
RT   "Structural and functional insights into the E3 ligase, RNF126.";
RL   Sci. Rep. 6:26433-26433(2016).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination
CC       oF target proteins (PubMed:23277564, PubMed:24275455,
CC       PubMed:24981174). Depending on the associated E2 ligase, mediates
CC       'Lys-48'- and 'Lys-63'-linked polyubiquitination of substrates (By
CC       similarity). Part of a BAG6-dependent quality control process
CC       ensuring that proteins of the secretory pathway that are
CC       mislocalized to the cytosol are degraded by the proteasome.
CC       Probably acts by providing the ubiquitin ligase activity
CC       associated with the BAG6 complex and be responsible for
CC       ubiquitination of the hydrophobic mislocalized proteins and their
CC       targeting to the proteasome (PubMed:24981174). May also play a
CC       role in the endosomal recycling of IGF2R, the cation-independent
CC       mannose-6-phosphate receptor (PubMed:24275455). May play a role in
CC       the endosomal sorting and degradation of several membrane
CC       receptors including EGFR, FLT3, MET and CXCR4, by mediating their
CC       ubiquitination (PubMed:23418353). By ubiquitinating CDKN1A/p21 and
CC       targeting it for degradation, may also promote cell proliferation
CC       (PubMed:23026136). May monoubiquitinate AICDA (PubMed:23277564).
CC       {ECO:0000250|UniProtKB:Q91YL2, ECO:0000269|PubMed:23277564,
CC       ECO:0000269|PubMed:23418353, ECO:0000269|PubMed:24275455,
CC       ECO:0000269|PubMed:24981174, ECO:0000305|PubMed:23026136}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:23026136,
CC       ECO:0000269|PubMed:24981174}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:23026136, ECO:0000269|PubMed:24981174}.
CC   -!- SUBUNIT: Interacts with CCDC50, EGFR, FLT3 and SCAMP3
CC       (PubMed:23418353). Interacts with BAG6 (via ubiquitin-like
CC       domain); required for BAG6-dependent ubiquitination of proteins
CC       mislocalized to the cytosol (PubMed:24981174, PubMed:27193484).
CC       Interacts with CDKN1A (PubMed:23026136). Interacts with AICDA
CC       (PubMed:23277564). {ECO:0000269|PubMed:23026136,
CC       ECO:0000269|PubMed:23277564, ECO:0000269|PubMed:23418353,
CC       ECO:0000269|PubMed:24981174, ECO:0000269|PubMed:27193484}.
CC   -!- INTERACTION:
CC       P46379:BAG6; NbExp=4; IntAct=EBI-357322, EBI-347552;
CC       P51668:UBE2D1; NbExp=8; IntAct=EBI-357322, EBI-743540;
CC       P62837:UBE2D2; NbExp=4; IntAct=EBI-357322, EBI-347677;
CC       P61077:UBE2D3; NbExp=5; IntAct=EBI-357322, EBI-348268;
CC       Q9Y2X8:UBE2D4; NbExp=5; IntAct=EBI-357322, EBI-745527;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23026136}.
CC       Nucleus {ECO:0000269|PubMed:23026136}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BV68-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BV68-2; Sequence=VSP_015693, VSP_015694;
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver and testis.
CC       {ECO:0000269|PubMed:23026136}.
CC   -!- DOMAIN: The C4-type zinc finger is required for interaction with
CC       BAG6. {ECO:0000269|PubMed:27193484}.
CC   -!- PTM: Ubiquitinated. May undergo autoubiquitination.
CC       {ECO:0000269|PubMed:23026136}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK000559; BAA91254.1; -; mRNA.
DR   EMBL; BC001442; AAH01442.1; -; mRNA.
DR   EMBL; BC025374; AAH25374.1; -; mRNA.
DR   CCDS; CCDS12039.1; -. [Q9BV68-2]
DR   RefSeq; NP_919442.1; NM_194460.2. [Q9BV68-2]
DR   UniGene; Hs.69554; -.
DR   PDB; 2N9O; NMR; -; A=1-40.
DR   PDB; 2N9P; NMR; -; A=1-40.
DR   PDBsum; 2N9O; -.
DR   PDBsum; 2N9P; -.
DR   ProteinModelPortal; Q9BV68; -.
DR   SMR; Q9BV68; -.
DR   BioGrid; 120790; 103.
DR   IntAct; Q9BV68; 31.
DR   MINT; Q9BV68; -.
DR   STRING; 9606.ENSP00000292363; -.
DR   iPTMnet; Q9BV68; -.
DR   PhosphoSitePlus; Q9BV68; -.
DR   BioMuta; RNF126; -.
DR   DMDM; 74762712; -.
DR   EPD; Q9BV68; -.
DR   MaxQB; Q9BV68; -.
DR   PaxDb; Q9BV68; -.
DR   PeptideAtlas; Q9BV68; -.
DR   PRIDE; Q9BV68; -.
DR   Ensembl; ENST00000292363; ENSP00000292363; ENSG00000070423. [Q9BV68-2]
DR   GeneID; 55658; -.
DR   KEGG; hsa:55658; -.
DR   UCSC; uc010drs.4; human. [Q9BV68-1]
DR   CTD; 55658; -.
DR   EuPathDB; HostDB:ENSG00000070423.17; -.
DR   GeneCards; RNF126; -.
DR   H-InvDB; HIX0014558; -.
DR   HGNC; HGNC:21151; RNF126.
DR   HPA; HPA043050; -.
DR   MIM; 615177; gene.
DR   neXtProt; NX_Q9BV68; -.
DR   OpenTargets; ENSG00000070423; -.
DR   PharmGKB; PA134876469; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   eggNOG; ENOG41121N2; LUCA.
DR   GeneTree; ENSGT00530000062967; -.
DR   HOGENOM; HOG000116417; -.
DR   HOVERGEN; HBG059832; -.
DR   InParanoid; Q9BV68; -.
DR   KO; K11982; -.
DR   OMA; WGMLHSN; -.
DR   OrthoDB; EOG091G0SOO; -.
DR   PhylomeDB; Q9BV68; -.
DR   TreeFam; TF317985; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF126; human.
DR   GenomeRNAi; 55658; -.
DR   PRO; PR:Q9BV68; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000070423; -.
DR   CleanEx; HS_RNF126; -.
DR   ExpressionAtlas; Q9BV68; baseline and differential.
DR   Genevisible; Q9BV68; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0071629; P:cytoplasm protein quality control by the ubiquitin-proteasome system; IMP:UniProtKB.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IBA:GO_Central.
DR   GO; GO:0042127; P:regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IMP:UniProtKB.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:20068231}.
FT   CHAIN         2    326       E3 ubiquitin-protein ligase RNF126.
FT                                /FTId=PRO_0000056093.
FT   ZN_FING      13     32       C4-type. {ECO:0000269|PubMed:27193484}.
FT   ZN_FING     229    270       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   REGION        5    100       Required for interaction with BAG6.
FT                                {ECO:0000269|PubMed:24981174}.
FT   REGION      200    304       Sufficient for interaction with AICDA.
FT                                {ECO:0000269|PubMed:23277564}.
FT   COMPBIAS    289    303       Ser-rich.
FT   METAL        13     13       Zinc. {ECO:0000244|PDB:2N9O,
FT                                ECO:0000269|PubMed:27193484}.
FT   METAL        16     16       Zinc. {ECO:0000244|PDB:2N9O,
FT                                ECO:0000269|PubMed:27193484}.
FT   METAL        29     29       Zinc. {ECO:0000244|PDB:2N9O,
FT                                ECO:0000269|PubMed:27193484}.
FT   METAL        32     32       Zinc. {ECO:0000244|PDB:2N9O,
FT                                ECO:0000269|PubMed:27193484}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES       5      5       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     309    311       WSP -> SNS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015693.
FT   VAR_SEQ     312    326       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015694.
FT   VARIANT      68     68       V -> M (in dbSNP:rs2285751).
FT                                /FTId=VAR_057217.
FT   MUTAGEN      14     14       H->A: Impaired interaction with BAG6.
FT                                {ECO:0000269|PubMed:27193484}.
FT   MUTAGEN      36     36       F->A: Impaired interaction with BAG6.
FT                                {ECO:0000269|PubMed:27193484}.
FT   MUTAGEN      38     39       EE->RR: Impaired interaction with BAG6.
FT                                {ECO:0000269|PubMed:27193484}.
FT   MUTAGEN     229    229       C->A: Loss of E3 ligase activity; when
FT                                associated with A-232.
FT                                {ECO:0000269|PubMed:23026136}.
FT   MUTAGEN     232    232       C->A: Loss of E3 ligase activity; when
FT                                associated with A-229.
FT                                {ECO:0000269|PubMed:23026136}.
FT   STRAND       11     13       {ECO:0000244|PDB:2N9O}.
FT   TURN         14     17       {ECO:0000244|PDB:2N9O}.
FT   STRAND       18     20       {ECO:0000244|PDB:2N9O}.
FT   TURN         24     26       {ECO:0000244|PDB:2N9O}.
FT   TURN         30     32       {ECO:0000244|PDB:2N9O}.
FT   STRAND       37     39       {ECO:0000244|PDB:2N9O}.
SQ   SEQUENCE   326 AA;  35585 MW;  D422FFB090362F46 CRC64;
     MAEASPHPGR YFCHCCSVEI VPRLPDYICP RCESGFIEEL PEETRSTENG SAPSTAPTDQ
     SRPPLEHVDQ HLFTLPQGYG QFAFGIFDDS FEIPTFPPGA QADDGRDPES RRERDHPSRH
     RYGARQPRAR LTTRRATGRH EGVPTLEGII QQLVNGIITP ATIPSLGPWG VLHSNPMDYA
     WGANGLDAII TQLLNQFENT GPPPADKEKI QALPTVPVTE EHVGSGLECP VCKDDYALGE
     RVRQLPCNHL FHDGCIVPWL EQHDSCPVCR KSLTGQNTAT NPPGLTGVSF SSSSSSSSSS
     SPSNENATWS PLGRPQPPRP LSNLTL
//
ID   DNJB2_HUMAN             Reviewed;         324 AA.
AC   P25686; A8K9P6; Q53QD7; Q8IUK1; Q8IUK2; Q96F52;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 3.
DT   28-FEB-2018, entry version 171.
DE   RecName: Full=DnaJ homolog subfamily B member 2 {ECO:0000305};
DE   AltName: Full=Heat shock 40 kDa protein 3 {ECO:0000312|MIM:604139};
DE   AltName: Full=Heat shock protein J1 {ECO:0000303|PubMed:1599432};
DE            Short=HSJ-1 {ECO:0000303|PubMed:1599432};
DE   Flags: Precursor;
GN   Name=DNAJB2 {ECO:0000312|HGNC:HGNC:5228};
GN   Synonyms=HSJ1 {ECO:0000303|PubMed:1599432},
GN   HSPF3 {ECO:0000312|MIM:604139};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1599432; DOI=10.1042/bj2840469;
RA   Cheetham M.E., Brion J.-P., Anderton B.H.;
RT   "Human homologues of the bacterial heat-shock protein DnaJ are
RT   preferentially expressed in neurons.";
RL   Biochem. J. 284:469-476(1992).
RN   [2]
RP   SEQUENCE REVISION TO 214.
RA   Cheetham M.E.;
RL   Submitted (JUL-1998) to UniProtKB.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain, and Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Colon, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION.
RX   PubMed=7957263; DOI=10.1111/j.1432-1033.1994.tb20030.x;
RA   Cheetham M.E., Jackson A.P., Anderton B.H.;
RT   "Regulation of 70-kDa heat-shock-protein ATPase activity and substrate
RT   binding by human DnaJ-like proteins, HSJ1a and HSJ1b.";
RL   Eur. J. Biochem. 226:99-107(1994).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION (ISOFORMS 1 AND 2), TOPOLOGY (ISOFORM
RP   1), TISSUE SPECIFICITY (ISOFORMS 1 AND 2), MUTAGENESIS OF HIS-31;
RP   CYS-321 AND LEU-324, ISOPRENYLATION AT CYS-321, METHYLATION AT
RP   CYS-321, AND MOTIF.
RX   PubMed=12754272; DOI=10.1074/jbc.M212349200;
RA   Chapple J.P., Cheetham M.E.;
RT   "The chaperone environment at the cytoplasmic face of the endoplasmic
RT   reticulum can modulate rhodopsin processing and inclusion formation.";
RL   J. Biol. Chem. 278:19087-19094(2003).
RN   [10]
RP   FUNCTION, INTERACTION WITH HSPA8 AND PSMA3, UBIQUITINATION BY STUB1,
RP   DOMAIN, AND MUTAGENESIS OF 31-HIS--ASP-33; SER-219; GLU-222; SER-262
RP   AND GLU-265.
RX   PubMed=15936278; DOI=10.1016/j.cub.2005.04.058;
RA   Westhoff B., Chapple J.P., van der Spuy J., Hoehfeld J.,
RA   Cheetham M.E.;
RT   "HSJ1 is a neuronal shuttling factor for the sorting of chaperone
RT   clients to the proteasome.";
RL   Curr. Biol. 15:1058-1064(2005).
RN   [11]
RP   FUNCTION, DOMAIN, AND MUTAGENESIS OF HIS-31.
RX   PubMed=20889486; DOI=10.1093/hmg/ddq428;
RA   Rose J.M., Novoselov S.S., Robinson P.A., Cheetham M.E.;
RT   "Molecular chaperone-mediated rescue of mitophagy by a Parkin RING1
RT   domain mutant.";
RL   Hum. Mol. Genet. 20:16-27(2011).
RN   [12]
RP   FUNCTION.
RX   PubMed=21719532; DOI=10.1210/me.2011-1020;
RA   Meimaridou E., Gooljar S.B., Ramnarace N., Anthonypillai L.,
RA   Clark A.J., Chapple J.P.;
RT   "The cytosolic chaperone Hsc70 promotes traffic to the cell surface of
RT   intracellular retained melanocortin-4 receptor mutants.";
RL   Mol. Endocrinol. 25:1650-1660(2011).
RN   [13]
RP   FUNCTION, INTERACTION WITH HSP70, SUBCELLULAR LOCATION, DOMAIN, AND
RP   MUTAGENESIS OF 31-HIS--ASP-33; SER-219; GLU-222; SER-262 AND GLU-265.
RX   PubMed=21625540; DOI=10.1371/journal.pone.0019763;
RA   Gao X.C., Zhou C.J., Zhou Z.R., Zhang Y.H., Zheng X.M., Song A.X.,
RA   Hu H.Y.;
RT   "Co-chaperone HSJ1a dually regulates the proteasomal degradation of
RT   ataxin-3.";
RL   PLoS ONE 6:E19763-E19763(2011).
RN   [14]
RP   INVOLVEMENT IN DSMA5.
RX   PubMed=22522442; DOI=10.1002/ana.22684;
RA   Blumen S.C., Astord S., Robin V., Vignaud L., Toumi N., Cieslik A.,
RA   Achiron A., Carasso R.L., Gurevich M., Braverman I., Blumen N.,
RA   Munich A., Barkats M., Viollet L.;
RT   "A rare recessive distal hereditary motor neuropathy with HSJ1
RT   chaperone mutation.";
RL   Ann. Neurol. 71:509-519(2012).
RN   [15]
RP   FUNCTION.
RX   PubMed=22396390; DOI=10.1093/brain/aws022;
RA   Labbadia J., Novoselov S.S., Bett J.S., Weiss A., Paganetti P.,
RA   Bates G.P., Cheetham M.E.;
RT   "Suppression of protein aggregation by chaperone modification of high
RT   molecular weight complexes.";
RL   Brain 135:1180-1196(2012).
RN   [16]
RP   FUNCTION.
RX   PubMed=24023695; DOI=10.1371/journal.pone.0073944;
RA   Novoselov S.S., Mustill W.J., Gray A.L., Dick J.R., Kanuga N.,
RA   Kalmar B., Greensmith L., Cheetham M.E.;
RT   "Molecular chaperone mediated late-stage neuroprotection in the
RT   SOD1(G93A) mouse model of amyotrophic lateral sclerosis.";
RL   PLoS ONE 8:E73944-E73944(2013).
RN   [17]
RP   INVOLVEMENT IN DSMA5, AND VARIANT DSMA5 CYS-5.
RX   PubMed=24627108; DOI=10.1007/s00415-014-7289-8;
RA   Schabhuettl M., Wieland T., Senderek J., Baets J., Timmerman V.,
RA   De Jonghe P., Reilly M.M., Stieglbauer K., Laich E., Windhager R.,
RA   Erwa W., Trajanoski S., Strom T.M., Auer-Grumbach M.;
RT   "Whole-exome sequencing in patients with inherited neuropathies:
RT   outcome and challenges.";
RL   J. Neurol. 261:970-982(2014).
RN   [18]
RP   INVOLVEMENT IN DSMA5, AND VARIANT DSMA5 CYS-5.
RX   PubMed=25274842; DOI=10.1212/WNL.0000000000000966;
RA   Gess B., Auer-Grumbach M., Schirmacher A., Strom T., Zitzelsberger M.,
RA   Rudnik-Schoneborn S., Rohr D., Halfter H., Young P., Senderek J.;
RT   "HSJ1-related hereditary neuropathies: novel mutations and extended
RT   clinical spectrum.";
RL   Neurology 83:1726-1732(2014).
RN   [19]
RP   STRUCTURE BY NMR OF 1-71, FUNCTION, INTERACTION WITH HSP70, AND
RP   DOMAIN.
RX   PubMed=22219199; DOI=10.1074/jbc.M111.294728;
RA   Gao X.C., Zhou C.J., Zhou Z.R., Wu M., Cao C.Y., Hu H.Y.;
RT   "The C-terminal helices of heat shock protein 70 are essential for J-
RT   domain binding and ATPase activation.";
RL   J. Biol. Chem. 287:6044-6052(2012).
CC   -!- FUNCTION: Functions as a co-chaperone, regulating the substrate
CC       binding and activating the ATPase activity of chaperones of the
CC       HSP70/heat shock protein 70 family (PubMed:7957263,
CC       PubMed:22219199). In parallel, also contributes to the ubiquitin-
CC       dependent proteasomal degradation of misfolded proteins
CC       (PubMed:15936278, PubMed:21625540). Thereby, may regulate the
CC       aggregation and promote the functional recovery of misfolded
CC       proteins like HTT, MC4R, PRKN, RHO and SOD1 and be crucial for
CC       many biological processes (PubMed:12754272, PubMed:20889486,
CC       PubMed:21719532, PubMed:22396390, PubMed:24023695). Isoform 1
CC       which is localized to the endoplasmic reticulum membranes may
CC       specifically function in ER-associated protein degradation of
CC       misfolded proteins (PubMed:15936278).
CC       {ECO:0000269|PubMed:12754272, ECO:0000269|PubMed:15936278,
CC       ECO:0000269|PubMed:20889486, ECO:0000269|PubMed:21625540,
CC       ECO:0000269|PubMed:21719532, ECO:0000269|PubMed:22219199,
CC       ECO:0000269|PubMed:22396390, ECO:0000269|PubMed:24023695,
CC       ECO:0000269|PubMed:7957263}.
CC   -!- SUBUNIT: Interacts with HSP70 (HSPA1A or HSPA1B) (PubMed:21625540,
CC       PubMed:22219199). Interacts with HSPA8/Hsc70 (PubMed:15936278).
CC       Interacts with PSMA3 and most probably with the whole proteasomal
CC       complex (PubMed:15936278). {ECO:0000269|PubMed:15936278,
CC       ECO:0000269|PubMed:21625540, ECO:0000269|PubMed:22219199}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm
CC       {ECO:0000269|PubMed:12754272, ECO:0000269|PubMed:21625540}.
CC       Nucleus {ECO:0000269|PubMed:12754272}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12754272}; Lipid-anchor
CC       {ECO:0000269|PubMed:12754272}; Cytoplasmic side
CC       {ECO:0000269|PubMed:12754272}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=HSJ1b {ECO:0000303|PubMed:1599432};
CC         IsoId=P25686-3; Sequence=Displayed;
CC       Name=2; Synonyms=HSJ1a {ECO:0000303|PubMed:1599432}, DNAJB2a
CC       {ECO:0000303|PubMed:20889486};
CC         IsoId=P25686-2; Sequence=VSP_001286, VSP_001287;
CC   -!- TISSUE SPECIFICITY: More abundantly expressed in neocortex,
CC       cerebellum, spinal cord and retina where it is expressed by
CC       neuronal cells (at protein level) (PubMed:1599432,
CC       PubMed:12754272). Detected at much lower level in non-neuronal
CC       tissues including kidney, lung, heart, skeletal muscle, spleen and
CC       testis (at protein level) (PubMed:12754272, PubMed:1599432).
CC       Isoform 1 is more abundant in neocortex and cerebellum compared to
CC       isoform 2 (at protein level) (PubMed:12754272).
CC       {ECO:0000269|PubMed:12754272, ECO:0000269|PubMed:1599432}.
CC   -!- DOMAIN: The J domain is sufficient to interact with HSP70 (HSPA1A
CC       or HSPA1B) and activate its ATPase activity (PubMed:22219199). The
CC       J domain is also required for the HSP70-mediated and ubiquitin-
CC       dependent proteasomal degradation of proteins like ATXN3
CC       (PubMed:21625540). The J domain is required to reduce PRKN
CC       cytoplasmic aggregation (PubMed:20889486).
CC       {ECO:0000269|PubMed:20889486, ECO:0000269|PubMed:21625540,
CC       ECO:0000269|PubMed:22219199}.
CC   -!- DOMAIN: The UIM domains mediate interaction with ubiquitinated
CC       chaperone clients and with the proteasome (PubMed:15936278). The
CC       UIM domains may have an opposite activity to the J domain, binding
CC       ubiquitinated proteins and protecting them from HSP70-mediated
CC       proteasomal degradation (PubMed:21625540). The UIM domains are not
CC       required to reduce PRKN cytoplasmic aggregation (PubMed:20889486).
CC       {ECO:0000269|PubMed:15936278, ECO:0000269|PubMed:20889486,
CC       ECO:0000269|PubMed:21625540}.
CC   -!- PTM: Ubiquitinated by STUB1; does not lead to proteasomal
CC       degradation. {ECO:0000269|PubMed:15936278}.
CC   -!- DISEASE: Distal spinal muscular atrophy, autosomal recessive, 5
CC       (DSMA5) [MIM:614881]: An autosomal recessive neurologic disorder
CC       characterized by young adult onset of slowly progressive distal
CC       muscle weakness and atrophy resulting in gait impairment and loss
CC       of reflexes due to impaired function of motor nerves. Sensation
CC       and cognition are not impaired. {ECO:0000269|PubMed:22522442,
CC       ECO:0000269|PubMed:24627108, ECO:0000269|PubMed:25274842}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA09035.1; Type=Frameshift; Positions=288; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S37375; AAA09034.1; -; mRNA.
DR   EMBL; S37374; AAA09035.1; ALT_FRAME; mRNA.
DR   EMBL; X63368; CAA44968.2; -; Genomic_DNA.
DR   EMBL; X63368; CAA44969.2; -; Genomic_DNA.
DR   EMBL; BT007088; AAP35751.1; -; mRNA.
DR   EMBL; AK292761; BAF85450.1; -; mRNA.
DR   EMBL; AK312723; BAG35597.1; -; mRNA.
DR   EMBL; AC114803; AAY24037.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70722.1; -; Genomic_DNA.
DR   EMBL; BC011609; AAH11609.1; -; mRNA.
DR   EMBL; BC047056; AAH47056.1; -; mRNA.
DR   CCDS; CCDS2439.1; -. [P25686-3]
DR   CCDS; CCDS46519.1; -. [P25686-2]
DR   PIR; S23508; S23508.
DR   RefSeq; NP_001034639.1; NM_001039550.1. [P25686-2]
DR   RefSeq; NP_006727.2; NM_006736.5. [P25686-3]
DR   UniGene; Hs.77768; -.
DR   PDB; 2LGW; NMR; -; A=1-91.
DR   PDBsum; 2LGW; -.
DR   ProteinModelPortal; P25686; -.
DR   SMR; P25686; -.
DR   BioGrid; 109533; 48.
DR   CORUM; P25686; -.
DR   DIP; DIP-29051N; -.
DR   IntAct; P25686; 17.
DR   MINT; P25686; -.
DR   STRING; 9606.ENSP00000338019; -.
DR   iPTMnet; P25686; -.
DR   PhosphoSitePlus; P25686; -.
DR   BioMuta; DNAJB2; -.
DR   DMDM; 158518384; -.
DR   EPD; P25686; -.
DR   PaxDb; P25686; -.
DR   PeptideAtlas; P25686; -.
DR   PRIDE; P25686; -.
DR   DNASU; 3300; -.
DR   Ensembl; ENST00000336576; ENSP00000338019; ENSG00000135924. [P25686-3]
DR   Ensembl; ENST00000392086; ENSP00000375936; ENSG00000135924. [P25686-2]
DR   GeneID; 3300; -.
DR   KEGG; hsa:3300; -.
DR   UCSC; uc002vkw.2; human. [P25686-3]
DR   UCSC; uc002vkx.2; human.
DR   CTD; 3300; -.
DR   DisGeNET; 3300; -.
DR   EuPathDB; HostDB:ENSG00000135924.15; -.
DR   GeneCards; DNAJB2; -.
DR   HGNC; HGNC:5228; DNAJB2.
DR   HPA; HPA036268; -.
DR   MalaCards; DNAJB2; -.
DR   MIM; 604139; gene.
DR   MIM; 614881; phenotype.
DR   neXtProt; NX_P25686; -.
DR   OpenTargets; ENSG00000135924; -.
DR   Orphanet; 314485; Young adult-onset distal hereditary motor neuropathy.
DR   PharmGKB; PA27415; -.
DR   eggNOG; KOG0714; Eukaryota.
DR   eggNOG; COG0484; LUCA.
DR   GeneTree; ENSGT00760000118947; -.
DR   HOGENOM; HOG000111538; -.
DR   HOVERGEN; HBG066998; -.
DR   InParanoid; P25686; -.
DR   KO; K09508; -.
DR   OMA; TFTFRNP; -.
DR   OrthoDB; EOG091G152F; -.
DR   PhylomeDB; P25686; -.
DR   TreeFam; TF105142; -.
DR   ChiTaRS; DNAJB2; human.
DR   GeneWiki; DNAJB2; -.
DR   GenomeRNAi; 3300; -.
DR   PRO; PR:P25686; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000135924; -.
DR   CleanEx; HS_DNAJB2; -.
DR   ExpressionAtlas; P25686; baseline and differential.
DR   Genevisible; P25686; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016234; C:inclusion body; IDA:BHF-UCL.
DR   GO; GO:0031227; C:intrinsic component of endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0001671; F:ATPase activator activity; IDA:UniProtKB.
DR   GO; GO:0051087; F:chaperone binding; IPI:UniProtKB.
DR   GO; GO:0030544; F:Hsp70 protein binding; IDA:UniProtKB.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0070628; F:proteasome binding; IDA:BHF-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0061077; P:chaperone-mediated protein folding; IMP:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; IGI:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IGI:UniProtKB.
DR   GO; GO:0090084; P:negative regulation of inclusion body assembly; IDA:BHF-UCL.
DR   GO; GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB.
DR   GO; GO:0090086; P:negative regulation of protein deubiquitination; IDA:BHF-UCL.
DR   GO; GO:0032781; P:positive regulation of ATPase activity; IDA:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0042026; P:protein refolding; IDA:UniProtKB.
DR   GO; GO:1903644; P:regulation of chaperone-mediated protein folding; IDA:UniProtKB.
DR   GO; GO:0032880; P:regulation of protein localization; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IMP:UniProtKB.
DR   GO; GO:0006986; P:response to unfolded protein; TAS:ProtInc.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:BHF-UCL.
DR   CDD; cd06257; DnaJ; 1.
DR   Gene3D; 1.10.287.110; -; 1.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR018253; DnaJ_domain_CS.
DR   InterPro; IPR036869; J_dom_sf.
DR   InterPro; IPR003903; UIM_dom.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF02809; UIM; 2.
DR   PRINTS; PR00625; JDOMAIN.
DR   SMART; SM00271; DnaJ; 1.
DR   SMART; SM00726; UIM; 2.
DR   SUPFAM; SSF46565; SSF46565; 1.
DR   PROSITE; PS00636; DNAJ_1; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
DR   PROSITE; PS50330; UIM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chaperone;
KW   Complete proteome; Cytoplasm; Endoplasmic reticulum; Lipoprotein;
KW   Membrane; Methylation; Neurodegeneration; Nucleus; Phosphoprotein;
KW   Polymorphism; Prenylation; Reference proteome; Repeat;
KW   Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:Q9QYI5}.
FT   CHAIN         2    321       DnaJ homolog subfamily B member 2.
FT                                /FTId=PRO_0000071018.
FT   PROPEP      322    324       Removed in mature form.
FT                                {ECO:0000305|PubMed:12754272}.
FT                                /FTId=PRO_0000438687.
FT   DOMAIN        2     71       J. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00286}.
FT   DOMAIN      210    226       UIM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00213}.
FT   DOMAIN      250    269       UIM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00213}.
FT   MOTIF       321    324       CAAX motif.
FT                                {ECO:0000269|PubMed:12754272}.
FT   COMPBIAS    141    170       Ser-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00016}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000250|UniProtKB:Q9QYI5}.
FT   MOD_RES     311    311       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9QYI5}.
FT   MOD_RES     321    321       Cysteine methyl ester.
FT                                {ECO:0000305|PubMed:12754272}.
FT   LIPID       321    321       S-geranylgeranyl cysteine.
FT                                {ECO:0000269|PubMed:12754272}.
FT   VAR_SEQ     275    277       GGR -> DVF (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001286.
FT   VAR_SEQ     278    324       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001287.
FT   VARIANT       5      5       Y -> C (in DSMA5; dbSNP:rs730882140).
FT                                {ECO:0000269|PubMed:24627108,
FT                                ECO:0000269|PubMed:25274842}.
FT                                /FTId=VAR_073286.
FT   VARIANT     270    270       G -> R (in dbSNP:rs34127289).
FT                                /FTId=VAR_048910.
FT   MUTAGEN      31     33       HPD->QPN: Loss of interaction with HSP70
FT                                and loss of the ability to promote ATXN3
FT                                proteasomal degradation.
FT                                {ECO:0000269|PubMed:21625540}.
FT   MUTAGEN      31     31       H->Q: Probable loss of interaction with
FT                                HSP70 and loss of the ability to reduce
FT                                PRKN aggregation.
FT                                {ECO:0000269|PubMed:12754272,
FT                                ECO:0000269|PubMed:20889486}.
FT   MUTAGEN     219    219       S->A: Loss of interaction with
FT                                polyubiquitin chains, loss of interaction
FT                                with PSMA3, and loss of the ability to
FT                                protect ATXN3 from proteasomal
FT                                degradation; when associated with A-222;
FT                                A-262 and A-265.
FT                                {ECO:0000269|PubMed:15936278,
FT                                ECO:0000269|PubMed:21625540}.
FT   MUTAGEN     222    222       E->A: Loss of interaction with
FT                                polyubiquitin chains, loss of interaction
FT                                with PSMA3, and loss of the ability to
FT                                protect ATXN3 from proteasomal
FT                                degradation; when associated with A-219;
FT                                A-262 and A-265.
FT                                {ECO:0000269|PubMed:15936278,
FT                                ECO:0000269|PubMed:21625540}.
FT   MUTAGEN     262    262       S->A: Loss of interaction with
FT                                polyubiquitin chains, loss of interaction
FT                                with PSMA3, and loss of the ability to
FT                                protect ATXN3 from proteasomal
FT                                degradation; when associated with A-219;
FT                                A-222 and A-265.
FT                                {ECO:0000269|PubMed:15936278,
FT                                ECO:0000269|PubMed:21625540}.
FT   MUTAGEN     265    265       E->A: Loss of interaction with
FT                                polyubiquitin chains, loss of interaction
FT                                with PSMA3, and loss of the ability to
FT                                protect ATXN3 from proteasomal
FT                                degradation; when associated with A-219;
FT                                A-222 and A-262.
FT                                {ECO:0000269|PubMed:15936278,
FT                                ECO:0000269|PubMed:21625540}.
FT   MUTAGEN     321    321       C->S: Loss of localization to the
FT                                endoplasmic reticulum and relocalization
FT                                to cytoplasm and nucleus.
FT                                {ECO:0000269|PubMed:12754272}.
FT   MUTAGEN     324    324       L->M: No effect on localization to the
FT                                endoplasmic reticulum membrane.
FT                                {ECO:0000269|PubMed:12754272}.
FT   CONFLICT    214    214       L -> R (in Ref. 1; AAA09034/AAA09035).
FT                                {ECO:0000305}.
FT   HELIX         4      7       {ECO:0000244|PDB:2LGW}.
FT   STRAND        8     10       {ECO:0000244|PDB:2LGW}.
FT   HELIX        16     29       {ECO:0000244|PDB:2LGW}.
FT   TURN         32     34       {ECO:0000244|PDB:2LGW}.
FT   HELIX        40     57       {ECO:0000244|PDB:2LGW}.
FT   HELIX        59     70       {ECO:0000244|PDB:2LGW}.
SQ   SEQUENCE   324 AA;  35580 MW;  0154ED3E29F34B4A CRC64;
     MASYYEILDV PRSASADDIK KAYRRKALQW HPDKNPDNKE FAEKKFKEVA EAYEVLSDKH
     KREIYDRYGR EGLTGTGTGP SRAEAGSGGP GFTFTFRSPE EVFREFFGSG DPFAELFDDL
     GPFSELQNRG SRHSGPFFTF SSSFPGHSDF SSSSFSFSPG AGAFRSVSTS TTFVQGRRIT
     TRRIMENGQE RVEVEEDGQL KSVTINGVPD DLALGLELSR REQQPSVTSR SGGTQVQQTP
     ASCPLDSDLS EDEDLQLAMA YSLSEMEAAG KKPAGGREAQ HRRQGRPKAQ HQDPGLGGTQ
     EGARGEATKR SPSPEEKASR CLIL
//
ID   A0A140VK45_HUMAN        Unreviewed;       241 AA.
AC   A0A140VK45;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   23-MAY-2018, entry version 17.
DE   RecName: Full=Proteasome subunit beta type {ECO:0000256|RuleBase:RU004203};
DE            EC=3.4.25.1 {ECO:0000256|RuleBase:RU004203};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE61182.1};
RN   [1] {ECO:0000313|EMBL:AEE61182.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000256|RuleBase:RU004203}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. {ECO:0000256|RuleBase:RU004203}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU004203}.
CC       Nucleus {ECO:0000256|RuleBase:RU004203,
CC       ECO:0000256|SAAS:SAAS00551005}.
CC   -!- SIMILARITY: Belongs to the peptidase T1B family.
CC       {ECO:0000256|RuleBase:RU004203}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005585; AEE61182.1; -; mRNA.
DR   RefSeq; NP_002784.1; NM_002793.3.
DR   UniGene; Hs.352768; -.
DR   ProteinModelPortal; A0A140VK45; -.
DR   SMR; A0A140VK45; -.
DR   PRIDE; A0A140VK45; -.
DR   GeneID; 5689; -.
DR   KEGG; hsa:5689; -.
DR   CTD; 5689; -.
DR   KO; K02732; -.
DR   OMA; EHRFNPY; -.
DR   PhylomeDB; A0A140VK45; -.
DR   ExpressionAtlas; A0A140VK45; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005839; C:proteasome core complex; IEA:Ensembl.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR035202; Proteasome_beta1.
DR   InterPro; IPR016050; Proteasome_bsu_CS.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR023333; Proteasome_suB-type.
DR   PANTHER; PTHR11599:SF59; PTHR11599:SF59; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00854; PROTEASOME_BETA_1; 1.
DR   PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm {ECO:0000256|RuleBase:RU004203};
KW   Hydrolase {ECO:0000256|RuleBase:RU004203};
KW   Nucleus {ECO:0000256|RuleBase:RU004203,
KW   ECO:0000256|SAAS:SAAS00039288};
KW   Protease {ECO:0000256|RuleBase:RU004203};
KW   Proteasome {ECO:0000256|RuleBase:RU004203};
KW   Threonine protease {ECO:0000256|RuleBase:RU004203}.
SQ   SEQUENCE   241 AA;  26489 MW;  AE8FC42799F39157 CRC64;
     MLSSTAMYSA PGRDLGMEPH RAAGPLQLRF SPYVFNGGTI LAIAGEDFAI VASDTRLSEG
     FSIHTRDSPK CYKLTDKTVI GCSGFHGDCL TLTKIIEARL KMYKHSNNKA MTTGAIAAML
     STILYSRRFF PYYVYNIIGG LDEEGKGAVY SFDPVGSYQR DSFKAGGSAS AMLQPLLDNQ
     VGFKNMQNVE HVPLSLDRAM RLVKDVFISA AERDVYTGDA LRICIVTKEG IREETVSLRK
     D
//
ID   PSB1_HUMAN              Reviewed;         241 AA.
AC   P20618; B5BU76; Q9BWA8;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 2.
DT   23-MAY-2018, entry version 199.
DE   RecName: Full=Proteasome subunit beta type-1;
DE            EC=3.4.25.1 {ECO:0000269|PubMed:27176742};
DE   AltName: Full=Macropain subunit C5;
DE   AltName: Full=Multicatalytic endopeptidase complex subunit C5;
DE   AltName: Full=Proteasome component C5;
DE   AltName: Full=Proteasome gamma chain;
DE   Flags: Precursor;
GN   Name=PSMB1; Synonyms=PSC5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2025653; DOI=10.1016/0167-4781(91)90090-9;
RA   Tamura T., Lee D.H., Osaka F., Fujiwara T., Shin S., Chung C.H.,
RA   Tanaka K., Ichihara A.;
RT   "Molecular cloning and sequence analysis of cDNAs for five major
RT   subunits of human proteasomes (multi-catalytic proteinase
RT   complexes).";
RL   Biochim. Biophys. Acta 1089:95-102(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-11.
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 29-52.
RX   PubMed=2306472; DOI=10.1016/0167-4838(90)90165-C;
RA   Lee L.W., Moomaw C.R., Orth K., McGuire M.J., DeMartino G.N.,
RA   Slaughter C.A.;
RT   "Relationships among the subunits of the high molecular weight
RT   proteinase, macropain (proteasome).";
RL   Biochim. Biophys. Acta 1037:178-185(1990).
RN   [7]
RP   FUNCTION IN ANTIGEN PRESENTATION.
RX   PubMed=8610016; DOI=10.1038/381166a0;
RA   Groettrup M., Soza A., Eggers M., Kuehn L., Dick T.P., Schild H.,
RA   Rammensee H.G., Koszinowski U.H., Kloetzel P.M.;
RT   "A role for the proteasome regulator PA28alpha in antigen
RT   presentation.";
RL   Nature 381:166-168(1996).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12181345; DOI=10.1091/mbc.E02-03-0122;
RA   Lafarga M., Berciano M.T., Pena E., Mayo I., Castano J.G., Bohmann D.,
RA   Rodrigues J.P., Tavanez J.P., Carmo-Fonseca M.;
RT   "Clastosome: a subtype of nuclear body enriched in 19S and 20S
RT   proteasomes, ubiquitin, and protein substrates of proteasome.";
RL   Mol. Biol. Cell 13:2771-2782(2002).
RN   [9]
RP   INTERACTION WITH HIV-1 TAT.
RX   PubMed=14550573; DOI=10.1016/S0014-5793(03)01025-1;
RA   Apcher G.S., Heink S., Zantopf D., Kloetzel P.-M., Schmid H.-P.,
RA   Mayer R.J., Krueger E.;
RT   "Human immunodeficiency virus-1 Tat protein interacts with distinct
RT   proteasomal alpha and beta subunits.";
RL   FEBS Lett. 553:200-204(2003).
RN   [10]
RP   INTERACTION WITH SERPINB2.
RX   PubMed=14732874; DOI=10.1093/abbs/36.1.42;
RA   Fan J., Zhang Y.Q., Li P., Hou M., Tan L., Wang X., Zhu Y.S.;
RT   "Interaction of plasminogen activator inhibitor-2 and proteasome
RT   subunit, beta type 1.";
RL   Acta Biochim. Biophys. Sin. 36:42-46(2004).
RN   [11]
RP   FUNCTION.
RX   PubMed=15244466; DOI=10.1021/bm049957a;
RA   Yano M., Koumoto Y., Kanesaki Y., Wu X., Kido H.;
RT   "20S proteasome prevents aggregation of heat-denatured proteins
RT   without PA700 regulatory subcomplex like a molecular chaperone.";
RL   Biomacromolecules 5:1465-1469(2004).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-204, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-68 AND SER-162,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=27176742; DOI=10.1515/hsz-2016-0176;
RA   Rut W., Drag M.;
RT   "Human 20S proteasome activity towards fluorogenic peptides of various
RT   chain lengths.";
RL   Biol. Chem. 397:921-926(2016).
RN   [19]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS) OF 35-239, AND
RP   SUBUNIT.
RX   PubMed=26133119; DOI=10.1038/ncomms8573;
RA   da Fonseca P.C., Morris E.P.;
RT   "Cryo-EM reveals the conformation of a substrate analogue in the human
RT   20S proteasome core.";
RL   Nat. Commun. 6:7573-7573(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 35-236, AND SUBUNIT.
RX   PubMed=25599644; DOI=10.1016/j.str.2014.11.017;
RA   Harshbarger W., Miller C., Diedrich C., Sacchettini J.;
RT   "Crystal structure of the human 20S proteasome in complex with
RT   carfilzomib.";
RL   Structure 23:418-424(2015).
RN   [21]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27428775; DOI=10.1038/nsmb.3273;
RA   Huang X., Luan B., Wu J., Shi Y.;
RT   "An atomic structure of the human 26S proteasome.";
RL   Nat. Struct. Mol. Biol. 23:778-785(2016).
RN   [22]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.02 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA   Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA   Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT   "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 35-239, AND SUBUNIT.
RX   PubMed=27493187; DOI=10.1126/science.aaf8993;
RA   Schrader J., Henneberg F., Mata R.A., Tittmann K., Schneider T.R.,
RA   Stark H., Bourenkov G., Chari A.;
RT   "The inhibition mechanism of human 20S proteasomes enables next-
RT   generation inhibitor design.";
RL   Science 353:594-598(2016).
CC   -!- FUNCTION: Component of the 20S core proteasome complex involved in
CC       the proteolytic degradation of most intracellular proteins. This
CC       complex plays numerous essential roles within the cell by
CC       associating with different regulatory particles. Associated with
CC       two 19S regulatory particles, forms the 26S proteasome and thus
CC       participates in the ATP-dependent degradation of ubiquitinated
CC       proteins. The 26S proteasome plays a key role in the maintenance
CC       of protein homeostasis by removing misfolded or damaged proteins
CC       that could impair cellular functions, and by removing proteins
CC       whose functions are no longer required. Associated with the PA200
CC       or PA28, the 20S proteasome mediates ubiquitin-independent protein
CC       degradation. This type of proteolysis is required in several
CC       pathways including spermatogenesis (20S-PA200 complex) or
CC       generation of a subset of MHC class I-presented antigenic peptides
CC       (20S-PA28 complex). {ECO:0000269|PubMed:15244466,
CC       ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000269|PubMed:27176742}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. The 20S proteasome core is a barrel-
CC       shaped complex made of 28 subunits that are arranged in four
CC       stacked rings. The two outer rings are each formed by seven alpha
CC       subunits, and the two inner rings are formed by seven beta
CC       subunits. The proteolytic activity is exerted by three beta-
CC       subunits PSMB5, PSMB6 and PSMB7. Interacts with SERPINB2
CC       (PubMed:14732874). Interacts with HIV-1 TAT protein
CC       (PubMed:14550573). {ECO:0000269|PubMed:14550573,
CC       ECO:0000269|PubMed:14732874, ECO:0000269|PubMed:25599644,
CC       ECO:0000269|PubMed:26133119, ECO:0000269|PubMed:27342858,
CC       ECO:0000269|PubMed:27428775, ECO:0000269|PubMed:27493187}.
CC   -!- INTERACTION:
CC       Q9BVG8:KIFC3; NbExp=3; IntAct=EBI-372273, EBI-2125614;
CC       A1A4E9:KRT13; NbExp=3; IntAct=EBI-372273, EBI-10171552;
CC       P19012:KRT15; NbExp=5; IntAct=EBI-372273, EBI-739566;
CC       Q9UPY8:MAPRE3; NbExp=3; IntAct=EBI-372273, EBI-726739;
CC       P28074:PSMB5; NbExp=3; IntAct=EBI-372273, EBI-357828;
CC       Q99436:PSMB7; NbExp=8; IntAct=EBI-372273, EBI-603319;
CC       Q13077:TRAF1; NbExp=5; IntAct=EBI-372273, EBI-359224;
CC       P14373:TRIM27; NbExp=5; IntAct=EBI-372273, EBI-719493;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12181345}.
CC       Nucleus {ECO:0000269|PubMed:12181345}.
CC   -!- SIMILARITY: Belongs to the peptidase T1B family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00809}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D00761; BAA00658.1; -; mRNA.
DR   EMBL; BT019720; AAV38525.1; -; mRNA.
DR   EMBL; AB451312; BAG70126.1; -; mRNA.
DR   EMBL; AB451442; BAG70256.1; -; mRNA.
DR   EMBL; AL031259; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000508; AAH00508.1; -; mRNA.
DR   EMBL; BC020807; AAH20807.1; -; mRNA.
DR   CCDS; CCDS34577.1; -.
DR   PIR; S15973; SNHUC5.
DR   RefSeq; NP_002784.1; NM_002793.3.
DR   UniGene; Hs.352768; -.
DR   PDB; 4R3O; X-ray; 2.60 A; 1/M=29-241.
DR   PDB; 4R67; X-ray; 2.89 A; 1/M/a/o=29-241.
DR   PDB; 5A0Q; EM; 3.50 A; M/a=29-241.
DR   PDB; 5GJQ; EM; 4.50 A; f/t=1-241.
DR   PDB; 5GJR; EM; 3.50 A; f/t=1-241.
DR   PDB; 5L4G; EM; 4.02 A; 1/U=1-241.
DR   PDB; 5L5B; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5D; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5E; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5F; X-ray; 2.50 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5H; X-ray; 2.60 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5I; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5J; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5O; X-ray; 2.60 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5P; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5Q; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5R; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5S; X-ray; 2.60 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5T; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5U; X-ray; 2.60 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5V; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5W; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5X; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5Y; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L5Z; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L60; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L61; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L62; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L63; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5L64; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5LE5; X-ray; 1.80 A; L/Z=29-241.
DR   PDB; 5LEX; X-ray; 2.20 A; L/Z=29-241.
DR   PDB; 5LEY; X-ray; 1.90 A; L/Z=29-241.
DR   PDB; 5LEZ; X-ray; 2.19 A; L/Z=29-241.
DR   PDB; 5LF0; X-ray; 2.41 A; L/Z=29-241.
DR   PDB; 5LF1; X-ray; 2.00 A; L/Z=29-241.
DR   PDB; 5LF3; X-ray; 2.10 A; L/Z=29-241.
DR   PDB; 5LF4; X-ray; 1.99 A; L/Z=29-241.
DR   PDB; 5LF6; X-ray; 2.07 A; L/Z=29-241.
DR   PDB; 5LF7; X-ray; 2.00 A; L/Z=29-241.
DR   PDB; 5LN3; EM; 6.80 A; 6=1-241.
DR   PDB; 5M2B; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR   PDB; 5M32; EM; 3.80 A; L/Z=1-241.
DR   PDB; 5T0C; EM; 3.80 A; AS/BS=2-241.
DR   PDB; 5T0G; EM; 4.40 A; S=2-241.
DR   PDB; 5T0H; EM; 6.80 A; S=2-241.
DR   PDB; 5T0I; EM; 8.00 A; S=2-241.
DR   PDB; 5T0J; EM; 8.00 A; S=2-241.
DR   PDB; 6AVO; EM; 3.80 A; S/X=29-241.
DR   PDBsum; 4R3O; -.
DR   PDBsum; 4R67; -.
DR   PDBsum; 5A0Q; -.
DR   PDBsum; 5GJQ; -.
DR   PDBsum; 5GJR; -.
DR   PDBsum; 5L4G; -.
DR   PDBsum; 5L5B; -.
DR   PDBsum; 5L5D; -.
DR   PDBsum; 5L5E; -.
DR   PDBsum; 5L5F; -.
DR   PDBsum; 5L5H; -.
DR   PDBsum; 5L5I; -.
DR   PDBsum; 5L5J; -.
DR   PDBsum; 5L5O; -.
DR   PDBsum; 5L5P; -.
DR   PDBsum; 5L5Q; -.
DR   PDBsum; 5L5R; -.
DR   PDBsum; 5L5S; -.
DR   PDBsum; 5L5T; -.
DR   PDBsum; 5L5U; -.
DR   PDBsum; 5L5V; -.
DR   PDBsum; 5L5W; -.
DR   PDBsum; 5L5X; -.
DR   PDBsum; 5L5Y; -.
DR   PDBsum; 5L5Z; -.
DR   PDBsum; 5L60; -.
DR   PDBsum; 5L61; -.
DR   PDBsum; 5L62; -.
DR   PDBsum; 5L63; -.
DR   PDBsum; 5L64; -.
DR   PDBsum; 5LE5; -.
DR   PDBsum; 5LEX; -.
DR   PDBsum; 5LEY; -.
DR   PDBsum; 5LEZ; -.
DR   PDBsum; 5LF0; -.
DR   PDBsum; 5LF1; -.
DR   PDBsum; 5LF3; -.
DR   PDBsum; 5LF4; -.
DR   PDBsum; 5LF6; -.
DR   PDBsum; 5LF7; -.
DR   PDBsum; 5LN3; -.
DR   PDBsum; 5M2B; -.
DR   PDBsum; 5M32; -.
DR   PDBsum; 5T0C; -.
DR   PDBsum; 5T0G; -.
DR   PDBsum; 5T0H; -.
DR   PDBsum; 5T0I; -.
DR   PDBsum; 5T0J; -.
DR   PDBsum; 6AVO; -.
DR   ProteinModelPortal; P20618; -.
DR   SMR; P20618; -.
DR   BioGrid; 111662; 131.
DR   CORUM; P20618; -.
DR   DIP; DIP-31193N; -.
DR   IntAct; P20618; 81.
DR   MINT; P20618; -.
DR   STRING; 9606.ENSP00000262193; -.
DR   BindingDB; P20618; -.
DR   ChEMBL; CHEMBL4208; -.
DR   DrugBank; DB00188; Bortezomib.
DR   DrugBank; DB08889; Carfilzomib.
DR   GuidetoPHARMACOLOGY; 2404; -.
DR   MEROPS; T01.986; -.
DR   iPTMnet; P20618; -.
DR   PhosphoSitePlus; P20618; -.
DR   SwissPalm; P20618; -.
DR   BioMuta; PSMB1; -.
DR   DMDM; 130853; -.
DR   REPRODUCTION-2DPAGE; IPI00025019; -.
DR   UCD-2DPAGE; P20618; -.
DR   EPD; P20618; -.
DR   MaxQB; P20618; -.
DR   PaxDb; P20618; -.
DR   PeptideAtlas; P20618; -.
DR   PRIDE; P20618; -.
DR   TopDownProteomics; P20618; -.
DR   DNASU; 5689; -.
DR   Ensembl; ENST00000262193; ENSP00000262193; ENSG00000008018.
DR   GeneID; 5689; -.
DR   KEGG; hsa:5689; -.
DR   UCSC; uc011ehe.3; human.
DR   CTD; 5689; -.
DR   DisGeNET; 5689; -.
DR   EuPathDB; HostDB:ENSG00000008018.8; -.
DR   GeneCards; PSMB1; -.
DR   HGNC; HGNC:9537; PSMB1.
DR   HPA; CAB033911; -.
DR   HPA; HPA029635; -.
DR   HPA; HPA029637; -.
DR   MIM; 602017; gene.
DR   neXtProt; NX_P20618; -.
DR   OpenTargets; ENSG00000008018; -.
DR   PharmGKB; PA33882; -.
DR   eggNOG; KOG0179; Eukaryota.
DR   eggNOG; COG0638; LUCA.
DR   GeneTree; ENSGT00550000075035; -.
DR   HOGENOM; HOG000091081; -.
DR   HOVERGEN; HBG000961; -.
DR   InParanoid; P20618; -.
DR   KO; K02732; -.
DR   OMA; EHRFNPY; -.
DR   OrthoDB; EOG091G0FUK; -.
DR   PhylomeDB; P20618; -.
DR   TreeFam; TF106218; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69229; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   ChiTaRS; PSMB1; human.
DR   GeneWiki; PSMB1; -.
DR   GenomeRNAi; 5689; -.
DR   PRO; PR:P20618; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000008018; -.
DR   CleanEx; HS_PSMB1; -.
DR   ExpressionAtlas; P20618; baseline and differential.
DR   Genevisible; P20618; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0005839; C:proteasome core complex; ISS:UniProtKB.
DR   GO; GO:0019774; C:proteasome core complex, beta-subunit complex; ISS:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:InterPro.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR035202; Proteasome_beta1.
DR   InterPro; IPR016050; Proteasome_bsu_CS.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR023333; Proteasome_suB-type.
DR   PANTHER; PTHR11599:SF59; PTHR11599:SF59; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00854; PROTEASOME_BETA_1; 1.
DR   PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Glycoprotein; Host-virus interaction;
KW   Hydrolase; Nucleus; Phosphoprotein; Polymorphism; Protease;
KW   Proteasome; Reference proteome; Threonine protease.
FT   PROPEP        1     28       {ECO:0000269|PubMed:2306472}.
FT                                /FTId=PRO_0000259623.
FT   CHAIN        29    241       Proteasome subunit beta type-1.
FT                                /FTId=PRO_0000148030.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      62     62       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      68     68       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     150    150       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O09061}.
FT   MOD_RES     162    162       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     204    204       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CARBOHYD     58     58       O-linked (GlcNAc) serine. {ECO:0000250}.
FT   CARBOHYD    209    209       O-linked (GlcNAc) serine. {ECO:0000250}.
FT   VARIANT      11     11       P -> A (in dbSNP:rs12717).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_051547.
FT   VARIANT     208    208       I -> N (in dbSNP:rs10541).
FT                                /FTId=VAR_051548.
FT   STRAND       39     44       {ECO:0000244|PDB:5LE5}.
FT   STRAND       49     54       {ECO:0000244|PDB:5LE5}.
FT   STRAND       57     59       {ECO:0000244|PDB:5LE5}.
FT   STRAND       62     66       {ECO:0000244|PDB:5LE5}.
FT   STRAND       71     75       {ECO:0000244|PDB:5LE5}.
FT   STRAND       78     84       {ECO:0000244|PDB:5LE5}.
FT   HELIX        86    107       {ECO:0000244|PDB:5LE5}.
FT   HELIX       113    126       {ECO:0000244|PDB:5LE5}.
FT   TURN        127    129       {ECO:0000244|PDB:5LE5}.
FT   STRAND      134    141       {ECO:0000244|PDB:5LE5}.
FT   STRAND      147    152       {ECO:0000244|PDB:5LE5}.
FT   STRAND      158    167       {ECO:0000244|PDB:5LE5}.
FT   HELIX       170    180       {ECO:0000244|PDB:5LE5}.
FT   HELIX       196    213       {ECO:0000244|PDB:5LE5}.
FT   STRAND      214    217       {ECO:0000244|PDB:4R3O}.
FT   STRAND      219    227       {ECO:0000244|PDB:5LE5}.
FT   STRAND      230    237       {ECO:0000244|PDB:5LE5}.
SQ   SEQUENCE   241 AA;  26489 MW;  AE8FC42799F39157 CRC64;
     MLSSTAMYSA PGRDLGMEPH RAAGPLQLRF SPYVFNGGTI LAIAGEDFAI VASDTRLSEG
     FSIHTRDSPK CYKLTDKTVI GCSGFHGDCL TLTKIIEARL KMYKHSNNKA MTTGAIAAML
     STILYSRRFF PYYVYNIIGG LDEEGKGAVY SFDPVGSYQR DSFKAGGSAS AMLQPLLDNQ
     VGFKNMQNVE HVPLSLDRAM RLVKDVFISA AERDVYTGDA LRICIVTKEG IREETVSLRK
     D
//
ID   A0A087WVV1_HUMAN        Unreviewed;        84 AA.
AC   A0A087WVV1;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   23-MAY-2018, entry version 31.
DE   SubName: Full=Proteasome subunit beta type-2 {ECO:0000313|Ensembl:ENSP00000479706};
GN   Name=PSMB2 {ECO:0000313|Ensembl:ENSP00000479706};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000479706, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000479706, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:17323924}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.F., Baker P.R., Chen P.L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000479706}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL157951; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL354864; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357035; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001186709.1; NM_001199780.1.
DR   UniGene; Hs.471441; -.
DR   ProteinModelPortal; A0A087WVV1; -.
DR   EPD; A0A087WVV1; -.
DR   PeptideAtlas; A0A087WVV1; -.
DR   PRIDE; A0A087WVV1; -.
DR   Ensembl; ENST00000621781; ENSP00000479706; ENSG00000126067.
DR   GeneID; 5690; -.
DR   UCSC; uc021olh.3; human.
DR   CTD; 5690; -.
DR   EuPathDB; HostDB:ENSG00000126067.11; -.
DR   HGNC; HGNC:9539; PSMB2.
DR   OpenTargets; ENSG00000126067; -.
DR   eggNOG; KOG0177; Eukaryota.
DR   eggNOG; COG0638; LUCA.
DR   GeneTree; ENSGT00640000091536; -.
DR   ChiTaRS; PSMB2; human.
DR   GenomeRNAi; 5690; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000126067; -.
DR   ExpressionAtlas; A0A087WVV1; baseline and differential.
DR   GO; GO:0005839; C:proteasome core complex; IEA:InterPro.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR035206; Proteasome_beta2.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   PANTHER; PTHR11599:SF6; PTHR11599:SF6; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WVV1,
KW   ECO:0000213|MaxQB:A0A087WVV1, ECO:0000213|PeptideAtlas:A0A087WVV1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   84 AA;  9557 MW;  CFF6BA35FD56AAE3 CRC64;
     MDYLAALAKA PFAAHGYGAF LTLSILDRYY TPTISRERAV ELLRKCLEEL QKRFILNLPT
     FSVRIIDKNG IHDLDNISFP KQGS
//
ID   A0A140VJS6_HUMAN        Unreviewed;       201 AA.
AC   A0A140VJS6;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   23-MAY-2018, entry version 16.
DE   RecName: Full=Proteasome subunit beta type {ECO:0000256|RuleBase:RU004203};
DE            EC=3.4.25.1 {ECO:0000256|RuleBase:RU004203};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE61063.1};
RN   [1] {ECO:0000313|EMBL:AEE61063.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000256|RuleBase:RU004203}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. {ECO:0000256|RuleBase:RU004203}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU004203}.
CC       Nucleus {ECO:0000256|RuleBase:RU004203,
CC       ECO:0000256|SAAS:SAAS00551005}.
CC   -!- SIMILARITY: Belongs to the peptidase T1B family.
CC       {ECO:0000256|RuleBase:RU004203}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005465; AEE61063.1; -; mRNA.
DR   RefSeq; NP_002785.1; NM_002794.4.
DR   UniGene; Hs.471441; -.
DR   ProteinModelPortal; A0A140VJS6; -.
DR   SMR; A0A140VJS6; -.
DR   PRIDE; A0A140VJS6; -.
DR   GeneID; 5690; -.
DR   KEGG; hsa:5690; -.
DR   CTD; 5690; -.
DR   KO; K02734; -.
DR   OMA; QLYSMRN; -.
DR   PhylomeDB; A0A140VJS6; -.
DR   ExpressionAtlas; A0A140VJS6; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005839; C:proteasome core complex; IEA:Ensembl.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:InterPro.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0010243; P:response to organonitrogen compound; IEA:Ensembl.
DR   CDD; cd03758; proteasome_beta_type_2; 1.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR035206; Proteasome_beta2.
DR   InterPro; IPR016050; Proteasome_bsu_CS.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR023333; Proteasome_suB-type.
DR   PANTHER; PTHR11599:SF6; PTHR11599:SF6; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00854; PROTEASOME_BETA_1; 1.
DR   PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm {ECO:0000256|RuleBase:RU004203};
KW   Hydrolase {ECO:0000256|RuleBase:RU004203};
KW   Nucleus {ECO:0000256|RuleBase:RU004203,
KW   ECO:0000256|SAAS:SAAS00039288};
KW   Protease {ECO:0000256|RuleBase:RU004203};
KW   Proteasome {ECO:0000256|RuleBase:RU004203};
KW   Threonine protease {ECO:0000256|RuleBase:RU004203}.
SQ   SEQUENCE   201 AA;  22836 MW;  04D085D7BAA76130 CRC64;
     MEYLIGIQGP DYVLVASDRV AASNIVQMKD DHDKMFKMSE KILLLCVGEA GDTVQFAEYI
     QKNVQLYKMR NGYELSPTAA ANFTRRNLAD CLRSRTPYHV NLLLAGYDEH EGPALYYMDY
     LAALAKAPFA AHGYGAFLTL SILDRYYTPT ISRERAVELL RKCLEELQKR FILNLPTFSV
     RIIDKNGIHD LDNISFPKQG S
//
ID   B7Z478_HUMAN            Unreviewed;       176 AA.
AC   B7Z478;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 50.
DE   SubName: Full=Proteasome (Prosome, macropain) subunit, beta type, 2, isoform CRA_b {ECO:0000313|EMBL:EAX07408.1};
DE   SubName: Full=cDNA FLJ51890, highly similar to Proteasome subunit beta type 2 (EC 3.4.25.1) {ECO:0000313|EMBL:BAH12464.1};
GN   Name=PSMB2 {ECO:0000313|EMBL:EAX07408.1};
GN   ORFNames=hCG_1812781 {ECO:0000313|EMBL:EAX07408.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH12464.1};
RN   [1] {ECO:0000313|EMBL:EAX07408.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX07408.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAH12464.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Tongue {ECO:0000313|EMBL:BAH12464.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK296956; BAH12464.1; -; mRNA.
DR   EMBL; CH471059; EAX07408.1; -; Genomic_DNA.
DR   RefSeq; NP_001186708.1; NM_001199779.1.
DR   UniGene; Hs.471441; -.
DR   SMR; B7Z478; -.
DR   PeptideAtlas; B7Z478; -.
DR   PRIDE; B7Z478; -.
DR   DNASU; 5690; -.
DR   GeneID; 5690; -.
DR   CTD; 5690; -.
DR   eggNOG; KOG0177; Eukaryota.
DR   eggNOG; COG0638; LUCA.
DR   HOVERGEN; HBG000815; -.
DR   ChiTaRS; PSMB2; human.
DR   GenomeRNAi; 5690; -.
DR   GO; GO:0005839; C:proteasome core complex; IEA:InterPro.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:InterPro.
DR   CDD; cd03758; proteasome_beta_type_2; 1.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR035206; Proteasome_beta2.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR023333; Proteasome_suB-type.
DR   PANTHER; PTHR11599:SF6; PTHR11599:SF6; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE   2: Evidence at transcript level;
KW   Proteasome {ECO:0000313|EMBL:BAH12464.1}.
SQ   SEQUENCE   176 AA;  20207 MW;  9F0DE24E01DA2139 CRC64;
     MEYLIDHDKM FKMSEKILLL CVGEAGDTVQ FAEYIQKNVQ LYKMRNGYEL SPTAAANFTR
     RNLADCLRSR TPYHVNLLLA GYDEHEGPAL YYMDYLAALA KAPFAAHGYG AFLTLSILDR
     YYTPTISRER AVELLRKCLE ELQKRFILNL PTFSVRIIDK NGIHDLDNIS FPKQGS
//
ID   PSB2_HUMAN              Reviewed;         201 AA.
AC   P49721; D3DPS0; P31145; Q9BWZ9;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   23-MAY-2018, entry version 190.
DE   RecName: Full=Proteasome subunit beta type-2;
DE            EC=3.4.25.1 {ECO:0000269|PubMed:27176742};
DE   AltName: Full=Macropain subunit C7-I;
DE   AltName: Full=Multicatalytic endopeptidase complex subunit C7-I;
DE   AltName: Full=Proteasome component C7-I;
GN   Name=PSMB2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7918633; DOI=10.1016/0167-4781(94)90060-4;
RA   Nothwang H.G., Tamura T., Tanaka K., Ichihara A.;
RT   "Sequence analyses and inter-species comparisons of three novel human
RT   proteasomal subunits, HsN3, HsC7-I and HsC10-II, confine potential
RT   proteolytic active-site residues.";
RL   Biochim. Biophys. Acta 1219:361-368(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 71-85 AND 171-181, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 172-177 AND 186-193.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [9]
RP   PROTEIN SEQUENCE OF 72-85.
RC   TISSUE=Placenta;
RX   PubMed=7811265; DOI=10.1006/bbrc.1994.2876;
RA   Kristensen P., Johnsen A.H., Uerkvitz W., Tanaka K., Hendil K.B.;
RT   "Human proteasome subunits from 2-dimensional gels identified by
RT   partial sequencing.";
RL   Biochem. Biophys. Res. Commun. 205:1785-1789(1994).
RN   [10]
RP   FUNCTION IN ANTIGEN PRESENTATION.
RX   PubMed=8610016; DOI=10.1038/381166a0;
RA   Groettrup M., Soza A., Eggers M., Kuehn L., Dick T.P., Schild H.,
RA   Rammensee H.G., Koszinowski U.H., Kloetzel P.M.;
RT   "A role for the proteasome regulator PA28alpha in antigen
RT   presentation.";
RL   Nature 381:166-168(1996).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12181345; DOI=10.1091/mbc.E02-03-0122;
RA   Lafarga M., Berciano M.T., Pena E., Mayo I., Castano J.G., Bohmann D.,
RA   Rodrigues J.P., Tavanez J.P., Carmo-Fonseca M.;
RT   "Clastosome: a subtype of nuclear body enriched in 19S and 20S
RT   proteasomes, ubiquitin, and protein substrates of proteasome.";
RL   Mol. Biol. Cell 13:2771-2782(2002).
RN   [12]
RP   INTERACTION WITH HIV-1 TAT.
RX   PubMed=14550573; DOI=10.1016/S0014-5793(03)01025-1;
RA   Apcher G.S., Heink S., Zantopf D., Kloetzel P.-M., Schmid H.-P.,
RA   Mayer R.J., Krueger E.;
RT   "Human immunodeficiency virus-1 Tat protein interacts with distinct
RT   proteasomal alpha and beta subunits.";
RL   FEBS Lett. 553:200-204(2003).
RN   [13]
RP   FUNCTION.
RX   PubMed=15244466; DOI=10.1021/bm049957a;
RA   Yano M., Koumoto Y., Kanesaki Y., Wu X., Kido H.;
RT   "20S proteasome prevents aggregation of heat-denatured proteins
RT   without PA700 regulatory subcomplex like a molecular chaperone.";
RL   Biomacromolecules 5:1465-1469(2004).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   INDUCTION.
RX   PubMed=19787249;
RA   Wada T., Yamashita Y., Saga Y., Takahashi K., Koinuma K., Choi Y.L.,
RA   Kaneda R., Fujiwara S., Soda M., Watanabe H., Kurashina K.,
RA   Hatanaka H., Enomoto M., Takada S., Mano H., Suzuki M.;
RT   "Screening for genetic abnormalities involved in ovarian
RT   carcinogenesis using retroviral expression libraries.";
RL   Int. J. Oncol. 35:973-976(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=27176742; DOI=10.1515/hsz-2016-0176;
RA   Rut W., Drag M.;
RT   "Human 20S proteasome activity towards fluorogenic peptides of various
RT   chain lengths.";
RL   Biol. Chem. 397:921-926(2016).
RN   [22]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=26133119; DOI=10.1038/ncomms8573;
RA   da Fonseca P.C., Morris E.P.;
RT   "Cryo-EM reveals the conformation of a substrate analogue in the human
RT   20S proteasome core.";
RL   Nat. Commun. 6:7573-7573(2015).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS), AND SUBUNIT.
RX   PubMed=25599644; DOI=10.1016/j.str.2014.11.017;
RA   Harshbarger W., Miller C., Diedrich C., Sacchettini J.;
RT   "Crystal structure of the human 20S proteasome in complex with
RT   carfilzomib.";
RL   Structure 23:418-424(2015).
RN   [24]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27428775; DOI=10.1038/nsmb.3273;
RA   Huang X., Luan B., Wu J., Shi Y.;
RT   "An atomic structure of the human 26S proteasome.";
RL   Nat. Struct. Mol. Biol. 23:778-785(2016).
RN   [25]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.02 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA   Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA   Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT   "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27493187; DOI=10.1126/science.aaf8993;
RA   Schrader J., Henneberg F., Mata R.A., Tittmann K., Schneider T.R.,
RA   Stark H., Bourenkov G., Chari A.;
RT   "The inhibition mechanism of human 20S proteasomes enables next-
RT   generation inhibitor design.";
RL   Science 353:594-598(2016).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (3.75 ANGSTROMS) OF 1-255, AND SUBUNIT.
RX   PubMed=26657688; DOI=10.1038/srep18167;
RA   Ishii K., Noda M., Yagi H., Thammaporn R., Seetaha S., Satoh T.,
RA   Kato K., Uchiyama S.;
RT   "Disassembly of the self-assembled, double-ring structure of
RT   proteasome alpha7 homo-tetradecamer by alpha6.";
RL   Sci. Rep. 5:18167-18167(2015).
CC   -!- FUNCTION: Component of the 20S core proteasome complex involved in
CC       the proteolytic degradation of most intracellular proteins. This
CC       complex plays numerous essential roles within the cell by
CC       associating with different regulatory particles. Associated with
CC       two 19S regulatory particles, forms the 26S proteasome and thus
CC       participates in the ATP-dependent degradation of ubiquitinated
CC       proteins. The 26S proteasome plays a key role in the maintenance
CC       of protein homeostasis by removing misfolded or damaged proteins
CC       that could impair cellular functions, and by removing proteins
CC       whose functions are no longer required. Associated with the PA200
CC       or PA28, the 20S proteasome mediates ubiquitin-independent protein
CC       degradation. This type of proteolysis is required in several
CC       pathways including spermatogenesis (20S-PA200 complex) or
CC       generation of a subset of MHC class I-presented antigenic peptides
CC       (20S-PA28 complex). {ECO:0000269|PubMed:15244466,
CC       ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000269|PubMed:27176742}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. The 20S proteasome core is a barrel-
CC       shaped complex made of 28 subunits that are arranged in four
CC       stacked rings. The two outer rings are each formed by seven alpha
CC       subunits, and the two inner rings are formed by seven beta
CC       subunits. The proteolytic activity is exerted by three beta-
CC       subunits PSMB5, PSMB6 and PSMB7. Interacts with HIV-1 TAT protein
CC       (PubMed:14550573). {ECO:0000269|PubMed:14550573,
CC       ECO:0000269|PubMed:25599644, ECO:0000269|PubMed:26133119,
CC       ECO:0000269|PubMed:26657688, ECO:0000269|PubMed:27342858,
CC       ECO:0000269|PubMed:27428775, ECO:0000269|PubMed:27493187}.
CC   -!- INTERACTION:
CC       Q7L273:KCTD9; NbExp=3; IntAct=EBI-359335, EBI-4397613;
CC       A1A4E9:KRT13; NbExp=3; IntAct=EBI-359335, EBI-10171552;
CC       P25786:PSMA1; NbExp=7; IntAct=EBI-359335, EBI-359352;
CC       P49720:PSMB3; NbExp=4; IntAct=EBI-359335, EBI-603340;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12181345}.
CC       Nucleus {ECO:0000269|PubMed:12181345}.
CC   -!- INDUCTION: Up-regulated in ovarian cancer cell lines.
CC       {ECO:0000269|PubMed:19787249}.
CC   -!- SIMILARITY: Belongs to the peptidase T1B family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00809}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D26599; BAA05646.1; -; mRNA.
DR   EMBL; CR456862; CAG33143.1; -; mRNA.
DR   EMBL; BT007137; AAP35801.1; -; mRNA.
DR   EMBL; AL354864; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357035; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL157951; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07406.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07407.1; -; Genomic_DNA.
DR   EMBL; BC101836; AAI01837.1; -; mRNA.
DR   EMBL; BC105126; AAI05127.1; -; mRNA.
DR   EMBL; BC107901; AAI07902.1; -; mRNA.
DR   CCDS; CCDS394.1; -.
DR   PIR; S55040; S55040.
DR   RefSeq; NP_002785.1; NM_002794.4.
DR   UniGene; Hs.471441; -.
DR   PDB; 4R3O; X-ray; 2.60 A; K/Y=1-199.
DR   PDB; 4R67; X-ray; 2.89 A; 0/K/Y/m=1-199.
DR   PDB; 5A0Q; EM; 3.50 A; K/Y=1-201.
DR   PDB; 5GJQ; EM; 4.50 A; d/r=1-201.
DR   PDB; 5GJR; EM; 3.50 A; d/r=1-201.
DR   PDB; 5L4G; EM; 4.02 A; 2/V=1-201.
DR   PDB; 5LE5; X-ray; 1.80 A; J/X=1-201.
DR   PDB; 5LEX; X-ray; 2.20 A; J/X=1-201.
DR   PDB; 5LEY; X-ray; 1.90 A; J/X=1-201.
DR   PDB; 5LEZ; X-ray; 2.19 A; J/X=1-201.
DR   PDB; 5LF0; X-ray; 2.41 A; J/X=1-201.
DR   PDB; 5LF1; X-ray; 2.00 A; J/X=1-201.
DR   PDB; 5LF3; X-ray; 2.10 A; J/X=1-201.
DR   PDB; 5LF4; X-ray; 1.99 A; J/X=1-201.
DR   PDB; 5LF6; X-ray; 2.07 A; J/X=1-201.
DR   PDB; 5LF7; X-ray; 2.00 A; J/X=1-201.
DR   PDB; 5LN3; EM; 6.80 A; 4=1-201.
DR   PDB; 5M32; EM; 3.80 A; J/X=1-196.
DR   PDB; 5T0C; EM; 3.80 A; AQ/BQ=1-201.
DR   PDB; 5T0G; EM; 4.40 A; Q=1-201.
DR   PDB; 5T0H; EM; 6.80 A; Q=1-201.
DR   PDB; 5T0I; EM; 8.00 A; Q=1-201.
DR   PDB; 5T0J; EM; 8.00 A; Q=1-201.
DR   PDB; 6AVO; EM; 3.80 A; T/V=1-201.
DR   PDBsum; 4R3O; -.
DR   PDBsum; 4R67; -.
DR   PDBsum; 5A0Q; -.
DR   PDBsum; 5GJQ; -.
DR   PDBsum; 5GJR; -.
DR   PDBsum; 5L4G; -.
DR   PDBsum; 5LE5; -.
DR   PDBsum; 5LEX; -.
DR   PDBsum; 5LEY; -.
DR   PDBsum; 5LEZ; -.
DR   PDBsum; 5LF0; -.
DR   PDBsum; 5LF1; -.
DR   PDBsum; 5LF3; -.
DR   PDBsum; 5LF4; -.
DR   PDBsum; 5LF6; -.
DR   PDBsum; 5LF7; -.
DR   PDBsum; 5LN3; -.
DR   PDBsum; 5M32; -.
DR   PDBsum; 5T0C; -.
DR   PDBsum; 5T0G; -.
DR   PDBsum; 5T0H; -.
DR   PDBsum; 5T0I; -.
DR   PDBsum; 5T0J; -.
DR   PDBsum; 6AVO; -.
DR   ProteinModelPortal; P49721; -.
DR   SMR; P49721; -.
DR   BioGrid; 111663; 99.
DR   CORUM; P49721; -.
DR   DIP; DIP-33848N; -.
DR   IntAct; P49721; 36.
DR   MINT; P49721; -.
DR   STRING; 9606.ENSP00000362334; -.
DR   BindingDB; P49721; -.
DR   ChEMBL; CHEMBL3492; -.
DR   DrugBank; DB08889; Carfilzomib.
DR   MEROPS; T01.984; -.
DR   iPTMnet; P49721; -.
DR   PhosphoSitePlus; P49721; -.
DR   SwissPalm; P49721; -.
DR   BioMuta; PSMB2; -.
DR   DMDM; 1709762; -.
DR   OGP; P49721; -.
DR   REPRODUCTION-2DPAGE; IPI00028006; -.
DR   REPRODUCTION-2DPAGE; P49721; -.
DR   EPD; P49721; -.
DR   MaxQB; P49721; -.
DR   PaxDb; P49721; -.
DR   PeptideAtlas; P49721; -.
DR   PRIDE; P49721; -.
DR   TopDownProteomics; P49721; -.
DR   DNASU; 5690; -.
DR   Ensembl; ENST00000373237; ENSP00000362334; ENSG00000126067.
DR   GeneID; 5690; -.
DR   KEGG; hsa:5690; -.
DR   UCSC; uc001bzf.4; human.
DR   CTD; 5690; -.
DR   DisGeNET; 5690; -.
DR   EuPathDB; HostDB:ENSG00000126067.11; -.
DR   GeneCards; PSMB2; -.
DR   HGNC; HGNC:9539; PSMB2.
DR   HPA; HPA026322; -.
DR   HPA; HPA026324; -.
DR   MIM; 602175; gene.
DR   neXtProt; NX_P49721; -.
DR   OpenTargets; ENSG00000126067; -.
DR   PharmGKB; PA33884; -.
DR   eggNOG; KOG0177; Eukaryota.
DR   eggNOG; COG0638; LUCA.
DR   GeneTree; ENSGT00640000091536; -.
DR   HOGENOM; HOG000188743; -.
DR   HOVERGEN; HBG000815; -.
DR   InParanoid; P49721; -.
DR   KO; K02734; -.
DR   OMA; QLYSMRN; -.
DR   OrthoDB; EOG091G0K9M; -.
DR   PhylomeDB; P49721; -.
DR   TreeFam; TF106219; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69229; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   ChiTaRS; PSMB2; human.
DR   GeneWiki; PSMB2; -.
DR   GenomeRNAi; 5690; -.
DR   PRO; PR:P49721; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000126067; -.
DR   CleanEx; HS_PSMB2; -.
DR   ExpressionAtlas; P49721; baseline and differential.
DR   Genevisible; P49721; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0005839; C:proteasome core complex; ISS:UniProtKB.
DR   GO; GO:0019774; C:proteasome core complex, beta-subunit complex; ISS:UniProtKB.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:InterPro.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0010243; P:response to organonitrogen compound; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd03758; proteasome_beta_type_2; 1.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR035206; Proteasome_beta2.
DR   InterPro; IPR016050; Proteasome_bsu_CS.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR023333; Proteasome_suB-type.
DR   PANTHER; PTHR11599:SF6; PTHR11599:SF6; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00854; PROTEASOME_BETA_1; 1.
DR   PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Host-virus interaction; Hydrolase; Nucleus;
KW   Protease; Proteasome; Reference proteome; Threonine protease.
FT   CHAIN         1    201       Proteasome subunit beta type-2.
FT                                /FTId=PRO_0000148043.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   STRAND        4      8       {ECO:0000244|PDB:5LE5}.
FT   STRAND       13     18       {ECO:0000244|PDB:5LE5}.
FT   STRAND       21     23       {ECO:0000244|PDB:5LE5}.
FT   STRAND       26     31       {ECO:0000244|PDB:5LE5}.
FT   STRAND       35     39       {ECO:0000244|PDB:5LE5}.
FT   STRAND       42     49       {ECO:0000244|PDB:5LE5}.
FT   HELIX        52     71       {ECO:0000244|PDB:5LE5}.
FT   HELIX        77     89       {ECO:0000244|PDB:5LE5}.
FT   TURN         91     93       {ECO:0000244|PDB:4R67}.
FT   STRAND       94     96       {ECO:0000244|PDB:5LE5}.
FT   STRAND      100    108       {ECO:0000244|PDB:5LE5}.
FT   TURN        109    111       {ECO:0000244|PDB:5LE5}.
FT   STRAND      112    118       {ECO:0000244|PDB:5LE5}.
FT   STRAND      124    126       {ECO:0000244|PDB:5LE5}.
FT   STRAND      128    133       {ECO:0000244|PDB:5LE5}.
FT   HELIX       136    146       {ECO:0000244|PDB:5LE5}.
FT   HELIX       153    170       {ECO:0000244|PDB:5LE5}.
FT   STRAND      171    173       {ECO:0000244|PDB:5LE5}.
FT   STRAND      177    184       {ECO:0000244|PDB:5LE5}.
FT   STRAND      187    190       {ECO:0000244|PDB:5LE5}.
SQ   SEQUENCE   201 AA;  22836 MW;  04D085D7BAA76130 CRC64;
     MEYLIGIQGP DYVLVASDRV AASNIVQMKD DHDKMFKMSE KILLLCVGEA GDTVQFAEYI
     QKNVQLYKMR NGYELSPTAA ANFTRRNLAD CLRSRTPYHV NLLLAGYDEH EGPALYYMDY
     LAALAKAPFA AHGYGAFLTL SILDRYYTPT ISRERAVELL RKCLEELQKR FILNLPTFSV
     RIIDKNGIHD LDNISFPKQG S
//
ID   PSB3_HUMAN              Reviewed;         205 AA.
AC   P49720; P31147; Q0P6J7; Q96E27;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2002, sequence version 2.
DT   23-MAY-2018, entry version 191.
DE   RecName: Full=Proteasome subunit beta type-3;
DE            EC=3.4.25.1 {ECO:0000269|PubMed:27176742};
DE   AltName: Full=Proteasome chain 13;
DE   AltName: Full=Proteasome component C10-II;
DE   AltName: Full=Proteasome theta chain;
GN   Name=PSMB3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-34.
RX   PubMed=7918633; DOI=10.1016/0167-4781(94)90060-4;
RA   Nothwang H.G., Tamura T., Tanaka K., Ichihara A.;
RT   "Sequence analyses and inter-species comparisons of three novel human
RT   proteasomal subunits, HsN3, HsC7-I and HsC10-II, confine potential
RT   proteolytic active-site residues.";
RL   Biochim. Biophys. Acta 1219:361-368(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-15; 28-41; 49-66; 71-77; 100-115 AND 178-192,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., von Kriegsheim A.F., Kolch W.;
RL   Submitted (JUL-2008) to UniProtKB.
RN   [4]
RP   PROTEIN SEQUENCE OF 29-42; 50-67 AND 101-116, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [5]
RP   PROTEIN SEQUENCE OF 49-66 AND 99-111.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [6]
RP   PROTEIN SEQUENCE OF 100-115.
RC   TISSUE=Placenta;
RX   PubMed=7811265; DOI=10.1006/bbrc.1994.2876;
RA   Kristensen P., Johnsen A.H., Uerkvitz W., Tanaka K., Hendil K.B.;
RT   "Human proteasome subunits from 2-dimensional gels identified by
RT   partial sequencing.";
RL   Biochem. Biophys. Res. Commun. 205:1785-1789(1994).
RN   [7]
RP   FUNCTION IN ANTIGEN PRESENTATION.
RX   PubMed=8610016; DOI=10.1038/381166a0;
RA   Groettrup M., Soza A., Eggers M., Kuehn L., Dick T.P., Schild H.,
RA   Rammensee H.G., Koszinowski U.H., Kloetzel P.M.;
RT   "A role for the proteasome regulator PA28alpha in antigen
RT   presentation.";
RL   Nature 381:166-168(1996).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12181345; DOI=10.1091/mbc.E02-03-0122;
RA   Lafarga M., Berciano M.T., Pena E., Mayo I., Castano J.G., Bohmann D.,
RA   Rodrigues J.P., Tavanez J.P., Carmo-Fonseca M.;
RT   "Clastosome: a subtype of nuclear body enriched in 19S and 20S
RT   proteasomes, ubiquitin, and protein substrates of proteasome.";
RL   Mol. Biol. Cell 13:2771-2782(2002).
RN   [9]
RP   INTERACTION WITH HIV-1 TAT.
RX   PubMed=14550573; DOI=10.1016/S0014-5793(03)01025-1;
RA   Apcher G.S., Heink S., Zantopf D., Kloetzel P.-M., Schmid H.-P.,
RA   Mayer R.J., Krueger E.;
RT   "Human immunodeficiency virus-1 Tat protein interacts with distinct
RT   proteasomal alpha and beta subunits.";
RL   FEBS Lett. 553:200-204(2003).
RN   [10]
RP   FUNCTION.
RX   PubMed=15244466; DOI=10.1021/bm049957a;
RA   Yano M., Koumoto Y., Kanesaki Y., Wu X., Kido H.;
RT   "20S proteasome prevents aggregation of heat-denatured proteins
RT   without PA700 regulatory subcomplex like a molecular chaperone.";
RL   Biomacromolecules 5:1465-1469(2004).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [12]
RP   INDUCTION.
RX   PubMed=18281682; DOI=10.1093/humrep/den024;
RA   Martinez-Heredia J., de Mateo S., Vidal-Taboada J.M., Ballesca J.L.,
RA   Oliva R.;
RT   "Identification of proteomic differences in asthenozoospermic sperm
RT   samples.";
RL   Hum. Reprod. 23:783-791(2008).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-77, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=27176742; DOI=10.1515/hsz-2016-0176;
RA   Rut W., Drag M.;
RT   "Human 20S proteasome activity towards fluorogenic peptides of various
RT   chain lengths.";
RL   Biol. Chem. 397:921-926(2016).
RN   [19]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=26133119; DOI=10.1038/ncomms8573;
RA   da Fonseca P.C., Morris E.P.;
RT   "Cryo-EM reveals the conformation of a substrate analogue in the human
RT   20S proteasome core.";
RL   Nat. Commun. 6:7573-7573(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS), AND SUBUNIT.
RX   PubMed=25599644; DOI=10.1016/j.str.2014.11.017;
RA   Harshbarger W., Miller C., Diedrich C., Sacchettini J.;
RT   "Crystal structure of the human 20S proteasome in complex with
RT   carfilzomib.";
RL   Structure 23:418-424(2015).
RN   [21]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27428775; DOI=10.1038/nsmb.3273;
RA   Huang X., Luan B., Wu J., Shi Y.;
RT   "An atomic structure of the human 26S proteasome.";
RL   Nat. Struct. Mol. Biol. 23:778-785(2016).
RN   [22]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.02 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA   Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA   Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT   "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27493187; DOI=10.1126/science.aaf8993;
RA   Schrader J., Henneberg F., Mata R.A., Tittmann K., Schneider T.R.,
RA   Stark H., Bourenkov G., Chari A.;
RT   "The inhibition mechanism of human 20S proteasomes enables next-
RT   generation inhibitor design.";
RL   Science 353:594-598(2016).
CC   -!- FUNCTION: Component of the 20S core proteasome complex involved in
CC       the proteolytic degradation of most intracellular proteins. This
CC       complex plays numerous essential roles within the cell by
CC       associating with different regulatory particles. Associated with
CC       two 19S regulatory particles, forms the 26S proteasome and thus
CC       participates in the ATP-dependent degradation of ubiquitinated
CC       proteins. The 26S proteasome plays a key role in the maintenance
CC       of protein homeostasis by removing misfolded or damaged proteins
CC       that could impair cellular functions, and by removing proteins
CC       whose functions are no longer required. Associated with the PA200
CC       or PA28, the 20S proteasome mediates ubiquitin-independent protein
CC       degradation. This type of proteolysis is required in several
CC       pathways including spermatogenesis (20S-PA200 complex) or
CC       generation of a subset of MHC class I-presented antigenic peptides
CC       (20S-PA28 complex). {ECO:0000269|PubMed:15244466,
CC       ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000269|PubMed:27176742}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. The 20S proteasome core is a barrel-
CC       shaped complex made of 28 subunits that are arranged in four
CC       stacked rings. The two outer rings are each formed by seven alpha
CC       subunits, and the two inner rings are formed by seven beta
CC       subunits. The proteolytic activity is exerted by three beta-
CC       subunits PSMB5, PSMB6 and PSMB7. Interacts with HIV-1 TAT protein
CC       (PubMed:14550573). {ECO:0000269|PubMed:14550573,
CC       ECO:0000269|PubMed:25599644, ECO:0000269|PubMed:26133119,
CC       ECO:0000269|PubMed:27342858, ECO:0000269|PubMed:27428775,
CC       ECO:0000269|PubMed:27493187}.
CC   -!- INTERACTION:
CC       P49721:PSMB2; NbExp=4; IntAct=EBI-603340, EBI-359335;
CC       P14373:TRIM27; NbExp=5; IntAct=EBI-603340, EBI-719493;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12181345}.
CC       Nucleus {ECO:0000269|PubMed:12181345}.
CC   -!- INDUCTION: Up-regulated in asthenozoospermic sperm.
CC       {ECO:0000269|PubMed:18281682}.
CC   -!- SIMILARITY: Belongs to the peptidase T1B family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00809}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D26598; BAA05645.1; -; mRNA.
DR   EMBL; BC013008; AAH13008.1; -; mRNA.
DR   CCDS; CCDS11328.1; -.
DR   PIR; S55041; S55041.
DR   RefSeq; NP_002786.2; NM_002795.3.
DR   UniGene; Hs.82793; -.
DR   PDB; 4R3O; X-ray; 2.60 A; J/X=2-205.
DR   PDB; 4R67; X-ray; 2.89 A; J/X/l/z=2-205.
DR   PDB; 5A0Q; EM; 3.50 A; J/X=2-205.
DR   PDB; 5GJQ; EM; 4.50 A; c/q=1-205.
DR   PDB; 5GJR; EM; 3.50 A; c/q=1-205.
DR   PDB; 5L4G; EM; 4.02 A; 3/W=1-205.
DR   PDB; 5LE5; X-ray; 1.80 A; I/W=1-205.
DR   PDB; 5LEX; X-ray; 2.20 A; I/W=1-205.
DR   PDB; 5LEY; X-ray; 1.90 A; I/W=1-205.
DR   PDB; 5LEZ; X-ray; 2.19 A; I/W=1-205.
DR   PDB; 5LF0; X-ray; 2.41 A; I/W=1-205.
DR   PDB; 5LF1; X-ray; 2.00 A; I/W=1-205.
DR   PDB; 5LF3; X-ray; 2.10 A; I/W=1-205.
DR   PDB; 5LF4; X-ray; 1.99 A; I/W=1-205.
DR   PDB; 5LF6; X-ray; 2.07 A; I/W=1-205.
DR   PDB; 5LF7; X-ray; 2.00 A; I/W=1-205.
DR   PDB; 5LN3; EM; 6.80 A; 3=1-205.
DR   PDB; 5M32; EM; 3.80 A; I/W=1-205.
DR   PDB; 5T0C; EM; 3.80 A; AP/BP=2-205.
DR   PDB; 5T0G; EM; 4.40 A; P=2-205.
DR   PDB; 5T0H; EM; 6.80 A; P=2-205.
DR   PDB; 5T0I; EM; 8.00 A; P=2-205.
DR   PDB; 5T0J; EM; 8.00 A; P=2-205.
DR   PDB; 6AVO; EM; 3.80 A; U/Y=1-205.
DR   PDBsum; 4R3O; -.
DR   PDBsum; 4R67; -.
DR   PDBsum; 5A0Q; -.
DR   PDBsum; 5GJQ; -.
DR   PDBsum; 5GJR; -.
DR   PDBsum; 5L4G; -.
DR   PDBsum; 5LE5; -.
DR   PDBsum; 5LEX; -.
DR   PDBsum; 5LEY; -.
DR   PDBsum; 5LEZ; -.
DR   PDBsum; 5LF0; -.
DR   PDBsum; 5LF1; -.
DR   PDBsum; 5LF3; -.
DR   PDBsum; 5LF4; -.
DR   PDBsum; 5LF6; -.
DR   PDBsum; 5LF7; -.
DR   PDBsum; 5LN3; -.
DR   PDBsum; 5M32; -.
DR   PDBsum; 5T0C; -.
DR   PDBsum; 5T0G; -.
DR   PDBsum; 5T0H; -.
DR   PDBsum; 5T0I; -.
DR   PDBsum; 5T0J; -.
DR   PDBsum; 6AVO; -.
DR   ProteinModelPortal; P49720; -.
DR   SMR; P49720; -.
DR   BioGrid; 111664; 99.
DR   CORUM; P49720; -.
DR   DIP; DIP-33846N; -.
DR   IntAct; P49720; 33.
DR   MINT; P49720; -.
DR   STRING; 9606.ENSP00000225426; -.
DR   BindingDB; P49720; -.
DR   ChEMBL; CHEMBL3831201; -.
DR   MEROPS; T01.983; -.
DR   iPTMnet; P49720; -.
DR   PhosphoSitePlus; P49720; -.
DR   SwissPalm; P49720; -.
DR   BioMuta; PSMB3; -.
DR   DMDM; 20532411; -.
DR   OGP; P49720; -.
DR   REPRODUCTION-2DPAGE; IPI00028004; -.
DR   EPD; P49720; -.
DR   MaxQB; P49720; -.
DR   PaxDb; P49720; -.
DR   PeptideAtlas; P49720; -.
DR   PRIDE; P49720; -.
DR   TopDownProteomics; P49720; -.
DR   DNASU; 5691; -.
DR   Ensembl; ENST00000619426; ENSP00000483688; ENSG00000277791.
DR   Ensembl; ENST00000619951; ENSP00000483956; ENSG00000275903.
DR   GeneID; 5691; -.
DR   KEGG; hsa:5691; -.
DR   UCSC; uc002hqr.5; human.
DR   CTD; 5691; -.
DR   EuPathDB; HostDB:ENSG00000277791.4; -.
DR   GeneCards; PSMB3; -.
DR   H-InvDB; HIX0030292; -.
DR   HGNC; HGNC:9540; PSMB3.
DR   HPA; HPA042775; -.
DR   HPA; HPA048147; -.
DR   MIM; 602176; gene.
DR   neXtProt; NX_P49720; -.
DR   OpenTargets; ENSG00000277791; -.
DR   PharmGKB; PA33885; -.
DR   eggNOG; KOG0180; Eukaryota.
DR   eggNOG; ENOG410XSC8; LUCA.
DR   GeneTree; ENSGT00550000074820; -.
DR   HOGENOM; HOG000090523; -.
DR   HOVERGEN; HBG004446; -.
DR   InParanoid; P49720; -.
DR   KO; K02735; -.
DR   OMA; EQLFGMC; -.
DR   OrthoDB; EOG091G0JTX; -.
DR   PhylomeDB; P49720; -.
DR   TreeFam; TF106216; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69229; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   ChiTaRS; PSMB3; human.
DR   GeneWiki; PSMB3; -.
DR   GenomeRNAi; 5691; -.
DR   PRO; PR:P49720; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000277791; -.
DR   CleanEx; HS_PSMB3; -.
DR   ExpressionAtlas; P49720; baseline and differential.
DR   Genevisible; P49720; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0005839; C:proteasome core complex; ISS:UniProtKB.
DR   GO; GO:0019774; C:proteasome core complex, beta-subunit complex; ISS:UniProtKB.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd03759; proteasome_beta_type_3; 1.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR033811; Proteasome_beta_3.
DR   InterPro; IPR016050; Proteasome_bsu_CS.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR023333; Proteasome_suB-type.
DR   PANTHER; PTHR11599:SF62; PTHR11599:SF62; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00854; PROTEASOME_BETA_1; 1.
DR   PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Host-virus interaction; Hydrolase; Nucleus;
KW   Polymorphism; Protease; Proteasome; Reference proteome;
KW   Threonine protease.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.3}.
FT   CHAIN         2    205       Proteasome subunit beta type-3.
FT                                /FTId=PRO_0000148057.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.3}.
FT   MOD_RES      77     77       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT      34     34       M -> L (in dbSNP:rs4907).
FT                                {ECO:0000269|PubMed:7918633}.
FT                                /FTId=VAR_034415.
FT   HELIX         3      5       {ECO:0000244|PDB:5LE5}.
FT   STRAND       10     15       {ECO:0000244|PDB:5LE5}.
FT   STRAND       20     25       {ECO:0000244|PDB:5LE5}.
FT   STRAND       28     30       {ECO:0000244|PDB:5LE5}.
FT   STRAND       33     37       {ECO:0000244|PDB:5LE5}.
FT   STRAND       42     46       {ECO:0000244|PDB:5LE5}.
FT   STRAND       49     55       {ECO:0000244|PDB:5LE5}.
FT   HELIX        57     78       {ECO:0000244|PDB:5LE5}.
FT   HELIX        84     97       {ECO:0000244|PDB:5LE5}.
FT   TURN         98    100       {ECO:0000244|PDB:5LE5}.
FT   STRAND      104    112       {ECO:0000244|PDB:5LE5}.
FT   TURN        114    116       {ECO:0000244|PDB:5LE5}.
FT   STRAND      119    124       {ECO:0000244|PDB:5LE5}.
FT   STRAND      130    140       {ECO:0000244|PDB:5LE5}.
FT   HELIX       143    153       {ECO:0000244|PDB:5LE5}.
FT   HELIX       160    175       {ECO:0000244|PDB:5LE5}.
FT   STRAND      178    181       {ECO:0000244|PDB:4R67}.
FT   STRAND      185    190       {ECO:0000244|PDB:5LE5}.
FT   STRAND      192    200       {ECO:0000244|PDB:5LE5}.
SQ   SEQUENCE   205 AA;  22949 MW;  624972384C0112FD CRC64;
     MSIMSYNGGA VMAMKGKNCV AIAADRRFGI QAQMVTTDFQ KIFPMGDRLY IGLAGLATDV
     QTVAQRLKFR LNLYELKEGR QIKPYTLMSM VANLLYEKRF GPYYTEPVIA GLDPKTFKPF
     ICSLDLIGCP MVTDDFVVSG TCAEQMYGMC ESLWEPNMDP DHLFETISQA MLNAVDRDAV
     SGMGVIVHII EKDKITTRTL KARMD
//
ID   A0A140VJS7_HUMAN        Unreviewed;       160 AA.
AC   A0A140VJS7;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   23-MAY-2018, entry version 12.
DE   SubName: Full=Testicular tissue protein Li 153 {ECO:0000313|EMBL:AEE61064.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE61064.1};
RN   [1] {ECO:0000313|EMBL:AEE61064.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005466; AEE61064.1; -; mRNA.
DR   RefSeq; NP_001124197.1; NM_001130725.1.
DR   UniGene; Hs.422990; -.
DR   SMR; A0A140VJS7; -.
DR   PRIDE; A0A140VJS7; -.
DR   GeneID; 5693; -.
DR   CTD; 5693; -.
DR   ExpressionAtlas; A0A140VJS7; baseline and differential.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005839; C:proteasome core complex; IEA:InterPro.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR000243; Pept_T1A_subB.
DR   InterPro; IPR037558; Proteasome_beta_5.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR023333; Proteasome_suB-type.
DR   PANTHER; PTHR11599:SF51; PTHR11599:SF51; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   PRINTS; PR00141; PROTEASOME.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   160 AA;  17782 MW;  47A97A3A9A849846 CRC64;
     MAGGAADCSF WERLLARQCR IYELRNKERI SVAAASKLLA NMVYQYKGMG LSMGTMICGW
     DKRGPGLYYV DSEGNRISGA TFSVGSGSVY AYGVMDRGYS YDLEVEQAYD LARRAIYQAT
     YRDAYSGGAV NLYHVREDGW IRVSSDNVAD LHEKYSGSTP
//
ID   PSB5_HUMAN              Reviewed;         263 AA.
AC   P28074; B2R4N9; B4DUM9; D3DS43; E9PAV2; Q16242; Q6PEW2; Q7Z3B5;
AC   Q86T01; Q9TNN9;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   29-APR-2008, sequence version 3.
DT   23-MAY-2018, entry version 208.
DE   RecName: Full=Proteasome subunit beta type-5;
DE            EC=3.4.25.1 {ECO:0000269|PubMed:27176742};
DE   AltName: Full=Macropain epsilon chain;
DE   AltName: Full=Multicatalytic endopeptidase complex epsilon chain;
DE   AltName: Full=Proteasome chain 6;
DE   AltName: Full=Proteasome epsilon chain;
DE   AltName: Full=Proteasome subunit MB1;
DE   AltName: Full=Proteasome subunit X;
DE   Flags: Precursor;
GN   Name=PSMB5; Synonyms=LMPX, MB1, X;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8753855; DOI=10.1007/BF02602554;
RA   Abdulla S., Beck S., Belich M., Jackson A., Nakamura T., Trowsdale J.;
RT   "Divergent intron arrangement in the MB1/LMP7 proteasome gene pair.";
RL   Immunogenetics 44:254-258(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Endometrial adenocarcinoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Embryonic stem cell, Hypothalamus, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3-203 (ISOFORM 2).
RC   TISSUE=Cervix carcinoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-263 (ISOFORM 1), AND INDUCTION.
RX   PubMed=8066462; DOI=10.1126/science.8066462;
RA   Akiyama K.-Y., Yokota K.-Y., Kagawa S., Shimbara N., Tamura T.,
RA   Akioka H., Nothwang H.G., Noda C., Tanaka K., Ichihara A.;
RT   "cDNA cloning and interferon gamma down-regulation of proteasomal
RT   subunits X and Y.";
RL   Science 265:1231-1234(1994).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 49-263 (ISOFORM 1).
RX   PubMed=7820546; DOI=10.1016/S0960-9822(00)00174-3;
RA   Belich M.P., Glynne R.J., Senger G., Sheer D., Trowsdale J.;
RT   "Proteasome components with reciprocal expression to that of the MHC-
RT   encoded LMP proteins.";
RL   Curr. Biol. 4:769-776(1994).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 56-263 (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 60-85.
RX   PubMed=2306472; DOI=10.1016/0167-4838(90)90165-C;
RA   Lee L.W., Moomaw C.R., Orth K., McGuire M.J., DeMartino G.N.,
RA   Slaughter C.A.;
RT   "Relationships among the subunits of the high molecular weight
RT   proteinase, macropain (proteasome).";
RL   Biochim. Biophys. Acta 1037:178-185(1990).
RN   [12]
RP   PROTEIN SEQUENCE OF 201-216 AND 226-239.
RX   PubMed=7811265; DOI=10.1006/bbrc.1994.2876;
RA   Kristensen P., Johnsen A.H., Uerkvitz W., Tanaka K., Hendil K.B.;
RT   "Human proteasome subunits from 2-dimensional gels identified by
RT   partial sequencing.";
RL   Biochem. Biophys. Res. Commun. 205:1785-1789(1994).
RN   [13]
RP   PROTEIN SEQUENCE OF 201-216, AND SUBUNIT.
RC   TISSUE=Kidney;
RX   PubMed=8163024; DOI=10.1016/0014-5793(94)80612-8;
RA   Akiyama K., Kagawa S., Tamura T., Shimbara N., Takashina M.,
RA   Kristensen P., Hendil K.B., Tanaka K., Ichihara A.;
RT   "Replacement of proteasome subunits X and Y by LMP7 and LMP2 induced
RT   by interferon-gamma for acquirement of the functional diversity
RT   responsible for antigen processing.";
RL   FEBS Lett. 343:85-88(1994).
RN   [14]
RP   ERRATUM.
RX   PubMed=7864893; DOI=10.1006/bbrc.1995.1294;
RA   Kristensen P., Johnsen A.H., Uerkvitz W., Tanaka K., Hendil K.B.;
RL   Biochem. Biophys. Res. Commun. 207:1059-1059(1995).
RN   [15]
RP   INDUCTION.
RX   PubMed=8663318; DOI=10.1074/jbc.271.29.17275;
RA   Gaczynska M., Goldberg A.L., Tanaka K., Hendil K.B., Rock K.L.;
RT   "Proteasome subunits X and Y alter peptidase activities in opposite
RT   ways to the interferon-gamma-induced subunits LMP2 and LMP7.";
RL   J. Biol. Chem. 271:17275-17280(1996).
RN   [16]
RP   FUNCTION IN ANTIGEN PRESENTATION.
RX   PubMed=8610016; DOI=10.1038/381166a0;
RA   Groettrup M., Soza A., Eggers M., Kuehn L., Dick T.P., Schild H.,
RA   Rammensee H.G., Koszinowski U.H., Kloetzel P.M.;
RT   "A role for the proteasome regulator PA28alpha in antigen
RT   presentation.";
RL   Nature 381:166-168(1996).
RN   [17]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12181345; DOI=10.1091/mbc.E02-03-0122;
RA   Lafarga M., Berciano M.T., Pena E., Mayo I., Castano J.G., Bohmann D.,
RA   Rodrigues J.P., Tavanez J.P., Carmo-Fonseca M.;
RT   "Clastosome: a subtype of nuclear body enriched in 19S and 20S
RT   proteasomes, ubiquitin, and protein substrates of proteasome.";
RL   Mol. Biol. Cell 13:2771-2782(2002).
RN   [18]
RP   INTERACTION WITH HIV-1 TAT.
RX   PubMed=14550573; DOI=10.1016/S0014-5793(03)01025-1;
RA   Apcher G.S., Heink S., Zantopf D., Kloetzel P.-M., Schmid H.-P.,
RA   Mayer R.J., Krueger E.;
RT   "Human immunodeficiency virus-1 Tat protein interacts with distinct
RT   proteasomal alpha and beta subunits.";
RL   FEBS Lett. 553:200-204(2003).
RN   [19]
RP   FUNCTION.
RX   PubMed=15244466; DOI=10.1021/bm049957a;
RA   Yano M., Koumoto Y., Kanesaki Y., Wu X., Kido H.;
RT   "20S proteasome prevents aggregation of heat-denatured proteins
RT   without PA700 regulatory subcomplex like a molecular chaperone.";
RL   Biomacromolecules 5:1465-1469(2004).
RN   [20]
RP   INTERACTION WITH ABCB1 AND TAP1.
RX   PubMed=15488952; DOI=10.1016/j.molimm.2004.07.005;
RA   Begley G.S., Horvath A.R., Taylor J.C., Higgins C.F.;
RT   "Cytoplasmic domains of the transporter associated with antigen
RT   processing and P-glycoprotein interact with subunits of the
RT   proteasome.";
RL   Mol. Immunol. 42:137-141(2005).
RN   [21]
RP   INTERACTION WITH POMP.
RX   PubMed=15944226; DOI=10.1073/pnas.0501711102;
RA   Heink S., Ludwig D., Kloetzel P.-M., Krueger E.;
RT   "IFN-gamma-induced immune adaptation of the proteasome system is an
RT   accelerated and transient response.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:9241-9246(2005).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [23]
RP   INDUCTION.
RX   PubMed=17004105; DOI=10.1007/s10549-006-9393-7;
RA   Deng S., Zhou H., Xiong R., Lu Y., Yan D., Xing T., Dong L., Tang E.,
RA   Yang H.;
RT   "Over-expression of genes and proteins of ubiquitin specific
RT   peptidases (USPs) and proteasome subunits (PSs) in breast cancer
RT   tissue observed by the methods of RFDD-PCR and proteomics.";
RL   Breast Cancer Res. Treat. 104:21-30(2007).
RN   [24]
RP   FUNCTION, AND MUTAGENESIS OF ALA-108.
RX   PubMed=18565852; DOI=10.1182/blood-2007-08-104950;
RA   Oerlemans R., Franke N.E., Assaraf Y.G., Cloos J., van Zantwijk I.,
RA   Berkers C.R., Scheffer G.L., Debipersad K., Vojtekova K., Lemos C.,
RA   van der Heijden J.W., Ylstra B., Peters G.J., Kaspers G.L.,
RA   Dijkmans B.A., Scheper R.J., Jansen G.;
RT   "Molecular basis of bortezomib resistance: proteasome subunit beta5
RT   (PSMB5) gene mutation and overexpression of PSMB5 protein.";
RL   Blood 112:2489-2499(2008).
RN   [25]
RP   FUNCTION, AND MUTAGENESIS OF ALA-108.
RX   PubMed=18502982; DOI=10.1124/jpet.108.138131;
RA   Lue S., Yang J., Song X., Gong S., Zhou H., Guo L., Song N., Bao X.,
RA   Chen P., Wang J.;
RT   "Point mutation of the proteasome beta5 subunit gene is an important
RT   mechanism of bortezomib resistance in bortezomib-selected variants of
RT   Jurkat T cell lymphoblastic lymphoma/leukemia line.";
RL   J. Pharmacol. Exp. Ther. 326:423-431(2008).
RN   [26]
RP   MUTAGENESIS OF ALA-108 AND ALA-109.
RX   PubMed=19426847; DOI=10.1016/j.exphem.2009.04.001;
RA   Lue S., Yang J., Chen Z., Gong S., Zhou H., Xu X., Wang J.;
RT   "Different mutants of PSMB5 confer varying bortezomib resistance in T
RT   lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell
RT   line.";
RL   Exp. Hematol. 37:831-837(2009).
RN   [27]
RP   INDUCTION BY SULFORAPHANE.
RX   PubMed=18602823; DOI=10.1016/j.jnutbio.2008.02.002;
RA   Ramirez M.C., Singletary K.;
RT   "Regulation of estrogen receptor alpha expression in human breast
RT   cancer cells by sulforaphane.";
RL   J. Nutr. Biochem. 20:195-201(2009).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=27176742; DOI=10.1515/hsz-2016-0176;
RA   Rut W., Drag M.;
RT   "Human 20S proteasome activity towards fluorogenic peptides of various
RT   chain lengths.";
RL   Biol. Chem. 397:921-926(2016).
RN   [31]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=26133119; DOI=10.1038/ncomms8573;
RA   da Fonseca P.C., Morris E.P.;
RT   "Cryo-EM reveals the conformation of a substrate analogue in the human
RT   20S proteasome core.";
RL   Nat. Commun. 6:7573-7573(2015).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 60-260, SUBUNIT, AND ACTIVE
RP   SITE.
RX   PubMed=25599644; DOI=10.1016/j.str.2014.11.017;
RA   Harshbarger W., Miller C., Diedrich C., Sacchettini J.;
RT   "Crystal structure of the human 20S proteasome in complex with
RT   carfilzomib.";
RL   Structure 23:418-424(2015).
RN   [33]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27428775; DOI=10.1038/nsmb.3273;
RA   Huang X., Luan B., Wu J., Shi Y.;
RT   "An atomic structure of the human 26S proteasome.";
RL   Nat. Struct. Mol. Biol. 23:778-785(2016).
RN   [34]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.02 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA   Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA   Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT   "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS), SUBUNIT, AND ACTIVE SITE.
RX   PubMed=27493187; DOI=10.1126/science.aaf8993;
RA   Schrader J., Henneberg F., Mata R.A., Tittmann K., Schneider T.R.,
RA   Stark H., Bourenkov G., Chari A.;
RT   "The inhibition mechanism of human 20S proteasomes enables next-
RT   generation inhibitor design.";
RL   Science 353:594-598(2016).
CC   -!- FUNCTION: Component of the 20S core proteasome complex involved in
CC       the proteolytic degradation of most intracellular proteins. This
CC       complex plays numerous essential roles within the cell by
CC       associating with different regulatory particles. Associated with
CC       two 19S regulatory particles, forms the 26S proteasome and thus
CC       participates in the ATP-dependent degradation of ubiquitinated
CC       proteins. The 26S proteasome plays a key role in the maintenance
CC       of protein homeostasis by removing misfolded or damaged proteins
CC       that could impair cellular functions, and by removing proteins
CC       whose functions are no longer required. Associated with the PA200
CC       or PA28, the 20S proteasome mediates ubiquitin-independent protein
CC       degradation. This type of proteolysis is required in several
CC       pathways including spermatogenesis (20S-PA200 complex) or
CC       generation of a subset of MHC class I-presented antigenic peptides
CC       (20S-PA28 complex). Within the 20S core complex, PSMB5 displays a
CC       chymotrypsin-like activity. {ECO:0000269|PubMed:15244466,
CC       ECO:0000269|PubMed:18502982, ECO:0000269|PubMed:18565852,
CC       ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000269|PubMed:27176742}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. The 20S proteasome core is a barrel-
CC       shaped complex made of 28 subunits that are arranged in four
CC       stacked rings. The two outer rings are each formed by seven alpha
CC       subunits, and the two inner rings are formed by seven beta
CC       subunits. The proteolytic activity is exerted by three beta-
CC       subunits PSMB5, PSMB6 and PSMB7. Directly interacts with POMP
CC       (PubMed:15944226). Interacts with HIV-1 TAT protein
CC       (PubMed:14550573). Interacts with ABCB1 and TAP1
CC       (PubMed:15488952). {ECO:0000269|PubMed:14550573,
CC       ECO:0000269|PubMed:15488952, ECO:0000269|PubMed:15944226,
CC       ECO:0000269|PubMed:25599644, ECO:0000269|PubMed:26133119,
CC       ECO:0000269|PubMed:27342858, ECO:0000269|PubMed:27428775,
CC       ECO:0000269|PubMed:27493187, ECO:0000269|PubMed:8163024}.
CC   -!- INTERACTION:
CC       Q9Y244:POMP; NbExp=3; IntAct=EBI-357828, EBI-696895;
CC       P20618:PSMB1; NbExp=3; IntAct=EBI-357828, EBI-372273;
CC       Q99436:PSMB7; NbExp=7; IntAct=EBI-357828, EBI-603319;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12181345}.
CC       Nucleus {ECO:0000269|PubMed:12181345}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P28074-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P28074-2; Sequence=VSP_041263;
CC       Name=3;
CC         IsoId=P28074-3; Sequence=VSP_045686;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: Down-regulated by IFNG/IFN-gamma (at protein level).
CC       Induced in breast cancer tissue. Up-regulated by sulforaphane in
CC       breast cancer cells. {ECO:0000269|PubMed:17004105,
CC       ECO:0000269|PubMed:18602823, ECO:0000269|PubMed:8066462,
CC       ECO:0000269|PubMed:8663318}.
CC   -!- SIMILARITY: Belongs to the peptidase T1B family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00809}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAP35423.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA06097.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAD97956.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X95586; CAA64838.1; -; Genomic_DNA.
DR   EMBL; AK300714; BAG62391.1; -; mRNA.
DR   EMBL; AK311895; BAG34836.1; -; mRNA.
DR   EMBL; BX538001; CAD97956.1; ALT_INIT; mRNA.
DR   EMBL; AL132780; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471078; EAW66193.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66195.1; -; Genomic_DNA.
DR   EMBL; BC004146; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC057840; AAH57840.1; -; mRNA.
DR   EMBL; BC107720; AAI07721.1; -; mRNA.
DR   EMBL; CD048996; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BX248299; CAD62626.1; -; mRNA.
DR   EMBL; D29011; BAA06097.1; ALT_INIT; mRNA.
DR   EMBL; S74378; AAB33092.1; -; mRNA.
DR   EMBL; BT006777; AAP35423.1; ALT_INIT; mRNA.
DR   CCDS; CCDS45083.1; -. [P28074-3]
DR   CCDS; CCDS45084.1; -. [P28074-2]
DR   CCDS; CCDS9584.1; -. [P28074-1]
DR   PIR; A54589; A54589.
DR   PIR; I52906; I52906.
DR   PIR; PC2328; PC2328.
DR   PIR; S08189; S08189.
DR   RefSeq; NP_001124197.1; NM_001130725.1. [P28074-3]
DR   RefSeq; NP_001138404.1; NM_001144932.2. [P28074-2]
DR   RefSeq; NP_002788.1; NM_002797.4. [P28074-1]
DR   UniGene; Hs.422990; -.
DR   PDB; 4R3O; X-ray; 2.60 A; L/Z=60-260.
DR   PDB; 4R67; X-ray; 2.89 A; 3/L/Z/n=60-260.
DR   PDB; 5A0Q; EM; 3.50 A; L/Z=60-263.
DR   PDB; 5GJQ; EM; 4.50 A; e/s=1-263.
DR   PDB; 5GJR; EM; 3.50 A; e/s=1-263.
DR   PDB; 5L4G; EM; 4.02 A; 5/Y=1-263.
DR   PDB; 5L5W; X-ray; 2.80 A; K/Y=60-197.
DR   PDB; 5L5X; X-ray; 2.90 A; K/Y=60-197.
DR   PDB; 5L5Y; X-ray; 2.70 A; K/Y=60-197.
DR   PDB; 5L5Z; X-ray; 2.70 A; K/Y=60-197.
DR   PDB; 5L60; X-ray; 2.70 A; K/Y=60-197.
DR   PDB; 5L61; X-ray; 2.80 A; K/Y=60-193.
DR   PDB; 5L62; X-ray; 2.80 A; K/Y=60-197.
DR   PDB; 5L63; X-ray; 2.70 A; K/Y=60-197.
DR   PDB; 5L64; X-ray; 2.70 A; K/Y=60-197.
DR   PDB; 5LE5; X-ray; 1.80 A; K/Y=60-263.
DR   PDB; 5LEX; X-ray; 2.20 A; K/Y=60-263.
DR   PDB; 5LEY; X-ray; 1.90 A; K/Y=60-263.
DR   PDB; 5LEZ; X-ray; 2.19 A; K/Y=60-263.
DR   PDB; 5LF0; X-ray; 2.41 A; K/Y=60-263.
DR   PDB; 5LF1; X-ray; 2.00 A; K/Y=60-263.
DR   PDB; 5LF3; X-ray; 2.10 A; K/Y=60-263.
DR   PDB; 5LF4; X-ray; 1.99 A; K/Y=60-263.
DR   PDB; 5LF6; X-ray; 2.07 A; K/Y=60-263.
DR   PDB; 5LF7; X-ray; 2.00 A; K/Y=60-263.
DR   PDB; 5LN3; EM; 6.80 A; 5=1-263.
DR   PDB; 5M32; EM; 3.80 A; K/Y=60-263.
DR   PDB; 5T0C; EM; 3.80 A; AR/BR=2-263.
DR   PDB; 5T0G; EM; 4.40 A; R=2-263.
DR   PDB; 5T0H; EM; 6.80 A; R=2-263.
DR   PDB; 5T0I; EM; 8.00 A; R=2-263.
DR   PDB; 5T0J; EM; 8.00 A; R=2-263.
DR   PDBsum; 4R3O; -.
DR   PDBsum; 4R67; -.
DR   PDBsum; 5A0Q; -.
DR   PDBsum; 5GJQ; -.
DR   PDBsum; 5GJR; -.
DR   PDBsum; 5L4G; -.
DR   PDBsum; 5L5W; -.
DR   PDBsum; 5L5X; -.
DR   PDBsum; 5L5Y; -.
DR   PDBsum; 5L5Z; -.
DR   PDBsum; 5L60; -.
DR   PDBsum; 5L61; -.
DR   PDBsum; 5L62; -.
DR   PDBsum; 5L63; -.
DR   PDBsum; 5L64; -.
DR   PDBsum; 5LE5; -.
DR   PDBsum; 5LEX; -.
DR   PDBsum; 5LEY; -.
DR   PDBsum; 5LEZ; -.
DR   PDBsum; 5LF0; -.
DR   PDBsum; 5LF1; -.
DR   PDBsum; 5LF3; -.
DR   PDBsum; 5LF4; -.
DR   PDBsum; 5LF6; -.
DR   PDBsum; 5LF7; -.
DR   PDBsum; 5LN3; -.
DR   PDBsum; 5M32; -.
DR   PDBsum; 5T0C; -.
DR   PDBsum; 5T0G; -.
DR   PDBsum; 5T0H; -.
DR   PDBsum; 5T0I; -.
DR   PDBsum; 5T0J; -.
DR   ProteinModelPortal; P28074; -.
DR   SMR; P28074; -.
DR   BioGrid; 111666; 106.
DR   CORUM; P28074; -.
DR   DIP; DIP-27540N; -.
DR   IntAct; P28074; 34.
DR   MINT; P28074; -.
DR   STRING; 9606.ENSP00000355325; -.
DR   BindingDB; P28074; -.
DR   ChEMBL; CHEMBL4662; -.
DR   DrugBank; DB00188; Bortezomib.
DR   DrugBank; DB08889; Carfilzomib.
DR   GuidetoPHARMACOLOGY; 2406; -.
DR   MEROPS; T01.012; -.
DR   iPTMnet; P28074; -.
DR   PhosphoSitePlus; P28074; -.
DR   SwissPalm; P28074; -.
DR   BioMuta; PSMB5; -.
DR   DMDM; 187608890; -.
DR   REPRODUCTION-2DPAGE; IPI00479306; -.
DR   EPD; P28074; -.
DR   MaxQB; P28074; -.
DR   PaxDb; P28074; -.
DR   PeptideAtlas; P28074; -.
DR   PRIDE; P28074; -.
DR   TopDownProteomics; P28074-1; -. [P28074-1]
DR   DNASU; 5693; -.
DR   Ensembl; ENST00000361611; ENSP00000355325; ENSG00000100804. [P28074-1]
DR   Ensembl; ENST00000425762; ENSP00000395206; ENSG00000100804. [P28074-3]
DR   Ensembl; ENST00000493471; ENSP00000452424; ENSG00000100804. [P28074-2]
DR   GeneID; 5693; -.
DR   KEGG; hsa:5693; -.
DR   UCSC; uc001wii.3; human. [P28074-1]
DR   CTD; 5693; -.
DR   DisGeNET; 5693; -.
DR   EuPathDB; HostDB:ENSG00000100804.18; -.
DR   GeneCards; PSMB5; -.
DR   HGNC; HGNC:9542; PSMB5.
DR   HPA; HPA049518; -.
DR   HPA; HPA061796; -.
DR   MIM; 600306; gene.
DR   neXtProt; NX_P28074; -.
DR   OpenTargets; ENSG00000100804; -.
DR   PharmGKB; PA33887; -.
DR   eggNOG; KOG0175; Eukaryota.
DR   eggNOG; ENOG410XQRP; LUCA.
DR   GeneTree; ENSGT00510000046395; -.
DR   HOVERGEN; HBG108297; -.
DR   InParanoid; P28074; -.
DR   KO; K02737; -.
DR   OMA; TMCAGVT; -.
DR   OrthoDB; EOG091G0BPS; -.
DR   PhylomeDB; P28074; -.
DR   TreeFam; TF106223; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69229; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SIGNOR; P28074; -.
DR   ChiTaRS; PSMB5; human.
DR   GeneWiki; PSMB5; -.
DR   GenomeRNAi; 5693; -.
DR   PRO; PR:P28074; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100804; -.
DR   CleanEx; HS_PSMB5; -.
DR   ExpressionAtlas; P28074; baseline and differential.
DR   Genevisible; P28074; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0005839; C:proteasome core complex; ISS:UniProtKB.
DR   GO; GO:0019774; C:proteasome core complex, beta-subunit complex; ISS:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; IDA:MGI.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0006508; P:proteolysis; IDA:MGI.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR000243; Pept_T1A_subB.
DR   InterPro; IPR037558; Proteasome_beta_5.
DR   InterPro; IPR016050; Proteasome_bsu_CS.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR023333; Proteasome_suB-type.
DR   PANTHER; PTHR11599:SF51; PTHR11599:SF51; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   PRINTS; PR00141; PROTEASOME.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00854; PROTEASOME_BETA_1; 1.
DR   PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Host-virus interaction; Hydrolase; Nucleus;
KW   Polymorphism; Protease; Proteasome; Reference proteome;
KW   Threonine protease; Zymogen.
FT   PROPEP        1     59       Removed in mature form.
FT                                {ECO:0000269|PubMed:2306472}.
FT                                /FTId=PRO_0000026589.
FT   CHAIN        60    263       Proteasome subunit beta type-5.
FT                                /FTId=PRO_0000026590.
FT   ACT_SITE     60     60       Nucleophile.
FT                                {ECO:0000269|PubMed:25599644,
FT                                ECO:0000269|PubMed:27493187}.
FT   BINDING     108    108       Bortezomib; via amide nitrogen.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1    103       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045686.
FT   VAR_SEQ     169    263       GLYYVDSEGNRISGATFSVGSGSVYAYGVMDRGYSYDLEVE
FT                                QAYDLARRAIYQATYRDAYSGGAVNLYHVREDGWIRVSSDN
FT                                VADLHEKYSGSTP -> VSEVLCLKPKSFGMYLFCGCAERI
FT                                GNMARPLLRGQ (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.7}.
FT                                /FTId=VSP_041263.
FT   VARIANT      24     24       R -> C (in dbSNP:rs11543947).
FT                                /FTId=VAR_051549.
FT   MUTAGEN     108    108       A->T: Displays resistance to the
FT                                bortezomib, a proteasome inhibitor of the
FT                                chymotrypsin-like activity. Displays high
FT                                resistance to the bortezomib, a
FT                                proteasome inhibitor of the chymotrypsin-
FT                                like activity; when associated with V-
FT                                109. {ECO:0000269|PubMed:18502982,
FT                                ECO:0000269|PubMed:18565852,
FT                                ECO:0000269|PubMed:19426847}.
FT   MUTAGEN     108    108       A->V: Displays high resistance to the
FT                                bortezomib, a proteasome inhibitor of the
FT                                chymotrypsin-like activity.
FT                                {ECO:0000269|PubMed:18502982,
FT                                ECO:0000269|PubMed:18565852,
FT                                ECO:0000269|PubMed:19426847}.
FT   MUTAGEN     109    109       A->V: Displays high resistance to the
FT                                bortezomib, a proteasome inhibitor of the
FT                                chymotrypsin-like activity; when
FT                                associated with T-108.
FT                                {ECO:0000269|PubMed:19426847}.
FT   CONFLICT      3      6       LASV -> IRGR (in Ref. 8; BAA06097).
FT                                {ECO:0000305}.
FT   CONFLICT      3      5       LAS -> HEG (in Ref. 6; BC004146).
FT                                {ECO:0000305}.
FT   CONFLICT     85     85       I -> F (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    109    109       A -> G (in Ref. 9; AAB33092).
FT                                {ECO:0000305}.
FT   CONFLICT    158    158       T -> S (in Ref. 9; AAB33092).
FT                                {ECO:0000305}.
FT   STRAND       62     67       {ECO:0000244|PDB:5LE5}.
FT   STRAND       70     75       {ECO:0000244|PDB:5LE5}.
FT   STRAND       79     81       {ECO:0000244|PDB:5LE5}.
FT   STRAND       84     88       {ECO:0000244|PDB:5LE5}.
FT   STRAND       93     97       {ECO:0000244|PDB:5LE5}.
FT   STRAND      100    103       {ECO:0000244|PDB:5LE5}.
FT   HELIX       108    129       {ECO:0000244|PDB:5LE5}.
FT   HELIX       135    147       {ECO:0000244|PDB:5LE5}.
FT   TURN        148    151       {ECO:0000244|PDB:5LE5}.
FT   STRAND      156    164       {ECO:0000244|PDB:5LE5}.
FT   STRAND      167    174       {ECO:0000244|PDB:5LE5}.
FT   STRAND      179    181       {ECO:0000244|PDB:5LE5}.
FT   STRAND      183    188       {ECO:0000244|PDB:5LE5}.
FT   HELIX       191    201       {ECO:0000244|PDB:5LE5}.
FT   HELIX       208    225       {ECO:0000244|PDB:5LE5}.
FT   STRAND      231    239       {ECO:0000244|PDB:5LE5}.
FT   STRAND      242    250       {ECO:0000244|PDB:5LE5}.
FT   HELIX       251    258       {ECO:0000244|PDB:5LE5}.
SQ   SEQUENCE   263 AA;  28480 MW;  AED4A73DF41AA6EF CRC64;
     MALASVLERP LPVNQRGFFG LGGRADLLDL GPGSLSDGLS LAAPGWGVPE EPGIEMLHGT
     TTLAFKFRHG VIVAADSRAT AGAYIASQTV KKVIEINPYL LGTMAGGAAD CSFWERLLAR
     QCRIYELRNK ERISVAAASK LLANMVYQYK GMGLSMGTMI CGWDKRGPGL YYVDSEGNRI
     SGATFSVGSG SVYAYGVMDR GYSYDLEVEQ AYDLARRAIY QATYRDAYSG GAVNLYHVRE
     DGWIRVSSDN VADLHEKYSG STP
//
ID   A0A087X2I4_HUMAN        Unreviewed;       213 AA.
AC   A0A087X2I4;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   23-MAY-2018, entry version 34.
DE   RecName: Full=Proteasome subunit beta type {ECO:0000256|RuleBase:RU004203};
DE            EC=3.4.25.1 {ECO:0000256|RuleBase:RU004203};
GN   Name=PSMB6 {ECO:0000313|Ensembl:ENSP00000485006};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000485006, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000485006, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000213|PubMed:17323924}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.F., Baker P.R., Chen P.L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000313|Ensembl:ENSP00000485006}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000256|RuleBase:RU004203}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. {ECO:0000256|RuleBase:RU004203}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU004203}.
CC       Nucleus {ECO:0000256|RuleBase:RU004203,
CC       ECO:0000256|SAAS:SAAS00551005}.
CC   -!- SIMILARITY: Belongs to the peptidase T1B family.
CC       {ECO:0000256|RuleBase:RU004203}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC233723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001257410.1; NM_001270481.1.
DR   UniGene; Hs.77060; -.
DR   ProteinModelPortal; A0A087X2I4; -.
DR   SMR; A0A087X2I4; -.
DR   PeptideAtlas; A0A087X2I4; -.
DR   Ensembl; ENST00000614486; ENSP00000485006; ENSG00000142507.
DR   GeneID; 5694; -.
DR   UCSC; uc031qye.2; human.
DR   CTD; 5694; -.
DR   EuPathDB; HostDB:ENSG00000142507.9; -.
DR   HGNC; HGNC:9543; PSMB6.
DR   OpenTargets; ENSG00000142507; -.
DR   eggNOG; KOG0174; Eukaryota.
DR   eggNOG; ENOG410XS23; LUCA.
DR   GeneTree; ENSGT00510000046484; -.
DR   ChiTaRS; PSMB6; human.
DR   GenomeRNAi; 5694; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000142507; -.
DR   ExpressionAtlas; A0A087X2I4; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005839; C:proteasome core complex; IEA:InterPro.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR000243; Pept_T1A_subB.
DR   InterPro; IPR035140; Proteasome_beta6.
DR   InterPro; IPR016050; Proteasome_bsu_CS.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR023333; Proteasome_suB-type.
DR   PANTHER; PTHR11599:SF46; PTHR11599:SF46; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   PRINTS; PR00141; PROTEASOME.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00854; PROTEASOME_BETA_1; 1.
DR   PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Cytoplasm {ECO:0000256|RuleBase:RU004203};
KW   Hydrolase {ECO:0000256|RuleBase:RU004203};
KW   Nucleus {ECO:0000256|RuleBase:RU004203,
KW   ECO:0000256|SAAS:SAAS00039288};
KW   Protease {ECO:0000256|RuleBase:RU004203};
KW   Proteasome {ECO:0000256|RuleBase:RU004203};
KW   Proteomics identification {ECO:0000213|EPD:A0A087X2I4,
KW   ECO:0000213|MaxQB:A0A087X2I4, ECO:0000213|PeptideAtlas:A0A087X2I4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Threonine protease {ECO:0000256|RuleBase:RU004203}.
SQ   SEQUENCE   213 AA;  23100 MW;  544AA171650A7BD8 CRC64;
     MAATLLAARG AGPAPAWGPE AFTPDWESRE VSTGTTIMAV QFDGGVVLGA DSRTTTGSYI
     ANRVTDKLTP IHDRIFCCRS GSAADTQAVA DAVTYQLGFH SIELNEPPLV HTAASLFKEM
     CYRYREDLMA GIIIAGWDPQ EGGQVYSVPM GGMMVRQSFA IGGSGSSYIY GYVDATYREG
     MTKEECLQFT ANAFFFYPQL SLWPWSGMAP VEE
//
ID   PSB6_HUMAN              Reviewed;         239 AA.
AC   P28072; Q96J55;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2002, sequence version 4.
DT   23-MAY-2018, entry version 197.
DE   RecName: Full=Proteasome subunit beta type-6;
DE            EC=3.4.25.1 {ECO:0000269|PubMed:27176742};
DE   AltName: Full=Macropain delta chain;
DE   AltName: Full=Multicatalytic endopeptidase complex delta chain;
DE   AltName: Full=Proteasome delta chain;
DE   AltName: Full=Proteasome subunit Y;
DE   Flags: Precursor;
GN   Name=PSMB6; Synonyms=LMPY, Y;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RX   PubMed=8066462; DOI=10.1126/science.8066462;
RA   Akiyama K.-Y., Yokota K.-Y., Kagawa S., Shimbara N., Tamura T.,
RA   Akioka H., Nothwang H.G., Noda C., Tanaka K., Ichihara A.;
RT   "cDNA cloning and interferon gamma down-regulation of proteasomal
RT   subunits X and Y.";
RL   Science 265:1231-1234(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-9; 54-63 AND 210-230, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Zebisch A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 60-239, AND PROTEIN SEQUENCE OF 35-75;
RP   80-110 AND 210-233.
RX   PubMed=1888762; DOI=10.1016/0167-4838(91)90020-Z;
RA   DeMartino G.N., Orth K., McCullough M.L., Lee L.W., Munn T.Z.,
RA   Moomaw C.R., Dawson P.A., Slaughter C.A.;
RT   "The primary structures of four subunits of the human, high-molecular-
RT   weight proteinase, macropain (proteasome), are distinct but
RT   homologous.";
RL   Biochim. Biophys. Acta 1079:29-38(1991).
RN   [5]
RP   PROTEIN SEQUENCE OF 35-60.
RX   PubMed=2306472; DOI=10.1016/0167-4838(90)90165-C;
RA   Lee L.W., Moomaw C.R., Orth K., McGuire M.J., DeMartino G.N.,
RA   Slaughter C.A.;
RT   "Relationships among the subunits of the high molecular weight
RT   proteinase, macropain (proteasome).";
RL   Biochim. Biophys. Acta 1037:178-185(1990).
RN   [6]
RP   PROTEIN SEQUENCE OF 157-178, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [7]
RP   SUBUNIT.
RX   PubMed=8163024; DOI=10.1016/0014-5793(94)80612-8;
RA   Akiyama K., Kagawa S., Tamura T., Shimbara N., Takashina M.,
RA   Kristensen P., Hendil K.B., Tanaka K., Ichihara A.;
RT   "Replacement of proteasome subunits X and Y by LMP7 and LMP2 induced
RT   by interferon-gamma for acquirement of the functional diversity
RT   responsible for antigen processing.";
RL   FEBS Lett. 343:85-88(1994).
RN   [8]
RP   FUNCTION IN ANTIGEN PRESENTATION.
RX   PubMed=8610016; DOI=10.1038/381166a0;
RA   Groettrup M., Soza A., Eggers M., Kuehn L., Dick T.P., Schild H.,
RA   Rammensee H.G., Koszinowski U.H., Kloetzel P.M.;
RT   "A role for the proteasome regulator PA28alpha in antigen
RT   presentation.";
RL   Nature 381:166-168(1996).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12181345; DOI=10.1091/mbc.E02-03-0122;
RA   Lafarga M., Berciano M.T., Pena E., Mayo I., Castano J.G., Bohmann D.,
RA   Rodrigues J.P., Tavanez J.P., Carmo-Fonseca M.;
RT   "Clastosome: a subtype of nuclear body enriched in 19S and 20S
RT   proteasomes, ubiquitin, and protein substrates of proteasome.";
RL   Mol. Biol. Cell 13:2771-2782(2002).
RN   [10]
RP   INTERACTION WITH HIV-1 TAT.
RX   PubMed=14550573; DOI=10.1016/S0014-5793(03)01025-1;
RA   Apcher G.S., Heink S., Zantopf D., Kloetzel P.-M., Schmid H.-P.,
RA   Mayer R.J., Krueger E.;
RT   "Human immunodeficiency virus-1 Tat protein interacts with distinct
RT   proteasomal alpha and beta subunits.";
RL   FEBS Lett. 553:200-204(2003).
RN   [11]
RP   FUNCTION.
RX   PubMed=15244466; DOI=10.1021/bm049957a;
RA   Yano M., Koumoto Y., Kanesaki Y., Wu X., Kido H.;
RT   "20S proteasome prevents aggregation of heat-denatured proteins
RT   without PA700 regulatory subcomplex like a molecular chaperone.";
RL   Biomacromolecules 5:1465-1469(2004).
RN   [12]
RP   INDUCTION.
RX   PubMed=15613457; DOI=10.1677/erc.1.00818;
RA   Onda M., Emi M., Yoshida A., Miyamoto S., Akaishi J., Asaka S.,
RA   Mizutani K., Shimizu K., Nagahama M., Ito K., Tanaka T., Tsunoda T.;
RT   "Comprehensive gene expression profiling of anaplastic thyroid cancers
RT   with cDNA microarray of 25 344 genes.";
RL   Endocr. Relat. Cancer 11:843-854(2004).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-69, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=27176742; DOI=10.1515/hsz-2016-0176;
RA   Rut W., Drag M.;
RT   "Human 20S proteasome activity towards fluorogenic peptides of various
RT   chain lengths.";
RL   Biol. Chem. 397:921-926(2016).
RN   [18]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=26133119; DOI=10.1038/ncomms8573;
RA   da Fonseca P.C., Morris E.P.;
RT   "Cryo-EM reveals the conformation of a substrate analogue in the human
RT   20S proteasome core.";
RL   Nat. Commun. 6:7573-7573(2015).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 35-236, SUBUNIT, AND ACTIVE
RP   SITE.
RX   PubMed=25599644; DOI=10.1016/j.str.2014.11.017;
RA   Harshbarger W., Miller C., Diedrich C., Sacchettini J.;
RT   "Crystal structure of the human 20S proteasome in complex with
RT   carfilzomib.";
RL   Structure 23:418-424(2015).
RN   [20]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27428775; DOI=10.1038/nsmb.3273;
RA   Huang X., Luan B., Wu J., Shi Y.;
RT   "An atomic structure of the human 26S proteasome.";
RL   Nat. Struct. Mol. Biol. 23:778-785(2016).
RN   [21]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.02 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA   Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA   Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT   "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS), SUBUNIT, AND ACTIVE SITE.
RX   PubMed=27493187; DOI=10.1126/science.aaf8993;
RA   Schrader J., Henneberg F., Mata R.A., Tittmann K., Schneider T.R.,
RA   Stark H., Bourenkov G., Chari A.;
RT   "The inhibition mechanism of human 20S proteasomes enables next-
RT   generation inhibitor design.";
RL   Science 353:594-598(2016).
CC   -!- FUNCTION: Component of the 20S core proteasome complex involved in
CC       the proteolytic degradation of most intracellular proteins. This
CC       complex plays numerous essential roles within the cell by
CC       associating with different regulatory particles. Associated with
CC       two 19S regulatory particles, forms the 26S proteasome and thus
CC       participates in the ATP-dependent degradation of ubiquitinated
CC       proteins. The 26S proteasome plays a key role in the maintenance
CC       of protein homeostasis by removing misfolded or damaged proteins
CC       that could impair cellular functions, and by removing proteins
CC       whose functions are no longer required. Associated with the PA200
CC       or PA28, the 20S proteasome mediates ubiquitin-independent protein
CC       degradation. This type of proteolysis is required in several
CC       pathways including spermatogenesis (20S-PA200 complex) or
CC       generation of a subset of MHC class I-presented antigenic peptides
CC       (20S-PA28 complex). Within the 20S core complex, PSMB6 displays a
CC       peptidylglutamyl-hydrolizing activity also termed postacidic or
CC       caspase-like activity, meaning that the peptides bond hydrolysis
CC       occurs directly after acidic residues.
CC       {ECO:0000269|PubMed:15244466, ECO:0000269|PubMed:27176742,
CC       ECO:0000269|PubMed:8610016}.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000269|PubMed:27176742}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. The 20S proteasome core is a barrel-
CC       shaped complex made of 28 subunits that are arranged in four
CC       stacked rings. The two outer rings are each formed by seven alpha
CC       subunits, and the two inner rings are formed by seven beta
CC       subunits. The proteolytic activity is exerted by three beta-
CC       subunits PSMB5, PSMB6 and PSMB7. Interacts with HIV-1 TAT protein
CC       (PubMed:14550573). {ECO:0000269|PubMed:14550573,
CC       ECO:0000269|PubMed:25599644, ECO:0000269|PubMed:26133119,
CC       ECO:0000269|PubMed:27342858, ECO:0000269|PubMed:27428775,
CC       ECO:0000269|PubMed:27493187, ECO:0000269|PubMed:8163024}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12181345}.
CC       Nucleus {ECO:0000269|PubMed:12181345}.
CC   -!- INDUCTION: Down-regulated by IFNG/IFN-gamma (at protein level).
CC       Up-regulated in anaplastic thyroid cancer cell lines.
CC       {ECO:0000269|PubMed:15613457, ECO:0000269|PubMed:8066462}.
CC   -!- SIMILARITY: Belongs to the peptidase T1B family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00809}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D29012; BAA06098.1; -; mRNA.
DR   EMBL; BC000835; AAH00835.1; -; mRNA.
DR   EMBL; X61971; CAA43963.1; -; mRNA.
DR   CCDS; CCDS11056.1; -.
DR   PIR; B54589; B54589.
DR   PIR; S17522; S17522.
DR   RefSeq; NP_002789.1; NM_002798.2.
DR   UniGene; Hs.77060; -.
DR   PDB; 4R3O; X-ray; 2.60 A; H/V=35-236.
DR   PDB; 4R67; X-ray; 2.89 A; H/V/j/x=35-236.
DR   PDB; 5A0Q; EM; 3.50 A; H/V=35-239.
DR   PDB; 5GJQ; EM; 4.50 A; a/o=1-239.
DR   PDB; 5GJR; EM; 3.50 A; a/o=1-239.
DR   PDB; 5L4G; EM; 4.02 A; 6/Z=1-239.
DR   PDB; 5LE5; X-ray; 1.80 A; N/b=35-239.
DR   PDB; 5LEX; X-ray; 2.20 A; N/b=35-239.
DR   PDB; 5LEY; X-ray; 1.90 A; N/b=35-239.
DR   PDB; 5LEZ; X-ray; 2.19 A; N/b=35-239.
DR   PDB; 5LF0; X-ray; 2.41 A; N/b=35-239.
DR   PDB; 5LF1; X-ray; 2.00 A; N/b=35-239.
DR   PDB; 5LF3; X-ray; 2.10 A; N/b=36-239.
DR   PDB; 5LF4; X-ray; 1.99 A; N/b=35-239.
DR   PDB; 5LF6; X-ray; 2.07 A; N/b=35-239.
DR   PDB; 5LF7; X-ray; 2.00 A; N/b=35-239.
DR   PDB; 5LN3; EM; 6.80 A; 1=1-239.
DR   PDB; 5M32; EM; 3.80 A; N/b=1-239.
DR   PDB; 5T0C; EM; 3.80 A; AN/BN=2-239.
DR   PDB; 5T0G; EM; 4.40 A; N=2-239.
DR   PDB; 5T0H; EM; 6.80 A; N=2-239.
DR   PDB; 5T0I; EM; 8.00 A; N=2-239.
DR   PDB; 5T0J; EM; 8.00 A; N=2-239.
DR   PDBsum; 4R3O; -.
DR   PDBsum; 4R67; -.
DR   PDBsum; 5A0Q; -.
DR   PDBsum; 5GJQ; -.
DR   PDBsum; 5GJR; -.
DR   PDBsum; 5L4G; -.
DR   PDBsum; 5LE5; -.
DR   PDBsum; 5LEX; -.
DR   PDBsum; 5LEY; -.
DR   PDBsum; 5LEZ; -.
DR   PDBsum; 5LF0; -.
DR   PDBsum; 5LF1; -.
DR   PDBsum; 5LF3; -.
DR   PDBsum; 5LF4; -.
DR   PDBsum; 5LF6; -.
DR   PDBsum; 5LF7; -.
DR   PDBsum; 5LN3; -.
DR   PDBsum; 5M32; -.
DR   PDBsum; 5T0C; -.
DR   PDBsum; 5T0G; -.
DR   PDBsum; 5T0H; -.
DR   PDBsum; 5T0I; -.
DR   PDBsum; 5T0J; -.
DR   ProteinModelPortal; P28072; -.
DR   SMR; P28072; -.
DR   BioGrid; 111667; 89.
DR   CORUM; P28072; -.
DR   DIP; DIP-33847N; -.
DR   IntAct; P28072; 25.
DR   MINT; P28072; -.
DR   STRING; 9606.ENSP00000270586; -.
DR   BindingDB; P28072; -.
DR   ChEMBL; CHEMBL1944496; -.
DR   MEROPS; T01.010; -.
DR   iPTMnet; P28072; -.
DR   PhosphoSitePlus; P28072; -.
DR   SwissPalm; P28072; -.
DR   BioMuta; PSMB6; -.
DR   DMDM; 20532407; -.
DR   OGP; P28072; -.
DR   SWISS-2DPAGE; P28072; -.
DR   EPD; P28072; -.
DR   PaxDb; P28072; -.
DR   PeptideAtlas; P28072; -.
DR   PRIDE; P28072; -.
DR   DNASU; 5694; -.
DR   Ensembl; ENST00000270586; ENSP00000270586; ENSG00000142507.
DR   GeneID; 5694; -.
DR   KEGG; hsa:5694; -.
DR   CTD; 5694; -.
DR   DisGeNET; 5694; -.
DR   EuPathDB; HostDB:ENSG00000142507.9; -.
DR   GeneCards; PSMB6; -.
DR   HGNC; HGNC:9543; PSMB6.
DR   HPA; HPA023312; -.
DR   HPA; HPA063656; -.
DR   MIM; 600307; gene.
DR   neXtProt; NX_P28072; -.
DR   OpenTargets; ENSG00000142507; -.
DR   PharmGKB; PA33888; -.
DR   eggNOG; KOG0174; Eukaryota.
DR   eggNOG; ENOG410XS23; LUCA.
DR   GeneTree; ENSGT00510000046484; -.
DR   HOGENOM; HOG000091079; -.
DR   HOVERGEN; HBG000123; -.
DR   InParanoid; P28072; -.
DR   KO; K02738; -.
DR   OMA; HDRIYCC; -.
DR   OrthoDB; EOG091G0GUI; -.
DR   PhylomeDB; P28072; -.
DR   TreeFam; TF106221; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69229; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   ChiTaRS; PSMB6; human.
DR   GeneWiki; PSMB6; -.
DR   GenomeRNAi; 5694; -.
DR   PRO; PR:P28072; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000142507; -.
DR   CleanEx; HS_PSMB6; -.
DR   ExpressionAtlas; P28072; baseline and differential.
DR   Genevisible; P28072; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0005839; C:proteasome core complex; ISS:UniProtKB.
DR   GO; GO:0019774; C:proteasome core complex, beta-subunit complex; ISS:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0004175; F:endopeptidase activity; NAS:UniProtKB.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:InterPro.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR000243; Pept_T1A_subB.
DR   InterPro; IPR035140; Proteasome_beta6.
DR   InterPro; IPR016050; Proteasome_bsu_CS.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR023333; Proteasome_suB-type.
DR   PANTHER; PTHR11599:SF46; PTHR11599:SF46; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   PRINTS; PR00141; PROTEASOME.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00854; PROTEASOME_BETA_1; 1.
DR   PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Host-virus interaction; Hydrolase; Nucleus;
KW   Phosphoprotein; Polymorphism; Protease; Proteasome;
KW   Reference proteome; Threonine protease; Zymogen.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.3}.
FT   PROPEP        2     34       Removed in mature form.
FT                                {ECO:0000269|PubMed:1888762,
FT                                ECO:0000269|PubMed:2306472}.
FT                                /FTId=PRO_0000026613.
FT   CHAIN        35    239       Proteasome subunit beta type-6.
FT                                /FTId=PRO_0000026614.
FT   ACT_SITE     35     35       Nucleophile.
FT                                {ECO:0000269|PubMed:25599644,
FT                                ECO:0000269|PubMed:27493187}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.3}.
FT   MOD_RES      69     69       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     107    107       P -> A (in dbSNP:rs2304974).
FT                                /FTId=VAR_020030.
FT   CONFLICT    145    145       V -> G (in Ref. 1; BAA06098).
FT                                {ECO:0000305}.
FT   STRAND       37     42       {ECO:0000244|PDB:5LE5}.
FT   STRAND       45     50       {ECO:0000244|PDB:5LE5}.
FT   STRAND       54     56       {ECO:0000244|PDB:5LE5}.
FT   STRAND       59     64       {ECO:0000244|PDB:5LE5}.
FT   STRAND       68     72       {ECO:0000244|PDB:5LE5}.
FT   STRAND       75     81       {ECO:0000244|PDB:5LE5}.
FT   HELIX        83    104       {ECO:0000244|PDB:5LE5}.
FT   HELIX       110    123       {ECO:0000244|PDB:5LE5}.
FT   HELIX       125    127       {ECO:0000244|PDB:5LE5}.
FT   STRAND      130    138       {ECO:0000244|PDB:5LE5}.
FT   TURN        139    141       {ECO:0000244|PDB:5LE5}.
FT   STRAND      142    148       {ECO:0000244|PDB:5LE5}.
FT   STRAND      158    163       {ECO:0000244|PDB:5LE5}.
FT   HELIX       164    169       {ECO:0000244|PDB:5LE5}.
FT   HELIX       170    176       {ECO:0000244|PDB:5LE5}.
FT   HELIX       183    200       {ECO:0000244|PDB:5LE5}.
FT   STRAND      201    203       {ECO:0000244|PDB:4R67}.
FT   STRAND      208    214       {ECO:0000244|PDB:5LE5}.
FT   STRAND      217    223       {ECO:0000244|PDB:5LE5}.
FT   HELIX       225    227       {ECO:0000244|PDB:5LE5}.
SQ   SEQUENCE   239 AA;  25358 MW;  7DF4081DC735930C CRC64;
     MAATLLAARG AGPAPAWGPE AFTPDWESRE VSTGTTIMAV QFDGGVVLGA DSRTTTGSYI
     ANRVTDKLTP IHDRIFCCRS GSAADTQAVA DAVTYQLGFH SIELNEPPLV HTAASLFKEM
     CYRYREDLMA GIIIAGWDPQ EGGQVYSVPM GGMMVRQSFA IGGSGSSYIY GYVDATYREG
     MTKEECLQFT ANALALAMER DGSSGGVIRL AAIAESGVER QVLLGDQIPK FAVATLPPA
//
ID   Q6IAT9_HUMAN            Unreviewed;       239 AA.
AC   Q6IAT9;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   23-MAY-2018, entry version 123.
DE   RecName: Full=Proteasome subunit beta type {ECO:0000256|RuleBase:RU004203};
DE            EC=3.4.25.1 {ECO:0000256|RuleBase:RU004203};
GN   Name=PSMB6 {ECO:0000313|EMBL:CAG33346.1};
GN   ORFNames=hCG_32695 {ECO:0000313|EMBL:EAW90407.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG33346.1};
RN   [1] {ECO:0000313|EMBL:EAW90407.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAP88811.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:CAG33346.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW90407.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BAG34711.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Tongue {ECO:0000313|EMBL:BAG34711.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000256|RuleBase:RU004203}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. {ECO:0000256|RuleBase:RU004203}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU004203}.
CC       Nucleus {ECO:0000256|RuleBase:RU004203,
CC       ECO:0000256|SAAS:SAAS00551005}.
CC   -!- SIMILARITY: Belongs to the peptidase T1B family.
CC       {ECO:0000256|RuleBase:RU004203}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BT009809; AAP88811.1; -; mRNA.
DR   EMBL; AK311768; BAG34711.1; -; mRNA.
DR   EMBL; CR457065; CAG33346.1; -; mRNA.
DR   EMBL; CH471108; EAW90407.1; -; Genomic_DNA.
DR   RefSeq; NP_002789.1; NM_002798.2.
DR   UniGene; Hs.77060; -.
DR   SMR; Q6IAT9; -.
DR   IntAct; Q6IAT9; 1.
DR   MaxQB; Q6IAT9; -.
DR   PRIDE; Q6IAT9; -.
DR   DNASU; 5694; -.
DR   GeneID; 5694; -.
DR   KEGG; hsa:5694; -.
DR   UCSC; uc002fzb.4; human.
DR   CTD; 5694; -.
DR   EuPathDB; HostDB:ENSG00000142507.9; -.
DR   PharmGKB; PA33888; -.
DR   eggNOG; KOG0174; Eukaryota.
DR   eggNOG; ENOG410XS23; LUCA.
DR   HOVERGEN; HBG000123; -.
DR   KO; K02738; -.
DR   OMA; HDRIYCC; -.
DR   OrthoDB; EOG091G0GUI; -.
DR   ChiTaRS; PSMB6; human.
DR   GenomeRNAi; 5694; -.
DR   Bgee; ENSG00000142507; -.
DR   ExpressionAtlas; Q6IAT9; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005839; C:proteasome core complex; IEA:Ensembl.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR000243; Pept_T1A_subB.
DR   InterPro; IPR035140; Proteasome_beta6.
DR   InterPro; IPR016050; Proteasome_bsu_CS.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR023333; Proteasome_suB-type.
DR   PANTHER; PTHR11599:SF46; PTHR11599:SF46; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   PRINTS; PR00141; PROTEASOME.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00854; PROTEASOME_BETA_1; 1.
DR   PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm {ECO:0000256|RuleBase:RU004203};
KW   Hydrolase {ECO:0000256|RuleBase:RU004203};
KW   Nucleus {ECO:0000256|RuleBase:RU004203,
KW   ECO:0000256|SAAS:SAAS00039288};
KW   Protease {ECO:0000256|RuleBase:RU004203};
KW   Proteasome {ECO:0000256|RuleBase:RU004203,
KW   ECO:0000313|EMBL:AAP88811.1};
KW   Threonine protease {ECO:0000256|RuleBase:RU004203}.
SQ   SEQUENCE   239 AA;  25358 MW;  7DF4081DC735930C CRC64;
     MAATLLAARG AGPAPAWGPE AFTPDWESRE VSTGTTIMAV QFDGGVVLGA DSRTTTGSYI
     ANRVTDKLTP IHDRIFCCRS GSAADTQAVA DAVTYQLGFH SIELNEPPLV HTAASLFKEM
     CYRYREDLMA GIIIAGWDPQ EGGQVYSVPM GGMMVRQSFA IGGSGSSYIY GYVDATYREG
     MTKEECLQFT ANALALAMER DGSSGGVIRL AAIAESGVER QVLLGDQIPK FAVATLPPA
//
ID   TARB1_HUMAN             Reviewed;        1621 AA.
AC   Q13395; Q9H581;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   28-MAR-2018, entry version 137.
DE   RecName: Full=Probable methyltransferase TARBP1;
DE            EC=2.1.1.-;
DE   AltName: Full=TAR RNA-binding protein 1;
DE   AltName: Full=TAR RNA-binding protein of 185 kDa;
DE            Short=TRP-185;
GN   Name=TARBP1; Synonyms=TRM3, TRP185;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 1404-1427 AND
RP   1535-1548, FUNCTION, SUBUNIT, AND RNA-BINDING.
RX   PubMed=8846792;
RA   Wu-Baer F., Lane W.S., Gaynor R.B.;
RT   "The cellular factor TRP-185 regulates RNA polymerase II binding to
RT   HIV-1 TAR RNA.";
RL   EMBO J. 14:5995-6009(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   FUNCTION.
RX   PubMed=7638159; DOI=10.1073/pnas.92.16.7153;
RA   Wu-Baer F., Sigman D., Gaynor R.B.;
RT   "Specific binding of RNA polymerase II to the human immunodeficiency
RT   virus trans-activating region RNA is regulated by cellular cofactors
RT   and Tat.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7153-7157(1995).
RN   [4]
RP   FUNCTION.
RX   PubMed=8626763; DOI=10.1074/jbc.271.8.4201;
RA   Wu-Baer F., Lane W.S., Gaynor R.B.;
RT   "Identification of a group of cellular cofactors that stimulate the
RT   binding of RNA polymerase II and TRP-185 to human immunodeficiency
RT   virus 1 TAR RNA.";
RL   J. Biol. Chem. 271:4201-4208(1996).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1442, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 1438-1621 IN COMPLEX WITH
RP   S-ADENOSYL-L-HOMOCYSTEINE, AND SUBUNIT.
RX   PubMed=18412263; DOI=10.1002/prot.22065;
RA   Wu H., Min J., Zeng H., Plotnikov A.N.;
RT   "Crystal structure of the methyltransferase domain of human TARBP1.";
RL   Proteins 72:519-525(2008).
CC   -!- FUNCTION: Probable S-adenosyl-L-methionine-dependent
CC       methyltransferase which methylates RNA molecules such as tRNAs. In
CC       case of infection by HIV-1, it binds to the loop region of TAR
CC       RNA, a region also bound by RNA polymerase II. Binding of TARBP1
CC       and RNA polymerase II to HIV-1 TAR RNA is mutually exclusive,
CC       suggesting that TARBP1 may function alone or in conjunction with
CC       HIV-1 Tat to disengage RNA polymerase II from HIV-1 TAR RNA. May
CC       act by methylating HIV-1 TAR RNA. {ECO:0000269|PubMed:7638159,
CC       ECO:0000269|PubMed:8626763, ECO:0000269|PubMed:8846792}.
CC   -!- SUBUNIT: Monomer and homodimer. {ECO:0000269|PubMed:18412263,
CC       ECO:0000269|PubMed:8846792}.
CC   -!- SIMILARITY: Belongs to the class IV-like SAM-binding
CC       methyltransferase superfamily. RNA methyltransferase TrmH family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U38847; AAC50379.1; -; mRNA.
DR   EMBL; AL136124; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355472; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS1601.1; -.
DR   PIR; S62356; S62356.
DR   RefSeq; NP_005637.3; NM_005646.3.
DR   UniGene; Hs.498115; -.
DR   PDB; 2HA8; X-ray; 1.60 A; A/B=1438-1621.
DR   PDBsum; 2HA8; -.
DR   ProteinModelPortal; Q13395; -.
DR   SMR; Q13395; -.
DR   BioGrid; 112757; 42.
DR   IntAct; Q13395; 8.
DR   STRING; 9606.ENSP00000040877; -.
DR   iPTMnet; Q13395; -.
DR   PhosphoSitePlus; Q13395; -.
DR   BioMuta; TARBP1; -.
DR   DMDM; 74739787; -.
DR   EPD; Q13395; -.
DR   MaxQB; Q13395; -.
DR   PaxDb; Q13395; -.
DR   PeptideAtlas; Q13395; -.
DR   PRIDE; Q13395; -.
DR   DNASU; 6894; -.
DR   Ensembl; ENST00000040877; ENSP00000040877; ENSG00000059588.
DR   GeneID; 6894; -.
DR   KEGG; hsa:6894; -.
DR   UCSC; uc001hwd.3; human.
DR   CTD; 6894; -.
DR   DisGeNET; 6894; -.
DR   EuPathDB; HostDB:ENSG00000059588.9; -.
DR   GeneCards; TARBP1; -.
DR   HGNC; HGNC:11568; TARBP1.
DR   HPA; CAB020810; -.
DR   HPA; HPA024632; -.
DR   MIM; 605052; gene.
DR   neXtProt; NX_Q13395; -.
DR   OpenTargets; ENSG00000059588; -.
DR   PharmGKB; PA36333; -.
DR   eggNOG; KOG0839; Eukaryota.
DR   eggNOG; COG0566; LUCA.
DR   GeneTree; ENSGT00390000003939; -.
DR   HOGENOM; HOG000154511; -.
DR   HOVERGEN; HBG094026; -.
DR   InParanoid; Q13395; -.
DR   KO; K15333; -.
DR   OMA; EGNQIHV; -.
DR   OrthoDB; EOG091G0UYQ; -.
DR   PhylomeDB; Q13395; -.
DR   TreeFam; TF314976; -.
DR   ChiTaRS; TARBP1; human.
DR   EvolutionaryTrace; Q13395; -.
DR   GeneWiki; TARBP1; -.
DR   GenomeRNAi; 6894; -.
DR   PRO; PR:Q13395; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000059588; -.
DR   CleanEx; HS_TARBP1; -.
DR   Genevisible; Q13395; HS.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; TAS:ProtInc.
DR   GO; GO:0070039; F:rRNA (guanosine-2'-O-)-methyltransferase activity; IBA:GO_Central.
DR   GO; GO:0016423; F:tRNA (guanine) methyltransferase activity; IBA:GO_Central.
DR   GO; GO:0000453; P:enzyme-directed rRNA 2'-O-methylation; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0030488; P:tRNA methylation; IBA:GO_Central.
DR   Gene3D; 3.40.1280.10; -; 1.
DR   InterPro; IPR029028; Alpha/beta_knot_MTases.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR025806; Prob_MeTrfase_TARBP1.
DR   InterPro; IPR001537; SpoU_MeTrfase.
DR   InterPro; IPR029026; tRNA_m1G_MTases_N.
DR   Pfam; PF00588; SpoU_methylase; 1.
DR   SUPFAM; SSF48371; SSF48371; 3.
DR   SUPFAM; SSF75217; SSF75217; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Methyltransferase; Phosphoprotein;
KW   Polymorphism; Reference proteome; RNA-binding;
KW   S-adenosyl-L-methionine; Transferase.
FT   CHAIN         1   1621       Probable methyltransferase TARBP1.
FT                                /FTId=PRO_0000273201.
FT   REGION     1543   1545       S-adenosyl-L-methionine binding.
FT                                {ECO:0000269|PubMed:18412263}.
FT   REGION     1586   1595       S-adenosyl-L-methionine binding.
FT                                {ECO:0000269|PubMed:18412263}.
FT   COMPBIAS     99    219       Ala-rich.
FT   BINDING    1566   1566       S-adenosyl-L-methionine; via amide
FT                                nitrogen. {ECO:0000269|PubMed:18412263}.
FT   BINDING    1600   1600       S-adenosyl-L-methionine.
FT                                {ECO:0000269|PubMed:18412263}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   MOD_RES    1442   1442       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   VARIANT     221    221       L -> P (in dbSNP:rs12082990).
FT                                /FTId=VAR_030101.
FT   VARIANT     425    425       A -> T (in dbSNP:rs10910439).
FT                                /FTId=VAR_030102.
FT   VARIANT     513    513       D -> G (in dbSNP:rs35562024).
FT                                /FTId=VAR_061907.
FT   VARIANT     678    678       S -> G (in dbSNP:rs4920246).
FT                                /FTId=VAR_030103.
FT   VARIANT     743    743       N -> S (in dbSNP:rs2273872).
FT                                /FTId=VAR_030104.
FT   VARIANT     864    864       H -> P (in dbSNP:rs4272658).
FT                                /FTId=VAR_030105.
FT   VARIANT     997    997       F -> L (in dbSNP:rs12135427).
FT                                /FTId=VAR_030106.
FT   VARIANT    1038   1038       T -> I (in dbSNP:rs3820602).
FT                                /FTId=VAR_030107.
FT   VARIANT    1359   1359       I -> V (in dbSNP:rs3738616).
FT                                /FTId=VAR_030108.
FT   VARIANT    1461   1461       I -> V (in dbSNP:rs2275654).
FT                                /FTId=VAR_030109.
FT   STRAND     1465   1467       {ECO:0000244|PDB:2HA8}.
FT   HELIX      1474   1486       {ECO:0000244|PDB:2HA8}.
FT   STRAND     1490   1495       {ECO:0000244|PDB:2HA8}.
FT   HELIX      1497   1501       {ECO:0000244|PDB:2HA8}.
FT   HELIX      1503   1509       {ECO:0000244|PDB:2HA8}.
FT   HELIX      1512   1514       {ECO:0000244|PDB:2HA8}.
FT   STRAND     1518   1520       {ECO:0000244|PDB:2HA8}.
FT   HELIX      1523   1525       {ECO:0000244|PDB:2HA8}.
FT   HELIX      1526   1535       {ECO:0000244|PDB:2HA8}.
FT   STRAND     1539   1543       {ECO:0000244|PDB:2HA8}.
FT   HELIX      1552   1554       {ECO:0000244|PDB:2HA8}.
FT   STRAND     1559   1565       {ECO:0000244|PDB:2HA8}.
FT   TURN       1568   1570       {ECO:0000244|PDB:2HA8}.
FT   HELIX      1574   1577       {ECO:0000244|PDB:2HA8}.
FT   STRAND     1581   1585       {ECO:0000244|PDB:2HA8}.
FT   STRAND     1590   1593       {ECO:0000244|PDB:2HA8}.
FT   HELIX      1597   1613       {ECO:0000244|PDB:2HA8}.
SQ   SEQUENCE   1621 AA;  181675 MW;  A8C2BC62B7F1ADA8 CRC64;
     MEWVLAEALL SQSRDPRALL GALCQGEASA ERVETLRFLL QRLEDEEARG SGGAGALPEA
     AREVAAGYLV PLLRSLRGRP AGGPDPSLQP RHRRRVLRAA GAALRSCVRL AGRPQLAAAL
     AEEALRDLLA GWRAPGAEAA VEVLAAVGPC LRPREDGPLL ERVAGTAVAL ALGGGGDGDE
     AGPAEDAAAL VAGRLLPVLV QCGGAALRAV WGGLAAPGAS LGSGRVEEKL LVLSALAEKL
     LPEPGGDRAR GAREAGPDAR RCWRFWRTVQ AGLGQADALT RKRARYLLQR AVEVSAELGA
     DCTCGPQEGN GPSLFWWSER KKDELLKFWE NYILIMETLE GNQIHVIKPV LPKLNNLFEY
     AVSEENGCWL FHPSWHMCIY KRMFESENKI LSKEGVIHFL ELYETKILPF SPEFSEFIIG
     PLMDALSESS LYSRSPGQPI GSCSPLGLKL QKFLVTYISL LPEEIKSSFL LKFIRKMTSR
     HWCAVPILFL SKALANVPRH KALGIDGLLA LRDVIHCTMI THQILLRGAA QCYLLQTAMN
     LLDVEKVSLS DVSTFLMSLR QEESLGRGTS LWTELCDWLR VNESYFKPSP TCSSIGLHKT
     SLNAYVKSIV QEYVKSSAWE TGENCFMPDW FEAKLVSLMV LLAVDVEGMK TQYSGKQRTE
     NVLRIFLDPL LDVLMKFSTN AYMPLLKTDR CLQLLLKLLN TCRLKGSSAQ DDEVSTVLQN
     FFMSTTESIS EFILRRLTMN ELNSVSDLDR CHLYLMVLTE LINLHLKVGW KRGNPIWRVI
     SLLKNASIQH LQEMDSGQEP TVGSQIQRVV SMAALAMVCE AIDQKPELQL DSLHAGPLES
     FLSSLQLNQT LQKPHAEEQS SYAHPLECSS VLEESSSSQG WGKIVAQYIH DQWVCLSFLL
     KKYHTLIPTT GSEILEPFLP AVQMPIRTLQ SALEALTVLS SDQVLPVFHC LKVLVPKLLT
     SSESLCIESF DMAWKIISSL SNTQLIFWAN LKAFVQFVFD NKVLTIAAKI KGQAYFKIKE
     IMYKIIEMSA IKTGVFNTLI SYCCQSWIVS ASNVSQGSLS SAKNYSELIL EACIFGTVFR
     RDQRLVQDVQ TFIENLGHDC AANIVMENTK REDHYVRICA VKFLCLLDGS NMSHKLFIED
     LAIKLLDKDE LVSKSKKRYY VNSLQHRVKN RVWQTLLVLF PRLDQNFLNG IIDRIFQAGF
     TNNQASIKYF IEWIIILILH KFPQFLPKFW DCFSYGEENL KTSICTFLAV LSHLDIITQN
     IPEKKLILKQ ALIVVLQWCF NHNFSVRLYA LVALKKLWTV CKVLSVEEFD ALTPVIESSL
     HQVESMHGAG NAKKNWQRIQ EHFFFATFHP LKDYCLETIF YILPRLSGLI EDEWITIDKF
     TRFTDVPLAA GFQWYLSQTQ LSKLKPGDWS QQDIGTNLVE ADNQAEWTDV QKKIIPWNSR
     VSDLDLELLF QDRAARLGKS ISRLIVVASL IDKPTNLGGL CRTCEVFGAS VLVVGSLQCI
     SDKQFQHLSV SAEQWLPLVE VKPPQLIDYL QQKKTEGYTI IGVEQTAKSL DLTQYCFPEK
     SLLLLGNERE GIPANLIQQL DVCVEIPQQG IIRSLNVHVS GALLIWEYTR QQLLSHGDTK
     P
//
ID   A0A024RA52_HUMAN        Unreviewed;       234 AA.
AC   A0A024RA52;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 37.
DE   RecName: Full=Proteasome subunit alpha type {ECO:0000256|RuleBase:RU000551};
DE            EC=3.4.25.1 {ECO:0000256|RuleBase:RU000551};
GN   Name=PSMA2 {ECO:0000313|EMBL:EAW94153.1,
GN   ECO:0000313|Ensembl:ENSP00000455744};
GN   ORFNames=hCG_19883 {ECO:0000313|EMBL:EAW94153.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW94153.1};
RN   [1] {ECO:0000313|EMBL:EAW94153.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000455744, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000213|PubMed:15592455}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [4] {ECO:0000313|EMBL:EAW94153.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000213|PubMed:17323924}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.F., Baker P.R., Chen P.L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [6] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [8] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13] {ECO:0000313|Ensembl:ENSP00000455744}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUN-2015) to UniProtKB.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000256|PROSITE-ProRule:PRU00808,
CC       ECO:0000256|RuleBase:RU000551}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. {ECO:0000256|RuleBase:RU000551}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU000551}.
CC       Nucleus {ECO:0000256|RuleBase:RU000551,
CC       ECO:0000256|SAAS:SAAS00594407}.
CC   -!- SIMILARITY: Belongs to the peptidase T1A family.
CC       {ECO:0000256|PROSITE-ProRule:PRU00808,
CC       ECO:0000256|RuleBase:RU000551}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC010132; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW94153.1; -; Genomic_DNA.
DR   RefSeq; NP_002778.1; NM_002787.4.
DR   UniGene; Hs.333786; -.
DR   SMR; A0A024RA52; -.
DR   PRIDE; A0A024RA52; -.
DR   Ensembl; ENST00000442788; ENSP00000455744; ENSG00000256646.
DR   GeneID; 5683; -.
DR   KEGG; hsa:5683; -.
DR   CTD; 5683; -.
DR   EuPathDB; HostDB:ENSG00000256646.7; -.
DR   GeneCards; ENSG00000256646; -.
DR   HGNC; HGNC:9531; PSMA2.
DR   OpenTargets; ENSG00000256646; -.
DR   eggNOG; KOG0181; Eukaryota.
DR   eggNOG; ENOG410XPQ8; LUCA.
DR   KO; K02726; -.
DR   OMA; FAWKASA; -.
DR   OrthoDB; EOG091G0GX6; -.
DR   GenomeRNAi; 5683; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000256646; -.
DR   ExpressionAtlas; A0A024RA52; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000932; C:P-body; IEA:Ensembl.
DR   GO; GO:0019773; C:proteasome core complex, alpha-subunit complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR023332; Proteasome_alpha-type.
DR   InterPro; IPR000426; Proteasome_asu_N.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR034644; Proteasome_subunit_alpha2.
DR   PANTHER; PTHR11599:SF16; PTHR11599:SF16; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   Pfam; PF10584; Proteasome_A_N; 1.
DR   SMART; SM00948; Proteasome_A_N; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00388; PROTEASOME_ALPHA_1; 1.
DR   PROSITE; PS51475; PROTEASOME_ALPHA_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Cytoplasm {ECO:0000256|PROSITE-ProRule:PRU00808,
KW   ECO:0000256|RuleBase:RU000551};
KW   Hydrolase {ECO:0000256|PROSITE-ProRule:PRU00808,
KW   ECO:0000256|RuleBase:RU000551};
KW   Nucleus {ECO:0000256|RuleBase:RU000551,
KW   ECO:0000256|SAAS:SAAS00487709};
KW   Protease {ECO:0000256|PROSITE-ProRule:PRU00808,
KW   ECO:0000256|RuleBase:RU000551};
KW   Proteasome {ECO:0000256|PROSITE-ProRule:PRU00808,
KW   ECO:0000256|RuleBase:RU000551, ECO:0000313|EMBL:EAW94153.1};
KW   Proteomics identification {ECO:0000213|EPD:A0A024RA52,
KW   ECO:0000213|MaxQB:A0A024RA52, ECO:0000213|PeptideAtlas:A0A024RA52};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Threonine protease {ECO:0000256|PROSITE-ProRule:PRU00808,
KW   ECO:0000256|RuleBase:RU000551}.
FT   DOMAIN        6     28       PROTEASOME_ALPHA_1.
FT                                {ECO:0000259|PROSITE:PS00388}.
SQ   SEQUENCE   234 AA;  25899 MW;  63CB56A233583836 CRC64;
     MAERGYSFSL TTFSPSGKLV QIEYALAAVA GGAPSVGIKA ANGVVLATEK KQKSILYDER
     SVHKVEPITK HIGLVYSGMG PDYRVLVHRA RKLAQQYYLV YQEPIPTAQL VQRVASVMQE
     YTQSGGVRPF GVSLLICGWN EGRPYLFQSD PSGAYFAWKA TAMGKNYVNG KTFLEKRYNE
     DLELEDAIHT AILTLKESFE GQMTEDNIEV GICNEAGFRR LTPTEVKDYL AAIA
//
ID   PSA2_HUMAN              Reviewed;         234 AA.
AC   P25787; Q6ICS6; Q9BU45;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   23-MAY-2018, entry version 197.
DE   RecName: Full=Proteasome subunit alpha type-2;
DE            EC=3.4.25.1 {ECO:0000269|PubMed:27176742};
DE   AltName: Full=Macropain subunit C3;
DE   AltName: Full=Multicatalytic endopeptidase complex subunit C3;
DE   AltName: Full=Proteasome component C3;
GN   Name=PSMA2; Synonyms=HC3, PSC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2025653; DOI=10.1016/0167-4781(91)90090-9;
RA   Tamura T., Lee D.H., Osaka F., Fujiwara T., Shin S., Chung C.H.,
RA   Tanaka K., Ichihara A.;
RT   "Molecular cloning and sequence analysis of cDNAs for five major
RT   subunits of human proteasomes (multi-catalytic proteinase
RT   complexes).";
RL   Biochim. Biophys. Acta 1089:95-102(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 5-39; 71-84; 93-113 AND 178-196, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 5-14.
RX   PubMed=7811265; DOI=10.1006/bbrc.1994.2876;
RA   Kristensen P., Johnsen A.H., Uerkvitz W., Tanaka K., Hendil K.B.;
RT   "Human proteasome subunits from 2-dimensional gels identified by
RT   partial sequencing.";
RL   Biochem. Biophys. Res. Commun. 205:1785-1789(1994).
RN   [9]
RP   FUNCTION IN ANTIGEN PRESENTATION.
RX   PubMed=8610016; DOI=10.1038/381166a0;
RA   Groettrup M., Soza A., Eggers M., Kuehn L., Dick T.P., Schild H.,
RA   Rammensee H.G., Koszinowski U.H., Kloetzel P.M.;
RT   "A role for the proteasome regulator PA28alpha in antigen
RT   presentation.";
RL   Nature 381:166-168(1996).
RN   [10]
RP   INDUCTION BY BO-653 AND PROBUCOL.
RX   PubMed=11521686; DOI=10.5551/jat1994.7.223;
RA   Takabe W., Mataki C., Wada Y., Ishii M., Izumi A., Aburatani H.,
RA   Hamakubo T., Niki E., Kodama T., Noguchi N.;
RT   "Gene expression induced by BO-653, probucol and BHQ in human
RT   endothelial cells.";
RL   J. Atheroscler. Thromb. 7:223-230(2000).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12181345; DOI=10.1091/mbc.E02-03-0122;
RA   Lafarga M., Berciano M.T., Pena E., Mayo I., Castano J.G., Bohmann D.,
RA   Rodrigues J.P., Tavanez J.P., Carmo-Fonseca M.;
RT   "Clastosome: a subtype of nuclear body enriched in 19S and 20S
RT   proteasomes, ubiquitin, and protein substrates of proteasome.";
RL   Mol. Biol. Cell 13:2771-2782(2002).
RN   [12]
RP   FUNCTION.
RX   PubMed=15244466; DOI=10.1021/bm049957a;
RA   Yano M., Koumoto Y., Kanesaki Y., Wu X., Kido H.;
RT   "20S proteasome prevents aggregation of heat-denatured proteins
RT   without PA700 regulatory subcomplex like a molecular chaperone.";
RL   Biomacromolecules 5:1465-1469(2004).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-24, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [14]
RP   INDUCTION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16548883; DOI=10.1111/j.1462-5822.2005.00644.x;
RA   Leong W.F., Chow V.T.;
RT   "Transcriptomic and proteomic analyses of rhabdomyosarcoma cells
RT   reveal differential cellular gene expression in response to
RT   enterovirus 71 infection.";
RL   Cell. Microbiol. 8:565-580(2006).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-70 AND LYS-171, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; SER-14; SER-16 AND
RP   TYR-76, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [23]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=27176742; DOI=10.1515/hsz-2016-0176;
RA   Rut W., Drag M.;
RT   "Human 20S proteasome activity towards fluorogenic peptides of various
RT   chain lengths.";
RL   Biol. Chem. 397:921-926(2016).
RN   [24]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=26133119; DOI=10.1038/ncomms8573;
RA   da Fonseca P.C., Morris E.P.;
RT   "Cryo-EM reveals the conformation of a substrate analogue in the human
RT   20S proteasome core.";
RL   Nat. Commun. 6:7573-7573(2015).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS), AND SUBUNIT.
RX   PubMed=25599644; DOI=10.1016/j.str.2014.11.017;
RA   Harshbarger W., Miller C., Diedrich C., Sacchettini J.;
RT   "Crystal structure of the human 20S proteasome in complex with
RT   carfilzomib.";
RL   Structure 23:418-424(2015).
RN   [26]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27428775; DOI=10.1038/nsmb.3273;
RA   Huang X., Luan B., Wu J., Shi Y.;
RT   "An atomic structure of the human 26S proteasome.";
RL   Nat. Struct. Mol. Biol. 23:778-785(2016).
RN   [27]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.02 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA   Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA   Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT   "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27493187; DOI=10.1126/science.aaf8993;
RA   Schrader J., Henneberg F., Mata R.A., Tittmann K., Schneider T.R.,
RA   Stark H., Bourenkov G., Chari A.;
RT   "The inhibition mechanism of human 20S proteasomes enables next-
RT   generation inhibitor design.";
RL   Science 353:594-598(2016).
RN   [29]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-110.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Component of the 20S core proteasome complex involved in
CC       the proteolytic degradation of most intracellular proteins. This
CC       complex plays numerous essential roles within the cell by
CC       associating with different regulatory particles. Associated with
CC       two 19S regulatory particles, forms the 26S proteasome and thus
CC       participates in the ATP-dependent degradation of ubiquitinated
CC       proteins. The 26S proteasome plays a key role in the maintenance
CC       of protein homeostasis by removing misfolded or damaged proteins
CC       that could impair cellular functions, and by removing proteins
CC       whose functions are no longer required. Associated with the PA200
CC       or PA28, the 20S proteasome mediates ubiquitin-independent protein
CC       degradation. This type of proteolysis is required in several
CC       pathways including spermatogenesis (20S-PA200 complex) or
CC       generation of a subset of MHC class I-presented antigenic peptides
CC       (20S-PA28 complex). {ECO:0000269|PubMed:15244466,
CC       ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000255|PROSITE-ProRule:PRU00808,
CC       ECO:0000269|PubMed:27176742}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. The 20S proteasome core is a barrel-
CC       shaped complex made of 28 subunits that are arranged in four
CC       stacked rings. The two outer rings are each formed by seven alpha
CC       subunits, and the two inner rings are formed by seven beta
CC       subunits. The proteolytic activity is exerted by three beta-
CC       subunits PSMB5, PSMB6 and PSMB7. {ECO:0000269|PubMed:25599644,
CC       ECO:0000269|PubMed:26133119, ECO:0000269|PubMed:27342858,
CC       ECO:0000269|PubMed:27428775, ECO:0000269|PubMed:27493187}.
CC   -!- INTERACTION:
CC       P25786:PSMA1; NbExp=8; IntAct=EBI-603262, EBI-359352;
CC       P25789:PSMA4; NbExp=7; IntAct=EBI-603262, EBI-359310;
CC       P60900:PSMA6; NbExp=5; IntAct=EBI-603262, EBI-357793;
CC       O14818:PSMA7; NbExp=5; IntAct=EBI-603262, EBI-603272;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12181345}.
CC       Nucleus {ECO:0000269|PubMed:12181345}. Note=Colocalizes with TRIM5
CC       in cytoplasmic bodies. {ECO:0000250|UniProtKB:P49722}.
CC   -!- INDUCTION: Down-regulated by antioxidants BO-653 and probucol.
CC       Down-regulated in response to enterovirus 71 (EV71) infection (at
CC       protein level). {ECO:0000269|PubMed:11521686,
CC       ECO:0000269|PubMed:16548883}.
CC   -!- PTM: Phosphorylated on tyrosine residues; which may be important
CC       for nuclear import. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase T1A family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00808}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D00760; BAA00657.1; -; mRNA.
DR   EMBL; AK290654; BAF83343.1; -; mRNA.
DR   EMBL; CR450317; CAG29313.1; -; mRNA.
DR   EMBL; CH236951; EAL24005.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW94152.1; -; Genomic_DNA.
DR   EMBL; BC002900; AAH02900.2; -; mRNA.
DR   EMBL; BC047697; AAH47697.1; -; mRNA.
DR   CCDS; CCDS5467.1; -.
DR   PIR; S15970; SNHUC3.
DR   RefSeq; NP_002778.1; NM_002787.4.
DR   UniGene; Hs.333786; -.
DR   PDB; 4R3O; X-ray; 2.60 A; B/P=2-234.
DR   PDB; 4R67; X-ray; 2.89 A; B/P/d/r=2-234.
DR   PDB; 5A0Q; EM; 3.50 A; B/P=1-234.
DR   PDB; 5GJQ; EM; 4.50 A; C/i=1-234.
DR   PDB; 5GJR; EM; 3.50 A; C/i=1-234.
DR   PDB; 5L4G; EM; 4.02 A; B/O=1-234.
DR   PDB; 5LE5; X-ray; 1.80 A; A/O=1-234.
DR   PDB; 5LEX; X-ray; 2.20 A; A/O=1-234.
DR   PDB; 5LEY; X-ray; 1.90 A; A/O=1-234.
DR   PDB; 5LEZ; X-ray; 2.19 A; A/O=1-234.
DR   PDB; 5LF0; X-ray; 2.41 A; A/O=1-234.
DR   PDB; 5LF1; X-ray; 2.00 A; A/O=1-234.
DR   PDB; 5LF3; X-ray; 2.10 A; A/O=1-234.
DR   PDB; 5LF4; X-ray; 1.99 A; A/O=1-234.
DR   PDB; 5LF6; X-ray; 2.07 A; A/O=1-234.
DR   PDB; 5LF7; X-ray; 2.00 A; A/O=1-234.
DR   PDB; 5LN3; EM; 6.80 A; B=1-234.
DR   PDB; 5M32; EM; 3.80 A; A/O=1-234.
DR   PDB; 5T0C; EM; 3.80 A; AH/BH=2-234.
DR   PDB; 5T0G; EM; 4.40 A; H=2-234.
DR   PDB; 5T0H; EM; 6.80 A; H=2-234.
DR   PDB; 5T0I; EM; 8.00 A; H=2-234.
DR   PDB; 5T0J; EM; 8.00 A; H=2-234.
DR   PDB; 6AVO; EM; 3.80 A; P/b=1-234.
DR   PDBsum; 4R3O; -.
DR   PDBsum; 4R67; -.
DR   PDBsum; 5A0Q; -.
DR   PDBsum; 5GJQ; -.
DR   PDBsum; 5GJR; -.
DR   PDBsum; 5L4G; -.
DR   PDBsum; 5LE5; -.
DR   PDBsum; 5LEX; -.
DR   PDBsum; 5LEY; -.
DR   PDBsum; 5LEZ; -.
DR   PDBsum; 5LF0; -.
DR   PDBsum; 5LF1; -.
DR   PDBsum; 5LF3; -.
DR   PDBsum; 5LF4; -.
DR   PDBsum; 5LF6; -.
DR   PDBsum; 5LF7; -.
DR   PDBsum; 5LN3; -.
DR   PDBsum; 5M32; -.
DR   PDBsum; 5T0C; -.
DR   PDBsum; 5T0G; -.
DR   PDBsum; 5T0H; -.
DR   PDBsum; 5T0I; -.
DR   PDBsum; 5T0J; -.
DR   PDBsum; 6AVO; -.
DR   ProteinModelPortal; P25787; -.
DR   SMR; P25787; -.
DR   BioGrid; 111656; 137.
DR   CORUM; P25787; -.
DR   DIP; DIP-29364N; -.
DR   IntAct; P25787; 36.
DR   MINT; P25787; -.
DR   STRING; 9606.ENSP00000455744; -.
DR   BindingDB; P25787; -.
DR   ChEMBL; CHEMBL3831201; -.
DR   MEROPS; T01.972; -.
DR   iPTMnet; P25787; -.
DR   PhosphoSitePlus; P25787; -.
DR   SwissPalm; P25787; -.
DR   BioMuta; PSMA2; -.
DR   DMDM; 130850; -.
DR   OGP; P25787; -.
DR   REPRODUCTION-2DPAGE; IPI00219622; -.
DR   EPD; P25787; -.
DR   MaxQB; P25787; -.
DR   PaxDb; P25787; -.
DR   PeptideAtlas; P25787; -.
DR   PRIDE; P25787; -.
DR   TopDownProteomics; P25787; -.
DR   DNASU; 5683; -.
DR   Ensembl; ENST00000223321; ENSP00000223321; ENSG00000106588.
DR   GeneID; 5683; -.
DR   KEGG; hsa:5683; -.
DR   UCSC; uc003thy.5; human.
DR   CTD; 5683; -.
DR   DisGeNET; 5683; -.
DR   EuPathDB; HostDB:ENSG00000106588.10; -.
DR   GeneCards; PSMA2; -.
DR   HGNC; HGNC:9531; PSMA2.
DR   HPA; HPA008188; -.
DR   MIM; 176842; gene.
DR   neXtProt; NX_P25787; -.
DR   OpenTargets; ENSG00000106588; -.
DR   OpenTargets; ENSG00000256646; -.
DR   PharmGKB; PA33876; -.
DR   eggNOG; KOG0181; Eukaryota.
DR   eggNOG; ENOG410XPQ8; LUCA.
DR   GeneTree; ENSGT00550000074870; -.
DR   HOGENOM; HOG000091085; -.
DR   HOVERGEN; HBG003005; -.
DR   InParanoid; P25787; -.
DR   KO; K02726; -.
DR   OMA; FAWKASA; -.
DR   OrthoDB; EOG091G0GX6; -.
DR   PhylomeDB; P25787; -.
DR   TreeFam; TF106207; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69229; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   GeneWiki; PSMA2; -.
DR   GenomeRNAi; 5683; -.
DR   PRO; PR:P25787; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106588; -.
DR   CleanEx; HS_PSMA2; -.
DR   ExpressionAtlas; P25787; baseline and differential.
DR   Genevisible; P25787; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0000932; C:P-body; ISS:UniProtKB.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0005839; C:proteasome core complex; ISS:UniProtKB.
DR   GO; GO:0019773; C:proteasome core complex, alpha-subunit complex; ISS:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0009615; P:response to virus; IEP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR023332; Proteasome_alpha-type.
DR   InterPro; IPR000426; Proteasome_asu_N.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR034644; Proteasome_subunit_alpha2.
DR   PANTHER; PTHR11599:SF16; PTHR11599:SF16; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   Pfam; PF10584; Proteasome_A_N; 1.
DR   SMART; SM00948; Proteasome_A_N; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00388; PROTEASOME_ALPHA_1; 1.
DR   PROSITE; PS51475; PROTEASOME_ALPHA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Hydrolase; Nucleus; Phosphoprotein;
KW   Polymorphism; Protease; Proteasome; Reference proteome;
KW   Threonine protease.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    234       Proteasome subunit alpha type-2.
FT                                /FTId=PRO_0000124077.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES       6      6       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P49722}.
FT   MOD_RES       7      7       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      16     16       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      24     24       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES      70     70       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      76     76       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     121    121       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P17220}.
FT   MOD_RES     171    171       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT     110    110       L -> V (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036278.
FT   STRAND        8     10       {ECO:0000244|PDB:5LF3}.
FT   HELIX        20     30       {ECO:0000244|PDB:5LE5}.
FT   STRAND       35     39       {ECO:0000244|PDB:5LE5}.
FT   STRAND       44     49       {ECO:0000244|PDB:5LE5}.
FT   STRAND       53     57       {ECO:0000244|PDB:4R67}.
FT   HELIX        59     61       {ECO:0000244|PDB:5LEY}.
FT   STRAND       64     69       {ECO:0000244|PDB:5LE5}.
FT   STRAND       72     78       {ECO:0000244|PDB:5LE5}.
FT   HELIX        80    101       {ECO:0000244|PDB:5LE5}.
FT   HELIX       107    120       {ECO:0000244|PDB:5LE5}.
FT   TURN        121    123       {ECO:0000244|PDB:5LE5}.
FT   STRAND      131    140       {ECO:0000244|PDB:5LE5}.
FT   STRAND      143    149       {ECO:0000244|PDB:5LE5}.
FT   STRAND      155    164       {ECO:0000244|PDB:5LE5}.
FT   HELIX       167    177       {ECO:0000244|PDB:5LE5}.
FT   HELIX       184    196       {ECO:0000244|PDB:5LE5}.
FT   STRAND      207    214       {ECO:0000244|PDB:5LE5}.
FT   STRAND      217    220       {ECO:0000244|PDB:5LE5}.
FT   HELIX       223    231       {ECO:0000244|PDB:5LE5}.
SQ   SEQUENCE   234 AA;  25899 MW;  63CB56A233583836 CRC64;
     MAERGYSFSL TTFSPSGKLV QIEYALAAVA GGAPSVGIKA ANGVVLATEK KQKSILYDER
     SVHKVEPITK HIGLVYSGMG PDYRVLVHRA RKLAQQYYLV YQEPIPTAQL VQRVASVMQE
     YTQSGGVRPF GVSLLICGWN EGRPYLFQSD PSGAYFAWKA TAMGKNYVNG KTFLEKRYNE
     DLELEDAIHT AILTLKESFE GQMTEDNIEV GICNEAGFRR LTPTEVKDYL AAIA
//
ID   H0YLC2_HUMAN            Unreviewed;       174 AA.
AC   H0YLC2;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   25-APR-2018, entry version 51.
DE   RecName: Full=Proteasome subunit alpha type {ECO:0000256|RuleBase:RU000551};
DE            EC=3.4.25.1 {ECO:0000256|RuleBase:RU000551};
GN   Name=PSMA4 {ECO:0000313|Ensembl:ENSP00000453145};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000453145, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000453145, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [2] {ECO:0000213|PubMed:17323924}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.F., Baker P.R., Chen P.L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [5] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [6] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7] {ECO:0000313|Ensembl:ENSP00000453145}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [8] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000256|PROSITE-ProRule:PRU00808,
CC       ECO:0000256|RuleBase:RU000551}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. {ECO:0000256|RuleBase:RU000551}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU000551}.
CC       Nucleus {ECO:0000256|RuleBase:RU000551,
CC       ECO:0000256|SAAS:SAAS00594407}.
CC   -!- SIMILARITY: Belongs to the peptidase T1A family.
CC       {ECO:0000256|PROSITE-ProRule:PRU00808,
CC       ECO:0000256|RuleBase:RU000551}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC027228; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317602.1; NM_001330673.1.
DR   UniGene; Hs.251531; -.
DR   ProteinModelPortal; H0YLC2; -.
DR   MaxQB; H0YLC2; -.
DR   PeptideAtlas; H0YLC2; -.
DR   PRIDE; H0YLC2; -.
DR   Ensembl; ENST00000558281; ENSP00000453145; ENSG00000041357.
DR   GeneID; 5685; -.
DR   UCSC; uc059men.1; human.
DR   CTD; 5685; -.
DR   EuPathDB; HostDB:ENSG00000041357.15; -.
DR   HGNC; HGNC:9533; PSMA4.
DR   OpenTargets; ENSG00000041357; -.
DR   eggNOG; KOG0178; Eukaryota.
DR   eggNOG; COG0638; LUCA.
DR   GeneTree; ENSGT00550000074827; -.
DR   ChiTaRS; PSMA4; human.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000041357; -.
DR   ExpressionAtlas; H0YLC2; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0019773; C:proteasome core complex, alpha-subunit complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR023332; Proteasome_alpha-type.
DR   InterPro; IPR000426; Proteasome_asu_N.
DR   InterPro; IPR016050; Proteasome_bsu_CS.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR034647; Proteasome_subunit_alpha4.
DR   PANTHER; PTHR11599:SF13; PTHR11599:SF13; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   Pfam; PF10584; Proteasome_A_N; 1.
DR   SMART; SM00948; Proteasome_A_N; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00388; PROTEASOME_ALPHA_1; 1.
DR   PROSITE; PS51475; PROTEASOME_ALPHA_2; 1.
DR   PROSITE; PS00854; PROTEASOME_BETA_1; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Cytoplasm {ECO:0000256|PROSITE-ProRule:PRU00808,
KW   ECO:0000256|RuleBase:RU000551};
KW   Hydrolase {ECO:0000256|PROSITE-ProRule:PRU00808,
KW   ECO:0000256|RuleBase:RU000551};
KW   Nucleus {ECO:0000256|RuleBase:RU000551,
KW   ECO:0000256|SAAS:SAAS00487709};
KW   Protease {ECO:0000256|PROSITE-ProRule:PRU00808,
KW   ECO:0000256|RuleBase:RU000551};
KW   Proteasome {ECO:0000256|PROSITE-ProRule:PRU00808,
KW   ECO:0000256|RuleBase:RU000551};
KW   Proteomics identification {ECO:0000213|EPD:H0YLC2,
KW   ECO:0000213|MaxQB:H0YLC2, ECO:0000213|PeptideAtlas:H0YLC2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Threonine protease {ECO:0000256|PROSITE-ProRule:PRU00808,
KW   ECO:0000256|RuleBase:RU000551}.
FT   DOMAIN        5     27       PROTEASOME_ALPHA_1.
FT                                {ECO:0000259|PROSITE:PS00388}.
SQ   SEQUENCE   174 AA;  19654 MW;  D460FA2903E98F50 CRC64;
     MSRRYDSRTT IFSPEGRLYQ VEYAMEAIGH AGTCLGILAN DGVLLAAERR NIHKLLDEVF
     FSEKIYKLNE DMACSVAGIT SDANVLTNEL RLIAQRYLLQ YQEPIPCEQL VTALCDIKQA
     YTQFGGKRPF GVSLLYIGWD KHYGFQLYQS DPSGNYGGWK ATCIGNNSAW KLQH
//
ID   H0YN18_HUMAN            Unreviewed;       230 AA.
AC   H0YN18;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   28-MAR-2018, entry version 44.
DE   RecName: Full=Proteasome endopeptidase complex {ECO:0000256|PROSITE-ProRule:PRU00808};
DE            EC=3.4.25.1 {ECO:0000256|PROSITE-ProRule:PRU00808};
GN   Name=PSMA4 {ECO:0000313|Ensembl:ENSP00000453829};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000453829, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000453829, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [2] {ECO:0000213|PubMed:17323924}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.F., Baker P.R., Chen P.L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [3] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000453829}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000256|PROSITE-ProRule:PRU00808}.
CC   -!- SIMILARITY: Belongs to the peptidase T1A family.
CC       {ECO:0000256|PROSITE-ProRule:PRU00808}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC027228; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317604.1; NM_001330675.1.
DR   UniGene; Hs.251531; -.
DR   ProteinModelPortal; H0YN18; -.
DR   SMR; H0YN18; -.
DR   MaxQB; H0YN18; -.
DR   PeptideAtlas; H0YN18; -.
DR   PRIDE; H0YN18; -.
DR   Ensembl; ENST00000560217; ENSP00000453829; ENSG00000041357.
DR   GeneID; 5685; -.
DR   UCSC; uc059mee.1; human.
DR   CTD; 5685; -.
DR   EuPathDB; HostDB:ENSG00000041357.15; -.
DR   HGNC; HGNC:9533; PSMA4.
DR   OpenTargets; ENSG00000041357; -.
DR   GeneTree; ENSGT00550000074827; -.
DR   ChiTaRS; PSMA4; human.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000041357; -.
DR   ExpressionAtlas; H0YN18; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0019773; C:proteasome core complex, alpha-subunit complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR023332; Proteasome_alpha-type.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR034647; Proteasome_subunit_alpha4.
DR   PANTHER; PTHR11599:SF13; PTHR11599:SF13; 2.
DR   Pfam; PF00227; Proteasome; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS51475; PROTEASOME_ALPHA_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Cytoplasm {ECO:0000256|PROSITE-ProRule:PRU00808};
KW   Hydrolase {ECO:0000256|PROSITE-ProRule:PRU00808};
KW   Protease {ECO:0000256|PROSITE-ProRule:PRU00808};
KW   Proteasome {ECO:0000256|PROSITE-ProRule:PRU00808};
KW   Proteomics identification {ECO:0000213|EPD:H0YN18,
KW   ECO:0000213|MaxQB:H0YN18, ECO:0000213|PeptideAtlas:H0YN18};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Threonine protease {ECO:0000256|PROSITE-ProRule:PRU00808}.
FT   COILED      195    229       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   230 AA;  26282 MW;  CF22629F371B4A6A CRC64;
     MSRRYDSRTT IFSPEAERRN IHKLLDEVFF SEKIYKLNED MACSVAGITS DANVLTNELR
     LIAQRYLLQY QEPIPCEQLV TALCDIKQAY TQFGGKRPFG VSLLYIGWDK HYGFQLYQSD
     PSGNYGGWKA TCIGNNSAAA VSMLKQDYKE GEMTLKSALA LAIKVLNKTM DVSKLSAEKV
     EIATLTRENG KTVIRVLKQK EVEQLIKKHE EEEAKAEREK KEKEQKEKDK
//
ID   PSA4_HUMAN              Reviewed;         261 AA.
AC   P25789; D3DW86; Q53XP2; Q567Q5; Q8TBD1;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   23-MAY-2018, entry version 198.
DE   RecName: Full=Proteasome subunit alpha type-4;
DE            EC=3.4.25.1 {ECO:0000269|PubMed:27176742};
DE   AltName: Full=Macropain subunit C9;
DE   AltName: Full=Multicatalytic endopeptidase complex subunit C9;
DE   AltName: Full=Proteasome component C9;
DE   AltName: Full=Proteasome subunit L;
GN   Name=PSMA4; Synonyms=HC9, PSC9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2025653; DOI=10.1016/0167-4781(91)90090-9;
RA   Tamura T., Lee D.H., Osaka F., Fujiwara T., Shin S., Chung C.H.,
RA   Tanaka K., Ichihara A.;
RT   "Molecular cloning and sequence analysis of cDNAs for five major
RT   subunits of human proteasomes (multi-catalytic proteinase
RT   complexes).";
RL   Biochim. Biophys. Acta 1089:95-102(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Blood, Brain, Lung, Pancreas, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 18-39.
RX   PubMed=7811265; DOI=10.1006/bbrc.1994.2876;
RA   Kristensen P., Johnsen A.H., Uerkvitz W., Tanaka K., Hendil K.B.;
RT   "Human proteasome subunits from 2-dimensional gels identified by
RT   partial sequencing.";
RL   Biochem. Biophys. Res. Commun. 205:1785-1789(1994).
RN   [7]
RP   FUNCTION IN ANTIGEN PRESENTATION.
RX   PubMed=8610016; DOI=10.1038/381166a0;
RA   Groettrup M., Soza A., Eggers M., Kuehn L., Dick T.P., Schild H.,
RA   Rammensee H.G., Koszinowski U.H., Kloetzel P.M.;
RT   "A role for the proteasome regulator PA28alpha in antigen
RT   presentation.";
RL   Nature 381:166-168(1996).
RN   [8]
RP   INTERACTION WITH HTLV-1 TAX.
RX   PubMed=8692272; DOI=10.1038/381328a0;
RA   Rousset R., Desbois C., Bantignies F., Jalinot P.;
RT   "Effects on NF-kappa B1/p105 processing of the interaction between the
RT   HTLV-1 transactivator Tax and the proteasome.";
RL   Nature 381:328-331(1996).
RN   [9]
RP   INDUCTION BY BO-653 AND PROBUCOL.
RX   PubMed=11521686; DOI=10.5551/jat1994.7.223;
RA   Takabe W., Mataki C., Wada Y., Ishii M., Izumi A., Aburatani H.,
RA   Hamakubo T., Niki E., Kodama T., Noguchi N.;
RT   "Gene expression induced by BO-653, probucol and BHQ in human
RT   endothelial cells.";
RL   J. Atheroscler. Thromb. 7:223-230(2000).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12181345; DOI=10.1091/mbc.E02-03-0122;
RA   Lafarga M., Berciano M.T., Pena E., Mayo I., Castano J.G., Bohmann D.,
RA   Rodrigues J.P., Tavanez J.P., Carmo-Fonseca M.;
RT   "Clastosome: a subtype of nuclear body enriched in 19S and 20S
RT   proteasomes, ubiquitin, and protein substrates of proteasome.";
RL   Mol. Biol. Cell 13:2771-2782(2002).
RN   [11]
RP   FUNCTION.
RX   PubMed=15244466; DOI=10.1021/bm049957a;
RA   Yano M., Koumoto Y., Kanesaki Y., Wu X., Kido H.;
RT   "20S proteasome prevents aggregation of heat-denatured proteins
RT   without PA700 regulatory subcomplex like a molecular chaperone.";
RL   Biomacromolecules 5:1465-1469(2004).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-127 AND LYS-176, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=27176742; DOI=10.1515/hsz-2016-0176;
RA   Rut W., Drag M.;
RT   "Human 20S proteasome activity towards fluorogenic peptides of various
RT   chain lengths.";
RL   Biol. Chem. 397:921-926(2016).
RN   [20]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=26133119; DOI=10.1038/ncomms8573;
RA   da Fonseca P.C., Morris E.P.;
RT   "Cryo-EM reveals the conformation of a substrate analogue in the human
RT   20S proteasome core.";
RL   Nat. Commun. 6:7573-7573(2015).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 2-251, AND SUBUNIT.
RX   PubMed=25599644; DOI=10.1016/j.str.2014.11.017;
RA   Harshbarger W., Miller C., Diedrich C., Sacchettini J.;
RT   "Crystal structure of the human 20S proteasome in complex with
RT   carfilzomib.";
RL   Structure 23:418-424(2015).
RN   [22]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27428775; DOI=10.1038/nsmb.3273;
RA   Huang X., Luan B., Wu J., Shi Y.;
RT   "An atomic structure of the human 26S proteasome.";
RL   Nat. Struct. Mol. Biol. 23:778-785(2016).
RN   [23]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.02 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA   Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA   Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT   "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27493187; DOI=10.1126/science.aaf8993;
RA   Schrader J., Henneberg F., Mata R.A., Tittmann K., Schneider T.R.,
RA   Stark H., Bourenkov G., Chari A.;
RT   "The inhibition mechanism of human 20S proteasomes enables next-
RT   generation inhibitor design.";
RL   Science 353:594-598(2016).
CC   -!- FUNCTION: Component of the 20S core proteasome complex involved in
CC       the proteolytic degradation of most intracellular proteins. This
CC       complex plays numerous essential roles within the cell by
CC       associating with different regulatory particles. Associated with
CC       two 19S regulatory particles, forms the 26S proteasome and thus
CC       participates in the ATP-dependent degradation of ubiquitinated
CC       proteins. The 26S proteasome plays a key role in the maintenance
CC       of protein homeostasis by removing misfolded or damaged proteins
CC       that could impair cellular functions, and by removing proteins
CC       whose functions are no longer required. Associated with the PA200
CC       or PA28, the 20S proteasome mediates ubiquitin-independent protein
CC       degradation. This type of proteolysis is required in several
CC       pathways including spermatogenesis (20S-PA200 complex) or
CC       generation of a subset of MHC class I-presented antigenic peptides
CC       (20S-PA28 complex). {ECO:0000269|PubMed:15244466,
CC       ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}.
CC   -!- CATALYTIC ACTIVITY: Cleavage of peptide bonds with very broad
CC       specificity. {ECO:0000255|PROSITE-ProRule:PRU00808,
CC       ECO:0000269|PubMed:27176742}.
CC   -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and
CC       two 19S regulatory subunits. The 20S proteasome core is a barrel-
CC       shaped complex made of 28 subunits that are arranged in four
CC       stacked rings. The two outer rings are each formed by seven alpha
CC       subunits, and the two inner rings are formed by seven beta
CC       subunits. The proteolytic activity is exerted by three beta-
CC       subunits PSMB5, PSMB6 and PSMB7. Interaction with HTLV-1 TAX
CC       protein favors NFKB1 activation (PubMed:8692272).
CC       {ECO:0000269|PubMed:25599644, ECO:0000269|PubMed:26133119,
CC       ECO:0000269|PubMed:27342858, ECO:0000269|PubMed:27428775,
CC       ECO:0000269|PubMed:27493187, ECO:0000269|PubMed:8692272}.
CC   -!- INTERACTION:
CC       Q99PV5:Bhlhe41 (xeno); NbExp=2; IntAct=EBI-359310, EBI-6143801;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-359310, EBI-618309;
CC       Q16665:HIF1A; NbExp=4; IntAct=EBI-359310, EBI-447269;
CC       Q13422:IKZF1; NbExp=3; IntAct=EBI-359310, EBI-745305;
CC       P25786:PSMA1; NbExp=7; IntAct=EBI-359310, EBI-359352;
CC       P25787:PSMA2; NbExp=7; IntAct=EBI-359310, EBI-603262;
CC       P25788:PSMA3; NbExp=4; IntAct=EBI-359310, EBI-348380;
CC       P60900:PSMA6; NbExp=5; IntAct=EBI-359310, EBI-357793;
CC       O14818:PSMA7; NbExp=8; IntAct=EBI-359310, EBI-603272;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12181345}.
CC       Nucleus {ECO:0000269|PubMed:12181345}. Note=Colocalizes with TRIM5
CC       in the cytoplasmic bodies. {ECO:0000250|UniProtKB:Q9R1P0}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P25789-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P25789-2; Sequence=VSP_043102;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: Down-regulated by antioxidants BO-653 and probucol.
CC       {ECO:0000269|PubMed:11521686}.
CC   -!- SIMILARITY: Belongs to the peptidase T1A family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00808}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D00763; BAA00660.1; -; mRNA.
DR   EMBL; BT009784; AAP88786.1; -; mRNA.
DR   EMBL; AC027228; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471136; EAW99163.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99164.1; -; Genomic_DNA.
DR   EMBL; BC005361; AAH05361.1; -; mRNA.
DR   EMBL; BC022445; AAH22445.1; -; mRNA.
DR   EMBL; BC022817; AAH22817.2; -; mRNA.
DR   EMBL; BC047667; AAH47667.1; -; mRNA.
DR   EMBL; BC093069; AAH93069.1; -; mRNA.
DR   CCDS; CCDS10303.1; -. [P25789-1]
DR   CCDS; CCDS45319.1; -. [P25789-2]
DR   PIR; S15972; SNHUC9.
DR   RefSeq; NP_001096137.1; NM_001102667.2. [P25789-1]
DR   RefSeq; NP_001096138.1; NM_001102668.2. [P25789-2]
DR   RefSeq; NP_001317605.1; NM_001330676.1. [P25789-1]
DR   RefSeq; NP_002780.1; NM_002789.5. [P25789-1]
DR   UniGene; Hs.251531; -.
DR   PDB; 4R3O; X-ray; 2.60 A; C/Q=2-251.
DR   PDB; 4R67; X-ray; 2.89 A; C/Q/e/s=2-251.
DR   PDB; 5A0Q; EM; 3.50 A; C/Q=1-261.
DR   PDB; 5GJQ; EM; 4.50 A; D/j=1-261.
DR   PDB; 5GJR; EM; 3.50 A; D/j=1-261.
DR   PDB; 5L4G; EM; 4.02 A; C/P=1-261.
DR   PDB; 5LE5; X-ray; 1.80 A; B/P=1-261.
DR   PDB; 5LEX; X-ray; 2.20 A; B/P=1-261.
DR   PDB; 5LEY; X-ray; 1.90 A; B/P=1-261.
DR   PDB; 5LEZ; X-ray; 2.19 A; B/P=1-261.
DR   PDB; 5LF0; X-ray; 2.41 A; B/P=1-261.
DR   PDB; 5LF1; X-ray; 2.00 A; B/P=1-261.
DR   PDB; 5LF3; X-ray; 2.10 A; B/P=1-261.
DR   PDB; 5LF4; X-ray; 1.99 A; B/P=1-261.
DR   PDB; 5LF6; X-ray; 2.07 A; B/P=1-261.
DR   PDB; 5LF7; X-ray; 2.00 A; B/P=1-261.
DR   PDB; 5LN3; EM; 6.80 A; C=1-261.
DR   PDB; 5M32; EM; 3.80 A; B/P=1-261.
DR   PDB; 5T0C; EM; 3.80 A; AI/BI=2-261.
DR   PDB; 5T0G; EM; 4.40 A; I=2-261.
DR   PDB; 5T0H; EM; 6.80 A; I=2-261.
DR   PDB; 5T0I; EM; 8.00 A; I=2-261.
DR   PDB; 5T0J; EM; 8.00 A; I=2-261.
DR   PDB; 6AVO; EM; 3.80 A; O/Z=1-261.
DR   PDBsum; 4R3O; -.
DR   PDBsum; 4R67; -.
DR   PDBsum; 5A0Q; -.
DR   PDBsum; 5GJQ; -.
DR   PDBsum; 5GJR; -.
DR   PDBsum; 5L4G; -.
DR   PDBsum; 5LE5; -.
DR   PDBsum; 5LEX; -.
DR   PDBsum; 5LEY; -.
DR   PDBsum; 5LEZ; -.
DR   PDBsum; 5LF0; -.
DR   PDBsum; 5LF1; -.
DR   PDBsum; 5LF3; -.
DR   PDBsum; 5LF4; -.
DR   PDBsum; 5LF6; -.
DR   PDBsum; 5LF7; -.
DR   PDBsum; 5LN3; -.
DR   PDBsum; 5M32; -.
DR   PDBsum; 5T0C; -.
DR   PDBsum; 5T0G; -.
DR   PDBsum; 5T0H; -.
DR   PDBsum; 5T0I; -.
DR   PDBsum; 5T0J; -.
DR   PDBsum; 6AVO; -.
DR   ProteinModelPortal; P25789; -.
DR   SMR; P25789; -.
DR   BioGrid; 111658; 107.
DR   CORUM; P25789; -.
DR   DIP; DIP-29365N; -.
DR   IntAct; P25789; 37.
DR   MINT; P25789; -.
DR   STRING; 9606.ENSP00000044462; -.
DR   BindingDB; P25789; -.
DR   ChEMBL; CHEMBL3831201; -.
DR   MEROPS; T01.973; -.
DR   iPTMnet; P25789; -.
DR   PhosphoSitePlus; P25789; -.
DR   SwissPalm; P25789; -.
DR   BioMuta; PSMA4; -.
DR   DMDM; 130861; -.
DR   UCD-2DPAGE; P25789; -.
DR   EPD; P25789; -.
DR   MaxQB; P25789; -.
DR   PaxDb; P25789; -.
DR   PeptideAtlas; P25789; -.
DR   PRIDE; P25789; -.
DR   TopDownProteomics; P25789-1; -. [P25789-1]
DR   DNASU; 5685; -.
DR   Ensembl; ENST00000044462; ENSP00000044462; ENSG00000041357. [P25789-1]
DR   Ensembl; ENST00000413382; ENSP00000402118; ENSG00000041357. [P25789-2]
DR   Ensembl; ENST00000559082; ENSP00000453887; ENSG00000041357. [P25789-1]
DR   GeneID; 5685; -.
DR   KEGG; hsa:5685; -.
DR   UCSC; uc002bdu.5; human. [P25789-1]
DR   CTD; 5685; -.
DR   DisGeNET; 5685; -.
DR   EuPathDB; HostDB:ENSG00000041357.15; -.
DR   GeneCards; PSMA4; -.
DR   HGNC; HGNC:9533; PSMA4.
DR   HPA; CAB004973; -.
DR   HPA; HPA055466; -.
DR   HPA; HPA060613; -.
DR   MIM; 176846; gene.
DR   neXtProt; NX_P25789; -.
DR   OpenTargets; ENSG00000041357; -.
DR   PharmGKB; PA33878; -.
DR   eggNOG; KOG0178; Eukaryota.
DR   eggNOG; COG0638; LUCA.
DR   GeneTree; ENSGT00550000074827; -.
DR   HOGENOM; HOG000091085; -.
DR   HOVERGEN; HBG003005; -.
DR   InParanoid; P25789; -.
DR   KO; K02728; -.
DR   OMA; MSKTMDS; -.
DR   OrthoDB; EOG091G0F2L; -.
DR   PhylomeDB; P25789; -.
DR   TreeFam; TF106209; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69229; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   ChiTaRS; PSMA4; human.
DR   GeneWiki; PSMA4; -.
DR   GenomeRNAi; 5685; -.
DR   PRO; PR:P25789; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000041357; -.
DR   CleanEx; HS_PSMA4; -.
DR   ExpressionAtlas; P25789; baseline and differential.
DR   Genevisible; P25789; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0000932; C:P-body; ISS:UniProtKB.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0005839; C:proteasome core complex; ISS:UniProtKB.
DR   GO; GO:0019773; C:proteasome core complex, alpha-subunit complex; ISS:UniProtKB.
DR   GO; GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR023332; Proteasome_alpha-type.
DR   InterPro; IPR000426; Proteasome_asu_N.
DR   InterPro; IPR016050; Proteasome_bsu_CS.
DR   InterPro; IPR001353; Proteasome_sua/b.
DR   InterPro; IPR034647; Proteasome_subunit_alpha4.
DR   PANTHER; PTHR11599:SF13; PTHR11599:SF13; 1.
DR   Pfam; PF00227; Proteasome; 1.
DR   Pfam; PF10584; Proteasome_A_N; 1.
DR   SMART; SM00948; Proteasome_A_N; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   PROSITE; PS00388; PROTEASOME_ALPHA_1; 1.
DR   PROSITE; PS51475; PROTEASOME_ALPHA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Host-virus interaction;
KW   Hydrolase; Nucleus; Phosphoprotein; Protease; Proteasome;
KW   Reference proteome; Threonine protease.
FT   CHAIN         1    261       Proteasome subunit alpha type-4.
FT                                /FTId=PRO_0000124103.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      75     75       Phosphoserine.
FT                                {ECO:0000244|PubMed:17323924}.
FT   MOD_RES     127    127       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     173    173       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     176    176       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1     71       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043102.
FT   TURN          3      5       {ECO:0000244|PDB:5LE5}.
FT   TURN         14     16       {ECO:0000244|PDB:4R67}.
FT   HELIX        19     29       {ECO:0000244|PDB:5LE5}.
FT   STRAND       34     39       {ECO:0000244|PDB:5LE5}.
FT   STRAND       42     48       {ECO:0000244|PDB:5LE5}.
FT   STRAND       63     69       {ECO:0000244|PDB:5LE5}.
FT   STRAND       72     78       {ECO:0000244|PDB:5LE5}.
FT   HELIX        80    101       {ECO:0000244|PDB:5LE5}.
FT   HELIX       107    123       {ECO:0000244|PDB:5LE5}.
FT   STRAND      124    126       {ECO:0000244|PDB:5LE5}.
FT   STRAND      132    140       {ECO:0000244|PDB:5LE5}.
FT   TURN        141    143       {ECO:0000244|PDB:5LE5}.
FT   STRAND      144    150       {ECO:0000244|PDB:5LE5}.
FT   STRAND      152    154       {ECO:0000244|PDB:5A0Q}.
FT   STRAND      156    165       {ECO:0000244|PDB:5LE5}.
FT   HELIX       168    178       {ECO:0000244|PDB:5LE5}.
FT   TURN        181    183       {ECO:0000244|PDB:5LE5}.
FT   HELIX       186    200       {ECO:0000244|PDB:5LE5}.
FT   STRAND      203    205       {ECO:0000244|PDB:5LE5}.
FT   HELIX       208    210       {ECO:0000244|PDB:5LE5}.
FT   STRAND      211    219       {ECO:0000244|PDB:5LE5}.
FT   STRAND      222    227       {ECO:0000244|PDB:5LE5}.
FT   HELIX       230    246       {ECO:0000244|PDB:5LE5}.
SQ   SEQUENCE   261 AA;  29484 MW;  7867422B1B31F3B9 CRC64;
     MSRRYDSRTT IFSPEGRLYQ VEYAMEAIGH AGTCLGILAN DGVLLAAERR NIHKLLDEVF
     FSEKIYKLNE DMACSVAGIT SDANVLTNEL RLIAQRYLLQ YQEPIPCEQL VTALCDIKQA
     YTQFGGKRPF GVSLLYIGWD KHYGFQLYQS DPSGNYGGWK ATCIGNNSAA AVSMLKQDYK
     EGEMTLKSAL ALAIKVLNKT MDVSKLSAEK VEIATLTREN GKTVIRVLKQ KEVEQLIKKH
     EEEEAKAERE KKEKEQKEKD K
//
ID   NTRK1_HUMAN             Reviewed;         796 AA.
AC   P04629; B2R6T5; B7ZM34; P08119; Q15655; Q15656; Q5D056; Q5VZS2;
AC   Q7Z5C3; Q9UIU7;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2006, sequence version 4.
DT   23-MAY-2018, entry version 234.
DE   RecName: Full=High affinity nerve growth factor receptor;
DE            EC=2.7.10.1 {ECO:0000269|PubMed:1281417, ECO:0000269|PubMed:2927393};
DE   AltName: Full=Neurotrophic tyrosine kinase receptor type 1;
DE   AltName: Full=TRK1-transforming tyrosine kinase protein;
DE   AltName: Full=Tropomyosin-related kinase A;
DE   AltName: Full=Tyrosine kinase receptor;
DE   AltName: Full=Tyrosine kinase receptor A;
DE            Short=Trk-A;
DE   AltName: Full=gp140trk {ECO:0000303|PubMed:2927393};
DE   AltName: Full=p140-TrkA;
DE   Flags: Precursor;
GN   Name=NTRK1;
GN   Synonyms=MTC, TRK {ECO:0000303|PubMed:2927393},
GN   TRKA {ECO:0000303|PubMed:9290260};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TRKA-I), CATALYTIC ACTIVITY,
RP   PHOSPHORYLATION, GLYCOSYLATION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Colon;
RX   PubMed=2927393; DOI=10.1128/MCB.9.1.24;
RA   Martin-Zanca D., Oskam R., Mitra G., Copeland T.D., Barbacid M.;
RT   "Molecular and biochemical characterization of the human trk proto-
RT   oncogene.";
RL   Mol. Cell. Biol. 9:24-33(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7823156;
RA   Shelton D.L., Sutherland J., Gripp J., Camerato T., Armanini M.P.,
RA   Phillips H.S., Carroll K., Spencer S.D., Levinson A.D.;
RT   "Human trks: molecular cloning, tissue distribution, and expression of
RT   extracellular domain immunoadhesins.";
RL   J. Neurosci. 15:477-491(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9290260; DOI=10.1007/BF02766957;
RA   Indo Y., Mardy S., Tsuruta M., Karim M.A., Matsuda I.;
RT   "Structure and organization of the human TRKA gene encoding a high
RT   affinity receptor for nerve growth factor.";
RL   Jpn. J. Hum. Genet. 42:343-351(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM TRKA-II), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-175 (ISOFORM 3).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS TRKA-I AND TRKA-II).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-71.
RX   PubMed=15870692; DOI=10.1038/sj.onc.1208697;
RA   Fujimoto M., Kitazawa R., Maeda S., Kitazawa S.;
RT   "Methylation adjacent to negatively regulating AP-1 site reactivates
RT   TrkA gene expression during cancer progression.";
RL   Oncogene 24:5108-5118(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 399-796, AND CHROMOSOMAL TRANSLOCATION
RP   WITH TPM3.
RX   PubMed=2869410; DOI=10.1038/319743a0;
RA   Martin-Zanca D., Hughes S.H., Barbacid M.;
RT   "A human oncogene formed by the fusion of truncated tropomyosin and
RT   protein tyrosine kinase sequences.";
RL   Nature 319:743-748(1986).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 399-796.
RX   PubMed=2966065;
RA   Kozma S.C., Redmond S.M.S., Saurer S.M., Groner B., Hynes N.E.;
RT   "Activation of the receptor kinase domain of the trk oncogene by
RT   recombination with two different cellular sequences.";
RL   EMBO J. 7:147-154(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 399-796, AND CHROMOSOMAL TRANSLOCATION
RP   WITH TFG.
RX   PubMed=7565764; DOI=10.1128/MCB.15.11.6118;
RA   Greco A., Mariani C., Miranda C., Lupas A., Pagliardini S., Pomati M.,
RA   Pierotti M.A.;
RT   "The DNA rearrangement that generates the TRK-T3 oncogene involves a
RT   novel gene on chromosome 3 whose product has a potential coiled-coil
RT   domain.";
RL   Mol. Cell. Biol. 15:6118-6127(1995).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 486-796, AND CHROMOSOMAL REARRANGEMENT
RP   WITH TPR.
RX   PubMed=1532241;
RA   Greco A., Pierotti M.A., Bongarzone I., Pagliardini S., Lanzi C.,
RA   Della Porta G.;
RT   "TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes
RT   in human papillary thyroid carcinomas.";
RL   Oncogene 7:237-242(1992).
RN   [12]
RP   FUNCTION AS RECEPTOR FOR NGF.
RX   PubMed=1850821; DOI=10.1038/350678a0;
RA   Hempstead B.L., Martin-Zanca D., Kaplan D.R., Parada L.F., Chao M.V.;
RT   "High-affinity NGF binding requires coexpression of the trk proto-
RT   oncogene and the low-affinity NGF receptor.";
RL   Nature 350:678-683(1991).
RN   [13]
RP   FUNCTION IN NGF SIGNALING, AND IDENTIFICATION AS THE HIGH AFFINITY NGF
RP   RECEPTOR.
RX   PubMed=1849459; DOI=10.1016/0092-8674(91)90419-Y;
RA   Klein R., Jing S., Nanduri V., O'Rourke E., Barbacid M.;
RT   "The trk proto-oncogene encodes a receptor for nerve growth factor.";
RL   Cell 65:189-197(1991).
RN   [14]
RP   FUNCTION, SUBUNIT, CATALYTIC ACTIVITY, PHOSPHORYLATION, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF LYS-544.
RX   PubMed=1281417; DOI=10.1016/0896-6273(92)90066-M;
RA   Jing S., Tapley P., Barbacid M.;
RT   "Nerve growth factor mediates signal transduction through trk
RT   homodimer receptors.";
RL   Neuron 9:1067-1079(1992).
RN   [15]
RP   ALTERNATIVE SPLICING (ISOFORMS TRKA-I AND TRKA-II), FUNCTION IN CELL
RP   SURVIVAL, NGF-BINDING, PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=8325889;
RA   Barker P.A., Lomen-Hoerth C., Gensch E.M., Meakin S.O., Glass D.J.,
RA   Shooter E.M.;
RT   "Tissue-specific alternative splicing generates two isoforms of the
RT   trkA receptor.";
RL   J. Biol. Chem. 268:15150-15157(1993).
RN   [16]
RP   PHOSPHORYLATION AT TYR-791, INTERACTION WITH PLCG1, AND MUTAGENESIS OF
RP   TYR-791.
RX   PubMed=7510697;
RA   Loeb D.M., Stephens R.M., Copeland T.D., Kaplan D.R., Greene L.A.;
RT   "A Trk nerve growth factor (NGF) receptor point mutation affecting
RT   interaction with phospholipase C-gamma 1 abolishes NGF-promoted
RT   peripherin induction but not neurite outgrowth.";
RL   J. Biol. Chem. 269:8901-8910(1994).
RN   [17]
RP   FUNCTION IN NEURONAL DIFFERENTIATION, FUNCTION IN PHOSPHORYLATION OF
RP   SHC1 AND PLCG1, INTERACTION WITH SHC1, MUTAGENESIS OF TYR-496; LYS-544
RP   AND TYR-791, AND PHOSPHORYLATION AT TYR-496; TYR-676; TYR-680; TYR-681
RP   AND TYR-791.
RX   PubMed=8155326; DOI=10.1016/0896-6273(94)90223-2;
RA   Stephens R.M., Loeb D.M., Copeland T.D., Pawson T., Greene L.A.,
RA   Kaplan D.R.;
RT   "Trk receptors use redundant signal transduction pathways involving
RT   SHC and PLC-gamma 1 to mediate NGF responses.";
RL   Neuron 12:691-705(1994).
RN   [18]
RP   FUNCTION IN NF-KAPPA-B ACTIVATION, AND INTERACTION WITH SQSTM1.
RX   PubMed=11244088; DOI=10.1074/jbc.C000869200;
RA   Wooten M.W., Seibenhener M.L., Mamidipudi V., Diaz-Meco M.T.,
RA   Barker P.A., Moscat J.;
RT   "The atypical protein kinase C-interacting protein p62 is a scaffold
RT   for NF-kappaB activation by nerve growth factor.";
RL   J. Biol. Chem. 276:7709-7712(2001).
RN   [19]
RP   FUNCTION IN NEURONAL CELL PROLIFERATION AND DIFFERENTIATION, FUNCTION
RP   IN SIGNALING CASCADE ACTIVATION, NGF-BINDING, SUBCELLULAR LOCATION,
RP   ALTERNATIVE SPLICING (ISOFORM TRKA-III), CHARACTERIZATION OF ISOFORM
RP   TRKA-III, PHOSPHORYLATION AT TYR-496; TYR-680; TYR-681 AND TYR-791,
RP   INTERACTION WITH FRS2; GRB2; PIK3R1; PLCG1; SHC1, GLYCOSYLATION,
RP   TISSUE SPECIFICITY, AND INDUCTION BY HYPOXIA.
RX   PubMed=15488758; DOI=10.1016/j.ccr.2004.09.011;
RA   Tacconelli A., Farina A.R., Cappabianca L., Desantis G., Tessitore A.,
RA   Vetuschi A., Sferra R., Rucci N., Argenti B., Screpanti I., Gulino A.,
RA   Mackay A.R.;
RT   "TrkA alternative splicing: a regulated tumor-promoting switch in
RT   human neuroblastoma.";
RL   Cancer Cell 6:347-360(2004).
RN   [20]
RP   INTERACTION WITH SORT1, AND ENZYME REGULATION.
RX   PubMed=21102451; DOI=10.1038/nn.2689;
RA   Vaegter C.B., Jansen P., Fjorback A.W., Glerup S., Skeldal S.,
RA   Kjolby M., Richner M., Erdmann B., Nyengaard J.R., Tessarollo L.,
RA   Lewin G.R., Willnow T.E., Chao M.V., Nykjaer A.;
RT   "Sortilin associates with Trk receptors to enhance anterograde
RT   transport and neurotrophin signaling.";
RL   Nat. Neurosci. 14:54-61(2011).
RN   [21]
RP   FUNCTION, UBIQUITINATION BY NEDD4L, AND INTERACTION WITH USP36.
RX   PubMed=27445338; DOI=10.1074/jbc.M116.722637;
RA   Anta B., Martin-Rodriguez C., Gomis-Perez C., Calvo L.,
RA   Lopez-Benito S., Calderon-Garcia A.A., Vicente-Garcia C.,
RA   Villarroel A., Arevalo J.C.;
RT   "Ubiquitin-specific Protease 36 (USP36) Controls Neuronal Precursor
RT   Cell-expressed Developmentally Down-regulated 4-2 (Nedd4-2) Actions
RT   over the Neurotrophin Receptor TrkA and Potassium Voltage-gated
RT   Channels 7.2/3 (Kv7.2/3).";
RL   J. Biol. Chem. 291:19132-19145(2016).
RN   [22]
RP   PHOSPHORYLATION, VARIANTS CIPA 235-SER--GLY-796 DEL; ASN-596 AND
RP   TYR-674, AND CHARACTERIZATION OF VARIANTS CIPA 235-SER--GLY-796 DEL
RP   AND ASN-596.
RX   PubMed=28177573; DOI=10.1111/jns.12205;
RA   Nam T.S., Li W., Yoon S., Eom G.H., Kim M.K., Jung S.T., Choi S.Y.;
RT   "Novel NTRK1 mutations associated with congenital insensitivity to
RT   pain with anhidrosis verified by functional studies.";
RL   J. Peripher. Nerv. Syst. 22:92-99(2017).
RN   [23]
RP   STRUCTURE BY NMR OF 489-500.
RX   PubMed=8524391; DOI=10.1038/378584a0;
RA   Zhou M.-M., Ravichandran K.S., Olejniczak E.F., Petros A.M.,
RA   Meadows R.P., Sattler M., Harlan J.E., Wade W.S., Burakoff S.J.,
RA   Fesik S.W.;
RT   "Structure and ligand recognition of the phosphotyrosine binding
RT   domain of Shc.";
RL   Nature 378:584-592(1995).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 278-386, AND DISULFIDE
RP   BONDS.
RX   PubMed=10388563; DOI=10.1006/jmbi.1999.2816;
RA   Ultsch M.H., Wiesmann C., Simmons L.C., Henrich J., Yang M.,
RA   Reilly D., Bass S.H., de Vos A.M.;
RT   "Crystal structures of the neurotrophin-binding domain of TrkA, TrkB
RT   and TrkC.";
RL   J. Mol. Biol. 290:149-159(1999).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 282-382 IN COMPLEX WITH NGF,
RP   SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=10490030; DOI=10.1038/43705;
RA   Wiesmann C., Ultsch M.H., Bass S.H., de Vos A.M.;
RT   "Crystal structure of nerve growth factor in complex with the ligand-
RT   binding domain of the TrkA receptor.";
RL   Nature 401:184-188(1999).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 36-382 IN COMPLEX WITH NGF,
RP   HOMODIMERIZATION, SUBUNIT, SUBCELLULAR LOCATION, DISULFIDE BONDS, AND
RP   GLYCOSYLATION AT ASN-95; ASN-121; ASN-188; ASN-262; ASN-281 AND
RP   ASN-358.
RX   PubMed=17196528; DOI=10.1016/j.neuron.2006.09.034;
RA   Wehrman T., He X., Raab B., Dukipatti A., Blau H., Garcia K.C.;
RT   "Structural and mechanistic insights into nerve growth factor
RT   interactions with the TrkA and p75 receptors.";
RL   Neuron 53:25-38(2007).
RN   [27]
RP   VARIANT CIPA ARG-577.
RX   PubMed=8696348; DOI=10.1038/ng0896-485;
RA   Indo Y., Tsuruta M., Hayashida Y., Karim M.A., Ohta K., Kawano T.,
RA   Mitsubuchi H., Tonoki H., Awaya Y., Matsuda I.;
RT   "Mutations in the TRKA/NGF receptor gene in patients with congenital
RT   insensitivity to pain with anhidrosis.";
RL   Nat. Genet. 13:485-488(1996).
RN   [28]
RP   VARIANT CIPA PRO-780.
RX   PubMed=10090906; DOI=10.1086/302319;
RA   Greco A., Villa R., Tubino B., Romano L., Penso D., Pierotti M.A.;
RT   "A novel NTRK1 mutation associated with congenital insensitivity to
RT   pain with anhidrosis.";
RL   Am. J. Hum. Genet. 64:1207-1210(1999).
RN   [29]
RP   VARIANTS CIPA PRO-213; TRP-649 AND SER-714, AND VARIANTS SER-85;
RP   TYR-604 AND VAL-613.
RX   PubMed=10330344; DOI=10.1086/302422;
RA   Mardy S., Miura Y., Endo F., Matsuda I., Sztriha L., Frossard P.,
RA   Moosa A., Ismail E.A.R., Macaya A., Andria G., Toscano E., Gibson W.,
RA   Graham G.E., Indo Y.;
RT   "Congenital insensitivity to pain with anhidrosis: novel mutations in
RT   the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve
RT   growth factor.";
RL   Am. J. Hum. Genet. 64:1570-1579(1999).
RN   [30]
RP   VARIANTS TYR-604; VAL-613 AND GLN-780.
RX   PubMed=10443680; DOI=10.1210/jcem.84.8.5901;
RA   Gimm O., Greco A., Hoang-Vu C., Dralle H., Pierotti M.A., Eng C.;
RT   "Mutation analysis reveals novel sequence variants in NTRK1 in
RT   sporadic human medullary thyroid carcinoma.";
RL   J. Clin. Endocrinol. Metab. 84:2784-2787(1999).
RN   [31]
RP   VARIANT CIPA VAL-587.
RX   PubMed=10233776; DOI=10.1046/j.1523-1747.1999.00569.x;
RA   Yotsumoto S., Setoyama M., Hozumi H., Mizoguchi S., Fukumaru S.,
RA   Kobayashi K., Saheki T., Kanzaki T.;
RT   "A novel point mutation affecting the tyrosine kinase domain of the
RT   TRKA gene in a family with congenital insensitivity to pain with
RT   anhidrosis.";
RL   J. Invest. Dermatol. 112:810-814(1999).
RN   [32]
RP   VARIANTS TYR-604 AND VAL-613.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [33]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [34]
RP   VARIANT CIPA LEU-695, AND VARIANT VAL-613.
RC   TISSUE=Peripheral blood;
RX   PubMed=10861667;
RX   DOI=10.1002/1096-8628(20000619)92:5<353::AID-AJMG12>3.0.CO;2-C;
RA   Shatzky S., Moses S., Levy J., Pinsk V., Hershkovitz E., Herzog L.,
RA   Shorer Z., Luder A., Parvari R.;
RT   "Congenital insensitivity to pain with anhidrosis (CIPA) in Israeli-
RT   Bedouins: genetic heterogeneity, novel mutations in the TRKA/NGF
RT   receptor gene, clinical findings, and results of nerve conduction
RT   studies.";
RL   Am. J. Med. Genet. 92:353-360(2000).
RN   [35]
RP   VARIANTS CIPA PRO-93; ARG-522; ARG-577; CYS-654 AND TYR-674.
RX   PubMed=10982191; DOI=10.1007/s004390051018;
RA   Miura Y., Mardy S., Awaya Y., Nihei K., Endo F., Matsuda I., Indo Y.;
RT   "Mutation and polymorphism analysis of the TRKA (NTRK1) gene encoding
RT   a high-affinity receptor for nerve growth factor in congenital
RT   insensitivity to pain with anhidrosis (CIPA) families.";
RL   Hum. Genet. 106:116-124(2000).
RN   [36]
RP   VARIANT CIPA ARG-577.
RX   PubMed=10567924;
RX   DOI=10.1002/(SICI)1097-4652(200001)182:1<127::AID-JCP14>3.0.CO;2-0;
RA   Greco A., Villa R., Fusetti L., Orlandi R., Pierotti M.A.;
RT   "The Gly571Arg mutation, associated with the autonomic and sensory
RT   disorder congenital insensitivity to pain with anhidrosis, causes the
RT   inactivation of the NTRK1/nerve growth factor receptor.";
RL   J. Cell. Physiol. 182:127-133(2000).
RN   [37]
RP   VARIANT CIPA CYS-359, AND VARIANTS TYR-604 AND VAL-613.
RX   PubMed=11310631; DOI=10.1002/ana.103;
RA   Houlden H., King R.H., Hashemi-Nejad A., Wood N.W., Mathias C.J.,
RA   Reilly M., Thomas P.K.;
RT   "A novel TRK A (NTRK1) mutation associated with hereditary sensory and
RT   autonomic neuropathy type V.";
RL   Ann. Neurol. 49:521-525(2001).
RN   [38]
RP   CHARACTERIZATION OF VARIANTS CIPA PRO-93; PRO-213; ARG-522; ARG-577;
RP   TRP-649; CYS-654 AND SER-714, AND CHARACTERIZATION OF VARIANTS SER-85;
RP   TYR-604; VAL-613 AND TYR-674.
RX   PubMed=11159935; DOI=10.1093/hmg/10.3.179;
RA   Mardy S., Miura Y., Endo F., Matsuda I., Indo Y.;
RT   "Congenital insensitivity to pain with anhidrosis (CIPA): effect of
RT   TRKA (NTRK1) missense mutations on autophosphorylation of the receptor
RT   tyrosine kinase for nerve growth factor.";
RL   Hum. Mol. Genet. 10:179-188(2001).
RN   [39]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-80; VAL-107; MET-237; GLY-238;
RP   GLY-260; GLN-444; CYS-452; THR-566; TYR-604; VAL-613; GLN-780 AND
RP   ILE-790.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [40]
RP   VARIANTS CIPA SER-572 AND ARG-717.
RX   PubMed=18077166; DOI=10.1016/j.nmd.2007.10.005;
RA   Huehne K., Zweier C., Raab K., Odent S., Bonnaure-Mallet M.,
RA   Sixou J.L., Landrieu P., Goizet C., Sarlangue J., Baumann M.,
RA   Eggermann T., Rauch A., Ruppert S., Stettner G.M., Rautenstrauss B.;
RT   "Novel missense, insertion and deletion mutations in the neurotrophic
RT   tyrosine kinase receptor type 1 gene (NTRK1) associated with
RT   congenital insensitivity to pain with anhidrosis.";
RL   Neuromuscul. Disord. 18:159-166(2008).
RN   [41]
RP   VARIANTS CIPA LYS-492 AND CYS-654, AND VARIANT TRP-6.
RX   PubMed=22302274; DOI=10.1007/s00415-011-6397-y;
RA   Davidson G.L., Murphy S.M., Polke J.M., Laura M., Salih M.A.,
RA   Muntoni F., Blake J., Brandner S., Davies N., Horvath R., Price S.,
RA   Donaghy M., Roberts M., Foulds N., Ramdharry G., Soler D., Lunn M.P.,
RA   Manji H., Davis M.B., Houlden H., Reilly M.M.;
RT   "Frequency of mutations in the genes associated with hereditary
RT   sensory and autonomic neuropathy in a UK cohort.";
RL   J. Neurol. 259:1673-1685(2012).
RN   [42]
RP   VARIANTS CIPA ASP-110; 146-SER--GLY-796 DEL; 176-GLN--GLY-796 DEL;
RP   476-LEU--GLY-796 DEL; GLN-649 AND PRO-700.
RX   PubMed=28328124; DOI=10.1002/ajmg.a.38120;
RA   Altassan R., Saud H.A., Masoodi T.A., Dosssari H.A., Khalifa O.,
RA   Al-Zaidan H., Sakati N., Rhabeeni Z., Al-Hassnan Z., Binamer Y.,
RA   Alhashemi N., Wade W., Al-Zayed Z., Al-Sayed M., Al-Muhaizea M.A.,
RA   Meyer B., Al-Owain M., Wakil S.M.;
RT   "Exome sequencing identifies novel NTRK1 mutations in patients with
RT   HSAN-IV phenotype.";
RL   Am. J. Med. Genet. A 173:1009-1016(2017).
RN   [43]
RP   VARIANTS CIPA GLU-517; GLU-522; PRO-657; THR-699; SER-752; SER-763 AND
RP   CYS-771, CHARACTERIZATION OF VARIANTS CIPA GLU-517; GLU-522; PRO-657;
RP   THR-699; SER-752; SER-763 AND CYS-771, GLYCOSYLATION, SUBCELLULAR
RP   LOCATION, AUTOPHOSPHORYLATION AFTER NGF STIMULATION, AND FUNCTION.
RX   PubMed=27676246; DOI=10.1002/humu.23123;
RA   Shaikh S.S., Chen Y.C., Halsall S.A., Nahorski M.S., Omoto K.,
RA   Young G.T., Phelan A., Woods C.G.;
RT   "A comprehensive functional analysis of NTRK1 missense mutations
RT   causing hereditary sensory and autonomic neuropathy type IV (HSAN
RT   IV).";
RL   Hum. Mutat. 38:55-63(2017).
CC   -!- FUNCTION: Receptor tyrosine kinase involved in the development and
CC       the maturation of the central and peripheral nervous systems
CC       through regulation of proliferation, differentiation and survival
CC       of sympathetic and nervous neurons. High affinity receptor for NGF
CC       which is its primary ligand (PubMed:1850821, PubMed:1849459,
CC       PubMed:1281417, PubMed:8325889, PubMed:15488758, PubMed:17196528,
CC       PubMed:27445338). Can also bind and be activated by
CC       NTF3/neurotrophin-3. However, NTF3 only supports axonal extension
CC       through NTRK1 but has no effect on neuron survival (By
CC       similarity). Upon dimeric NGF ligand-binding, undergoes
CC       homodimerization, autophosphorylation and activation
CC       (PubMed:1281417). Recruits, phosphorylates and/or activates
CC       several downstream effectors including SHC1, FRS2, SH2B1, SH2B2
CC       and PLCG1 that regulate distinct overlapping signaling cascades
CC       driving cell survival and differentiation. Through SHC1 and FRS2
CC       activates a GRB2-Ras-MAPK cascade that regulates cell
CC       differentiation and survival. Through PLCG1 controls NF-Kappa-B
CC       activation and the transcription of genes involved in cell
CC       survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1
CC       signaling cascade that is also regulating survival. In absence of
CC       ligand and activation, may promote cell death, making the survival
CC       of neurons dependent on trophic factors.
CC       {ECO:0000250|UniProtKB:P35739, ECO:0000250|UniProtKB:Q3UFB7,
CC       ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:1281417,
CC       ECO:0000269|PubMed:15488758, ECO:0000269|PubMed:17196528,
CC       ECO:0000269|PubMed:1849459, ECO:0000269|PubMed:1850821,
CC       ECO:0000269|PubMed:27445338, ECO:0000269|PubMed:27676246,
CC       ECO:0000269|PubMed:8155326, ECO:0000269|PubMed:8325889}.
CC   -!- FUNCTION: Isoform TrkA-III: Resistant to NGF, it constitutively
CC       activates AKT1 and NF-kappa-B and is unable to activate the Ras-
CC       MAPK signaling cascade. Antagonizes the anti-proliferative NGF-
CC       NTRK1 signaling that promotes neuronal precursors differentiation.
CC       Isoform TrkA-III promotes angiogenesis and has oncogenic activity
CC       when overexpressed. {ECO:0000269|PubMed:15488758}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028, ECO:0000269|PubMed:1281417,
CC       ECO:0000269|PubMed:2927393}.
CC   -!- ENZYME REGULATION: The pro-survival signaling effect of NTRK1 in
CC       neurons requires its endocytosis into signaling early endosomes
CC       and its retrograde axonal transport. This is regulated by
CC       different proteins including CFL1, RAC1 and SORT1. NTF3 is unable
CC       to induce this signaling probably due to the lability of the NTF3-
CC       NTRK1 complex in endosomes. SH2D1A inhibits the
CC       autophosphorylation of the receptor, and alters the recruitment
CC       and activation of downstream effectors and signaling cascades (By
CC       similarity). Regulated by NGFR (By similarity).
CC       {ECO:0000250|UniProtKB:Q3UFB7}.
CC   -!- SUBUNIT: Exists in a dynamic equilibrium between monomeric (low
CC       affinity) and dimeric (high affinity) structures. Homodimerization
CC       is induced by binding of a NGF dimer (PubMed:1281417,
CC       PubMed:10490030, PubMed:17196528). Interacts with SQSTM1; bridges
CC       NTRK1 to NGFR (PubMed:11244088). Forms a ternary complex with NGFR
CC       and KIDINS220; this complex is affected by the expression levels
CC       of KIDINS220 and an increase in KIDINS220 expression leads to a
CC       decreased association of NGFR and NTRK1 (By similarity). Interacts
CC       with SH2D1A; regulates NTRK1 (By similarity). Interacts
CC       (phosphorylated upon activation by NGF) with SHC1; mediates SHC1
CC       phosphorylation and activation (PubMed:8155326, PubMed:15488758).
CC       Interacts (phosphorylated upon activation by NGF) with PLCG1;
CC       mediates PLCG1 phosphorylation and activation (PubMed:7510697,
CC       PubMed:15488758). Interacts (phosphorylated) with SH2B1 and SH2B2
CC       (By similarity). Interacts with GRB2 (PubMed:15488758). Interacts
CC       with PIK3R1 (PubMed:15488758). Interacts with FRS2
CC       (PubMed:15488758). Interacts with SORT1; may regulate NTRK1
CC       anterograde axonal transport (PubMed:21102451). Interacts with
CC       RAB7A (By similarity). Found in a complex, at least composed of
CC       KIDINS220, MAGI2, NTRK1 and RAPGEF2; the complex is mainly formed
CC       at late endosomes in a nerve growth factor (NGF)-dependent manner
CC       (By similarity). Interacts with RAPGEF2; the interaction is
CC       strengthened after NGF stimulation (By similarity). Interacts with
CC       PTPRS (By similarity). Interacts with USP36; USP36 does not
CC       deubiquitinate NTRK1 (PubMed:27445338). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P35739, ECO:0000269|PubMed:10490030,
CC       ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:1281417,
CC       ECO:0000269|PubMed:15488758, ECO:0000269|PubMed:17196528,
CC       ECO:0000269|PubMed:21102451, ECO:0000269|PubMed:27445338,
CC       ECO:0000269|PubMed:7510697, ECO:0000269|PubMed:8155326,
CC       ECO:0000269|PubMed:8325889}.
CC   -!- INTERACTION:
CC       P22681:CBL; NbExp=2; IntAct=EBI-1028226, EBI-518228;
CC       P01138:NGF; NbExp=3; IntAct=EBI-1028226, EBI-1028250;
CC       Q8K4V6:Pirb (xeno); NbExp=2; IntAct=EBI-1028226, EBI-8602514;
CC       P18031:PTPN1; NbExp=2; IntAct=EBI-1028226, EBI-968788;
CC       Q99523:SORT1; NbExp=3; IntAct=EBI-1028226, EBI-1057058;
CC       Q13501:SQSTM1; NbExp=2; IntAct=EBI-1028226, EBI-307104;
CC       O75385:ULK1; NbExp=2; IntAct=EBI-1028226, EBI-908831;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1281417,
CC       ECO:0000269|PubMed:15488758, ECO:0000269|PubMed:17196528,
CC       ECO:0000269|PubMed:27676246, ECO:0000269|PubMed:2927393}; Single-
CC       pass type I membrane protein {ECO:0000269|PubMed:1281417,
CC       ECO:0000269|PubMed:15488758}. Early endosome membrane
CC       {ECO:0000250|UniProtKB:P35739}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:P35739}. Late endosome membrane
CC       {ECO:0000250|UniProtKB:P35739}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:P35739}. Note=Rapidly internalized
CC       after NGF binding (PubMed:1281417). Internalized to endosomes upon
CC       binding of NGF or NTF3 and further transported to the cell body
CC       via a retrograde axonal transport. Localized at cell membrane and
CC       early endosomes before nerve growth factor (NGF) stimulation.
CC       Recruited to late endosomes after NGF stimulation. Colocalized
CC       with RAPGEF2 at late endosomes. {ECO:0000250|UniProtKB:P35739,
CC       ECO:0000269|PubMed:1281417}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=TrkA-I and TrkA-II isoforms have similar biological
CC         properties but are differentially expressed.;
CC       Name=TrkA-II; Synonyms=TrkAII;
CC         IsoId=P04629-1; Sequence=Displayed;
CC         Note=Major isoform.;
CC       Name=TrkA-I; Synonyms=TrkAI;
CC         IsoId=P04629-2; Sequence=VSP_002899;
CC         Note=Has enhanced responsiveness to NTF3 neurotrophin.;
CC       Name=3;
CC         IsoId=P04629-3; Sequence=VSP_041905, VSP_002899;
CC       Name=TrkA-III; Synonyms=TrkAIII;
CC         IsoId=P04629-4; Sequence=VSP_042152, VSP_002899;
CC         Note=Constitutively active. Does not bind NGF and does not
CC         interact with GRB2 and FRS2.;
CC   -!- TISSUE SPECIFICITY: Isoform TrkA-I is found in most non-neuronal
CC       tissues. Isoform TrkA-II is primarily expressed in neuronal cells.
CC       TrkA-III is specifically expressed by pluripotent neural stem and
CC       neural crest progenitors. {ECO:0000269|PubMed:15488758,
CC       ECO:0000269|PubMed:8325889}.
CC   -!- INDUCTION: Isoform TrkA-III is up-regulated upon hypoxia in cells
CC       normally expressing it. {ECO:0000269|PubMed:15488758}.
CC   -!- DOMAIN: The transmembrane domain mediates interaction with
CC       KIDINS220. {ECO:0000250|UniProtKB:P35739}.
CC   -!- DOMAIN: The extracellular domain mediates interaction with NGFR.
CC       {ECO:0000250|UniProtKB:P35739}.
CC   -!- PTM: Ligand-mediated autophosphorylation (PubMed:2927393,
CC       PubMed:1281417, PubMed:15488758, PubMed:7510697, PubMed:8155326,
CC       PubMed:8325889, PubMed:27676246, PubMed:28177573). Interaction
CC       with SQSTM1 is phosphotyrosine-dependent. Autophosphorylation at
CC       Tyr-496 mediates interaction and phosphorylation of SHC1
CC       (PubMed:15488758, PubMed:7510697, PubMed:8155326, PubMed:8325889).
CC       {ECO:0000269|PubMed:1281417, ECO:0000269|PubMed:15488758,
CC       ECO:0000269|PubMed:27676246, ECO:0000269|PubMed:28177573,
CC       ECO:0000269|PubMed:2927393, ECO:0000269|PubMed:7510697,
CC       ECO:0000269|PubMed:8155326, ECO:0000269|PubMed:8325889}.
CC   -!- PTM: N-glycosylated (PubMed:2927393). Isoform TrkA-I and isoform
CC       TrkA-II are N-glycosylated. {ECO:0000269|PubMed:15488758,
CC       ECO:0000269|PubMed:17196528, ECO:0000269|PubMed:27676246,
CC       ECO:0000269|PubMed:2927393}.
CC   -!- PTM: Ubiquitinated (PubMed:27445338). Undergoes polyubiquitination
CC       upon activation; regulated by NGFR (PubMed:27445338).
CC       Ubiquitination by NEDD4L leads to degradation (PubMed:27445338).
CC       Ubiquitination regulates the internalization of the receptor (By
CC       similarity). {ECO:0000250|UniProtKB:Q3UFB7,
CC       ECO:0000269|PubMed:27445338}.
CC   -!- DISEASE: Congenital insensitivity to pain with anhidrosis (CIPA)
CC       [MIM:256800]: Characterized by a congenital insensitivity to pain,
CC       anhidrosis (absence of sweating), absence of reaction to noxious
CC       stimuli, self-mutilating behavior, and mental retardation. This
CC       rare autosomal recessive disorder is also known as congenital
CC       sensory neuropathy with anhidrosis or hereditary sensory and
CC       autonomic neuropathy type IV or familial dysautonomia type II.
CC       {ECO:0000269|PubMed:10090906, ECO:0000269|PubMed:10233776,
CC       ECO:0000269|PubMed:10330344, ECO:0000269|PubMed:10567924,
CC       ECO:0000269|PubMed:10861667, ECO:0000269|PubMed:10982191,
CC       ECO:0000269|PubMed:11159935, ECO:0000269|PubMed:11310631,
CC       ECO:0000269|PubMed:18077166, ECO:0000269|PubMed:22302274,
CC       ECO:0000269|PubMed:27676246, ECO:0000269|PubMed:28177573,
CC       ECO:0000269|PubMed:28328124, ECO:0000269|PubMed:8696348}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Note=Chromosomal aberrations involving NTRK1 are found in
CC       papillary thyroid carcinomas (PTCs) (PubMed:2869410,
CC       PubMed:7565764, PubMed:1532241). Translocation t(1;3)(q21;q11)
CC       with TFG generates the TRKT3 (TRK-T3) transcript by fusing TFG to
CC       the 3'-end of NTRK1 (PubMed:7565764). A rearrangement with TPM3
CC       generates the TRK transcript by fusing TPM3 to the 3'-end of NTRK1
CC       (PubMed:2869410). An intrachromosomal rearrangement that links the
CC       protein kinase domain of NTRK1 to the 5'-end of the TPR gene forms
CC       the fusion protein TRK-T1. TRK-T1 is a 55 kDa protein reacting
CC       with antibodies against the C-terminus of the NTRK1 protein
CC       (PubMed:1532241). {ECO:0000269|PubMed:1532241,
CC       ECO:0000269|PubMed:2869410, ECO:0000269|PubMed:7565764}.
CC   -!- MISCELLANEOUS: Trk also stands for tropomyosin-related kinase
CC       since it was first isolated as an oncogenic protein which was the
CC       result of a fusion between the tropomyosin gene TPM3 and NTRK1.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA27243.1; Type=Erroneous termination; Positions=786; Note=Translated as Gln.; Evidence={ECO:0000305};
CC       Sequence=CAA27243.1; Type=Frameshift; Positions=769; Evidence={ECO:0000305};
CC       Sequence=CAA27243.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=CAA29888.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=CAA44719.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=CAA59936.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M23102; AAA36770.1; -; mRNA.
DR   EMBL; AB019488; BAA34355.1; -; Genomic_DNA.
DR   EMBL; AK312704; BAG35582.1; -; mRNA.
DR   EMBL; DB265639; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL158169; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC062580; AAH62580.1; -; mRNA.
DR   EMBL; BC136554; AAI36555.1; -; mRNA.
DR   EMBL; BC144239; AAI44240.1; -; mRNA.
DR   EMBL; AY321513; AAP88292.1; -; Genomic_DNA.
DR   EMBL; X03541; CAA27243.1; ALT_SEQ; mRNA.
DR   EMBL; X06704; CAA29888.1; ALT_SEQ; mRNA.
DR   EMBL; X85960; CAA59936.1; ALT_SEQ; mRNA.
DR   EMBL; X62947; CAA44719.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS1161.1; -. [P04629-1]
DR   CCDS; CCDS30890.1; -. [P04629-3]
DR   CCDS; CCDS30891.1; -. [P04629-2]
DR   PIR; A30124; TVHUTT.
DR   PIR; S23741; S23741.
DR   RefSeq; NP_001007793.1; NM_001007792.1. [P04629-3]
DR   RefSeq; NP_001012331.1; NM_001012331.1. [P04629-2]
DR   RefSeq; NP_002520.2; NM_002529.3. [P04629-1]
DR   UniGene; Hs.406293; -.
DR   PDB; 1HE7; X-ray; 2.00 A; A=285-413.
DR   PDB; 1SHC; NMR; -; B=489-500.
DR   PDB; 1WWA; X-ray; 2.50 A; X/Y=278-386.
DR   PDB; 1WWW; X-ray; 2.20 A; X/Y=282-382.
DR   PDB; 2IFG; X-ray; 3.40 A; A/B=36-382.
DR   PDB; 2N90; NMR; -; A/B=410-447.
DR   PDB; 4AOJ; X-ray; 2.75 A; A/B/C=473-796.
DR   PDB; 4CRP; NMR; -; A=282-383.
DR   PDB; 4F0I; X-ray; 2.30 A; A/B=498-796.
DR   PDB; 4GT5; X-ray; 2.40 A; A=498-796.
DR   PDB; 4PMM; X-ray; 2.00 A; A=501-787.
DR   PDB; 4PMP; X-ray; 1.80 A; A=501-787.
DR   PDB; 4PMS; X-ray; 2.80 A; A=501-787.
DR   PDB; 4PMT; X-ray; 2.10 A; A=501-787.
DR   PDB; 4YNE; X-ray; 2.02 A; A=502-796.
DR   PDB; 4YPS; X-ray; 2.10 A; A=502-796.
DR   PDB; 5H3Q; X-ray; 2.10 A; A=473-796.
DR   PDB; 5I8A; X-ray; 2.33 A; A=498-787.
DR   PDB; 5JFS; X-ray; 2.07 A; A=502-796.
DR   PDB; 5JFV; X-ray; 1.59 A; A=502-796.
DR   PDB; 5JFW; X-ray; 1.52 A; A=502-796.
DR   PDB; 5JFX; X-ray; 1.63 A; A=502-796.
DR   PDB; 5KMI; X-ray; 1.87 A; A=474-796.
DR   PDB; 5KMJ; X-ray; 2.04 A; A=474-796.
DR   PDB; 5KMK; X-ray; 2.24 A; A=474-796.
DR   PDB; 5KML; X-ray; 2.01 A; A=474-796.
DR   PDB; 5KMM; X-ray; 2.12 A; A=474-796.
DR   PDB; 5KMN; X-ray; 2.14 A; A=474-796.
DR   PDB; 5KMO; X-ray; 2.67 A; A=474-796.
DR   PDB; 5KVT; X-ray; 2.45 A; A=501-787.
DR   PDB; 5WR7; X-ray; 2.76 A; A=489-792.
DR   PDBsum; 1HE7; -.
DR   PDBsum; 1SHC; -.
DR   PDBsum; 1WWA; -.
DR   PDBsum; 1WWW; -.
DR   PDBsum; 2IFG; -.
DR   PDBsum; 2N90; -.
DR   PDBsum; 4AOJ; -.
DR   PDBsum; 4CRP; -.
DR   PDBsum; 4F0I; -.
DR   PDBsum; 4GT5; -.
DR   PDBsum; 4PMM; -.
DR   PDBsum; 4PMP; -.
DR   PDBsum; 4PMS; -.
DR   PDBsum; 4PMT; -.
DR   PDBsum; 4YNE; -.
DR   PDBsum; 4YPS; -.
DR   PDBsum; 5H3Q; -.
DR   PDBsum; 5I8A; -.
DR   PDBsum; 5JFS; -.
DR   PDBsum; 5JFV; -.
DR   PDBsum; 5JFW; -.
DR   PDBsum; 5JFX; -.
DR   PDBsum; 5KMI; -.
DR   PDBsum; 5KMJ; -.
DR   PDBsum; 5KMK; -.
DR   PDBsum; 5KML; -.
DR   PDBsum; 5KMM; -.
DR   PDBsum; 5KMN; -.
DR   PDBsum; 5KMO; -.
DR   PDBsum; 5KVT; -.
DR   PDBsum; 5WR7; -.
DR   ProteinModelPortal; P04629; -.
DR   SMR; P04629; -.
DR   BioGrid; 110969; 1943.
DR   CORUM; P04629; -.
DR   DIP; DIP-5714N; -.
DR   ELM; P04629; -.
DR   IntAct; P04629; 19.
DR   MINT; P04629; -.
DR   STRING; 9606.ENSP00000431418; -.
DR   BindingDB; P04629; -.
DR   ChEMBL; CHEMBL2815; -.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00619; Imatinib.
DR   DrugBank; DB08896; Regorafenib.
DR   GuidetoPHARMACOLOGY; 1817; -.
DR   iPTMnet; P04629; -.
DR   PhosphoSitePlus; P04629; -.
DR   BioMuta; NTRK1; -.
DR   DMDM; 94730402; -.
DR   PaxDb; P04629; -.
DR   PeptideAtlas; P04629; -.
DR   PRIDE; P04629; -.
DR   Ensembl; ENST00000368196; ENSP00000357179; ENSG00000198400. [P04629-2]
DR   Ensembl; ENST00000392302; ENSP00000376120; ENSG00000198400. [P04629-3]
DR   Ensembl; ENST00000524377; ENSP00000431418; ENSG00000198400. [P04629-1]
DR   GeneID; 4914; -.
DR   KEGG; hsa:4914; -.
DR   UCSC; uc001fqf.2; human. [P04629-1]
DR   CTD; 4914; -.
DR   DisGeNET; 4914; -.
DR   EuPathDB; HostDB:ENSG00000198400.11; -.
DR   GeneCards; NTRK1; -.
DR   GeneReviews; NTRK1; -.
DR   HGNC; HGNC:8031; NTRK1.
DR   HPA; CAB004606; -.
DR   HPA; HPA035799; -.
DR   HPA; HPA076570; -.
DR   MalaCards; NTRK1; -.
DR   MIM; 164970; gene.
DR   MIM; 191315; gene.
DR   MIM; 256800; phenotype.
DR   neXtProt; NX_P04629; -.
DR   OpenTargets; ENSG00000198400; -.
DR   Orphanet; 99361; Familial medullary thyroid carcinoma.
DR   Orphanet; 642; Hereditary sensory and autonomic neuropathy type 4.
DR   Orphanet; 64752; Hereditary sensory and autonomic neuropathy type 5.
DR   Orphanet; 146; Papillary or follicular thyroid carcinoma.
DR   PharmGKB; PA31817; -.
DR   eggNOG; ENOG410IMMI; Eukaryota.
DR   eggNOG; ENOG410XTGG; LUCA.
DR   GeneTree; ENSGT00760000118818; -.
DR   HOVERGEN; HBG056735; -.
DR   InParanoid; P04629; -.
DR   KO; K03176; -.
DR   OMA; PEVYAIM; -.
DR   OrthoDB; EOG091G01JY; -.
DR   PhylomeDB; P04629; -.
DR   TreeFam; TF106465; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-167021; PLC-gamma1 signalling.
DR   Reactome; R-HSA-167044; Signalling to RAS.
DR   Reactome; R-HSA-170968; Frs2-mediated activation.
DR   Reactome; R-HSA-170984; ARMS-mediated activation.
DR   Reactome; R-HSA-177504; Retrograde neurotrophin signalling.
DR   Reactome; R-HSA-187024; NGF-independant TRKA activation.
DR   Reactome; R-HSA-187042; TRKA activation by NGF.
DR   Reactome; R-HSA-187706; Signalling to p38 via RIT and RIN.
DR   Reactome; R-HSA-198203; PI3K/AKT activation.
DR   Reactome; R-HSA-198745; Signalling to STAT3.
DR   SignaLink; P04629; -.
DR   SIGNOR; P04629; -.
DR   ChiTaRS; NTRK1; human.
DR   EvolutionaryTrace; P04629; -.
DR   GenomeRNAi; 4914; -.
DR   PRO; PR:P04629; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000198400; -.
DR   ExpressionAtlas; P04629; baseline and differential.
DR   Genevisible; P04629; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005769; C:early endosome; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005770; C:late endosome; ISS:UniProtKB.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0032991; C:protein-containing complex; ISS:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005004; F:GPI-linked ephrin receptor activity; IEA:Ensembl.
DR   GO; GO:0048406; F:nerve growth factor binding; IDA:UniProtKB.
DR   GO; GO:0010465; F:nerve growth factor receptor activity; IDA:UniProtKB.
DR   GO; GO:0043121; F:neurotrophin binding; TAS:ProtInc.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:MGI.
DR   GO; GO:0000186; P:activation of MAPKK activity; TAS:Reactome.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0060385; P:axonogenesis involved in innervation; ISS:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; IEA:Ensembl.
DR   GO; GO:0061368; P:behavioral response to formalin induced pain; IEA:Ensembl.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IMP:UniProtKB.
DR   GO; GO:0071316; P:cellular response to nicotine; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0042490; P:mechanoreceptor differentiation; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:ARUK-UCL.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0038180; P:nerve growth factor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0048666; P:neuron development; IDA:MGI.
DR   GO; GO:0031175; P:neuron projection development; IDA:MGI.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0021553; P:olfactory nerve development; IEA:Ensembl.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IDA:MGI.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0043068; P:positive regulation of programmed cell death; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; TAS:BHF-UCL.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0010623; P:programmed cell death involved in cell development; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048678; P:response to axon injury; IEA:Ensembl.
DR   GO; GO:0051602; P:response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0051599; P:response to hydrostatic pressure; IEA:Ensembl.
DR   GO; GO:0031667; P:response to nutrient levels; IEA:Ensembl.
DR   GO; GO:0009314; P:response to radiation; IEA:Ensembl.
DR   GO; GO:0060009; P:Sertoli cell development; IEA:Ensembl.
DR   GO; GO:0048485; P:sympathetic nervous system development; ISS:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 2.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR031635; NTRK_C2.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR020461; Tyr_kinase_neurotrophic_rcpt_1.
DR   InterPro; IPR020777; Tyr_kinase_NGF_rcpt.
DR   InterPro; IPR002011; Tyr_kinase_rcpt_2_CS.
DR   Pfam; PF13855; LRR_8; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF16920; TPKR_C2; 1.
DR   PRINTS; PR01939; NTKRECEPTOR.
DR   PRINTS; PR01940; NTKRECEPTOR1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00082; LRRCT; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00239; RECEPTOR_TYR_KIN_II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Chromosomal rearrangement; Complete proteome; Developmental protein;
KW   Differentiation; Disease mutation; Disulfide bond; Endosome;
KW   Glycoprotein; Immunoglobulin domain; Kinase; Leucine-rich repeat;
KW   Membrane; Neurogenesis; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Receptor; Reference proteome; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL        1     32       {ECO:0000255}.
FT   CHAIN        33    796       High affinity nerve growth factor
FT                                receptor.
FT                                /FTId=PRO_0000016724.
FT   TOPO_DOM     33    423       Extracellular. {ECO:0000255}.
FT   TRANSMEM    424    439       Helical. {ECO:0000255}.
FT   TOPO_DOM    440    796       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       90    113       LRR 1.
FT   REPEAT      116    137       LRR 2.
FT   DOMAIN      148    193       LRRCT.
FT   DOMAIN      194    283       Ig-like C2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00114}.
FT   DOMAIN      299    365       Ig-like C2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00114}.
FT   DOMAIN      510    781       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     516    524       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      469    490       Interaction with SQSTM1. {ECO:0000250}.
FT   ACT_SITE    650    650       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     544    544       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   SITE        398    399       Breakpoint for translocation to form TRK
FT                                and TRK-T3.
FT   SITE        486    486       Breakpoint for translocation to form TRK-
FT                                T1.
FT   SITE        496    496       Interaction with SHC1.
FT   SITE        791    791       Interaction with PLCG1.
FT   MOD_RES     496    496       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:15488758,
FT                                ECO:0000269|PubMed:27676246,
FT                                ECO:0000269|PubMed:8155326}.
FT   MOD_RES     676    676       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:8155326}.
FT   MOD_RES     680    680       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:15488758,
FT                                ECO:0000269|PubMed:8155326}.
FT   MOD_RES     681    681       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:15488758,
FT                                ECO:0000269|PubMed:8155326}.
FT   MOD_RES     791    791       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:15488758,
FT                                ECO:0000269|PubMed:7510697,
FT                                ECO:0000269|PubMed:8155326}.
FT   CARBOHYD     67     67       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     95     95       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    188    188       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:2IFG,
FT                                ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    202    202       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    253    253       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    262    262       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:2IFG,
FT                                ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    281    281       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:2IFG,
FT                                ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    318    318       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    323    323       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    338    338       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    358    358       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:2IFG,
FT                                ECO:0000269|PubMed:17196528}.
FT   CARBOHYD    401    401       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     36     41       {ECO:0000244|PDB:2IFG}.
FT   DISULFID     40     50       {ECO:0000244|PDB:2IFG}.
FT   DISULFID    154    191       {ECO:0000244|PDB:2IFG,
FT                                ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:17196528}.
FT   DISULFID    215    265       {ECO:0000244|PDB:2IFG,
FT                                ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:17196528}.
FT   DISULFID    300    345       {ECO:0000244|PDB:1HE7,
FT                                ECO:0000244|PDB:1WWA,
FT                                ECO:0000244|PDB:1WWW,
FT                                ECO:0000244|PDB:2IFG,
FT                                ECO:0000244|PDB:4CRP}.
FT   VAR_SEQ       1     71       MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACC
FT                                PHGSSGLRCTRDGALDSLHHLPGAENLTEL -> MKEAALI
FT                                CLAPSVPPILTVKSWDTMQLRAARSRCTNLLAAS (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041905.
FT   VAR_SEQ     192    284       GVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTEL
FT                                EQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGR
FT                                AEVSVQVNVSF -> V (in isoform TrkA-III).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_042152.
FT   VAR_SEQ     393    398       Missing (in isoform TrkA-I, isoform 3 and
FT                                isoform TrkA-III).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2927393}.
FT                                /FTId=VSP_002899.
FT   VARIANT       6      6       R -> W (in dbSNP:rs201472270).
FT                                {ECO:0000269|PubMed:22302274}.
FT                                /FTId=VAR_068480.
FT   VARIANT      18     18       G -> E (in dbSNP:rs1007211).
FT                                /FTId=VAR_049714.
FT   VARIANT      80     80       Q -> R (in dbSNP:rs55891455).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041461.
FT   VARIANT      85     85       R -> S (in dbSNP:rs543320028).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009623.
FT   VARIANT      93     93       L -> P (in CIPA; aberrantly processed;
FT                                shows diminished autophosphorylation in
FT                                neuronal cells).
FT                                {ECO:0000269|PubMed:10982191,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009624.
FT   VARIANT     107    107       A -> V (in an ovarian serous carcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs540521894).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041462.
FT   VARIANT     110    110       A -> D (in CIPA).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079399.
FT   VARIANT     146    796       Missing (in CIPA).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079400.
FT   VARIANT     176    796       Missing (in CIPA).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079401.
FT   VARIANT     213    213       L -> P (in CIPA; aberrantly processed;
FT                                shows diminished autophosphorylation in
FT                                neuronal cells; dbSNP:rs747711259).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009625.
FT   VARIANT     235    796       Missing (in CIPA; loss of protein).
FT                                {ECO:0000269|PubMed:28177573}.
FT                                /FTId=VAR_079402.
FT   VARIANT     237    237       T -> M (in dbSNP:rs55909005).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041463.
FT   VARIANT     238    238       V -> G (in dbSNP:rs56000394).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041464.
FT   VARIANT     260    260       R -> G (in dbSNP:rs35116695).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041465.
FT   VARIANT     359    359       Y -> C (in CIPA; dbSNP:rs121964869).
FT                                {ECO:0000269|PubMed:11310631}.
FT                                /FTId=VAR_068481.
FT   VARIANT     444    444       R -> Q (in dbSNP:rs56320207).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041466.
FT   VARIANT     452    452       R -> C (in dbSNP:rs34900547).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041467.
FT   VARIANT     476    796       Missing (in CIPA).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079403.
FT   VARIANT     492    492       E -> K (in CIPA; dbSNP:rs144901788).
FT                                {ECO:0000269|PubMed:22302274}.
FT                                /FTId=VAR_068482.
FT   VARIANT     517    517       G -> E (in CIPA; following transfection
FT                                in neuroblastoma cells and NGF treatment,
FT                                small decrease in the percentage of cells
FT                                differentiated into neuronal phenotype,
FT                                but in differentiated cells, the average
FT                                neurite length is comparable to wild-
FT                                type; no effect on N-glycosylation,
FT                                subcellular location, nor on basal and
FT                                NGF-induced autophosphorylation; loss of
FT                                NGF-stimulated calcium flux;
FT                                dbSNP:rs606231467).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077472.
FT   VARIANT     522    522       G -> E (in CIPA; no effect on N-
FT                                glycosylation, nor on subcellular
FT                                location; reduced basal
FT                                autophosphorylation and complete loss of
FT                                NGF-induced autophosphorylation; loss of
FT                                NGF-stimulated calcium flux).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077473.
FT   VARIANT     522    522       G -> R (in CIPA; processed as wild-type
FT                                but shows significantly diminished
FT                                autophosphorylation in both neuronal and
FT                                non-neuronal cells).
FT                                {ECO:0000269|PubMed:10982191,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009626.
FT   VARIANT     566    566       M -> T (in dbSNP:rs55892037).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041468.
FT   VARIANT     572    572       I -> S (in CIPA).
FT                                {ECO:0000269|PubMed:18077166}.
FT                                /FTId=VAR_077474.
FT   VARIANT     577    577       G -> R (in CIPA; loss of function;
FT                                processed as wild-type but shows
FT                                significantly diminished
FT                                autophosphorylation in both neuronal and
FT                                non-neuronal cells; dbSNP:rs121964866).
FT                                {ECO:0000269|PubMed:10567924,
FT                                ECO:0000269|PubMed:10982191,
FT                                ECO:0000269|PubMed:11159935,
FT                                ECO:0000269|PubMed:8696348}.
FT                                /FTId=VAR_004103.
FT   VARIANT     587    587       M -> V (in CIPA; dbSNP:rs121964870).
FT                                {ECO:0000269|PubMed:10233776}.
FT                                /FTId=VAR_009627.
FT   VARIANT     596    596       D -> N (in CIPA; abolishes
FT                                autophosphorylation).
FT                                {ECO:0000269|PubMed:28177573}.
FT                                /FTId=VAR_079404.
FT   VARIANT     604    604       H -> Y (in dbSNP:rs6336).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:10443680,
FT                                ECO:0000269|PubMed:11159935,
FT                                ECO:0000269|PubMed:11310631,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_009628.
FT   VARIANT     613    613       G -> V (in dbSNP:rs6339).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:10443680,
FT                                ECO:0000269|PubMed:10861667,
FT                                ECO:0000269|PubMed:11159935,
FT                                ECO:0000269|PubMed:11310631,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_009629.
FT   VARIANT     649    649       R -> Q (in CIPA; dbSNP:rs786205449).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079405.
FT   VARIANT     649    649       R -> W (in CIPA; processed as wild-type
FT                                but shows significantly diminished
FT                                autophosphorylation in both neuronal and
FT                                non-neuronal cells; dbSNP:rs369353892).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009630.
FT   VARIANT     654    654       R -> C (in CIPA; processed as wild-type
FT                                but shows significantly diminished
FT                                autophosphorylation in both neuronal and
FT                                non-neuronal cells; dbSNP:rs764992664).
FT                                {ECO:0000269|PubMed:10982191,
FT                                ECO:0000269|PubMed:11159935,
FT                                ECO:0000269|PubMed:22302274}.
FT                                /FTId=VAR_009631.
FT   VARIANT     657    657       L -> P (in CIPA; following transfection
FT                                in neuroblastoma cells and NGF treatment,
FT                                loss of differentiation into neuronal
FT                                phenotype; partially decreased N-
FT                                glycosylation; reduced expression at the
FT                                plasma membrane; reduced basal
FT                                autophosphorylation and complete loss of
FT                                NGF-induced autophosphorylation; loss of
FT                                NGF-stimulated calcium flux).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077475.
FT   VARIANT     674    674       D -> Y (in CIPA; might impair the
FT                                function of the enzyme without
FT                                compromising autophosphorylation;
FT                                dbSNP:rs80356677).
FT                                {ECO:0000269|PubMed:10982191,
FT                                ECO:0000269|PubMed:11159935,
FT                                ECO:0000269|PubMed:28177573}.
FT                                /FTId=VAR_009632.
FT   VARIANT     695    695       P -> L (in CIPA; dbSNP:rs121964868).
FT                                {ECO:0000269|PubMed:10861667}.
FT                                /FTId=VAR_009633.
FT   VARIANT     699    699       I -> T (in CIPA; partially decreased N-
FT                                glycosylation; reduced expression at the
FT                                plasma membrane; reduced basal
FT                                autophosphorylation and complete loss of
FT                                NGF-induced autophosphorylation; loss of
FT                                NGF-stimulated calcium flux).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077476.
FT   VARIANT     700    700       L -> P (in CIPA).
FT                                {ECO:0000269|PubMed:28328124}.
FT                                /FTId=VAR_079406.
FT   VARIANT     714    714       G -> S (in CIPA; processed as wild-type
FT                                but shows significantly diminished
FT                                autophosphorylation in both neuronal and
FT                                non-neuronal cells; dbSNP:rs770727871).
FT                                {ECO:0000269|PubMed:10330344,
FT                                ECO:0000269|PubMed:11159935}.
FT                                /FTId=VAR_009634.
FT   VARIANT     717    717       L -> R (in CIPA; found in a compound
FT                                heterozygote also carrying an premature
FT                                stop codon at position 558).
FT                                {ECO:0000269|PubMed:18077166}.
FT                                /FTId=VAR_077477.
FT   VARIANT     752    752       C -> S (in CIPA; unknown pathological
FT                                significance; following transfection in
FT                                neuroblastoma cells and NGF treatment, no
FT                                effect on neurite outgrowth, nor neurite
FT                                length; no effect on N-glycosylation,
FT                                subcellular location, basal and NGF-
FT                                induced autophosphorylation, nor on NGF-
FT                                stimulated calcium flux).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077478.
FT   VARIANT     763    763       C -> S (in CIPA; following transfection
FT                                in neuroblastoma cells and NGF treatment,
FT                                decreased percentage of cells
FT                                differentiated into neuronal phenotype
FT                                and reduced neurite length compared with
FT                                wild-type; slightly decreased N-
FT                                glycosylation; reduced expression at the
FT                                plasma membrane; reduced basal and NGF-
FT                                induced autophosphorylation; small
FT                                reduction in NGF-stimulated calcium
FT                                flux). {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077479.
FT   VARIANT     771    771       R -> C (in CIPA; partially decreased N-
FT                                glycosylation; reduced expression at the
FT                                plasma membrane; reduced basal
FT                                autophosphorylation and complete loss of
FT                                NGF-induced autophosphorylation; loss of
FT                                NGF-stimulated calcium flux).
FT                                {ECO:0000269|PubMed:27676246}.
FT                                /FTId=VAR_077480.
FT   VARIANT     780    780       R -> P (in CIPA; loss of function;
FT                                dbSNP:rs35669708).
FT                                {ECO:0000269|PubMed:10090906}.
FT                                /FTId=VAR_009635.
FT   VARIANT     780    780       R -> Q (in dbSNP:rs35669708).
FT                                {ECO:0000269|PubMed:10443680,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_009636.
FT   VARIANT     790    790       V -> I (in dbSNP:rs55948542).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041469.
FT   MUTAGEN     496    496       Y->F: Loss of interaction with SHC1 and
FT                                altered phosphorylation of SHC1. Altered
FT                                neurite outgrowth and altered activation
FT                                of the MAPK pathway; when associated with
FT                                F-791. {ECO:0000269|PubMed:8155326}.
FT   MUTAGEN     544    544       K->N: Loss of kinase activity.
FT                                {ECO:0000269|PubMed:1281417,
FT                                ECO:0000269|PubMed:8155326}.
FT   MUTAGEN     791    791       Y->F: Loss of interaction with PLCG1 and
FT                                altered phosphorylation of PLCG1. Altered
FT                                neurite outgrowth and altered activation
FT                                of the MAPK pathway; when associated with
FT                                F-496. {ECO:0000269|PubMed:7510697,
FT                                ECO:0000269|PubMed:8155326}.
FT   CONFLICT    263    263       V -> L (in Ref. 1; AAA36770).
FT                                {ECO:0000305}.
FT   CONFLICT    300    300       C -> S (in Ref. 1; AAA36770).
FT                                {ECO:0000305}.
FT   CONFLICT    529    529       C -> S (in Ref. 10; CAA59936).
FT                                {ECO:0000305}.
FT   STRAND       38     40       {ECO:0000244|PDB:2IFG}.
FT   STRAND       43     46       {ECO:0000244|PDB:2IFG}.
FT   TURN         57     61       {ECO:0000244|PDB:2IFG}.
FT   STRAND       69     72       {ECO:0000244|PDB:2IFG}.
FT   HELIX        84     86       {ECO:0000244|PDB:2IFG}.
FT   STRAND       94     97       {ECO:0000244|PDB:2IFG}.
FT   HELIX       110    112       {ECO:0000244|PDB:2IFG}.
FT   STRAND      119    121       {ECO:0000244|PDB:2IFG}.
FT   TURN        133    135       {ECO:0000244|PDB:2IFG}.
FT   STRAND      142    144       {ECO:0000244|PDB:2IFG}.
FT   HELIX       154    156       {ECO:0000244|PDB:2IFG}.
FT   HELIX       157    164       {ECO:0000244|PDB:2IFG}.
FT   HELIX       171    173       {ECO:0000244|PDB:2IFG}.
FT   STRAND      178    181       {ECO:0000244|PDB:2IFG}.
FT   STRAND      195    199       {ECO:0000244|PDB:2IFG}.
FT   STRAND      211    218       {ECO:0000244|PDB:2IFG}.
FT   STRAND      227    230       {ECO:0000244|PDB:2IFG}.
FT   STRAND      234    238       {ECO:0000244|PDB:2IFG}.
FT   STRAND      244    253       {ECO:0000244|PDB:2IFG}.
FT   TURN        257    260       {ECO:0000244|PDB:2IFG}.
FT   STRAND      263    265       {ECO:0000244|PDB:2IFG}.
FT   STRAND      276    278       {ECO:0000244|PDB:2IFG}.
FT   STRAND      284    290       {ECO:0000244|PDB:1WWW}.
FT   STRAND      298    305       {ECO:0000244|PDB:1HE7}.
FT   STRAND      312    317       {ECO:0000244|PDB:1HE7}.
FT   STRAND      326    333       {ECO:0000244|PDB:1HE7}.
FT   STRAND      342    350       {ECO:0000244|PDB:1HE7}.
FT   HELIX       353    355       {ECO:0000244|PDB:1HE7}.
FT   STRAND      357    365       {ECO:0000244|PDB:1HE7}.
FT   STRAND      368    376       {ECO:0000244|PDB:1HE7}.
FT   HELIX       418    441       {ECO:0000244|PDB:2N90}.
FT   STRAND      476    478       {ECO:0000244|PDB:5KML}.
FT   HELIX       490    492       {ECO:0000244|PDB:5KMI}.
FT   TURN        494    496       {ECO:0000244|PDB:1SHC}.
FT   HELIX       507    509       {ECO:0000244|PDB:5JFW}.
FT   STRAND      510    517       {ECO:0000244|PDB:5JFW}.
FT   STRAND      520    522       {ECO:0000244|PDB:5JFW}.
FT   STRAND      524    533       {ECO:0000244|PDB:5JFW}.
FT   TURN        534    536       {ECO:0000244|PDB:5KMI}.
FT   STRAND      537    545       {ECO:0000244|PDB:5JFW}.
FT   HELIX       552    566       {ECO:0000244|PDB:5JFW}.
FT   STRAND      575    579       {ECO:0000244|PDB:5JFW}.
FT   STRAND      581    584       {ECO:0000244|PDB:5JFW}.
FT   STRAND      586    590       {ECO:0000244|PDB:5JFW}.
FT   HELIX       597    603       {ECO:0000244|PDB:5JFW}.
FT   STRAND      605    607       {ECO:0000244|PDB:4F0I}.
FT   HELIX       608    611       {ECO:0000244|PDB:4PMP}.
FT   STRAND      615    617       {ECO:0000244|PDB:4YNE}.
FT   STRAND      619    621       {ECO:0000244|PDB:5KMI}.
FT   HELIX       624    643       {ECO:0000244|PDB:5JFW}.
FT   STRAND      646    648       {ECO:0000244|PDB:5KML}.
FT   HELIX       653    655       {ECO:0000244|PDB:5JFW}.
FT   STRAND      656    659       {ECO:0000244|PDB:5JFW}.
FT   HELIX       660    662       {ECO:0000244|PDB:5JFW}.
FT   STRAND      663    666       {ECO:0000244|PDB:5JFW}.
FT   HELIX       672    675       {ECO:0000244|PDB:5KMI}.
FT   HELIX       677    679       {ECO:0000244|PDB:4PMP}.
FT   STRAND      680    683       {ECO:0000244|PDB:5KMI}.
FT   TURN        684    686       {ECO:0000244|PDB:5KMI}.
FT   STRAND      687    689       {ECO:0000244|PDB:5KMI}.
FT   HELIX       691    693       {ECO:0000244|PDB:5JFW}.
FT   HELIX       696    701       {ECO:0000244|PDB:5JFW}.
FT   HELIX       706    721       {ECO:0000244|PDB:5JFW}.
FT   TURN        722    724       {ECO:0000244|PDB:5JFV}.
FT   TURN        727    730       {ECO:0000244|PDB:5JFW}.
FT   HELIX       733    742       {ECO:0000244|PDB:5JFW}.
FT   HELIX       754    763       {ECO:0000244|PDB:5JFW}.
FT   HELIX       768    770       {ECO:0000244|PDB:5JFW}.
FT   HELIX       774    786       {ECO:0000244|PDB:5JFW}.
FT   HELIX       789    793       {ECO:0000244|PDB:5KMI}.
SQ   SEQUENCE   796 AA;  87497 MW;  6C15C721E336B601 CRC64;
     MLRGGRRGQL GWHSWAAGPG SLLAWLILAS AGAAPCPDAC CPHGSSGLRC TRDGALDSLH
     HLPGAENLTE LYIENQQHLQ HLELRDLRGL GELRNLTIVK SGLRFVAPDA FHFTPRLSRL
     NLSFNALESL SWKTVQGLSL QELVLSGNPL HCSCALRWLQ RWEEEGLGGV PEQKLQCHGQ
     GPLAHMPNAS CGVPTLKVQV PNASVDVGDD VLLRCQVEGR GLEQAGWILT ELEQSATVMK
     SGGLPSLGLT LANVTSDLNR KNVTCWAEND VGRAEVSVQV NVSFPASVQL HTAVEMHHWC
     IPFSVDGQPA PSLRWLFNGS VLNETSFIFT EFLEPAANET VRHGCLRLNQ PTHVNNGNYT
     LLAANPFGQA SASIMAAFMD NPFEFNPEDP IPVSFSPVDT NSTSGDPVEK KDETPFGVSV
     AVGLAVFACL FLSTLLLVLN KCGRRNKFGI NRPAVLAPED GLAMSLHFMT LGGSSLSPTE
     GKGSGLQGHI IENPQYFSDA CVHHIKRRDI VLKWELGEGA FGKVFLAECH NLLPEQDKML
     VAVKALKEAS ESARQDFQRE AELLTMLQHQ HIVRFFGVCT EGRPLLMVFE YMRHGDLNRF
     LRSHGPDAKL LAGGEDVAPG PLGLGQLLAV ASQVAAGMVY LAGLHFVHRD LATRNCLVGQ
     GLVVKIGDFG MSRDIYSTDY YRVGGRTMLP IRWMPPESIL YRKFTTESDV WSFGVVLWEI
     FTYGKQPWYQ LSNTEAIDCI TQGRELERPR ACPPEVYAIM RGCWQREPQQ RHSIKDVHAR
     LQALAQAPPV YLDVLG
//
ID   X5DR71_HUMAN            Unreviewed;       790 AA.
AC   X5DR71;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   28-FEB-2018, entry version 34.
DE   RecName: Full=Tyrosine-protein kinase receptor {ECO:0000256|RuleBase:RU000312};
DE            EC=2.7.10.1 {ECO:0000256|RuleBase:RU000312};
DE   Flags: Fragment;
GN   Name=NTRK1 {ECO:0000313|EMBL:AHW56542.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHW56542.1};
RN   [1] {ECO:0000313|EMBL:AHW56542.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adult whole brain {ECO:0000313|EMBL:AHW56542.1};
RX   PubMed=24722188;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L.,
RA   Broly M., Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S.,
RA   Tasan M., Lemmens I., Kuang X., Zhao N., Malhotra D., Michaelson J.J.,
RA   Vacic V., Calderwood M.A., Roth F.P., Tavernier J., Horvath S.,
RA   Salehi-Ashtiani K., Korkin D., Sebat J., Hill D.E., Hao T., Vidal M.,
RA   Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from
RT   brain links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000256|RuleBase:RU000312}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily.
CC       {ECO:0000256|RuleBase:RU000312}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KJ534902; AHW56542.1; -; mRNA.
DR   RefSeq; NP_001012331.1; NM_001012331.1.
DR   UniGene; Hs.406293; -.
DR   ProteinModelPortal; X5DR71; -.
DR   SMR; X5DR71; -.
DR   GeneID; 4914; -.
DR   UCSC; uc001fqi.2; human.
DR   CTD; 4914; -.
DR   EuPathDB; HostDB:ENSG00000198400.11; -.
DR   eggNOG; ENOG410IMMI; Eukaryota.
DR   eggNOG; ENOG410XTGG; LUCA.
DR   ChiTaRS; NTRK1; human.
DR   GenomeRNAi; 4914; -.
DR   Bgee; ENSG00000198400; -.
DR   ExpressionAtlas; X5DR71; baseline and differential.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005030; F:neurotrophin receptor activity; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 2.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR031635; NTRK_C2.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR020461; Tyr_kinase_neurotrophic_rcpt_1.
DR   InterPro; IPR020777; Tyr_kinase_NGF_rcpt.
DR   InterPro; IPR002011; Tyr_kinase_rcpt_2_CS.
DR   Pfam; PF13855; LRR_8; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF16920; TPKR_C2; 1.
DR   PRINTS; PR01939; NTKRECEPTOR.
DR   PRINTS; PR01940; NTKRECEPTOR1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00082; LRRCT; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00239; RECEPTOR_TYR_KIN_II; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS01010727};
KW   Immunoglobulin domain {ECO:0000256|SAAS:SAAS00941986};
KW   Kinase {ECO:0000313|EMBL:AHW56542.1};
KW   Leucine-rich repeat {ECO:0000256|SAAS:SAAS00488662};
KW   Membrane {ECO:0000256|SAAS:SAAS00602683, ECO:0000256|SAM:Phobius};
KW   Phosphoprotein {ECO:0000256|RuleBase:RU000312};
KW   Receptor {ECO:0000256|RuleBase:RU000312,
KW   ECO:0000256|SAAS:SAAS00600436, ECO:0000313|EMBL:AHW56542.1};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transferase {ECO:0000313|EMBL:AHW56542.1};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00602683,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00602683,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     33       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        34    790       Tyrosine-protein kinase receptor.
FT                                {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004955970.
FT   TRANSMEM    410    433       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      194    283       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      504    775       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   NON_TER     790    790       {ECO:0000313|EMBL:AHW56542.1}.
SQ   SEQUENCE   790 AA;  86880 MW;  25F05BADA8A2A50C CRC64;
     MLRGGRRGQL GWHSWAAGPG SLLAWLILAS AGAAPCPDAC CPHGSSGLRC TRDGALDSLH
     HLPGAENLTE LYIENQQHLQ HLELRDLRGL GELRNLTIVK SGLRFVAPDA FHFTPRLSRL
     NLSFNALESL SWKTVQGLSL QELVLSGNPL HCSCALRWLQ RWEEEGLGGV PEQKLQCHGQ
     GPLAHMPNAS CGVPTLKVQV PNASVDVGDD VLLRCQVEGR GLEQAGWILT ELEQSATVMK
     SGGLPSLGLT LANVTSDLNR KNVTCWAEND VGRAEVSVQV NVSFPASVQL HTAVEMHHWC
     IPFSVDGQPA PSLRWLFNGS VLNETSFIFT EFLEPAANET VRHGCLRLNQ PTHVNNGNYT
     LLAANPFGQA SASIMAAFMD NPFEFNPEDP IPDTNSTSGD PVEKKDETPF GVSVAVGLAV
     FACLFLSTLL LVLNKCGRRN KFGINRPAVL APEDGLAMSL HFMTLGGSSL SPTEGKGSGL
     QGHIIENPQY FSDACVHHIK RRDIVLKWEL GEGAFGKVFL AECHNLLPEQ DKMLVAVKAL
     KEASESARQD FQREAELLTM LQHQHIVRFF GVCTEGRPLL MVFEYMRHGD LNRFLRSHGP
     DAKLLAGGED VAPGPLGLGQ LLAVASQVAA GMVYLAGLHF VHRDLATRNC LVGQGLVVKI
     GDFGMSRDIY STDYYRVGGR TMLPIRWMPP ESILYRKFTT ESDVWSFGVV LWEIFTYGKQ
     PWYQLSNTEA IDCITQGREL ERPRACPPEV YAIMRGCWQR EPQQRHSIKD VHARLQALAQ
     APPVYLDVLG
//
ID   2AAA_MOUSE              Reviewed;         589 AA.
AC   Q76MZ3;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   23-MAY-2018, entry version 131.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform;
DE   AltName: Full=PP2A subunit A isoform PR65-alpha;
DE   AltName: Full=PP2A subunit A isoform R1-alpha;
GN   Name=Ppp2r1a;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=10100624; DOI=10.1016/S0014-5793(99)00189-1;
RA   Nanahoshi M., Tsujishita Y., Tokunaga C., Inui S., Sakaguchi N.,
RA   Hara K., Yonezawa K.;
RT   "Alpha4 protein as a common regulator of type 2A-related
RT   serine/threonine protein phosphatases.";
RL   FEBS Lett. 446:108-112(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Medulla oblongata, and Oviduct;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH FOXO1.
RX   PubMed=22417654; DOI=10.1042/BJ20111606;
RA   Yan L., Guo S., Brault M., Harmon J., Robertson R.P., Hamid R.,
RA   Stein R., Yang E.;
RT   "The B55alpha-containing PP2A holoenzyme dephosphorylates FOXO1 in
RT   islet beta-cells under oxidative stress.";
RL   Biochem. J. 444:239-247(2012).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-280, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z.,
RA   Zhang Y., Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
CC   -!- FUNCTION: The PR65 subunit of protein phosphatase 2A serves as a
CC       scaffolding molecule to coordinate the assembly of the catalytic
CC       subunit and a variable regulatory B subunit (PubMed:10100624).
CC       Upon interaction with GNA12 promotes dephosphorylation of
CC       microtubule associated protein TAU/MAPT (By similarity). Required
CC       for proper chromosome segregation and for centromeric localization
CC       of SGO1 in mitosis (By similarity). {ECO:0000250|UniProtKB:P30153,
CC       ECO:0000269|PubMed:10100624}.
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of PPP2CA a 36 kDa catalytic subunit (subunit C) and
CC       PPP2R1A a 65 kDa constant regulatory subunit (PR65 or subunit A),
CC       that associates with a variety of regulatory subunits. Proteins
CC       that associate with the core dimer include three families of
CC       regulatory subunits B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59
CC       and R5/B'/B56 families), the 48 kDa variable regulatory subunit,
CC       viral proteins, and cell signaling molecules. Interacts with IPO9
CC       (By similarity). Interacts with TP53 and SGO1 (By similarity).
CC       Found in a complex with at least ARL2, PPP2CB, PPP2R1A, PPP2R2A,
CC       PPP2R5E and TBCD (By similarity). Interacts with PLA2G16; this
CC       interaction might decrease PP2A activity (By similarity).
CC       Interacts with FOXO1; the interaction dephosphorylates FOXO1 on
CC       AKT-mediated phosphorylation sites (PubMed:22417654). Interacts
CC       with CTTNBP2NL (By similarity). Interacts with GNA12; the
CC       interaction promotes protein phosphatase 2A activation causing
CC       dephosphorylation of MAPT (By similarity).Interacts with CIP2A;
CC       this interaction stabilizes CIP2A (By similarity).
CC       {ECO:0000250|UniProtKB:P30153, ECO:0000250|UniProtKB:Q32PI5,
CC       ECO:0000269|PubMed:22417654}.
CC   -!- INTERACTION:
CC       O56327:- (xeno); NbExp=2; IntAct=EBI-400413, EBI-15646000;
CC       P63330:Ppp2ca; NbExp=3; IntAct=EBI-400413, EBI-397144;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q32PI5}.
CC       Chromosome, centromere {ECO:0000250|UniProtKB:P30153}. Lateral
CC       cell membrane {ECO:0000250|UniProtKB:P30153}. Cell projection,
CC       dendrite {ECO:0000250|UniProtKB:P30153}. Note=Centromeric
CC       localization requires the presence of BUB1.
CC       {ECO:0000250|UniProtKB:P30153}.
CC   -!- DOMAIN: Each HEAT repeat appears to consist of two alpha helices
CC       joined by a hydrophilic region, the intrarepeat loop. The repeat
CC       units may be arranged laterally to form a rod-like structure.
CC   -!- SIMILARITY: Belongs to the phosphatase 2A regulatory subunit A
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB021743; BAA75478.1; -; mRNA.
DR   EMBL; AK054239; BAC35700.1; -; mRNA.
DR   EMBL; AK078135; BAC37143.1; -; mRNA.
DR   EMBL; BC006606; AAH06606.1; -; mRNA.
DR   CCDS; CCDS28432.1; -.
DR   RefSeq; NP_058587.1; NM_016891.3.
DR   UniGene; Mm.294138; -.
DR   PDB; 2IAE; X-ray; 3.50 A; A/D=1-589.
DR   PDB; 2PF4; X-ray; 3.10 A; A/B/C/D=1-589.
DR   PDB; 3FGA; X-ray; 2.70 A; A=2-589.
DR   PDBsum; 2IAE; -.
DR   PDBsum; 2PF4; -.
DR   PDBsum; 3FGA; -.
DR   ProteinModelPortal; Q76MZ3; -.
DR   SMR; Q76MZ3; -.
DR   BioGrid; 206176; 120.
DR   CORUM; Q76MZ3; -.
DR   DIP; DIP-29429N; -.
DR   IntAct; Q76MZ3; 139.
DR   MINT; Q76MZ3; -.
DR   STRING; 10090.ENSMUSP00000007708; -.
DR   BindingDB; Q76MZ3; -.
DR   ChEMBL; CHEMBL3557; -.
DR   iPTMnet; Q76MZ3; -.
DR   PhosphoSitePlus; Q76MZ3; -.
DR   SwissPalm; Q76MZ3; -.
DR   REPRODUCTION-2DPAGE; Q76MZ3; -.
DR   EPD; Q76MZ3; -.
DR   MaxQB; Q76MZ3; -.
DR   PaxDb; Q76MZ3; -.
DR   PeptideAtlas; Q76MZ3; -.
DR   PRIDE; Q76MZ3; -.
DR   Ensembl; ENSMUST00000007708; ENSMUSP00000007708; ENSMUSG00000007564.
DR   GeneID; 51792; -.
DR   KEGG; mmu:51792; -.
DR   UCSC; uc008aqi.1; mouse.
DR   CTD; 5518; -.
DR   MGI; MGI:1926334; Ppp2r1a.
DR   eggNOG; KOG0211; Eukaryota.
DR   eggNOG; ENOG410XQVI; LUCA.
DR   GeneTree; ENSGT00730000110944; -.
DR   HOGENOM; HOG000078539; -.
DR   HOVERGEN; HBG000011; -.
DR   InParanoid; Q76MZ3; -.
DR   KO; K03456; -.
DR   OMA; WAQNTVI; -.
DR   OrthoDB; EOG091G045V; -.
DR   PhylomeDB; Q76MZ3; -.
DR   TreeFam; TF105552; -.
DR   Reactome; R-MMU-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.
DR   Reactome; R-MMU-1295596; Spry regulation of FGF signaling.
DR   Reactome; R-MMU-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-MMU-180024; DARPP-32 events.
DR   Reactome; R-MMU-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-MMU-196299; Beta-catenin phosphorylation cascade.
DR   Reactome; R-MMU-198753; ERK/MAPK targets.
DR   Reactome; R-MMU-202670; ERKs are inactivated.
DR   Reactome; R-MMU-2467813; Separation of Sister Chromatids.
DR   Reactome; R-MMU-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-MMU-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-MMU-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-MMU-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-MMU-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-MMU-389513; CTLA4 inhibitory signaling.
DR   Reactome; R-MMU-4641262; Disassembly of the destruction complex and recruitment of AXIN to the membrane.
DR   Reactome; R-MMU-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-MMU-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-MMU-5673000; RAF activation.
DR   Reactome; R-MMU-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-MMU-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-MMU-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-MMU-68877; Mitotic Prometaphase.
DR   Reactome; R-MMU-69231; Cyclin D associated events in G1.
DR   Reactome; R-MMU-69273; Cyclin A/B1/B2 associated events during G2/M transition.
DR   Reactome; R-MMU-8854518; AURKA Activation by TPX2.
DR   Reactome; R-MMU-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   ChiTaRS; Ppp2r1a; mouse.
DR   EvolutionaryTrace; Q76MZ3; -.
DR   PRO; PR:Q76MZ3; -.
DR   Proteomes; UP000000589; Chromosome 17.
DR   Bgee; ENSMUSG00000007564; -.
DR   ExpressionAtlas; Q76MZ3; baseline and differential.
DR   Genevisible; Q76MZ3; MM.
DR   GO; GO:0000775; C:chromosome, centromeric region; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0016328; C:lateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IDA:MGI.
DR   GO; GO:1990405; F:protein antigen binding; ISO:MGI.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:MGI.
DR   GO; GO:0019888; F:protein phosphatase regulator activity; IEA:InterPro.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IDA:MGI.
DR   GO; GO:0007059; P:chromosome segregation; ISS:UniProtKB.
DR   GO; GO:0007143; P:female meiotic nuclear division; IMP:MGI.
DR   GO; GO:0051754; P:meiotic sister chromatid cohesion, centromeric; IMP:MGI.
DR   GO; GO:0051232; P:meiotic spindle elongation; IMP:MGI.
DR   GO; GO:0051306; P:mitotic sister chromatid separation; IMP:MGI.
DR   GO; GO:0070262; P:peptidyl-serine dephosphorylation; IDA:MGI.
DR   GO; GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:MGI.
DR   GO; GO:0065003; P:protein-containing complex assembly; IEA:InterPro.
DR   GO; GO:1903538; P:regulation of meiotic cell cycle process involved in oocyte maturation; IMP:MGI.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000357; HEAT.
DR   InterPro; IPR021133; HEAT_type_2.
DR   InterPro; IPR031090; PP2A_A_meta.
DR   PANTHER; PTHR10648:SF2; PTHR10648:SF2; 1.
DR   Pfam; PF02985; HEAT; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS50077; HEAT_REPEAT; 11.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell membrane; Cell projection; Centromere;
KW   Chromosome; Chromosome partition; Complete proteome; Cytoplasm;
KW   Membrane; Reference proteome; Repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P30153}.
FT   CHAIN         2    589       Serine/threonine-protein phosphatase 2A
FT                                65 kDa regulatory subunit A alpha
FT                                isoform.
FT                                /FTId=PRO_0000071401.
FT   REPEAT        8     46       HEAT 1.
FT   REPEAT       47     84       HEAT 2.
FT   REPEAT       85    123       HEAT 3.
FT   REPEAT      124    161       HEAT 4.
FT   REPEAT      162    200       HEAT 5.
FT   REPEAT      201    239       HEAT 6.
FT   REPEAT      240    278       HEAT 7.
FT   REPEAT      279    321       HEAT 8.
FT   REPEAT      322    360       HEAT 9.
FT   REPEAT      361    399       HEAT 10.
FT   REPEAT      400    438       HEAT 11.
FT   REPEAT      439    477       HEAT 12.
FT   REPEAT      478    516       HEAT 13.
FT   REPEAT      517    555       HEAT 14.
FT   REPEAT      556    589       HEAT 15.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000250|UniProtKB:P30153}.
FT   MOD_RES     280    280       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:23806337}.
FT   HELIX        11     21       {ECO:0000244|PDB:3FGA}.
FT   HELIX        25     33       {ECO:0000244|PDB:3FGA}.
FT   HELIX        35     41       {ECO:0000244|PDB:3FGA}.
FT   HELIX        44     49       {ECO:0000244|PDB:3FGA}.
FT   HELIX        51     56       {ECO:0000244|PDB:3FGA}.
FT   HELIX        63     73       {ECO:0000244|PDB:3FGA}.
FT   TURN         77     81       {ECO:0000244|PDB:3FGA}.
FT   HELIX        83     85       {ECO:0000244|PDB:2IAE}.
FT   HELIX        86     89       {ECO:0000244|PDB:3FGA}.
FT   HELIX        90     98       {ECO:0000244|PDB:3FGA}.
FT   HELIX       102    116       {ECO:0000244|PDB:3FGA}.
FT   HELIX       121    126       {ECO:0000244|PDB:3FGA}.
FT   HELIX       128    136       {ECO:0000244|PDB:3FGA}.
FT   HELIX       141    147       {ECO:0000244|PDB:3FGA}.
FT   TURN        148    150       {ECO:0000244|PDB:3FGA}.
FT   HELIX       151    154       {ECO:0000244|PDB:3FGA}.
FT   HELIX       155    157       {ECO:0000244|PDB:3FGA}.
FT   HELIX       160    174       {ECO:0000244|PDB:3FGA}.
FT   HELIX       179    187       {ECO:0000244|PDB:3FGA}.
FT   HELIX       189    193       {ECO:0000244|PDB:3FGA}.
FT   HELIX       198    213       {ECO:0000244|PDB:3FGA}.
FT   HELIX       218    232       {ECO:0000244|PDB:3FGA}.
FT   HELIX       237    242       {ECO:0000244|PDB:3FGA}.
FT   HELIX       244    251       {ECO:0000244|PDB:3FGA}.
FT   HELIX       257    265       {ECO:0000244|PDB:3FGA}.
FT   HELIX       267    274       {ECO:0000244|PDB:3FGA}.
FT   HELIX       276    291       {ECO:0000244|PDB:3FGA}.
FT   HELIX       296    303       {ECO:0000244|PDB:3FGA}.
FT   HELIX       306    311       {ECO:0000244|PDB:3FGA}.
FT   TURN        315    317       {ECO:0000244|PDB:3FGA}.
FT   HELIX       318    324       {ECO:0000244|PDB:3FGA}.
FT   HELIX       327    334       {ECO:0000244|PDB:3FGA}.
FT   HELIX       339    346       {ECO:0000244|PDB:3FGA}.
FT   HELIX       349    352       {ECO:0000244|PDB:3FGA}.
FT   HELIX       353    373       {ECO:0000244|PDB:3FGA}.
FT   HELIX       378    385       {ECO:0000244|PDB:3FGA}.
FT   HELIX       386    388       {ECO:0000244|PDB:2IAE}.
FT   HELIX       389    394       {ECO:0000244|PDB:3FGA}.
FT   HELIX       397    403       {ECO:0000244|PDB:3FGA}.
FT   HELIX       405    411       {ECO:0000244|PDB:3FGA}.
FT   HELIX       417    424       {ECO:0000244|PDB:3FGA}.
FT   HELIX       427    434       {ECO:0000244|PDB:3FGA}.
FT   HELIX       436    442       {ECO:0000244|PDB:3FGA}.
FT   HELIX       444    451       {ECO:0000244|PDB:3FGA}.
FT   HELIX       456    473       {ECO:0000244|PDB:3FGA}.
FT   HELIX       475    481       {ECO:0000244|PDB:3FGA}.
FT   HELIX       483    488       {ECO:0000244|PDB:3FGA}.
FT   HELIX       489    491       {ECO:0000244|PDB:3FGA}.
FT   HELIX       495    520       {ECO:0000244|PDB:3FGA}.
FT   HELIX       522    528       {ECO:0000244|PDB:3FGA}.
FT   HELIX       534    547       {ECO:0000244|PDB:3FGA}.
FT   HELIX       548    550       {ECO:0000244|PDB:3FGA}.
FT   HELIX       553    558       {ECO:0000244|PDB:3FGA}.
FT   HELIX       560    568       {ECO:0000244|PDB:3FGA}.
FT   STRAND      569    571       {ECO:0000244|PDB:2IAE}.
FT   HELIX       573    585       {ECO:0000244|PDB:3FGA}.
SQ   SEQUENCE   589 AA;  65323 MW;  5175409E4D50A366 CRC64;
     MAAADGDDSL YPIAVLIDEL RNEDVQLRLN SIKKLSTIAL ALGVERTRSE LLPFLTDTIY
     DEDEVLLALA EQLGTFTTLV GGPEYVHCLL PPLESLATVE ETVVRDKAVE SLRAISHEHS
     PSDLEAHFVP LVKRLAGGDW FTSRTSACGL FSVCYPRVSS AVKAELRQYF RNLCSDDTPM
     VRRAAASKLG EFAKVLELDN VKSEIIPMFS NLASDEQDSV RLLAVEACVN IAQLLPQEDL
     EALVMPTLRQ AAEDKSWRVR YMVADKFTEL QKAVGPEITK TDLVPAFQNL MKDCEAEVRA
     AASHKVKEFC ENLSADCREN VIMTQILPCI KELVSDANQH VKSALASVIM GLSPILGKDN
     TIEHLLPLFL AQLKDECPEV RLNIISNLDC VNEVIGIRQL SQSLLPAIVE LAEDAKWRVR
     LAIIEYMPLL AGQLGVEFFD EKLNSLCMAW LVDHVYAIRE AATSNLKKLV EKFGKEWAHA
     TIIPKVLAMS GDPNYLHRMT TLFCINVLSE VCGQDITTKH MLPTVLRMAG DPVANVRFNV
     AKSLQKIGPI LDNSTLQSEV KPILEKLTQD QDVDVKYFAQ EALTVLSLA
//
ID   GET4_MOUSE              Reviewed;         327 AA.
AC   Q9D1H7; Q78J86;
DT   21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 2.
DT   28-FEB-2018, entry version 120.
DE   RecName: Full=Golgi to ER traffic protein 4 homolog;
GN   Name=Get4;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Embryo;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=FVB/N; TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Heart, Kidney, Liver, Lung, Pancreas, Spleen, and
RC   Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: As part of a cytosolic protein quality control complex,
CC       the BAG6/BAT3 complex, maintains misfolded and hydrophobic
CC       patches-containing proteins in a soluble state and participates to
CC       their proper delivery to the endoplasmic reticulum or
CC       alternatively can promote their sorting to the proteasome where
CC       they undergo degradation. The BAG6/BAT3 complex is involved in the
CC       post-translational delivery of tail-anchored/type II transmembrane
CC       proteins to the endoplasmic reticulum membrane. Recruited to
CC       ribosomes, it interacts with the transmembrane region of newly
CC       synthesized tail-anchored proteins and together with SGTA and
CC       ASNA1 mediates their delivery to the endoplasmic reticulum. Client
CC       proteins that cannot be properly delivered to the endoplasmic
CC       reticulum are ubiquitinated and sorted to the proteasome.
CC       Similarly, the BAG6/BAT3 complex also functions as a sorting
CC       platform for proteins of the secretory pathway that are
CC       mislocalized to the cytosol either delivering them to the
CC       proteasome for degradation or to the endoplasmic reticulum. The
CC       BAG6/BAT3 complex also plays a role in the endoplasmic reticulum-
CC       associated degradation (ERAD), a quality control mechanism that
CC       eliminates unwanted proteins of the endoplasmic reticulum through
CC       their retrotranslocation to the cytosol and their targeting to the
CC       proteasome. It maintains these retrotranslocated proteins in an
CC       unfolded yet soluble state condition in the cytosol to ensure
CC       their proper delivery to the proteasome.
CC       {ECO:0000250|UniProtKB:Q7L5D6}.
CC   -!- SUBUNIT: Component of the BAG6/BAT3 complex, at least composed of
CC       BAG6, UBL4A and GET4/TRC35. Interacts with BAG6; the interaction
CC       is direct and localizes BAG6 in the cytosol.
CC       {ECO:0000250|UniProtKB:Q7L5D6}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q7L5D6}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9D1H7-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=2;
CC         IsoId=Q9D1H7-2; Sequence=VSP_017653;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the GET4 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK003551; BAB22851.2; -; mRNA.
DR   EMBL; BC019557; AAH19557.1; -; mRNA.
DR   CCDS; CCDS19805.1; -. [Q9D1H7-1]
DR   CCDS; CCDS51682.1; -. [Q9D1H7-2]
DR   RefSeq; NP_001156788.1; NM_001163316.1. [Q9D1H7-2]
DR   RefSeq; NP_080545.2; NM_026269.2. [Q9D1H7-1]
DR   UniGene; Mm.270137; -.
DR   ProteinModelPortal; Q9D1H7; -.
DR   SMR; Q9D1H7; -.
DR   BioGrid; 212305; 24.
DR   IntAct; Q9D1H7; 23.
DR   STRING; 10090.ENSMUSP00000026976; -.
DR   iPTMnet; Q9D1H7; -.
DR   PhosphoSitePlus; Q9D1H7; -.
DR   EPD; Q9D1H7; -.
DR   PaxDb; Q9D1H7; -.
DR   PeptideAtlas; Q9D1H7; -.
DR   PRIDE; Q9D1H7; -.
DR   Ensembl; ENSMUST00000026976; ENSMUSP00000026976; ENSMUSG00000025858. [Q9D1H7-1]
DR   Ensembl; ENSMUST00000110878; ENSMUSP00000106502; ENSMUSG00000025858. [Q9D1H7-2]
DR   GeneID; 67604; -.
DR   KEGG; mmu:67604; -.
DR   UCSC; uc009agg.2; mouse. [Q9D1H7-1]
DR   CTD; 51608; -.
DR   MGI; MGI:1914854; Get4.
DR   eggNOG; KOG3024; Eukaryota.
DR   eggNOG; ENOG410XRWE; LUCA.
DR   GeneTree; ENSGT00390000015750; -.
DR   HOGENOM; HOG000264232; -.
DR   HOVERGEN; HBG059877; -.
DR   InParanoid; Q9D1H7; -.
DR   OMA; QMYRTLF; -.
DR   OrthoDB; EOG091G0DTD; -.
DR   PhylomeDB; Q9D1H7; -.
DR   TreeFam; TF315163; -.
DR   ChiTaRS; Get4; mouse.
DR   PRO; PR:Q9D1H7; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   Bgee; ENSMUSG00000025858; -.
DR   CleanEx; MM_1110007L15RIK; -.
DR   ExpressionAtlas; Q9D1H7; baseline and differential.
DR   Genevisible; Q9D1H7; MM.
DR   GO; GO:0071818; C:BAT3 complex; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0051087; F:chaperone binding; ISO:MGI.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; ISO:MGI.
DR   GO; GO:1904378; P:maintenance of unfolded protein involved in ERAD pathway; ISO:MGI.
DR   GO; GO:0045048; P:protein insertion into ER membrane; IBA:GO_Central.
DR   GO; GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; ISS:UniProtKB.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR007317; UPF0363.
DR   PANTHER; PTHR12875; PTHR12875; 1.
DR   Pfam; PF04190; DUF410; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Cytoplasm;
KW   Reference proteome; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:Q7L5D6}.
FT   CHAIN         2    327       Golgi to ER traffic protein 4 homolog.
FT                                /FTId=PRO_0000228105.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000250|UniProtKB:Q7L5D6}.
FT   VAR_SEQ       1     53       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_017653.
SQ   SEQUENCE   327 AA;  36525 MW;  04B8DCC8E75FB022 CRC64;
     MAAAAAMAEQ EGARNGARNR GGVQRVEGKL RASVEKGDYY EAHQMYRTLF FRYMSQSKHA
     EARELMYSGA LLFFSHGQQN SAADLSMLVL ESLEKAEVDV ADELLENLAK VFSLMDPNSP
     ERVAFVSRAL KWSSGGSGKL GHPRLHQLLA LTLWKEQNYC ESRYHFLHSS DGEGCANMLV
     EYSTARGFRS EVDMFVAQAV LQFLCLKNKN SALVVFTTYT QKHPSIEDGP PFVQPLLNFI
     WFLLLAVDGG KLAVFTVLCE QYQPSLRRDP MYNEYLDRIG QLFFGVPPKQ TSSYGGLLGN
     LLSSLMGSSE QEEGEESQDD SSPIELD
//
ID   B3KUV5_HUMAN            Unreviewed;       315 AA.
AC   B3KUV5;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 47.
DE   SubName: Full=cDNA FLJ40710 fis, clone THYMU2027125, highly similar to Ubiquitin thioesterase protein OTUB1 (EC 3.4.-.-) {ECO:0000313|EMBL:BAG53567.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG53567.1};
RN   [1] {ECO:0000313|EMBL:BAG53567.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thymus {ECO:0000313|EMBL:BAG53567.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK098029; BAG53567.1; -; mRNA.
DR   RefSeq; NP_060140.2; NM_017670.2.
DR   UniGene; Hs.473788; -.
DR   PeptideAtlas; B3KUV5; -.
DR   PRIDE; B3KUV5; -.
DR   DNASU; 55611; -.
DR   GeneID; 55611; -.
DR   KEGG; hsa:55611; -.
DR   CTD; 55611; -.
DR   PharmGKB; PA134988141; -.
DR   eggNOG; KOG3991; Eukaryota.
DR   eggNOG; ENOG410ZMN7; LUCA.
DR   HOGENOM; HOG000171237; -.
DR   HOVERGEN; HBG103908; -.
DR   KO; K09602; -.
DR   GenomeRNAi; 55611; -.
DR   Genevisible; B3KUV5; HS.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IEA:InterPro.
DR   GO; GO:0016579; P:protein deubiquitination; IEA:InterPro.
DR   InterPro; IPR003323; OTU_dom.
DR   InterPro; IPR030298; OTUB1.
DR   InterPro; IPR019400; Peptidase_C65_otubain.
DR   PANTHER; PTHR12931; PTHR12931; 1.
DR   PANTHER; PTHR12931:SF19; PTHR12931:SF19; 1.
DR   Pfam; PF10275; Peptidase_C65; 1.
DR   PROSITE; PS50802; OTU; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN      203    315       OTU. {ECO:0000259|PROSITE:PS50802}.
SQ   SEQUENCE   315 AA;  35313 MW;  1967EB8F1B28868E CRC64;
     MMKPSWLSRT EFSKRLLCRT LWCQSGWSSR SYTRSMLKMT TSINRRSRTS TKSTRTSARP
     GLTATVSIGL SDSPTWRHCW MTARSCSGEK GGHWAPRQVG VYLLPGRVGC VSSRVSPSFP
     GDGLDSGLAR RGSAVSALAS GLVEEPMLGP PFHPTPRFKA VSAKSKEDLV SQGFTEFTIE
     DFHNTFMDLI EQVEKQTSVA DLLASFNDQS TSDYLVVYLR LLTSGYLQRE SKFFEHFIEG
     GRTVKEFCQQ EVEPMCKESD HIHIIALAQV LSVSIQVEYM DRGEGGTTNP HIFPEGSEPK
     VYLLYRPGHY DILYK
//
ID   OTUB1_HUMAN             Reviewed;         271 AA.
AC   Q96FW1; Q32Q78; Q96II3; Q9NXQ4; Q9P0B8;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   23-MAY-2018, entry version 159.
DE   RecName: Full=Ubiquitin thioesterase OTUB1;
DE            EC=3.4.19.12 {ECO:0000269|PubMed:23827681};
DE   AltName: Full=Deubiquitinating enzyme OTUB1;
DE   AltName: Full=OTU domain-containing ubiquitin aldehyde-binding protein 1;
DE   AltName: Full=Otubain-1;
DE            Short=hOTU1;
DE   AltName: Full=Ubiquitin-specific-processing protease OTUB1;
GN   Name=OTUB1; Synonyms=OTB1, OTU1; ORFNames=HSPC263;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION BY MASS
RP   SPECTROMETRY, FUNCTION, TISSUE SPECIFICITY, AND MUTAGENESIS OF ASP-88;
RP   CYS-91 AND HIS-265.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12704427; DOI=10.1038/sj.embor.embor824;
RA   Balakirev M.Y., Tcherniuk S.O., Jaquinod M., Chroboczek J.;
RT   "Otubains: a new family of cysteine proteases in the ubiquitin
RT   pathway.";
RL   EMBO Rep. 4:517-522(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), ALTERNATIVE SPLICING,
RP   FUNCTION, TISSUE SPECIFICITY, INTERACTION WITH RNF128 AND USP8, AND
RP   MUTAGENESIS OF CYS-91; ARG-176 AND CYS-212.
RX   PubMed=14661020; DOI=10.1038/ni1017;
RA   Soares L., Seroogy C., Skrenta H., Anandasabapathy N., Lovelace P.,
RA   Chung C.D., Engleman E., Fathman C.G.;
RT   "Two isoforms of otubain 1 regulate T cell anergy via GRAIL.";
RL   Nat. Immunol. 5:45-54(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PARTIAL PROTEIN SEQUENCE, AND FUNCTION.
RX   PubMed=12401499; DOI=10.1016/S1074-5521(02)00248-X;
RA   Borodovsky A., Ovaa H., Kolli N., Gan-Erdene T., Wilkinson K.D.,
RA   Ploegh H.L., Kessler B.M.;
RT   "Chemistry-based functional proteomics reveals novel members of the
RT   deubiquitinating enzyme family.";
RL   Chem. Biol. 9:1149-1159(2002).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   FUNCTION, INTERACTION WITH ESR1, AND MUTAGENESIS OF CYS-91.
RX   PubMed=19383985; DOI=10.1074/jbc.M109.007484;
RA   Stanisic V., Malovannaya A., Qin J., Lonard D.M., O'Malley B.W.;
RT   "OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1)
RT   deubiquitinates estrogen receptor (ER) alpha and affects ERalpha
RT   transcriptional activity.";
RL   J. Biol. Chem. 284:16135-16145(2009).
RN   [11]
RP   FUNCTION, UBIQUITIN-BINDING, DOMAIN, AND MUTAGENESIS OF CYS-23; CYS-91
RP   AND CYS-212.
RX   PubMed=19211026; DOI=10.1016/j.jmb.2008.12.085;
RA   Wang T., Yin L., Cooper E.M., Lai M.-Y., Dickey S., Pickart C.M.,
RA   Fushman D., Wilkinson K.D., Cohen R.E., Wolberger C.;
RT   "Evidence for bidentate substrate binding as the basis for the K48
RT   linkage specificity of otubain 1.";
RL   J. Mol. Biol. 386:1011-1023(2009).
RN   [12]
RP   FUNCTION IN INHIBITION OF RNF168, INTERACTION WITH UBE2N/UBC13, AND
RP   MUTAGENESIS OF ASP-88; CYS-91 AND HIS-265.
RX   PubMed=20725033; DOI=10.1038/nature09297;
RA   Nakada S., Tai I., Panier S., Al-Hakim A., Iemura S., Juang Y.C.,
RA   O'Donnell L., Kumakubo A., Munro M., Sicheri F., Gingras A.C.,
RA   Natsume T., Suda T., Durocher D.;
RT   "Non-canonical inhibition of DNA damage-dependent ubiquitination by
RT   OTUB1.";
RL   Nature 466:941-946(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=23827681; DOI=10.1016/j.cell.2013.05.046;
RA   Mevissen T.E., Hospenthal M.K., Geurink P.P., Elliott P.R., Akutsu M.,
RA   Arnaudo N., Ekkebus R., Kulathu Y., Wauer T., El Oualid F.,
RA   Freund S.M., Ovaa H., Komander D.;
RT   "OTU deubiquitinases reveal mechanisms of linkage specificity and
RT   enable ubiquitin chain restriction analysis.";
RL   Cell 154:169-184(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.69 ANGSTROMS) OF 40-271, FUNCTION,
RP   INTERACTION WITH FUS AND RACK1, MUTAGENESIS OF PRO-87 AND CYS-91, AND
RP   ACTIVE SITE.
RX   PubMed=18954305; DOI=10.1042/BJ20081318;
RA   Edelmann M.J., Iphoefer A., Akutsu M., Altun M., di Gleria K.,
RA   Kramer H.B., Fiebiger E., Dhe-Paganon S., Kessler B.M.;
RT   "Structural basis and specificity of human otubain 1-mediated
RT   deubiquitination.";
RL   Biochem. J. 418:379-390(2009).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 25-271 IN COMPLEX WITH UBE2V2
RP   AND UBE2N, FREE UBIQUITIN-BINDING, ENZYME REGULATION, AND MUTAGENESIS
RP   OF GLN-33; ILE-37; GLN-39; CYS-91; ALA-116; THR-134; ASP-137; PHE-190;
RP   TYR-261 AND PRO-263.
RX   PubMed=22325355; DOI=10.1016/j.molcel.2012.01.011;
RA   Juang Y.C., Landry M.C., Sanches M., Vittal V., Leung C.C.,
RA   Ceccarelli D.F., Mateo A.R., Pruneda J.N., Mao D.Y., Szilard R.K.,
RA   Orlicky S., Munro M., Brzovic P.S., Klevit R.E., Sicheri F.,
RA   Durocher D.;
RT   "OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2
RT   enzyme function.";
RL   Mol. Cell 45:384-397(2012).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (3.11 ANGSTROMS) OF 1-45 IN COMPLEX WITH UBE2N
RP   AND UBIQUITIN, ENZYME REGULATION, AND FREE UBIQUITIN-BINDING.
RX   PubMed=22367539; DOI=10.1038/nature10911;
RA   Wiener R., Zhang X., Wang T., Wolberger C.;
RT   "The mechanism of OTUB1-mediated inhibition of ubiquitination.";
RL   Nature 483:618-622(2012).
CC   -!- FUNCTION: Hydrolase that can specifically remove 'Lys-48'-linked
CC       conjugated ubiquitin from proteins and plays an important
CC       regulatory role at the level of protein turnover by preventing
CC       degradation. Regulator of T-cell anergy, a phenomenon that occurs
CC       when T-cells are rendered unresponsive to antigen rechallenge and
CC       no longer respond to their cognate antigen. Acts via its
CC       interaction with RNF128/GRAIL, a crucial inductor of CD4 T-cell
CC       anergy. Isoform 1 destabilizes RNF128, leading to prevent anergy.
CC       In contrast, isoform 2 stabilizes RNF128 and promotes anergy.
CC       Surprisingly, it regulates RNF128-mediated ubiquitination, but
CC       does not deubiquitinate polyubiquitinated RNF128. Deubiquitinates
CC       estrogen receptor alpha (ESR1). Mediates deubiquitination of 'Lys-
CC       48'-linked polyubiquitin chains, but not 'Lys-63'-linked
CC       polyubiquitin chains. Not able to cleave di-ubiquitin. Also
CC       capable of removing NEDD8 from NEDD8 conjugates, but with a much
CC       lower preference compared to 'Lys-48'-linked ubiquitin.
CC   -!- FUNCTION: Plays a key non-catalytic role in DNA repair regulation
CC       by inhibiting activity of RNF168, an E3 ubiquitin-protein ligase
CC       that promotes accumulation of 'Lys-63'-linked histone H2A and H2AX
CC       at DNA damage sites. Inhibits RNF168 independently of ubiquitin
CC       thioesterase activity by binding and inhibiting UBE2N/UBC13, the
CC       E2 partner of RNF168, thereby limiting spreading of 'Lys-63'-
CC       linked histone H2A and H2AX marks. Inhibition occurs by binding to
CC       free ubiquitin: free ubiquitin acts as an allosteric regulator
CC       that increases affinity for UBE2N/UBC13 and disrupts interaction
CC       with UBE2V1. The OTUB1-UBE2N/UBC13-free ubiquitin complex adopts a
CC       configuration that mimics a cleaved 'Lys48'-linked di-ubiquitin
CC       chain.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:23827681}.
CC   -!- ENZYME REGULATION: By free ubiquitin: binding of free ubiquitin
CC       triggers conformational changes in the OTU domain and formation of
CC       a ubiquitin-binding helix in the N-terminus, promoting binding of
CC       the conjugated donor ubiquitin in UBE2N/UBC13 to OTUB1.
CC       {ECO:0000269|PubMed:22325355, ECO:0000269|PubMed:22367539}.
CC   -!- SUBUNIT: Isoform 1 and isoform 2 interact with RNF128. Isoform 1
CC       forms a ternary complex with RNF128 and USP8. Isoform 1 interacts
CC       with the C-terminal UCH catalytic domain of USP8. Isoform 2 does
CC       not associate with USP8. Interacts with FUS, ESR1 and RACK1.
CC       Interacts with UBE2N/UBC13. {ECO:0000269|PubMed:14661020,
CC       ECO:0000269|PubMed:18954305, ECO:0000269|PubMed:19383985,
CC       ECO:0000269|PubMed:20725033, ECO:0000269|PubMed:22325355,
CC       ECO:0000269|PubMed:22367539}.
CC   -!- INTERACTION:
CC       Q13490:BIRC2; NbExp=3; IntAct=EBI-1058491, EBI-514538;
CC       Q9NWT6:HIF1AN; NbExp=4; IntAct=EBI-1058491, EBI-745632;
CC       Q00987:MDM2; NbExp=5; IntAct=EBI-1058491, EBI-389668;
CC       P04637:TP53; NbExp=8; IntAct=EBI-1058491, EBI-366083;
CC       P51668:UBE2D1; NbExp=10; IntAct=EBI-1058491, EBI-743540;
CC       P62837:UBE2D2; NbExp=11; IntAct=EBI-1058491, EBI-347677;
CC       P61077:UBE2D3; NbExp=13; IntAct=EBI-1058491, EBI-348268;
CC       Q9Y2X8:UBE2D4; NbExp=5; IntAct=EBI-1058491, EBI-745527;
CC       P51965:UBE2E1; NbExp=3; IntAct=EBI-1058491, EBI-348546;
CC       Q96LR5:UBE2E2; NbExp=4; IntAct=EBI-1058491, EBI-2129763;
CC       Q969T4:UBE2E3; NbExp=4; IntAct=EBI-1058491, EBI-348496;
CC       P61088:UBE2N; NbExp=5; IntAct=EBI-15972141, EBI-1052908;
CC       Q56921:ypkA (xeno); NbExp=5; IntAct=EBI-1058491, EBI-8022937;
CC       Q9RI12:ypkA (xeno); NbExp=3; IntAct=EBI-1058491, EBI-2849107;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Otubain-1;
CC         IsoId=Q96FW1-1; Sequence=Displayed;
CC       Name=2; Synonyms=ARF-1;
CC         IsoId=Q96FW1-2; Sequence=VSP_009464;
CC         Note=Lacks the catalytic sites for protease activity.;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is ubiquitous. Isoform 2 is
CC       expressed only in lymphoid tissues such as tonsils, lymph nodes
CC       and spleen, as well as peripheral blood mononuclear cells.
CC       {ECO:0000269|PubMed:12704427, ECO:0000269|PubMed:14661020}.
CC   -!- DOMAIN: In addition to ubiquitin-binding at the Cys-91 active
CC       site, a proximal ubiquitin-binding site is also present at Cys-23
CC       Occupancy of the active site is needed to enable tight binding to
CC       the second site. Distinct binding sites for the ubiquitins may
CC       allow to discriminate among different isopeptide linkages (i.e.
CC       'Lys-48'-, 'Lys-63'-linked polyubiquitin) in polyubiquitin
CC       substrates and achieve linkage-specific deubiquitination.
CC       {ECO:0000269|PubMed:19211026}.
CC   -!- MISCELLANEOUS: In the structure described by PubMed:18954305, the
CC       His-265 active site of the catalytic triad is located too far to
CC       interact directly with the active site Cys-91. A possible
CC       explanation is that OTUB1 is in inactive conformation in absence
CC       of ubiquitin and a conformation change may move His-265 in the
CC       proximity of Cys-91 in presence of ubiquitin substrate.
CC   -!- SIMILARITY: Belongs to the peptidase C65 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF28941.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY177200; AAO27702.1; -; mRNA.
DR   EMBL; AF161381; AAF28941.1; ALT_INIT; mRNA.
DR   EMBL; AK000120; BAA90956.1; -; mRNA.
DR   EMBL; AP000721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007519; AAH07519.1; -; mRNA.
DR   EMBL; BC010368; AAH10368.1; -; mRNA.
DR   EMBL; BC107701; AAI07702.1; -; mRNA.
DR   CCDS; CCDS8055.1; -. [Q96FW1-1]
DR   RefSeq; NP_060140.2; NM_017670.2. [Q96FW1-1]
DR   UniGene; Hs.473788; -.
DR   PDB; 2ZFY; X-ray; 1.69 A; A=40-271.
DR   PDB; 3VON; X-ray; 3.15 A; A/H/O/V/c/j=45-271.
DR   PDB; 4DDG; X-ray; 3.30 A; A/B/C/J/K/L=25-271.
DR   PDB; 4DDI; X-ray; 3.80 A; A/B/C=25-271.
DR   PDB; 4DHZ; X-ray; 3.11 A; A=1-45.
DR   PDB; 4I6L; X-ray; 2.49 A; A=45-271.
DR   PDB; 4LDT; X-ray; 1.90 A; A=1-45.
DR   PDBsum; 2ZFY; -.
DR   PDBsum; 3VON; -.
DR   PDBsum; 4DDG; -.
DR   PDBsum; 4DDI; -.
DR   PDBsum; 4DHZ; -.
DR   PDBsum; 4I6L; -.
DR   PDBsum; 4LDT; -.
DR   ProteinModelPortal; Q96FW1; -.
DR   SMR; Q96FW1; -.
DR   BioGrid; 120751; 213.
DR   DIP; DIP-41158N; -.
DR   IntAct; Q96FW1; 330.
DR   MINT; Q96FW1; -.
DR   STRING; 9606.ENSP00000402551; -.
DR   MEROPS; C65.001; -.
DR   iPTMnet; Q96FW1; -.
DR   PhosphoSitePlus; Q96FW1; -.
DR   SwissPalm; Q96FW1; -.
DR   BioMuta; OTUB1; -.
DR   DMDM; 44888286; -.
DR   EPD; Q96FW1; -.
DR   MaxQB; Q96FW1; -.
DR   PaxDb; Q96FW1; -.
DR   PeptideAtlas; Q96FW1; -.
DR   PRIDE; Q96FW1; -.
DR   DNASU; 55611; -.
DR   Ensembl; ENST00000428192; ENSP00000402551; ENSG00000167770. [Q96FW1-1]
DR   Ensembl; ENST00000538426; ENSP00000444357; ENSG00000167770. [Q96FW1-1]
DR   GeneID; 55611; -.
DR   KEGG; hsa:55611; -.
DR   UCSC; uc001nyf.2; human. [Q96FW1-1]
DR   CTD; 55611; -.
DR   DisGeNET; 55611; -.
DR   EuPathDB; HostDB:ENSG00000167770.11; -.
DR   GeneCards; OTUB1; -.
DR   HGNC; HGNC:23077; OTUB1.
DR   HPA; CAB072836; -.
DR   HPA; HPA039176; -.
DR   MIM; 608337; gene.
DR   neXtProt; NX_Q96FW1; -.
DR   OpenTargets; ENSG00000167770; -.
DR   PharmGKB; PA134988141; -.
DR   eggNOG; KOG3991; Eukaryota.
DR   eggNOG; ENOG410ZMN7; LUCA.
DR   GeneTree; ENSGT00390000006979; -.
DR   HOVERGEN; HBG053383; -.
DR   InParanoid; Q96FW1; -.
DR   KO; K09602; -.
DR   PhylomeDB; Q96FW1; -.
DR   TreeFam; TF314145; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689896; Ovarian tumor domain proteases.
DR   SIGNOR; Q96FW1; -.
DR   ChiTaRS; OTUB1; human.
DR   EvolutionaryTrace; Q96FW1; -.
DR   GeneWiki; OTUB1; -.
DR   GenomeRNAi; 55611; -.
DR   PRO; PR:Q96FW1; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000167770; -.
DR   CleanEx; HS_OTUB1; -.
DR   ExpressionAtlas; Q96FW1; baseline and differential.
DR   Genevisible; Q96FW1; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0019784; F:NEDD8-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:2000780; P:negative regulation of double-strand break repair; IMP:UniProtKB.
DR   GO; GO:1901315; P:negative regulation of histone H2A K63-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB.
DR   InterPro; IPR003323; OTU_dom.
DR   InterPro; IPR030298; OTUB1.
DR   InterPro; IPR016615; Otubain.
DR   InterPro; IPR019400; Peptidase_C65_otubain.
DR   PANTHER; PTHR12931; PTHR12931; 1.
DR   PANTHER; PTHR12931:SF19; PTHR12931:SF19; 1.
DR   Pfam; PF10275; Peptidase_C65; 1.
DR   PIRSF; PIRSF013503; Ubiquitin_thioesterase_Otubain; 1.
DR   PROSITE; PS50802; OTU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Adaptive immunity; Alternative splicing;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; DNA damage;
KW   DNA repair; Hydrolase; Immunity; Phosphoprotein; Protease;
KW   Reference proteome; Thiol protease; Ubl conjugation pathway.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    271       Ubiquitin thioesterase OTUB1.
FT                                /FTId=PRO_0000221008.
FT   DOMAIN       80    271       OTU. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00139}.
FT   REGION      130    138       Ubiquitin-conjugating enzyme E2 binding.
FT                                {ECO:0000269|PubMed:22325355}.
FT   REGION      169    177       Ubiquitin-conjugating enzyme E2 binding.
FT                                {ECO:0000269|PubMed:22325355}.
FT   REGION      189    195       Free ubiquitin binding.
FT                                {ECO:0000244|PDB:4DHZ,
FT                                ECO:0000269|PubMed:22325355,
FT                                ECO:0000269|PubMed:22367539}.
FT   REGION      206    213       Ubiquitin-conjugating enzyme E2 binding.
FT                                {ECO:0000244|PDB:4DHZ,
FT                                ECO:0000269|PubMed:22325355,
FT                                ECO:0000269|PubMed:22367539}.
FT   REGION      214    221       Free ubiquitin binding.
FT                                {ECO:0000244|PDB:4DHZ,
FT                                ECO:0000269|PubMed:22325355,
FT                                ECO:0000269|PubMed:22367539}.
FT   REGION      245    251       Free ubiquitin binding.
FT                                {ECO:0000244|PDB:4DHZ,
FT                                ECO:0000269|PubMed:22325355,
FT                                ECO:0000269|PubMed:22367539}.
FT   ACT_SITE     88     88       {ECO:0000244|PDB:4DHZ,
FT                                ECO:0000269|PubMed:22367539}.
FT   ACT_SITE     91     91       Nucleophile.
FT                                {ECO:0000269|PubMed:22325355,
FT                                ECO:0000305|PubMed:18954305}.
FT   ACT_SITE    265    265       {ECO:0000269|PubMed:22325355,
FT                                ECO:0000305|PubMed:18954305}.
FT   BINDING     221    221       Free ubiquitin.
FT                                {ECO:0000269|PubMed:22325355}.
FT   BINDING     235    235       Free ubiquitin.
FT                                {ECO:0000269|PubMed:22325355}.
FT   BINDING     237    237       Free ubiquitin.
FT                                {ECO:0000269|PubMed:22325355}.
FT   BINDING     261    261       Free ubiquitin.
FT                                {ECO:0000269|PubMed:22325355}.
FT   BINDING     266    266       Free ubiquitin. {ECO:0000244|PDB:4DHZ,
FT                                ECO:0000269|PubMed:22325355,
FT                                ECO:0000269|PubMed:22367539}.
FT   SITE         23     23       Required for proximal ubiquitin-binding.
FT                                {ECO:0000269|PubMed:19211026}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      16     16       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ       1    112       MAAEEPQQQKQEPLGSDSEGVNCLAYDEAIMAQQDRIQQEI
FT                                AVQNPLVSERLELSVLYKEYAEDDNIYQQKIKDLHKKYSYI
FT                                RKTRPDGNCFYRAFGFSHLEALLDDSKELQ -> MMKPSWL
FT                                SRTEFSKRLLCRTLWCQSGWSSRSYTRSMLKMTTSINRRSR
FT                                TSTKSTRTSARPGLTATVSIGLSDSPTWRHCWMTARSCSGE
FT                                KGGHWAPRQVGVYLLPGRVGCVSSRVSPSFPGDGLDSGLAR
FT                                RGSAVSALASGLVEEPMLGPPFHPTP (in isoform
FT                                2). {ECO:0000303|PubMed:14661020}.
FT                                /FTId=VSP_009464.
FT   MUTAGEN      23     23       C->A: Abolishes only ubiquitin-
FT                                vinylsulfone adduct formation.
FT                                {ECO:0000269|PubMed:19211026}.
FT   MUTAGEN      33     33       Q->R: Impairs inhibition of UBE2N/UBC13.
FT                                {ECO:0000269|PubMed:22325355}.
FT   MUTAGEN      37     37       I->T: Impairs inhibition of UBE2N/UBC13.
FT                                {ECO:0000269|PubMed:22325355}.
FT   MUTAGEN      39     39       Q->L: Does not affect activity in DNA
FT                                repair and ability to inhibit
FT                                UBE2N/UBC13.
FT                                {ECO:0000269|PubMed:22325355}.
FT   MUTAGEN      87     87       P->G: Slightly improves ability to cleave
FT                                'K63'-linked ubiquitin.
FT                                {ECO:0000269|PubMed:18954305}.
FT   MUTAGEN      88     88       D->E: Abolishes hydrolase activity in
FT                                vitro. Abolishes ability to inhibit
FT                                RNF168; when associated with S-91 and A-
FT                                265. {ECO:0000269|PubMed:12704427,
FT                                ECO:0000269|PubMed:20725033}.
FT   MUTAGEN      91     91       C->A: Prevents RNF128 autoubiquitination,
FT                                and stabilizes RNF128 in vivo. Abolishes
FT                                both ubiquitin-binding and adduct
FT                                formation with ubiquitin-vinylsulfone.
FT                                {ECO:0000269|PubMed:12704427,
FT                                ECO:0000269|PubMed:14661020,
FT                                ECO:0000269|PubMed:18954305,
FT                                ECO:0000269|PubMed:19211026,
FT                                ECO:0000269|PubMed:19383985,
FT                                ECO:0000269|PubMed:20725033,
FT                                ECO:0000269|PubMed:22325355}.
FT   MUTAGEN      91     91       C->S: Abolishes hydrolase activity in
FT                                vitro. Does not affect ability to inhibit
FT                                RNF168. Abolishes ability to inhibit
FT                                RNF168; when associated with A-88 and A-
FT                                265. {ECO:0000269|PubMed:12704427,
FT                                ECO:0000269|PubMed:14661020,
FT                                ECO:0000269|PubMed:18954305,
FT                                ECO:0000269|PubMed:19211026,
FT                                ECO:0000269|PubMed:19383985,
FT                                ECO:0000269|PubMed:20725033,
FT                                ECO:0000269|PubMed:22325355}.
FT   MUTAGEN     116    116       A->T: Does not affect ability to inhibit
FT                                UBE2N/UBC13.
FT                                {ECO:0000269|PubMed:22325355}.
FT   MUTAGEN     134    134       T->R: Impairs inhibition of UBE2N/UBC13.
FT                                {ECO:0000269|PubMed:22325355}.
FT   MUTAGEN     137    137       D->G: Impairs inhibition of UBE2N/UBC13.
FT                                {ECO:0000269|PubMed:22325355}.
FT   MUTAGEN     176    176       R->L: No effect on RNF128.
FT                                {ECO:0000269|PubMed:14661020}.
FT   MUTAGEN     190    190       F->S: Fails to inhibit ubiquitin
FT                                conjugation by UBE2N/UBC13.
FT                                {ECO:0000269|PubMed:22325355}.
FT   MUTAGEN     212    212       C->A: No effect on RNF128.
FT                                {ECO:0000269|PubMed:14661020,
FT                                ECO:0000269|PubMed:19211026}.
FT   MUTAGEN     261    261       Y->H: Impairs inhibition of UBE2N/UBC13.
FT                                {ECO:0000269|PubMed:22325355}.
FT   MUTAGEN     263    263       P->L: Fails to inhibit ubiquitin
FT                                conjugation by UBE2N/UBC13.
FT                                {ECO:0000269|PubMed:22325355}.
FT   MUTAGEN     265    265       H->A: Abolishes ability to inhibit
FT                                RNF168; when associated with A-88 and S-
FT                                91. {ECO:0000269|PubMed:12704427,
FT                                ECO:0000269|PubMed:20725033}.
FT   MUTAGEN     265    265       H->R: Abolishes hydrolase activity in
FT                                vitro. {ECO:0000269|PubMed:12704427,
FT                                ECO:0000269|PubMed:20725033}.
FT   CONFLICT     61     61       Y -> C (in Ref. 6; AAH10368).
FT                                {ECO:0000305}.
FT   CONFLICT    151    151       K -> R (in Ref. 4; BAA90956).
FT                                {ECO:0000305}.
FT   HELIX        24     44       {ECO:0000244|PDB:4LDT}.
FT   STRAND       47     53       {ECO:0000244|PDB:4I6L}.
FT   HELIX        54     60       {ECO:0000244|PDB:2ZFY}.
FT   HELIX        66     75       {ECO:0000244|PDB:2ZFY}.
FT   TURN         76     78       {ECO:0000244|PDB:2ZFY}.
FT   STRAND       81     83       {ECO:0000244|PDB:2ZFY}.
FT   STRAND       87     89       {ECO:0000244|PDB:4I6L}.
FT   HELIX        91    104       {ECO:0000244|PDB:2ZFY}.
FT   HELIX       108    127       {ECO:0000244|PDB:2ZFY}.
FT   HELIX       132    150       {ECO:0000244|PDB:2ZFY}.
FT   HELIX       155    162       {ECO:0000244|PDB:2ZFY}.
FT   HELIX       165    185       {ECO:0000244|PDB:2ZFY}.
FT   HELIX       187    190       {ECO:0000244|PDB:2ZFY}.
FT   HELIX       191    193       {ECO:0000244|PDB:2ZFY}.
FT   STRAND      194    197       {ECO:0000244|PDB:4DDG}.
FT   HELIX       200    207       {ECO:0000244|PDB:2ZFY}.
FT   HELIX       217    227       {ECO:0000244|PDB:2ZFY}.
FT   STRAND      231    235       {ECO:0000244|PDB:2ZFY}.
FT   STRAND      240    242       {ECO:0000244|PDB:4DDG}.
FT   STRAND      245    250       {ECO:0000244|PDB:2ZFY}.
FT   STRAND      256    262       {ECO:0000244|PDB:2ZFY}.
FT   STRAND      265    270       {ECO:0000244|PDB:2ZFY}.
SQ   SEQUENCE   271 AA;  31284 MW;  63188EE1DC5FD66F CRC64;
     MAAEEPQQQK QEPLGSDSEG VNCLAYDEAI MAQQDRIQQE IAVQNPLVSE RLELSVLYKE
     YAEDDNIYQQ KIKDLHKKYS YIRKTRPDGN CFYRAFGFSH LEALLDDSKE LQRFKAVSAK
     SKEDLVSQGF TEFTIEDFHN TFMDLIEQVE KQTSVADLLA SFNDQSTSDY LVVYLRLLTS
     GYLQRESKFF EHFIEGGRTV KEFCQQEVEP MCKESDHIHI IALAQALSVS IQVEYMDRGE
     GGTTNPHIFP EGSEPKVYLL YRPGHYDILY K
//
ID   CAMLG_HUMAN             Reviewed;         296 AA.
AC   P49069; A1L3Y3;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   23-MAY-2018, entry version 144.
DE   RecName: Full=Calcium signal-modulating cyclophilin ligand;
DE            Short=CAML;
GN   Name=CAMLG; Synonyms=CAML;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7522304; DOI=10.1038/371355a0;
RA   Bram R.J., Crabtree G.R.;
RT   "Calcium signalling in T cells stimulated by a cyclophilin B-binding
RT   protein.";
RL   Nature 371:355-358(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 49-296.
RC   TISSUE=Colon adenocarcinoma;
RA   Morales V.M., Blumberg R.S.;
RT   "An immature transcript of the CAMLG gene.";
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   INTERACTION WITH HHV-8 PROTEIN K7.
RX   PubMed=12388711; DOI=10.1128/JVI.76.22.11491-11504.2002;
RA   Feng P., Park J., Lee B.S., Lee S.H., Bram R.J., Jung J.U.;
RT   "Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein
RT   targets a cellular calcium-modulating cyclophilin ligand to modulate
RT   intracellular calcium concentration and inhibit apoptosis.";
RL   J. Virol. 76:11491-11504(2002).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Likely involved in the mobilization of calcium as a
CC       result of the TCR/CD3 complex interaction. Binds to cyclophilin B.
CC   -!- SUBUNIT: The N-terminal domain binds to TNFRSF13B/TACI. Interacts
CC       with human herpes virus 8/HHV-8 protein K7; this interaction
CC       modulates intracellular calcium concentration.
CC       {ECO:0000269|PubMed:12388711}.
CC   -!- INTERACTION:
CC       P00533:EGFR; NbExp=2; IntAct=EBI-1748958, EBI-297353;
CC       P46695:IER3; NbExp=2; IntAct=EBI-1748958, EBI-1748945;
CC       P16389:KCNA2; NbExp=3; IntAct=EBI-1748958, EBI-10210559;
CC       P16389-2:KCNA2; NbExp=4; IntAct=EBI-1748958, EBI-11987131;
CC       Q96AQ6:PBXIP1; NbExp=4; IntAct=EBI-1748958, EBI-740845;
CC       P08F94:PKHD1; NbExp=3; IntAct=EBI-1748958, EBI-11693144;
CC       E9PZ36:Pkhd1 (xeno); NbExp=4; IntAct=EBI-1748958, EBI-11693075;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highest levels in brain, testis
CC       and ovary.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U18242; AAA59420.1; -; mRNA.
DR   EMBL; AK313156; BAG35974.1; -; mRNA.
DR   EMBL; CH471062; EAW62243.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW62244.1; -; Genomic_DNA.
DR   EMBL; BC130325; AAI30326.1; -; mRNA.
DR   EMBL; AF068179; AAC23596.1; -; mRNA.
DR   CCDS; CCDS4178.1; -.
DR   PIR; S47594; S47594.
DR   RefSeq; NP_001736.1; NM_001745.3.
DR   UniGene; Hs.529846; -.
DR   ProteinModelPortal; P49069; -.
DR   BioGrid; 107269; 17.
DR   CORUM; P49069; -.
DR   IntAct; P49069; 31.
DR   STRING; 9606.ENSP00000297156; -.
DR   DrugBank; DB00091; Cyclosporine.
DR   TCDB; 3.A.19.1.1; the tms recognition/insertion complex (trc) family.
DR   iPTMnet; P49069; -.
DR   PhosphoSitePlus; P49069; -.
DR   BioMuta; CAMLG; -.
DR   DMDM; 1345662; -.
DR   EPD; P49069; -.
DR   MaxQB; P49069; -.
DR   PaxDb; P49069; -.
DR   PeptideAtlas; P49069; -.
DR   PRIDE; P49069; -.
DR   DNASU; 819; -.
DR   Ensembl; ENST00000297156; ENSP00000297156; ENSG00000164615.
DR   GeneID; 819; -.
DR   KEGG; hsa:819; -.
DR   UCSC; uc003kzt.4; human.
DR   CTD; 819; -.
DR   DisGeNET; 819; -.
DR   EuPathDB; HostDB:ENSG00000164615.4; -.
DR   GeneCards; CAMLG; -.
DR   H-InvDB; HIX0164331; -.
DR   HGNC; HGNC:1471; CAMLG.
DR   HPA; HPA052636; -.
DR   HPA; HPA056472; -.
DR   MIM; 601118; gene.
DR   neXtProt; NX_P49069; -.
DR   OpenTargets; ENSG00000164615; -.
DR   PharmGKB; PA26053; -.
DR   eggNOG; ENOG410IEK3; Eukaryota.
DR   eggNOG; ENOG4111HUY; LUCA.
DR   GeneTree; ENSGT00390000015996; -.
DR   HOGENOM; HOG000220891; -.
DR   HOVERGEN; HBG050786; -.
DR   InParanoid; P49069; -.
DR   KO; K22385; -.
DR   OMA; HHGLEQY; -.
DR   OrthoDB; EOG091G0HL4; -.
DR   PhylomeDB; P49069; -.
DR   TreeFam; TF331902; -.
DR   ChiTaRS; CAMLG; human.
DR   GeneWiki; CAMLG; -.
DR   GenomeRNAi; 819; -.
DR   PMAP-CutDB; P49069; -.
DR   PRO; PR:P49069; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164615; -.
DR   CleanEx; HS_CAMLG; -.
DR   ExpressionAtlas; P49069; baseline and differential.
DR   Genevisible; P49069; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0006952; P:defense response; TAS:ProtInc.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0001881; P:receptor recycling; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   InterPro; IPR016719; Ca_signal-mod_cyclophilin_lig.
DR   PANTHER; PTHR15026; PTHR15026; 1.
DR   Pfam; PF14963; CAML; 1.
DR   PIRSF; PIRSF018259; CAML; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Host-virus interaction; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    296       Calcium signal-modulating cyclophilin
FT                                ligand.
FT                                /FTId=PRO_0000089291.
FT   TOPO_DOM      1    189       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    190    210       Helical. {ECO:0000255}.
FT   TOPO_DOM    211    240       Extracellular. {ECO:0000255}.
FT   TRANSMEM    241    257       Helical. {ECO:0000255}.
FT   TOPO_DOM    258    296       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES      55     55       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT      78     78       V -> I (in dbSNP:rs12657663).
FT                                /FTId=VAR_024297.
FT   VARIANT     100    100       G -> S (in dbSNP:rs11552197).
FT                                /FTId=VAR_050710.
SQ   SEQUENCE   296 AA;  32953 MW;  22DCD8CF022FEF09 CRC64;
     MESMAVATDG GERPGVPAGS GLSASQRRAE LRRRKLLMNS EQRINRIMGF HRPGSGAEEE
     SQTKSKQQDS DKLNSLSVPS VSKRVVLGDS VSTGTTDQQG GVAEVKGTQL GDKLDSFIKP
     PECSSDVNLE LRQRNRGDLT ADSVQRGSRH GLEQYLSRFE EAMKLRKQLI SEKPSQEDGN
     TTEEFDSFRI FRLVGCALLA LGVRAFVCKY LSIFAPFLTL QLAYMGLYKY FPKSEKKIKT
     TVLTAALLLS GIPAEVINRS MDTYSKMGEV FTDLCVYFFT FIFCHELLDY WGSEVP
//
ID   WRB_HUMAN               Reviewed;         174 AA.
AC   O00258; A8KAP8; A8MQ44; D3DSH9; O60740;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   28-MAR-2018, entry version 125.
DE   RecName: Full=Tail-anchored protein insertion receptor WRB;
DE   AltName: Full=Congenital heart disease 5 protein;
DE   AltName: Full=Tryptophan-rich basic protein;
DE            Short=WRB;
GN   Name=WRB; Synonyms=CHD5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RC   TISSUE=Heart;
RX   PubMed=9544840; DOI=10.1007/s004390050693;
RA   Egeo A., Mazzocco M., Sotgia F., Arrigo P., Oliva R., Bergonon S.,
RA   Nizetic D., Rasore-Quartino A., Scartezzini P.;
RT   "Identification and characterization of a new human cDNA from
RT   chromosome 21q22.3 encoding a basic nuclear protein.";
RL   Hum. Genet. 102:289-293(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, TOPOLOGY, INTERACTION WITH ASNA1/TRC40, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=21444755; DOI=10.1242/jcs.084277;
RA   Vilardi F., Lorenz H., Dobberstein B.;
RT   "WRB is the receptor for TRC40/Asna1-mediated insertion of tail-
RT   anchored proteins into the ER membrane.";
RL   J. Cell Sci. 124:1301-1307(2011).
CC   -!- FUNCTION: Receptor for ASNA1/TRC40-mediated insertion of tail-
CC       anchored (TA) proteins into the ER membrane.
CC       {ECO:0000269|PubMed:21444755}.
CC   -!- SUBUNIT: Interacts with ASNA1/TRC40.
CC       {ECO:0000269|PubMed:21444755}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:21444755, ECO:0000269|PubMed:9544840}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:21444755,
CC       ECO:0000269|PubMed:9544840}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O00258-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00258-2; Sequence=VSP_043081;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the WRB/GET1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y12478; CAA73081.1; -; mRNA.
DR   EMBL; AK293113; BAF85802.1; -; mRNA.
DR   EMBL; AK299144; BAG61196.1; -; mRNA.
DR   EMBL; AF064861; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF121781; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL163279; CAB90454.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09645.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09647.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09649.1; -; Genomic_DNA.
DR   EMBL; BC012415; AAH12415.1; -; mRNA.
DR   CCDS; CCDS13664.1; -. [O00258-1]
DR   CCDS; CCDS54485.1; -. [O00258-2]
DR   RefSeq; NP_001139690.1; NM_001146218.1. [O00258-2]
DR   RefSeq; NP_004618.2; NM_004627.4. [O00258-1]
DR   UniGene; Hs.198308; -.
DR   UniGene; Hs.744958; -.
DR   ProteinModelPortal; O00258; -.
DR   BioGrid; 113322; 21.
DR   STRING; 9606.ENSP00000327716; -.
DR   TCDB; 3.A.19.1.1; the tms recognition/insertion complex (trc) family.
DR   iPTMnet; O00258; -.
DR   PhosphoSitePlus; O00258; -.
DR   BioMuta; WRB; -.
DR   EPD; O00258; -.
DR   MaxQB; O00258; -.
DR   PaxDb; O00258; -.
DR   PeptideAtlas; O00258; -.
DR   PRIDE; O00258; -.
DR   Ensembl; ENST00000333781; ENSP00000327716; ENSG00000182093. [O00258-1]
DR   Ensembl; ENST00000380708; ENSP00000370084; ENSG00000182093. [O00258-2]
DR   Ensembl; ENST00000398753; ENSP00000381737; ENSG00000182093. [O00258-2]
DR   GeneID; 7485; -.
DR   KEGG; hsa:7485; -.
DR   UCSC; uc002yxs.4; human. [O00258-1]
DR   CTD; 7485; -.
DR   DisGeNET; 7485; -.
DR   EuPathDB; HostDB:ENSG00000182093.14; -.
DR   GeneCards; WRB; -.
DR   HGNC; HGNC:12790; WRB.
DR   HPA; HPA018527; -.
DR   MIM; 602915; gene.
DR   neXtProt; NX_O00258; -.
DR   OpenTargets; ENSG00000182093; -.
DR   PharmGKB; PA37391; -.
DR   eggNOG; KOG4253; Eukaryota.
DR   eggNOG; ENOG41120B0; LUCA.
DR   GeneTree; ENSGT00390000002415; -.
DR   HOGENOM; HOG000013223; -.
DR   HOVERGEN; HBG010388; -.
DR   InParanoid; O00258; -.
DR   KO; K22384; -.
DR   OMA; ITCWLVV; -.
DR   OrthoDB; EOG091G0O4W; -.
DR   PhylomeDB; O00258; -.
DR   TreeFam; TF314708; -.
DR   GenomeRNAi; 7485; -.
DR   PRO; PR:O00258; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000182093; -.
DR   CleanEx; HS_CHD5; -.
DR   CleanEx; HS_WRB; -.
DR   ExpressionAtlas; O00258; baseline and differential.
DR   Genevisible; O00258; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; IEA:InterPro.
DR   InterPro; IPR028945; WRB/Get1.
DR   Pfam; PF04420; CHD5; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome;
KW   Endoplasmic reticulum; Membrane; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    174       Tail-anchored protein insertion receptor
FT                                WRB.
FT                                /FTId=PRO_0000065979.
FT   TOPO_DOM      1      8       Lumenal. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   TOPO_DOM     30     99       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    100    120       Helical. {ECO:0000255}.
FT   TOPO_DOM    121    148       Lumenal. {ECO:0000255}.
FT   TRANSMEM    149    169       Helical. {ECO:0000255}.
FT   TOPO_DOM    170    174       Cytoplasmic. {ECO:0000255}.
FT   REGION       39     97       Interaction with ASNA1/TRC40.
FT   COILED       39     94       {ECO:0000255}.
FT   VAR_SEQ       1     34       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043081.
FT   VARIANT     110    110       V -> I (in dbSNP:rs35946782).
FT                                /FTId=VAR_051491.
FT   CONFLICT     31     31       F -> I (in Ref. 1; CAA73081).
FT                                {ECO:0000305}.
SQ   SEQUENCE   174 AA;  19780 MW;  A01F11CC564EAB6E CRC64;
     MSSAAADHWA WLLVLSFVFG CNVLRILLPS FSSFMSRVLQ KDAEQESQMR AEIQDMKQEL
     STVNMMDEFA RYARLERKIN KMTDKLKTHV KARTAQLAKI KWVISVAFYV LQAALMISLI
     WKYYSVPVAV VPSKWITPLD RLVAFPTRVA GGVGITCWIL VCNKVVAIVL HPFS
//
ID   ZN579_HUMAN             Reviewed;         562 AA.
AC   Q8NAF0;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   23-MAY-2018, entry version 135.
DE   RecName: Full=Zinc finger protein 579;
GN   Name=ZNF579;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194 AND SER-196, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194 AND SER-483, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-92, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK092772; BAC03972.1; -; mRNA.
DR   EMBL; AC008735; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS12927.1; -.
DR   RefSeq; NP_689813.2; NM_152600.2.
DR   UniGene; Hs.112529; -.
DR   ProteinModelPortal; Q8NAF0; -.
DR   BioGrid; 127842; 46.
DR   IntAct; Q8NAF0; 13.
DR   MINT; Q8NAF0; -.
DR   STRING; 9606.ENSP00000320188; -.
DR   iPTMnet; Q8NAF0; -.
DR   PhosphoSitePlus; Q8NAF0; -.
DR   BioMuta; ZNF579; -.
DR   DMDM; 296453047; -.
DR   EPD; Q8NAF0; -.
DR   MaxQB; Q8NAF0; -.
DR   PaxDb; Q8NAF0; -.
DR   PeptideAtlas; Q8NAF0; -.
DR   PRIDE; Q8NAF0; -.
DR   Ensembl; ENST00000325421; ENSP00000320188; ENSG00000218891.
DR   GeneID; 163033; -.
DR   KEGG; hsa:163033; -.
DR   UCSC; uc002qlh.4; human.
DR   CTD; 163033; -.
DR   EuPathDB; HostDB:ENSG00000218891.4; -.
DR   GeneCards; ZNF579; -.
DR   HGNC; HGNC:26646; ZNF579.
DR   HPA; HPA062812; -.
DR   neXtProt; NX_Q8NAF0; -.
DR   OpenTargets; ENSG00000218891; -.
DR   PharmGKB; PA134930711; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00900000141245; -.
DR   HOGENOM; HOG000054202; -.
DR   HOVERGEN; HBG098620; -.
DR   InParanoid; Q8NAF0; -.
DR   OMA; QDEGVEQ; -.
DR   OrthoDB; EOG091G0766; -.
DR   PhylomeDB; Q8NAF0; -.
DR   TreeFam; TF331849; -.
DR   GenomeRNAi; 163033; -.
DR   PRO; PR:Q8NAF0; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000218891; -.
DR   CleanEx; HS_ZNF579; -.
DR   ExpressionAtlas; Q8NAF0; baseline and differential.
DR   Genevisible; Q8NAF0; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISA:NTNU_SB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF57667; SSF57667; 5.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 8.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 8.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Metal-binding; Methylation; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN         1    562       Zinc finger protein 579.
FT                                /FTId=PRO_0000047669.
FT   ZN_FING      44     66       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING      72     94       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     100    123       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     270    292       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     298    320       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     384    406       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     412    434       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     441    463       C2H2-type 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   COMPBIAS    331    370       Gly-rich.
FT   COMPBIAS    481    525       Pro-rich.
FT   MOD_RES      92     92       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     194    194       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     196    196       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     483    483       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT     353    353       E -> D (in dbSNP:rs10403008).
FT                                /FTId=VAR_061956.
FT   CONFLICT    228    228       W -> R (in Ref. 1; BAC03972).
FT                                {ECO:0000305}.
SQ   SEQUENCE   562 AA;  60509 MW;  9A1C83911B9F20A7 CRC64;
     MDPQPPPPAQ GSPPHRGRGR GRGRGRGRGR GRGRGGAGAP RAPLPCPTCG RLFRFPYYLS
     RHRLSHSGLR PHACPLCPKA FRRPAHLSRH LRGHGPQPPL RCAACPRTFP EPAQLRRHLA
     QEHAGGEVEL AIERVAKETA EPSWGPQDEG SEPPTTAAAG ATEEEAVAAW PETWPAGEPS
     TLAAPTSAAE PRESESEEAE AGAAELRAEL ALAAGRQEEK QVLLQADWTL LCLRCREAFA
     TKGELKAHPC LRPEGEQEGE GGPPPRPKRH QCSICLKAFA RPWSLSRHRL VHSTDRPFVC
     PDCGLAFRLA SYLRQHRRVH GPLSLLAPLP AAGKKDDKAS GARNSAKGPE GGEGAECGGA
     SEGGEGQNGG DAAPARPPAG EPRFWCPECG KGFRRRAHLR QHGVTHSGAR PFQCVRCQRE
     FKRLADLARH AQVHAGGPAP HPCPRCPRRF SRAYSLLRHQ RCHRAELERA AALQALQAQA
     PTSPPPPPPP LKAEQEEEGL PLPLANIKEE PPSPGTPPQS PPAPPVFLSA SCFDSQDHSA
     FEMEEEEVDS KAHLRGLGGL AS
//
ID   ASPC1_HUMAN             Reviewed;         553 AA.
AC   Q9BZE9; A8K3K9; Q7Z6N7; Q8WV59; Q96LS5; Q96M40;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   28-FEB-2018, entry version 128.
DE   RecName: Full=Tether containing UBX domain for GLUT4;
DE   AltName: Full=Alveolar soft part sarcoma chromosomal region candidate gene 1 protein;
DE   AltName: Full=Alveolar soft part sarcoma locus;
DE   AltName: Full=Renal papillary cell carcinoma protein 17;
DE   AltName: Full=UBX domain-containing protein 9;
GN   Name=ASPSCR1; Synonyms=ASPL, RCC17, TUG, UBXD9, UBXN9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION WITH
RP   TFE3, TISSUE SPECIFICITY, AND INVOLVEMENT IN ASPS.
RX   PubMed=11244503; DOI=10.1038/sj.onc.1204074;
RA   Ladanyi M., Lui M.Y., Antonescu C.R., Krause-Boehm A., Meindl A.,
RA   Argani P., Healey J.H., Ueda T., Yoshikawa H., Meloni-Ehrig A.,
RA   Sorensen P.H.B., Mertens F., Mandahl N., van den Berghe H., Sciot R.,
RA   Dal Cin P., Bridge J.;
RT   "The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses
RT   the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.";
RL   Oncogene 20:48-57(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND
RP   VARIANT GLN-252.
RC   TISSUE=Brain, Heart, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), AND VARIANT
RP   GLN-252.
RC   TISSUE=Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   CHROMOSOMAL TRANSLOCATION WITH TFE3, AND TISSUE SPECIFICITY.
RX   PubMed=11358836;
RA   Heimann P., El Housni H., Ogur G., Weterman M.A.J., Petty E.M.,
RA   Vassart G.;
RT   "Fusion of a novel gene, RCC17, to the TFE3 gene in
RT   t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas.";
RL   Cancer Res. 61:4130-4135(2001).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-500, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH VCP.
RX   PubMed=22207755; DOI=10.1074/jbc.M111.284232;
RA   Orme C.M., Bogan J.S.;
RT   "The ubiquitin regulatory X (UBX) domain-containing protein TUG
RT   regulates the p97 ATPase and resides at the endoplasmic reticulum-
RT   golgi intermediate compartment.";
RL   J. Biol. Chem. 287:6679-6692(2012).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275; SER-500 AND
RP   SER-502, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   FUNCTION IN VCP METHYLATION, INTERACTION WITH VCPKMT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine
RT   methyltransferases preferentially interact with molecular chaperones
RT   to regulate their activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275; SER-500 AND
RP   SER-502, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Tethering protein that sequesters GLUT4-containing
CC       vesicles in the cytoplasm in the absence of insulin. Modulates the
CC       amount of GLUT4 that is available at the cell surface (By
CC       similarity). Enhances VCP methylation catalyzed by VCPKMT.
CC       {ECO:0000250, ECO:0000269|PubMed:23349634}.
CC   -!- SUBUNIT: Interacts with GLUT4 (By similarity). Interacts with
CC       VCPKMT. Interacts with VCP. {ECO:0000250,
CC       ECO:0000269|PubMed:22207755, ECO:0000269|PubMed:23349634}.
CC   -!- INTERACTION:
CC       Q6UY14-3:ADAMTSL4; NbExp=3; IntAct=EBI-1993677, EBI-10173507;
CC       V9HW80:HEL-S-70; NbExp=3; IntAct=EBI-1993677, EBI-10175326;
CC       Q15323:KRT31; NbExp=3; IntAct=EBI-1993677, EBI-948001;
CC       P60410:KRTAP10-8; NbExp=3; IntAct=EBI-1993677, EBI-10171774;
CC       Q7Z3S9:NOTCH2NL; NbExp=3; IntAct=EBI-1993677, EBI-945833;
CC       Q9Y6A5:TACC3; NbExp=3; IntAct=EBI-1993677, EBI-2554984;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-1993677, EBI-533224;
CC       P55072:VCP; NbExp=6; IntAct=EBI-1993677, EBI-355164;
CC   -!- SUBCELLULAR LOCATION: Endomembrane system {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}. Endoplasmic reticulum-
CC       Golgi intermediate compartment membrane
CC       {ECO:0000269|PubMed:22207755}; Peripheral membrane protein.
CC       Cytoplasm {ECO:0000269|PubMed:23349634}. Nucleus
CC       {ECO:0000269|PubMed:23349634}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9BZE9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BZE9-2; Sequence=VSP_020578;
CC       Name=3;
CC         IsoId=Q9BZE9-3; Sequence=VSP_020574, VSP_020577;
CC       Name=4;
CC         IsoId=Q9BZE9-4; Sequence=VSP_020574, VSP_020575, VSP_020576;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in testis, heart,
CC       skeletal muscle and pancreas. {ECO:0000269|PubMed:11244503,
CC       ECO:0000269|PubMed:11358836}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ASPSCR1 is found
CC       in patients with alveolar soft part sarcoma. Translocation
CC       t(X;17)(p11;q25) with TFE3 forms a ASPSCR1-TFE3 fusion protein.
CC       {ECO:0000269|PubMed:11244503}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ASPSCR1 has been
CC       found in two patients with of papillary renal cell carcinoma.
CC       Translocation t(X;17)(p11.2;q25). {ECO:0000269|PubMed:11358836}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ASPSCR1ID358.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF324219; AAK08959.2; -; mRNA.
DR   EMBL; AK057403; BAB71472.1; -; mRNA.
DR   EMBL; AK057851; BAB71595.1; -; mRNA.
DR   EMBL; AK290624; BAF83313.1; -; mRNA.
DR   EMBL; BC006152; AAH06152.1; -; mRNA.
DR   EMBL; BC018722; AAH18722.1; -; mRNA.
DR   CCDS; CCDS11796.1; -. [Q9BZE9-1]
DR   CCDS; CCDS58611.1; -. [Q9BZE9-2]
DR   CCDS; CCDS82222.1; -. [Q9BZE9-3]
DR   RefSeq; NP_001238817.1; NM_001251888.1. [Q9BZE9-2]
DR   RefSeq; NP_001317457.1; NM_001330528.1. [Q9BZE9-3]
DR   RefSeq; NP_076988.1; NM_024083.3. [Q9BZE9-1]
DR   UniGene; Hs.298351; -.
DR   PDB; 5IFS; X-ray; 2.46 A; A/C=317-553.
DR   PDB; 5IFW; X-ray; 3.40 A; A=317-504.
DR   PDBsum; 5IFS; -.
DR   PDBsum; 5IFW; -.
DR   ProteinModelPortal; Q9BZE9; -.
DR   SMR; Q9BZE9; -.
DR   BioGrid; 122516; 51.
DR   IntAct; Q9BZE9; 15.
DR   MINT; Q9BZE9; -.
DR   STRING; 9606.ENSP00000302176; -.
DR   iPTMnet; Q9BZE9; -.
DR   PhosphoSitePlus; Q9BZE9; -.
DR   BioMuta; ASPSCR1; -.
DR   DMDM; 74717746; -.
DR   EPD; Q9BZE9; -.
DR   MaxQB; Q9BZE9; -.
DR   PaxDb; Q9BZE9; -.
DR   PeptideAtlas; Q9BZE9; -.
DR   PRIDE; Q9BZE9; -.
DR   DNASU; 79058; -.
DR   Ensembl; ENST00000306729; ENSP00000306625; ENSG00000169696. [Q9BZE9-2]
DR   Ensembl; ENST00000306739; ENSP00000302176; ENSG00000169696. [Q9BZE9-1]
DR   Ensembl; ENST00000580534; ENSP00000462329; ENSG00000169696. [Q9BZE9-3]
DR   GeneID; 79058; -.
DR   KEGG; hsa:79058; -.
DR   UCSC; uc002kcx.3; human. [Q9BZE9-1]
DR   CTD; 79058; -.
DR   DisGeNET; 79058; -.
DR   EuPathDB; HostDB:ENSG00000169696.15; -.
DR   GeneCards; ASPSCR1; -.
DR   H-InvDB; HIX0022398; -.
DR   HGNC; HGNC:13825; ASPSCR1.
DR   HPA; HPA026749; -.
DR   MalaCards; ASPSCR1; -.
DR   MIM; 606236; gene.
DR   neXtProt; NX_Q9BZE9; -.
DR   OpenTargets; ENSG00000169696; -.
DR   Orphanet; 163699; Alveolar soft-tissue sarcoma.
DR   Orphanet; 319308; Translocation renal cell carcinoma.
DR   PharmGKB; PA25058; -.
DR   eggNOG; KOG2699; Eukaryota.
DR   eggNOG; ENOG410XQQK; LUCA.
DR   GeneTree; ENSGT00910000144171; -.
DR   HOGENOM; HOG000231241; -.
DR   HOVERGEN; HBG066860; -.
DR   InParanoid; Q9BZE9; -.
DR   KO; K15627; -.
DR   OMA; AEEHCLK; -.
DR   OrthoDB; EOG091G0EB3; -.
DR   PhylomeDB; Q9BZE9; -.
DR   TreeFam; TF320363; -.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   SIGNOR; Q9BZE9; -.
DR   ChiTaRS; ASPSCR1; human.
DR   GeneWiki; ASPSCR1; -.
DR   GenomeRNAi; 79058; -.
DR   PRO; PR:Q9BZE9; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000169696; -.
DR   CleanEx; HS_ASPSCR1; -.
DR   ExpressionAtlas; Q9BZE9; baseline and differential.
DR   Genevisible; Q9BZE9; HS.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0019898; C:extrinsic component of membrane; IEA:Ensembl.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0012506; C:vesicle membrane; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:Ensembl.
DR   GO; GO:0031401; P:positive regulation of protein modification process; IMP:UniProtKB.
DR   GO; GO:0046324; P:regulation of glucose import; IEA:Ensembl.
DR   InterPro; IPR021569; TUG-UBL1.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR001012; UBX_dom.
DR   Pfam; PF11470; TUG-UBL1; 1.
DR   Pfam; PF00789; UBX; 1.
DR   SUPFAM; SSF54236; SSF54236; 2.
DR   PROSITE; PS50033; UBX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm; Membrane;
KW   Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    553       Tether containing UBX domain for GLUT4.
FT                                /FTId=PRO_0000249885.
FT   DOMAIN      386    462       UBX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00215}.
FT   REGION      317    380       Interaction with GLUT4. {ECO:0000250}.
FT   SITE        311    312       Breakpoint for translocation to form
FT                                ASPSCR1-TFE3.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     184    184       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VBT9}.
FT   MOD_RES     275    275       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     500    500       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     502    502       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1     77       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020574.
FT   VAR_SEQ     390    425       KVALRVLFPDRYVLQGFFRPSETVGDLRDFVRSHLG -> R
FT                                RSLSLSPRLESVVPSQLTASSASRVQVVLLPQPPK (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020575.
FT   VAR_SEQ     426    553       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020576.
FT   VAR_SEQ     434    434       F -> CLSSFGRMDGRGPRCFLTRRCLLSSV (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020577.
FT   VAR_SEQ     451    451       Q -> QPQLGDRVAPFTLGPSLKRCLGPEQRTRLPVVGDGG
FT                                DVDSGRLLFWGPSRGRASPSTGQPPCHPVCRPSSPPSPRPS
FT                                SGDPSRVKAGHKHVGTGR (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_020578.
FT   VARIANT     252    252       L -> Q (in dbSNP:rs8074498).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027503.
FT   VARIANT     318    318       V -> M (in dbSNP:rs34085048).
FT                                /FTId=VAR_034745.
FT   VARIANT     487    487       D -> E (in dbSNP:rs13087).
FT                                /FTId=VAR_027504.
FT   CONFLICT    257    257       G -> E (in Ref. 2; BAB71595).
FT                                {ECO:0000305}.
FT   CONFLICT    444    444       D -> G (in Ref. 2; BAB71595).
FT                                {ECO:0000305}.
FT   STRAND      323    325       {ECO:0000244|PDB:5IFS}.
FT   HELIX       327    329       {ECO:0000244|PDB:5IFS}.
FT   HELIX       342    345       {ECO:0000244|PDB:5IFS}.
FT   HELIX       349    368       {ECO:0000244|PDB:5IFS}.
FT   HELIX       374    387       {ECO:0000244|PDB:5IFS}.
FT   STRAND      391    396       {ECO:0000244|PDB:5IFS}.
FT   STRAND      402    407       {ECO:0000244|PDB:5IFS}.
FT   HELIX       413    422       {ECO:0000244|PDB:5IFS}.
FT   STRAND      424    426       {ECO:0000244|PDB:5IFS}.
FT   STRAND      432    435       {ECO:0000244|PDB:5IFS}.
FT   TURN        436    439       {ECO:0000244|PDB:5IFS}.
FT   STRAND      445    448       {ECO:0000244|PDB:5IFW}.
FT   TURN        449    453       {ECO:0000244|PDB:5IFS}.
FT   STRAND      456    463       {ECO:0000244|PDB:5IFS}.
FT   HELIX       467    469       {ECO:0000244|PDB:5IFW}.
FT   HELIX       474    477       {ECO:0000244|PDB:5IFS}.
FT   HELIX       483    494       {ECO:0000244|PDB:5IFS}.
SQ   SEQUENCE   553 AA;  60183 MW;  B013FDF9A48D2E5E CRC64;
     MAAPAGGGGS AVSVLAPNGR RHTVKVTPST VLLQVLEDTC RRQDFNPCEY DLKFQRSVLD
     LSLQWRFANL PNNAKLEMVP ASRSREGPEN MVRIALQLDD GSRLQDSFCS GQTLWELLSH
     FPQIRECLQH PGGATPVCVY TRDEVTGEAA LRGTTLQSLG LTGGSATIRF VMKCYDPVGK
     TPGSLGSSAS AGQAAASAPL PLESGELSRG DLSRPEDADT SGPCCEHTQE KQSTRAPAAA
     PFVPFSGGGQ RLGGPPGPTR PLTSSSAKLP KSLSSPGGPS KPKKSKSGQD PQQEQEQERE
     RDPQQEQERE RPVDREPVDR EPVVCHPDLE ERLQAWPAEL PDEFFELTVD DVRRRLAQLK
     SERKRLEEAP LVTKAFREAQ IKEKLERYPK VALRVLFPDR YVLQGFFRPS ETVGDLRDFV
     RSHLGNPELS FYLFITPPKT VLDDHTQTLF QANLFPAALV HLGAEEPAGV YLEPGLLEHA
     ISPSAADVLV ARYMSRAAGS PSPLPAPDPA PKSEPAAEEG ALVPPEPIPG TAQPVKRSLG
     KVPKWLKLPA SKR
//
ID   A0A024RDI6_HUMAN        Unreviewed;       350 AA.
AC   A0A024RDI6;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 40.
DE   SubName: Full=Nudix (Nucleoside diphosphate linked moiety X)-type motif 9, isoform CRA_b {ECO:0000313|EMBL:EAX05990.1};
GN   Name=NUDT9 {ECO:0000313|EMBL:EAX05990.1};
GN   ORFNames=hCG_1647600 {ECO:0000313|EMBL:EAX05990.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX05990.1};
RN   [1] {ECO:0000313|EMBL:EAX05990.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX05990.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471057; EAX05989.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX05990.1; -; Genomic_DNA.
DR   RefSeq; NP_076952.1; NM_024047.4.
DR   UniGene; Hs.149500; -.
DR   SMR; A0A024RDI6; -.
DR   PRIDE; A0A024RDI6; -.
DR   GeneID; 53343; -.
DR   KEGG; hsa:53343; -.
DR   CTD; 53343; -.
DR   EuPathDB; HostDB:ENSG00000170502.12; -.
DR   eggNOG; KOG4195; Eukaryota.
DR   eggNOG; ENOG410XPYY; LUCA.
DR   KO; K13988; -.
DR   OMA; DDFRNTD; -.
DR   OrthoDB; EOG091G0H75; -.
DR   ChiTaRS; NUDT9; human.
DR   GenomeRNAi; 53343; -.
DR   Bgee; ENSG00000170502; -.
DR   ExpressionAtlas; A0A024RDI6; baseline and differential.
DR   GO; GO:0043262; F:adenosine-diphosphatase activity; IEA:Ensembl.
DR   GO; GO:0046032; P:ADP catabolic process; IEA:Ensembl.
DR   GO; GO:0046709; P:IDP catabolic process; IEA:Ensembl.
DR   InterPro; IPR015797; NUDIX_hydrolase-like_dom_sf.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   Pfam; PF00293; NUDIX; 1.
DR   SUPFAM; SSF55811; SSF55811; 1.
DR   PROSITE; PS51462; NUDIX; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}; Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21    350       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014214310.
FT   DOMAIN      178    334       Nudix hydrolase.
FT                                {ECO:0000259|PROSITE:PS51462}.
FT   COILED      232    259       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   350 AA;  39125 MW;  2EA5B24B88FB3420 CRC64;
     MAGRLLGKAL AAVSLSLALA SVTIRSSRCR GIQAFRNSFS SSWFHLNTNV MSGSNGSKEN
     SHNKARTSPY PGSKVERSQV PNEKVGWLVE WQDYKPVEYT AVSVLAGPRW ADPQISESNF
     SPKFNEKDGH VERKSKNGLY EIENGRPRNP AGRTGLVGRG LLGRWGPNHA ADPIITRWKR
     DSSGNKIMHP VSGKHILQFV AIKRKDCGEW AIPGGMVDPG EKISATLKRE FGEEALNSLQ
     KTSAEKREIE EKLHKLFSQD HLVIYKGYVD DPRNTDNAWM ETEAVNYHDE TGEIMDNLML
     EAGDDAGKVK WVDINDKLKL YASHSQFIKL VAEKRDAHWS EDSEADCHAL
//
ID   Q8NG26_HUMAN            Unreviewed;       300 AA.
AC   Q8NG26;
DT   01-OCT-2002, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2002, sequence version 1.
DT   31-JAN-2018, entry version 74.
DE   SubName: Full=Putative nudix hydrolyase {ECO:0000313|EMBL:AAM46066.1};
DE            EC=3.6.1.- {ECO:0000313|EMBL:AAM46066.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAM46066.1};
RN   [1] {ECO:0000313|EMBL:AAM46066.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:AAM46066.1};
RA   Lin S., Ying K., Xie Y., Mao Y.;
RT   "A Novel Human 'Nudix' Hydrolyase Gene, Cloning, Expression Analysis
RT   and Genome Localization.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF265341; AAM46066.1; -; mRNA.
DR   RefSeq; NP_932155.1; NM_198038.2.
DR   UniGene; Hs.149500; -.
DR   ProteinModelPortal; Q8NG26; -.
DR   PeptideAtlas; Q8NG26; -.
DR   PRIDE; Q8NG26; -.
DR   DNASU; 53343; -.
DR   GeneID; 53343; -.
DR   CTD; 53343; -.
DR   PharmGKB; PA31842; -.
DR   eggNOG; KOG4195; Eukaryota.
DR   eggNOG; ENOG410XPYY; LUCA.
DR   HOGENOM; HOG000130166; -.
DR   HOVERGEN; HBG052693; -.
DR   GenomeRNAi; 53343; -.
DR   Genevisible; Q8NG26; HS.
DR   GO; GO:0005622; C:intracellular; NAS:UniProtKB.
DR   GO; GO:0019144; F:ADP-sugar diphosphatase activity; NAS:UniProtKB.
DR   GO; GO:0005227; F:calcium activated cation channel activity; NAS:UniProtKB.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006812; P:cation transport; NAS:UniProtKB.
DR   InterPro; IPR015797; NUDIX_hydrolase-like_dom_sf.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   Pfam; PF00293; NUDIX; 1.
DR   SUPFAM; SSF55811; SSF55811; 1.
DR   PROSITE; PS51462; NUDIX; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Hydrolase {ECO:0000313|EMBL:AAM46066.1};
KW   Lyase {ECO:0000313|EMBL:AAM46066.1}.
FT   DOMAIN      128    284       Nudix hydrolase.
FT                                {ECO:0000259|PROSITE:PS51462}.
FT   COILED      182    209       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   300 AA;  33746 MW;  9C35210C703657AE CRC64;
     MSGSNGSKEN SHNKARTSPY PGSKVERSQV PNEKVGWLVE WQDYKPVEYT AVSVLAGPRW
     ADPQISEGNF SPKFNEKDGH VERKSKNGLY EIENGRPRNP AGRTGLVGRG LLGRWGPNHA
     ADPIITRWKR DSSGNKIMHP VSGKHILQFV AIKRKDCGEW AIPGGMVDPG EKISATLKRE
     FGEEALNSLQ KTSAEKREIE EKLHKLFSQD HLVIYKGYVD DPRNTDNAWM ETEAVNYHDE
     TGEIMDNLML EAGDDAGKVK WVDINDKLKL YASHSQFIKL VAEKRDAHWS EDSEADCHAL
//
ID   Q96KB3_HUMAN            Unreviewed;       350 AA.
AC   Q96KB3;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   31-JAN-2018, entry version 85.
DE   SubName: Full=cDNA FLJ14389 fis, clone HEMBA1002876 {ECO:0000313|EMBL:BAB55021.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAB55021.1};
RN   [1] {ECO:0000313|EMBL:BAB55021.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Whole embryo {ECO:0000313|EMBL:BAB55021.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK027295; BAB55021.1; -; mRNA.
DR   RefSeq; NP_001234940.1; NM_001248011.1.
DR   RefSeq; NP_076952.1; NM_024047.4.
DR   UniGene; Hs.149500; -.
DR   ProteinModelPortal; Q96KB3; -.
DR   PeptideAtlas; Q96KB3; -.
DR   PRIDE; Q96KB3; -.
DR   DNASU; 53343; -.
DR   GeneID; 53343; -.
DR   KEGG; hsa:53343; -.
DR   CTD; 53343; -.
DR   PharmGKB; PA31842; -.
DR   eggNOG; KOG4195; Eukaryota.
DR   eggNOG; ENOG410XPYY; LUCA.
DR   HOVERGEN; HBG052693; -.
DR   KO; K13988; -.
DR   GenomeRNAi; 53343; -.
DR   Genevisible; Q96KB3; HS.
DR   GO; GO:0005622; C:intracellular; NAS:UniProtKB.
DR   GO; GO:0019144; F:ADP-sugar diphosphatase activity; NAS:UniProtKB.
DR   GO; GO:0005227; F:calcium activated cation channel activity; NAS:UniProtKB.
DR   GO; GO:0006812; P:cation transport; NAS:UniProtKB.
DR   InterPro; IPR015797; NUDIX_hydrolase-like_dom_sf.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   Pfam; PF00293; NUDIX; 1.
DR   SUPFAM; SSF55811; SSF55811; 1.
DR   PROSITE; PS51462; NUDIX; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}; Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21    350       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004321917.
FT   DOMAIN      178    334       Nudix hydrolase.
FT                                {ECO:0000259|PROSITE:PS51462}.
FT   COILED      232    259       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   350 AA;  39042 MW;  8BE1A31ECCFB343D CRC64;
     MAGRLLGKAL AAVSLSLALA SVTIRSSRCR GIQAFRNSFS SSWFHLNTNV MSGSNGSKEN
     SHNKARTSPY PGSKVERSQV PNEKVGWLVE WQDYKPVEYT AVSVLAGPRW ADPQISESNF
     SPKFNEKDGH VERKSKNGLY EIENGRPRNP AGRTGLVGRG LLGRWGPNHA ADPIITRWKR
     DSSGNKIMHP VSGKHILQFV AIKRKDCGEW AIPGGMVDPG EKISATLKRE FGEEALNSLQ
     KTSAEKREIE EKLHKLFSQD HLVIYKGYVD DPRNTDNACM ETEAVNYHDE TGEIMDNLML
     EAGDDAGKVK WVDINDKLKL YASHSQFIKL VAEKRDAHWS EDSEADCHAL
//
ID   NUDT9_HUMAN             Reviewed;         350 AA.
AC   Q9BW91; Q8NBN1; Q8NCB9; Q8NG25;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   28-FEB-2018, entry version 154.
DE   RecName: Full=ADP-ribose pyrophosphatase, mitochondrial;
DE            EC=3.6.1.13;
DE   AltName: Full=ADP-ribose diphosphatase;
DE   AltName: Full=ADP-ribose phosphohydrolase;
DE   AltName: Full=Adenosine diphosphoribose pyrophosphatase;
DE            Short=ADPR-PPase;
DE   AltName: Full=Nucleoside diphosphate-linked moiety X motif 9;
DE            Short=Nudix motif 9;
DE   Flags: Precursor;
GN   Name=NUDT9; Synonyms=NUDT10; ORFNames=PSEC0099, UNQ3012/PRO9771;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=11385575; DOI=10.1038/35079100;
RA   Perraud A.-L., Fleig A., Dunn C.A., Bagley L.A., Launay P.,
RA   Schmitz C., Stokes A.J., Zhu Q., Bessman M.J., Penner R., Kinet J.-P.,
RA   Scharenberg A.M.;
RT   "ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by
RT   Nudix motif homology.";
RL   Nature 411:595-599(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), COFACTOR, SUBCELLULAR
RP   LOCATION, AND INDUCTION.
RC   TISSUE=Fetal brain;
RX   PubMed=11825615; DOI=10.1016/S0167-4838(01)00296-5;
RA   Lin S., Gasmi L., Xie Y., Ying K., Gu S., Wang Z., Jin H., Chao Y.,
RA   Wu C., Zhou Z., Tang R., Mao Y., McLennan A.G.;
RT   "Cloning, expression and characterisation of a human Nudix hydrolase
RT   specific for adenosine 5'-diphosphoribose (ADP-ribose).";
RL   Biochim. Biophys. Acta 1594:127-135(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), COFACTOR, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Spleen;
RX   PubMed=12427752; DOI=10.1074/jbc.M205601200;
RA   Perraud A.-L., Shen B., Dunn C.A., Rippe K., Smith M.K., Bessman M.J.,
RA   Stoddard B.L., Scharenberg A.M.;
RT   "NUDT9, a member of the Nudix hydrolase family, is an evolutionarily
RT   conserved mitochondrial ADP-ribose pyrophosphatase.";
RL   J. Biol. Chem. 278:1794-1801(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Lin S., Ying K.;
RT   "NUDT10, a new member of human nudix hydrolase family.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH GLOD4.
RX   PubMed=12897971;
RA   Zhang H.-T., Yan Z.-Q., Hu X.-B., Yang S.-L., Gong Y.;
RT   "Interaction of C17orf25 with ADP-ribose pyrophosphatase NUDT9
RT   detected via yeast two-hybrid method.";
RL   Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 35:747-751(2003).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS) OF 59-350.
RX   PubMed=12948489; DOI=10.1016/S0022-2836(03)00954-9;
RA   Shen B.W., Perraud A.-L., Scharenberg A., Stoddard B.L.;
RT   "The crystal structure and mutational analysis of human NUDT9.";
RL   J. Mol. Biol. 332:385-398(2003).
CC   -!- FUNCTION: Hydrolyzes ADP-ribose (ADPR) to AMP and ribose 5'-
CC       phosphate.
CC   -!- CATALYTIC ACTIVITY: ADP-D-ribose + H(2)O = AMP + D-ribose 5-
CC       phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC   -!- SUBUNIT: Monomer. Interacts with GLOD4.
CC       {ECO:0000269|PubMed:12427752, ECO:0000269|PubMed:12897971}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=NUDT9a;
CC         IsoId=Q9BW91-1; Sequence=Displayed;
CC       Name=2; Synonyms=NUDT9b;
CC         IsoId=Q9BW91-2; Sequence=VSP_010552;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed but isoform 1 is the
CC       most predominant isoform. {ECO:0000269|PubMed:12427752}.
CC   -!- INDUCTION: Isoform 1 is inhibited by fluoride and N-acetyl-p-
CC       benzoquinoneimine. {ECO:0000269|PubMed:11825615}.
CC   -!- SIMILARITY: Belongs to the Nudix hydrolase family. NudF subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY026252; AAK07671.1; -; mRNA.
DR   EMBL; AY359123; AAQ89480.1; -; mRNA.
DR   EMBL; AF273028; AAM46068.1; -; mRNA.
DR   EMBL; AK074845; BAC11239.1; -; mRNA.
DR   EMBL; AK075408; BAC11601.1; -; mRNA.
DR   EMBL; BC000542; AAH00542.1; -; mRNA.
DR   CCDS; CCDS3620.1; -. [Q9BW91-1]
DR   CCDS; CCDS3621.1; -. [Q9BW91-2]
DR   RefSeq; NP_001234940.1; NM_001248011.1.
DR   RefSeq; NP_076952.1; NM_024047.4. [Q9BW91-1]
DR   RefSeq; NP_932155.1; NM_198038.2. [Q9BW91-2]
DR   RefSeq; XP_011530334.1; XM_011532032.2. [Q9BW91-2]
DR   UniGene; Hs.149500; -.
DR   PDB; 1Q33; X-ray; 1.81 A; A=59-350.
DR   PDB; 1QVJ; X-ray; 1.91 A; A=59-350.
DR   PDBsum; 1Q33; -.
DR   PDBsum; 1QVJ; -.
DR   ProteinModelPortal; Q9BW91; -.
DR   SMR; Q9BW91; -.
DR   BioGrid; 119744; 17.
DR   IntAct; Q9BW91; 2.
DR   STRING; 9606.ENSP00000303575; -.
DR   DrugBank; DB02379; Beta-D-Glucose.
DR   iPTMnet; Q9BW91; -.
DR   PhosphoSitePlus; Q9BW91; -.
DR   BioMuta; NUDT9; -.
DR   DMDM; 20455184; -.
DR   EPD; Q9BW91; -.
DR   MaxQB; Q9BW91; -.
DR   PaxDb; Q9BW91; -.
DR   PeptideAtlas; Q9BW91; -.
DR   PRIDE; Q9BW91; -.
DR   DNASU; 53343; -.
DR   Ensembl; ENST00000302174; ENSP00000303575; ENSG00000170502. [Q9BW91-1]
DR   Ensembl; ENST00000473942; ENSP00000421811; ENSG00000170502. [Q9BW91-2]
DR   GeneID; 53343; -.
DR   KEGG; hsa:53343; -.
DR   UCSC; uc003hqq.4; human. [Q9BW91-1]
DR   CTD; 53343; -.
DR   EuPathDB; HostDB:ENSG00000170502.12; -.
DR   GeneCards; NUDT9; -.
DR   HGNC; HGNC:8056; NUDT9.
DR   HPA; HPA036917; -.
DR   HPA; HPA044866; -.
DR   HPA; HPA078535; -.
DR   MIM; 606022; gene.
DR   neXtProt; NX_Q9BW91; -.
DR   OpenTargets; ENSG00000170502; -.
DR   PharmGKB; PA31842; -.
DR   eggNOG; KOG4195; Eukaryota.
DR   eggNOG; ENOG410XPYY; LUCA.
DR   GeneTree; ENSGT00390000017405; -.
DR   HOGENOM; HOG000130166; -.
DR   HOVERGEN; HBG052693; -.
DR   InParanoid; Q9BW91; -.
DR   KO; K13988; -.
DR   OMA; DDFRNTD; -.
DR   OrthoDB; EOG091G0H75; -.
DR   PhylomeDB; Q9BW91; -.
DR   TreeFam; TF106351; -.
DR   Reactome; R-HSA-2393930; Phosphate bond hydrolysis by NUDT proteins.
DR   ChiTaRS; NUDT9; human.
DR   EvolutionaryTrace; Q9BW91; -.
DR   GeneWiki; NUDT9; -.
DR   GenomeRNAi; 53343; -.
DR   PRO; PR:Q9BW91; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000170502; -.
DR   CleanEx; HS_NUDT10; -.
DR   CleanEx; HS_NUDT9; -.
DR   ExpressionAtlas; Q9BW91; baseline and differential.
DR   Genevisible; Q9BW91; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; NAS:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0043262; F:adenosine-diphosphatase activity; IBA:GO_Central.
DR   GO; GO:0047631; F:ADP-ribose diphosphatase activity; EXP:Reactome.
DR   GO; GO:0019144; F:ADP-sugar diphosphatase activity; NAS:UniProtKB.
DR   GO; GO:0046032; P:ADP catabolic process; IEA:Ensembl.
DR   GO; GO:0046709; P:IDP catabolic process; IEA:Ensembl.
DR   GO; GO:0034656; P:nucleobase-containing small molecule catabolic process; TAS:Reactome.
DR   InterPro; IPR015797; NUDIX_hydrolase-like_dom_sf.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   Pfam; PF00293; NUDIX; 1.
DR   SUPFAM; SSF55811; SSF55811; 1.
DR   PROSITE; PS51462; NUDIX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Hydrolase;
KW   Magnesium; Manganese; Mitochondrion; Phosphoprotein;
KW   Reference proteome; Transit peptide.
FT   TRANSIT       1     46       Mitochondrion. {ECO:0000255}.
FT   CHAIN        47    350       ADP-ribose pyrophosphatase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000019950.
FT   DOMAIN      178    334       Nudix hydrolase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00794}.
FT   MOTIF       215    237       Nudix box.
FT   MOD_RES     121    121       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     50       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11825615,
FT                                ECO:0000303|PubMed:12427752,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_010552.
FT   CONFLICT    118    118       S -> G (in Ref. 4; AAM46068).
FT                                {ECO:0000305}.
FT   CONFLICT    293    293       E -> V (in Ref. 7; BAC11601).
FT                                {ECO:0000305}.
FT   HELIX        64     66       {ECO:0000244|PDB:1Q33}.
FT   HELIX        82     84       {ECO:0000244|PDB:1Q33}.
FT   STRAND       97    100       {ECO:0000244|PDB:1Q33}.
FT   HELIX       102    105       {ECO:0000244|PDB:1Q33}.
FT   STRAND      126    128       {ECO:0000244|PDB:1Q33}.
FT   STRAND      155    160       {ECO:0000244|PDB:1Q33}.
FT   STRAND      163    178       {ECO:0000244|PDB:1Q33}.
FT   TURN        190    192       {ECO:0000244|PDB:1Q33}.
FT   STRAND      197    203       {ECO:0000244|PDB:1Q33}.
FT   TURN        205    207       {ECO:0000244|PDB:1Q33}.
FT   STRAND      209    211       {ECO:0000244|PDB:1Q33}.
FT   HELIX       223    235       {ECO:0000244|PDB:1Q33}.
FT   HELIX       238    240       {ECO:0000244|PDB:1Q33}.
FT   HELIX       245    256       {ECO:0000244|PDB:1Q33}.
FT   TURN        257    259       {ECO:0000244|PDB:1Q33}.
FT   STRAND      260    268       {ECO:0000244|PDB:1Q33}.
FT   STRAND      276    292       {ECO:0000244|PDB:1Q33}.
FT   TURN        293    297       {ECO:0000244|PDB:1Q33}.
FT   STRAND      307    313       {ECO:0000244|PDB:1Q33}.
FT   HELIX       324    335       {ECO:0000244|PDB:1Q33}.
FT   HELIX       345    347       {ECO:0000244|PDB:1Q33}.
SQ   SEQUENCE   350 AA;  39125 MW;  2EA5B24B88FB3420 CRC64;
     MAGRLLGKAL AAVSLSLALA SVTIRSSRCR GIQAFRNSFS SSWFHLNTNV MSGSNGSKEN
     SHNKARTSPY PGSKVERSQV PNEKVGWLVE WQDYKPVEYT AVSVLAGPRW ADPQISESNF
     SPKFNEKDGH VERKSKNGLY EIENGRPRNP AGRTGLVGRG LLGRWGPNHA ADPIITRWKR
     DSSGNKIMHP VSGKHILQFV AIKRKDCGEW AIPGGMVDPG EKISATLKRE FGEEALNSLQ
     KTSAEKREIE EKLHKLFSQD HLVIYKGYVD DPRNTDNAWM ETEAVNYHDE TGEIMDNLML
     EAGDDAGKVK WVDINDKLKL YASHSQFIKL VAEKRDAHWS EDSEADCHAL
//
ID   CCND2_HUMAN             Reviewed;         289 AA.
AC   P30279; A8K531; Q13955; Q5U035;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   23-MAY-2018, entry version 181.
DE   RecName: Full=G1/S-specific cyclin-D2;
GN   Name=CCND2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1386336; DOI=10.1016/0888-7543(92)90127-E;
RA   Xiong Y., Menninger J., Beach D., Ward D.C.;
RT   "Molecular cloning and chromosomal mapping of CCND genes encoding
RT   human D-type cyclins.";
RL   Genomics 13:575-584(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8455931;
RA   Palmero I., Holder A., Sinclair A.J., Dickson C., Peters G.;
RT   "Cyclins D1 and D2 are differentially expressed in human B-lymphoid
RT   cell lines.";
RL   Oncogene 8:1049-1054(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RA   Miyajima N.;
RL   Submitted (MAR-1993) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ARG-268.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-240.
RC   TISSUE=Placenta;
RX   PubMed=1386335; DOI=10.1016/0888-7543(92)90126-D;
RA   Inaba T., Matsushime H., Valentine M., Roussel M.F., Sherr C.J.,
RA   Look A.T.;
RT   "Genomic organization, chromosomal localization, and independent
RT   expression of human cyclin D genes.";
RL   Genomics 13:565-574(1992).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 105-140 (ISOFORM 2).
RC   TISSUE=Glioblastoma;
RG   The Cancer Genome Anatomy Project (CGAP) at the National Cancer Institute;
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   INTERACTION WITH CDK4, AND SUBCELLULAR LOCATION.
RX   PubMed=18827403; DOI=10.1247/csf.08019;
RA   Wang Z., Xie Y., Zhang L., Zhang H., An X., Wang T., Meng A.;
RT   "Migratory localization of cyclin D2-Cdk4 complex suggests a spatial
RT   regulation of the G1-S transition.";
RL   Cell Struct. Funct. 33:171-183(2008).
RN   [13]
RP   SUBCELLULAR LOCATION (ISOFORM 2), AND ALTERNATIVE SPLICING.
RX   PubMed=17873913; DOI=10.1038/sj.onc.1210750;
RA   Denicourt C., Legault P., McNabb F.A., Rassart E.;
RT   "Human and mouse cyclin D2 splice variants: transforming activity and
RT   subcellular localization.";
RL   Oncogene 27:1253-1262(2008).
RN   [14]
RP   UBIQUITINATION BY SCF(FBXL2).
RX   PubMed=22323446; DOI=10.1182/blood-2011-06-358911;
RA   Chen B.B., Glasser J.R., Coon T.A., Zou C., Miller H.L., Fenton M.,
RA   McDyer J.F., Boyiadzis M., Mallampalli R.K.;
RT   "F-box protein FBXL2 targets cyclin D2 for ubiquitination and
RT   degradation to inhibit leukemic cell proliferation.";
RL   Blood 119:3132-3141(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   INVOLVEMENT IN MPPH3, AND VARIANTS MPPH3 ASN-280; ALA-280; ARG-281;
RP   LEU-281 AND GLY-284.
RX   PubMed=24705253; DOI=10.1038/ng.2948;
RG   FORGE Canada Consortium;
RA   Mirzaa G.M., Parry D.A., Fry A.E., Giamanco K.A., Schwartzentruber J.,
RA   Vanstone M., Logan C.V., Roberts N., Johnson C.A., Singh S.,
RA   Kholmanskikh S.S., Adams C., Hodge R.D., Hevner R.F., Bonthron D.T.,
RA   Braun K.P., Faivre L., Riviere J.B., St-Onge J., Gripp K.W.,
RA   Mancini G.M., Pang K., Sweeney E., van Esch H., Verbeek N.,
RA   Wieczorek D., Steinraths M., Majewski J., Boycott K.M., Pilz D.T.,
RA   Ross M.E., Dobyns W.B., Sheridan E.G.;
RT   "De novo CCND2 mutations leading to stabilization of cyclin D2 cause
RT   megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.";
RL   Nat. Genet. 46:510-515(2014).
CC   -!- FUNCTION: Regulatory component of the cyclin D2-CDK4 (DC) complex
CC       that phosphorylates and inhibits members of the retinoblastoma
CC       (RB) protein family including RB1 and regulates the cell-cycle
CC       during G(1)/S transition. Phosphorylation of RB1 allows
CC       dissociation of the transcription factor E2F from the RB/E2F
CC       complex and the subsequent transcription of E2F target genes which
CC       are responsible for the progression through the G(1) phase.
CC       Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4
CC       complexes are major integrators of various mitogenenic and
CC       antimitogenic signals. Also substrate for SMAD3, phosphorylating
CC       SMAD3 in a cell-cycle-dependent manner and repressing its
CC       transcriptional activity. Component of the ternary complex, cyclin
CC       D2/CDK4/CDKN1B, required for nuclear translocation and activity of
CC       the cyclin D-CDK4 complex (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with either CDK4 or CDK6 protein kinase to form
CC       a serine/threonine kinase holoenzyme complex. The cyclin subunit
CC       imparts substrate specificity to the complex. Component of the
CC       ternary complex cyclin D/CDK4/CDKN1B required for nuclear
CC       translocation and modulation of CDK4-mediated kinase activity.
CC       {ECO:0000269|PubMed:18827403}.
CC   -!- INTERACTION:
CC       P11802:CDK4; NbExp=12; IntAct=EBI-748789, EBI-295644;
CC       Q00535:CDK5; NbExp=13; IntAct=EBI-748789, EBI-1041567;
CC       P38936:CDKN1A; NbExp=14; IntAct=EBI-748789, EBI-375077;
CC       P46527:CDKN1B; NbExp=5; IntAct=EBI-748789, EBI-519280;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18827403}.
CC       Cytoplasm {ECO:0000269|PubMed:18827403}. Membrane
CC       {ECO:0000269|PubMed:18827403}. Note=Cyclin D-CDK4 complexes
CC       accumulate at the nuclear membrane and are then translocated into
CC       the nucleus through interaction with KIP/CIP family members.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm
CC       {ECO:0000269|PubMed:17873913}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P30279-1; Sequence=Displayed;
CC       Name=2; Synonyms=Truncated;
CC         IsoId=P30279-2; Sequence=VSP_057295, VSP_057296;
CC         Note=Acts as proto-oncogene. Retains ability to bind CDK4, but
CC         unable to catalyze efficiently RB phosphorylation and
CC         inactivation. {ECO:0000269|PubMed:17873913};
CC   -!- PTM: Polyubiquitinated by the SCF(FBXL2) complex, leading to
CC       proteasomal degradation. {ECO:0000269|PubMed:22323446}.
CC   -!- DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus
CC       syndrome 3 (MPPH3) [MIM:615938]: A syndrome characterized by
CC       megalencephaly, ventriculomegaly that may lead to hydrocephalus,
CC       and polymicrogyria; polydactyly may also be seen. There is
CC       considerable phenotypic similarity between this disorder and the
CC       megalencephaly-capillary malformation syndrome.
CC       {ECO:0000269|PubMed:24705253}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cyclin family. Cyclin D subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ccnd2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M90813; AAA51926.1; -; mRNA.
DR   EMBL; X68452; CAA48493.1; -; mRNA.
DR   EMBL; D13639; BAA02802.1; -; mRNA.
DR   EMBL; BT019847; AAV38650.1; -; mRNA.
DR   EMBL; AF518005; AAM54041.1; -; Genomic_DNA.
DR   EMBL; AK291146; BAF83835.1; -; mRNA.
DR   EMBL; AC006122; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471116; EAW88851.1; -; Genomic_DNA.
DR   EMBL; BC010958; AAH10958.1; -; mRNA.
DR   EMBL; BC089384; AAH89384.1; -; mRNA.
DR   EMBL; M88083; AAA51928.1; -; Genomic_DNA.
DR   EMBL; M88080; AAA51928.1; JOINED; Genomic_DNA.
DR   EMBL; M88081; AAA51928.1; JOINED; Genomic_DNA.
DR   EMBL; M88082; AAA51928.1; JOINED; Genomic_DNA.
DR   EMBL; AI146555; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS8524.1; -. [P30279-1]
DR   PIR; A42822; A42822.
DR   RefSeq; NP_001750.1; NM_001759.3. [P30279-1]
DR   UniGene; Hs.376071; -.
DR   PDB; 6EI2; X-ray; 1.61 A; C=114-123.
DR   PDBsum; 6EI2; -.
DR   ProteinModelPortal; P30279; -.
DR   SMR; P30279; -.
DR   BioGrid; 107334; 90.
DR   CORUM; P30279; -.
DR   DIP; DIP-178N; -.
DR   IntAct; P30279; 8.
DR   MINT; P30279; -.
DR   STRING; 9606.ENSP00000261254; -.
DR   ChEMBL; CHEMBL3301386; -.
DR   iPTMnet; P30279; -.
DR   PhosphoSitePlus; P30279; -.
DR   BioMuta; CCND2; -.
DR   DMDM; 231741; -.
DR   EPD; P30279; -.
DR   MaxQB; P30279; -.
DR   PaxDb; P30279; -.
DR   PeptideAtlas; P30279; -.
DR   PRIDE; P30279; -.
DR   DNASU; 894; -.
DR   Ensembl; ENST00000261254; ENSP00000261254; ENSG00000118971. [P30279-1]
DR   GeneID; 894; -.
DR   KEGG; hsa:894; -.
DR   UCSC; uc001qmo.4; human. [P30279-1]
DR   CTD; 894; -.
DR   DisGeNET; 894; -.
DR   EuPathDB; HostDB:ENSG00000118971.7; -.
DR   GeneCards; CCND2; -.
DR   HGNC; HGNC:1583; CCND2.
DR   HPA; HPA049138; -.
DR   HPA; HPA054196; -.
DR   MalaCards; CCND2; -.
DR   MIM; 123833; gene.
DR   MIM; 615938; phenotype.
DR   neXtProt; NX_P30279; -.
DR   OpenTargets; ENSG00000118971; -.
DR   Orphanet; 83473; Megalencephaly - polymicrogyria - postaxial polydactyly - hydrocephalus.
DR   PharmGKB; PA26150; -.
DR   eggNOG; KOG0656; Eukaryota.
DR   eggNOG; ENOG410XRKC; LUCA.
DR   GeneTree; ENSGT00910000144111; -.
DR   HOGENOM; HOG000008182; -.
DR   HOVERGEN; HBG050837; -.
DR   InParanoid; P30279; -.
DR   KO; K10151; -.
DR   OMA; VVPTKKC; -.
DR   OrthoDB; EOG091G0URX; -.
DR   PhylomeDB; P30279; -.
DR   TreeFam; TF101004; -.
DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.
DR   Reactome; R-HSA-8934593; Regulation of RUNX1 Expression and Activity.
DR   SignaLink; P30279; -.
DR   SIGNOR; P30279; -.
DR   ChiTaRS; CCND2; human.
DR   GeneWiki; Cyclin_D2; -.
DR   GenomeRNAi; 894; -.
DR   PRO; PR:P30279; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000118971; -.
DR   CleanEx; HS_CCND2; -.
DR   ExpressionAtlas; P30279; baseline and differential.
DR   Genevisible; P30279; HS.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0097129; C:cyclin D2-CDK4 complex; IEA:Ensembl.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0071481; P:cellular response to X-ray; IEA:Ensembl.
DR   GO; GO:0007616; P:long-term memory; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0045737; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL.
DR   CDD; cd00043; CYCLIN; 1.
DR   InterPro; IPR013763; Cyclin-like.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR004367; Cyclin_C-dom.
DR   InterPro; IPR015451; Cyclin_D.
DR   InterPro; IPR006671; Cyclin_N.
DR   PANTHER; PTHR10177:SF66; PTHR10177:SF66; 1.
DR   Pfam; PF02984; Cyclin_C; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   SMART; SM00385; CYCLIN; 1.
DR   SMART; SM01332; Cyclin_C; 1.
DR   SUPFAM; SSF47954; SSF47954; 2.
DR   PROSITE; PS00292; CYCLINS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Cell division;
KW   Complete proteome; Cyclin; Cytoplasm; Disease mutation; Membrane;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN         1    289       G1/S-specific cyclin-D2.
FT                                /FTId=PRO_0000080437.
FT   DOMAIN       26    151       Cyclin N-terminal.
FT   MOD_RES     271    271       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     280    280       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P30280}.
FT   VAR_SEQ     138    209       EWELVVLGKLKWNLAAVTPHDFIEHILRKLPQQREKLSLIR
FT                                KHAQTFIALCATDFKFAMYPPSMIATGSVGA -> VMTGPF
FT                                LPSFLRFPLSPGQQYAFYHHCQSKFLGSRMTPPIEFTHLWA
FT                                IAHLIGNHCLFFVCSYYVPRLRAQH (in isoform 2).
FT                                {ECO:0000303|Ref.11}.
FT                                /FTId=VSP_057295.
FT   VAR_SEQ     210    289       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.11}.
FT                                /FTId=VSP_057296.
FT   VARIANT     268    268       G -> R (in dbSNP:rs3217921).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_018820.
FT   VARIANT     280    280       T -> A (in MPPH3; dbSNP:rs587777618).
FT                                {ECO:0000269|PubMed:24705253}.
FT                                /FTId=VAR_072370.
FT   VARIANT     280    280       T -> N (in MPPH3; dbSNP:rs587777620).
FT                                {ECO:0000269|PubMed:24705253}.
FT                                /FTId=VAR_072371.
FT   VARIANT     281    281       P -> L (in MPPH3; dbSNP:rs587777622).
FT                                {ECO:0000269|PubMed:24705253}.
FT                                /FTId=VAR_072372.
FT   VARIANT     281    281       P -> R (in MPPH3; dbSNP:rs587777622).
FT                                {ECO:0000269|PubMed:24705253}.
FT                                /FTId=VAR_072373.
FT   VARIANT     284    284       V -> G (in MPPH3; dbSNP:rs777786993).
FT                                {ECO:0000269|PubMed:24705253}.
FT                                /FTId=VAR_072374.
FT   CONFLICT    166    167       KL -> NV (in Ref. 10; AAA51928).
FT                                {ECO:0000305}.
FT   CONFLICT    224    224       T -> H (in Ref. 10; AAA51928).
FT                                {ECO:0000305}.
SQ   SEQUENCE   289 AA;  33067 MW;  E4E5FEF476D76D90 CRC64;
     MELLCHEVDP VRRAVRDRNL LRDDRVLQNL LTIEERYLPQ CSYFKCVQKD IQPYMRRMVA
     TWMLEVCEEQ KCEEEVFPLA MNYLDRFLAG VPTPKSHLQL LGAVCMFLAS KLKETSPLTA
     EKLCIYTDNS IKPQELLEWE LVVLGKLKWN LAAVTPHDFI EHILRKLPQQ REKLSLIRKH
     AQTFIALCAT DFKFAMYPPS MIATGSVGAA ICGLQQDEEV SSLTCDALTE LLAKITNTDV
     DCLKACQEQI EAVLLNSLQQ YRQDQRDGSK SEDELDQAST PTDVRDIDL
//
ID   CYPD_YEAST              Reviewed;         225 AA.
AC   P35176; D6VST3;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   23-MAY-2018, entry version 160.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase D;
DE            Short=PPIase D;
DE            EC=5.2.1.8;
DE   AltName: Full=Cyclophilin D;
DE   AltName: Full=Rotamase D;
DE   Flags: Precursor;
GN   Name=CPR5; Synonyms=CYP5, CYPD; OrderedLocusNames=YDR304C;
GN   ORFNames=D9740.14;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8377189; DOI=10.1006/jmbi.1993.1497;
RA   Frigerio G., Pelham H.R.B.;
RT   "A Saccharomyces cerevisiae cyclophilin resident in the endoplasmic
RT   reticulum.";
RL   J. Mol. Biol. 233:183-188(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169867;
RA   Jacq C., Alt-Moerbe J., Andre B., Arnold W., Bahr A., Ballesta J.P.G.,
RA   Bargues M., Baron L., Becker A., Biteau N., Bloecker H., Blugeon C.,
RA   Boskovic J., Brandt P., Brueckner M., Buitrago M.J., Coster F.,
RA   Delaveau T., del Rey F., Dujon B., Eide L.G., Garcia-Cantalejo J.M.,
RA   Goffeau A., Gomez-Peris A., Granotier C., Hanemann V., Hankeln T.,
RA   Hoheisel J.D., Jaeger W., Jimenez A., Jonniaux J.-L., Kraemer C.,
RA   Kuester H., Laamanen P., Legros Y., Louis E.J., Moeller-Rieker S.,
RA   Monnet A., Moro M., Mueller-Auer S., Nussbaumer B., Paricio N.,
RA   Paulin L., Perea J., Perez-Alonso M., Perez-Ortin J.E., Pohl T.M.,
RA   Prydz H., Purnelle B., Rasmussen S.W., Remacha M.A., Revuelta J.L.,
RA   Rieger M., Salom D., Saluz H.P., Saiz J.E., Saren A.-M., Schaefer M.,
RA   Scharfe M., Schmidt E.R., Schneider C., Scholler P., Schwarz S.,
RA   Soler-Mira A., Urrestarazu L.A., Verhasselt P., Vissers S., Voet M.,
RA   Volckaert G., Wagner G., Wambutt R., Wedler E., Wedler H., Woelfl S.,
RA   Harris D.E., Bowman S., Brown D., Churcher C.M., Connor R., Dedman K.,
RA   Gentles S., Hamlin N., Hunt S., Jones L., McDonald S., Murphy L.D.,
RA   Niblett D., Odell C., Oliver K., Rajandream M.A., Richards C.,
RA   Shore L., Walsh S.V., Barrell B.G., Dietrich F.S., Mulligan J.T.,
RA   Allen E., Araujo R., Aviles E., Berno A., Carpenter J., Chen E.,
RA   Cherry J.M., Chung E., Duncan M., Hunicke-Smith S., Hyman R.W.,
RA   Komp C., Lashkari D., Lew H., Lin D., Mosedale D., Nakahara K.,
RA   Namath A., Oefner P., Oh C., Petel F.X., Roberts D., Schramm S.,
RA   Schroeder M., Shogren T., Shroff N., Winant A., Yelton M.A.,
RA   Botstein D., Davis R.W., Johnston M., Andrews S., Brinkman R.,
RA   Cooper J., Ding H., Du Z., Favello A., Fulton L., Gattung S.,
RA   Greco T., Hallsworth K., Hawkins J., Hillier L.W., Jier M.,
RA   Johnson D., Johnston L., Kirsten J., Kucaba T., Langston Y.,
RA   Latreille P., Le T., Mardis E., Menezes S., Miller N., Nhan M.,
RA   Pauley A., Peluso D., Rifkin L., Riles L., Taich A., Trevaskis E.,
RA   Vignati D., Wilcox L., Wohldman P., Vaudin M., Wilson R.,
RA   Waterston R., Albermann K., Hani J., Heumann K., Kleine K.,
RA   Mewes H.-W., Zollner A., Zaccaria P.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome IV.";
RL   Nature 387:75-78(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A.,
RA   Raphael J., Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F.,
RA   Williamson J., Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G.,
RA   Kolodner R.D., LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-
RT   encoding clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes
CC       the cis-trans isomerization of proline imidic peptide bonds in
CC       oligopeptides.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen.
CC   -!- SIMILARITY: Belongs to the cyclophilin-type PPIase family. PPIase
CC       B subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X73142; CAA51658.1; -; mRNA.
DR   EMBL; U28374; AAB64740.1; -; Genomic_DNA.
DR   EMBL; AY557734; AAS56060.1; -; Genomic_DNA.
DR   EMBL; BK006938; DAA12143.1; -; Genomic_DNA.
DR   PIR; S38324; S38324.
DR   RefSeq; NP_010590.3; NM_001180612.3.
DR   ProteinModelPortal; P35176; -.
DR   SMR; P35176; -.
DR   BioGrid; 32356; 87.
DR   DIP; DIP-5222N; -.
DR   IntAct; P35176; 1.
DR   MINT; P35176; -.
DR   STRING; 4932.YDR304C; -.
DR   iPTMnet; P35176; -.
DR   SWISS-2DPAGE; P35176; -.
DR   MaxQB; P35176; -.
DR   PaxDb; P35176; -.
DR   PRIDE; P35176; -.
DR   EnsemblFungi; YDR304C; YDR304C; YDR304C.
DR   GeneID; 851898; -.
DR   KEGG; sce:YDR304C; -.
DR   EuPathDB; FungiDB:YDR304C; -.
DR   SGD; S000002712; CPR5.
DR   GeneTree; ENSGT00760000119072; -.
DR   HOGENOM; HOG000065981; -.
DR   InParanoid; P35176; -.
DR   KO; K03770; -.
DR   OMA; VYFDIKH; -.
DR   OrthoDB; EOG092C5DG5; -.
DR   BioCyc; YEAST:YDR304C-MONOMER; -.
DR   PRO; PR:P35176; -.
DR   Proteomes; UP000002311; Chromosome IV.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:SGD.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; ISS:SGD.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom_sf.
DR   InterPro; IPR024936; Cyclophilin-type_PPIase.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   PANTHER; PTHR11071; PTHR11071; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   PIRSF; PIRSF001467; Peptidylpro_ismrse; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Endoplasmic reticulum; Glycoprotein; Isomerase;
KW   Reference proteome; Rotamase; Signal.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    225       Peptidyl-prolyl cis-trans isomerase D.
FT                                /FTId=PRO_0000025488.
FT   DOMAIN       37    195       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   MOTIF       222    225       Prevents secretion from ER.
FT   CARBOHYD    139    139       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   225 AA;  25327 MW;  F4861424C8443B58 CRC64;
     MKLQFFSFIT LFACLFTTAI FAKEDTAEDP EITHKVYFDI NHGDKQIGRI VMGLYGLTTP
     QTVENFYQLT ISRDPKMGYL NSIFHRVIPN FMIQGGDFTH RSGIGGKSIF GNTFKDENFD
     VKHDKPGRLS MANRGKNTNG SQFFITTVPC PWLDGKHVVF GEVLDGMDVV HYIENVKTDS
     RNMPVKEVII VESGELETVP LDNKDAAKLQ EEIKAEASEA AHDEL
//
